data_1bm5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bm5 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.42 0.628 . . . . 1.8799999999999999 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 m-85 -99.73 -8.15 24.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.915 -0.772 . . . . 0.20000000000000001 108.915 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 23.0 t -66.62 116.39 7.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.405 -0.81 . . . . 1.52 111.352 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -169.89 37.65 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.609 -1.796 . . . . 0.16 108.609 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -96.62 169.88 9.58 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.537 -1.653 . . . . 0.57999999999999996 106.537 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.602 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -150.84 119.78 6.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.474 -1.29 . . . . 0.20999999999999999 112.385 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -114.12 113.72 25.09 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.829 -1.175 . . . . 2.27 107.829 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.472 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 7.3 tt -56.52 154.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.847 0.832 . . . . 1.4099999999999999 110.907 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.99 -31.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.979 -0.748 . . . . 1.1799999999999999 108.979 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -139.88 168.1 20.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 3.4700000000000002 108.753 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 t 177.74 152.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.3700000000000001 109.689 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.54 171.01 16.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.579 -0.701 . . . . 1.25 109.456 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.532 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 62.7 m-20 61.34 32.11 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 1.78 109.865 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.587 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.18 -62.65 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.54000000000000004 110.084 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -59.2 -36.51 75.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.268 -0.895 . . . . 2.2799999999999998 110.354 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 8.1 pt-20 -68.02 -28.62 67.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.274 -0.97 . . . . 2.0800000000000001 109.795 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 22' ' ' LEU . 43.4 tp -79.41 -21.34 45.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.191 -0.943 . . . . 1.3400000000000001 108.998 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 3.9 mt -89.5 -18.45 26.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.161 -0.962 . . . . 1.3500000000000001 108.596 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -84.13 -30.3 26.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.738 -1.208 . . . . 1.6599999999999999 107.738 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 22' ' ' LEU . 13.7 p -77.48 -41.02 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.875 -1.157 . . . . 1.1399999999999999 107.875 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.444 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.4 mp -65.51 -50.62 64.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.608 -0.886 . . . . 1.1799999999999999 108.608 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -142.25 12.46 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.136 -1.186 . . . . 0.71999999999999997 110.136 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -164.67 -34.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.655 -0.909 . . . . 2.1299999999999999 109.415 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.0 t30 -61.71 -159.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.806 . . . . 1.73 109.497 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -48.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.78 109.397 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.9 ttt -68.96 -24.46 64.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.54 -0.911 . . . . 2.6899999999999999 108.54 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -60.8 -27.75 68.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.763 -0.586 . . . . 1.9199999999999999 110.219 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -87.38 -45.19 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 2.8300000000000001 109.901 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -61.43 -25.09 66.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 3.2799999999999998 110.526 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.9 mt -76.5 -29.66 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.989 . . . . 2.0099999999999998 108.85 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -82.22 -26.04 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.561 -0.712 . . . . 1.1399999999999999 109.166 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.1 t -77.15 -36.15 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.768 -1.197 . . . . 1.1899999999999999 107.768 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -33.57 48.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.13 -1.063 . . . . 1.1799999999999999 108.13 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.31 94.91 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.912 -0.773 . . . . 1.22 108.912 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.84 -69.07 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.741 -0.837 . . . . 1.6899999999999999 108.741 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 44.18 46.78 7.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.608 -0.683 . . . . 1.76 109.348 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 67.34 73.46 0.36 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.436 -0.95 . . . . 3.52 108.436 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -74.58 157.13 44.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.596 2.198 . . . . 0.57999999999999996 110.437 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.67 173.15 6.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.447 -0.783 . . . . 1.05 109.488 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 54' ' ' THR . 13.3 t -156.15 160.74 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.89 -0.781 . . . . 1.0900000000000001 108.89 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 35.3 tt0 -146.68 113.11 5.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 1.47 108.746 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.463 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.9 mt -99.94 136.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.395 -0.816 . . . . 1.1599999999999999 110.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.544 ' HG3' ' HB3' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.23 111.06 20.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.297 -1.371 . . . . 1.8100000000000001 107.297 178.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.471 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.5 tt0 -98.52 122.33 41.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.985 -1.072 . . . . 1.6100000000000001 110.781 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -125.47 46.72 2.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.565 -0.902 . . . . 1.97 108.565 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.47 -131.33 10.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.749 -1.74 . . . . 0.40999999999999998 108.749 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.26 -0.31 19.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -1.179 . . . . 1.1299999999999999 109.555 179.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.3 m -98.81 131.53 44.86 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.897 -1.127 . . . . 1.02 108.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.471 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.3 m-85 -128.25 118.62 23.62 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.27000000000000002 110.049 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.0 t80 -102.24 144.71 30.42 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.082 -1.451 . . . . 0.73999999999999999 107.082 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.5 mt -141.79 107.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.684 -1.26 . . . . 1.26 110.562 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 1.6 tttt -104.72 115.46 30.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 2.3300000000000001 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.433 ' CG2' HG21 ' A' ' 41' ' ' VAL . 44.4 m -104.2 144.79 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 1.0800000000000001 109.1 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.65 134.57 30.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 0.93000000000000005 109.615 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.93 0.871 . . . . 1.3200000000000001 109.329 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.301 -0.629 . . . . 1.1699999999999999 109.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -101.71 172.69 6.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 1.4199999999999999 109.504 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 3.7 pt-20 -171.87 125.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 1.8500000000000001 109.332 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.0 pt -117.57 170.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 1.1200000000000001 109.289 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.667 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -161.25 130.53 4.68 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.942 . . . . 1.79 108.939 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.5 p90 -161.54 -172.93 3.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.17000000000000001 111.484 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 11.6 ptpt -128.91 152.74 48.21 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.027 -1.101 . . . . 2.1899999999999999 108.027 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.2 92.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 1.04 109.734 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.67 -26.97 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.519 -1.324 . . . . 0.27000000000000002 110.579 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -124.65 159.51 30.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.246 . . . . 2.3799999999999999 109.995 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 84' ' ' LEU . 27.2 mt-10 -87.51 167.96 13.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 1.6499999999999999 109.207 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 18.3 p90 -161.38 178.36 9.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.419 -0.801 . . . . 0.20999999999999999 109.713 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -107.56 143.31 36.17 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.374 -0.973 . . . . 1.1399999999999999 108.374 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.99 -176.21 5.07 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.462 -0.774 . . . . 1.5900000000000001 109.46 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -99.55 153.06 19.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.817 -0.808 . . . . 1.9199999999999999 108.817 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 t -90.18 -144.99 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 1.6299999999999999 109.529 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.96 -19.21 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.78 -1.2 . . . . 2.5 110.56 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.6 -44.21 10.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.063 -1.023 . . . . 2.0299999999999998 109.305 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.88 39.65 0.09 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.425 . . . . 0.53000000000000003 109.536 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HD2' ' HD2' ' A' ' 80' ' ' PRO . 1.5 mmm180 -129.41 152.91 80.36 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.469 -1.019 . . . . 3.1800000000000002 109.052 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD2' ' HD2' ' A' ' 79' ' ' ARG . 35.9 Cg_endo -78.41 139.71 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.164 1.909 . . . . 0.32000000000000001 110.537 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 13.1 p -160.58 144.06 13.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.79000000000000004 109.559 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -86.4 117.28 25.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.293 -1.003 . . . . 2.0299999999999998 108.293 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.9 t -99.88 165.63 11.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -0.787 . . . . 0.88 109.971 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HA ' HD11 ' A' ' 84' ' ' LEU . 46.0 tp -144.94 155.63 43.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.473 -1.306 . . . . 1.26 107.473 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 65' ' ' PHE . 38.8 t -148.41 128.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.37 -1.332 . . . . 1.0600000000000001 111.855 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.66 158.48 28.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.274 -1.38 . . . . 2.3999999999999999 107.274 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.438 ' CZ2' ' HE2' ' A' ' 93' ' ' MET . 82.6 m95 -81.36 166.53 20.36 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.959 -1.088 . . . . 0.16 110.178 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.7 tp10 -130.99 -42.2 1.11 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.845 -1.169 . . . . 1.1100000000000001 107.845 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -136.71 -153.31 0.49 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.75 -1.204 . . . . 0.46000000000000002 107.75 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.94 -18.94 49.17 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.118 -0.989 . . . . 2.1499999999999999 109.594 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -147.93 26.84 0.99 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.091 -1.005 . . . . 0.28000000000000003 110.355 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 57.5 tttt -134.38 109.33 8.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.73 -1.231 . . . . 1.9399999999999999 108.617 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.438 ' HE2' ' CZ2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.17 148.02 39.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.404 -0.81 . . . . 1.0900000000000001 110.073 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 110' ' ' THR . 1.6 t -100.32 172.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 1.05 108.774 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 53.6 t -147.99 140.12 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.018 . . . . 0.88 111.078 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -107.57 164.49 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.867 -1.531 . . . . 2.1099999999999999 106.867 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.413 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 4.5 tt0 -160.2 135.84 8.29 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.412 -1.315 . . . . 0.85999999999999999 111.554 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 56.0 pttt -145.16 144.28 30.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.134 -1.061 . . . . 2.9500000000000002 108.134 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 168.14 1.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.898 -1.126 . . . . 1.4099999999999999 110.808 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HG ' ' HA ' ' A' ' 81' ' ' CYS . 67.3 mt -102.78 -3.83 25.83 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.931 -1.137 . . . . 1.6000000000000001 107.931 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -153.88 148.2 25.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.942 -0.762 . . . . 3.2599999999999998 108.942 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.16 -162.71 22.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.079 -1.609 . . . . 2.4300000000000002 109.079 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.94 141.73 0.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.266 -1.138 . . . . 5.2599999999999998 109.645 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.45 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.856 -1.697 . . . . 2.0699999999999998 108.856 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.17 -176.15 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.448 2.099 . . . . 0.94999999999999996 110.056 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -137.18 136.8 38.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.232 -1.025 . . . . 1.75 108.232 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.91 145.2 46.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 1.0700000000000001 110.753 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.8 m -162.73 136.59 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.819 -1.178 . . . . 1.2 107.819 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 53.4 p-90 -142.96 176.7 8.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.26000000000000001 110.323 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.419 ' CG2' HG11 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -142.43 171.83 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.462 0.649 . . . . 1.05 109.599 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.487 ' HE1' ' CE2' ' A' ' 3' ' ' PHE . 13.3 ptm -153.97 125.83 7.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.584 -0.895 . . . . 2.4700000000000002 108.584 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -120.53 154.12 35.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 1.97 110.232 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.93 144.78 41.91 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.436 ' N ' HD11 ' A' ' 113' ' ' LEU . 41.4 p -93.26 161.55 14.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.854 -1.154 . . . . 1.0800000000000001 109.715 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -62.14 -19.49 63.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 2.7400000000000002 109.794 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.21 -26.46 23.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.8600000000000001 109.184 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.1 -9.68 8.4 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.847 -1.301 . . . . 0.17999999999999999 109.847 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -55.88 172.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 1.48 109.03 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.602 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.9 tt -144.84 113.21 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 1.04 110.18 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.74 154.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.914 -1.143 . . . . 1.3600000000000001 107.914 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.91 131.3 30.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.023 -1.048 . . . . 2.0 109.893 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.02 162.32 14.34 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.835 -1.172 . . . . 1.0900000000000001 107.835 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 13.9 mtp -142.4 159.09 42.92 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.164 -0.96 . . . . 1.3200000000000001 109.774 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.4 m -143.87 152.56 41.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.15 -0.685 . . . . 1.0800000000000001 109.15 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' ASP . . . -155.94 91.14 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 1.0800000000000001 109.586 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER 78.72 -76.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.924 -0.769 . . . . 1.21 108.924 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.25 22.67 1.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.36 179.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.197 -1.038 . . . . 1.1000000000000001 108.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.2 t -158.85 117.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.132 -1.027 . . . . 1.0900000000000001 110.077 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 t -99.14 107.74 20.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 1.04 109.321 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -99.71 145.98 27.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 109.507 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -151.02 122.69 8.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.503 -0.925 . . . . 2.3399999999999999 108.503 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.54 135.52 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.911 -1.118 . . . . 1.05 108.767 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.472 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.1 m-85 -124.37 124.35 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.508 -0.877 . . . . 1.01 109.916 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.575 -1.269 . . . . 1.04 107.575 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -44.52 125.88 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.99 110.565 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' ARG . 9.1 tt0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.101 -0.952 . . . . 2.2999999999999998 111.057 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.425 0.631 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 3.4 m-85 -99.4 -11.46 21.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -66.12 117.08 7.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 111.958 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.11 -174.09 38.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 3.9 m120 -95.02 171.73 8.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.3 m95 -151.22 128.79 11.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.513 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -120.41 115.82 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.1 tt -58.51 153.56 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.918 0.866 . . . . 0.0 111.2 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.48 -32.89 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -140.77 168.69 19.19 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t 177.95 147.09 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -144.39 168.79 19.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.433 0.635 . . . . 0.0 109.951 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.4 m-80 61.66 31.38 18.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.672 . . . . 0.0 109.66 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -75.11 -64.72 0.99 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.528 -0.732 . . . . 0.0 110.111 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 46.8 mt-10 -56.51 -34.83 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 110.959 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -69.81 -29.97 67.39 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.469 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.3 tp -77.46 -19.8 55.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 109.908 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 6.6 mt -89.99 -16.85 28.99 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.97 . . . . 0.0 109.291 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mtmm -86.19 -33.69 20.72 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 22' ' ' LEU . 14.7 p -72.07 -39.76 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.7 mp -68.56 -46.26 69.92 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.832 0.825 . . . . 0.0 109.266 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.12 -163.44 27.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.21 -40.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.894 -0.768 . . . . 0.0 109.75 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.5 t30 -59.74 -165.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.483 -0.761 . . . . 0.0 109.482 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.45 -48.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.29 -28.17 67.79 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.9 mm? -56.98 -20.31 23.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.78 -50.48 5.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.787 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -62.35 -19.84 63.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.7 . . . . 0.0 111.076 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.58 -29.86 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.195 -0.941 . . . . 0.0 108.752 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.66 -25.1 33.38 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 13.9 t -76.89 -37.08 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.61 49.04 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.03 93.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.36 -69.93 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m 47.79 49.84 16.17 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.498 0.666 . . . . 0.0 109.626 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mttp 66.37 72.49 0.43 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.9 166.4 30.11 Favored 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.974 1.782 . . . . 0.0 110.811 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.53 173.02 6.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.65 -0.657 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 53.5 t -154.55 165.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 41.4 tt0 -151.82 110.92 3.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.6 mt -97.83 138.43 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.806 0.812 . . . . 0.0 110.084 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttt -116.95 104.96 11.81 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.2 tt0 -97.34 125.37 41.9 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.33 54.15 1.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -126.18 8.35 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.5 -1.36 23.86 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.252 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -97.14 136.49 37.6 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.741 -1.224 . . . . 0.0 108.338 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -131.16 116.48 17.76 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.857 0.837 . . . . 0.0 109.297 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.8 t80 -102.29 148.95 24.83 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.432 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.3 mt -146.31 99.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.996 -1.065 . . . . 0.0 110.426 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -99.98 114.23 27.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 109.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -101.96 144.69 30.26 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.57 131.65 23.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.408 -0.807 . . . . 0.0 109.777 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.665 . . . . 0.0 109.446 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -102.07 172.85 6.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.767 . . . . 0.0 109.329 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -171.94 119.58 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.69 . . . . 0.0 109.736 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -110.43 170.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.35 133.87 5.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.292 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.475 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.1 p90 -161.98 -172.37 3.23 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.637 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -129.19 153.01 48.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.39 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.139 -0.976 . . . . 0.0 109.825 -178.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.12 -27.36 1.72 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.013 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -119.39 156.19 30.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -86.28 167.27 14.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.7 p90 -162.72 174.46 12.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.698 . . . . 0.0 109.634 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.94 147.5 26.85 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -161.74 179.49 8.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.679 -0.638 . . . . 0.0 109.324 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.72 128.1 55.05 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.265 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.6 t -63.86 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.1 -16.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 111.322 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.66 -40.85 14.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.28 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.51 43.49 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -130.52 148.89 71.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.661 -0.905 . . . . 0.0 108.937 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 140.51 17.15 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.454 1.436 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.6 p -160.86 141.69 11.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.682 -0.636 . . . . 0.0 109.633 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.45 114.27 26.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.21 176.21 5.33 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.947 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -152.93 153.32 32.76 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 6.6 t -140.75 127.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.989 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.07 155.3 34.7 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.436 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.6 m95 -78.01 173.16 12.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.058 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -135.11 -46.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -129.99 -152.67 0.52 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.25 -25.71 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -143.78 25.27 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 110.981 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -130.08 110.93 12.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.893 -1.13 . . . . 0.0 108.065 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.436 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.41 150.17 38.22 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.661 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.52 172.15 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.2 t -149.15 129.76 14.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.88 . . . . 0.0 110.752 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -101.04 162.37 12.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.44 139.76 10.78 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.878 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.05 149.74 37.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.69 165.59 3.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 111.085 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 mt -100.49 -2.97 31.77 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -153.36 134.31 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 108.807 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.87 -160.7 41.46 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -176.26 141.41 0.43 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.467 -1.019 . . . . 0.0 109.841 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.0 -85.39 0.05 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.53 -177.14 3.05 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.82 1.68 . . . . 0.0 109.857 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -134.44 138.51 44.83 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.03 145.25 48.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.008 0.909 . . . . 0.0 110.69 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.5 m -163.39 132.53 4.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -135.96 170.45 15.98 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.037 -1.039 . . . . 0.0 110.422 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 p -134.54 173.12 12.0 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.532 0.682 . . . . 0.0 109.722 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.7 ptp -158.6 139.57 12.97 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.0 pt-20 -140.64 144.87 35.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.366 -0.834 . . . . 0.0 109.1 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -105.02 144.79 31.34 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.402 ' N ' HD11 ' A' ' 113' ' ' LEU . 18.8 p -91.75 160.38 15.36 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.559 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.15 -19.87 55.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.62 -0.675 . . . . 0.0 110.337 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.11 -28.56 22.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.29 -8.79 7.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -57.94 171.3 0.53 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.046 -1.267 . . . . 0.0 108.95 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.5 tt -146.01 110.87 5.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.883 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 120' ' ' ILE . 14.3 tt -107.34 148.47 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -132.87 138.56 47.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.378 -0.826 . . . . 0.0 109.59 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.44 169.04 9.46 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.2 mtp -146.96 165.25 30.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.197 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -147.63 151.11 35.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.67 92.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.559 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.78 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -146.57 24.11 1.25 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.74 -179.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.4 t -157.69 118.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.722 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 t -99.53 113.67 26.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.8 m -109.34 147.94 31.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.737 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -152.59 117.59 5.15 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.9 t -80.18 139.17 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 108.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.7 m-85 -127.68 123.51 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.315 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.03 138.45 31.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.495 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.15 128.56 16.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.181 -0.95 . . . . 0.0 111.543 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 4.1 tt0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.322 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.517 0.675 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.4 m-85 -98.69 1.38 46.11 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 120.12 18.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 111.925 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -174.19 38.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.5 m120 -95.58 172.03 8.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -151.49 125.23 9.05 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.573 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -117.54 114.04 22.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 4.6 tt -52.63 147.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.661 0.744 . . . . 0.0 111.13 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.67 -25.11 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 122.003 -0.436 . . . . 0.0 110.24 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -152.57 177.43 10.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.164 -0.96 . . . . 0.0 110.469 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -179.47 166.05 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.79 24.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 111.708 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -161.14 27.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.607 -0.683 . . . . 0.0 110.197 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.45 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -65.44 -66.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 108.738 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 14.9 pt-20 -56.52 -28.64 60.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.35 -38.9 91.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.677 -0.639 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 36.7 tp -79.4 -16.13 56.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.773 -0.58 . . . . 0.0 110.137 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD13 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.83 -20.29 22.47 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.954 -1.091 . . . . 0.0 109.18 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.7 mmmt -83.03 -28.17 29.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -80.42 -40.64 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 122.127 0.965 . . . . 0.0 108.477 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.76 -50.02 59.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.919 0.866 . . . . 0.0 109.87 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.77 -154.21 25.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.79 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.0 t -150.7 -39.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 122.029 -0.689 . . . . 0.0 110.029 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -60.8 -160.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.38 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.09 -45.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.892 . . . . 0.0 109.775 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -66.12 -30.9 71.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.857 -0.527 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -84.87 -47.48 10.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.499 -0.751 . . . . 0.0 109.968 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -61.61 -21.86 64.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.691 -0.63 . . . . 0.0 111.06 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mt -81.26 -28.8 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 108.917 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.87 36.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.665 -0.647 . . . . 0.0 109.354 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 3.0 t -80.33 -44.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.21 85.54 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.41 -56.23 23.9 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.9 57.96 4.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.757 -0.589 . . . . 0.0 110.287 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 t -64.21 -43.11 96.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.697 -1.252 . . . . 0.0 107.726 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -151.36 74.19 8.2 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.5 142.11 39.83 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.846 1.697 . . . . 0.0 111.262 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.94 174.73 6.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 50.8 t -155.74 163.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -151.31 111.6 4.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.6 mp -98.08 135.81 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.019 0.914 . . . . 0.0 110.442 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 4.4 mttm -109.91 93.45 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.65 125.44 41.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.31 -0.869 . . . . 0.0 110.42 -176.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -132.65 56.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.55 -132.29 10.97 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.71 -4.36 27.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.384 -1.068 . . . . 0.0 110.441 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 m -96.79 134.08 40.54 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.656 -1.278 . . . . 0.0 108.476 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.7 m-85 -131.15 119.06 21.36 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.687 0.756 . . . . 0.0 109.336 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 15.0 t80 -103.15 150.46 23.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -148.58 104.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.94 -1.1 . . . . 0.0 110.97 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -104.81 113.11 26.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 108.864 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -102.49 145.5 29.49 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -142.77 119.15 10.91 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.674 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 169.17 12.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.772 . . . . 0.0 109.724 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.34 111.35 1.22 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.489 -0.757 . . . . 0.0 109.699 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 pt -116.53 165.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.58 132.51 4.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 47.3 p90 -161.67 -172.7 3.43 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.404 1.097 . . . . 0.0 112.445 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.76 153.54 48.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.32 93.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.133 -0.98 . . . . 0.0 109.681 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.31 -22.91 1.55 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.906 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.69 155.63 37.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.22 -1.165 . . . . 0.0 110.219 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.64 166.41 15.38 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.17 174.57 12.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -105.55 144.22 32.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -162.31 -174.79 4.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -99.75 159.91 14.7 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -97.31 -142.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.13 -19.2 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.783 -1.198 . . . . 0.0 110.824 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.67 -37.11 13.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.486 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.71 45.14 0.15 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -133.3 153.54 80.65 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 121.691 -0.888 . . . . 0.0 109.447 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.0 142.04 17.05 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.767 1.645 . . . . 0.0 110.505 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -161.26 143.06 11.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.657 -0.652 . . . . 0.0 109.517 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 117.33 28.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.48 166.54 11.11 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.266 0.555 . . . . 0.0 109.988 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.77 153.02 37.56 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 24.8 t -143.4 136.13 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.417 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.21 157.22 41.45 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CE2' HG23 ' A' ' 67' ' ' VAL . 79.6 m95 -81.15 172.83 13.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.019 0.914 . . . . 0.0 110.627 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.69 -45.98 0.6 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.9 p -131.81 -153.63 0.57 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -76.47 -26.97 55.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.801 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -143.46 28.53 1.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -130.54 110.37 11.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.989 -1.069 . . . . 0.0 108.188 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.431 ' CE ' ' CE2' ' A' ' 50' ' ' PHE . 1.3 ptp -117.43 147.5 42.64 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.728 0.775 . . . . 0.0 110.572 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.73 171.5 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.0 t -146.83 137.43 23.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -108.77 156.13 19.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -154.65 142.2 19.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.974 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -143.73 152.05 40.78 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.17 168.03 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.755 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 mt -99.6 -5.75 28.51 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 137.2 14.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 108.621 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.85 -163.12 37.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -175.96 140.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.43 -1.041 . . . . 0.0 109.995 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.35 -86.83 0.06 OUTLIER Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.83 -176.91 2.87 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.783 1.655 . . . . 0.0 109.643 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -131.41 139.87 49.52 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.12 144.63 48.46 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.172 0.987 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 m -162.92 131.8 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 48.9 p-90 -137.12 172.79 12.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.143 -0.973 . . . . 0.0 110.231 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.8 p -135.92 174.16 10.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.542 0.687 . . . . 0.0 109.959 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.429 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 6.9 ptm -157.95 124.31 4.79 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -119.54 147.64 44.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.488 -0.758 . . . . 0.0 109.889 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.01 143.52 39.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 p -93.55 159.48 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -59.28 -21.9 60.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.96 -30.19 24.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.3 -9.82 6.56 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.9 173.91 0.13 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.084 -1.245 . . . . 0.0 109.349 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.5 tt -148.17 111.14 4.83 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.124 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -106.82 151.47 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.94 147.08 52.44 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.423 -0.798 . . . . 0.0 109.439 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 170.36 12.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 9.5 mtp -150.6 167.77 26.29 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.675 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.5 m -149.31 151.31 33.94 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.82 94.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.53 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.15 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.19 23.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.23 -178.86 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.5 t -157.86 118.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.589 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 t -97.9 121.52 39.92 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -119.93 134.62 55.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.224 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -139.86 108.43 5.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -72.39 140.38 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.2 m-85 -129.07 128.79 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.2 137.63 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -49.48 128.33 17.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.233 -0.917 . . . . 0.0 111.687 -178.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.4 tm-20 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.807 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.45 0.643 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.454 ' CD2' ' CE ' ' A' ' 111' ' ' MET . 3.3 m-85 -99.06 -2.13 37.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.7 p -71.82 118.74 15.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.955 . . . . 0.0 111.943 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.64 -173.62 38.04 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 4.6 m120 -95.36 170.67 9.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.49 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.4 m95 -150.91 128.12 11.23 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.488 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -121.66 116.36 24.42 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.4 tt -59.48 141.84 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.525 0.678 . . . . 0.0 110.294 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -119.52 -23.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.875 -0.516 . . . . 0.0 110.101 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -145.66 176.73 9.41 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 176.29 165.43 0.43 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -159.32 25.77 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.091 -1.006 . . . . 0.0 111.292 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.4 m-20 -160.85 29.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.665 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.49 -65.66 0.65 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 0.0 109.008 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.6 mt-10 -56.68 -27.07 58.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.81 -40.9 97.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.667 -0.645 . . . . 0.0 109.791 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.75 -16.73 58.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.662 -0.649 . . . . 0.0 110.091 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.401 HD12 ' CE1' ' A' ' 15' ' ' PHE . 7.7 mt -89.43 -19.24 25.39 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.055 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.1 mmmt -85.57 -28.6 24.76 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.57 -41.06 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.69 -53.13 45.29 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.018 0.913 . . . . 0.0 108.935 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.75 -146.26 17.13 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -155.93 -43.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -56.95 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.518 -0.739 . . . . 0.0 109.56 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.83 -44.49 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.416 -0.802 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.1 ttm -66.3 -27.27 67.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.71 -41.9 82.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.675 -0.641 . . . . 0.0 110.35 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -71.36 -42.66 68.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -62.44 -20.24 64.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.755 -0.59 . . . . 0.0 111.115 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.47 -30.04 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 108.879 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.99 -25.6 32.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.7 t -79.13 -35.93 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.69 -36.17 51.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.91 79.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.42 -67.56 0.47 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 49.23 52.08 15.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 67.36 73.7 0.36 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.46 158.35 54.23 Favored 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.017 1.811 . . . . 0.0 110.795 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.51 173.13 6.45 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.743 -0.598 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 48.8 t -155.0 164.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.3 tt0 -148.68 111.53 4.82 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -97.9 132.59 42.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.786 0.803 . . . . 0.0 110.054 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -111.78 106.49 15.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -97.47 123.97 41.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.064 -1.022 . . . . 0.0 111.176 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -123.62 55.22 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -126.03 8.15 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -1.09 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -1.034 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.44 136.05 37.47 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.782 -1.199 . . . . 0.0 108.551 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.9 m-85 -130.96 115.66 16.8 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.6 t80 -102.29 148.17 25.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -145.17 99.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.019 -1.05 . . . . 0.0 110.389 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -99.25 113.71 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.766 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 m -100.53 144.7 29.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.799 . . . . 0.0 108.964 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 136.9 32.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.46 -0.775 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.916 0.865 . . . . 0.0 109.708 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -101.84 173.87 6.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.8 . . . . 0.0 109.55 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -172.27 118.96 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.773 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -108.56 169.55 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.483 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 132.82 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.764 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.1 p90 -161.92 -172.21 3.18 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.069 0.938 . . . . 0.0 111.739 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.53 154.53 48.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.58 95.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.187 -0.945 . . . . 0.0 109.636 -178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.66 -21.8 0.62 Allowed Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.606 -1.283 . . . . 0.0 111.038 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.82 163.57 29.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -1.144 . . . . 0.0 110.714 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -86.28 169.31 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.4 p90 -162.6 174.39 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -103.14 144.78 30.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -161.89 178.65 8.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.84 151.61 21.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -88.26 -142.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.485 -0.759 . . . . 0.0 109.125 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.2 -19.77 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.741 -1.224 . . . . 0.0 110.657 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.75 -41.31 12.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 44.25 0.1 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -131.63 147.19 65.04 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.666 -0.902 . . . . 0.0 108.89 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -79.8 142.72 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.441 1.427 . . . . 0.0 110.237 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.3 p -161.05 143.24 12.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.645 -0.66 . . . . 0.0 109.569 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -89.64 114.36 25.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.6 t -98.91 176.29 5.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.706 -0.621 . . . . 0.0 109.71 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HA ' HD11 ' A' ' 84' ' ' LEU . 50.1 tp -150.32 154.41 37.79 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 10.1 t -143.33 129.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.089 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.94 155.46 39.55 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.9 m95 -79.67 173.16 12.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.39 -46.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -130.7 -153.61 0.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.08 -25.77 52.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.08 26.85 1.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 110.892 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -132.15 109.58 10.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.0 108.078 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.454 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.6 OUTLIER -115.66 150.36 36.87 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.243 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.09 173.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 48.4 t -149.81 135.84 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.04 163.3 12.65 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -160.92 138.69 9.42 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.798 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -152.46 144.55 23.82 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.74 164.27 2.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 110.651 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.87 5.6 26.58 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -153.75 113.14 3.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.99 -163.83 45.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -176.34 140.97 0.4 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.393 -1.063 . . . . 0.0 110.066 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.67 -86.95 0.06 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.31 -176.49 2.59 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.846 1.697 . . . . 0.0 109.695 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -131.55 139.87 49.33 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 145.15 49.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.121 0.963 . . . . 0.0 110.84 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.88 137.04 6.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -142.79 175.44 9.82 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.986 -1.085 . . . . 0.0 110.56 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.2 p -137.91 172.67 12.59 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.551 0.691 . . . . 0.0 110.028 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' A' ' 3' ' ' PHE . 21.8 ptm -157.84 128.59 6.43 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.9 pt-20 -131.67 154.89 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.586 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.13 144.71 41.05 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -91.99 162.19 14.48 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.585 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -61.36 -21.1 63.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.22 -26.58 24.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.15 -8.13 8.57 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.7 172.94 0.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.113 -1.227 . . . . 0.0 109.234 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.0 tt -144.92 110.36 5.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.501 -0.749 . . . . 0.0 109.618 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.404 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.0 tt -106.08 145.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.22 133.07 46.28 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.713 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.78 165.97 11.28 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 12.1 mtp -144.14 164.52 30.46 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.383 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 m -147.4 151.4 36.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.68 95.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.457 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.17 -80.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.33 24.89 1.25 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.525 -0.734 . . . . 0.0 109.168 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.34 -178.93 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.94 118.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 4.0 t -98.49 112.18 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -106.32 143.61 34.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -150.5 105.23 3.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.47 133.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 30.1 m-85 -121.2 123.5 42.41 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.075 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.32 139.71 26.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.59 128.08 16.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.221 -0.925 . . . . 0.0 111.351 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.245 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.426 ' CG ' HD22 ' A' ' 113' ' ' LEU . 4.9 m-85 -99.42 -11.36 21.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -67.78 117.42 9.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 111.841 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.45 -173.46 38.73 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 4.9 m120 -95.45 170.84 9.08 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.45 128.12 10.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.666 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -122.48 116.32 23.74 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.0 tt -58.94 142.07 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.587 0.708 . . . . 0.0 110.474 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.3 -24.26 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.959 -0.463 . . . . 0.0 110.068 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -143.25 174.83 10.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.277 -0.889 . . . . 0.0 110.08 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 178.42 163.1 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.34 24.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 111.457 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 76.0 m-20 -160.59 27.37 0.15 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.1 t80 -65.16 -64.76 0.79 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 110.192 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 27.2 tt0 -55.86 -31.0 62.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.581 -0.699 . . . . 0.0 111.296 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 7.0 pt-20 -73.1 -31.51 64.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.51 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 tp -75.58 -19.42 59.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.828 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 15' ' ' PHE . 6.6 mt -90.17 -18.18 26.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 109.388 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.8 mtmt -84.6 -32.63 23.64 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.61 -39.96 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.04 -45.59 73.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.756 0.788 . . . . 0.0 109.458 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.94 -159.97 27.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 t -144.61 -41.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.982 -0.717 . . . . 0.0 109.722 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.4 t30 -60.64 -162.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.63 -49.02 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -67.41 -27.73 67.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -58.15 -19.62 34.25 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.79 -0.569 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.72 -49.26 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.16 -0.962 . . . . 0.0 109.59 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -62.25 -20.25 64.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.645 -0.659 . . . . 0.0 110.793 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.6 mt -78.42 -29.64 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 108.831 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.16 -25.62 34.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 11.2 t -77.52 -36.98 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.41 -34.16 48.2 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.64 93.97 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.33 -67.87 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.67 52.41 14.96 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 67.25 73.41 0.37 Allowed Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.61 155.9 58.44 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 C-N-CA 122.055 1.837 . . . . 0.0 110.829 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.47 172.99 6.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.401 HG21 ' CG2' ' A' ' 54' ' ' THR . 53.4 t -155.49 164.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.11 110.6 3.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.447 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 1.8 mp -98.65 141.99 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.817 0.818 . . . . 0.0 110.543 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.36 111.93 18.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.36 117.73 33.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.97 -1.081 . . . . 0.0 111.026 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.63 50.05 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -125.43 8.11 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -75.66 -1.82 26.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.431 -1.04 . . . . 0.0 110.052 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 m -96.35 138.4 34.01 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.816 -1.177 . . . . 0.0 108.636 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -134.18 117.68 16.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.795 0.807 . . . . 0.0 109.217 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -103.43 147.98 26.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.6 mt -144.01 104.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 C-N-CA 118.974 -1.091 . . . . 0.0 111.445 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.13 113.61 26.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.514 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.401 ' CG2' HG21 ' A' ' 41' ' ' VAL . 31.9 m -103.28 142.35 34.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.87 143.16 38.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.401 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.917 0.865 . . . . 0.0 109.43 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 165.31 23.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 109.974 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -164.12 118.69 1.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.87 165.99 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 108.93 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.15 127.59 3.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 51.9 p90 -162.18 -172.64 3.29 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.009 -1.076 . . . . 0.0 111.763 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 154.65 48.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.57 95.05 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.92 . . . . 0.0 109.828 -178.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.87 -20.04 0.67 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.13 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.02 162.18 33.19 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.185 -1.185 . . . . 0.0 110.841 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.43 165.63 16.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.7 p90 -161.75 173.84 14.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -101.73 144.77 30.01 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -162.18 -178.28 6.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -99.66 155.69 17.48 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.7 t -92.91 -142.33 0.21 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 109.325 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.2 -21.01 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.717 -1.239 . . . . 0.0 110.837 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.75 -40.0 13.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.67 45.19 0.11 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -131.96 150.62 76.64 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.708 -0.878 . . . . 0.0 109.161 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.79 141.68 17.26 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.676 1.584 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.7 p -161.19 141.46 10.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.645 -0.659 . . . . 0.0 109.862 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -89.7 114.17 25.79 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -99.68 174.05 6.42 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.301 0.572 . . . . 0.0 110.416 -178.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -148.05 152.39 37.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.451 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 7.0 t -142.36 126.89 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.976 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -122.33 155.2 36.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.441 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 79.0 m95 -77.42 176.22 9.06 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.892 0.854 . . . . 0.0 110.242 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -138.44 -46.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.1 p -131.01 -152.51 0.51 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.6 -25.42 45.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -142.8 27.63 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -132.98 113.31 12.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.935 -1.103 . . . . 0.0 108.283 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.441 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.6 ptm -120.37 150.44 40.75 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.521 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.82 172.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.0 t -149.89 134.81 17.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -103.95 165.21 11.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -160.87 138.93 9.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.84 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -144.84 148.9 34.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.86 166.86 3.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 0.0 110.994 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 mt -101.54 -3.56 28.28 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -150.8 130.34 13.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 108.892 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.93 -157.4 42.66 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -176.43 140.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.47 -1.018 . . . . 0.0 109.863 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.39 -87.3 0.06 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.64 -176.82 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 C-N-CA 121.8 1.666 . . . . 0.0 109.645 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -130.66 138.52 50.1 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.67 144.83 48.88 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.189 0.995 . . . . 0.0 110.734 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.9 m -163.44 136.67 5.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -139.21 172.38 12.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -136.43 170.16 16.5 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.476 0.655 . . . . 0.0 109.848 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.1 ptp -154.01 137.16 15.6 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -134.01 146.26 50.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.392 -0.817 . . . . 0.0 109.225 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.7 141.53 42.18 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -90.27 160.65 16.05 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.791 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -21.45 61.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.657 -0.652 . . . . 0.0 110.078 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -85.08 -29.49 24.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.99 -9.21 7.12 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.12 172.2 0.31 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.158 -1.201 . . . . 0.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.4 tt -145.14 107.98 4.49 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.097 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.87 150.73 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.03 133.68 39.64 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.59 8.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 11.8 mtp -148.41 166.78 27.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.742 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -150.07 148.07 28.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.56 93.05 1.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.521 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.79 -78.26 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -147.07 23.72 1.18 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.31 -179.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.7 t -156.41 119.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.46 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.2 t -98.39 118.46 35.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -112.92 143.37 44.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.762 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -150.82 105.01 3.22 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.2 133.05 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.423 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.4 m-85 -120.83 120.81 36.65 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.154 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.14 139.98 22.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.98 128.48 18.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.196 -0.94 . . . . 0.0 111.322 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.342 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.332 0.587 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 m-85 -99.26 -7.85 25.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.3 p -69.11 117.54 10.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.955 . . . . 0.0 111.9 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.12 38.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.0 m120 -95.72 169.39 10.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.08 122.23 7.73 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.687 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -114.28 112.82 23.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.9 tt -56.53 146.93 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 110.67 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.64 -23.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.393 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.46 173.46 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t 169.57 168.51 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.66 28.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.013 -1.054 . . . . 0.0 112.02 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.01 31.69 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.205 -0.934 . . . . 0.0 109.106 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -68.0 -62.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 110.019 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.49 -31.15 67.59 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 111.097 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -71.18 -26.55 63.01 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.696 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 22' ' ' LEU . 12.9 tp -81.76 -21.38 37.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.424 -0.797 . . . . 0.0 109.975 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -86.94 -17.62 32.72 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.099 -1.001 . . . . 0.0 109.305 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.6 mtmt -85.05 -34.64 22.24 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -73.69 -40.54 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 18' ' ' LEU . 5.0 mp -67.32 -46.11 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.828 0.823 . . . . 0.0 108.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -162.59 27.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.98 -37.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.831 -0.805 . . . . 0.0 110.183 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.2 t30 -62.0 -158.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.443 -0.786 . . . . 0.0 109.163 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.07 -47.56 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 109.316 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 ttt -68.08 -28.42 67.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -59.39 -19.26 45.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.737 -0.602 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -47.4 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 109.876 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -62.73 -22.58 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.612 -0.68 . . . . 0.0 110.569 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.42 -28.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.842 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.59 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 11.3 t -76.67 -38.9 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.62 57.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.4 95.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.63 -65.57 0.66 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.627 -0.671 . . . . 0.0 109.237 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p 47.89 55.3 8.76 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.671 0.748 . . . . 0.0 109.082 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 69.29 72.73 0.32 Allowed Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.67 162.66 41.42 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.146 1.898 . . . . 0.0 110.808 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.97 172.8 6.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.711 -0.618 . . . . 0.0 109.432 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -154.07 165.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -150.69 110.75 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mt -98.34 137.1 26.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.677 0.751 . . . . 0.0 110.335 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.63 112.08 21.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.4 tt0 -98.24 121.7 40.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.008 -1.057 . . . . 0.0 111.106 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -121.52 51.77 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -125.4 7.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.27 -0.95 24.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.415 -1.05 . . . . 0.0 110.102 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 m -96.68 140.93 30.56 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.789 -1.194 . . . . 0.0 108.353 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 95.8 m-85 -136.07 115.33 12.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.923 0.868 . . . . 0.0 109.718 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.1 t80 -101.04 147.03 26.67 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 3.0 mt -142.31 100.92 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.989 -1.07 . . . . 0.0 110.327 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -98.8 114.64 27.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.535 -0.728 . . . . 0.0 109.961 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -99.22 142.2 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 p -136.54 118.32 15.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.357 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.455 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.3 p -92.43 176.04 6.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.102 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.4 139.81 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.139 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 pt -128.66 170.07 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.504 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.55 130.76 3.96 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' CG2' ' A' ' 85' ' ' VAL . 50.9 p90 -161.58 -172.2 3.25 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.896 -1.121 . . . . 0.0 112.062 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -128.89 153.31 47.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.44 96.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.529 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.6 -32.28 1.61 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.56 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -113.64 155.8 24.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -1.069 . . . . 0.0 109.893 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -86.33 167.72 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.461 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.2 p90 -162.14 173.08 14.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.551 -0.718 . . . . 0.0 109.809 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -104.24 144.52 31.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -162.13 -175.75 4.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -99.53 156.88 16.81 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.4 t -94.39 -142.1 0.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 109.22 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.45 -20.57 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.712 -1.242 . . . . 0.0 110.828 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.82 -38.18 13.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 109.428 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 44.13 0.15 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -130.28 151.9 79.26 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 121.656 -0.908 . . . . 0.0 109.256 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.66 141.06 17.1 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.644 1.563 . . . . 0.0 110.345 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.6 p -160.75 140.79 11.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.683 -0.636 . . . . 0.0 109.692 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -90.85 113.96 26.26 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -102.74 177.76 4.76 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.224 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.3 tp -152.94 153.15 32.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 10.0 t -141.37 127.72 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.874 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 155.78 33.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.459 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 84.2 m95 -78.69 172.38 13.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 109.851 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -133.44 -47.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 p -132.17 -151.69 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.98 -26.87 48.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.308 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -140.2 23.93 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 111.466 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -131.83 111.69 11.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.749 -1.22 . . . . 0.0 108.451 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.459 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.9 ptm -116.71 149.26 40.13 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.119 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.63 173.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -149.45 130.35 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -101.97 163.45 12.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -160.34 143.8 13.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.006 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -146.18 151.38 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.23 166.66 5.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 mt -101.03 -4.11 28.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 108.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.6 -157.03 42.09 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -177.34 140.43 0.28 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.514 -0.992 . . . . 0.0 109.529 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.19 -85.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.59 -176.84 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.82 1.68 . . . . 0.0 109.956 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -136.12 141.26 44.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.05 145.09 48.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.125 0.964 . . . . 0.0 110.596 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 p -162.79 129.65 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -136.57 173.69 11.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.226 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 p -135.84 172.43 13.03 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.54 0.686 . . . . 0.0 109.901 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.449 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 9.8 ptm -155.91 124.84 6.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.94 152.7 39.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.899 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.75 142.13 46.93 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.8 p -91.77 160.09 15.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -60.45 -21.8 62.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -83.76 -29.7 27.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.137 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.47 -9.01 7.36 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -57.32 172.44 0.32 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.12 -1.223 . . . . 0.0 109.061 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -145.62 110.13 5.04 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.86 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 120' ' ' ILE . 11.6 tt -105.99 148.97 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.58 145.95 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.668 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.59 169.65 11.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.419 -1.696 . . . . 0.0 106.419 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 35.4 mtp -151.66 164.26 37.32 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.574 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 m -146.34 152.51 39.22 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.94 97.61 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.635 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.97 -79.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.43 24.27 1.01 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.566 -0.709 . . . . 0.0 109.342 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 m -119.54 -179.73 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.2 t -158.05 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.593 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.27 131.65 45.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 97.2 m -123.39 127.58 48.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -125.18 102.56 7.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.68 134.13 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.5 m-85 -124.15 129.99 51.77 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.604 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.91 138.45 40.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -48.73 125.28 9.81 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 0.0 111.285 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.6 179.647 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 4.3 m-85 -98.62 -0.85 42.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -71.12 117.14 12.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.128 -0.983 . . . . 0.0 112.023 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.5 -172.18 38.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.78 168.26 10.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.8 m95 -151.88 125.0 8.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.493 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -120.86 115.36 23.09 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 tt -56.29 139.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.556 0.693 . . . . 0.0 110.582 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.15 -24.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.852 -0.53 . . . . 0.0 109.823 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -142.93 174.41 10.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.356 -0.84 . . . . 0.0 110.075 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t 178.86 164.51 0.84 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.45 25.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 74.8 m-20 -160.5 27.76 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.709 -0.619 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -63.49 -66.94 0.47 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.1 tt0 -55.54 -27.78 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.488 -0.757 . . . . 0.0 109.672 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -63.6 -40.56 97.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.674 -0.641 . . . . 0.0 110.205 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 tp -79.59 -16.44 55.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 8.2 mt -90.67 -17.49 26.72 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.97 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.3 mmmt -85.6 -30.45 23.3 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.55 -40.2 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.37 -47.5 70.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.86 0.838 . . . . 0.0 109.374 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -156.12 26.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.2 -36.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.925 -0.75 . . . . 0.0 110.311 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.7 t30 -62.41 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.0 -47.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.661 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.7 ttt -69.58 -33.13 72.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 6.1 mp -48.05 -34.62 9.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.937 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.73 -42.88 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -61.96 -19.8 63.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.687 -0.633 . . . . 0.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 31' ' ' ILE . 47.4 mm -80.31 -29.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 108.839 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.47 -25.77 33.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 10.7 t -77.33 -39.86 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.5 62.88 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.57 94.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.01 -67.62 0.44 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.36 55.22 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.4 mttm 65.08 73.35 0.43 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.5 Cg_endo -71.46 151.95 59.8 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.031 1.821 . . . . 0.0 110.822 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.87 173.64 6.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.4 t -155.8 164.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -147.77 111.98 5.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -98.01 131.47 44.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.805 0.812 . . . . 0.0 110.348 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -110.82 107.83 17.45 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.6 tt0 -97.63 123.81 41.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.114 -0.991 . . . . 0.0 111.177 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -124.17 54.43 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.41 -126.93 8.65 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -76.18 -1.09 24.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -1.049 . . . . 0.0 110.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m -96.81 136.8 36.84 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.763 -1.211 . . . . 0.0 108.394 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.5 m-85 -131.81 116.04 16.73 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.877 0.846 . . . . 0.0 109.346 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.1 t80 -101.42 147.98 25.71 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -144.77 100.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.982 -1.074 . . . . 0.0 110.328 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 112.1 24.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 m -99.1 146.31 26.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p -139.3 132.16 29.26 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 39' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.229 0.538 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.19 176.97 4.9 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.0 pt-20 -168.4 124.25 0.99 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.908 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.68 170.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p-10 -162.74 133.99 5.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.133 -0.98 . . . . 0.0 109.467 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.3 p90 -161.92 -171.66 2.97 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.372 1.082 . . . . 0.0 112.615 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -129.62 152.65 48.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.64 95.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.19 -29.86 1.49 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.733 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -119.24 157.32 28.27 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.302 -1.117 . . . . 0.0 110.035 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -86.14 169.15 13.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.594 -0.691 . . . . 0.0 109.22 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.5 p90 -162.13 174.09 13.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 0.0 109.765 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.55 145.87 29.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -162.14 -177.71 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.472 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -104.66 157.75 16.97 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.211 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -170.4 2.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.333 -0.854 . . . . 0.0 110.19 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.92 -20.71 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.89 -0.506 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.54 -41.66 13.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.73 43.63 0.2 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -127.9 152.19 76.89 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 121.628 -0.925 . . . . 0.0 109.142 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.61 137.36 14.43 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.336 1.357 . . . . 0.0 110.21 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.8 p -160.69 142.47 12.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.656 -0.653 . . . . 0.0 109.466 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.79 117.35 25.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.5 t -99.14 166.52 11.2 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.3 tp -147.28 153.97 40.4 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 21.3 t -145.79 131.16 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.019 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -125.63 159.9 31.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.428 ' CE2' HG23 ' A' ' 67' ' ' VAL . 87.3 m95 -82.86 170.04 15.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.4 -46.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 p -131.18 -154.28 0.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -77.66 -25.53 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.594 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -141.85 26.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -131.42 108.77 9.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.885 -1.134 . . . . 0.0 108.316 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.423 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 1.5 ptp -113.88 145.96 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.513 -0.742 . . . . 0.0 110.286 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.91 172.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 54.0 t -148.4 139.59 23.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.29 163.15 13.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.413 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 7.3 tt0 -160.5 137.99 9.45 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.729 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -144.5 147.52 33.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.46 166.83 2.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.0 mt -101.17 -3.43 29.13 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -156.01 139.94 16.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 108.79 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.17 -162.68 35.68 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -176.49 139.33 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.41 -1.053 . . . . 0.0 109.947 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.75 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.67 -176.88 2.65 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.824 1.683 . . . . 0.0 109.663 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -132.61 141.38 48.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.44 144.42 49.52 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.163 0.982 . . . . 0.0 110.861 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -163.67 138.66 6.19 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -140.66 172.52 12.6 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.953 -1.092 . . . . 0.0 110.729 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.9 p -134.16 169.16 17.59 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 109.422 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.1 ttt -154.53 122.01 5.74 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -118.82 154.62 32.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.478 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -118.7 144.96 45.88 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.3 p -96.83 161.36 13.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.791 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -22.38 63.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -84.36 -27.94 27.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.295 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.52 -11.1 7.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.87 172.12 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.067 -1.255 . . . . 0.0 109.073 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.475 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 8.0 tt -149.72 113.64 5.1 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.648 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -98.62 155.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.81 111.72 8.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.35 168.63 9.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 7.9 mtp -145.73 169.19 18.97 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.64 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.0 m -151.31 150.48 30.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.34 91.41 1.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.448 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -78.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.24 23.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.572 -0.705 . . . . 0.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.68 -179.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.8 t -156.7 119.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.474 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 3.2 t -98.08 109.92 22.59 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 m -101.48 147.0 26.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -152.19 97.26 2.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.48 129.97 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -116.47 124.3 49.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.49 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.83 139.0 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.474 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -48.1 125.15 8.69 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.051 -0.976 . . . . 0.0 111.66 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.653 0.74 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.467 ' CD2' ' CE ' ' A' ' 111' ' ' MET . 3.5 m-85 -99.56 1.22 43.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.665 -0.647 . . . . 0.0 109.573 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -73.04 118.19 15.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.117 -0.989 . . . . 0.0 111.939 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.47 -172.52 38.57 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.3 m120 -95.16 168.29 10.84 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.8 m95 -150.11 123.23 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.552 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -118.58 113.5 21.35 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.8 tt -56.93 145.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.711 0.767 . . . . 0.0 110.806 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.55 -23.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -141.54 175.62 9.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 0.0 110.468 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 169.15 168.04 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.06 30.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.877 -1.139 . . . . 0.0 112.036 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.52 32.95 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.195 -0.941 . . . . 0.0 108.975 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -66.35 -63.73 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.55 -0.719 . . . . 0.0 110.331 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 3.7 mt-10 -58.23 -27.17 63.71 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.497 -0.752 . . . . 0.0 111.25 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -73.08 -28.07 62.09 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.423 -178.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 7.6 tp -84.82 -17.69 37.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 110.277 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 15' ' ' PHE . 7.8 mt -90.33 -16.8 28.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.014 -1.054 . . . . 0.0 109.049 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' CD ' ' NE ' ' A' ' 29' ' ' ARG . 1.3 mmmm -86.52 -33.09 20.41 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 22' ' ' LEU . 14.9 p -74.17 -40.36 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.402 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.7 mp -67.48 -48.45 67.11 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.867 0.841 . . . . 0.0 109.05 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.65 -150.61 23.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.19 -43.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.922 -0.752 . . . . 0.0 109.275 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -56.72 -175.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.529 -0.732 . . . . 0.0 109.576 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -108.35 -44.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 0.0 110.034 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttt -68.23 -25.83 65.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 108.933 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.46 -34.97 71.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.63 -0.669 . . . . 0.0 110.66 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -76.37 -47.47 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.08 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -24.8 67.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 111.149 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.97 -28.47 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.304 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.03 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 0.0 109.266 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 10.5 t -77.57 -39.43 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.1 60.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.68 97.06 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 56' ' ' THR . . . -62.38 -68.84 0.29 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m 50.13 52.3 15.0 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 64.22 73.33 0.47 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HB3' HG23 ' A' ' 56' ' ' THR . 28.4 Cg_endo -71.32 153.22 61.55 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.051 1.834 . . . . 0.0 110.728 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.36 174.15 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.686 -0.634 . . . . 0.0 109.532 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 48.3 t -154.98 164.21 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 6.8 tp10 -145.71 110.86 5.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -99.05 132.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.442 -0.786 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -112.38 114.45 27.18 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.77 119.55 37.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -119.06 52.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 -125.24 7.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -76.88 -0.43 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.388 -1.066 . . . . 0.0 109.953 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.5 m -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.841 -1.162 . . . . 0.0 108.648 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -135.71 115.5 13.0 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.842 0.829 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.0 147.52 26.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -142.95 105.09 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.983 -1.073 . . . . 0.0 111.196 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.67 112.07 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -99.52 141.73 31.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.77 120.22 18.07 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.246 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 167.55 16.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 109.315 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -160.22 124.17 3.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 109.785 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 pt -123.71 165.56 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.3 128.13 3.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.043 -1.035 . . . . 0.0 109.669 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.452 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.5 p90 -162.04 -172.02 3.08 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.622 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.04 154.6 49.23 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.63 93.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -178.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.49 -24.16 0.51 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 161.93 32.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -1.075 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.68 168.8 13.25 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.671 -0.643 . . . . 0.0 109.359 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.452 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.06 173.59 14.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.699 -0.626 . . . . 0.0 109.456 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.25 144.18 31.1 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -162.24 -175.98 4.87 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -100.07 157.6 16.44 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -93.59 -141.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.345 -0.847 . . . . 0.0 108.856 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.9 t -112.81 -18.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.695 -1.253 . . . . 0.0 110.77 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.37 -37.41 13.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.97 45.64 0.12 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 151.03 76.34 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.883 . . . . 0.0 109.193 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.76 141.06 16.89 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.675 1.583 . . . . 0.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -161.05 142.18 11.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.655 -0.653 . . . . 0.0 109.592 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -87.97 117.31 26.74 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -99.32 162.27 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.733 -0.605 . . . . 0.0 109.837 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.87 153.5 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 65' ' ' PHE . 14.1 t -146.98 128.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.379 -1.329 . . . . 0.0 112.171 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 155.46 37.48 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 80.7 m95 -78.18 174.64 10.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 109.89 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -137.45 -46.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.1 p -130.9 -153.23 0.55 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.55 -24.87 45.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.725 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -143.09 28.13 1.56 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 110.502 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -133.79 110.43 9.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.888 -1.133 . . . . 0.0 108.277 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.458 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.6 ptm -117.47 149.68 40.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.861 . . . . 0.0 110.141 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.7 172.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 45.7 t -148.55 138.32 22.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -105.22 164.02 12.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -160.06 132.99 6.65 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.515 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -141.18 149.25 41.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.16 167.51 3.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.641 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 mt -96.19 -8.42 33.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -158.08 156.19 30.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.67 -162.74 20.34 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -176.85 139.06 0.28 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.512 -0.993 . . . . 0.0 109.829 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.77 -84.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.42 -176.95 2.74 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.938 1.758 . . . . 0.0 109.994 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -137.12 139.94 41.57 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 146.32 48.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.092 0.948 . . . . 0.0 110.759 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.18 137.86 6.34 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.413 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.9 p-90 -144.18 175.96 9.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.74 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -138.33 169.85 17.06 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.532 0.682 . . . . 0.0 109.955 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.467 ' CE ' ' CD2' ' A' ' 3' ' ' PHE . 20.5 ptm -152.8 124.16 7.65 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -124.38 153.04 42.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.957 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.9 45.33 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.426 ' N ' HD11 ' A' ' 113' ' ' LEU . 17.4 p -91.06 161.11 15.25 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.5 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.91 -20.72 62.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -28.3 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.48 -8.36 7.85 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.25 172.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -1.202 . . . . 0.0 109.146 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.0 tt -144.84 110.46 5.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.151 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tt -105.35 143.9 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 131.49 48.8 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.48 163.71 12.83 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 21.6 mtp -142.49 160.13 40.87 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.039 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 m -143.4 152.88 42.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.62 98.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.54 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.21 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.62 23.86 0.99 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.517 -0.74 . . . . 0.0 109.534 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.15 -179.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.2 t -157.54 116.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.659 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.65 112.06 24.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.591 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.8 m -100.85 151.47 21.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -150.63 102.43 3.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 133.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.3 m-85 -121.55 120.29 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.907 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.89 142.86 16.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.475 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -50.08 126.14 13.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.303 -0.873 . . . . 0.0 111.146 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.961 -1.018 . . . . 0.0 111.752 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.523 0.677 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 m-85 -98.01 -2.49 40.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -71.96 118.01 14.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 112.028 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.52 -173.84 38.83 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 4.3 m120 -95.16 171.45 8.73 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.493 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.4 m95 -151.13 126.95 10.29 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.014 -1.075 . . . . 0.0 112.777 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.49 118.04 31.1 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' CE2' ' A' ' 134' ' ' TYR . 13.6 tt -61.85 150.86 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.871 0.843 . . . . 0.0 111.016 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.65 -30.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.627 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -141.96 165.8 26.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 108.917 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.9 p -177.01 147.19 0.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 0.0 109.469 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -145.61 165.65 28.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 109.953 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.2 m-80 62.64 32.69 16.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.581 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CE1' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.35 -64.22 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.472 -0.767 . . . . 0.0 110.188 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 mm-40 -57.41 -36.08 70.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 110.903 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.28 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.7 tp -78.89 -22.04 46.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.0 mt -89.33 -16.26 31.48 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.204 -0.935 . . . . 0.0 109.143 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.2 mmmm -87.02 -32.61 19.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 22' ' ' LEU . 13.2 p -73.42 -38.3 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.6 mp -70.43 -45.12 66.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 109.562 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.84 -161.45 27.74 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.301 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.36 -36.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.925 -0.75 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.28 -148.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.462 -0.774 . . . . 0.0 109.617 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.48 -45.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.744 -1.223 . . . . 0.0 109.237 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -72.35 -26.91 62.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.22 -17.14 39.43 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.706 -0.621 . . . . 0.0 111.205 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.15 -47.77 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.578 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -62.8 -22.33 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.636 -0.665 . . . . 0.0 110.516 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.1 mt -78.05 -28.59 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 108.934 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.9 -25.47 34.95 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 9.8 t -77.38 -37.67 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.77 -31.62 46.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.33 83.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -69.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.514 -0.741 . . . . 0.0 109.139 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m 48.79 49.09 19.49 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.658 -0.652 . . . . 0.0 109.677 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.3 mttt 65.27 72.17 0.48 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.15 151.26 49.18 Favored 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 122.026 1.817 . . . . 0.0 110.726 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.8 174.75 7.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.655 -0.653 . . . . 0.0 109.466 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 10.1 t -153.58 164.91 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.0 tt0 -154.94 115.14 3.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 109.236 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -106.15 138.83 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.764 0.792 . . . . 0.0 110.279 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.44 113.51 21.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.7 tt0 -98.53 115.34 28.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.162 -0.961 . . . . 0.0 110.796 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -118.52 56.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.54 8.78 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -77.69 -0.13 25.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.366 -1.079 . . . . 0.0 110.047 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.91 137.01 36.65 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.706 -1.246 . . . . 0.0 108.555 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -132.56 117.0 17.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.783 0.802 . . . . 0.0 108.871 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.9 t80 -104.46 125.51 50.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.0 141.06 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.948 -1.095 . . . . 0.0 108.658 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -138.55 101.44 4.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.171 -0.956 . . . . 0.0 108.946 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 31.5 m -99.76 147.25 25.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.63 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.949 0.881 . . . . 0.0 109.451 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.9 153.29 29.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.106 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -156.23 97.78 1.8 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.51 -0.744 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.2 pt -105.34 167.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.506 -0.746 . . . . 0.0 109.052 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.19 135.13 5.97 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.374 -0.829 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 48.6 p90 -162.74 -172.29 3.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.388 1.089 . . . . 0.0 112.545 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.11 152.75 48.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.81 95.07 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.102 -0.999 . . . . 0.0 109.833 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.8 -25.06 1.63 Allowed Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.929 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.5 156.95 34.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.295 -1.12 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.8 167.98 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.31 174.0 13.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.565 -0.709 . . . . 0.0 109.42 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.31 144.59 31.42 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.14 -177.19 5.58 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -99.65 156.99 16.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -93.2 -142.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.418 -0.801 . . . . 0.0 108.98 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.72 -21.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.723 -1.236 . . . . 0.0 110.672 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.35 -39.97 13.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 109.354 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.97 44.73 0.12 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.97 151.87 79.7 Favored Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 121.669 -0.901 . . . . 0.0 109.283 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.71 141.38 17.24 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.665 1.577 . . . . 0.0 110.604 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.2 p -161.12 141.26 10.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.2 113.63 25.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -100.58 174.48 6.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.768 -0.582 . . . . 0.0 109.933 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -147.92 153.47 39.11 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 3.9 t -141.86 128.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.465 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -125.97 164.5 20.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 93' ' ' MET . 86.5 m95 -86.09 169.58 13.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.097 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.19 -45.2 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -133.46 -154.25 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.81 -25.66 53.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.219 -0.925 . . . . 0.0 110.062 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -143.26 27.47 1.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 110.774 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -132.92 110.0 9.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.885 -1.134 . . . . 0.0 108.114 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.45 ' CE ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 ptp -114.87 151.98 33.02 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.481 -0.762 . . . . 0.0 110.13 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.04 171.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 48.0 t -148.29 131.97 16.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 110.621 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.7 165.07 11.41 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -160.96 138.67 9.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.818 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -144.85 150.3 36.86 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.29 167.48 2.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -98.4 -6.88 29.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 137.95 18.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.13 -158.85 41.3 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -175.8 142.64 0.55 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.414 -1.05 . . . . 0.0 109.759 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 -85.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.5 -176.96 2.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.922 1.748 . . . . 0.0 109.93 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -136.54 135.14 38.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 145.98 47.39 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.163 0.982 . . . . 0.0 110.712 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.3 p -163.01 133.02 4.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -136.7 169.41 17.77 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.049 -1.061 . . . . 0.0 110.727 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.5 p -134.43 170.72 15.33 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.561 0.696 . . . . 0.0 109.935 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.407 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 1.7 ptp -153.38 134.35 13.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -129.71 152.9 48.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.93 143.55 44.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.3 162.14 14.12 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.29 -22.63 65.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.077 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.13 -27.68 27.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.432 -0.793 . . . . 0.0 109.236 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.93 -9.75 7.96 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -56.49 172.35 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.166 -1.197 . . . . 0.0 109.18 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.488 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -145.6 109.69 4.89 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.919 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tt -103.61 160.7 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.52 153.64 46.25 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.374 -0.829 . . . . 0.0 109.218 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.24 165.86 24.44 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 26.7 mtp -147.27 165.24 30.69 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.491 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 m -147.09 150.42 35.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.33 93.86 1.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.0 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.84 24.84 1.33 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 -179.65 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.4 t -157.54 117.81 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.017 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t -99.93 112.5 24.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.7 m -107.39 146.73 31.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 119.74 6.29 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.12 143.61 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.141 -0.974 . . . . 0.0 108.666 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -130.99 127.94 39.39 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.477 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.54 138.39 37.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.62 128.21 17.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.204 -0.935 . . . . 0.0 111.518 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.346 0.593 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 m-85 -99.1 -5.74 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.1 p -68.3 117.23 9.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 111.939 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.85 -172.13 37.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.7 m120 -95.69 168.08 10.89 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.498 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.88 124.97 8.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.485 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -120.01 113.7 20.91 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 tt -56.42 143.21 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.563 0.697 . . . . 0.0 110.381 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.8 -23.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.942 -0.474 . . . . 0.0 110.181 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 178.3 7.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 t 169.13 168.81 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.76 28.93 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.898 -1.126 . . . . 0.0 112.093 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.52 34.99 0.11 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -67.18 -60.38 2.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.442 -0.786 . . . . 0.0 110.097 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.8 pt-20 -58.42 -26.86 63.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 111.082 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 2.1 pt-20 -72.79 -29.37 63.23 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.493 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.2 tp -82.28 -18.3 42.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.917 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 ' CD1' HG21 ' A' ' 33' ' ' VAL . 22.9 mt -90.28 -16.35 29.47 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.149 -0.969 . . . . 0.0 109.397 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.9 mmmm -87.21 -31.76 20.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.54 -40.74 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.75 -49.58 65.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.953 0.882 . . . . 0.0 108.776 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.8 -147.5 19.99 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 m -155.34 -42.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.852 -0.793 . . . . 0.0 109.396 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.2 t30 -57.42 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 109.615 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.35 -43.71 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.362 -0.836 . . . . 0.0 110.116 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -69.88 -25.6 63.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 2.2 mm? -57.07 -43.9 82.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.603 -0.685 . . . . 0.0 110.694 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.29 -41.73 99.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.577 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -61.31 -21.5 64.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.658 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.68 -29.31 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 109.059 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.41 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG21 ' CD1' ' A' ' 19' ' ' LEU . 7.3 t -76.52 -40.39 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.01 65.0 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.19 90.16 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.68 -68.69 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.1 t 49.19 51.05 16.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.432 0.634 . . . . 0.0 109.376 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm 63.75 72.36 0.55 Allowed Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -72.11 157.38 54.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.973 1.782 . . . . 0.0 111.045 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.99 174.07 6.04 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -156.18 163.94 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.24 112.26 5.45 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.3 mt -98.54 134.2 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.798 0.808 . . . . 0.0 110.497 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -113.78 109.16 18.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -97.89 120.82 38.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.035 -1.041 . . . . 0.0 111.146 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -120.93 53.57 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.44 -126.43 8.35 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.59 -1.25 23.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.4 -1.059 . . . . 0.0 110.095 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 m -96.08 137.37 35.24 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.795 -1.19 . . . . 0.0 108.619 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.4 m-85 -132.83 114.45 14.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.826 0.822 . . . . 0.0 109.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.2 t80 -100.93 148.73 24.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -144.95 103.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.009 -1.057 . . . . 0.0 110.844 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.81 111.49 23.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.508 -0.745 . . . . 0.0 109.023 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.8 m -99.53 148.27 24.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.41 128.82 18.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.357 -0.839 . . . . 0.0 110.45 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.07 168.82 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -158.7 112.37 2.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.637 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.6 pt -115.32 165.06 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.4 p-10 -162.68 131.83 4.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.4 p90 -161.6 -171.68 3.04 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.175 0.988 . . . . 0.0 111.769 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.96 155.34 49.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.8 96.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.31 -20.97 0.74 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.923 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -138.06 163.53 31.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.188 -1.184 . . . . 0.0 110.941 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -86.99 168.8 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.17 174.48 12.86 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -101.5 145.02 29.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.17 -177.11 5.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -104.62 154.17 20.28 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.374 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.9 t -91.75 -170.28 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.63 -6.27 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 0.0 111.21 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.18 -55.07 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.997 -1.065 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.7 46.22 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -137.08 152.6 74.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.73 -0.865 . . . . 0.0 109.214 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 141.14 16.75 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.533 1.489 . . . . 0.0 110.303 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -160.82 141.17 11.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.64 -0.663 . . . . 0.0 109.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -87.63 118.94 27.46 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -99.7 167.16 10.74 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -146.03 152.25 39.05 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 11.3 t -144.74 127.68 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.112 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -123.13 155.97 35.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 82.4 m95 -78.76 173.69 12.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.779 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -136.73 -46.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.7 p -131.43 -153.55 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.76 -25.43 49.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.777 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -142.72 27.43 1.67 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.588 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -132.85 109.68 9.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.962 -1.086 . . . . 0.0 108.376 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.452 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.9 ptm -116.38 148.89 40.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.828 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.64 172.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 44.9 t -148.54 134.58 19.19 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.693 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -103.05 165.15 11.19 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.45 135.31 7.68 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.293 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.67 40.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.95 166.7 3.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.065 -1.022 . . . . 0.0 110.722 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.5 mt -98.76 -5.51 31.18 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -152.45 137.2 17.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 108.962 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.47 -158.72 42.71 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.14 141.05 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.461 -1.023 . . . . 0.0 109.795 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.97 -85.47 0.05 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.35 -176.83 2.95 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.883 1.722 . . . . 0.0 109.752 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -136.18 137.03 40.47 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.9 146.08 47.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.051 0.929 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.3 m -163.03 136.48 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.0 p-90 -138.91 175.11 9.84 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.891 -1.13 . . . . 0.0 110.343 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 p -137.7 166.45 23.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.547 0.689 . . . . 0.0 109.831 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.429 ' HE1' ' CE2' ' A' ' 3' ' ' PHE . 10.8 ptm -149.2 119.74 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -118.46 152.77 35.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.589 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.26 143.3 45.71 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -97.13 161.07 13.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.907 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.89 -21.39 63.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.675 -0.64 . . . . 0.0 110.217 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.37 -29.13 28.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.75 -7.59 8.86 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.96 171.27 0.98 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -1.233 . . . . 0.0 108.643 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.498 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -144.01 114.7 7.69 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.343 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.8 tt -99.17 148.32 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 110.32 11.85 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.97 171.3 8.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.3 mtp -150.35 165.87 31.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.596 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 m -148.85 151.92 35.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.54 96.39 1.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.51 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.83 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -148.38 23.57 1.03 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.539 -0.726 . . . . 0.0 109.617 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.17 179.64 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.405 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -155.48 118.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 35.7 t -99.11 133.38 43.46 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.6 m -120.44 156.02 32.31 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.865 0.841 . . . . 0.0 109.818 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.419 ' O ' ' CD2' ' A' ' 134' ' ' TYR . 15.3 mtm180 -151.97 92.35 1.72 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.16 117.03 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 42.6 m-85 -102.13 133.92 46.2 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.562 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.77 138.08 47.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.83 124.49 7.42 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.3 -0.875 . . . . 0.0 111.331 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.757 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.425 0.631 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 m-85 -99.29 -17.38 18.1 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 t -60.97 113.94 2.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.85 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 -172.64 40.96 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.01 170.44 9.28 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -150.86 123.11 8.32 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.601 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -116.02 113.33 23.07 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.0 tt -56.06 154.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 122.09 0.947 . . . . 0.0 111.37 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.19 -32.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.382 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -137.08 167.49 21.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.865 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -177.12 152.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -0.773 . . . . 0.0 109.792 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -151.45 168.42 24.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.833 -0.542 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.5 m-80 59.85 26.48 15.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.749 . . . . 0.0 110.059 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -63.75 -62.87 1.37 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.31 -0.869 . . . . 0.0 108.686 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.1 mt-10 -57.03 -28.42 62.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.278 -0.889 . . . . 0.0 109.281 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.08 -38.69 92.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.729 -0.607 . . . . 0.0 109.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -79.43 -17.96 53.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.59 -17.32 28.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.194 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.3 mmmm -87.44 -29.63 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.71 -41.15 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -66.62 -52.63 43.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.038 0.923 . . . . 0.0 108.667 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 -148.36 20.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -155.87 -34.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.958 -0.731 . . . . 0.0 110.387 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.96 -153.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.61 -48.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.024 -1.047 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.11 -30.24 69.35 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -51.61 -35.35 41.36 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.913 -0.492 . . . . 0.0 110.698 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -77.21 -38.54 51.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.561 -0.712 . . . . 0.0 109.59 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -64.88 -24.35 67.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.69 -0.631 . . . . 0.0 110.297 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.63 -29.56 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 108.956 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.42 -24.23 34.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 11.0 t -76.22 -37.77 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.36 -35.51 61.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.69 88.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -69.63 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t 47.82 50.04 15.98 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.465 0.65 . . . . 0.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 mttt 65.47 72.81 0.44 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -72.11 153.98 57.28 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.083 1.856 . . . . 0.0 110.769 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.59 175.66 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 109.741 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 23.7 t -155.07 166.25 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -157.41 113.68 2.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.725 . . . . 0.0 109.384 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.8 mp -101.33 144.3 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.894 0.854 . . . . 0.0 110.303 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 7.3 mttt -123.7 104.35 8.94 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.4 tt0 -98.06 121.93 40.58 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.178 -0.951 . . . . 0.0 111.219 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -124.07 52.35 1.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -129.14 9.79 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.4 -2.45 28.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -1.063 . . . . 0.0 110.111 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.9 m -96.7 124.49 40.7 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.821 -1.174 . . . . 0.0 108.516 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 87.9 m-85 -120.5 122.98 41.84 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.857 0.836 . . . . 0.0 108.9 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.4 t80 -107.09 138.2 43.72 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.54 137.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -137.75 105.92 5.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -98.77 147.12 25.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.255 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.12 116.86 10.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.19 169.04 8.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.09 112.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 110.516 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.5 pt -98.94 172.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.545 -0.722 . . . . 0.0 109.1 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.0 134.81 5.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.0 110.05 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 41.4 p90 -163.04 -171.26 2.59 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.437 1.113 . . . . 0.0 112.508 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -130.7 153.15 49.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.71 94.82 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.099 -1.001 . . . . 0.0 109.557 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.46 -27.65 1.35 Allowed Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.699 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -122.99 157.49 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -1.105 . . . . 0.0 110.131 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -86.72 169.61 12.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.635 -0.666 . . . . 0.0 109.359 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.2 p90 -161.94 -172.89 3.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.6 -0.687 . . . . 0.0 109.386 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -115.83 147.76 40.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -161.64 179.74 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.682 -0.636 . . . . 0.0 109.596 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -105.73 159.18 16.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.327 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 t -92.38 -143.73 0.21 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.78 -17.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.161 . . . . 0.0 110.67 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -87.95 -34.64 18.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.363 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.75 45.99 0.18 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.6 146.85 62.2 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.749 -0.854 . . . . 0.0 109.268 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -80.02 136.09 11.5 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.687 1.591 . . . . 0.0 110.284 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.0 p -161.0 141.48 11.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -80.41 161.71 24.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.449 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.5 t -141.88 160.69 39.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.0 tp -142.07 154.27 44.81 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 20.3 t -144.25 129.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.358 -1.337 . . . . 0.0 112.222 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -124.24 159.58 29.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 82.8 m95 -82.82 172.06 13.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 0.0 110.498 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.99 -45.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.7 p -132.65 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.74 -26.35 54.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.858 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -143.09 27.82 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -131.8 111.12 11.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.441 ' CE ' ' CE1' ' A' ' 50' ' ' PHE . 1.7 ptp -116.23 148.86 40.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.45 -0.781 . . . . 0.0 110.239 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.26 171.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.409 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 42.0 t -147.46 141.75 26.25 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.41 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -107.4 164.12 12.46 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -162.15 131.31 4.38 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.616 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -138.74 155.12 48.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.76 169.29 4.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.59 -2.66 28.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.73 133.93 10.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 108.968 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.57 -155.71 43.89 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -175.7 140.5 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.439 -1.036 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.8 -87.0 0.06 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.6 -176.9 2.92 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.816 1.677 . . . . 0.0 109.697 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -132.84 138.44 47.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 144.8 49.82 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.215 1.007 . . . . 0.0 110.867 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.9 m -163.13 139.32 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.409 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.3 p-90 -142.62 175.73 9.58 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.956 -1.09 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 p -140.05 171.39 14.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.529 0.68 . . . . 0.0 109.838 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.407 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.1 ptp -154.14 140.52 18.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.15 149.44 47.28 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.324 -0.86 . . . . 0.0 109.501 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.3 46.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.67 160.9 14.78 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.725 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -60.45 -21.75 62.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.643 -0.66 . . . . 0.0 110.218 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.98 -28.67 25.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.9 -9.13 7.6 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.76 171.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.097 -1.237 . . . . 0.0 108.966 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.9 tt -146.62 110.11 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.19 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 120' ' ' ILE . 12.5 tt -102.77 153.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 133.3 36.84 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.496 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.88 167.2 10.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.7 mtp -146.49 164.74 31.55 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.399 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.2 m -147.86 152.27 37.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.67 95.93 1.35 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.595 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.21 -79.25 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -147.6 24.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.248 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.97 -179.25 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -157.61 117.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.696 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t -98.46 113.81 25.96 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 0.0 109.715 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.46 118.74 5.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.19 136.98 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -125.77 121.74 34.22 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.16 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.39 141.13 20.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.76 126.25 13.45 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.23 -0.919 . . . . 0.0 111.189 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.635 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.5 m120 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.45 0.643 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 3.5 m-85 -99.22 -8.11 25.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -67.01 115.64 6.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.301 -0.874 . . . . 0.0 111.893 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.32 -173.38 41.08 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.16 169.99 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.3 m95 -152.38 131.4 12.61 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.079 -1.049 . . . . 0.0 113.038 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -122.82 116.72 24.16 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 9' ' ' ILE . 10.0 tt -58.57 145.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.603 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.15 -24.43 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.961 -0.462 . . . . 0.0 110.324 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -149.66 168.02 24.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.221 -0.924 . . . . 0.0 110.602 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p 178.0 170.11 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.19 30.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.903 -1.123 . . . . 0.0 111.635 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.9 33.49 0.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.284 -0.885 . . . . 0.0 109.134 -178.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.66 -64.99 0.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 21.7 tt0 -57.09 -27.12 61.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.58 -39.66 94.97 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.756 -0.59 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.03 -15.8 56.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.675 -0.641 . . . . 0.0 110.016 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 33' ' ' VAL . 11.6 mt -90.22 -18.97 24.75 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.054 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.22 -28.66 25.25 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.46 -41.22 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.97 -51.71 56.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.05 0.929 . . . . 0.0 109.041 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.15 -147.76 20.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 m -155.74 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.978 -0.719 . . . . 0.0 109.721 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.0 t30 -60.46 -159.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.682 . . . . 0.0 109.885 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.18 -49.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.875 . . . . 0.0 109.429 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -66.39 -29.79 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -57.05 -25.68 59.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.827 -0.545 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.24 -42.7 12.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.785 . . . . 0.0 109.272 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -22.37 66.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.753 -0.592 . . . . 0.0 110.54 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.68 -29.99 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 108.774 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.17 -24.97 34.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 8.9 t -77.11 -35.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.52 -35.89 52.97 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.34 -35.51 80.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.19 -67.14 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.6 m 49.23 51.37 16.41 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.8 mttt 65.64 73.73 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -72.37 154.28 55.96 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 111.063 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.54 176.37 5.88 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -155.57 164.59 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -152.21 112.49 4.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -98.04 136.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.767 0.794 . . . . 0.0 110.002 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.445 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.35 106.38 13.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.9 tt0 -97.7 124.3 41.97 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.112 -0.993 . . . . 0.0 111.193 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -124.44 53.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.3 -127.26 8.87 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -1.13 24.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -1.029 . . . . 0.0 110.074 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.7 m -97.14 138.58 34.43 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.706 -1.246 . . . . 0.0 108.31 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 93.6 m-85 -134.11 118.11 17.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.764 0.793 . . . . 0.0 109.464 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.5 t80 -102.65 146.97 27.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 2.9 mt -141.73 100.81 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.947 -1.096 . . . . 0.0 110.45 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -99.39 114.07 26.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.393 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.0 m -99.87 144.76 28.55 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -135.51 144.19 46.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.878 0.847 . . . . 0.0 108.738 179.605 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.224 0.535 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.01 177.58 4.8 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.2 pm0 -171.37 143.75 1.88 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.69 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.18 170.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.0 132.69 4.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.987 -1.071 . . . . 0.0 109.457 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.7 p90 -162.25 -172.39 3.18 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.409 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.81 152.6 48.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.97 96.89 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.36 -34.88 1.48 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.559 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.76 157.34 21.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -1.046 . . . . 0.0 109.968 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.8 168.88 13.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.102 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 22.3 p90 -161.21 -172.9 3.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 21.8 mt-10 -116.39 148.86 40.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -161.29 179.8 8.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.444 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.8 144.14 42.85 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -81.54 177.62 8.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.407 -0.808 . . . . 0.0 108.985 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.7 -0.35 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.6 -0.688 . . . . 0.0 111.396 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -95.68 -44.61 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.89 -1.132 . . . . 0.0 109.955 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.19 45.3 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.9 149.88 60.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.796 -0.826 . . . . 0.0 109.088 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -80.46 135.03 10.33 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.49 1.46 . . . . 0.0 110.048 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.1 p -160.45 141.45 12.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.701 -0.624 . . . . 0.0 109.55 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 2.1 ptmm? -80.69 163.34 23.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 6.9 t -144.56 160.52 40.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 tp -142.13 153.57 44.2 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 9.6 t -144.7 125.77 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.772 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -120.58 162.28 19.89 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.446 ' CE2' HG23 ' A' ' 67' ' ' VAL . 87.1 m95 -85.51 168.7 14.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -131.81 -45.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.6 p -133.04 -153.81 0.57 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -77.14 -25.14 51.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -143.83 26.6 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.877 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -131.5 109.65 10.43 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.437 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -115.25 150.67 35.82 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.8 171.36 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 43.3 t -148.93 140.41 23.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.185 -0.947 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -107.17 164.75 11.9 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -161.96 133.41 5.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.988 -1.07 . . . . 0.0 110.752 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -140.89 153.67 45.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.35 169.59 3.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 0.0 110.684 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.01 -7.48 29.83 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -159.98 157.03 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 108.774 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.69 -158.5 18.94 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -176.73 139.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.514 -0.992 . . . . 0.0 109.691 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.35 -85.35 0.06 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.48 -176.75 2.65 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.95 1.767 . . . . 0.0 110.17 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -138.67 141.19 39.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.81 145.28 50.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.163 0.982 . . . . 0.0 110.839 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 m -162.99 137.23 6.22 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.7 p-90 -143.21 174.55 10.61 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.2 p -139.29 175.31 9.67 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.512 0.672 . . . . 0.0 109.674 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.415 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.7 ptp -158.34 141.1 14.62 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -136.09 150.28 49.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.451 -0.78 . . . . 0.0 109.158 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.42 143.3 44.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -93.03 160.49 14.84 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.809 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -60.01 -21.04 60.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 110.229 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.0 -29.7 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.838 . . . . 0.0 109.177 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.07 -9.84 7.03 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.9 172.88 0.23 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.215 -1.168 . . . . 0.0 109.432 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.481 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.4 tt -146.12 108.57 4.46 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.225 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.8 tt -103.62 147.87 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tt -129.93 147.75 51.72 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.263 -0.898 . . . . 0.0 109.637 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 164.57 18.48 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.5 mtp -146.88 164.49 32.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.534 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 m -146.52 153.08 39.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.5 98.72 1.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.51 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.43 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.27 24.19 1.03 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.519 -0.738 . . . . 0.0 109.426 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -119.15 -179.22 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -158.07 116.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.423 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.0 t -99.68 114.49 27.62 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.79 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 76.9 m -104.57 126.61 51.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.36 -0.838 . . . . 0.0 109.296 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -126.39 101.96 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.15 136.17 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.412 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.3 m-85 -125.43 127.59 46.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.0 137.56 41.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.494 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.57 127.57 15.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 111.405 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.246 0.546 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 5.5 m-85 -99.33 -8.79 24.38 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.732 -0.605 . . . . 0.0 109.61 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p -68.87 116.91 9.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.207 -0.933 . . . . 0.0 111.895 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.61 -171.95 39.39 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.89 169.04 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -150.56 121.55 7.67 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.717 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -115.25 113.7 24.24 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.424 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.6 tt -56.55 144.88 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.686 0.755 . . . . 0.0 110.804 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.21 -23.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.934 -0.479 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -144.98 173.5 11.83 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.225 -0.922 . . . . 0.0 110.527 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t 170.29 168.79 0.06 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.78 31.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.961 -1.087 . . . . 0.0 111.893 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.38 32.11 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.167 -0.958 . . . . 0.0 109.237 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -66.92 -61.86 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.462 -0.774 . . . . 0.0 110.174 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.3 mm-40 -58.07 -30.08 65.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.357 -0.839 . . . . 0.0 110.988 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -71.69 -27.45 63.05 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.621 -178.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 tp -81.52 -20.65 39.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 33' ' ' VAL . 13.7 mt -88.43 -16.68 32.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 109.187 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.9 mtmt -85.56 -32.86 21.91 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.47 -40.58 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.52 -48.74 66.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.886 0.85 . . . . 0.0 109.099 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.86 -160.52 26.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.61 -44.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.896 -0.767 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.69 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.86 -43.52 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.6 ttp -66.92 -28.53 68.38 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.6 -23.57 63.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.729 -0.607 . . . . 0.0 110.57 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -86.82 -47.59 8.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.641 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.74 -23.61 65.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 110.696 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.1 mt -77.25 -29.18 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.306 -0.871 . . . . 0.0 109.086 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.44 34.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 9.7 t -76.86 -37.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 -33.47 55.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.55 92.77 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.92 -67.83 0.4 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m 51.13 53.4 13.05 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mttt 66.04 73.32 0.41 Allowed Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -71.22 143.41 43.85 Favored 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 121.939 1.759 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.1 176.13 6.21 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -155.36 163.97 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -148.15 111.53 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.8 mt -99.68 140.9 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.81 0.814 . . . . 0.0 110.75 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -118.86 116.12 25.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -98.92 116.91 32.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.085 -1.009 . . . . 0.0 110.948 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -118.5 52.11 1.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.75 -125.97 8.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.91 -0.65 24.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.395 -1.062 . . . . 0.0 110.029 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.63 139.97 31.92 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.772 -1.205 . . . . 0.0 108.371 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.7 m-85 -135.02 116.94 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.879 0.847 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -102.18 148.72 25.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.3 mt -147.24 105.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 O-C-N 120.909 -1.119 . . . . 0.0 111.665 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -102.17 115.36 30.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.331 -0.856 . . . . 0.0 108.836 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.1 m -103.08 137.15 41.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.34 143.16 50.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.303 -0.873 . . . . 0.0 110.032 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.593 0.711 . . . . 0.0 109.27 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.5 p -79.37 162.87 25.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.707 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -156.12 122.92 5.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.69 -0.631 . . . . 0.0 109.499 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.56 165.66 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.48 129.34 3.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.144 -0.972 . . . . 0.0 108.833 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.2 p90 -161.33 -172.43 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -128.55 153.38 47.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.54 95.3 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.554 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.91 -35.55 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -112.05 155.86 23.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.411 -1.052 . . . . 0.0 109.909 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.61 170.51 11.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.56 173.7 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.0 109.811 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -103.18 143.98 31.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.22 -175.4 4.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 109.445 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -102.55 154.87 18.7 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.2 t -90.19 -142.34 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.4 -0.813 . . . . 0.0 108.958 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.95 -20.8 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.733 -1.229 . . . . 0.0 110.445 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.57 -42.62 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.0 109.438 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.4 44.66 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -131.07 150.03 75.43 Favored Pre-proline 0 C--N 1.308 -1.237 0 O-C-N 121.696 -0.885 . . . . 0.0 109.003 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.94 140.72 18.4 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.615 1.543 . . . . 0.0 110.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -160.84 141.48 11.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.683 -0.636 . . . . 0.0 109.668 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -87.23 116.35 25.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -99.48 164.58 12.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.295 0.569 . . . . 0.0 110.117 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.9 tp -143.98 153.18 41.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 14.3 t -145.58 124.94 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.656 -1.218 . . . . 0.0 111.761 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -119.17 155.34 31.81 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.434 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 80.6 m95 -77.19 175.15 9.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.881 0.848 . . . . 0.0 110.163 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -138.08 -46.41 0.52 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.9 p -131.22 -152.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -78.14 -25.56 47.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -142.99 27.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 110.571 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -133.34 113.34 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.891 -1.131 . . . . 0.0 108.288 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.434 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -119.38 150.82 39.53 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.493 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.71 172.21 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 47.7 t -147.79 139.66 24.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.781 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.93 162.84 13.65 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.23 133.59 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.552 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -141.93 151.13 42.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.23 167.93 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.98 . . . . 0.0 110.718 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.9 mt -98.41 -6.27 30.95 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -155.09 141.1 18.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.99 -158.07 38.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -175.97 140.98 0.44 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.458 -1.024 . . . . 0.0 109.871 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.13 -85.51 0.05 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.19 -176.52 2.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.905 1.737 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -137.17 136.21 38.02 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.55 145.51 48.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.123 0.964 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.1 m -162.84 135.75 5.69 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.4 p-90 -141.73 175.41 9.72 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -138.15 174.38 10.62 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.696 . . . . 0.0 109.888 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.77 133.35 10.06 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -131.07 146.45 52.37 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.393 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.3 143.07 39.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.407 ' N ' HD11 ' A' ' 113' ' ' LEU . 80.7 p -92.65 161.41 14.58 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.833 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -60.27 -21.27 61.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.18 -29.62 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 0.0 109.179 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.15 -7.91 8.05 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.37 172.37 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -1.167 . . . . 0.0 109.05 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -143.41 108.96 5.09 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.122 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.3 tt -103.13 148.48 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.68 145.35 51.9 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.489 -0.885 . . . . 0.0 109.489 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.14 167.19 12.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 14.2 mtp -148.32 164.65 33.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.474 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 m -146.71 152.38 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.1 97.73 1.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.87 -79.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -149.65 24.47 0.87 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.398 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.92 -179.3 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.414 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -156.85 117.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.689 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.9 t -99.92 116.71 32.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.581 . . . . 0.0 109.499 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -108.11 130.28 55.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.561 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 104.01 7.18 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.76 135.58 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.6 m-85 -124.52 122.08 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.394 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.34 140.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.45 126.0 12.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.254 -0.904 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.64 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.532 0.682 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.461 ' CE2' ' CE ' ' A' ' 111' ' ' MET . 3.0 m-85 -99.56 -11.44 21.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 116.81 6.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.25 -0.906 . . . . 0.0 111.689 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.72 -172.95 39.74 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.02 170.11 9.51 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.11 122.83 8.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.547 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -115.75 112.07 21.48 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 9' ' ' ILE . 9.1 tt -52.47 156.5 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.994 0.902 . . . . 0.0 111.547 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 -33.31 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -146.69 170.14 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -179.35 155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.3 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -152.08 171.95 17.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.688 -0.633 . . . . 0.0 110.048 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.3 m-80 60.31 27.77 17.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 109.798 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 36' ' ' ALA . 3.5 t80 -66.32 -64.27 0.89 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 108.976 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 tt0 -59.1 -28.53 66.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.613 -0.679 . . . . 0.0 109.719 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.77 -37.63 84.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.411 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 48.2 tp -83.58 -13.61 53.98 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.684 -0.635 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.46 -21.7 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.003 -1.061 . . . . 0.0 108.946 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mmmt -82.64 -29.28 30.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.25 -41.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 122.098 0.951 . . . . 0.0 108.472 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.6 mp -65.66 -53.56 39.63 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.149 0.976 . . . . 0.0 108.99 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.95 -146.37 17.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -155.58 -37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.014 -0.698 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -57.52 -170.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 109.744 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.78 -43.8 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 110.084 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 16.6 ttp -68.68 -23.02 64.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 0.0 109.281 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.35 -30.59 71.44 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.522 -0.736 . . . . 0.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.11 -45.31 12.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 0.0 110.65 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -25.43 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.0 110.834 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.0 mt -80.04 -27.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.365 -0.835 . . . . 0.0 108.879 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -81.99 -24.45 35.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.686 -0.634 . . . . 0.0 109.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 15' ' ' PHE . 2.5 t -82.23 -49.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.95 97.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.25 86.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 15' ' ' PHE . . . -84.58 40.72 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.684 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -64.25 -54.46 32.97 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.777 -1.202 . . . . 0.0 108.12 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -139.21 71.06 40.42 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 31.9 Cg_endo -72.89 147.95 44.88 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.947 1.765 . . . . 0.0 110.954 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.31 172.52 8.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 17.0 t -155.3 166.34 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.0 tt0 -156.77 112.44 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.331 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.5 mp -100.07 141.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.753 0.787 . . . . 0.0 110.105 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 29.7 mttt -117.03 91.28 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.21 126.28 42.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -177.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -135.54 64.88 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.43 -131.62 10.85 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.75 -2.34 26.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -1.044 . . . . 0.0 110.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -96.44 132.09 42.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.543 -1.348 . . . . 0.0 108.31 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 97.6 m-85 -130.04 121.11 25.8 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.811 0.815 . . . . 0.0 109.047 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 52' ' ' ILE . 13.3 t80 -105.78 151.41 24.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -138.55 135.48 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -138.89 105.35 5.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.315 -0.866 . . . . 0.0 108.797 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.2 m -98.74 148.43 23.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 108.975 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.01 113.02 5.79 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.037 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 35.6 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.61 168.53 9.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -165.73 113.37 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.2 pt -99.84 172.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.463 -0.773 . . . . 0.0 109.059 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.4 135.66 5.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 42.2 p90 -163.02 -171.69 2.76 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.354 1.073 . . . . 0.0 112.661 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 153.68 47.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 96.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.095 -1.003 . . . . 0.0 109.615 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.1 -22.69 1.92 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.941 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -126.03 156.95 39.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.256 -1.144 . . . . 0.0 110.261 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.65 168.3 13.73 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.5 p90 -161.93 175.17 12.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -110.32 142.75 41.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 4.9 pm0 -162.08 -169.69 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -99.71 159.79 14.78 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.17 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -96.85 -143.04 0.29 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.379 -0.825 . . . . 0.0 109.242 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.44 -23.86 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.762 -1.211 . . . . 0.0 110.914 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.87 -41.61 12.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.43 45.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.45 153.08 81.49 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.683 -0.892 . . . . 0.0 109.188 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.52 140.09 14.82 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.76 1.64 . . . . 0.0 110.439 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.2 p -160.57 144.65 13.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.517 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -90.48 122.09 33.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 11.9 t -104.52 168.92 8.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.543 . . . . 0.0 110.206 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -148.24 153.43 38.72 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.416 HG23 ' CE2' ' A' ' 65' ' ' PHE . 10.6 t -144.92 126.48 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.908 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.414 ' CZ2' ' HE2' ' A' ' 93' ' ' MET . 76.6 m95 -76.94 174.01 11.1 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.913 0.863 . . . . 0.0 110.769 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.65 -45.68 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.4 p -134.89 -150.66 0.4 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.87 -26.59 49.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -142.36 24.03 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -131.13 113.86 14.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.93 -1.106 . . . . 0.0 108.289 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.423 ' HE3' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.24 149.96 40.89 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.512 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.15 173.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.415 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 42.5 t -147.57 141.09 25.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.2 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.55 163.25 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -160.33 138.83 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.654 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -145.59 150.73 36.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.55 166.56 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.032 -1.043 . . . . 0.0 110.775 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 mt -98.68 -5.48 31.53 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -147.76 129.79 15.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 108.945 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.18 -155.83 45.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -176.27 141.82 0.45 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.524 -0.986 . . . . 0.0 109.686 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.76 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -82.18 -176.89 3.19 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.749 1.632 . . . . 0.0 109.925 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -130.42 133.83 46.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.4 144.16 46.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.115 0.96 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -163.34 135.55 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -142.78 177.66 8.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.061 -1.024 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -139.23 166.86 23.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.516 0.674 . . . . 0.0 109.956 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.461 ' CE ' ' CE2' ' A' ' 3' ' ' PHE . 19.2 ptm -148.92 124.72 10.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -122.64 151.14 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.38 144.48 43.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 p -93.87 161.77 14.18 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.859 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -60.65 -23.05 64.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.635 -0.666 . . . . 0.0 110.114 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.4 -27.95 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.67 -10.08 7.6 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.47 173.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.156 -1.202 . . . . 0.0 109.412 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.5 tt -147.71 114.63 6.12 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.45 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.25 150.92 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 132.98 42.16 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.49 -0.756 . . . . 0.0 109.546 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 165.23 13.27 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 32.4 mtp -144.73 163.45 33.98 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.649 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.6 m -146.86 149.09 32.59 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -154.99 93.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.52 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -147.47 23.16 1.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.47 -179.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.4 t -157.57 118.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.893 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 28.1 t -98.96 112.8 24.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 97.7 m -110.77 147.64 34.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -151.37 120.29 6.64 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.1 t -81.31 138.71 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.098 -1.001 . . . . 0.0 108.428 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.423 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.3 m-85 -127.07 125.98 42.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.153 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.99 139.92 28.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.2 125.72 11.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.224 -0.922 . . . . 0.0 111.102 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.48 179.662 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.389 0.614 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 2.6 m-85 -98.65 0.59 45.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -73.25 118.5 16.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 111.97 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.66 -171.77 38.56 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.82 170.03 9.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 99.0 m95 -150.52 121.77 7.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.508 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -115.25 113.22 23.6 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 9' ' ' ILE . 8.6 tt -52.22 157.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.012 0.911 . . . . 0.0 111.684 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.57 -32.72 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.441 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -146.52 171.3 15.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.877 . . . . 0.0 109.034 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.7 p -177.52 158.15 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.781 . . . . 0.0 109.641 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.64 169.86 22.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.678 -0.638 . . . . 0.0 110.034 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 43.9 m-20 58.68 23.88 11.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.538 -0.726 . . . . 0.0 110.194 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -66.42 -63.39 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -56.88 -27.8 61.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.57 -39.02 93.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.634 -0.666 . . . . 0.0 109.681 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -78.49 -18.04 55.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.717 -0.614 . . . . 0.0 110.157 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.424 HD12 ' CE1' ' A' ' 15' ' ' PHE . 8.5 mt -90.23 -17.76 26.9 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -86.29 -28.32 23.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.21 -40.96 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.28 -52.31 42.23 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.097 0.951 . . . . 0.0 109.314 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.1 -149.34 22.06 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.462 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 m -155.71 -34.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 122.104 -0.645 . . . . 0.0 110.375 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.71 -152.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.12 -50.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.977 -1.077 . . . . 0.0 109.051 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 8.9 ttm -65.95 -30.98 71.64 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.82 -33.93 51.46 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.465 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 2.4 mtp180 -83.31 -46.55 12.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -62.88 -15.19 53.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.691 -0.631 . . . . 0.0 111.206 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.6 -30.46 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.094 -1.004 . . . . 0.0 108.474 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.75 -24.14 33.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.5 t -80.45 -44.33 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.06 -41.33 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.07 83.49 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.21 45.21 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.844 -0.535 . . . . 0.0 110.889 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -60.66 -34.72 74.72 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.572 -1.33 . . . . 0.0 108.37 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -165.68 72.88 1.32 Allowed Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.15 149.78 46.67 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.811 1.674 . . . . 0.0 110.759 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.73 175.07 5.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 55.8 t -155.61 164.43 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 44.2 tt0 -150.58 110.82 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -98.25 133.38 40.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.786 0.803 . . . . 0.0 110.161 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -113.03 106.9 15.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.7 tt0 -97.48 122.99 41.17 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.14 -0.975 . . . . 0.0 111.017 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -122.58 56.42 1.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.86 -126.06 8.13 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -76.77 -0.42 23.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.378 -1.072 . . . . 0.0 110.163 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.89 138.06 35.02 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 120.712 -1.243 . . . . 0.0 108.556 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 96.6 m-85 -132.49 116.01 16.22 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.891 0.853 . . . . 0.0 109.342 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.4 t80 -101.77 146.98 27.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.6 mt -143.15 99.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.026 -1.046 . . . . 0.0 110.161 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -99.45 111.82 24.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.449 -0.782 . . . . 0.0 109.718 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 m -99.51 146.4 26.42 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.2 p -139.9 119.5 13.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.997 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.766 0.793 . . . . 0.0 108.917 179.576 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.6 m . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.239 0.543 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 p -108.25 176.96 4.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.0 109.34 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -170.26 124.05 0.71 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 pt -114.87 170.91 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 133.88 5.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.949 . . . . 0.0 109.51 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 47.5 p90 -161.91 -171.52 2.92 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.44 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.09 152.81 49.13 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -83.0 94.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.129 -0.982 . . . . 0.0 109.64 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.08 -27.56 1.26 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.662 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.38 156.81 34.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.322 -1.105 . . . . 0.0 110.177 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.39 169.78 12.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.592 -0.692 . . . . 0.0 109.395 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.9 p90 -163.0 174.42 12.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.616 -0.678 . . . . 0.0 109.612 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -103.65 144.33 31.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 -174.93 4.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.564 -0.71 . . . . 0.0 109.443 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -99.83 159.25 15.21 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -95.13 -150.05 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.7 p -98.54 -21.18 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.976 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -91.99 -51.21 5.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.64 44.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -128.88 152.63 79.38 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.584 -0.951 . . . . 0.0 109.05 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.07 139.88 17.46 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.599 1.532 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.82 140.96 11.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.745 -0.597 . . . . 0.0 109.445 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.4 117.28 25.1 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.0 t -99.41 168.25 10.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.18 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -147.01 154.08 40.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 65' ' ' PHE . 24.6 t -146.65 130.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 118.441 -1.303 . . . . 0.0 112.153 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -125.51 160.04 30.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.428 ' CE2' HG23 ' A' ' 67' ' ' VAL . 85.9 m95 -83.63 169.83 14.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.129 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 6.1 tp10 -132.45 -46.22 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.0 p -130.6 -153.47 0.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.11 -26.35 47.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -142.2 27.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.806 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 1.2 tttt -132.03 108.58 9.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.822 -1.173 . . . . 0.0 107.933 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.409 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 1.7 ptp -114.77 149.74 36.47 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.43 -0.794 . . . . 0.0 110.509 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.21 171.5 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 49.2 t -146.71 141.5 26.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.756 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.66 162.91 13.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -160.69 136.96 8.53 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.655 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -142.25 149.8 40.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.62 166.06 4.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 110.805 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.2 mt -101.07 -3.15 29.82 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 132.41 13.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 108.796 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.77 -159.86 42.24 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.25 141.33 0.43 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.396 -1.061 . . . . 0.0 109.857 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.98 -85.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.18 -177.05 3.1 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.816 1.677 . . . . 0.0 109.793 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -132.55 138.14 47.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.37 144.47 48.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.106 0.955 . . . . 0.0 110.698 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.96 135.82 5.61 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -139.21 173.71 11.27 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.056 -1.028 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -137.57 174.05 11.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.482 0.658 . . . . 0.0 110.073 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.0 ptp -160.35 132.83 6.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 15.3 pt-20 -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.62 145.23 40.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.4 ' N ' HD11 ' A' ' 113' ' ' LEU . 19.2 p -92.95 161.0 14.64 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.541 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -60.14 -21.92 62.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.655 -0.653 . . . . 0.0 110.323 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -85.31 -28.37 25.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.87 -8.84 7.64 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.18 172.53 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.095 -1.238 . . . . 0.0 109.087 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.48 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.7 tt -147.29 112.13 5.39 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.111 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.1 tt -108.04 146.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 139.8 52.3 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.47 169.9 9.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 34.8 mtp -148.81 166.25 29.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.355 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 m -149.0 151.75 35.08 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.434 0.635 . . . . 0.0 109.459 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.36 95.07 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -147.42 24.0 1.13 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.54 -0.725 . . . . 0.0 109.282 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.78 -178.75 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -157.61 117.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.841 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 4.4 t -98.38 120.08 38.18 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.0 m -117.85 145.51 44.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.056 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.25 118.0 7.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.56 138.48 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.0 108.398 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.7 m-85 -127.13 123.84 37.74 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.226 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 140.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.25 125.69 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.239 -0.913 . . . . 0.0 111.137 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.593 179.645 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.305 0.574 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 4.3 m-85 -98.96 -2.42 37.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.704 -0.623 . . . . 0.0 109.366 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 t -72.15 117.71 14.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 111.936 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.6 -172.25 38.62 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 170.08 9.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -149.97 118.93 6.67 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.653 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -110.65 115.28 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.4 tt -56.67 158.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.01 0.91 . . . . 0.0 111.117 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.7 -33.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.421 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt85 -146.23 168.4 21.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 108.844 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.0 p -177.56 139.76 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.512 -0.743 . . . . 0.0 109.406 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.9 169.71 16.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.672 -0.642 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 42.2 m-20 61.24 29.4 18.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.735 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 4.8 t80 -64.68 -63.64 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.0 109.074 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.1 pt-20 -60.53 -26.58 66.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.675 -0.641 . . . . 0.0 109.629 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -64.57 -41.48 96.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 46.6 tp -80.67 -13.24 59.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -91.0 -20.33 22.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.038 -1.038 . . . . 0.0 109.207 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.6 mmmm -84.23 -29.54 26.45 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -78.61 -40.78 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.88 -53.1 29.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.139 0.971 . . . . 0.0 109.159 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.73 -148.72 20.8 Favored Glycine 0 N--CA 1.491 2.364 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.265 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.96 -36.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.982 -0.716 . . . . 0.0 110.418 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.37 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.865 . . . . 0.0 109.993 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.43 -48.24 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.362 -0.836 . . . . 0.0 109.705 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.2 -25.95 66.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.96 -28.83 70.35 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.697 -0.627 . . . . 0.0 110.647 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CZ ' ' CD ' ' A' ' 20' ' ' LYS . 2.5 mtp180 -87.71 -46.88 9.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 0.0 110.449 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -60.44 -30.77 69.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.505 -0.747 . . . . 0.0 110.656 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.5 mt -76.18 -27.34 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.474 -0.766 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.2 -22.3 36.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 3.1 t -81.21 -43.41 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.86 85.38 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.0 -46.17 88.92 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB1' ' CE2' ' A' ' 15' ' ' PHE . . . -84.2 41.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -65.69 -32.73 74.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.908 -1.12 . . . . 0.0 108.293 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -159.11 70.54 3.47 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.8 Cg_endo -73.92 135.2 20.9 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.897 1.731 . . . . 0.0 109.741 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.55 170.29 12.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.581 -0.7 . . . . 0.0 109.803 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.2 t -156.76 130.91 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.18 112.03 18.14 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.0 mt -99.21 136.13 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.657 0.741 . . . . 0.0 110.106 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -113.59 114.99 27.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.87 117.15 32.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.1 -1.0 . . . . 0.0 110.9 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -118.21 52.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 -125.1 7.67 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -77.75 0.04 25.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.366 -1.079 . . . . 0.0 109.991 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.7 m -96.42 140.2 31.43 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.763 -1.21 . . . . 0.0 108.424 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.9 m-85 -136.02 116.57 13.82 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.85 0.834 . . . . 0.0 109.488 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.7 t80 -102.36 148.44 25.47 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.472 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.7 mt -144.46 105.59 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 120.937 -1.102 . . . . 0.0 111.275 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.35 106.29 18.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 108.928 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 m -98.17 144.61 27.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 108.559 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 118.79 12.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.852 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.413 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 p -91.11 166.87 12.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.367 -0.833 . . . . 0.0 109.99 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.04 123.06 4.36 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.4 pt -123.06 167.59 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.49 128.98 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.184 -0.947 . . . . 0.0 109.26 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.468 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 48.4 p90 -162.09 -172.24 3.16 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.281 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -129.75 153.57 48.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.95 93.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 109.668 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.87 -26.44 1.3 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.741 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -122.82 157.68 31.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.321 -1.105 . . . . 0.0 110.079 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.63 168.08 13.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.12 173.33 14.47 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.708 -0.62 . . . . 0.0 109.398 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -102.68 143.11 32.76 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.34 -175.74 4.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.628 . . . . 0.0 109.433 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.92 157.63 16.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -91.88 -142.97 0.19 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.406 -0.809 . . . . 0.0 109.005 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.27 -19.56 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.785 -1.197 . . . . 0.0 110.649 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.89 -44.52 8.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.557 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.99 45.1 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.79 151.17 78.1 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 121.617 -0.931 . . . . 0.0 109.019 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.51 140.26 16.84 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.618 1.546 . . . . 0.0 110.677 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.94 141.72 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.657 -0.652 . . . . 0.0 109.606 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -87.03 116.26 24.96 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -99.54 166.39 11.17 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.499 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -146.09 153.07 40.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 12.0 t -145.03 126.65 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.861 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.39 155.46 33.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 82.5 m95 -78.0 173.62 11.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.78 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -136.29 -46.26 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.8 p -131.47 -153.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.91 -23.09 44.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.85 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -144.3 26.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -133.82 112.25 11.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.905 -1.122 . . . . 0.0 108.363 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.452 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.5 ptm -118.18 149.84 40.39 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.26 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.84 172.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 46.4 t -147.78 137.78 22.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.818 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.98 163.48 12.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -160.23 135.41 7.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.563 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -141.22 148.41 39.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.69 167.3 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.3 mt -94.98 -8.81 35.85 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.66 155.29 31.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.53 -161.04 16.97 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -176.89 138.64 0.27 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.503 -0.999 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.25 -85.05 0.05 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.02 -176.83 2.79 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.91 1.74 . . . . 0.0 109.9 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -135.97 136.42 40.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.16 47.56 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.154 0.978 . . . . 0.0 110.966 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -162.92 136.27 5.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.3 p-90 -140.54 174.68 10.28 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.31 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -138.83 171.21 14.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.598 0.713 . . . . 0.0 109.855 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.8 ptp -153.04 136.48 15.86 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -132.99 149.93 52.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.703 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.99 143.73 43.79 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.9 p -92.75 161.02 14.7 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.58 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -60.42 -21.67 62.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.624 -0.672 . . . . 0.0 110.214 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.42 -28.45 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 109.32 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.35 -9.84 7.34 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -56.16 172.28 0.22 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.148 -1.207 . . . . 0.0 109.212 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.495 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.7 tt -146.84 111.46 5.25 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.405 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.06 156.45 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.72 133.67 32.56 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.354 -0.841 . . . . 0.0 109.515 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 166.76 11.23 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 7.4 mtp -144.93 163.13 35.09 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.243 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -147.01 151.17 36.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.407 0.622 . . . . 0.0 109.331 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -157.54 95.13 1.42 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.564 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.27 -79.12 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.63 23.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.519 -0.738 . . . . 0.0 109.319 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.22 -179.88 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.52 118.4 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.744 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -98.32 113.0 24.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.6 m -107.14 148.34 28.95 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.911 0.862 . . . . 0.0 109.985 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -152.81 119.02 5.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.0 138.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.571 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -126.53 131.07 51.67 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.3 139.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.47 125.58 11.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.262 -0.899 . . . . 0.0 111.21 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.59 179.473 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 122.116 0.96 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 3.1 m-85 -104.49 -3.79 23.52 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.7 p -68.15 118.81 11.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 112.132 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.06 -173.33 38.37 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.2 m120 -95.75 170.22 9.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.22 122.86 7.98 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.814 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -114.36 114.03 25.34 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.3 tt -54.4 157.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.97 0.89 . . . . 0.0 111.46 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.72 -32.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.34 169.57 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.3 p -176.94 160.84 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -0.794 . . . . 0.0 109.824 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.45 166.58 32.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 110.016 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.28 29.67 18.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CD1' ' CG2' ' A' ' 33' ' ' VAL . 4.4 t80 -64.19 -64.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 109.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 36.2 tt0 -60.4 -26.39 66.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.721 -0.612 . . . . 0.0 109.623 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.36 -41.56 96.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 0.0 109.922 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 46.5 tp -81.13 -12.84 59.14 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -91.1 -20.59 21.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.95 -1.094 . . . . 0.0 109.102 179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.2 mmmt -84.5 -30.05 25.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -77.4 -40.9 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.7 mp -67.41 -53.02 32.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.19 0.995 . . . . 0.0 109.075 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.63 21.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -150.91 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.861 -0.788 . . . . 0.0 110.343 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -58.21 -169.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.261 -0.899 . . . . 0.0 109.786 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.7 -43.59 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.594 -0.692 . . . . 0.0 110.121 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 7.5 ttm -68.46 -28.02 66.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.753 . . . . 0.0 109.03 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.98 -50.29 73.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.734 -0.604 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -44.46 92.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 110.22 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -59.87 -25.63 65.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.624 -0.672 . . . . 0.0 111.219 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -80.27 -28.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.165 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -82.43 -23.36 34.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.61 -0.681 . . . . 0.0 109.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' CG2' ' CD1' ' A' ' 15' ' ' PHE . 3.0 t -82.25 -47.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.24 96.82 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 15' ' ' PHE . . . -83.49 37.39 0.57 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 p -63.69 -33.19 75.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.694 -1.254 . . . . 0.0 108.224 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -163.12 71.58 1.96 Allowed Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.23 -176.31 2.85 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 122.033 1.822 . . . . 0.0 110.793 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.21 172.11 10.34 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 41.4 t -155.57 164.95 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 39.6 tt0 -153.72 112.4 3.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.6 mp -98.73 133.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 109.99 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.3 mttt -113.92 103.59 11.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 59.1 tt0 -97.49 127.18 43.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.143 -0.973 . . . . 0.0 111.156 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.54 55.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.05 -126.05 8.34 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.34 -0.07 24.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.434 -1.039 . . . . 0.0 110.148 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 m -97.48 140.64 31.63 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.745 -1.222 . . . . 0.0 108.545 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -136.4 118.09 15.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.693 0.759 . . . . 0.0 109.547 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.8 t80 -102.47 145.78 29.06 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.434 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 3.9 mt -140.34 99.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 120.987 -1.071 . . . . 0.0 110.663 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -98.79 113.46 25.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.756 . . . . 0.0 109.764 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.6 m -106.18 143.3 34.5 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -148.8 123.44 9.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.837 . . . . 0.0 109.195 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.96 -179.295 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -109.28 177.22 4.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.576 -0.703 . . . . 0.0 109.939 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -170.66 136.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.714 -0.616 . . . . 0.0 109.342 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.97 172.54 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.0 109.292 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -162.45 130.34 3.91 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 108.882 179.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.465 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.2 p90 -161.97 -172.72 3.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.313 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 152.79 48.54 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.23 95.69 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.89 1.57 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.911 -1.137 . . . . 0.0 110.666 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -111.2 154.91 23.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.302 -1.117 . . . . 0.0 110.065 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.46 167.38 14.72 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.0 p90 -162.43 173.28 14.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 110.005 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.84 145.54 29.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.1 -177.8 5.98 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -99.82 155.51 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -91.14 -142.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.3 -20.22 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.205 . . . . 0.0 110.618 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -89.19 -41.91 11.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.78 45.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -131.91 151.51 78.64 Favored Pre-proline 0 N--CA 1.485 1.322 0 O-C-N 121.618 -0.931 . . . . 0.0 109.31 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.69 141.55 17.41 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.715 1.61 . . . . 0.0 110.482 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.21 141.07 10.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.676 -0.64 . . . . 0.0 109.772 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.5 115.22 27.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -103.04 176.43 5.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.754 -0.591 . . . . 0.0 110.136 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -151.18 152.97 34.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 5.7 t -140.17 130.27 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -124.43 159.31 30.74 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.443 ' CE2' HG23 ' A' ' 67' ' ' VAL . 87.2 m95 -84.54 170.19 13.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.266 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -133.53 -46.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.7 p -131.63 -154.75 0.64 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -76.74 -24.44 53.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.677 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -144.49 27.07 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.2 tttm -130.81 108.1 9.61 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.918 -1.114 . . . . 0.0 107.995 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 87' ' ' TRP . 1.1 ptp -115.84 148.85 39.47 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.63 0.729 . . . . 0.0 110.497 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.03 171.01 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.63 129.95 14.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.197 -0.939 . . . . 0.0 110.675 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.49 164.46 11.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.48 143.49 13.35 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.773 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -146.28 149.24 33.48 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.74 166.17 3.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.054 -1.029 . . . . 0.0 110.84 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.0 mt -98.54 -5.49 32.01 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -151.52 139.6 20.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 108.958 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.71 -159.19 42.97 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -176.86 140.59 0.33 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.492 -1.005 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.8 -84.66 0.05 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.53 -177.11 3.04 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.86 1.707 . . . . 0.0 110.12 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -136.11 135.8 39.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.97 145.67 46.56 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.119 0.961 . . . . 0.0 110.793 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 m -162.64 130.4 3.82 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -133.41 168.68 18.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 p -134.25 174.6 10.33 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.412 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.6 ptp -159.13 130.23 6.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -123.66 151.5 43.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.81 142.78 46.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.6 159.15 15.35 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.761 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -59.65 -21.59 60.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.692 . . . . 0.0 110.234 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.38 -30.23 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.77 -9.48 6.79 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -56.67 171.8 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.146 -1.208 . . . . 0.0 109.08 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.8 tt -147.18 111.2 5.08 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.189 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.6 tt -105.24 156.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -135.76 153.89 51.41 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.461 -0.775 . . . . 0.0 109.302 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 169.05 18.24 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.6 mtp -150.15 165.82 31.68 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.669 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -148.34 151.24 34.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -158.16 95.93 1.41 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.4 -79.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.13 23.87 1.17 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.539 -0.726 . . . . 0.0 109.311 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.77 -179.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -157.88 118.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -98.15 121.13 39.71 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.8 m -119.55 145.95 45.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -150.56 121.24 7.5 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.23 139.8 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.1 m-85 -128.3 126.77 41.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.89 139.03 31.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.486 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.07 125.62 10.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.212 -0.93 . . . . 0.0 111.289 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.699 179.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.327 0.584 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 3.9 m-85 -99.39 -5.43 29.55 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.627 -0.67 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 p -71.92 117.8 13.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.147 -0.97 . . . . 0.0 111.805 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.26 -173.58 39.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.0 m120 -95.61 172.27 8.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -150.6 124.51 9.25 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.643 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -116.46 113.7 23.2 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 6.3 tt -53.05 152.76 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.73 0.776 . . . . 0.0 111.183 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.16 -25.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.99 -0.444 . . . . 0.0 110.543 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -152.42 -179.85 7.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 110.72 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 170.22 168.91 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.81 29.33 0.06 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.941 -1.1 . . . . 0.0 112.252 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -162.21 37.79 0.12 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.16 -0.962 . . . . 0.0 108.999 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE1' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.76 -63.33 1.41 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.562 -0.712 . . . . 0.0 109.558 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 17.3 mt-10 -57.52 -30.67 65.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.382 -0.824 . . . . 0.0 110.581 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -30.58 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.243 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.1 tp -78.71 -17.1 56.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.25 -19.97 23.51 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.067 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.1 mtmt -81.14 -30.6 34.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.72 -41.4 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.977 0.894 . . . . 0.0 108.848 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -66.59 -50.94 61.43 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.081 0.943 . . . . 0.0 109.279 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.23 -153.01 24.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -150.42 -37.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.956 -0.732 . . . . 0.0 110.335 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -60.9 -159.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.6 t -127.93 -47.34 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 0.0 109.471 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.3 ttt -65.82 -30.42 71.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.18 -28.19 67.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.724 -0.61 . . . . 0.0 110.49 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -89.49 -44.95 9.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.379 -0.825 . . . . 0.0 110.145 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -61.56 -25.08 67.08 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.632 -0.667 . . . . 0.0 110.895 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.5 -26.73 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 108.914 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.09 -25.89 36.66 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.631 -0.668 . . . . 0.0 109.232 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 3.0 t -80.67 -45.64 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.13 85.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.99 49.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.73 50.62 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.854 -0.529 . . . . 0.0 110.467 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.4 p -61.99 -34.03 75.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.707 -1.246 . . . . 0.0 108.236 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -162.93 74.31 2.0 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 32.9 Cg_endo -73.5 134.25 20.27 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.941 1.761 . . . . 0.0 111.267 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 177.3 7.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 19.1 t -155.98 164.58 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -153.51 113.17 3.85 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -105.71 141.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.705 0.764 . . . . 0.0 110.676 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HE3' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.84 117.09 27.24 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.3 tt0 -99.04 118.17 35.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.115 -0.99 . . . . 0.0 110.996 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -119.69 45.8 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.31 -128.56 9.57 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -74.35 -3.48 30.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -1.066 . . . . 0.0 110.006 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -96.45 133.86 40.35 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.81 -1.181 . . . . 0.0 108.142 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.8 m-85 -129.54 114.87 16.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.758 0.79 . . . . 0.0 109.7 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.4 t80 -99.67 148.02 24.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.5 mt -140.81 143.45 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.096 -1.002 . . . . 0.0 108.745 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -139.58 107.24 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.402 -0.811 . . . . 0.0 109.247 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 m -98.74 147.89 24.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -145.64 118.58 8.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.327 -0.858 . . . . 0.0 110.37 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 76.1 p . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 156.49 18.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.449 -0.782 . . . . 0.0 109.877 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -151.05 103.08 3.01 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.8 pt -102.85 165.46 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.328 -0.857 . . . . 0.0 108.945 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.18 129.15 3.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.075 -1.015 . . . . 0.0 109.201 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 85' ' ' VAL . 48.3 p90 -161.48 -172.4 3.35 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.344 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -128.86 153.37 47.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.4 95.52 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.145 -0.972 . . . . 0.0 109.755 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.05 -33.89 1.58 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.672 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.99 154.99 23.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -1.088 . . . . 0.0 109.978 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -86.12 168.02 14.41 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.65 175.27 11.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.0 109.567 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.33 144.67 31.31 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.11 -177.71 5.93 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -99.6 155.47 17.58 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -93.26 -142.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.4 -0.812 . . . . 0.0 109.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.39 -20.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -87.21 -39.23 15.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.186 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.31 44.82 0.14 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -132.36 151.82 78.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.739 -0.859 . . . . 0.0 109.311 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.81 142.13 17.54 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.603 1.535 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 p -161.04 142.32 11.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.673 -0.642 . . . . 0.0 109.81 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.55 113.69 25.75 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.3 t -102.08 175.2 5.61 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.139 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 84' ' ' LEU . 50.6 tp -151.32 152.92 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 6.1 t -140.81 126.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.762 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -119.51 155.62 31.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.437 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.2 m95 -77.46 173.3 12.12 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.018 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -136.07 -46.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.9 p -131.52 -152.61 0.51 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -78.06 -25.92 47.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -142.96 26.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 110.782 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -132.16 111.2 11.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.937 -1.102 . . . . 0.0 108.084 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.437 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.4 ptm -117.94 149.58 40.67 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.388 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.66 172.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.7 t -149.13 128.71 13.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 0.0 110.731 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -99.9 163.5 12.42 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -160.35 142.15 12.65 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.963 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -146.82 148.92 32.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -58.94 166.49 1.96 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.985 . . . . 0.0 110.972 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.3 mt -97.44 -6.5 33.77 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -152.27 141.13 21.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 108.962 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.91 -159.78 39.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -176.8 141.19 0.35 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.998 . . . . 0.0 109.665 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.68 -84.77 0.05 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.04 -176.54 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.89 1.727 . . . . 0.0 110.022 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -136.08 137.59 41.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.41 145.3 48.41 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.101 0.953 . . . . 0.0 110.676 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.77 130.08 3.66 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -134.13 172.1 13.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.041 -1.037 . . . . 0.0 110.121 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 p -135.15 175.21 9.79 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 111' ' ' MET . 8.4 ptp -158.08 133.8 9.06 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -131.81 147.68 52.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.386 -0.821 . . . . 0.0 109.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.96 143.17 38.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.406 ' N ' HD11 ' A' ' 113' ' ' LEU . 16.3 p -90.97 160.29 15.72 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.648 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -60.19 -21.54 61.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.666 -0.646 . . . . 0.0 110.064 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.59 -29.81 25.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.97 -8.97 7.14 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.11 174.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.0 tt -146.04 110.27 5.0 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.914 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 tt -106.11 146.32 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.76 141.96 51.44 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.639 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.49 171.99 7.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.3 mtp -152.75 165.11 36.35 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.583 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.23 152.99 39.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.48 97.46 1.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.627 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.95 -79.83 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.33 24.26 1.02 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 109.387 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.75 -179.72 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.83 117.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.374 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 6.4 t -98.93 133.95 42.47 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -125.61 125.73 43.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -122.38 101.54 7.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.18 136.95 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.409 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 28.3 m-85 -127.9 130.79 49.08 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.416 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.5 137.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -49.12 128.63 16.71 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.211 -0.931 . . . . 0.0 111.634 -178.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.688 179.643 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.751 0.786 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 2.6 m-85 -99.59 -2.74 34.9 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.634 -0.666 . . . . 0.0 109.441 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -70.53 118.5 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.944 . . . . 0.0 112.186 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.46 -172.08 38.46 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.77 170.48 9.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.23 122.17 7.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.609 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -114.13 114.49 26.13 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.4 tt -57.68 153.64 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.928 0.87 . . . . 0.0 111.326 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.25 -31.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 173.08 12.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.338 -0.851 . . . . 0.0 108.842 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t 179.94 165.29 1.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.303 -0.873 . . . . 0.0 109.715 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -159.99 163.12 34.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.748 -0.595 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 26.6 m-80 62.64 33.3 15.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.72 . . . . 0.0 109.719 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -75.7 -64.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 110.165 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 18.7 mt-10 -56.91 -33.82 67.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.869 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.7 66.04 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.467 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.61 -21.4 52.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.037 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.439 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -88.99 -16.13 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.036 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -86.14 -32.6 21.2 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -75.14 -38.91 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -69.28 -45.63 69.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.797 0.808 . . . . 0.0 109.476 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.8 -159.56 27.66 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.63 -38.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.963 -0.728 . . . . 0.0 110.051 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -61.28 -156.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.422 -0.799 . . . . 0.0 109.138 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.45 -47.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.429 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.5 ttt -68.01 -27.98 67.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.94 -16.96 34.17 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.684 -0.635 . . . . 0.0 111.243 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.11 -50.14 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.009 . . . . 0.0 110.048 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -23.38 67.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.73 . . . . 0.0 110.717 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.3 mt -77.17 -28.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 108.768 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.15 35.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 13.5 t -76.06 -37.98 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.88 46.33 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.57 92.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -70.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t 48.51 52.62 13.41 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.497 0.665 . . . . 0.0 109.763 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 66.23 70.39 0.52 Allowed Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.87 164.55 35.25 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.988 1.792 . . . . 0.0 111.027 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.36 173.77 6.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -154.8 166.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -154.38 110.24 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.8 mt -97.33 133.52 38.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.845 0.831 . . . . 0.0 110.298 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 6.8 mttm -107.94 93.79 4.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.72 125.53 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.4 -0.813 . . . . 0.0 110.373 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.45 59.36 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.64 -130.05 10.15 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 1.1 p30 -74.65 -2.42 26.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.394 -1.062 . . . . 0.0 110.209 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -96.93 137.05 36.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.571 -1.331 . . . . 0.0 108.269 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE2' ' NE2' ' A' ' 45' ' ' GLN . 97.5 m-85 -135.35 125.97 27.05 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.69 0.757 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.3 t80 -108.74 143.06 38.37 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' CG1' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -130.05 106.54 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 106.21 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -99.22 146.82 25.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 108.896 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.7 p -142.69 134.31 26.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.433 -0.792 . . . . 0.0 110.323 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.87 0.843 . . . . 0.0 108.829 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 3.2 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.292 0.567 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -119.65 171.44 8.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -160.93 157.09 25.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' CG1' HG12 ' A' ' 52' ' ' ILE . 29.7 pt -144.22 170.72 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.56 -0.712 . . . . 0.0 109.157 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -161.6 134.65 6.23 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 45.8 p90 -162.96 -173.23 3.37 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.289 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -127.88 153.0 47.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.72 95.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.257 -0.902 . . . . 0.0 109.666 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.85 -24.57 1.63 Allowed Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.815 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -124.57 155.57 38.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.296 -1.12 . . . . 0.0 110.229 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.18 168.02 14.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.47 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.58 174.35 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.617 -0.677 . . . . 0.0 109.717 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -103.04 144.93 30.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -176.04 4.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.655 -0.653 . . . . 0.0 109.513 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.88 156.98 16.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -94.58 -143.82 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.375 -0.828 . . . . 0.0 109.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.4 t -111.59 -21.07 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.825 -1.172 . . . . 0.0 110.876 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -89.03 -39.84 13.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.649 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 46.89 0.09 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -136.3 151.99 74.28 Favored Pre-proline 0 C--N 1.306 -1.308 0 O-C-N 121.759 -0.847 . . . . 0.0 109.353 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.07 141.76 16.73 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.764 1.643 . . . . 0.0 110.512 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 p -161.01 142.26 11.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.666 -0.646 . . . . 0.0 109.707 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -86.68 117.65 25.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.24 164.48 12.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.845 -0.534 . . . . 0.0 109.731 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 tp -144.24 153.81 42.44 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' A' ' 65' ' ' PHE . 29.0 t -147.09 130.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 118.5 -1.28 . . . . 0.0 112.108 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -125.04 157.85 35.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.428 ' CE2' HG23 ' A' ' 67' ' ' VAL . 79.8 m95 -79.82 172.26 14.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -135.68 -45.85 0.67 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.8 p -131.47 -154.18 0.61 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -76.59 -25.13 53.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.666 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -144.36 26.88 1.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.823 . . . . 0.0 110.817 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -130.75 110.86 11.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.901 -1.124 . . . . 0.0 108.154 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.434 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 1.5 ptp -115.5 146.96 41.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.446 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.18 170.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 52.2 t -146.38 140.94 26.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.739 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.7 162.8 14.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -160.21 135.74 8.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 149.97 41.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.87 167.63 2.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.64 -6.55 29.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.02 143.66 19.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.77 -162.66 34.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.99 139.38 0.38 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.44 -1.035 . . . . 0.0 109.975 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.18 -85.84 0.05 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.86 -176.94 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.811 1.674 . . . . 0.0 109.721 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -135.29 139.67 44.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.14 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.139 0.971 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.3 m -163.01 139.1 7.1 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -142.64 173.25 11.71 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.037 -1.039 . . . . 0.0 110.568 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.0 p -137.58 172.65 12.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.909 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.402 ' HE1' ' CZ3' ' A' ' 109' ' ' TRP . 11.6 ptp -160.11 136.34 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.406 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.6 pt-20 -135.41 154.76 51.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.237 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.71 144.36 42.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.7 p -91.18 159.95 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.406 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.73 -19.45 50.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.591 -0.693 . . . . 0.0 110.45 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.98 -28.54 21.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.3 -9.16 7.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -57.63 172.67 0.34 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.082 -1.246 . . . . 0.0 109.11 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 8.0 tt -147.13 112.15 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.251 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 120' ' ' ILE . 14.3 tt -108.52 148.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -131.35 137.99 48.99 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.363 -0.836 . . . . 0.0 109.684 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.54 170.75 8.02 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.8 mtp -147.65 168.19 22.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.573 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.1 m -151.85 150.94 30.67 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.9 94.21 1.42 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.534 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.9 -78.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -146.88 24.62 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.13 -179.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.4 t -157.33 119.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.827 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -99.46 123.25 43.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.4 m -116.61 148.04 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -151.94 120.37 6.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 50.3 t -82.38 137.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.005 . . . . 0.0 108.351 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.8 m-85 -127.28 124.99 40.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.351 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.64 139.85 28.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.483 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.12 125.72 11.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.176 -0.952 . . . . 0.0 111.193 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.942 -1.028 . . . . 0.0 111.607 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.322 0.582 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.5 m-85 -98.86 -1.78 39.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.712 -0.617 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 t -70.9 116.61 11.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.144 -0.972 . . . . 0.0 112.011 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.45 -172.83 39.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.8 168.23 10.78 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.67 124.65 8.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.566 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -118.83 112.59 19.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.7 tt -54.25 143.92 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.626 0.727 . . . . 0.0 110.882 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.61 -24.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.999 -0.438 . . . . 0.0 109.936 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.05 174.24 10.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.282 -0.886 . . . . 0.0 110.069 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t 170.2 168.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.62 28.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.91 -1.119 . . . . 0.0 111.654 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.53 29.65 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -178.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -64.05 -66.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -0.851 . . . . 0.0 108.752 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 15.4 mt-10 -55.97 -31.1 62.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -61.29 -38.46 86.88 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.129 0.49 . . . . 0.0 110.469 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -80.17 -17.45 52.41 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.717 -0.614 . . . . 0.0 110.137 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -89.67 -17.65 27.96 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.088 -1.007 . . . . 0.0 109.013 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -84.05 -32.19 24.98 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.28 -40.21 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.84 -46.28 72.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.838 0.827 . . . . 0.0 109.6 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.16 -157.01 27.16 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.341 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -148.78 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 122.037 -0.684 . . . . 0.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.65 -156.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.474 -0.767 . . . . 0.0 109.132 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.97 -47.09 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 109.695 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 ttp -68.16 -28.36 67.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.49 -23.79 63.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.811 -0.556 . . . . 0.0 110.64 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.4 ' CZ ' ' HD2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -91.33 -46.91 7.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.905 . . . . 0.0 109.727 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -62.15 -20.88 64.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.664 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.54 -28.92 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.261 -0.9 . . . . 0.0 108.925 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -26.05 34.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 9.8 t -76.48 -41.21 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.62 64.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.92 97.47 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.43 -66.19 0.59 Allowed 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.566 -0.708 . . . . 0.0 109.289 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m 52.83 57.64 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 66.71 73.61 0.38 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.0 Cg_endo -70.91 153.39 63.69 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 122.167 1.912 . . . . 0.0 111.003 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.28 174.02 6.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.698 -0.626 . . . . 0.0 109.464 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 47.2 t -154.86 165.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 43.1 tt0 -149.7 112.47 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mp -97.81 133.88 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.806 0.812 . . . . 0.0 110.264 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.05 106.29 14.23 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 61.2 tt0 -97.55 126.43 42.83 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.078 -1.014 . . . . 0.0 111.36 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -125.76 55.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -126.94 8.62 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.53 -0.33 22.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 110.12 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -97.22 139.98 32.38 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.72 -1.237 . . . . 0.0 108.498 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 96.7 m-85 -134.57 118.27 17.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.536 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.2 t80 -102.78 144.98 30.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 3.3 mt -140.67 101.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -98.92 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.572 -0.705 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 m -99.38 141.01 32.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.55 118.92 17.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 110.434 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -95.66 175.43 6.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.3 pm0 -171.35 142.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.04 171.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.524 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.89 130.58 4.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.178 -0.951 . . . . 0.0 109.217 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.5 p90 -162.07 -172.17 3.14 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 153.35 48.28 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.35 89.26 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.143 -0.973 . . . . 0.0 109.661 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.1 -23.26 0.99 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.938 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -122.02 154.94 36.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -86.26 165.56 16.37 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.18 173.93 13.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.866 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -102.28 146.74 27.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -162.53 -175.49 4.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 109.408 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -101.01 155.65 17.86 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -93.89 -143.75 0.24 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.354 -0.841 . . . . 0.0 109.12 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -112.67 -19.87 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.807 -1.183 . . . . 0.0 110.638 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -88.04 -40.89 13.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.44 44.77 0.1 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -135.98 154.13 77.42 Favored Pre-proline 0 C--N 1.308 -1.229 0 O-C-N 121.654 -0.91 . . . . 0.0 109.095 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 144.61 20.92 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.7 1.6 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.5 p -161.24 141.75 11.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.688 -0.633 . . . . 0.0 109.616 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -88.02 117.21 26.73 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 4.0 t -99.94 168.11 10.07 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.207 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -150.61 152.99 34.89 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 25.9 t -144.08 135.88 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.236 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -128.3 159.23 35.93 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.434 ' CE2' HG23 ' A' ' 67' ' ' VAL . 88.6 m95 -84.97 167.3 16.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 110.062 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -129.79 -45.61 1.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.6 p -131.83 -154.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.31 -25.38 51.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -142.67 26.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.898 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -131.41 104.96 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 108.302 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.417 ' HE2' ' CH2' ' A' ' 87' ' ' TRP . 1.2 ptp -112.22 147.55 35.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.581 -0.699 . . . . 0.0 110.221 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.57 169.05 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.9 t -144.55 140.76 29.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.169 -0.957 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.55 160.73 15.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -158.95 139.6 12.57 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.433 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -143.53 150.56 39.07 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.42 166.39 3.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.7 mt -99.74 -4.24 31.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.95 130.68 15.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 108.672 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.49 -159.46 45.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -176.82 141.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.469 -1.018 . . . . 0.0 109.713 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.29 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.46 -176.78 2.91 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.804 1.669 . . . . 0.0 109.752 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -131.95 142.8 49.74 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.2 146.32 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.85 126.75 2.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -130.86 163.94 26.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.136 -0.977 . . . . 0.0 110.39 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.6 p -130.02 166.44 20.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.2 ptp -150.01 117.75 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 151.98 28.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.433 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -117.06 143.12 46.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.4 p -94.35 178.46 5.61 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.932 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -75.76 -24.15 56.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.641 -0.662 . . . . 0.0 110.448 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.73 -19.64 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.741 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 119.41 -5.13 13.27 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.1 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.48 177.99 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 118.924 1.362 . . . . 0.0 108.439 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.8 tt -153.4 115.89 4.43 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.965 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.27 154.59 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.61 109.2 7.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.09 167.21 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 38.4 mtp -145.93 164.35 32.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.552 -0.717 . . . . 0.0 109.603 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.9 m -146.89 152.67 39.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.73 94.94 1.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.537 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.52 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -148.11 23.72 1.06 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.57 -0.706 . . . . 0.0 109.382 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.23 -179.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.423 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -157.46 117.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.456 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.7 t -99.37 111.7 24.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 75.1 m -99.26 152.74 19.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.866 0.841 . . . . 0.0 109.469 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 134' ' ' TYR . 27.7 mtm180 -151.88 94.83 2.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.61 128.74 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.5 m-85 -115.82 133.88 55.58 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.491 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.85 137.75 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.479 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.9 mtm180 -47.38 124.22 6.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.387 -0.821 . . . . 0.0 111.468 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.755 179.816 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.708 0.766 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 m-85 -111.58 0.54 16.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -72.95 117.5 14.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 112.13 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.86 -171.74 37.86 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.446 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 169.39 10.05 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.5 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -150.38 118.6 6.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.591 -177.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -110.51 113.74 26.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE2' ' A' ' 134' ' ' TYR . 11.1 tt -55.61 157.78 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.921 0.867 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 -32.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.497 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -146.13 170.33 16.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 108.812 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.6 t 177.64 141.24 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -136.58 178.44 7.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.701 -0.625 . . . . 0.0 109.875 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 72.2 m-20 58.86 26.59 15.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.728 . . . . 0.0 109.99 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' CZ ' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t80 -65.55 -62.95 1.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.822 . . . . 0.0 109.072 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 8.4 pt-20 -58.73 -29.13 66.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.643 -0.661 . . . . 0.0 109.565 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.01 -39.61 93.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.738 -0.601 . . . . 0.0 110.235 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 47.6 tp -82.02 -13.97 56.6 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.708 -0.62 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -91.34 -20.27 22.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.931 -1.106 . . . . 0.0 109.11 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.5 mtmt -83.32 -29.58 28.18 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.79 -41.82 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.66 -56.39 10.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 122.381 1.086 . . . . 0.0 108.523 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.59 -145.84 15.6 Favored Glycine 0 N--CA 1.489 2.221 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.79 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -156.29 -37.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.706 . . . . 0.0 110.364 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.51 -175.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.204 -0.935 . . . . 0.0 110.126 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.3 -44.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.554 -0.716 . . . . 0.0 109.574 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 37.1 ttp -65.41 -24.75 67.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.11 -40.14 95.56 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.675 -0.64 . . . . 0.0 110.57 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -70.54 -48.33 55.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.379 -0.825 . . . . 0.0 110.139 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -55.72 -46.65 77.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.1 -26.07 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.801 . . . . 0.0 109.688 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -81.25 -21.95 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.353 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.12 -44.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.29 91.63 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.63 -53.28 56.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -83.93 37.71 0.61 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.868 -0.52 . . . . 0.0 110.511 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 t -66.02 -34.09 77.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.796 -1.19 . . . . 0.0 108.501 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -157.27 69.68 4.37 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -74.24 137.37 23.47 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 121.948 1.765 . . . . 0.0 110.2 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.57 166.86 15.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.583 -0.698 . . . . 0.0 109.37 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG21 ' CG2' ' A' ' 54' ' ' THR . 16.0 t -154.34 127.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -117.9 111.02 18.45 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.5 mt -98.33 132.16 43.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.728 0.775 . . . . 0.0 110.334 -178.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttm -106.48 94.15 4.98 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.68 123.85 40.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.344 -0.848 . . . . 0.0 110.366 -177.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -132.61 68.17 1.51 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.11 -130.59 10.26 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -75.43 -1.6 24.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.357 -1.084 . . . . 0.0 110.388 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -95.98 139.28 32.4 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.701 -1.249 . . . . 0.0 109.003 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.9 m-85 -136.31 118.81 15.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.753 0.787 . . . . 0.0 108.951 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 52' ' ' ILE . 16.2 t80 -104.41 150.85 24.17 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -149.35 104.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.895 -1.128 . . . . 0.0 111.288 -176.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -103.23 102.44 12.41 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.419 ' CG2' HG21 ' A' ' 41' ' ' VAL . 32.5 m -98.09 127.1 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.849 . . . . 0.0 109.359 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.11 130.48 53.76 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.799 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.267 0.556 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 p -156.86 156.41 33.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.45 109.19 2.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 110.247 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.5 164.32 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p-10 -162.44 132.25 4.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.131 -0.981 . . . . 0.0 109.497 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.7 p90 -161.87 -171.42 2.89 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.224 1.011 . . . . 0.0 111.83 -178.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.85 154.72 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.28 93.9 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.09 -1.006 . . . . 0.0 109.657 -178.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.26 -19.46 0.63 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.683 -1.246 . . . . 0.0 111.298 179.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.9 160.7 37.42 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.121 -1.223 . . . . 0.0 111.205 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -86.63 164.83 16.6 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.1 p90 -162.2 173.62 14.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -102.1 144.53 30.56 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.36 -176.67 5.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.62 . . . . 0.0 109.363 -179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.27 157.3 16.7 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.4 t -93.05 -144.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -0.867 . . . . 0.0 109.258 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 t -107.75 -22.2 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.856 -1.152 . . . . 0.0 110.571 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -86.62 -47.71 8.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 108.955 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.1 151.69 78.86 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.671 -0.899 . . . . 0.0 109.226 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.35 140.5 17.36 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.618 1.545 . . . . 0.0 110.374 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.3 p -161.05 142.38 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -88.25 118.56 27.93 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -99.57 168.08 10.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.496 0.665 . . . . 0.0 110.459 -178.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.2 tp -148.0 149.95 33.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 5.3 t -141.78 134.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.111 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -130.47 161.83 30.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.426 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 85.0 m95 -85.44 170.27 12.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -133.63 -45.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -132.9 -153.18 0.53 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.97 -23.78 44.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -143.0 22.26 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.834 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -130.78 111.81 12.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.832 -1.167 . . . . 0.0 108.639 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.46 ' CE ' ' CE2' ' A' ' 50' ' ' PHE . 3.7 ptp -116.0 154.97 28.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.601 -0.687 . . . . 0.0 109.981 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.8 t -108.92 168.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.41 132.81 20.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -104.02 158.11 16.64 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -154.76 142.04 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.91 -177.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -144.0 150.87 38.94 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.59 168.17 2.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 110.783 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.2 mt -99.79 -5.29 28.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -153.99 138.7 17.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 108.84 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.63 -158.79 39.56 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -176.33 140.55 0.39 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.475 -1.015 . . . . 0.0 109.888 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.83 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.96 -176.7 2.75 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.822 1.681 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -134.31 137.24 44.07 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.69 145.81 47.64 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.123 0.963 . . . . 0.0 110.854 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.41 131.56 4.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -134.98 169.78 16.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.364 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.7 p -134.34 170.17 16.13 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.5 0.667 . . . . 0.0 109.817 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.426 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 6.6 ptm -153.05 124.38 7.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -119.05 152.39 36.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.431 -0.793 . . . . 0.0 110.185 -178.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.77 144.43 44.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.8 p -89.87 167.12 13.08 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.802 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -63.81 -20.36 65.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.647 -0.658 . . . . 0.0 110.687 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.35 -32.66 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.06 -13.24 2.84 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.704 -1.236 . . . . 0.0 111.336 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -53.11 170.89 0.08 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 118.828 1.314 . . . . 0.0 109.345 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.9 tt -147.36 114.23 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.725 -178.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.19 158.62 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.81 134.37 30.08 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.393 -0.817 . . . . 0.0 109.57 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.0 170.04 8.57 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 17.6 mtp -147.8 164.53 33.34 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.178 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 m -148.46 151.97 36.11 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.448 0.642 . . . . 0.0 109.434 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -158.35 96.88 1.45 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.518 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.86 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.44 24.41 1.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.559 -0.713 . . . . 0.0 109.268 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.87 -179.29 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.78 118.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.651 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -98.33 115.57 28.72 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.6 m -110.8 147.63 34.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 -179.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 120.74 6.34 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.78 142.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -129.39 133.28 47.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.59 139.31 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.1 125.29 10.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.244 -0.91 . . . . 0.0 111.33 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.602 179.466 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.261 0.553 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.449 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 6.3 m-85 -99.37 -10.92 21.66 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.712 -0.617 . . . . 0.0 109.576 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 t -65.71 115.39 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.219 -0.925 . . . . 0.0 111.819 -177.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.78 -172.71 39.73 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.71 168.49 10.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 178.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.72 124.63 8.57 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.375 -177.288 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -118.91 112.95 20.29 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.11 140.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.41 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.95 -23.18 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.9 -0.5 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.42 172.81 12.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t 171.29 168.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.15 29.97 0.12 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.948 -1.095 . . . . 0.0 111.713 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.09 33.55 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.285 -0.884 . . . . 0.0 109.082 -178.51 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -65.7 -66.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -0.784 . . . . 0.0 108.979 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 pt-20 -57.5 -26.73 61.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -64.3 -39.66 94.36 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.65 -0.656 . . . . 0.0 109.706 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -80.17 -15.3 57.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.697 -0.627 . . . . 0.0 110.016 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.05 -19.8 23.96 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.976 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmt -84.98 -28.15 25.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.82 -41.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.93 -53.71 35.79 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.04 0.924 . . . . 0.0 109.114 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 -151.62 23.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.56 -42.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.981 -0.717 . . . . 0.0 109.407 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -56.37 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.793 . . . . 0.0 109.681 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.2 -43.77 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.03 -26.69 66.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.532 -0.73 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.61 -45.26 85.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.681 -0.637 . . . . 0.0 110.491 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 4.2 mtp180 -67.34 -40.95 85.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -62.75 -24.38 67.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.678 -0.639 . . . . 0.0 110.838 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.2 mt -78.67 -28.81 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.062 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.42 -24.92 34.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 109.237 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.9 t -79.22 -38.72 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.67 -35.65 62.81 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.03 -37.58 81.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.1 -67.7 0.43 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t 49.87 50.46 18.38 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm 66.3 74.19 0.37 Allowed Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -71.72 146.21 48.09 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 122.01 1.807 . . . . 0.0 110.797 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.56 175.48 6.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.765 -0.584 . . . . 0.0 109.778 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 24.7 t -155.31 165.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.9 tt0 -149.88 112.87 4.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.44 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.7 mt -99.85 140.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.806 0.812 . . . . 0.0 110.443 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.9 mttt -119.14 114.37 22.36 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 57.1 tt0 -98.9 111.61 23.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.0 110.786 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -115.57 47.95 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.18 -127.57 9.07 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -74.85 -3.28 31.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.444 -1.033 . . . . 0.0 110.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 m -96.39 134.9 38.97 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.689 -1.257 . . . . 0.0 108.309 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 95.9 m-85 -131.37 119.2 21.34 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.875 0.845 . . . . 0.0 109.22 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.0 t80 -104.61 133.16 49.92 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.5 mm -115.45 137.18 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -132.4 98.65 4.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.0 108.704 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 17.8 m -98.45 145.37 26.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.446 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.59 136.42 24.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.853 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.848 0.832 . . . . 0.0 109.511 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 152.83 19.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.409 -0.807 . . . . 0.0 109.123 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -150.98 101.7 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.563 -0.711 . . . . 0.0 109.735 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.403 ' CG1' HG12 ' A' ' 52' ' ' ILE . 26.2 pt -104.71 167.35 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.632 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.78 132.49 5.07 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.483 -0.761 . . . . 0.0 109.064 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.3 p90 -161.88 -172.46 3.29 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.061 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.45 154.27 46.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.27 95.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -33.77 1.68 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.712 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.42 153.77 23.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.367 -1.078 . . . . 0.0 109.977 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.96 166.95 15.51 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.24 173.3 14.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.875 -178.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.13 145.04 30.52 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.11 -178.21 6.24 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.62 155.2 17.72 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 t -91.66 -152.2 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 109.331 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.29 -20.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.992 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.61 -50.86 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.211 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.06 44.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -130.67 152.01 79.72 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 121.613 -0.933 . . . . 0.0 109.127 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.54 141.05 17.36 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.581 1.521 . . . . 0.0 110.431 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 p -161.07 142.02 11.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -90.65 115.08 27.48 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -102.95 176.66 5.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.36 152.15 31.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 6.5 t -140.87 125.54 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.543 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -120.47 156.0 32.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 83.8 m95 -77.91 172.28 13.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.805 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -134.52 -46.61 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.9 p -129.27 -152.79 0.53 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.17 -24.98 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -143.3 25.68 1.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -131.06 108.29 9.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.82 -1.175 . . . . 0.0 108.211 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.46 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.6 ptm -114.47 148.21 38.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.366 -0.834 . . . . 0.0 110.239 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.66 172.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.37 129.81 14.82 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.754 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.21 141.35 12.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.9 -178.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -145.75 148.4 32.94 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 110.872 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.98 -7.09 33.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -154.18 146.31 23.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.839 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.73 -162.51 34.23 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -176.94 140.14 0.3 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -1.033 . . . . 0.0 109.798 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.92 -84.79 0.05 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.93 -176.79 2.8 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.883 1.722 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -137.74 139.22 39.99 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.24 146.04 47.65 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.072 0.939 . . . . 0.0 110.669 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -162.61 131.27 4.07 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -135.85 170.05 16.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.968 -1.082 . . . . 0.0 110.362 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 p -133.55 165.33 25.14 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.462 0.649 . . . . 0.0 109.395 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.415 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 8.3 ptm -152.72 124.86 8.04 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.5 pt-20 -129.98 158.8 38.58 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.965 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.65 145.2 41.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 p -92.38 161.26 14.73 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.425 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.72 -18.62 55.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.528 -0.732 . . . . 0.0 110.515 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -88.39 -27.02 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.17 -7.87 8.58 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.97 172.33 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.243 . . . . 0.0 108.579 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -145.64 113.11 6.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.065 -178.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 12.5 tt -99.76 151.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.87 112.14 11.05 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 166.51 11.19 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 31.1 mtp -145.4 163.97 32.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.543 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 m -146.12 152.35 39.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.56 95.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.548 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 78.08 -79.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -147.64 23.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.25 -179.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -157.16 117.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.594 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.6 112.64 24.84 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -99.2 153.81 18.64 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.847 0.832 . . . . 0.0 109.139 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.408 ' O ' ' CD2' ' A' ' 134' ' ' TYR . 36.5 mtm180 -151.42 93.6 1.91 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.54 127.39 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.7 m-85 -114.79 130.34 56.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.239 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.24 138.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.57 124.12 6.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.307 -0.871 . . . . 0.0 111.391 -178.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.702 179.907 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.34 0.591 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 5.3 m-85 -99.59 -18.08 17.52 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -60.65 116.21 4.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 111.827 -177.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.33 -173.06 39.43 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -96.03 169.53 9.91 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.498 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -151.95 126.21 9.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.718 -176.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -117.36 113.08 21.59 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -61.59 140.99 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.711 0.767 . . . . 0.0 110.236 -178.929 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.36 -22.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.597 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -133.22 167.29 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.159 -0.963 . . . . 0.0 110.442 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 170.05 167.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -161.04 29.3 0.14 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.019 -1.05 . . . . 0.0 111.289 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.85 34.3 0.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.06 -65.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.534 -0.729 . . . . 0.0 109.235 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.2 mt-10 -58.65 -26.44 63.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.429 -0.795 . . . . 0.0 109.138 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.11 -38.12 89.92 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.717 -0.614 . . . . 0.0 109.841 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.58 -16.28 52.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.686 -0.634 . . . . 0.0 110.033 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.67 -19.25 25.07 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.947 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -85.84 -29.09 24.01 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.651 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.5 -41.25 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.0 -52.51 48.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.001 0.905 . . . . 0.0 108.905 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.32 -147.58 19.63 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -154.91 -41.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.927 -0.749 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -57.68 -171.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.536 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.14 -43.91 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 110.077 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.81 -29.52 68.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.39 -46.31 76.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -64.49 -39.75 94.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.429 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -63.41 -15.68 58.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.575 . . . . 0.0 111.22 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mm -84.2 -30.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 108.709 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.99 -25.36 32.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.0 t -80.4 -44.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.49 85.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -48.95 77.65 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.87 -72.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.954 -0.466 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t 47.39 48.56 16.41 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.574 0.702 . . . . 0.0 109.171 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.2 mttp 71.19 73.23 0.26 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -177.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -71.4 -179.54 3.72 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.053 1.836 . . . . 0.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.36 172.56 8.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.464 -0.773 . . . . 0.0 110.401 -178.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 41.2 t -155.31 166.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 12.7 tm-20 -155.47 111.33 3.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 108.768 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mp -96.48 143.16 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.964 0.888 . . . . 0.0 110.151 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 2.7 mttm -119.73 108.66 14.69 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.3 tt0 -98.52 117.41 32.89 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.05 . . . . 0.0 110.993 -178.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -119.43 45.92 2.02 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.44 -127.41 9.13 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.93 -3.05 26.66 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -1.079 . . . . 0.0 110.045 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -96.73 133.98 40.58 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.623 -1.298 . . . . 0.0 108.196 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.5 m-85 -130.41 122.86 28.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.763 0.792 . . . . 0.0 109.164 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.2 t80 -106.03 140.46 38.99 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.429 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.3 mm -123.95 110.88 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -107.79 100.56 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -99.65 143.57 29.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 0.0 109.01 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 p -156.56 125.88 6.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.306 -1.312 0 O-C-N 121.705 -0.622 . . . . 0.0 110.021 -179.54 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.6 p -106.76 160.87 15.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.04 136.62 14.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.314 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.429 ' CG1' HG12 ' A' ' 52' ' ' ILE . 27.2 pt -138.81 168.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.554 -0.716 . . . . 0.0 109.394 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.51 132.78 5.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 43.5 p90 -162.05 -173.61 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.948 -1.101 . . . . 0.0 112.095 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -127.94 154.25 45.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.43 93.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.069 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.15 -23.64 1.58 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.727 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.87 156.99 35.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.279 -1.13 . . . . 0.0 110.119 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.61 169.58 12.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.693 -0.629 . . . . 0.0 109.357 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 11.8 p90 -162.41 174.24 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.371 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -111.43 143.11 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.4 pm0 -162.43 -168.66 1.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.449 0.642 . . . . 0.0 109.341 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -99.9 159.52 15.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -94.77 -144.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 109.02 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -107.33 -19.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.841 -1.162 . . . . 0.0 110.74 -179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.24 -44.93 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.17 45.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -132.67 152.57 80.17 Favored Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.634 -0.921 . . . . 0.0 109.232 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.73 140.41 16.48 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.707 1.605 . . . . 0.0 110.471 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.5 p -160.76 143.41 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.632 -0.667 . . . . 0.0 109.822 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -90.9 120.3 31.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -103.52 168.43 9.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.671 -0.643 . . . . 0.0 110.299 -178.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -147.54 153.2 39.17 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.453 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 13.3 t -145.46 126.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.962 -178.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -120.2 155.54 32.95 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.44 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 79.4 m95 -77.89 173.88 11.66 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.857 0.837 . . . . 0.0 110.27 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -136.73 -45.98 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -131.83 -153.41 0.55 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -25.6 52.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 110.042 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -143.93 27.38 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.817 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -132.39 110.73 10.76 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.44 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -117.41 149.86 39.85 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.285 -179.229 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.43 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.412 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 42.0 t -147.71 141.12 25.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.976 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.06 162.3 14.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.27 135.52 8.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.82 -178.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -142.47 154.21 44.34 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.21 169.38 5.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.041 -1.037 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.1 mt -101.47 -5.64 25.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.38 135.11 12.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.904 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.78 -160.46 37.62 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -175.86 139.2 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.426 -1.044 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.42 -88.38 0.09 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.13 -176.78 2.75 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.677 1.585 . . . . 0.0 109.368 178.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -131.53 141.31 49.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.94 145.02 48.85 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.141 0.972 . . . . 0.0 110.686 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -162.96 136.75 6.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.412 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.8 p-90 -144.54 175.57 10.04 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.522 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -139.61 171.83 13.68 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.499 0.666 . . . . 0.0 109.636 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.8 ptp -153.56 139.29 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -136.94 150.18 48.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 109.522 -178.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.1 140.91 48.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.464 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.2 p -89.72 160.15 16.72 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.471 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -60.18 -20.59 59.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 110.29 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.18 -29.74 24.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.232 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.52 -9.31 6.9 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -57.34 171.9 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.108 -1.231 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.498 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.2 tt -144.73 107.95 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.973 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -103.4 147.65 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.72 145.33 51.91 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.55 162.34 19.77 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 22.0 mtp -143.99 162.1 37.05 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.324 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.2 m -145.89 152.41 39.42 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.73 97.24 1.3 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.489 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.78 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.12 23.85 0.94 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.5 -0.75 . . . . 0.0 109.506 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.2 179.34 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.98 116.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.63 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.73 113.7 26.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.625 . . . . 0.0 109.576 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -103.11 128.92 49.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.413 -0.805 . . . . 0.0 109.312 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -126.56 102.89 7.3 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.19 132.59 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.432 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -122.08 121.69 37.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.513 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.08 140.24 22.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.18 125.31 10.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.269 -0.894 . . . . 0.0 111.303 -178.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.667 179.582 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.36 0.6 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.8 m-85 -99.16 -15.17 19.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -63.17 115.54 4.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -0.819 . . . . 0.0 111.597 -177.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.04 -172.04 39.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -96.14 169.2 10.12 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -151.1 120.89 7.04 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.619 -177.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -112.75 112.22 23.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.3 tt -56.0 141.67 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.667 0.746 . . . . 0.0 110.842 -178.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.71 -23.55 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.959 -0.463 . . . . 0.0 110.171 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mtt-85 -143.73 170.64 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.877 . . . . 0.0 110.393 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t 170.65 167.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.02 31.83 0.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 111.988 -179.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.13 29.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.075 -1.016 . . . . 0.0 109.803 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.59 -60.03 3.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.775 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 24.3 mt-10 -58.09 -29.07 65.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 111.283 -178.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.421 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 1.7 pt-20 -72.63 -27.39 62.11 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.734 -178.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 2.2 tp -83.34 -18.81 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 15' ' ' PHE . 14.1 mt -90.25 -16.18 29.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.11 -0.994 . . . . 0.0 109.094 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.8 -33.01 21.49 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.634 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.09 -40.53 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -66.95 -48.06 69.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.883 0.849 . . . . 0.0 108.921 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.11 21.09 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -154.8 -42.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.825 -0.809 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -57.14 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 0.0 109.66 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.47 -43.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.813 . . . . 0.0 110.096 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -27.12 65.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.29 -48.13 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.669 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.793 . . . . 0.0 110.213 -178.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.23 -23.49 64.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 111.615 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.78 -27.5 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.42 -26.41 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 3.5 t -79.1 -46.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.1 75.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.95 92.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HA ' HG23 ' A' ' 56' ' ' THR . . . -64.46 -66.96 0.47 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.4 -0.812 . . . . 0.0 109.161 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 p 51.83 61.61 3.13 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.87 70.85 0.46 Allowed Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 30.2 Cg_endo -71.53 139.73 34.9 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 122.102 1.868 . . . . 0.0 110.857 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.39 176.5 7.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 25.5 t -154.86 165.67 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.5 tt0 -154.05 113.2 3.72 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.3 mp -100.17 149.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.759 0.79 . . . . 0.0 110.19 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 4.3 mttt -129.01 106.4 8.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 66.7 tt0 -98.22 120.44 38.64 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 111.191 -177.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -123.76 49.14 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -130.17 10.14 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -2.96 30.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.201 178.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -97.43 118.59 34.25 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.857 -1.152 . . . . 0.0 108.782 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 85.3 m-85 -114.11 127.57 55.98 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.867 0.842 . . . . 0.0 109.126 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 19.8 t80 -109.58 147.13 33.54 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -133.46 138.07 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.234 -0.916 . . . . 0.0 108.636 -178.891 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.28 103.66 5.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -98.41 143.13 29.19 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -140.46 118.14 11.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.206 -179.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.433 HG23 ' HA ' ' A' ' 36' ' ' ALA . 70.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -85.27 158.99 20.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -155.8 100.75 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 0.0 109.86 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.5 pt -101.78 168.27 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.516 -0.74 . . . . 0.0 109.33 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.02 135.3 5.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.438 -0.789 . . . . 0.0 109.603 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.486 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 42.2 p90 -162.61 -171.82 2.89 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.35 1.071 . . . . 0.0 112.358 -178.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -129.79 153.24 48.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.44 95.5 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.157 -0.964 . . . . 0.0 109.542 -179.135 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.98 -31.65 1.45 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.684 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -117.09 157.34 26.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -1.077 . . . . 0.0 110.127 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -86.05 169.42 13.19 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.06 172.85 15.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 -179.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -104.11 144.35 31.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.25 -176.86 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.99 158.73 15.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.6 t -92.6 -144.07 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.418 -0.801 . . . . 0.0 109.109 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.42 -21.61 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.857 -1.152 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.51 -46.93 8.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.414 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.47 44.71 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -129.95 152.41 79.9 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.572 -0.958 . . . . 0.0 108.994 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.83 140.69 16.48 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 121.696 1.597 . . . . 0.0 110.875 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.05 141.81 11.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -88.2 117.07 26.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 4.1 t -99.63 166.53 11.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.847 -0.533 . . . . 0.0 109.809 -178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -145.83 155.41 42.89 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' CE2' ' A' ' 65' ' ' PHE . 25.3 t -146.46 129.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.088 -178.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -123.85 161.74 24.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.422 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 83.9 m95 -84.29 171.38 12.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.499 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -136.12 -45.31 0.64 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -132.78 -154.51 0.62 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.19 -26.49 56.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.786 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -143.68 29.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.794 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -132.3 109.26 9.76 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.422 ' HE2' ' CH2' ' A' ' 87' ' ' TRP . 1.2 ptp -115.09 147.69 39.88 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.665 0.745 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.88 172.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 44.4 t -146.79 141.88 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.922 . . . . 0.0 110.951 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.72 162.04 14.83 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -160.45 133.87 6.82 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.597 -178.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 150.05 39.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.07 167.3 1.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.869 -178.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 mt -94.35 -9.28 36.34 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -156.93 156.28 32.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 108.927 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.31 -160.15 17.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -176.24 139.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.484 -1.01 . . . . 0.0 109.837 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.64 -84.13 0.05 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.54 -177.05 3.0 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 121.938 1.758 . . . . 0.0 110.177 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -139.74 137.9 35.48 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.37 145.89 49.18 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.109 0.957 . . . . 0.0 110.831 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.7 m -162.76 135.48 5.64 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.414 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.4 p-90 -141.92 175.62 9.58 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.942 -1.099 . . . . 0.0 110.686 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -138.01 173.23 11.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.479 0.657 . . . . 0.0 109.987 -179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.425 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 8.5 ptm -157.17 126.63 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -124.65 153.75 41.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.82 142.73 46.16 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.032 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.423 ' N ' HD11 ' A' ' 113' ' ' LEU . 17.9 p -91.2 160.78 15.36 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.525 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -60.21 -21.0 61.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.457 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.07 -28.31 24.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -8.46 7.52 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.19 171.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -1.223 . . . . 0.0 109.032 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -144.28 109.77 5.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.0 109.963 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -104.35 150.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.27 145.25 51.17 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.479 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 169.26 10.88 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.1 mtp -150.3 165.87 31.7 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.51 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 m -147.81 152.53 37.82 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.431 0.634 . . . . 0.0 109.367 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.17 97.92 1.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.607 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.57 -79.34 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.23 24.77 0.91 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.527 -0.733 . . . . 0.0 109.252 178.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.89 -179.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.413 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.2 t -156.36 118.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.754 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.5 t -99.67 118.81 37.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.5 m -111.37 130.38 55.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.908 . . . . 0.0 109.55 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -129.77 103.95 7.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 136.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -125.88 127.47 46.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.499 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.12 139.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 177.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.03 125.35 10.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.0 111.219 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.599 179.574 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.354 0.597 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 m-85 -98.86 -3.91 34.28 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.9 p -72.13 119.98 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.112 -0.992 . . . . 0.0 112.194 -177.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.74 -173.56 37.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 8.8 m120 -95.22 171.77 8.52 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 177.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -151.9 126.11 9.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.336 -176.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -116.28 111.52 20.25 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -62.86 140.64 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.607 0.718 . . . . 0.0 109.711 -179.378 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.13 -23.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.19 162.77 32.02 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.195 -0.941 . . . . 0.0 110.745 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p 178.26 168.88 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.35 26.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.91 -1.119 . . . . 0.0 111.443 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -161.65 29.06 0.13 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.488 -0.757 . . . . 0.0 108.986 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.56 -64.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.3 tt0 -57.0 -28.74 62.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.19 -35.96 82.69 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.773 -0.579 . . . . 0.0 110.375 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.46 -17.34 45.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.637 -0.665 . . . . 0.0 110.363 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD13 ' CE1' ' A' ' 15' ' ' PHE . 8.1 mt -90.61 -18.29 25.41 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.763 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.4 mmmm -85.32 -29.54 24.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 22' ' ' LEU . 14.7 p -77.69 -39.46 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.6 mp -69.03 -46.56 67.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.781 0.801 . . . . 0.0 110.008 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -156.58 27.14 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.708 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -149.67 -36.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.985 -0.715 . . . . 0.0 110.477 -179.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -62.86 -148.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.473 -0.767 . . . . 0.0 109.466 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.28 -46.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.661 -1.274 . . . . 0.0 109.151 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.7 ttt -67.59 -33.52 75.17 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -57.31 -24.36 54.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.811 -0.555 . . . . 0.0 110.544 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -92.69 -48.4 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 110.181 -179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -63.93 -16.87 62.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.549 -0.719 . . . . 0.0 111.447 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.6 mm -85.7 -28.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.944 . . . . 0.0 108.634 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.9 -25.73 34.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 3.8 t -80.17 -48.22 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.16 60.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.68 57.06 4.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.722 -0.611 . . . . 0.0 110.68 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -66.27 -36.22 82.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.7 -1.25 . . . . 0.0 107.793 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -155.14 72.51 5.68 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 33.5 Cg_endo -72.37 163.16 39.47 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.138 1.892 . . . . 0.0 111.168 -178.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.37 173.41 6.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.696 -0.627 . . . . 0.0 109.668 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -155.4 165.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.52 109.12 3.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.5 mt -97.98 135.78 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.667 0.746 . . . . 0.0 110.22 -178.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -114.33 111.44 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.878 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.437 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -98.2 121.93 40.74 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.031 -1.043 . . . . 0.0 110.974 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -123.02 51.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.04 -127.96 9.16 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -74.97 -2.0 25.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 110.124 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -96.51 134.69 39.4 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.724 -1.235 . . . . 0.0 108.12 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.445 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 97.6 m-85 -130.09 116.69 18.86 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.931 0.872 . . . . 0.0 109.416 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.6 t80 -102.29 148.2 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.2 mt -145.45 101.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.991 -1.068 . . . . 0.0 110.459 -177.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -99.47 113.74 26.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.673 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -101.42 143.29 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 115.45 11.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 109.955 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.8 p -103.7 176.0 5.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -171.34 120.7 0.5 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.743 -0.598 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 pt -109.01 171.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.493 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.6 p-10 -162.58 134.61 5.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.165 -0.96 . . . . 0.0 109.361 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.479 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.1 p90 -161.95 -171.43 2.87 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.395 1.093 . . . . 0.0 112.5 -178.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -129.76 152.66 49.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.3 95.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -178.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -35.14 1.58 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.681 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -110.56 155.33 22.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -1.065 . . . . 0.0 109.999 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.16 169.2 13.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.567 -0.708 . . . . 0.0 109.245 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.08 173.92 13.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.63 144.04 32.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -177.34 5.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.298 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.96 155.95 17.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -92.86 -143.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 0.0 109.158 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.92 -20.44 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.789 -1.195 . . . . 0.0 110.608 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.02 -40.99 13.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.92 . . . . 0.0 109.26 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.16 44.69 0.1 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -133.02 151.89 78.75 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.619 -0.93 . . . . 0.0 109.323 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.97 141.76 16.91 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.737 1.625 . . . . 0.0 110.519 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -161.03 143.26 12.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.734 -0.604 . . . . 0.0 109.46 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.67 117.16 27.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.9 t -99.78 166.36 11.13 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.283 0.564 . . . . 0.0 109.749 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.2 tp -148.77 150.76 33.65 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 10.7 t -141.92 127.18 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.024 -177.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.73 156.03 28.97 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.465 ' CH2' ' CE ' ' A' ' 93' ' ' MET . 75.8 m95 -76.87 -175.04 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.576 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -142.68 -53.76 0.4 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.0 p -131.36 -152.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.54 -24.15 45.81 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 110.003 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -138.82 22.26 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 0.0 111.167 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -130.49 129.65 43.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.746 -1.221 . . . . 0.0 108.325 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -134.96 151.09 50.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.918 -179.622 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.31 171.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.2 t -147.91 133.2 18.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.3 -0.875 . . . . 0.0 110.82 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -105.95 153.28 22.2 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -151.36 140.53 21.24 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.939 -177.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -144.92 148.45 33.89 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.11 168.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.049 -1.032 . . . . 0.0 110.886 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.78 -10.1 35.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.95 160.19 35.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.74 -161.58 22.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -176.72 138.62 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.427 -1.043 . . . . 0.0 109.941 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.94 -85.42 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.91 -176.73 2.54 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.932 1.755 . . . . 0.0 110.142 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -139.97 138.8 35.82 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.81 146.01 47.92 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.071 0.939 . . . . 0.0 110.778 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 m -162.38 129.89 3.84 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -136.39 171.05 15.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.092 -1.005 . . . . 0.0 110.608 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -134.06 176.0 8.98 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.472 0.653 . . . . 0.0 109.884 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.23 124.07 3.62 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -120.06 146.6 45.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.679 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.92 143.52 38.05 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.101 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.401 ' N ' HD11 ' A' ' 113' ' ' LEU . 18.9 p -92.73 160.94 14.74 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.39 -22.67 63.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.646 . . . . 0.0 110.21 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.49 -29.22 28.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.164 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.29 7.22 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -56.2 171.7 0.25 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.145 -1.209 . . . . 0.0 109.333 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -146.4 110.16 4.9 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.995 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.5 tt -106.24 145.01 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -126.59 142.08 51.65 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.322 -0.861 . . . . 0.0 109.604 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.01 170.67 8.85 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 68.1 mtp -152.18 166.09 32.79 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.659 -178.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.1 m -147.07 152.54 38.69 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.35 96.74 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.14 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.1 23.96 1.05 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 178.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.14 -179.2 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.3 t -157.27 117.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.589 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 5.6 t -99.25 132.64 44.43 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.7 m -124.96 126.16 45.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.36 -0.838 . . . . 0.0 109.436 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -123.15 100.4 6.85 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.58 130.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.7 m-85 -120.1 132.25 55.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.404 -179.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.81 137.18 47.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.14 127.63 14.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.215 -0.928 . . . . 0.0 111.867 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.992 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.342 0.591 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.9 m-85 -99.11 -5.34 30.35 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.714 -0.616 . . . . 0.0 109.509 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 p -72.15 118.66 15.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 111.945 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.87 -173.36 38.21 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.4 m120 -95.45 171.87 8.43 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.2 m95 -150.73 125.35 9.64 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.482 -176.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -118.9 114.76 23.1 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.0 tt -58.15 143.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.414 -179.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.15 -24.44 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.893 -0.504 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -150.16 176.32 10.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -0.912 . . . . 0.0 110.383 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t 176.56 167.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.56 26.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.2 m-20 -160.53 27.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.752 -0.592 . . . . 0.0 109.851 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -63.19 -66.36 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.854 . . . . 0.0 109.053 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.9 mt-10 -55.53 -31.56 62.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.446 -0.784 . . . . 0.0 109.476 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.61 -39.54 91.61 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.157 0.504 . . . . 0.0 110.506 -179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 22' ' ' LEU . 17.0 tp -79.0 -16.88 56.3 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 15' ' ' PHE . 4.8 mt -90.14 -18.92 24.91 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.055 -1.028 . . . . 0.0 109.077 179.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mtmm -82.3 -31.48 29.97 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -77.84 -40.37 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.011 0.91 . . . . 0.0 108.714 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.6 mp -67.32 -47.17 71.33 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.884 0.849 . . . . 0.0 109.428 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -151.31 24.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -153.74 -41.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.968 -0.725 . . . . 0.0 109.506 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.89 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.525 -0.734 . . . . 0.0 109.444 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.62 -46.84 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.809 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.58 -29.39 68.73 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.34 -32.17 68.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.788 -0.57 . . . . 0.0 110.63 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -82.69 -44.29 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 109.903 -179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -61.96 -22.3 65.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 110.682 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mt -79.48 -28.54 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.0 109.04 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.06 -26.21 33.9 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 8.8 t -77.94 -39.83 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.65 -33.59 60.45 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.69 94.45 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -67.48 0.43 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.618 -0.676 . . . . 0.0 109.253 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 m 51.64 55.3 9.56 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mttm 66.69 73.51 0.38 Allowed Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.4 Cg_endo -70.99 153.92 63.08 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.024 1.816 . . . . 0.0 110.605 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.95 173.2 6.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 54' ' ' THR . 53.9 t -154.99 164.49 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 12.3 tm-20 -149.43 109.49 4.11 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -98.61 139.7 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 121.802 0.81 . . . . 0.0 110.605 -178.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.0 116.47 27.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.666 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.0 tt0 -98.77 116.52 31.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.123 -0.985 . . . . 0.0 110.837 -178.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -116.9 49.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.3 -125.84 8.19 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.78 -1.83 26.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -1.04 . . . . 0.0 110.023 178.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.56 138.91 33.43 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.787 -1.196 . . . . 0.0 108.434 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 92.5 m-85 -134.06 116.31 15.32 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.865 0.84 . . . . 0.0 109.431 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.9 147.75 26.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -143.45 105.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.289 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.23 112.09 24.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 109.466 179.041 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.404 ' CG2' HG21 ' A' ' 41' ' ' VAL . 34.4 m -102.54 141.09 35.93 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.48 140.99 39.42 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.129 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.841 0.829 . . . . 0.0 109.466 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.55 165.27 16.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.731 . . . . 0.0 109.679 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -159.57 123.51 3.79 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.641 -0.662 . . . . 0.0 109.307 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.7 pt -123.98 166.34 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.02 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.19 129.45 3.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 109.052 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.461 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.0 p90 -161.65 -173.0 3.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.689 -1.204 . . . . 0.0 112.273 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 153.6 47.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.44 94.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.649 -178.997 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.72 -34.1 1.37 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.495 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -112.42 156.61 22.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.403 -1.057 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -86.39 169.16 13.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.461 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.26 173.47 14.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.563 -0.711 . . . . 0.0 109.816 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.28 145.2 29.79 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.32 -176.17 4.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 109.528 -179.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -100.71 157.51 16.64 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 t -95.2 -143.13 0.26 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.862 . . . . 0.0 109.24 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -110.1 -22.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.754 -1.216 . . . . 0.0 110.814 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -88.12 -40.27 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.589 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.38 45.1 0.1 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 152.1 78.76 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.714 -0.874 . . . . 0.0 109.046 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.42 142.38 18.63 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.655 1.57 . . . . 0.0 110.876 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.14 141.12 10.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 109.552 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -86.67 116.13 24.58 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.91 165.42 11.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.735 -0.603 . . . . 0.0 110.268 -178.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -145.69 153.84 41.43 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 14.7 t -146.17 125.13 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.728 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.1 156.05 29.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.4 m95 -78.03 174.84 10.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.876 0.846 . . . . 0.0 110.126 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -137.84 -46.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.2 p -130.51 -152.68 0.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.67 -28.35 51.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -141.04 28.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -132.69 111.52 11.23 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.43 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -118.36 150.17 39.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.25 -0.906 . . . . 0.0 110.398 -179.295 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.47 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 49.8 t -147.45 140.3 24.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 110.895 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.68 163.01 13.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -160.3 135.38 7.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.781 -1.167 . . . . 0.0 111.642 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -143.63 150.55 38.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.94 168.94 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.005 . . . . 0.0 110.842 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 mt -99.04 -5.98 29.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.68 133.72 14.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.669 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.86 -157.37 38.94 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -176.15 139.97 0.39 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.438 -1.036 . . . . 0.0 109.915 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.0 -87.9 0.09 OUTLIER Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.36 -176.69 2.89 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.682 1.588 . . . . 0.0 109.474 178.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -130.46 136.31 48.87 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.95 144.41 48.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.151 0.977 . . . . 0.0 110.749 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.7 m -163.04 136.88 6.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.8 p-90 -142.49 174.83 10.28 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.436 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.0 p -138.36 170.53 15.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.556 0.693 . . . . 0.0 109.801 -179.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 ptp -153.37 137.0 15.99 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -133.19 149.42 52.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.388 -0.82 . . . . 0.0 109.413 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -111.84 141.44 45.47 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 p -90.4 161.12 15.72 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.763 -179.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.33 -22.01 62.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -84.35 -29.19 26.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.284 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.63 -9.85 7.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.55 172.62 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.158 -1.201 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.2 tt -145.08 108.38 4.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 109.974 -179.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.6 137.52 42.02 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.248 -0.907 . . . . 0.0 109.771 -178.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.65 168.59 9.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.7 mtp -147.55 167.86 23.43 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.636 -179.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.0 m -150.65 150.2 30.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.25 93.84 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.522 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.83 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -146.69 23.52 1.25 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.576 -0.702 . . . . 0.0 109.286 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.2 m -117.14 -178.52 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.79 118.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.436 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.6 t -97.66 116.98 30.92 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -114.45 126.26 54.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -0.999 . . . . 0.0 110.17 -179.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -133.22 107.76 8.36 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.04 135.4 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -123.36 126.12 46.26 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.274 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.48 138.48 33.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.496 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -49.96 128.22 18.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.242 -0.911 . . . . 0.0 111.559 -178.617 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.6 tm-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.762 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.348 0.594 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 4.3 m-85 -98.84 -9.8 23.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -65.37 118.09 8.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 112.293 -177.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.24 -172.84 37.57 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.63 171.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.9 m95 -150.22 120.01 7.08 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.891 -1.123 . . . . 0.0 112.613 -177.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -111.43 114.11 27.02 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.424 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 7.2 tt -56.26 155.45 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.907 0.861 . . . . 0.0 111.195 -178.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.41 -32.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.436 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -145.0 171.04 15.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.029 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t 179.52 157.44 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 109.335 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 170.74 19.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.616 . . . . 0.0 110.049 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 37.5 m-80 61.04 29.99 19.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.476 -0.765 . . . . 0.0 109.887 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.431 ' CZ ' ' HB1' ' A' ' 36' ' ' ALA . 3.7 t80 -65.55 -63.17 1.16 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.282 -0.886 . . . . 0.0 108.85 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 2.5 pt-20 -59.76 -28.35 67.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.736 -0.603 . . . . 0.0 109.641 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.73 -38.97 90.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.626 -0.671 . . . . 0.0 110.411 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 47.8 tp -83.12 -13.39 55.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.686 -0.634 . . . . 0.0 109.711 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.82 -20.96 20.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.959 -1.088 . . . . 0.0 108.952 179.572 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmm -83.37 -30.04 27.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.43 -41.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.6 mp -66.41 -53.55 34.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.25 1.024 . . . . 0.0 108.865 179.251 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.06 -144.9 14.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -154.99 -38.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.901 -0.764 . . . . 0.0 110.244 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.29 -171.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.248 -0.907 . . . . 0.0 109.779 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.12 -43.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.77 . . . . 0.0 110.112 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.0 ttm -67.83 -26.35 66.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.57 -0.706 . . . . 0.0 109.131 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.74 -49.2 78.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.704 -0.622 . . . . 0.0 110.525 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -66.03 -42.3 89.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.463 -0.773 . . . . 0.0 110.029 -178.87 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -57.52 -38.98 75.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.567 -0.708 . . . . 0.0 110.705 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.03 -26.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.429 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -81.51 -22.1 38.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.66 -0.65 . . . . 0.0 110.169 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.408 HG12 ' CG ' ' A' ' 15' ' ' PHE . 3.5 t -81.99 -45.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.25 91.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.27 71.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.35 42.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.547 179.15 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.8 t -64.97 -35.39 81.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.841 -1.162 . . . . 0.0 108.313 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -157.4 71.22 4.43 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 30.5 Cg_endo -73.57 146.33 38.89 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 122.012 1.808 . . . . 0.0 110.545 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.04 173.22 7.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.664 -0.648 . . . . 0.0 109.618 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 4.7 t -153.53 165.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.2 tt0 -156.87 116.98 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.653 -0.654 . . . . 0.0 109.427 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.1 mp -107.21 138.04 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.582 0.706 . . . . 0.0 109.769 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.432 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 3.8 mttt -117.53 109.16 16.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.2 tt0 -98.1 117.07 31.63 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.07 -1.019 . . . . 0.0 111.113 -177.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.84 56.01 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.08 -126.37 8.39 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -77.79 -0.4 26.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.418 -1.048 . . . . 0.0 109.954 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 m -96.19 139.99 31.54 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.781 -1.2 . . . . 0.0 108.862 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE1' ' HE2' ' A' ' 93' ' ' MET . 95.4 m-85 -136.66 117.44 14.06 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.774 0.797 . . . . 0.0 108.92 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 4.5 t80 -104.53 119.12 38.24 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.7 mm -99.84 146.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 120.785 -1.197 . . . . 0.0 107.991 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -145.11 102.58 3.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.93 . . . . 0.0 108.785 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 25.0 m -99.56 154.9 17.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.723 . . . . 0.0 109.486 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.69 116.0 6.59 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.01 169.53 8.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.395 -0.816 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.1 pt-20 -173.44 113.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' CG1' HG12 ' A' ' 52' ' ' ILE . 37.5 pt -103.65 173.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.467 -0.77 . . . . 0.0 110.052 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -160.68 130.34 5.02 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.479 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 43.2 p90 -162.38 -171.62 2.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.089 0.947 . . . . 0.0 111.448 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -132.31 154.67 49.47 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.59 94.3 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -178.541 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.74 -23.02 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.865 -1.159 . . . . 0.0 110.607 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 163.59 30.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.296 -1.12 . . . . 0.0 110.727 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.16 171.2 11.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.765 -0.584 . . . . 0.0 109.578 -179.511 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.0 p90 -162.63 175.32 11.51 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.03 143.62 39.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.7 pm0 -162.16 -169.18 2.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 109.343 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -99.6 160.07 14.57 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.348 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -97.84 -143.72 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.386 -0.821 . . . . 0.0 109.227 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 t -110.78 -20.99 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.731 -1.23 . . . . 0.0 110.897 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -90.39 -40.39 12.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.821 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.89 46.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -137.28 154.01 75.24 Favored Pre-proline 0 C--N 1.306 -1.292 0 O-C-N 121.743 -0.857 . . . . 0.0 109.269 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.34 142.94 17.05 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.6 p -160.66 142.41 12.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -90.71 120.76 32.03 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 2.6 t -100.31 172.8 6.93 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.516 0.674 . . . . 0.0 110.347 -178.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.7 tp -148.7 152.72 37.14 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' CE2' ' A' ' 65' ' ' PHE . 15.5 t -147.74 131.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 118.441 -1.304 . . . . 0.0 112.266 -178.059 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.64 161.23 29.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CE2' HG23 ' A' ' 67' ' ' VAL . 86.0 m95 -84.36 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.923 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.84 -46.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -132.25 -153.66 0.57 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -24.77 47.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -142.16 24.76 1.95 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -130.77 111.85 12.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 0.0 108.522 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.431 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.06 149.42 38.96 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.628 0.728 . . . . 0.0 110.39 -178.876 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.88 171.74 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.416 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 47.4 t -149.12 138.29 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.915 . . . . 0.0 110.966 -179.498 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -108.59 163.39 13.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.65 139.69 10.46 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.873 -178.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -141.42 157.13 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.75 168.81 12.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 110.612 -179.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 mt -101.65 -6.07 24.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 138.73 18.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.46 -156.86 41.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -176.87 140.08 0.31 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.567 -0.961 . . . . 0.0 109.603 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.46 -85.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.43 -177.11 3.06 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.88 1.72 . . . . 0.0 109.936 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -135.92 139.02 42.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.84 145.09 48.42 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.16 0.981 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.1 p -163.07 137.71 6.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CZ3' ' CE ' ' A' ' 111' ' ' MET . 61.7 p-90 -142.32 176.0 9.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.023 -1.048 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -140.41 174.46 10.49 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.817 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.452 ' CE ' ' CZ3' ' A' ' 109' ' ' TRP . 2.4 mtm -157.16 128.5 6.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -124.35 146.83 48.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.529 -0.732 . . . . 0.0 109.63 -179.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.46 144.25 39.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.349 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.406 ' N ' HD11 ' A' ' 113' ' ' LEU . 19.2 p -93.18 160.52 14.81 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.6 -179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.66 -21.61 62.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.171 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.99 -29.23 27.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 109.106 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.45 -9.39 7.34 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.65 171.68 0.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -1.227 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.496 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -146.25 112.03 5.63 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.149 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 120' ' ' ILE . 12.1 tt -106.72 147.7 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.329 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.401 ' CD1' ' CE ' ' A' ' 111' ' ' MET . 7.5 tt -129.43 147.96 51.3 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.193 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.96 163.37 24.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 20.0 mtp -143.13 163.34 33.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.368 -179.23 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 m -146.7 152.05 38.21 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -158.33 96.75 1.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.98 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.73 23.91 1.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.546 -0.721 . . . . 0.0 109.407 178.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.0 m -119.3 -179.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -158.03 117.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.3 t -98.89 112.08 24.29 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -107.92 148.9 29.0 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.767 0.794 . . . . 0.0 110.074 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -151.0 118.18 5.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.32 138.97 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.123 -0.986 . . . . 0.0 108.385 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 22.5 m-85 -127.49 125.3 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.367 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.03 139.59 28.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.36 125.63 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.215 -0.928 . . . . 0.0 111.207 -178.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.515 179.578 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.383 0.611 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 m-85 -98.85 -8.1 26.29 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.7 p -69.6 118.09 12.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.209 -0.932 . . . . 0.0 111.938 -177.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.3 -171.54 37.34 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.1 m120 -95.59 169.94 9.69 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 177.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.486 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.9 m95 -150.67 120.43 7.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.643 -177.344 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -112.66 120.76 42.64 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.7 tt -64.56 151.97 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.845 0.831 . . . . 0.0 111.116 -178.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.03 -31.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -139.73 168.84 18.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 108.985 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -176.82 149.61 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.489 -0.757 . . . . 0.0 109.606 -179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -148.2 163.64 36.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.86 27.48 16.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -64.85 -65.47 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.588 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.8 pt-20 -58.01 -27.89 63.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.39 -34.83 79.22 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.553 -0.717 . . . . 0.0 110.018 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.9 -18.58 39.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.729 -0.607 . . . . 0.0 110.254 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -91.37 -16.81 26.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.909 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 mmmt -87.94 -28.49 21.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.156 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.77 -41.14 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.1 -54.6 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.99 -148.2 19.86 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -157.28 -43.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.815 -0.815 . . . . 0.0 109.407 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.28 176.07 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.472 -0.767 . . . . 0.0 109.516 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.68 -43.68 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.6 ttm -62.74 -26.38 68.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.8 -69.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.634 -0.666 . . . . 0.0 109.993 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -38.32 57.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 110.62 -179.299 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -61.01 -39.33 89.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.61 -0.681 . . . . 0.0 110.373 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.82 -26.8 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.02 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 10.6 t -75.9 -35.98 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.01 41.74 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.52 93.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.41 -69.49 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m 49.19 51.19 16.71 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.495 0.664 . . . . 0.0 109.46 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.3 mttt 65.38 72.31 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -72.1 156.96 55.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.05 1.833 . . . . 0.0 110.613 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.95 174.38 5.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.355 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.8 t -154.23 164.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -149.68 108.61 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.2 mt -98.45 139.13 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.19 113.1 21.74 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.711 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.421 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.2 tt0 -98.48 118.38 35.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.07 -1.019 . . . . 0.0 110.976 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.38 52.45 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -124.44 7.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -178.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -76.31 -1.25 25.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 178.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.33 141.77 29.26 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 120.808 -1.183 . . . . 0.0 108.807 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -137.3 115.52 11.73 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.839 0.828 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -101.43 147.5 26.28 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -142.09 107.52 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.197 -177.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.7 109.84 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.091 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -99.36 135.86 40.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.37 121.01 26.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.25 -0.906 . . . . 0.0 110.314 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.75 160.97 22.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -152.51 125.21 8.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 0.0 109.791 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.73 165.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.72 129.03 3.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.001 -1.062 . . . . 0.0 109.887 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 49.0 p90 -162.25 -171.87 2.98 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.734 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' CG ' ' HG2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -132.06 155.91 47.24 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.689 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -83.47 91.63 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.109 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.78 -27.08 0.65 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.124 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' HG2' ' CG ' ' A' ' 66' ' ' LYS . 4.9 pt-20 -124.77 159.09 31.73 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.182 -1.187 . . . . 0.0 110.3 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.82 166.23 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.2 173.6 14.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.686 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.97 146.12 28.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.37 -177.52 5.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.667 -0.645 . . . . 0.0 109.342 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.44 155.83 17.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.0 t -94.49 -142.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.71 -18.64 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.218 . . . . 0.0 110.64 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.39 -36.59 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.42 44.84 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -134.23 151.85 77.15 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.779 -0.836 . . . . 0.0 109.224 -179.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.8 143.4 18.49 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.658 1.572 . . . . 0.0 110.553 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -161.14 141.65 11.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.717 -0.615 . . . . 0.0 109.625 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -88.32 116.74 26.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.4 t -99.47 168.08 10.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.428 0.632 . . . . 0.0 110.458 -178.241 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.2 tp -151.12 153.77 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 65' ' ' PHE . 38.7 t -146.04 134.63 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.214 -177.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -126.17 157.4 38.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.432 ' CE2' HG23 ' A' ' 67' ' ' VAL . 84.6 m95 -81.58 171.05 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.098 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -134.17 -45.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -132.31 -154.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -76.56 -25.52 54.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.18 27.69 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.825 . . . . 0.0 110.717 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -130.84 106.87 8.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 108.16 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.422 ' HE2' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 ptp -115.18 145.88 41.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.12 171.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.6 t -145.47 138.74 26.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.268 -0.895 . . . . 0.0 110.475 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -109.62 154.35 22.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -152.46 142.02 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.905 -177.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -143.6 153.32 42.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.66 169.3 3.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.092 -1.005 . . . . 0.0 110.527 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 mt -98.07 -7.93 28.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -155.14 145.31 21.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 108.946 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.04 -158.71 37.51 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.54 140.41 0.36 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.505 -0.997 . . . . 0.0 109.743 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.43 -85.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.99 -176.9 2.83 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.872 1.714 . . . . 0.0 109.905 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -137.92 138.95 39.52 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.99 145.97 48.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.024 0.916 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -162.49 131.1 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.426 ' CZ3' ' HE1' ' A' ' 111' ' ' MET . 46.4 p-90 -136.16 167.26 21.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.123 -0.986 . . . . 0.0 110.839 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 p -131.63 169.77 15.7 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.386 0.612 . . . . 0.0 109.9 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.426 ' HE1' ' CZ3' ' A' ' 109' ' ' TRP . 11.4 ptp -154.98 123.44 6.01 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.31 155.68 29.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 110.412 -178.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.45 141.65 48.95 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.823 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.5 p -93.86 161.03 14.48 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.804 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -60.79 -22.01 63.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.678 . . . . 0.0 110.142 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.65 -28.9 28.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.67 -10.36 7.15 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -54.97 170.89 0.16 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.159 -1.201 . . . . 0.0 109.275 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.486 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.8 tt -147.42 110.12 4.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 120' ' ' ILE . 12.3 tt -103.49 161.07 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.08 132.22 20.43 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.41 171.55 7.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.219 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 16.0 mtp -149.76 163.91 36.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.093 -179.514 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 m -147.51 152.7 38.44 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.436 0.636 . . . . 0.0 109.415 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.72 96.53 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.645 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.76 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 24.12 1.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.563 -0.711 . . . . 0.0 109.312 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.09 -179.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.56 117.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 4.0 t -98.21 117.33 32.35 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -111.35 149.77 30.68 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.882 0.848 . . . . 0.0 109.925 -179.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -152.49 118.2 5.38 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.17 137.8 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.434 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.8 m-85 -126.93 124.87 40.51 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.446 -179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.55 140.78 24.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -50.02 125.99 13.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.176 -0.952 . . . . 0.0 111.131 -178.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.544 179.569 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.706 0.765 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 3.3 m-85 -99.59 -1.09 39.06 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.66 -0.65 . . . . 0.0 109.44 179.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -72.37 120.56 18.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.123 -0.986 . . . . 0.0 112.122 -177.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.54 -171.97 36.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -95.86 169.78 9.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.501 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -150.47 120.97 7.41 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.639 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -113.69 115.7 28.27 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.0 tt -55.6 156.61 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.994 0.902 . . . . 0.0 111.418 -178.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.21 -32.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -143.82 169.61 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.254 -0.904 . . . . 0.0 108.938 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -177.19 145.37 0.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -141.18 165.7 26.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.759 -0.588 . . . . 0.0 109.657 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.1 m-80 58.77 22.54 10.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.474 -0.766 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -65.19 -64.2 0.92 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 108.943 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 42.9 tt0 -57.5 -29.12 64.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -65.36 -34.19 77.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.664 -0.648 . . . . 0.0 110.167 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.72 -19.0 38.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.758 -0.589 . . . . 0.0 110.375 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -90.86 -17.03 27.2 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -87.33 -29.28 21.69 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.216 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.06 -41.01 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.73 -50.8 63.49 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -143.93 14.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 m -154.5 -43.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.697 -0.884 . . . . 0.0 109.985 179.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.97 -172.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.483 -0.761 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.46 -42.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -61.45 -23.34 65.79 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.82 -39.63 30.31 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.736 -0.602 . . . . 0.0 110.086 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -37.39 85.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.701 -0.624 . . . . 0.0 109.502 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -11.97 57.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 111.043 -179.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.84 -30.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 108.459 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.28 -27.25 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 2.7 t -79.52 -46.13 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.65 89.86 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.98 88.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -83.47 40.69 0.74 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.824 -0.547 . . . . 0.0 111.56 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.4 p -58.31 -26.66 63.3 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.487 -1.383 . . . . 0.0 108.679 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.19 73.01 0.23 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -73.18 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.996 1.798 . . . . 0.0 111.089 -178.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.96 173.43 11.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.1 t -156.43 163.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.47 111.0 4.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -99.37 133.37 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.636 0.731 . . . . 0.0 110.366 -178.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -112.72 111.92 23.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.666 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.44 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 61.8 tt0 -98.57 119.39 37.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.11 -0.994 . . . . 0.0 111.002 -178.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -120.69 54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.9 -126.74 8.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -0.44 25.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.387 -1.066 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.65 140.75 30.8 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.653 -1.279 . . . . 0.0 108.512 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.7 m-85 -136.67 116.39 13.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.8 0.81 . . . . 0.0 109.465 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.67 147.45 26.42 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.6 mt -142.27 104.8 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.25 -177.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.44 109.35 21.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.067 178.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.6 m -103.21 141.8 35.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -148.88 124.88 10.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 109.592 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.532 -0.73 . . . . 0.0 109.634 -179.703 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.42 169.06 10.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.554 -0.716 . . . . 0.0 110.079 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -160.42 123.32 3.37 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 pt -124.49 168.85 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.376 -0.827 . . . . 0.0 109.407 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.54 129.32 3.61 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.234 -0.916 . . . . 0.0 109.08 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 51.2 p90 -162.14 -172.16 3.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.388 -179.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -130.54 153.12 49.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.42 95.15 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 109.79 -178.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.3 -33.58 1.57 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.772 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -110.88 153.59 25.23 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.356 -1.085 . . . . 0.0 109.869 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 167.21 15.13 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.463 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.39 173.61 13.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.818 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -103.94 143.66 32.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.09 -176.86 5.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.82 155.67 17.53 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -91.19 -142.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.46 -0.775 . . . . 0.0 109.194 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.02 -20.63 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.74 -1.225 . . . . 0.0 110.624 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.43 -39.96 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.57 44.88 0.11 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 150.82 77.43 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.629 -0.924 . . . . 0.0 109.342 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.92 140.29 15.98 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.7 1.6 . . . . 0.0 110.26 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.4 p -161.36 141.86 10.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.637 -0.664 . . . . 0.0 109.811 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.57 114.32 26.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.81 177.5 4.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.715 -0.615 . . . . 0.0 110.235 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 96' ' ' GLU . 64.4 tp -151.75 152.01 32.15 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 3.4 t -140.74 130.25 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.516 -177.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -125.89 162.48 25.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.426 ' CZ2' ' HE2' ' A' ' 93' ' ' MET . 88.3 m95 -85.69 167.35 15.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.969 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -129.93 -45.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 p -132.01 -154.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.29 -24.65 50.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.733 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -143.91 27.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -132.27 106.4 7.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 107.977 179.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.435 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 1.4 ptp -113.18 149.89 33.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.316 -178.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.7 172.11 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.8 t -149.58 129.79 13.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 110.747 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -100.68 163.99 12.08 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 176.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.41 142.91 13.09 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.945 -178.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -147.08 149.25 32.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.43 167.9 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.065 -1.022 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.0 -7.44 29.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -152.44 141.14 20.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 108.922 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.07 -159.72 36.04 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -176.37 139.91 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.493 -1.004 . . . . 0.0 109.829 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.45 -86.67 0.06 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.1 -176.97 2.83 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.834 1.689 . . . . 0.0 109.774 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -135.5 138.53 43.2 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 146.05 47.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.068 0.937 . . . . 0.0 110.872 -179.362 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -162.7 128.79 3.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -133.34 166.01 23.49 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.098 -1.001 . . . . 0.0 110.85 -179.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.8 p -130.4 174.69 9.61 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.415 0.626 . . . . 0.0 109.692 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.09 122.33 3.31 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -116.95 154.1 31.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -115.22 142.73 46.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.282 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -95.03 160.34 14.61 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.987 -179.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.9 -23.19 63.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.688 -0.632 . . . . 0.0 110.139 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -81.69 -31.06 32.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.16 -8.6 7.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -58.12 170.73 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.124 -1.221 . . . . 0.0 108.97 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.501 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -143.87 113.74 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.123 -178.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.81 152.45 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.01 132.78 38.71 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.46 -0.775 . . . . 0.0 109.557 -179.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.29 170.65 8.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 34.4 mtp -150.01 165.04 33.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.418 -179.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 m -146.9 152.22 38.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.94 96.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.561 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.45 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -146.38 24.23 1.27 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.456 -0.778 . . . . 0.0 109.393 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.4 m -119.59 -178.29 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.39 117.49 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.665 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 13.9 t -98.41 119.4 37.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.0 m -115.5 149.79 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 110.075 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -152.07 118.27 5.57 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.52 138.38 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.96 . . . . 0.0 108.446 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.4 m-85 -126.88 124.48 39.67 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.019 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.35 139.94 26.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -49.2 125.67 11.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.228 -0.92 . . . . 0.0 111.214 -178.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.628 179.573 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.576 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.43 ' CG ' HD22 ' A' ' 113' ' ' LEU . 5.0 m-85 -99.18 -8.87 24.48 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.744 -0.598 . . . . 0.0 109.478 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.6 p -68.73 118.05 11.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.225 -0.922 . . . . 0.0 111.869 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.4 -174.41 38.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.2 m120 -95.45 172.24 8.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -151.72 124.66 8.59 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.964 -1.094 . . . . 0.0 112.54 -176.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -116.8 117.77 30.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.446 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 13.9 tt -61.73 151.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.914 0.864 . . . . 0.0 111.082 -178.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.28 -31.37 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -141.72 172.1 13.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -179.7 145.68 0.24 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.456 -0.777 . . . . 0.0 109.443 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -142.19 163.11 33.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.0 109.992 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.2 m-20 62.87 32.8 15.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.607 -0.683 . . . . 0.0 109.754 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -74.88 -64.11 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.139 -179.728 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 tt0 -57.22 -35.87 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.815 . . . . 0.0 110.919 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.7 68.79 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.179 -178.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.2 tp -77.49 -22.28 51.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 6.3 mt -89.95 -15.97 30.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.301 -0.875 . . . . 0.0 109.14 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -87.58 -31.4 19.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -74.59 -39.03 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -69.2 -45.8 69.02 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.736 0.779 . . . . 0.0 109.492 179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.88 -161.63 27.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -146.29 -35.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.891 -0.77 . . . . 0.0 110.463 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -62.21 -149.72 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 109.372 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.98 -47.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.7 -1.25 . . . . 0.0 109.323 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 ttt -71.27 -26.89 63.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.73 -18.8 34.57 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.74 -0.6 . . . . 0.0 111.054 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -96.19 -47.9 5.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.754 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -21.32 65.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.662 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.21 -29.09 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -0.904 . . . . 0.0 108.728 179.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 14.4 t -76.56 -37.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -31.73 45.98 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.49 -39.18 91.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.46 -69.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 p 48.33 50.79 16.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.467 0.651 . . . . 0.0 109.662 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 64.63 72.3 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.06 159.32 47.98 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 122.059 1.84 . . . . 0.0 110.714 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.88 174.34 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.561 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.402 HG21 ' CG2' ' A' ' 54' ' ' THR . 53.7 t -155.58 164.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -151.23 110.53 3.95 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mp -98.62 140.14 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.753 0.787 . . . . 0.0 110.376 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -118.18 111.09 18.38 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.478 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.25 120.62 38.98 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.068 -1.02 . . . . 0.0 111.091 -177.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.03 54.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.89 -127.55 8.89 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.211 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.36 -0.85 24.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.403 -1.057 . . . . 0.0 110.079 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 m -97.02 138.74 34.09 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.753 -1.217 . . . . 0.0 108.489 -179.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.1 m-85 -133.98 118.02 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 0.0 109.446 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.98 147.97 26.27 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.337 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.8 mt -144.57 103.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.884 -1.135 . . . . 0.0 111.585 -177.488 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 113.02 25.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 ' CG2' HG21 ' A' ' 41' ' ' VAL . 57.1 m -104.44 141.83 35.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.96 144.33 41.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.323 -0.86 . . . . 0.0 110.059 -179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.934 0.873 . . . . 0.0 109.291 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.59 164.97 23.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.787 . . . . 0.0 109.585 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -165.41 119.41 1.23 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 pt -123.44 168.61 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 109.341 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.26 129.23 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.186 -0.946 . . . . 0.0 108.937 179.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.484 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 45.3 p90 -162.03 -172.44 3.25 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.394 -179.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -129.56 153.33 48.15 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.64 90.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.121 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.41 -24.68 1.09 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.795 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.88 156.89 33.72 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.266 -1.137 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.3 167.47 14.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.705 -0.622 . . . . 0.0 109.489 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.484 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.41 175.81 11.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.698 -0.626 . . . . 0.0 109.49 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.39 145.81 29.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -162.26 -175.81 4.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.69 -0.631 . . . . 0.0 109.375 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -100.19 158.3 15.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -97.96 -144.34 0.31 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.396 -0.815 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -109.93 -24.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.86 -1.15 . . . . 0.0 110.841 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.5 -40.74 17.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.75 45.41 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -135.4 154.66 78.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.731 -0.864 . . . . 0.0 108.971 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.89 144.29 18.98 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.703 1.602 . . . . 0.0 110.703 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 p -160.86 141.81 11.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.718 -0.614 . . . . 0.0 109.549 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.05 116.75 25.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.48 166.45 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 -178.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -146.25 154.51 41.81 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 65' ' ' PHE . 25.4 t -146.24 131.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.319 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -125.57 160.55 29.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.427 ' CE2' HG23 ' A' ' 67' ' ' VAL . 85.8 m95 -83.65 171.76 12.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.193 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -134.87 -46.16 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -131.9 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.66 -24.58 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 109.745 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -143.65 26.45 1.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 110.788 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -131.44 110.48 11.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.902 -1.124 . . . . 0.0 108.085 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.424 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 1.1 ptp -116.13 148.29 40.46 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.297 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.88 170.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 49.9 t -146.36 142.46 28.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -109.77 163.47 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -160.36 135.34 7.79 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.528 -178.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -143.1 148.94 37.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.59 166.37 2.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.052 -1.03 . . . . 0.0 110.94 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -98.45 -5.99 31.33 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -150.91 133.87 15.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.72 -161.21 36.26 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.95 140.79 0.44 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.43 -1.041 . . . . 0.0 109.874 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.04 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.25 -176.71 2.93 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.712 1.608 . . . . 0.0 109.536 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -129.94 137.65 50.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.95 145.04 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.118 0.961 . . . . 0.0 110.608 -179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -163.13 143.44 9.14 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.3 p-90 -144.05 173.47 11.7 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 p -139.51 170.33 16.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.6 ptp -154.56 137.1 15.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -131.11 151.37 51.51 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.371 -0.831 . . . . 0.0 109.468 -179.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.7 142.09 46.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -90.63 161.47 15.39 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.36 -22.1 62.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.653 . . . . 0.0 110.182 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.9 -28.69 25.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.07 -9.24 7.51 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.02 172.99 0.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.079 -1.248 . . . . 0.0 109.455 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.499 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.4 tt -146.1 112.47 5.85 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.923 -178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -105.06 158.43 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.41 134.02 26.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.38 166.91 10.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 75.2 mmm -141.27 165.86 26.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 108.992 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -151.72 149.78 29.47 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.446 0.641 . . . . 0.0 109.338 178.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.77 94.58 1.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.9 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -147.67 24.14 1.1 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.533 -0.73 . . . . 0.0 109.137 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.38 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.68 119.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -99.44 114.15 26.93 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.067 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.0 m -104.08 149.51 25.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.16 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -153.21 120.13 5.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.6 137.07 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.0 m-85 -126.0 125.36 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.082 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.54 137.08 40.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.426 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.48 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.2 127.98 15.72 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.011 0.91 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 6.8 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.725 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.348 0.594 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 5.0 m-85 -99.01 -13.47 19.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -63.21 117.67 6.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.359 -0.838 . . . . 0.0 112.033 -177.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.57 -175.06 38.17 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.0 m120 -95.5 172.2 8.22 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.592 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.9 m95 -150.7 120.4 7.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.753 -176.404 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -109.08 117.15 33.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 7.2 tt -60.4 154.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.921 0.867 . . . . 0.0 111.072 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.79 -32.3 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -149.49 169.25 21.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.108 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.7 p -177.46 139.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.528 -0.733 . . . . 0.0 109.301 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.66 174.83 10.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.622 -0.674 . . . . 0.0 109.868 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 69.4 m-20 59.17 25.43 13.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.066 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -64.8 -64.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 108.718 179.582 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 pt-20 -56.78 -28.06 60.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 0.0 109.509 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -65.14 -39.88 93.64 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.052 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -80.91 -14.33 58.09 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.748 -0.595 . . . . 0.0 109.821 179.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 15' ' ' PHE . 1.3 mt -91.41 -20.16 22.09 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.063 -1.023 . . . . 0.0 109.173 178.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mmmt -83.65 -28.62 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.172 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.81 -41.48 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.456 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -66.18 -53.54 36.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.198 0.999 . . . . 0.0 108.908 179.323 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 -145.5 15.87 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 m -155.35 -39.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.914 -0.757 . . . . 0.0 110.234 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -57.93 -171.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.43 -43.44 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.593 -0.692 . . . . 0.0 110.244 -179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 6.7 ttt -68.23 -28.15 66.98 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.77 -52.04 67.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.758 -0.589 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 1.5 mpp_? -60.35 -39.51 87.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.506 -0.746 . . . . 0.0 110.262 -178.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -60.33 -29.24 68.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 110.667 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.8 mt -77.54 -27.76 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.115 179.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -82.21 -22.54 35.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.01 -42.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.22 81.79 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.34 -49.79 75.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.49 48.63 1.54 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.783 -0.573 . . . . 0.0 110.6 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -63.33 -33.1 74.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.777 -1.202 . . . . 0.0 108.55 179.441 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 72.12 2.01 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.01 141.05 29.25 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.909 1.739 . . . . 0.0 111.085 -178.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.96 177.07 5.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 50.4 t -155.74 165.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 42.9 tt0 -151.62 110.18 3.8 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -97.93 138.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.849 0.833 . . . . 0.0 110.124 -178.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 12.7 mttt -116.56 108.93 16.58 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.1 tt0 -98.56 114.72 27.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -178.483 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -120.45 60.64 0.88 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.71 -127.93 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.02 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -78.56 0.74 25.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -1.085 . . . . 0.0 110.014 178.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -97.05 142.11 29.39 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.713 -1.242 . . . . 0.0 108.778 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 96.9 m-85 -138.45 120.1 15.13 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.808 0.813 . . . . 0.0 109.288 179.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.424 ' CG ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 t80 -102.9 139.91 37.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.447 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.3 mm -123.34 116.97 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.022 -1.048 . . . . 0.0 109.292 -179.518 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -115.08 101.08 8.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.523 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -100.0 144.89 28.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 109.056 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.16 125.94 14.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.429 -0.794 . . . . 0.0 110.028 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.551 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -95.88 156.14 16.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.397 -0.815 . . . . 0.0 109.322 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -151.03 137.58 18.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.594 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' CG1' HG12 ' A' ' 52' ' ' ILE . 24.4 pt -142.85 169.5 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.557 -0.715 . . . . 0.0 109.519 179.39 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -162.6 135.95 6.01 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.46 -0.775 . . . . 0.0 108.945 179.325 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 52.5 p90 -161.85 -173.45 3.71 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.93 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 152.87 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.722 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 92.2 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -178.881 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.91 -29.8 1.25 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.841 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -116.33 155.84 27.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.308 -1.113 . . . . 0.0 110.26 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.72 167.35 15.35 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.1 p90 -162.84 174.74 12.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.894 -178.514 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -104.38 144.89 31.03 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.1 -177.27 5.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.42 156.21 17.14 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.011 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 t -93.53 -142.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.366 -179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.64 -23.23 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.751 -1.218 . . . . 0.0 110.875 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.38 -40.86 14.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.397 -179.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.35 44.53 0.1 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -130.72 152.11 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.676 -0.896 . . . . 0.0 109.146 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.09 142.24 19.3 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.643 1.562 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.0 p -160.91 141.47 11.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.672 -0.643 . . . . 0.0 109.782 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.56 114.05 26.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.5 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -101.78 177.22 4.97 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.88 -178.756 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -151.83 152.92 33.26 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 9.1 t -140.36 131.99 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.843 -177.916 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -126.83 159.89 32.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.433 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 86.5 m95 -83.8 170.13 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.025 -179.602 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.99 -45.7 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -133.19 -153.94 0.58 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -77.6 -24.87 49.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 109.792 179.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -143.03 26.74 1.66 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -131.21 107.96 9.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.943 -1.098 . . . . 0.0 108.113 179.59 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.436 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -115.61 147.29 40.95 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.501 -0.749 . . . . 0.0 110.175 -179.141 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.55 172.16 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.572 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.0 t -149.38 130.5 14.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.789 -179.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.35 163.62 12.18 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -160.18 143.25 13.65 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.962 -178.222 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -147.37 150.74 35.28 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.83 167.1 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.861 -179.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.5 -7.61 31.08 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 134.26 18.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.8 -158.39 44.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.414 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -176.35 141.37 0.41 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.501 -1.0 . . . . 0.0 109.808 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.65 -86.23 0.05 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.26 -176.87 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.841 1.694 . . . . 0.0 109.911 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -132.46 135.04 45.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.56 145.49 47.92 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.068 0.937 . . . . 0.0 110.774 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 p -163.14 134.27 4.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -135.6 169.29 17.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.086 -1.009 . . . . 0.0 110.202 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -134.95 171.4 14.46 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.429 0.633 . . . . 0.0 109.791 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.1 ptp -154.46 130.82 10.47 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 154.04 39.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.246 -178.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.47 141.71 48.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.032 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.5 p -93.77 160.55 14.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.682 -179.477 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -60.74 -21.48 63.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.104 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.22 -29.33 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.16 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.36 -9.18 7.39 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 170.32 0.4 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.256 . . . . 0.0 108.944 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.6 tt -146.75 112.54 5.69 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.228 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.9 tt -104.45 160.3 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.69 132.63 27.67 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.359 -0.838 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.75 170.8 7.99 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.362 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 27.9 mtp -148.4 166.0 29.42 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.353 -179.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 5.7 m -150.11 151.96 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.44 0.638 . . . . 0.0 109.369 179.212 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.85 96.08 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.501 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.13 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -147.37 24.03 1.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.495 -0.753 . . . . 0.0 109.22 178.516 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.7 m -117.87 -179.07 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.3 t -157.81 118.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.628 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 t -97.36 121.32 39.13 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -116.72 148.17 41.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.007 0.908 . . . . 0.0 110.283 -178.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -153.1 121.82 6.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.95 139.19 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.087 -1.008 . . . . 0.0 108.697 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 21.7 m-85 -127.65 133.38 49.65 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.232 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.15 138.32 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.24 128.25 16.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.204 -0.935 . . . . 0.0 111.644 -178.482 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.656 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.498 1.741 0 N-CA-C 109.868 -0.858 . . . . 1.8 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -162.78 123.0 2.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 1.8799999999999999 109.564 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 m-85 -99.73 -8.15 24.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.915 -0.772 . . . . 0.20000000000000001 108.915 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 23.0 t -66.62 116.39 7.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.405 -0.81 . . . . 1.52 111.352 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -169.89 37.65 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.609 -1.796 . . . . 0.16 108.609 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -96.62 169.88 9.58 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.537 -1.653 . . . . 0.57999999999999996 106.537 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.602 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -150.84 119.78 6.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.474 -1.29 . . . . 0.20999999999999999 112.385 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -114.12 113.72 25.09 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.829 -1.175 . . . . 2.27 107.829 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.472 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 7.3 tt -56.52 154.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.847 0.832 . . . . 1.4099999999999999 110.907 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.99 -31.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.979 -0.748 . . . . 1.1799999999999999 108.979 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -139.88 168.1 20.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 3.4700000000000002 108.753 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 t 177.74 152.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.3700000000000001 109.689 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.54 171.01 16.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.579 -0.701 . . . . 1.25 109.456 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.532 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 62.7 m-20 61.34 32.11 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 1.78 109.865 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.587 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.18 -62.65 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.54000000000000004 110.084 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -59.2 -36.51 75.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.268 -0.895 . . . . 2.2799999999999998 110.354 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 8.1 pt-20 -68.02 -28.62 67.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.274 -0.97 . . . . 2.0800000000000001 109.795 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 22' ' ' LEU . 43.4 tp -79.41 -21.34 45.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.191 -0.943 . . . . 1.3400000000000001 108.998 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 3.9 mt -89.5 -18.45 26.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.161 -0.962 . . . . 1.3500000000000001 108.596 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -84.13 -30.3 26.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.738 -1.208 . . . . 1.6599999999999999 107.738 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 22' ' ' LEU . 13.7 p -77.48 -41.02 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.875 -1.157 . . . . 1.1399999999999999 107.875 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.444 ' N ' HG12 ' A' ' 21' ' ' VAL . 4.4 mp -65.51 -50.62 64.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.608 -0.886 . . . . 1.1799999999999999 108.608 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -142.25 12.46 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.136 -1.186 . . . . 0.71999999999999997 110.136 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -164.67 -34.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.655 -0.909 . . . . 2.1299999999999999 109.415 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.0 t30 -61.71 -159.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.806 . . . . 1.73 109.497 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.97 -48.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.78 109.397 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.9 ttt -68.96 -24.46 64.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.54 -0.911 . . . . 2.6899999999999999 108.54 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -60.8 -27.75 68.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.763 -0.586 . . . . 1.9199999999999999 110.219 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -87.38 -45.19 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 2.8300000000000001 109.901 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -61.43 -25.09 66.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 3.2799999999999998 110.526 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.9 mt -76.5 -29.66 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.989 . . . . 2.0099999999999998 108.85 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -82.22 -26.04 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.561 -0.712 . . . . 1.1399999999999999 109.166 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 7.1 t -77.15 -36.15 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.768 -1.197 . . . . 1.1899999999999999 107.768 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -33.57 48.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.13 -1.063 . . . . 1.1799999999999999 108.13 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.31 94.91 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.912 -0.773 . . . . 1.22 108.912 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.84 -69.07 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.741 -0.837 . . . . 1.6899999999999999 108.741 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 44.18 46.78 7.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.608 -0.683 . . . . 1.76 109.348 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 67.34 73.46 0.36 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.436 -0.95 . . . . 3.52 108.436 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -74.58 157.13 44.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.596 2.198 . . . . 0.57999999999999996 110.437 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.67 173.15 6.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.447 -0.783 . . . . 1.05 109.488 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.433 HG21 ' CG2' ' A' ' 54' ' ' THR . 13.3 t -156.15 160.74 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.89 -0.781 . . . . 1.0900000000000001 108.89 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 35.3 tt0 -146.68 113.11 5.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 1.47 108.746 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.463 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.9 mt -99.94 136.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.395 -0.816 . . . . 1.1599999999999999 110.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.544 ' HG3' ' HB3' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.23 111.06 20.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.297 -1.371 . . . . 1.8100000000000001 107.297 178.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.471 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.5 tt0 -98.52 122.33 41.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.985 -1.072 . . . . 1.6100000000000001 110.781 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -125.47 46.72 2.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.565 -0.902 . . . . 1.97 108.565 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.47 -131.33 10.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.749 -1.74 . . . . 0.40999999999999998 108.749 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.26 -0.31 19.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -1.179 . . . . 1.1299999999999999 109.555 179.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.3 m -98.81 131.53 44.86 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.897 -1.127 . . . . 1.02 108.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.471 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.3 m-85 -128.25 118.62 23.62 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.27000000000000002 110.049 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.0 t80 -102.24 144.71 30.42 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.082 -1.451 . . . . 0.73999999999999999 107.082 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.5 mt -141.79 107.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.684 -1.26 . . . . 1.26 110.562 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HB2' ' HE1' ' A' ' 51' ' ' TYR . 1.6 tttt -104.72 115.46 30.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 2.3300000000000001 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.433 ' CG2' HG21 ' A' ' 41' ' ' VAL . 44.4 m -104.2 144.79 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 1.0800000000000001 109.1 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.65 134.57 30.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 0.93000000000000005 109.615 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.8 -71.73 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.93 0.871 . . . . 1.3200000000000001 109.329 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -172.95 -41.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.809 -1.552 . . . . 1.74 106.809 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -113.96 -9.85 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.701 -0.851 . . . . 1.8200000000000001 108.701 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' CG ' ' N ' ' A' ' 60' ' ' THR . 35.8 ttm180 -123.3 163.81 20.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.278 -0.889 . . . . 3.9700000000000002 109.411 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 20.4 m -164.31 102.96 0.85 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.545 -0.722 . . . . 1.1699999999999999 109.301 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -101.71 172.69 6.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 1.4199999999999999 109.504 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 3.7 pt-20 -171.87 125.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 1.8500000000000001 109.332 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.0 pt -117.57 170.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 1.1200000000000001 109.289 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.667 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -161.25 130.53 4.68 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.942 . . . . 1.79 108.939 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.5 p90 -161.54 -172.93 3.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.17000000000000001 111.484 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 11.6 ptpt -128.91 152.74 48.21 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.027 -1.101 . . . . 2.1899999999999999 108.027 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.2 92.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 1.04 109.734 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.67 -26.97 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.519 -1.324 . . . . 0.27000000000000002 110.579 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -124.65 159.51 30.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.246 . . . . 2.3799999999999999 109.995 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 84' ' ' LEU . 27.2 mt-10 -87.51 167.96 13.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 1.6499999999999999 109.207 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 18.3 p90 -161.38 178.36 9.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.419 -0.801 . . . . 0.20999999999999999 109.713 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -107.56 143.31 36.17 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.374 -0.973 . . . . 1.1399999999999999 108.374 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.99 -176.21 5.07 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.462 -0.774 . . . . 1.5900000000000001 109.46 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -99.55 153.06 19.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.817 -0.808 . . . . 1.9199999999999999 108.817 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 t -90.18 -144.99 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 1.6299999999999999 109.529 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.96 -19.21 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.78 -1.2 . . . . 2.5 110.56 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.6 -44.21 10.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.063 -1.023 . . . . 2.0299999999999998 109.305 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.88 39.65 0.09 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.425 . . . . 0.53000000000000003 109.536 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HD2' ' HD2' ' A' ' 80' ' ' PRO . 1.5 mmm180 -129.41 152.91 80.36 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.469 -1.019 . . . . 3.1800000000000002 109.052 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD2' ' HD2' ' A' ' 79' ' ' ARG . 35.9 Cg_endo -78.41 139.71 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.164 1.909 . . . . 0.32000000000000001 110.537 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 13.1 p -160.58 144.06 13.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.79000000000000004 109.559 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -86.4 117.28 25.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.293 -1.003 . . . . 2.0299999999999998 108.293 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.9 t -99.88 165.63 11.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -0.787 . . . . 0.88 109.971 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HA ' HD11 ' A' ' 84' ' ' LEU . 46.0 tp -144.94 155.63 43.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.473 -1.306 . . . . 1.26 107.473 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 65' ' ' PHE . 38.8 t -148.41 128.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.37 -1.332 . . . . 1.0600000000000001 111.855 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.66 158.48 28.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.274 -1.38 . . . . 2.3999999999999999 107.274 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.438 ' CZ2' ' HE2' ' A' ' 93' ' ' MET . 82.6 m95 -81.36 166.53 20.36 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.959 -1.088 . . . . 0.16 110.178 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.7 tp10 -130.99 -42.2 1.11 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.845 -1.169 . . . . 1.1100000000000001 107.845 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -136.71 -153.31 0.49 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.75 -1.204 . . . . 0.46000000000000002 107.75 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.94 -18.94 49.17 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.118 -0.989 . . . . 2.1499999999999999 109.594 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -147.93 26.84 0.99 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.091 -1.005 . . . . 0.28000000000000003 110.355 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 57.5 tttt -134.38 109.33 8.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.73 -1.231 . . . . 1.9399999999999999 108.617 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.438 ' HE2' ' CZ2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.17 148.02 39.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.404 -0.81 . . . . 1.0900000000000001 110.073 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 110' ' ' THR . 1.6 t -100.32 172.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 1.05 108.774 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 53.6 t -147.99 140.12 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.018 . . . . 0.88 111.078 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -107.57 164.49 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.867 -1.531 . . . . 2.1099999999999999 106.867 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.413 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 4.5 tt0 -160.2 135.84 8.29 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.412 -1.315 . . . . 0.85999999999999999 111.554 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 56.0 pttt -145.16 144.28 30.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.134 -1.061 . . . . 2.9500000000000002 108.134 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 168.14 1.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.898 -1.126 . . . . 1.4099999999999999 110.808 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 ' HG ' ' HA ' ' A' ' 81' ' ' CYS . 67.3 mt -102.78 -3.83 25.83 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.931 -1.137 . . . . 1.6000000000000001 107.931 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -153.88 148.2 25.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.942 -0.762 . . . . 3.2599999999999998 108.942 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.16 -162.71 22.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.079 -1.609 . . . . 2.4300000000000002 109.079 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.94 141.73 0.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.266 -1.138 . . . . 5.2599999999999998 109.645 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.45 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.856 -1.697 . . . . 2.0699999999999998 108.856 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.17 -176.15 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.448 2.099 . . . . 0.94999999999999996 110.056 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -137.18 136.8 38.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.232 -1.025 . . . . 1.75 108.232 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.91 145.2 46.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 1.0700000000000001 110.753 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.8 m -162.73 136.59 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.819 -1.178 . . . . 1.2 107.819 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 53.4 p-90 -142.96 176.7 8.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.26000000000000001 110.323 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.419 ' CG2' HG11 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -142.43 171.83 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.462 0.649 . . . . 1.05 109.599 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.487 ' HE1' ' CE2' ' A' ' 3' ' ' PHE . 13.3 ptm -153.97 125.83 7.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.584 -0.895 . . . . 2.4700000000000002 108.584 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -120.53 154.12 35.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 1.97 110.232 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.93 144.78 41.91 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.436 ' N ' HD11 ' A' ' 113' ' ' LEU . 41.4 p -93.26 161.55 14.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.854 -1.154 . . . . 1.0800000000000001 109.715 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -62.14 -19.49 63.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 2.7400000000000002 109.794 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.21 -26.46 23.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.8600000000000001 109.184 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.1 -9.68 8.4 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.847 -1.301 . . . . 0.17999999999999999 109.847 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -55.88 172.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 1.48 109.03 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.602 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.9 tt -144.84 113.21 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 1.04 110.18 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.74 154.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.914 -1.143 . . . . 1.3600000000000001 107.914 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.91 131.3 30.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.023 -1.048 . . . . 2.0 109.893 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.02 162.32 14.34 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.835 -1.172 . . . . 1.0900000000000001 107.835 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 13.9 mtp -142.4 159.09 42.92 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.164 -0.96 . . . . 1.3200000000000001 109.774 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.4 m -143.87 152.56 41.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.15 -0.685 . . . . 1.0800000000000001 109.15 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' A' ' 126' ' ' ASP . . . -155.94 91.14 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 1.0800000000000001 109.586 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER 78.72 -76.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.924 -0.769 . . . . 1.21 108.924 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.25 22.67 1.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.36 179.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.197 -1.038 . . . . 1.1000000000000001 108.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.2 t -158.85 117.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.132 -1.027 . . . . 1.0900000000000001 110.077 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 t -99.14 107.74 20.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 1.04 109.321 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -99.71 145.98 27.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 109.507 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -151.02 122.69 8.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.503 -0.925 . . . . 2.3399999999999999 108.503 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.54 135.52 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.911 -1.118 . . . . 1.05 108.767 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.472 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.1 m-85 -124.37 124.35 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.508 -0.877 . . . . 1.01 109.916 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.575 -1.269 . . . . 1.04 107.575 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -44.52 125.88 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.99 110.565 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' ARG . 9.1 tt0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.101 -0.952 . . . . 2.2999999999999998 111.057 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.972 0 N-CA-C 110.359 -0.67 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -153.65 121.64 6.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.506 -0.747 . . . . 0.0 109.707 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 3.4 m-85 -99.4 -11.46 21.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -66.12 117.08 7.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 111.958 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.11 -174.09 38.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 3.9 m120 -95.02 171.73 8.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.3 m95 -151.22 128.79 11.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.513 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -120.41 115.82 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.1 tt -58.51 153.56 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.918 0.866 . . . . 0.0 111.2 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.48 -32.89 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -140.77 168.69 19.19 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 t 177.95 147.09 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -144.39 168.79 19.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.433 0.635 . . . . 0.0 109.951 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.4 m-80 61.66 31.38 18.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.672 . . . . 0.0 109.66 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -75.11 -64.72 0.99 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.528 -0.732 . . . . 0.0 110.111 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 46.8 mt-10 -56.51 -34.83 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 110.959 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -69.81 -29.97 67.39 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.469 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.3 tp -77.46 -19.8 55.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 109.908 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 6.6 mt -89.99 -16.85 28.99 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.97 . . . . 0.0 109.291 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mtmm -86.19 -33.69 20.72 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 22' ' ' LEU . 14.7 p -72.07 -39.76 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.7 mp -68.56 -46.26 69.92 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.832 0.825 . . . . 0.0 109.266 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.12 -163.44 27.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.21 -40.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.894 -0.768 . . . . 0.0 109.75 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.5 t30 -59.74 -165.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.483 -0.761 . . . . 0.0 109.482 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.45 -48.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.29 -28.17 67.79 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.9 mm? -56.98 -20.31 23.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.78 -50.48 5.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.787 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -62.35 -19.84 63.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.7 . . . . 0.0 111.076 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.58 -29.86 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.195 -0.941 . . . . 0.0 108.752 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.66 -25.1 33.38 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 13.9 t -76.89 -37.08 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.61 49.04 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.03 93.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.36 -69.93 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m 47.79 49.84 16.17 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.498 0.666 . . . . 0.0 109.626 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mttp 66.37 72.49 0.43 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -72.9 166.4 30.11 Favored 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.974 1.782 . . . . 0.0 110.811 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.53 173.02 6.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.65 -0.657 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 53.5 t -154.55 165.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 41.4 tt0 -151.82 110.92 3.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.6 mt -97.83 138.43 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.806 0.812 . . . . 0.0 110.084 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttt -116.95 104.96 11.81 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.2 tt0 -97.34 125.37 41.9 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.33 54.15 1.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -126.18 8.35 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -75.5 -1.36 23.86 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.252 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -97.14 136.49 37.6 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.741 -1.224 . . . . 0.0 108.338 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -131.16 116.48 17.76 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.857 0.837 . . . . 0.0 109.297 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.8 t80 -102.29 148.95 24.83 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.432 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.3 mt -146.31 99.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.996 -1.065 . . . . 0.0 110.426 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -99.98 114.23 27.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 109.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -101.96 144.69 30.26 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.57 131.65 23.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.408 -0.807 . . . . 0.0 109.777 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.37 -80.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.665 . . . . 0.0 109.446 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.5 p -158.06 -46.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 t -112.7 -10.45 12.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -117.24 162.02 18.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 m -163.83 103.47 0.9 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -102.07 172.85 6.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.767 . . . . 0.0 109.329 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -171.94 119.58 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.69 . . . . 0.0 109.736 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -110.43 170.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.35 133.87 5.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.292 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.475 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.1 p90 -161.98 -172.37 3.23 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.637 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -129.19 153.01 48.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.39 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.139 -0.976 . . . . 0.0 109.825 -178.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.12 -27.36 1.72 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.013 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -119.39 156.19 30.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -86.28 167.27 14.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.7 p90 -162.72 174.46 12.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.698 . . . . 0.0 109.634 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.94 147.5 26.85 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -161.74 179.49 8.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.679 -0.638 . . . . 0.0 109.324 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.72 128.1 55.05 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.265 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.6 t -63.86 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.1 -16.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 111.322 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.66 -40.85 14.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.28 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.51 43.49 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -130.52 148.89 71.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.661 -0.905 . . . . 0.0 108.937 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 140.51 17.15 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.454 1.436 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.6 p -160.86 141.69 11.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.682 -0.636 . . . . 0.0 109.633 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.45 114.27 26.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.21 176.21 5.33 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.947 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -152.93 153.32 32.76 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 6.6 t -140.75 127.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.989 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.07 155.3 34.7 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.436 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.6 m95 -78.01 173.16 12.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.058 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -135.11 -46.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -129.99 -152.67 0.52 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.25 -25.71 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -143.78 25.27 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 110.981 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -130.08 110.93 12.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.893 -1.13 . . . . 0.0 108.065 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.436 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.41 150.17 38.22 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.661 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.52 172.15 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.2 t -149.15 129.76 14.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.88 . . . . 0.0 110.752 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -101.04 162.37 12.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.44 139.76 10.78 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.878 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.05 149.74 37.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.69 165.59 3.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 111.085 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 mt -100.49 -2.97 31.77 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -153.36 134.31 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 108.807 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.87 -160.7 41.46 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -176.26 141.41 0.43 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.467 -1.019 . . . . 0.0 109.841 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.0 -85.39 0.05 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.53 -177.14 3.05 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.82 1.68 . . . . 0.0 109.857 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -134.44 138.51 44.83 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.03 145.25 48.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.008 0.909 . . . . 0.0 110.69 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.5 m -163.39 132.53 4.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -135.96 170.45 15.98 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.037 -1.039 . . . . 0.0 110.422 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 p -134.54 173.12 12.0 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.532 0.682 . . . . 0.0 109.722 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.7 ptp -158.6 139.57 12.97 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.0 pt-20 -140.64 144.87 35.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.366 -0.834 . . . . 0.0 109.1 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -105.02 144.79 31.34 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.402 ' N ' HD11 ' A' ' 113' ' ' LEU . 18.8 p -91.75 160.38 15.36 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.559 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.15 -19.87 55.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.62 -0.675 . . . . 0.0 110.337 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.11 -28.56 22.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.29 -8.79 7.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -57.94 171.3 0.53 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.046 -1.267 . . . . 0.0 108.95 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.5 tt -146.01 110.87 5.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.883 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 120' ' ' ILE . 14.3 tt -107.34 148.47 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -132.87 138.56 47.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.378 -0.826 . . . . 0.0 109.59 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.44 169.04 9.46 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.2 mtp -146.96 165.25 30.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.197 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -147.63 151.11 35.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.67 92.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.559 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.78 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -146.57 24.11 1.25 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.74 -179.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.4 t -157.69 118.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.722 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 t -99.53 113.67 26.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.8 m -109.34 147.94 31.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.737 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -152.59 117.59 5.15 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.9 t -80.18 139.17 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 108.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.7 m-85 -127.68 123.51 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.315 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.03 138.45 31.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.495 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.15 128.56 16.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.181 -0.95 . . . . 0.0 111.543 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 4.1 tt0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.322 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.502 1.987 0 N-CA-C 110.381 -0.661 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -132.49 135.41 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.503 -0.748 . . . . 0.0 110.143 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.4 m-85 -98.69 1.38 46.11 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 120.12 18.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 111.925 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -174.19 38.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.5 m120 -95.58 172.03 8.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -151.49 125.23 9.05 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.573 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -117.54 114.04 22.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 4.6 tt -52.63 147.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.661 0.744 . . . . 0.0 111.13 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.67 -25.11 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 122.003 -0.436 . . . . 0.0 110.24 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -152.57 177.43 10.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.164 -0.96 . . . . 0.0 110.469 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -179.47 166.05 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.79 24.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 111.708 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -161.14 27.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.607 -0.683 . . . . 0.0 110.197 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.45 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -65.44 -66.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 108.738 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 14.9 pt-20 -56.52 -28.64 60.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.35 -38.9 91.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.677 -0.639 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 36.7 tp -79.4 -16.13 56.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.773 -0.58 . . . . 0.0 110.137 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD13 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.83 -20.29 22.47 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.954 -1.091 . . . . 0.0 109.18 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.7 mmmt -83.03 -28.17 29.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -80.42 -40.64 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 122.127 0.965 . . . . 0.0 108.477 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.76 -50.02 59.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.919 0.866 . . . . 0.0 109.87 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.77 -154.21 25.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.79 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.0 t -150.7 -39.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 122.029 -0.689 . . . . 0.0 110.029 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -60.8 -160.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.38 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.09 -45.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.892 . . . . 0.0 109.775 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -66.12 -30.9 71.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.857 -0.527 . . . . 0.0 110.213 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -84.87 -47.48 10.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.499 -0.751 . . . . 0.0 109.968 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -61.61 -21.86 64.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.691 -0.63 . . . . 0.0 111.06 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.5 mt -81.26 -28.8 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 108.917 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.22 -25.87 36.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.665 -0.647 . . . . 0.0 109.354 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 3.0 t -80.33 -44.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.21 85.54 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.41 -56.23 23.9 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.9 57.96 4.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.757 -0.589 . . . . 0.0 110.287 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 t -64.21 -43.11 96.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.697 -1.252 . . . . 0.0 107.726 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -151.36 74.19 8.2 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.5 142.11 39.83 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.846 1.697 . . . . 0.0 111.262 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.94 174.73 6.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 50.8 t -155.74 163.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -151.31 111.6 4.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.6 mp -98.08 135.81 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.019 0.914 . . . . 0.0 110.442 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 4.4 mttm -109.91 93.45 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.65 125.44 41.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.31 -0.869 . . . . 0.0 110.42 -176.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -132.65 56.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.55 -132.29 10.97 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -71.71 -4.36 27.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.384 -1.068 . . . . 0.0 110.441 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 m -96.79 134.08 40.54 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.656 -1.278 . . . . 0.0 108.476 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.7 m-85 -131.15 119.06 21.36 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.687 0.756 . . . . 0.0 109.336 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 15.0 t80 -103.15 150.46 23.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -148.58 104.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.94 -1.1 . . . . 0.0 110.97 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -104.81 113.11 26.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 108.864 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.6 m -102.49 145.5 29.49 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -142.77 119.15 10.91 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.674 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 p -99.26 -158.87 0.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.6 t -57.39 -45.11 84.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.942 . . . . 0.0 110.923 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 t -131.42 -7.67 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.314 -0.866 . . . . 0.0 111.975 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -98.94 165.75 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.072 -1.017 . . . . 0.0 110.008 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 m -163.71 95.44 0.81 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 169.17 12.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.772 . . . . 0.0 109.724 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.34 111.35 1.22 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.489 -0.757 . . . . 0.0 109.699 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 pt -116.53 165.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.58 132.51 4.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 47.3 p90 -161.67 -172.7 3.43 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.404 1.097 . . . . 0.0 112.445 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.76 153.54 48.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.32 93.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.133 -0.98 . . . . 0.0 109.681 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.31 -22.91 1.55 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.906 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.69 155.63 37.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.22 -1.165 . . . . 0.0 110.219 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.64 166.41 15.38 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.17 174.57 12.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -105.55 144.22 32.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -162.31 -174.79 4.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -99.75 159.91 14.7 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -97.31 -142.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.13 -19.2 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.783 -1.198 . . . . 0.0 110.824 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.67 -37.11 13.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.486 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.71 45.14 0.15 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -133.3 153.54 80.65 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 121.691 -0.888 . . . . 0.0 109.447 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.0 142.04 17.05 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.767 1.645 . . . . 0.0 110.505 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -161.26 143.06 11.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.657 -0.652 . . . . 0.0 109.517 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.46 117.33 28.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.48 166.54 11.11 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.266 0.555 . . . . 0.0 109.988 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.77 153.02 37.56 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 24.8 t -143.4 136.13 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.417 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.21 157.22 41.45 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CE2' HG23 ' A' ' 67' ' ' VAL . 79.6 m95 -81.15 172.83 13.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.019 0.914 . . . . 0.0 110.627 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -136.69 -45.98 0.6 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.9 p -131.81 -153.63 0.57 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -76.47 -26.97 55.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.801 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -143.46 28.53 1.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -130.54 110.37 11.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.989 -1.069 . . . . 0.0 108.188 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.431 ' CE ' ' CE2' ' A' ' 50' ' ' PHE . 1.3 ptp -117.43 147.5 42.64 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.728 0.775 . . . . 0.0 110.572 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.73 171.5 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.0 t -146.83 137.43 23.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -108.77 156.13 19.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -154.65 142.2 19.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.974 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -143.73 152.05 40.78 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.17 168.03 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.755 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 mt -99.6 -5.75 28.51 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 137.2 14.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 108.621 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.85 -163.12 37.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -175.96 140.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.43 -1.041 . . . . 0.0 109.995 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.35 -86.83 0.06 OUTLIER Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.83 -176.91 2.87 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.783 1.655 . . . . 0.0 109.643 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -131.41 139.87 49.52 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.12 144.63 48.46 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.172 0.987 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 m -162.92 131.8 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 48.9 p-90 -137.12 172.79 12.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.143 -0.973 . . . . 0.0 110.231 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.8 p -135.92 174.16 10.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.542 0.687 . . . . 0.0 109.959 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.429 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 6.9 ptm -157.95 124.31 4.79 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -119.54 147.64 44.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.488 -0.758 . . . . 0.0 109.889 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.01 143.52 39.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 p -93.55 159.48 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -59.28 -21.9 60.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.96 -30.19 24.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.3 -9.82 6.56 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.9 173.91 0.13 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.084 -1.245 . . . . 0.0 109.349 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.5 tt -148.17 111.14 4.83 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.124 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -106.82 151.47 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.94 147.08 52.44 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.423 -0.798 . . . . 0.0 109.439 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.73 170.36 12.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 9.5 mtp -150.6 167.77 26.29 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.675 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.5 m -149.31 151.31 33.94 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.82 94.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.53 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.15 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.19 23.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.23 -178.86 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.5 t -157.86 118.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.589 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 t -97.9 121.52 39.92 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -119.93 134.62 55.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.224 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -139.86 108.43 5.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -72.39 140.38 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.2 m-85 -129.07 128.79 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.2 137.63 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -49.48 128.33 17.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.233 -0.917 . . . . 0.0 111.687 -178.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.4 tm-20 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.807 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.501 1.931 0 N-CA-C 110.58 -0.585 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.34 128.96 38.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 110.044 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.454 ' CD2' ' CE ' ' A' ' 111' ' ' MET . 3.3 m-85 -99.06 -2.13 37.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.7 p -71.82 118.74 15.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.955 . . . . 0.0 111.943 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.64 -173.62 38.04 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 4.6 m120 -95.36 170.67 9.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.49 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.4 m95 -150.91 128.12 11.23 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.488 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -121.66 116.36 24.42 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.4 tt -59.48 141.84 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.525 0.678 . . . . 0.0 110.294 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -119.52 -23.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.875 -0.516 . . . . 0.0 110.101 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -145.66 176.73 9.41 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 176.29 165.43 0.43 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -159.32 25.77 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.091 -1.006 . . . . 0.0 111.292 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.4 m-20 -160.85 29.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.665 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.49 -65.66 0.65 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 0.0 109.008 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.6 mt-10 -56.68 -27.07 58.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.81 -40.9 97.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.667 -0.645 . . . . 0.0 109.791 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.75 -16.73 58.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.662 -0.649 . . . . 0.0 110.091 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.401 HD12 ' CE1' ' A' ' 15' ' ' PHE . 7.7 mt -89.43 -19.24 25.39 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.055 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.1 mmmt -85.57 -28.6 24.76 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.57 -41.06 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.69 -53.13 45.29 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.018 0.913 . . . . 0.0 108.935 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.75 -146.26 17.13 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -155.93 -43.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -56.95 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.518 -0.739 . . . . 0.0 109.56 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.83 -44.49 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.416 -0.802 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.1 ttm -66.3 -27.27 67.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.71 -41.9 82.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.675 -0.641 . . . . 0.0 110.35 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -71.36 -42.66 68.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -62.44 -20.24 64.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.755 -0.59 . . . . 0.0 111.115 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.47 -30.04 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 108.879 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.99 -25.6 32.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.7 t -79.13 -35.93 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.69 -36.17 51.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.91 79.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.42 -67.56 0.47 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 49.23 52.08 15.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 67.36 73.7 0.36 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.46 158.35 54.23 Favored 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.017 1.811 . . . . 0.0 110.795 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.51 173.13 6.45 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.743 -0.598 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 48.8 t -155.0 164.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.3 tt0 -148.68 111.53 4.82 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -97.9 132.59 42.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.786 0.803 . . . . 0.0 110.054 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -111.78 106.49 15.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -97.47 123.97 41.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.064 -1.022 . . . . 0.0 111.176 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -123.62 55.22 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -126.03 8.15 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -1.09 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -1.034 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.44 136.05 37.47 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.782 -1.199 . . . . 0.0 108.551 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.9 m-85 -130.96 115.66 16.8 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.6 t80 -102.29 148.17 25.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -145.17 99.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.019 -1.05 . . . . 0.0 110.389 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -99.25 113.71 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.766 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 m -100.53 144.7 29.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.799 . . . . 0.0 108.964 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 136.9 32.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.46 -0.775 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.27 -65.93 1.04 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.916 0.865 . . . . 0.0 109.708 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t 178.64 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.4 t -112.93 -11.64 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -124.37 163.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.083 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 m -163.28 103.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -101.84 173.87 6.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.8 . . . . 0.0 109.55 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -172.27 118.96 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.773 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.2 pt -108.56 169.55 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.483 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 132.82 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.764 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.1 p90 -161.92 -172.21 3.18 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.069 0.938 . . . . 0.0 111.739 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.53 154.53 48.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.58 95.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.187 -0.945 . . . . 0.0 109.636 -178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.66 -21.8 0.62 Allowed Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.606 -1.283 . . . . 0.0 111.038 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.82 163.57 29.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -1.144 . . . . 0.0 110.714 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -86.28 169.31 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.4 p90 -162.6 174.39 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -103.14 144.78 30.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -161.89 178.65 8.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.84 151.61 21.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 t -88.26 -142.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.485 -0.759 . . . . 0.0 109.125 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.2 -19.77 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.741 -1.224 . . . . 0.0 110.657 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.75 -41.31 12.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 44.25 0.1 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -131.63 147.19 65.04 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.666 -0.902 . . . . 0.0 108.89 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -79.8 142.72 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.441 1.427 . . . . 0.0 110.237 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.3 p -161.05 143.24 12.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.645 -0.66 . . . . 0.0 109.569 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -89.64 114.36 25.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.6 t -98.91 176.29 5.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.706 -0.621 . . . . 0.0 109.71 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HA ' HD11 ' A' ' 84' ' ' LEU . 50.1 tp -150.32 154.41 37.79 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 10.1 t -143.33 129.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.089 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.94 155.46 39.55 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.9 m95 -79.67 173.16 12.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -135.39 -46.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -130.7 -153.61 0.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.08 -25.77 52.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.08 26.85 1.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 110.892 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -132.15 109.58 10.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.0 108.078 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.454 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.6 OUTLIER -115.66 150.36 36.87 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.243 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.09 173.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 48.4 t -149.81 135.84 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.04 163.3 12.65 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -160.92 138.69 9.42 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.798 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -152.46 144.55 23.82 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -58.74 164.27 2.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 110.651 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.87 5.6 26.58 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptt -153.75 113.14 3.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.99 -163.83 45.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -176.34 140.97 0.4 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.393 -1.063 . . . . 0.0 110.066 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.67 -86.95 0.06 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.31 -176.49 2.59 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.846 1.697 . . . . 0.0 109.695 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -131.55 139.87 49.33 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 145.15 49.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.121 0.963 . . . . 0.0 110.84 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.88 137.04 6.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -142.79 175.44 9.82 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.986 -1.085 . . . . 0.0 110.56 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.2 p -137.91 172.67 12.59 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.551 0.691 . . . . 0.0 110.028 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' A' ' 3' ' ' PHE . 21.8 ptm -157.84 128.59 6.43 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.9 pt-20 -131.67 154.89 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.586 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.13 144.71 41.05 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -91.99 162.19 14.48 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.585 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -61.36 -21.1 63.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.22 -26.58 24.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.15 -8.13 8.57 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.7 172.94 0.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.113 -1.227 . . . . 0.0 109.234 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.0 tt -144.92 110.36 5.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.501 -0.749 . . . . 0.0 109.618 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.404 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.0 tt -106.08 145.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.22 133.07 46.28 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.713 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.78 165.97 11.28 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 12.1 mtp -144.14 164.52 30.46 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.383 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 m -147.4 151.4 36.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.68 95.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.457 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.17 -80.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.33 24.89 1.25 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.525 -0.734 . . . . 0.0 109.168 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.34 -178.93 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.94 118.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 4.0 t -98.49 112.18 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -106.32 143.61 34.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -150.5 105.23 3.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.47 133.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 30.1 m-85 -121.2 123.5 42.41 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.075 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.32 139.71 26.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.59 128.08 16.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.221 -0.925 . . . . 0.0 111.351 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.245 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.023 0 N-CA-C 110.362 -0.668 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -150.66 126.38 10.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.724 . . . . 0.0 109.361 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.426 ' CG ' HD22 ' A' ' 113' ' ' LEU . 4.9 m-85 -99.42 -11.36 21.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -67.78 117.42 9.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 111.841 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.45 -173.46 38.73 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 4.9 m120 -95.45 170.84 9.08 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.45 128.12 10.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.666 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -122.48 116.32 23.74 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.0 tt -58.94 142.07 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.587 0.708 . . . . 0.0 110.474 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.3 -24.26 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.959 -0.463 . . . . 0.0 110.068 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -143.25 174.83 10.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.277 -0.889 . . . . 0.0 110.08 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 178.42 163.1 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.34 24.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 111.457 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 76.0 m-20 -160.59 27.37 0.15 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.1 t80 -65.16 -64.76 0.79 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 110.192 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 27.2 tt0 -55.86 -31.0 62.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.581 -0.699 . . . . 0.0 111.296 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 7.0 pt-20 -73.1 -31.51 64.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.51 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 tp -75.58 -19.42 59.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.828 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 15' ' ' PHE . 6.6 mt -90.17 -18.18 26.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 109.388 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.8 mtmt -84.6 -32.63 23.64 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.61 -39.96 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.04 -45.59 73.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.756 0.788 . . . . 0.0 109.458 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.94 -159.97 27.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 t -144.61 -41.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.982 -0.717 . . . . 0.0 109.722 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.4 t30 -60.64 -162.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.63 -49.02 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -67.41 -27.73 67.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -58.15 -19.62 34.25 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.79 -0.569 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.72 -49.26 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.16 -0.962 . . . . 0.0 109.59 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -62.25 -20.25 64.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.645 -0.659 . . . . 0.0 110.793 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.6 mt -78.42 -29.64 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 108.831 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.16 -25.62 34.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 11.2 t -77.52 -36.98 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.41 -34.16 48.2 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.64 93.97 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.33 -67.87 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.67 52.41 14.96 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 67.25 73.41 0.37 Allowed Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.61 155.9 58.44 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 C-N-CA 122.055 1.837 . . . . 0.0 110.829 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.47 172.99 6.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.401 HG21 ' CG2' ' A' ' 54' ' ' THR . 53.4 t -155.49 164.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.11 110.6 3.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.447 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 1.8 mp -98.65 141.99 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.817 0.818 . . . . 0.0 110.543 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.36 111.93 18.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.36 117.73 33.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.97 -1.081 . . . . 0.0 111.026 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.63 50.05 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -125.43 8.11 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -75.66 -1.82 26.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.431 -1.04 . . . . 0.0 110.052 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 m -96.35 138.4 34.01 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.816 -1.177 . . . . 0.0 108.636 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -134.18 117.68 16.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.795 0.807 . . . . 0.0 109.217 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -103.43 147.98 26.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.6 mt -144.01 104.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 C-N-CA 118.974 -1.091 . . . . 0.0 111.445 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.13 113.61 26.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.514 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.401 ' CG2' HG21 ' A' ' 41' ' ' VAL . 31.9 m -103.28 142.35 34.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.87 143.16 38.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.401 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -115.55 -65.91 1.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.917 0.865 . . . . 0.0 109.43 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t 178.82 -41.76 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.58 -10.83 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -125.08 164.71 19.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 109.103 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.9 m -162.44 96.25 0.95 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.697 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 165.31 23.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 109.974 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -164.12 118.69 1.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.87 165.99 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 108.93 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.15 127.59 3.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 51.9 p90 -162.18 -172.64 3.29 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.009 -1.076 . . . . 0.0 111.763 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 154.65 48.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.57 95.05 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.92 . . . . 0.0 109.828 -178.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.87 -20.04 0.67 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.13 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.02 162.18 33.19 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.185 -1.185 . . . . 0.0 110.841 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.43 165.63 16.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.7 p90 -161.75 173.84 14.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -101.73 144.77 30.01 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -162.18 -178.28 6.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -99.66 155.69 17.48 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.7 t -92.91 -142.33 0.21 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 109.325 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.2 -21.01 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.717 -1.239 . . . . 0.0 110.837 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.75 -40.0 13.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.67 45.19 0.11 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -131.96 150.62 76.64 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.708 -0.878 . . . . 0.0 109.161 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.79 141.68 17.26 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.676 1.584 . . . . 0.0 110.408 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.7 p -161.19 141.46 10.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.645 -0.659 . . . . 0.0 109.862 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -89.7 114.17 25.79 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -99.68 174.05 6.42 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.301 0.572 . . . . 0.0 110.416 -178.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 tp -148.05 152.39 37.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.451 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 7.0 t -142.36 126.89 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.976 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -122.33 155.2 36.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.441 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 79.0 m95 -77.42 176.22 9.06 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.892 0.854 . . . . 0.0 110.242 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -138.44 -46.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.1 p -131.01 -152.51 0.51 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.6 -25.42 45.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -142.8 27.63 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -132.98 113.31 12.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.935 -1.103 . . . . 0.0 108.283 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.441 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.6 ptm -120.37 150.44 40.75 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.521 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.82 172.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.0 t -149.89 134.81 17.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -103.95 165.21 11.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -160.87 138.93 9.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.84 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -144.84 148.9 34.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.86 166.86 3.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 0.0 110.994 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 mt -101.54 -3.56 28.28 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -150.8 130.34 13.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 108.892 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.93 -157.4 42.66 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -176.43 140.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.47 -1.018 . . . . 0.0 109.863 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.39 -87.3 0.06 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.64 -176.82 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 C-N-CA 121.8 1.666 . . . . 0.0 109.645 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -130.66 138.52 50.1 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.67 144.83 48.88 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.189 0.995 . . . . 0.0 110.734 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.9 m -163.44 136.67 5.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -139.21 172.38 12.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -136.43 170.16 16.5 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.476 0.655 . . . . 0.0 109.848 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.1 ptp -154.01 137.16 15.6 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -134.01 146.26 50.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.392 -0.817 . . . . 0.0 109.225 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.7 141.53 42.18 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -90.27 160.65 16.05 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.791 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -21.45 61.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.657 -0.652 . . . . 0.0 110.078 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -85.08 -29.49 24.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.99 -9.21 7.12 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.12 172.2 0.31 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.158 -1.201 . . . . 0.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.4 tt -145.14 107.98 4.49 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.097 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.87 150.73 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.03 133.68 39.64 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.59 8.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 11.8 mtp -148.41 166.78 27.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.742 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -150.07 148.07 28.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.56 93.05 1.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.521 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.79 -78.26 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -147.07 23.72 1.18 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.31 -179.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.7 t -156.41 119.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.46 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.2 t -98.39 118.46 35.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -112.92 143.37 44.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.762 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -150.82 105.01 3.22 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.2 133.05 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.423 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.4 m-85 -120.83 120.81 36.65 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.154 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.14 139.98 22.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.98 128.48 18.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.196 -0.94 . . . . 0.0 111.322 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.342 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.009 0 N-CA-C 110.222 -0.722 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -152.39 124.07 7.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.555 -0.716 . . . . 0.0 109.766 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 m-85 -99.26 -7.85 25.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.3 p -69.11 117.54 10.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.955 . . . . 0.0 111.9 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.12 38.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.0 m120 -95.72 169.39 10.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.08 122.23 7.73 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.687 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -114.28 112.82 23.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.9 tt -56.53 146.93 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 110.67 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.64 -23.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.393 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.46 173.46 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t 169.57 168.51 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.66 28.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.013 -1.054 . . . . 0.0 112.02 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.01 31.69 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.205 -0.934 . . . . 0.0 109.106 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -68.0 -62.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 110.019 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.49 -31.15 67.59 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 111.097 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -71.18 -26.55 63.01 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.696 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 22' ' ' LEU . 12.9 tp -81.76 -21.38 37.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.424 -0.797 . . . . 0.0 109.975 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -86.94 -17.62 32.72 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.099 -1.001 . . . . 0.0 109.305 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.6 mtmt -85.05 -34.64 22.24 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -73.69 -40.54 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 18' ' ' LEU . 5.0 mp -67.32 -46.11 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.828 0.823 . . . . 0.0 108.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -162.59 27.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.98 -37.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.831 -0.805 . . . . 0.0 110.183 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.2 t30 -62.0 -158.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.443 -0.786 . . . . 0.0 109.163 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.07 -47.56 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 109.316 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 ttt -68.08 -28.42 67.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -59.39 -19.26 45.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.737 -0.602 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -47.4 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 109.876 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -62.73 -22.58 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.612 -0.68 . . . . 0.0 110.569 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.42 -28.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.842 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.59 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 11.3 t -76.67 -38.9 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.62 57.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.4 95.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.63 -65.57 0.66 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.627 -0.671 . . . . 0.0 109.237 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p 47.89 55.3 8.76 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.671 0.748 . . . . 0.0 109.082 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 69.29 72.73 0.32 Allowed Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.67 162.66 41.42 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.146 1.898 . . . . 0.0 110.808 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.97 172.8 6.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.711 -0.618 . . . . 0.0 109.432 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -154.07 165.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -150.69 110.75 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mt -98.34 137.1 26.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.677 0.751 . . . . 0.0 110.335 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.63 112.08 21.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.4 tt0 -98.24 121.7 40.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.008 -1.057 . . . . 0.0 111.106 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -121.52 51.77 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -125.4 7.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.27 -0.95 24.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.415 -1.05 . . . . 0.0 110.102 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 m -96.68 140.93 30.56 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.789 -1.194 . . . . 0.0 108.353 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 95.8 m-85 -136.07 115.33 12.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.923 0.868 . . . . 0.0 109.718 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.1 t80 -101.04 147.03 26.67 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 3.0 mt -142.31 100.92 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.989 -1.07 . . . . 0.0 110.327 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -98.8 114.64 27.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.535 -0.728 . . . . 0.0 109.961 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -99.22 142.2 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 p -136.54 118.32 15.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.357 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.455 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -99.28 -169.7 1.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -51.66 -42.35 62.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.493 -0.755 . . . . 0.0 111.204 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -132.36 -7.36 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.274 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -106.13 173.33 6.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.917 -1.114 . . . . 0.0 110.228 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -164.39 93.91 0.69 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.3 p -92.43 176.04 6.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.102 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.4 139.81 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.139 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.2 pt -128.66 170.07 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.504 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.55 130.76 3.96 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' CG2' ' A' ' 85' ' ' VAL . 50.9 p90 -161.58 -172.2 3.25 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.896 -1.121 . . . . 0.0 112.062 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -128.89 153.31 47.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.44 96.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.529 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.6 -32.28 1.61 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.56 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -113.64 155.8 24.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -1.069 . . . . 0.0 109.893 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -86.33 167.72 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.461 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.2 p90 -162.14 173.08 14.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.551 -0.718 . . . . 0.0 109.809 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -104.24 144.52 31.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -162.13 -175.75 4.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -99.53 156.88 16.81 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.4 t -94.39 -142.1 0.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 109.22 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.45 -20.57 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.712 -1.242 . . . . 0.0 110.828 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.82 -38.18 13.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 109.428 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 44.13 0.15 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 mtm-85 -130.28 151.9 79.26 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 121.656 -0.908 . . . . 0.0 109.256 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.66 141.06 17.1 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.644 1.563 . . . . 0.0 110.345 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.6 p -160.75 140.79 11.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.683 -0.636 . . . . 0.0 109.692 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -90.85 113.96 26.26 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -102.74 177.76 4.76 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.224 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.3 tp -152.94 153.15 32.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 10.0 t -141.37 127.72 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.874 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 155.78 33.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.459 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 84.2 m95 -78.69 172.38 13.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 109.851 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -133.44 -47.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 p -132.17 -151.69 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.98 -26.87 48.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.308 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -140.2 23.93 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 111.466 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -131.83 111.69 11.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.749 -1.22 . . . . 0.0 108.451 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.459 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.9 ptm -116.71 149.26 40.13 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.119 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.63 173.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -149.45 130.35 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -101.97 163.45 12.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -160.34 143.8 13.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.006 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -146.18 151.38 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.23 166.66 5.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 mt -101.03 -4.11 28.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 108.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.6 -157.03 42.09 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -177.34 140.43 0.28 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.514 -0.992 . . . . 0.0 109.529 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.19 -85.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.59 -176.84 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.82 1.68 . . . . 0.0 109.956 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -136.12 141.26 44.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.05 145.09 48.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.125 0.964 . . . . 0.0 110.596 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 p -162.79 129.65 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -136.57 173.69 11.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.226 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 p -135.84 172.43 13.03 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.54 0.686 . . . . 0.0 109.901 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.449 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 9.8 ptm -155.91 124.84 6.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.94 152.7 39.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.899 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.75 142.13 46.93 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.8 p -91.77 160.09 15.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -60.45 -21.8 62.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -83.76 -29.7 27.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.137 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.47 -9.01 7.36 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -57.32 172.44 0.32 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.12 -1.223 . . . . 0.0 109.061 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -145.62 110.13 5.04 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.86 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 120' ' ' ILE . 11.6 tt -105.99 148.97 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.58 145.95 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.668 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.59 169.65 11.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.419 -1.696 . . . . 0.0 106.419 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 35.4 mtp -151.66 164.26 37.32 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.574 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.6 m -146.34 152.51 39.22 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.94 97.61 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.635 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.97 -79.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.43 24.27 1.01 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.566 -0.709 . . . . 0.0 109.342 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 m -119.54 -179.73 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.2 t -158.05 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.593 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.8 t -99.27 131.65 45.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 97.2 m -123.39 127.58 48.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -125.18 102.56 7.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.68 134.13 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.5 m-85 -124.15 129.99 51.77 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.604 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.91 138.45 40.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -48.73 125.28 9.81 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 0.0 111.285 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.6 179.647 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.011 0 N-CA-C 110.35 -0.673 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -163.53 123.11 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 4.3 m-85 -98.62 -0.85 42.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -71.12 117.14 12.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.128 -0.983 . . . . 0.0 112.023 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.5 -172.18 38.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.78 168.26 10.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.8 m95 -151.88 125.0 8.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.493 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -120.86 115.36 23.09 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 tt -56.29 139.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.556 0.693 . . . . 0.0 110.582 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.15 -24.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.852 -0.53 . . . . 0.0 109.823 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -142.93 174.41 10.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.356 -0.84 . . . . 0.0 110.075 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t 178.86 164.51 0.84 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.45 25.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 74.8 m-20 -160.5 27.76 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.709 -0.619 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -63.49 -66.94 0.47 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.1 tt0 -55.54 -27.78 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.488 -0.757 . . . . 0.0 109.672 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -63.6 -40.56 97.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.674 -0.641 . . . . 0.0 110.205 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 tp -79.59 -16.44 55.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 8.2 mt -90.67 -17.49 26.72 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.97 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.3 mmmt -85.6 -30.45 23.3 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.55 -40.2 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.37 -47.5 70.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.86 0.838 . . . . 0.0 109.374 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -156.12 26.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.2 -36.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.925 -0.75 . . . . 0.0 110.311 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.7 t30 -62.41 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 m -132.0 -47.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.661 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.7 ttt -69.58 -33.13 72.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 6.1 mp -48.05 -34.62 9.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.937 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.73 -42.88 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -61.96 -19.8 63.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.687 -0.633 . . . . 0.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 31' ' ' ILE . 47.4 mm -80.31 -29.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 108.839 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.47 -25.77 33.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 10.7 t -77.33 -39.86 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.5 62.88 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.57 94.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.01 -67.62 0.44 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.36 55.22 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.4 mttm 65.08 73.35 0.43 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.5 Cg_endo -71.46 151.95 59.8 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.031 1.821 . . . . 0.0 110.822 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.87 173.64 6.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.4 t -155.8 164.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -147.77 111.98 5.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -98.01 131.47 44.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.805 0.812 . . . . 0.0 110.348 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -110.82 107.83 17.45 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.6 tt0 -97.63 123.81 41.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.114 -0.991 . . . . 0.0 111.177 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -124.17 54.43 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.41 -126.93 8.65 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -76.18 -1.09 24.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -1.049 . . . . 0.0 110.088 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m -96.81 136.8 36.84 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.763 -1.211 . . . . 0.0 108.394 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.5 m-85 -131.81 116.04 16.73 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.877 0.846 . . . . 0.0 109.346 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.1 t80 -101.42 147.98 25.71 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -144.77 100.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.982 -1.074 . . . . 0.0 110.328 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 112.1 24.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 m -99.1 146.31 26.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p -139.3 132.16 29.26 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -111.75 -63.14 1.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 t 177.37 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.81 -9.64 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.753 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -97.47 -83.25 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.044 . . . . 0.0 109.473 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.4 m 69.36 85.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.0 110.105 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.19 176.97 4.9 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.0 pt-20 -168.4 124.25 0.99 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.908 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.6 pt -111.68 170.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p-10 -162.74 133.99 5.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.133 -0.98 . . . . 0.0 109.467 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.3 p90 -161.92 -171.66 2.97 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.372 1.082 . . . . 0.0 112.615 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -129.62 152.65 48.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.64 95.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.19 -29.86 1.49 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.733 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -119.24 157.32 28.27 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.302 -1.117 . . . . 0.0 110.035 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -86.14 169.15 13.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.594 -0.691 . . . . 0.0 109.22 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.5 p90 -162.13 174.09 13.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 0.0 109.765 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.55 145.87 29.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -162.14 -177.71 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.472 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -104.66 157.75 16.97 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.211 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -170.4 2.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.333 -0.854 . . . . 0.0 110.19 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.92 -20.71 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.89 -0.506 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.54 -41.66 13.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.73 43.63 0.2 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -127.9 152.19 76.89 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 121.628 -0.925 . . . . 0.0 109.142 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.61 137.36 14.43 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.336 1.357 . . . . 0.0 110.21 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.8 p -160.69 142.47 12.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.656 -0.653 . . . . 0.0 109.466 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.79 117.35 25.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.5 t -99.14 166.52 11.2 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.3 tp -147.28 153.97 40.4 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 21.3 t -145.79 131.16 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.019 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -125.63 159.9 31.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.428 ' CE2' HG23 ' A' ' 67' ' ' VAL . 87.3 m95 -82.86 170.04 15.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.4 -46.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 p -131.18 -154.28 0.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -77.66 -25.53 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.594 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -141.85 26.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -131.42 108.77 9.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.885 -1.134 . . . . 0.0 108.316 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.423 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 1.5 ptp -113.88 145.96 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.513 -0.742 . . . . 0.0 110.286 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.91 172.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 54.0 t -148.4 139.59 23.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.29 163.15 13.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.413 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 7.3 tt0 -160.5 137.99 9.45 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.729 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -144.5 147.52 33.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.46 166.83 2.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.0 mt -101.17 -3.43 29.13 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -156.01 139.94 16.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 108.79 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.17 -162.68 35.68 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -176.49 139.33 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.41 -1.053 . . . . 0.0 109.947 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.75 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.67 -176.88 2.65 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.824 1.683 . . . . 0.0 109.663 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -132.61 141.38 48.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.44 144.42 49.52 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.163 0.982 . . . . 0.0 110.861 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -163.67 138.66 6.19 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -140.66 172.52 12.6 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.953 -1.092 . . . . 0.0 110.729 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.9 p -134.16 169.16 17.59 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 109.422 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.1 ttt -154.53 122.01 5.74 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -118.82 154.62 32.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.478 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -118.7 144.96 45.88 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.3 p -96.83 161.36 13.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.791 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -22.38 63.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -84.36 -27.94 27.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.295 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.52 -11.1 7.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.87 172.12 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.067 -1.255 . . . . 0.0 109.073 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.475 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 8.0 tt -149.72 113.64 5.1 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.648 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -98.62 155.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.81 111.72 8.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.35 168.63 9.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 7.9 mtp -145.73 169.19 18.97 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.64 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.0 m -151.31 150.48 30.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.34 91.41 1.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.448 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -78.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.24 23.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.572 -0.705 . . . . 0.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.68 -179.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.8 t -156.7 119.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.474 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 3.2 t -98.08 109.92 22.59 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 m -101.48 147.0 26.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -152.19 97.26 2.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.48 129.97 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -116.47 124.3 49.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.49 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.83 139.0 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.474 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -48.1 125.15 8.69 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.051 -0.976 . . . . 0.0 111.66 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.31 123.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.653 0.74 . . . . 0.0 110.236 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.467 ' CD2' ' CE ' ' A' ' 111' ' ' MET . 3.5 m-85 -99.56 1.22 43.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.665 -0.647 . . . . 0.0 109.573 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -73.04 118.19 15.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.117 -0.989 . . . . 0.0 111.939 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.47 -172.52 38.57 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.3 m120 -95.16 168.29 10.84 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.8 m95 -150.11 123.23 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.552 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -118.58 113.5 21.35 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.8 tt -56.93 145.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.711 0.767 . . . . 0.0 110.806 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.55 -23.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -141.54 175.62 9.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 0.0 110.468 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 169.15 168.04 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.06 30.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.877 -1.139 . . . . 0.0 112.036 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.52 32.95 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.195 -0.941 . . . . 0.0 108.975 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -66.35 -63.73 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.55 -0.719 . . . . 0.0 110.331 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 3.7 mt-10 -58.23 -27.17 63.71 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.497 -0.752 . . . . 0.0 111.25 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -73.08 -28.07 62.09 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.423 -178.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 7.6 tp -84.82 -17.69 37.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 110.277 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 15' ' ' PHE . 7.8 mt -90.33 -16.8 28.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.014 -1.054 . . . . 0.0 109.049 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' CD ' ' NE ' ' A' ' 29' ' ' ARG . 1.3 mmmm -86.52 -33.09 20.41 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 22' ' ' LEU . 14.9 p -74.17 -40.36 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.402 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.7 mp -67.48 -48.45 67.11 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.867 0.841 . . . . 0.0 109.05 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.65 -150.61 23.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.19 -43.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.922 -0.752 . . . . 0.0 109.275 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -56.72 -175.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.529 -0.732 . . . . 0.0 109.576 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -108.35 -44.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 0.0 110.034 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttt -68.23 -25.83 65.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 108.933 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -58.46 -34.97 71.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.63 -0.669 . . . . 0.0 110.66 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -76.37 -47.47 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.08 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -24.8 67.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 111.149 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.97 -28.47 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.304 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.76 -26.03 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 0.0 109.266 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 10.5 t -77.57 -39.43 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.1 60.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.68 97.06 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 56' ' ' THR . . . -62.38 -68.84 0.29 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m 50.13 52.3 15.0 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 64.22 73.33 0.47 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HB3' HG23 ' A' ' 56' ' ' THR . 28.4 Cg_endo -71.32 153.22 61.55 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.051 1.834 . . . . 0.0 110.728 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.36 174.15 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.686 -0.634 . . . . 0.0 109.532 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 48.3 t -154.98 164.21 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 6.8 tp10 -145.71 110.86 5.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -99.05 132.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.442 -0.786 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -112.38 114.45 27.18 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.77 119.55 37.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -119.06 52.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 -125.24 7.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -76.88 -0.43 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.388 -1.066 . . . . 0.0 109.953 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.5 m -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.841 -1.162 . . . . 0.0 108.648 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -135.71 115.5 13.0 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.842 0.829 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.0 147.52 26.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -142.95 105.09 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.983 -1.073 . . . . 0.0 111.196 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.67 112.07 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -99.52 141.73 31.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.77 120.22 18.07 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.246 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -99.22 -169.45 1.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 t -51.49 -42.36 61.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.82 -6.9 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.382 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -106.29 175.98 5.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.955 -1.09 . . . . 0.0 110.223 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -164.57 96.56 0.76 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.765 -0.584 . . . . 0.0 109.646 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 167.55 16.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 109.315 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -160.22 124.17 3.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 109.785 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 pt -123.71 165.56 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.3 128.13 3.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.043 -1.035 . . . . 0.0 109.669 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.452 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.5 p90 -162.04 -172.02 3.08 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.622 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.04 154.6 49.23 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.63 93.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -178.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.49 -24.16 0.51 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.43 161.93 32.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -1.075 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.68 168.8 13.25 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.671 -0.643 . . . . 0.0 109.359 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.452 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.06 173.59 14.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.699 -0.626 . . . . 0.0 109.456 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.25 144.18 31.1 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -162.24 -175.98 4.87 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -100.07 157.6 16.44 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -93.59 -141.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.345 -0.847 . . . . 0.0 108.856 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.9 t -112.81 -18.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.695 -1.253 . . . . 0.0 110.77 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.37 -37.41 13.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.97 45.64 0.12 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 151.03 76.34 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.883 . . . . 0.0 109.193 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.76 141.06 16.89 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.675 1.583 . . . . 0.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -161.05 142.18 11.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.655 -0.653 . . . . 0.0 109.592 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -87.97 117.31 26.74 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -99.32 162.27 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.733 -0.605 . . . . 0.0 109.837 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.87 153.5 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 65' ' ' PHE . 14.1 t -146.98 128.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.379 -1.329 . . . . 0.0 112.171 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 155.46 37.48 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 80.7 m95 -78.18 174.64 10.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 109.89 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -137.45 -46.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.1 p -130.9 -153.23 0.55 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.55 -24.87 45.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.725 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -143.09 28.13 1.56 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 110.502 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -133.79 110.43 9.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.888 -1.133 . . . . 0.0 108.277 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.458 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.6 ptm -117.47 149.68 40.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.861 . . . . 0.0 110.141 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.7 172.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 45.7 t -148.55 138.32 22.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -105.22 164.02 12.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -160.06 132.99 6.65 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.515 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -141.18 149.25 41.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.16 167.51 3.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.641 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 mt -96.19 -8.42 33.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -158.08 156.19 30.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.67 -162.74 20.34 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -176.85 139.06 0.28 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.512 -0.993 . . . . 0.0 109.829 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.77 -84.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.42 -176.95 2.74 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.938 1.758 . . . . 0.0 109.994 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -137.12 139.94 41.57 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 146.32 48.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.092 0.948 . . . . 0.0 110.759 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.18 137.86 6.34 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.413 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.9 p-90 -144.18 175.96 9.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.74 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -138.33 169.85 17.06 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.532 0.682 . . . . 0.0 109.955 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.467 ' CE ' ' CD2' ' A' ' 3' ' ' PHE . 20.5 ptm -152.8 124.16 7.65 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -124.38 153.04 42.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.957 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.9 45.33 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.426 ' N ' HD11 ' A' ' 113' ' ' LEU . 17.4 p -91.06 161.11 15.25 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.5 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.91 -20.72 62.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -28.3 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.48 -8.36 7.85 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.25 172.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -1.202 . . . . 0.0 109.146 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.0 tt -144.84 110.46 5.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.151 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.1 tt -105.35 143.9 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.23 131.49 48.8 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.48 163.71 12.83 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 21.6 mtp -142.49 160.13 40.87 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.039 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 m -143.4 152.88 42.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.62 98.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.54 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.21 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.62 23.86 0.99 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.517 -0.74 . . . . 0.0 109.534 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.15 -179.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.2 t -157.54 116.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.659 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.0 t -99.65 112.06 24.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.591 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.8 m -100.85 151.47 21.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -150.63 102.43 3.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.02 133.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.3 m-85 -121.55 120.29 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.907 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.89 142.86 16.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -50.08 126.14 13.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.303 -0.873 . . . . 0.0 111.146 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.961 -1.018 . . . . 0.0 111.752 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.499 1.847 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -156.29 141.1 17.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.509 -0.744 . . . . 0.0 110.169 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 m-85 -98.01 -2.49 40.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -71.96 118.01 14.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 112.028 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.52 -173.84 38.83 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 4.3 m120 -95.16 171.45 8.73 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.493 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.4 m95 -151.13 126.95 10.29 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.014 -1.075 . . . . 0.0 112.777 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.49 118.04 31.1 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' CE2' ' A' ' 134' ' ' TYR . 13.6 tt -61.85 150.86 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.871 0.843 . . . . 0.0 111.016 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.65 -30.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.627 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -141.96 165.8 26.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 108.917 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.9 p -177.01 147.19 0.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 0.0 109.469 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -145.61 165.65 28.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 109.953 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.2 m-80 62.64 32.69 16.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.581 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CE1' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.35 -64.22 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.472 -0.767 . . . . 0.0 110.188 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 mm-40 -57.41 -36.08 70.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 110.903 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.28 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.7 tp -78.89 -22.04 46.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.0 mt -89.33 -16.26 31.48 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.204 -0.935 . . . . 0.0 109.143 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.2 mmmm -87.02 -32.61 19.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 22' ' ' LEU . 13.2 p -73.42 -38.3 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.6 mp -70.43 -45.12 66.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 109.562 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.84 -161.45 27.74 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.301 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.36 -36.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.925 -0.75 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -62.28 -148.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.462 -0.774 . . . . 0.0 109.617 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.48 -45.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.744 -1.223 . . . . 0.0 109.237 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -72.35 -26.91 62.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.22 -17.14 39.43 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.706 -0.621 . . . . 0.0 111.205 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.15 -47.77 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.578 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -62.8 -22.33 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.636 -0.665 . . . . 0.0 110.516 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.1 mt -78.05 -28.59 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 108.934 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.9 -25.47 34.95 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 9.8 t -77.38 -37.67 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.77 -31.62 46.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.33 83.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -69.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.514 -0.741 . . . . 0.0 109.139 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m 48.79 49.09 19.49 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.658 -0.652 . . . . 0.0 109.677 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.3 mttt 65.27 72.17 0.48 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.15 151.26 49.18 Favored 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 122.026 1.817 . . . . 0.0 110.726 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.8 174.75 7.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.655 -0.653 . . . . 0.0 109.466 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 10.1 t -153.58 164.91 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.0 tt0 -154.94 115.14 3.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 109.236 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -106.15 138.83 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.764 0.792 . . . . 0.0 110.279 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.44 113.51 21.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.7 tt0 -98.53 115.34 28.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.162 -0.961 . . . . 0.0 110.796 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -118.52 56.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.54 8.78 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -77.69 -0.13 25.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.366 -1.079 . . . . 0.0 110.047 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.91 137.01 36.65 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.706 -1.246 . . . . 0.0 108.555 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -132.56 117.0 17.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.783 0.802 . . . . 0.0 108.871 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.9 t80 -104.46 125.51 50.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.0 141.06 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.948 -1.095 . . . . 0.0 108.658 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -138.55 101.44 4.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.171 -0.956 . . . . 0.0 108.946 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 31.5 m -99.76 147.25 25.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.63 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.01 -63.93 1.36 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.949 0.881 . . . . 0.0 109.451 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 t 179.2 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.99 -11.66 11.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -122.31 165.03 16.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.896 . . . . 0.0 109.026 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -162.63 100.48 1.03 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.499 -0.75 . . . . 0.0 109.423 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.9 153.29 29.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.106 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -156.23 97.78 1.8 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.51 -0.744 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.2 pt -105.34 167.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.506 -0.746 . . . . 0.0 109.052 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.19 135.13 5.97 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.374 -0.829 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 48.6 p90 -162.74 -172.29 3.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.388 1.089 . . . . 0.0 112.545 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.11 152.75 48.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.81 95.07 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.102 -0.999 . . . . 0.0 109.833 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.8 -25.06 1.63 Allowed Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.929 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.5 156.95 34.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.295 -1.12 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.8 167.98 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.31 174.0 13.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.565 -0.709 . . . . 0.0 109.42 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.31 144.59 31.42 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.14 -177.19 5.58 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -99.65 156.99 16.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -93.2 -142.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.418 -0.801 . . . . 0.0 108.98 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.72 -21.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.723 -1.236 . . . . 0.0 110.672 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.35 -39.97 13.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 109.354 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.97 44.73 0.12 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.97 151.87 79.7 Favored Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 121.669 -0.901 . . . . 0.0 109.283 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.71 141.38 17.24 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.665 1.577 . . . . 0.0 110.604 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.2 p -161.12 141.26 10.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.2 113.63 25.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -100.58 174.48 6.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.768 -0.582 . . . . 0.0 109.933 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -147.92 153.47 39.11 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 3.9 t -141.86 128.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.465 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -125.97 164.5 20.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 93' ' ' MET . 86.5 m95 -86.09 169.58 13.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.097 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.19 -45.2 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -133.46 -154.25 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.81 -25.66 53.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.219 -0.925 . . . . 0.0 110.062 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -143.26 27.47 1.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 110.774 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -132.92 110.0 9.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.885 -1.134 . . . . 0.0 108.114 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.45 ' CE ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 ptp -114.87 151.98 33.02 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.481 -0.762 . . . . 0.0 110.13 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.04 171.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 48.0 t -148.29 131.97 16.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 110.621 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.7 165.07 11.41 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -160.96 138.67 9.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.818 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -144.85 150.3 36.86 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.29 167.48 2.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.6 mt -98.4 -6.88 29.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 137.95 18.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.13 -158.85 41.3 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -175.8 142.64 0.55 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.414 -1.05 . . . . 0.0 109.759 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 -85.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.5 -176.96 2.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.922 1.748 . . . . 0.0 109.93 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -136.54 135.14 38.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 145.98 47.39 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.163 0.982 . . . . 0.0 110.712 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.3 p -163.01 133.02 4.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -136.7 169.41 17.77 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.049 -1.061 . . . . 0.0 110.727 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.5 p -134.43 170.72 15.33 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.561 0.696 . . . . 0.0 109.935 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.407 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 1.7 ptp -153.38 134.35 13.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -129.71 152.9 48.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.93 143.55 44.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.3 162.14 14.12 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.29 -22.63 65.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.077 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.13 -27.68 27.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.432 -0.793 . . . . 0.0 109.236 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.93 -9.75 7.96 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -56.49 172.35 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.166 -1.197 . . . . 0.0 109.18 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.488 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -145.6 109.69 4.89 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.919 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tt -103.61 160.7 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.52 153.64 46.25 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.374 -0.829 . . . . 0.0 109.218 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.24 165.86 24.44 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 26.7 mtp -147.27 165.24 30.69 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.491 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 m -147.09 150.42 35.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.33 93.86 1.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.0 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.84 24.84 1.33 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 -179.65 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.4 t -157.54 117.81 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.017 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t -99.93 112.5 24.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.7 m -107.39 146.73 31.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 119.74 6.29 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.12 143.61 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.141 -0.974 . . . . 0.0 108.666 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -130.99 127.94 39.39 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.477 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.54 138.39 37.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.62 128.21 17.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.204 -0.935 . . . . 0.0 111.518 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.019 0 N-CA-C 110.318 -0.686 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -156.12 124.52 5.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.756 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 m-85 -99.1 -5.74 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.1 p -68.3 117.23 9.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 111.939 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.85 -172.13 37.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.7 m120 -95.69 168.08 10.89 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.498 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.88 124.97 8.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.485 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -120.01 113.7 20.91 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 tt -56.42 143.21 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.563 0.697 . . . . 0.0 110.381 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.8 -23.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.942 -0.474 . . . . 0.0 110.181 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.4 178.3 7.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 t 169.13 168.81 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.76 28.93 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.898 -1.126 . . . . 0.0 112.093 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.52 34.99 0.11 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -67.18 -60.38 2.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.442 -0.786 . . . . 0.0 110.097 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.8 pt-20 -58.42 -26.86 63.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 111.082 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 2.1 pt-20 -72.79 -29.37 63.23 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.493 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.2 tp -82.28 -18.3 42.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.917 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' CD1' HG21 ' A' ' 33' ' ' VAL . 22.9 mt -90.28 -16.35 29.47 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.149 -0.969 . . . . 0.0 109.397 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.9 mmmm -87.21 -31.76 20.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.54 -40.74 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.75 -49.58 65.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.953 0.882 . . . . 0.0 108.776 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.8 -147.5 19.99 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 m -155.34 -42.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.852 -0.793 . . . . 0.0 109.396 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.2 t30 -57.42 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 109.615 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.35 -43.71 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.362 -0.836 . . . . 0.0 110.116 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -69.88 -25.6 63.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 2.2 mm? -57.07 -43.9 82.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.603 -0.685 . . . . 0.0 110.694 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -63.29 -41.73 99.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.577 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -61.31 -21.5 64.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.658 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.68 -29.31 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 109.059 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.4 -26.41 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG21 ' CD1' ' A' ' 19' ' ' LEU . 7.3 t -76.52 -40.39 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.01 65.0 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.19 90.16 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.68 -68.69 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.1 t 49.19 51.05 16.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.432 0.634 . . . . 0.0 109.376 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm 63.75 72.36 0.55 Allowed Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -72.11 157.38 54.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.973 1.782 . . . . 0.0 111.045 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.99 174.07 6.04 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.8 t -156.18 163.94 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.24 112.26 5.45 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.3 mt -98.54 134.2 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.798 0.808 . . . . 0.0 110.497 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -113.78 109.16 18.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -97.89 120.82 38.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.035 -1.041 . . . . 0.0 111.146 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -120.93 53.57 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.44 -126.43 8.35 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.59 -1.25 23.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.4 -1.059 . . . . 0.0 110.095 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 m -96.08 137.37 35.24 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.795 -1.19 . . . . 0.0 108.619 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.4 m-85 -132.83 114.45 14.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.826 0.822 . . . . 0.0 109.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.2 t80 -100.93 148.73 24.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -144.95 103.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.009 -1.057 . . . . 0.0 110.844 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.81 111.49 23.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.508 -0.745 . . . . 0.0 109.023 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.8 m -99.53 148.27 24.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.41 128.82 18.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.357 -0.839 . . . . 0.0 110.45 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -63.12 1.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 t 176.4 -39.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.61 -8.94 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -99.0 -80.73 0.46 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.965 -1.084 . . . . 0.0 109.684 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.6 m 69.89 90.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 109.643 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.07 168.82 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -158.7 112.37 2.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.637 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.6 pt -115.32 165.06 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.4 p-10 -162.68 131.83 4.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.4 p90 -161.6 -171.68 3.04 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.175 0.988 . . . . 0.0 111.769 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -132.96 155.34 49.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.8 96.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.31 -20.97 0.74 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.923 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -138.06 163.53 31.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.188 -1.184 . . . . 0.0 110.941 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -86.99 168.8 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.17 174.48 12.86 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -101.5 145.02 29.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -162.17 -177.11 5.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -104.62 154.17 20.28 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.374 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.9 t -91.75 -170.28 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.63 -6.27 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 0.0 111.21 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.18 -55.07 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.997 -1.065 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.7 46.22 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -137.08 152.6 74.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.73 -0.865 . . . . 0.0 109.214 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 141.14 16.75 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.533 1.489 . . . . 0.0 110.303 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -160.82 141.17 11.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.64 -0.663 . . . . 0.0 109.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -87.63 118.94 27.46 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -99.7 167.16 10.74 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -146.03 152.25 39.05 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 11.3 t -144.74 127.68 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.112 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -123.13 155.97 35.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 82.4 m95 -78.76 173.69 12.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.779 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -136.73 -46.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.7 p -131.43 -153.55 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.76 -25.43 49.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.777 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -142.72 27.43 1.67 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.588 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -132.85 109.68 9.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.962 -1.086 . . . . 0.0 108.376 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.452 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.9 ptm -116.38 148.89 40.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.828 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.64 172.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 44.9 t -148.54 134.58 19.19 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.693 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -103.05 165.15 11.19 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.45 135.31 7.68 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.293 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.67 40.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.95 166.7 3.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.065 -1.022 . . . . 0.0 110.722 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.5 mt -98.76 -5.51 31.18 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -152.45 137.2 17.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 108.962 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.47 -158.72 42.71 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.14 141.05 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.461 -1.023 . . . . 0.0 109.795 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.97 -85.47 0.05 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.35 -176.83 2.95 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.883 1.722 . . . . 0.0 109.752 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -136.18 137.03 40.47 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.9 146.08 47.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.051 0.929 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.3 m -163.03 136.48 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.0 p-90 -138.91 175.11 9.84 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.891 -1.13 . . . . 0.0 110.343 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 p -137.7 166.45 23.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.547 0.689 . . . . 0.0 109.831 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.429 ' HE1' ' CE2' ' A' ' 3' ' ' PHE . 10.8 ptm -149.2 119.74 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -118.46 152.77 35.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.589 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.26 143.3 45.71 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -97.13 161.07 13.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.907 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.89 -21.39 63.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.675 -0.64 . . . . 0.0 110.217 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.37 -29.13 28.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.75 -7.59 8.86 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.96 171.27 0.98 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -1.233 . . . . 0.0 108.643 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.498 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -144.01 114.7 7.69 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.343 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.8 tt -99.17 148.32 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 110.32 11.85 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.97 171.3 8.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.3 mtp -150.35 165.87 31.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.596 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 m -148.85 151.92 35.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.54 96.39 1.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.51 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.83 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -148.38 23.57 1.03 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.539 -0.726 . . . . 0.0 109.617 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.17 179.64 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.405 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -155.48 118.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 35.7 t -99.11 133.38 43.46 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.6 m -120.44 156.02 32.31 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.865 0.841 . . . . 0.0 109.818 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.419 ' O ' ' CD2' ' A' ' 134' ' ' TYR . 15.3 mtm180 -151.97 92.35 1.72 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.16 117.03 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 42.6 m-85 -102.13 133.92 46.2 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.562 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.77 138.08 47.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.83 124.49 7.42 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.3 -0.875 . . . . 0.0 111.331 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.757 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 2.029 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -147.8 127.46 13.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.543 -0.723 . . . . 0.0 109.605 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 m-85 -99.29 -17.38 18.1 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 t -60.97 113.94 2.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.85 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 -172.64 40.96 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.01 170.44 9.28 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -150.86 123.11 8.32 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.601 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -116.02 113.33 23.07 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.0 tt -56.06 154.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 122.09 0.947 . . . . 0.0 111.37 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.19 -32.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.382 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -137.08 167.49 21.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.865 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -177.12 152.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -0.773 . . . . 0.0 109.792 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -151.45 168.42 24.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.833 -0.542 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.5 m-80 59.85 26.48 15.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.749 . . . . 0.0 110.059 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -63.75 -62.87 1.37 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.31 -0.869 . . . . 0.0 108.686 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.1 mt-10 -57.03 -28.42 62.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.278 -0.889 . . . . 0.0 109.281 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.08 -38.69 92.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.729 -0.607 . . . . 0.0 109.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -79.43 -17.96 53.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.59 -17.32 28.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.194 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.3 mmmm -87.44 -29.63 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.71 -41.15 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -66.62 -52.63 43.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.038 0.923 . . . . 0.0 108.667 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 -148.36 20.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -155.87 -34.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.958 -0.731 . . . . 0.0 110.387 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.96 -153.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.61 -48.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.024 -1.047 . . . . 0.0 109.652 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.11 -30.24 69.35 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -51.61 -35.35 41.36 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.913 -0.492 . . . . 0.0 110.698 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -77.21 -38.54 51.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.561 -0.712 . . . . 0.0 109.59 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -64.88 -24.35 67.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.69 -0.631 . . . . 0.0 110.297 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.63 -29.56 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 108.956 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.42 -24.23 34.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 11.0 t -76.22 -37.77 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.36 -35.51 61.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.69 88.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.59 -69.63 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t 47.82 50.04 15.98 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.465 0.65 . . . . 0.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 mttt 65.47 72.81 0.44 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -72.11 153.98 57.28 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.083 1.856 . . . . 0.0 110.769 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.59 175.66 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 109.741 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 23.7 t -155.07 166.25 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -157.41 113.68 2.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.725 . . . . 0.0 109.384 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.8 mp -101.33 144.3 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.894 0.854 . . . . 0.0 110.303 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 7.3 mttt -123.7 104.35 8.94 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.4 tt0 -98.06 121.93 40.58 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.178 -0.951 . . . . 0.0 111.219 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -124.07 52.35 1.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -129.14 9.79 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.4 -2.45 28.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -1.063 . . . . 0.0 110.111 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.9 m -96.7 124.49 40.7 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.821 -1.174 . . . . 0.0 108.516 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 87.9 m-85 -120.5 122.98 41.84 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.857 0.836 . . . . 0.0 108.9 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.4 t80 -107.09 138.2 43.72 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.54 137.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -137.75 105.92 5.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -98.77 147.12 25.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.255 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.12 116.86 10.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.08 -169.78 1.87 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 t -52.93 -43.15 66.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 111.293 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.44 -6.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.363 -0.836 . . . . 0.0 112.093 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -109.07 172.86 6.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.963 -1.086 . . . . 0.0 110.473 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 m -165.1 100.79 0.75 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.19 169.04 8.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.09 112.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 110.516 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.5 pt -98.94 172.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.545 -0.722 . . . . 0.0 109.1 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.0 134.81 5.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.0 110.05 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 41.4 p90 -163.04 -171.26 2.59 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.437 1.113 . . . . 0.0 112.508 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -130.7 153.15 49.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.71 94.82 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.099 -1.001 . . . . 0.0 109.557 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.46 -27.65 1.35 Allowed Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.699 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -122.99 157.49 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -1.105 . . . . 0.0 110.131 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -86.72 169.61 12.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.635 -0.666 . . . . 0.0 109.359 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.2 p90 -161.94 -172.89 3.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.6 -0.687 . . . . 0.0 109.386 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -115.83 147.76 40.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -161.64 179.74 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.682 -0.636 . . . . 0.0 109.596 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -105.73 159.18 16.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.327 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 t -92.38 -143.73 0.21 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.78 -17.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.161 . . . . 0.0 110.67 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -87.95 -34.64 18.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.363 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.75 45.99 0.18 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.6 146.85 62.2 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.749 -0.854 . . . . 0.0 109.268 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -80.02 136.09 11.5 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.687 1.591 . . . . 0.0 110.284 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.0 p -161.0 141.48 11.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -80.41 161.71 24.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.449 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.5 t -141.88 160.69 39.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.0 tp -142.07 154.27 44.81 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 20.3 t -144.25 129.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.358 -1.337 . . . . 0.0 112.222 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -124.24 159.58 29.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 82.8 m95 -82.82 172.06 13.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 0.0 110.498 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.99 -45.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.7 p -132.65 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.74 -26.35 54.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.858 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -143.09 27.82 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -131.8 111.12 11.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.441 ' CE ' ' CE1' ' A' ' 50' ' ' PHE . 1.7 ptp -116.23 148.86 40.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.45 -0.781 . . . . 0.0 110.239 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.26 171.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.409 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 42.0 t -147.46 141.75 26.25 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.41 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -107.4 164.12 12.46 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -162.15 131.31 4.38 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.616 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -138.74 155.12 48.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.76 169.29 4.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.59 -2.66 28.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.73 133.93 10.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 108.968 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.57 -155.71 43.89 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -175.7 140.5 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.439 -1.036 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.8 -87.0 0.06 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.6 -176.9 2.92 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.816 1.677 . . . . 0.0 109.697 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -132.84 138.44 47.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 144.8 49.82 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.215 1.007 . . . . 0.0 110.867 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.9 m -163.13 139.32 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.409 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.3 p-90 -142.62 175.73 9.58 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.956 -1.09 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 p -140.05 171.39 14.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.529 0.68 . . . . 0.0 109.838 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.407 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.1 ptp -154.14 140.52 18.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.15 149.44 47.28 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.324 -0.86 . . . . 0.0 109.501 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.3 46.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.67 160.9 14.78 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.725 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -60.45 -21.75 62.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.643 -0.66 . . . . 0.0 110.218 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.98 -28.67 25.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.9 -9.13 7.6 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.76 171.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.097 -1.237 . . . . 0.0 108.966 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.9 tt -146.62 110.11 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.19 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 120' ' ' ILE . 12.5 tt -102.77 153.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 133.3 36.84 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.496 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.88 167.2 10.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 24.7 mtp -146.49 164.74 31.55 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.399 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.2 m -147.86 152.27 37.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.67 95.93 1.35 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.595 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.21 -79.25 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -147.6 24.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.248 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.97 -179.25 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -157.61 117.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.696 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t -98.46 113.81 25.96 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.3 m -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 0.0 109.715 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.46 118.74 5.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.19 136.98 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -125.77 121.74 34.22 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.16 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.39 141.13 20.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.76 126.25 13.45 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.23 -0.919 . . . . 0.0 111.189 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.635 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.021 0 N-CA-C 110.307 -0.689 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -154.7 125.43 7.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.549 -0.72 . . . . 0.0 109.727 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 3.5 m-85 -99.22 -8.11 25.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -67.01 115.64 6.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.301 -0.874 . . . . 0.0 111.893 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.32 -173.38 41.08 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.16 169.99 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 98.3 m95 -152.38 131.4 12.61 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.079 -1.049 . . . . 0.0 113.038 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -122.82 116.72 24.16 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 9' ' ' ILE . 10.0 tt -58.57 145.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.603 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.15 -24.43 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.961 -0.462 . . . . 0.0 110.324 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -149.66 168.02 24.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.221 -0.924 . . . . 0.0 110.602 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p 178.0 170.11 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.19 30.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.903 -1.123 . . . . 0.0 111.635 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.9 33.49 0.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.284 -0.885 . . . . 0.0 109.134 -178.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.66 -64.99 0.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 21.7 tt0 -57.09 -27.12 61.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.58 -39.66 94.97 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.756 -0.59 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -80.03 -15.8 56.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.675 -0.641 . . . . 0.0 110.016 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 33' ' ' VAL . 11.6 mt -90.22 -18.97 24.75 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.054 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.22 -28.66 25.25 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.46 -41.22 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.97 -51.71 56.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.05 0.929 . . . . 0.0 109.041 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.15 -147.76 20.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 m -155.74 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.978 -0.719 . . . . 0.0 109.721 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.0 t30 -60.46 -159.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.682 . . . . 0.0 109.885 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.18 -49.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.875 . . . . 0.0 109.429 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -66.39 -29.79 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -57.05 -25.68 59.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.827 -0.545 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.24 -42.7 12.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.785 . . . . 0.0 109.272 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -22.37 66.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.753 -0.592 . . . . 0.0 110.54 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.68 -29.99 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 108.774 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.17 -24.97 34.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 8.9 t -77.11 -35.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.52 -35.89 52.97 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.34 -35.51 80.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.19 -67.14 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.6 m 49.23 51.37 16.41 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.8 mttt 65.64 73.73 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -72.37 154.28 55.96 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 111.063 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.54 176.37 5.88 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -155.57 164.59 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -152.21 112.49 4.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -98.04 136.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.767 0.794 . . . . 0.0 110.002 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.445 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.35 106.38 13.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.9 tt0 -97.7 124.3 41.97 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.112 -0.993 . . . . 0.0 111.193 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -124.44 53.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.3 -127.26 8.87 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -1.13 24.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -1.029 . . . . 0.0 110.074 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.7 m -97.14 138.58 34.43 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.706 -1.246 . . . . 0.0 108.31 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 93.6 m-85 -134.11 118.11 17.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.764 0.793 . . . . 0.0 109.464 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.5 t80 -102.65 146.97 27.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 2.9 mt -141.73 100.81 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.947 -1.096 . . . . 0.0 110.45 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -99.39 114.07 26.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.393 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.0 m -99.87 144.76 28.55 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -135.51 144.19 46.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -123.78 -62.18 1.32 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.878 0.847 . . . . 0.0 108.738 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.0 t 176.49 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.15 -8.23 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.989 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -82.81 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.0 109.604 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 69.85 84.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.452 -0.78 . . . . 0.0 109.913 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.01 177.58 4.8 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.2 pm0 -171.37 143.75 1.88 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.69 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.18 170.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.0 132.69 4.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.987 -1.071 . . . . 0.0 109.457 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.7 p90 -162.25 -172.39 3.18 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.409 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.81 152.6 48.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.97 96.89 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.36 -34.88 1.48 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.559 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.76 157.34 21.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -1.046 . . . . 0.0 109.968 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.8 168.88 13.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.102 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 22.3 p90 -161.21 -172.9 3.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 21.8 mt-10 -116.39 148.86 40.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -161.29 179.8 8.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.444 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.8 144.14 42.85 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -81.54 177.62 8.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.407 -0.808 . . . . 0.0 108.985 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -84.7 -0.35 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.6 -0.688 . . . . 0.0 111.396 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -95.68 -44.61 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.89 -1.132 . . . . 0.0 109.955 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.19 45.3 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.9 149.88 60.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.796 -0.826 . . . . 0.0 109.088 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -80.46 135.03 10.33 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.49 1.46 . . . . 0.0 110.048 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.1 p -160.45 141.45 12.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.701 -0.624 . . . . 0.0 109.55 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 2.1 ptmm? -80.69 163.34 23.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 6.9 t -144.56 160.52 40.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.2 tp -142.13 153.57 44.2 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 9.6 t -144.7 125.77 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.772 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -120.58 162.28 19.89 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.446 ' CE2' HG23 ' A' ' 67' ' ' VAL . 87.1 m95 -85.51 168.7 14.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -131.81 -45.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.6 p -133.04 -153.81 0.57 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -77.14 -25.14 51.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -143.83 26.6 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.877 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -131.5 109.65 10.43 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.437 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -115.25 150.67 35.82 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.8 171.36 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 43.3 t -148.93 140.41 23.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.185 -0.947 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -107.17 164.75 11.9 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -161.96 133.41 5.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.988 -1.07 . . . . 0.0 110.752 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -140.89 153.67 45.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.35 169.59 3.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 0.0 110.684 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.01 -7.48 29.83 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -159.98 157.03 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 108.774 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.69 -158.5 18.94 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -176.73 139.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.514 -0.992 . . . . 0.0 109.691 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.35 -85.35 0.06 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.48 -176.75 2.65 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.95 1.767 . . . . 0.0 110.17 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -138.67 141.19 39.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.81 145.28 50.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.163 0.982 . . . . 0.0 110.839 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 m -162.99 137.23 6.22 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.7 p-90 -143.21 174.55 10.61 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.2 p -139.29 175.31 9.67 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.512 0.672 . . . . 0.0 109.674 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.415 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.7 ptp -158.34 141.1 14.62 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -136.09 150.28 49.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.451 -0.78 . . . . 0.0 109.158 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.42 143.3 44.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -93.03 160.49 14.84 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.809 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -60.01 -21.04 60.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 110.229 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.0 -29.7 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.838 . . . . 0.0 109.177 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.07 -9.84 7.03 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.9 172.88 0.23 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.215 -1.168 . . . . 0.0 109.432 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.481 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.4 tt -146.12 108.57 4.46 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.225 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.8 tt -103.62 147.87 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tt -129.93 147.75 51.72 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.263 -0.898 . . . . 0.0 109.637 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 164.57 18.48 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.5 mtp -146.88 164.49 32.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.534 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 m -146.52 153.08 39.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.5 98.72 1.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.51 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.43 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.27 24.19 1.03 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.519 -0.738 . . . . 0.0 109.426 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -119.15 -179.22 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -158.07 116.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.423 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.0 t -99.68 114.49 27.62 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.79 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 76.9 m -104.57 126.61 51.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.36 -0.838 . . . . 0.0 109.296 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -126.39 101.96 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.15 136.17 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.412 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.3 m-85 -125.43 127.59 46.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.0 137.56 41.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.494 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.57 127.57 15.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 111.405 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.98 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -161.13 122.39 2.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.766 . . . . 0.0 109.819 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 5.5 m-85 -99.33 -8.79 24.38 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.732 -0.605 . . . . 0.0 109.61 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p -68.87 116.91 9.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.207 -0.933 . . . . 0.0 111.895 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.61 -171.95 39.39 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.89 169.04 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -150.56 121.55 7.67 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.717 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -115.25 113.7 24.24 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.6 tt -56.55 144.88 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.686 0.755 . . . . 0.0 110.804 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.21 -23.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.934 -0.479 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -144.98 173.5 11.83 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.225 -0.922 . . . . 0.0 110.527 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t 170.29 168.79 0.06 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.78 31.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.961 -1.087 . . . . 0.0 111.893 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.38 32.11 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.167 -0.958 . . . . 0.0 109.237 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -66.92 -61.86 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.462 -0.774 . . . . 0.0 110.174 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.3 mm-40 -58.07 -30.08 65.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.357 -0.839 . . . . 0.0 110.988 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -71.69 -27.45 63.05 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.621 -178.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 tp -81.52 -20.65 39.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 33' ' ' VAL . 13.7 mt -88.43 -16.68 32.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 109.187 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.9 mtmt -85.56 -32.86 21.91 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.47 -40.58 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -67.52 -48.74 66.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.886 0.85 . . . . 0.0 109.099 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.86 -160.52 26.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.61 -44.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.896 -0.767 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -58.69 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -111.86 -43.52 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.6 ttp -66.92 -28.53 68.38 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.6 -23.57 63.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.729 -0.607 . . . . 0.0 110.57 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -86.82 -47.59 8.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.641 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.74 -23.61 65.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 110.696 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.1 mt -77.25 -29.18 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.306 -0.871 . . . . 0.0 109.086 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.62 -26.44 34.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 9.7 t -76.86 -37.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 -33.47 55.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.55 92.77 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.92 -67.83 0.4 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m 51.13 53.4 13.05 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mttt 66.04 73.32 0.41 Allowed Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -71.22 143.41 43.85 Favored 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 121.939 1.759 . . . . 0.0 110.632 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.1 176.13 6.21 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.2 t -155.36 163.97 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -148.15 111.53 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.8 mt -99.68 140.9 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.81 0.814 . . . . 0.0 110.75 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -118.86 116.12 25.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -98.92 116.91 32.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.085 -1.009 . . . . 0.0 110.948 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -118.5 52.11 1.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.75 -125.97 8.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.91 -0.65 24.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.395 -1.062 . . . . 0.0 110.029 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.63 139.97 31.92 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.772 -1.205 . . . . 0.0 108.371 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.7 m-85 -135.02 116.94 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.879 0.847 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -102.18 148.72 25.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.3 mt -147.24 105.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 O-C-N 120.909 -1.119 . . . . 0.0 111.665 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -102.17 115.36 30.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.331 -0.856 . . . . 0.0 108.836 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.1 m -103.08 137.15 41.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.34 143.16 50.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.303 -0.873 . . . . 0.0 110.032 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.9 -77.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.593 0.711 . . . . 0.0 109.27 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.9 p -157.73 -47.58 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.62 -9.56 12.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.522 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -115.87 163.65 15.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 m -162.81 94.17 0.84 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.5 p -79.37 162.87 25.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.707 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -156.12 122.92 5.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.69 -0.631 . . . . 0.0 109.499 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.56 165.66 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.48 129.34 3.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.144 -0.972 . . . . 0.0 108.833 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.2 p90 -161.33 -172.43 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -128.55 153.38 47.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.54 95.3 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.554 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.91 -35.55 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -112.05 155.86 23.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.411 -1.052 . . . . 0.0 109.909 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.61 170.51 11.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.56 173.7 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.0 109.811 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -103.18 143.98 31.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.22 -175.4 4.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 109.445 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -102.55 154.87 18.7 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.2 t -90.19 -142.34 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.4 -0.813 . . . . 0.0 108.958 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.95 -20.8 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.733 -1.229 . . . . 0.0 110.445 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.57 -42.62 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.0 109.438 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.4 44.66 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -131.07 150.03 75.43 Favored Pre-proline 0 C--N 1.308 -1.237 0 O-C-N 121.696 -0.885 . . . . 0.0 109.003 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.94 140.72 18.4 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.615 1.543 . . . . 0.0 110.674 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -160.84 141.48 11.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.683 -0.636 . . . . 0.0 109.668 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -87.23 116.35 25.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -99.48 164.58 12.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.295 0.569 . . . . 0.0 110.117 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.9 tp -143.98 153.18 41.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 14.3 t -145.58 124.94 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.656 -1.218 . . . . 0.0 111.761 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -119.17 155.34 31.81 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.434 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 80.6 m95 -77.19 175.15 9.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.881 0.848 . . . . 0.0 110.163 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -138.08 -46.41 0.52 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.9 p -131.22 -152.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -78.14 -25.56 47.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -142.99 27.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 110.571 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -133.34 113.34 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.891 -1.131 . . . . 0.0 108.288 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.434 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -119.38 150.82 39.53 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.493 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.71 172.21 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 47.7 t -147.79 139.66 24.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.781 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.93 162.84 13.65 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.23 133.59 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.552 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -141.93 151.13 42.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.23 167.93 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.98 . . . . 0.0 110.718 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.9 mt -98.41 -6.27 30.95 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -155.09 141.1 18.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.99 -158.07 38.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -175.97 140.98 0.44 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.458 -1.024 . . . . 0.0 109.871 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.13 -85.51 0.05 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.19 -176.52 2.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.905 1.737 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -137.17 136.21 38.02 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.55 145.51 48.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.123 0.964 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.1 m -162.84 135.75 5.69 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.4 p-90 -141.73 175.41 9.72 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.8 p -138.15 174.38 10.62 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.696 . . . . 0.0 109.888 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -156.77 133.35 10.06 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -131.07 146.45 52.37 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.393 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.3 143.07 39.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.407 ' N ' HD11 ' A' ' 113' ' ' LEU . 80.7 p -92.65 161.41 14.58 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.833 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -60.27 -21.27 61.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.18 -29.62 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 0.0 109.179 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.15 -7.91 8.05 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -59.37 172.37 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -1.167 . . . . 0.0 109.05 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -143.41 108.96 5.09 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.122 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.3 tt -103.13 148.48 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.68 145.35 51.9 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.489 -0.885 . . . . 0.0 109.489 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.14 167.19 12.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 14.2 mtp -148.32 164.65 33.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.474 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.3 m -146.71 152.38 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.1 97.73 1.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.87 -79.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -149.65 24.47 0.87 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.398 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.92 -179.3 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.414 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -156.85 117.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.689 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.9 t -99.92 116.71 32.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.581 . . . . 0.0 109.499 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -108.11 130.28 55.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.561 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 104.01 7.18 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.76 135.58 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.6 m-85 -124.52 122.08 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.394 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.34 140.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.45 126.0 12.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.254 -0.904 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.64 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 110.336 -0.678 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -170.63 128.73 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.576 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.461 ' CE2' ' CE ' ' A' ' 111' ' ' MET . 3.0 m-85 -99.56 -11.44 21.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 116.81 6.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.25 -0.906 . . . . 0.0 111.689 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.72 -172.95 39.74 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.02 170.11 9.51 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.11 122.83 8.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.547 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -115.75 112.07 21.48 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 9' ' ' ILE . 9.1 tt -52.47 156.5 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.994 0.902 . . . . 0.0 111.547 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 -33.31 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -146.69 170.14 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -179.35 155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.3 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -152.08 171.95 17.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.688 -0.633 . . . . 0.0 110.048 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.3 m-80 60.31 27.77 17.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 109.798 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 36' ' ' ALA . 3.5 t80 -66.32 -64.27 0.89 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 108.976 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 tt0 -59.1 -28.53 66.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.613 -0.679 . . . . 0.0 109.719 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.77 -37.63 84.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.411 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 48.2 tp -83.58 -13.61 53.98 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.684 -0.635 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.46 -21.7 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.003 -1.061 . . . . 0.0 108.946 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mmmt -82.64 -29.28 30.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.25 -41.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 122.098 0.951 . . . . 0.0 108.472 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.6 mp -65.66 -53.56 39.63 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.149 0.976 . . . . 0.0 108.99 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.95 -146.37 17.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -155.58 -37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.014 -0.698 . . . . 0.0 110.175 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -57.52 -170.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 109.744 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.78 -43.8 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 110.084 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 16.6 ttp -68.68 -23.02 64.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 0.0 109.281 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.35 -30.59 71.44 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.522 -0.736 . . . . 0.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.11 -45.31 12.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 0.0 110.65 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -25.43 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.0 110.834 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.0 mt -80.04 -27.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.365 -0.835 . . . . 0.0 108.879 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -81.99 -24.45 35.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.686 -0.634 . . . . 0.0 109.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 15' ' ' PHE . 2.5 t -82.23 -49.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.95 97.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.25 86.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 15' ' ' PHE . . . -84.58 40.72 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.684 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -64.25 -54.46 32.97 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.777 -1.202 . . . . 0.0 108.12 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -139.21 71.06 40.42 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 31.9 Cg_endo -72.89 147.95 44.88 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.947 1.765 . . . . 0.0 110.954 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.31 172.52 8.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 17.0 t -155.3 166.34 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.0 tt0 -156.77 112.44 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.331 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.5 mp -100.07 141.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.753 0.787 . . . . 0.0 110.105 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 29.7 mttt -117.03 91.28 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.21 126.28 42.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -177.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -135.54 64.88 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.43 -131.62 10.85 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.75 -2.34 26.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -1.044 . . . . 0.0 110.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -96.44 132.09 42.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.543 -1.348 . . . . 0.0 108.31 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 97.6 m-85 -130.04 121.11 25.8 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.811 0.815 . . . . 0.0 109.047 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 52' ' ' ILE . 13.3 t80 -105.78 151.41 24.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -138.55 135.48 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -138.89 105.35 5.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.315 -0.866 . . . . 0.0 108.797 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.2 m -98.74 148.43 23.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 108.975 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.01 113.02 5.79 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.037 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 35.6 p -98.22 -169.01 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.1 t -58.23 -39.76 79.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.6 -0.687 . . . . 0.0 111.517 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -125.67 -7.25 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.225 -0.922 . . . . 0.0 112.204 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -113.3 166.18 11.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 0.0 110.618 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -164.83 101.25 0.78 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.61 168.53 9.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -165.73 113.37 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.2 pt -99.84 172.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.463 -0.773 . . . . 0.0 109.059 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.4 135.66 5.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 42.2 p90 -163.02 -171.69 2.76 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.354 1.073 . . . . 0.0 112.661 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 153.68 47.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 96.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.095 -1.003 . . . . 0.0 109.615 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.1 -22.69 1.92 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.941 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -126.03 156.95 39.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.256 -1.144 . . . . 0.0 110.261 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.65 168.3 13.73 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.5 p90 -161.93 175.17 12.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -110.32 142.75 41.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 4.9 pm0 -162.08 -169.69 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -99.71 159.79 14.78 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.17 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -96.85 -143.04 0.29 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.379 -0.825 . . . . 0.0 109.242 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.44 -23.86 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.762 -1.211 . . . . 0.0 110.914 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -88.87 -41.61 12.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.43 45.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.45 153.08 81.49 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.683 -0.892 . . . . 0.0 109.188 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.52 140.09 14.82 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.76 1.64 . . . . 0.0 110.439 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.2 p -160.57 144.65 13.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.517 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -90.48 122.09 33.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 11.9 t -104.52 168.92 8.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.543 . . . . 0.0 110.206 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.2 tp -148.24 153.43 38.72 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.416 HG23 ' CE2' ' A' ' 65' ' ' PHE . 10.6 t -144.92 126.48 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.908 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.414 ' CZ2' ' HE2' ' A' ' 93' ' ' MET . 76.6 m95 -76.94 174.01 11.1 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.913 0.863 . . . . 0.0 110.769 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.65 -45.68 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.4 p -134.89 -150.66 0.4 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.87 -26.59 49.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -142.36 24.03 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -131.13 113.86 14.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.93 -1.106 . . . . 0.0 108.289 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.423 ' HE3' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.24 149.96 40.89 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.512 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.15 173.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.415 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 42.5 t -147.57 141.09 25.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.2 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.55 163.25 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -160.33 138.83 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.654 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -145.59 150.73 36.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.55 166.56 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.032 -1.043 . . . . 0.0 110.775 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 mt -98.68 -5.48 31.53 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -147.76 129.79 15.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 108.945 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.18 -155.83 45.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -176.27 141.82 0.45 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.524 -0.986 . . . . 0.0 109.686 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.76 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -82.18 -176.89 3.19 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.749 1.632 . . . . 0.0 109.925 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -130.42 133.83 46.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.4 144.16 46.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.115 0.96 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -163.34 135.55 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -142.78 177.66 8.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.061 -1.024 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -139.23 166.86 23.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.516 0.674 . . . . 0.0 109.956 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.461 ' CE ' ' CE2' ' A' ' 3' ' ' PHE . 19.2 ptm -148.92 124.72 10.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -122.64 151.14 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.38 144.48 43.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.7 p -93.87 161.77 14.18 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.859 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -60.65 -23.05 64.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.635 -0.666 . . . . 0.0 110.114 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.4 -27.95 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.67 -10.08 7.6 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.47 173.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.156 -1.202 . . . . 0.0 109.412 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.5 tt -147.71 114.63 6.12 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.45 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.25 150.92 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 132.98 42.16 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.49 -0.756 . . . . 0.0 109.546 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.67 165.23 13.27 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 32.4 mtp -144.73 163.45 33.98 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.649 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.6 m -146.86 149.09 32.59 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -154.99 93.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.52 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -147.47 23.16 1.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.47 -179.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.4 t -157.57 118.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.893 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 28.1 t -98.96 112.8 24.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 97.7 m -110.77 147.64 34.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -151.37 120.29 6.64 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.1 t -81.31 138.71 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.098 -1.001 . . . . 0.0 108.428 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.423 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.3 m-85 -127.07 125.98 42.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.153 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.99 139.92 28.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.2 125.72 11.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.224 -0.922 . . . . 0.0 111.102 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.48 179.662 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.029 0 N-CA-C 110.389 -0.658 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -133.64 132.01 40.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 2.6 m-85 -98.65 0.59 45.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -73.25 118.5 16.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 111.97 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.66 -171.77 38.56 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.82 170.03 9.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CZ3' ' N ' ' A' ' 136' ' ' ARG . 99.0 m95 -150.52 121.77 7.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.508 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -115.25 113.22 23.6 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 9' ' ' ILE . 8.6 tt -52.22 157.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.012 0.911 . . . . 0.0 111.684 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.57 -32.72 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.441 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -146.52 171.3 15.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.877 . . . . 0.0 109.034 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 81.7 p -177.52 158.15 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.781 . . . . 0.0 109.641 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.64 169.86 22.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.678 -0.638 . . . . 0.0 110.034 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 43.9 m-20 58.68 23.88 11.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.538 -0.726 . . . . 0.0 110.194 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -66.42 -63.39 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -56.88 -27.8 61.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.57 -39.02 93.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.634 -0.666 . . . . 0.0 109.681 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 tp -78.49 -18.04 55.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.717 -0.614 . . . . 0.0 110.157 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD12 ' CE1' ' A' ' 15' ' ' PHE . 8.5 mt -90.23 -17.76 26.9 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -86.29 -28.32 23.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.21 -40.96 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.28 -52.31 42.23 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.097 0.951 . . . . 0.0 109.314 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.1 -149.34 22.06 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.462 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 m -155.71 -34.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 122.104 -0.645 . . . . 0.0 110.375 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -61.71 -152.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.12 -50.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.977 -1.077 . . . . 0.0 109.051 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 8.9 ttm -65.95 -30.98 71.64 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.82 -33.93 51.46 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.465 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 2.4 mtp180 -83.31 -46.55 12.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -62.88 -15.19 53.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.691 -0.631 . . . . 0.0 111.206 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.6 -30.46 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.094 -1.004 . . . . 0.0 108.474 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.75 -24.14 33.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.5 t -80.45 -44.33 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.06 -41.33 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.07 83.49 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.21 45.21 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.844 -0.535 . . . . 0.0 110.889 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -60.66 -34.72 74.72 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.572 -1.33 . . . . 0.0 108.37 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -165.68 72.88 1.32 Allowed Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.15 149.78 46.67 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.811 1.674 . . . . 0.0 110.759 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.73 175.07 5.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 55.8 t -155.61 164.43 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 44.2 tt0 -150.58 110.82 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -98.25 133.38 40.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.786 0.803 . . . . 0.0 110.161 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -113.03 106.9 15.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.7 tt0 -97.48 122.99 41.17 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.14 -0.975 . . . . 0.0 111.017 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -122.58 56.42 1.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.86 -126.06 8.13 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -76.77 -0.42 23.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.378 -1.072 . . . . 0.0 110.163 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.89 138.06 35.02 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 120.712 -1.243 . . . . 0.0 108.556 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 96.6 m-85 -132.49 116.01 16.22 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.891 0.853 . . . . 0.0 109.342 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.4 t80 -101.77 146.98 27.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.6 mt -143.15 99.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.026 -1.046 . . . . 0.0 110.161 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -99.45 111.82 24.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.449 -0.782 . . . . 0.0 109.718 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 m -99.51 146.4 26.42 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.2 p -139.9 119.5 13.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.997 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -99.84 -63.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.766 0.793 . . . . 0.0 108.917 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t 174.94 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.6 -9.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -100.19 -81.89 0.46 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 109.599 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.6 m 69.63 85.12 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 109.752 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 p -108.25 176.96 4.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.0 109.34 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -170.26 124.05 0.71 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 109.849 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 pt -114.87 170.91 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 133.88 5.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.949 . . . . 0.0 109.51 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 47.5 p90 -161.91 -171.52 2.92 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.44 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.09 152.81 49.13 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -83.0 94.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.129 -0.982 . . . . 0.0 109.64 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.08 -27.56 1.26 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.662 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.38 156.81 34.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.322 -1.105 . . . . 0.0 110.177 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.39 169.78 12.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.592 -0.692 . . . . 0.0 109.395 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.9 p90 -163.0 174.42 12.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.616 -0.678 . . . . 0.0 109.612 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -103.65 144.33 31.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 -174.93 4.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.564 -0.71 . . . . 0.0 109.443 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -99.83 159.25 15.21 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -95.13 -150.05 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.7 p -98.54 -21.18 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.976 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -91.99 -51.21 5.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.64 44.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -128.88 152.63 79.38 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.584 -0.951 . . . . 0.0 109.05 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.07 139.88 17.46 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.599 1.532 . . . . 0.0 110.613 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.82 140.96 11.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.745 -0.597 . . . . 0.0 109.445 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.4 117.28 25.1 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.0 t -99.41 168.25 10.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.18 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -147.01 154.08 40.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 65' ' ' PHE . 24.6 t -146.65 130.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 118.441 -1.303 . . . . 0.0 112.153 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -125.51 160.04 30.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.428 ' CE2' HG23 ' A' ' 67' ' ' VAL . 85.9 m95 -83.63 169.83 14.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.129 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 6.1 tp10 -132.45 -46.22 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.0 p -130.6 -153.47 0.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.11 -26.35 47.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -142.2 27.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.806 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 1.2 tttt -132.03 108.58 9.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.822 -1.173 . . . . 0.0 107.933 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.409 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 1.7 ptp -114.77 149.74 36.47 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.43 -0.794 . . . . 0.0 110.509 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.21 171.5 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 49.2 t -146.71 141.5 26.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.756 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.66 162.91 13.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -160.69 136.96 8.53 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.655 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -142.25 149.8 40.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.62 166.06 4.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 110.805 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.2 mt -101.07 -3.15 29.82 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 132.41 13.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 108.796 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.77 -159.86 42.24 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.25 141.33 0.43 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.396 -1.061 . . . . 0.0 109.857 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.98 -85.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.18 -177.05 3.1 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.816 1.677 . . . . 0.0 109.793 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -132.55 138.14 47.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.37 144.47 48.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.106 0.955 . . . . 0.0 110.698 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.96 135.82 5.61 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -139.21 173.71 11.27 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.056 -1.028 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.8 p -137.57 174.05 11.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.482 0.658 . . . . 0.0 110.073 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.0 ptp -160.35 132.83 6.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 15.3 pt-20 -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.62 145.23 40.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.4 ' N ' HD11 ' A' ' 113' ' ' LEU . 19.2 p -92.95 161.0 14.64 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.541 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -60.14 -21.92 62.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.655 -0.653 . . . . 0.0 110.323 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -85.31 -28.37 25.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.87 -8.84 7.64 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.18 172.53 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.095 -1.238 . . . . 0.0 109.087 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.48 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.7 tt -147.29 112.13 5.39 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.111 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.1 tt -108.04 146.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 139.8 52.3 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.47 169.9 9.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 34.8 mtp -148.81 166.25 29.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.355 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 m -149.0 151.75 35.08 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.434 0.635 . . . . 0.0 109.459 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.36 95.07 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -147.42 24.0 1.13 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.54 -0.725 . . . . 0.0 109.282 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.78 -178.75 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -157.61 117.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.841 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 4.4 t -98.38 120.08 38.18 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.0 m -117.85 145.51 44.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.056 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.25 118.0 7.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.56 138.48 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.0 108.398 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.7 m-85 -127.13 123.84 37.74 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.226 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 140.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.25 125.69 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.239 -0.913 . . . . 0.0 111.137 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.593 179.645 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.501 1.969 0 N-CA-C 110.347 -0.674 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -159.86 122.33 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.749 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.429 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 4.3 m-85 -98.96 -2.42 37.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.704 -0.623 . . . . 0.0 109.366 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 t -72.15 117.71 14.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 111.936 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.6 -172.25 38.62 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 170.08 9.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.495 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -149.97 118.93 6.67 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.653 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -110.65 115.28 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.4 tt -56.67 158.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.01 0.91 . . . . 0.0 111.117 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.7 -33.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.421 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt85 -146.23 168.4 21.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 108.844 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.0 p -177.56 139.76 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.512 -0.743 . . . . 0.0 109.406 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.9 169.71 16.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.672 -0.642 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 42.2 m-20 61.24 29.4 18.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.735 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 4.8 t80 -64.68 -63.64 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.0 109.074 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.1 pt-20 -60.53 -26.58 66.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.675 -0.641 . . . . 0.0 109.629 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -64.57 -41.48 96.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 46.6 tp -80.67 -13.24 59.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -91.0 -20.33 22.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.038 -1.038 . . . . 0.0 109.207 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.6 mmmm -84.23 -29.54 26.45 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -78.61 -40.78 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -67.88 -53.1 29.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.139 0.971 . . . . 0.0 109.159 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.73 -148.72 20.8 Favored Glycine 0 N--CA 1.491 2.364 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.265 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.96 -36.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.982 -0.716 . . . . 0.0 110.418 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.37 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.865 . . . . 0.0 109.993 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.43 -48.24 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.362 -0.836 . . . . 0.0 109.705 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.2 -25.95 66.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -62.96 -28.83 70.35 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.697 -0.627 . . . . 0.0 110.647 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CZ ' ' CD ' ' A' ' 20' ' ' LYS . 2.5 mtp180 -87.71 -46.88 9.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 0.0 110.449 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -60.44 -30.77 69.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.505 -0.747 . . . . 0.0 110.656 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.5 mt -76.18 -27.34 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.474 -0.766 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.2 -22.3 36.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 3.1 t -81.21 -43.41 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.86 85.38 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.0 -46.17 88.92 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB1' ' CE2' ' A' ' 15' ' ' PHE . . . -84.2 41.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -65.69 -32.73 74.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.908 -1.12 . . . . 0.0 108.293 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -159.11 70.54 3.47 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.8 Cg_endo -73.92 135.2 20.9 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.897 1.731 . . . . 0.0 109.741 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.55 170.29 12.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.581 -0.7 . . . . 0.0 109.803 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.2 t -156.76 130.91 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.18 112.03 18.14 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.0 mt -99.21 136.13 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.657 0.741 . . . . 0.0 110.106 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -113.59 114.99 27.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.87 117.15 32.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.1 -1.0 . . . . 0.0 110.9 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -118.21 52.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 -125.1 7.67 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -77.75 0.04 25.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.366 -1.079 . . . . 0.0 109.991 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.7 m -96.42 140.2 31.43 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.763 -1.21 . . . . 0.0 108.424 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.9 m-85 -136.02 116.57 13.82 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.85 0.834 . . . . 0.0 109.488 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.7 t80 -102.36 148.44 25.47 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.472 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.7 mt -144.46 105.59 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 120.937 -1.102 . . . . 0.0 111.275 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.35 106.29 18.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 108.928 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 m -98.17 144.61 27.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 108.559 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 118.79 12.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.852 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -97.44 -159.04 0.71 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.5 t -62.23 -43.09 99.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.063 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.24 -6.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.529 -0.732 . . . . 0.0 111.892 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 -102.54 168.2 9.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.066 -1.021 . . . . 0.0 110.07 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 m -163.85 93.89 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 p -91.11 166.87 12.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.367 -0.833 . . . . 0.0 109.99 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.04 123.06 4.36 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.4 pt -123.06 167.59 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.49 128.98 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.184 -0.947 . . . . 0.0 109.26 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.468 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 48.4 p90 -162.09 -172.24 3.16 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.281 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -129.75 153.57 48.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.95 93.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 109.668 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.87 -26.44 1.3 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.741 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -122.82 157.68 31.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.321 -1.105 . . . . 0.0 110.079 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -86.63 168.08 13.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.12 173.33 14.47 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.708 -0.62 . . . . 0.0 109.398 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -102.68 143.11 32.76 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.34 -175.74 4.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.628 . . . . 0.0 109.433 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.92 157.63 16.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -91.88 -142.97 0.19 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.406 -0.809 . . . . 0.0 109.005 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.27 -19.56 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.785 -1.197 . . . . 0.0 110.649 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -91.89 -44.52 8.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.557 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.99 45.1 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.79 151.17 78.1 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 121.617 -0.931 . . . . 0.0 109.019 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.51 140.26 16.84 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.618 1.546 . . . . 0.0 110.677 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.94 141.72 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.657 -0.652 . . . . 0.0 109.606 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -87.03 116.26 24.96 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -99.54 166.39 11.17 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.499 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -146.09 153.07 40.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 12.0 t -145.03 126.65 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.861 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.39 155.46 33.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 82.5 m95 -78.0 173.62 11.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.78 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -136.29 -46.26 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.8 p -131.47 -153.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.91 -23.09 44.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.85 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -144.3 26.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -133.82 112.25 11.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.905 -1.122 . . . . 0.0 108.363 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.452 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.5 ptm -118.18 149.84 40.39 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.26 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.84 172.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 46.4 t -147.78 137.78 22.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.818 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.98 163.48 12.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -160.23 135.41 7.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.563 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -141.22 148.41 39.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.69 167.3 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.3 mt -94.98 -8.81 35.85 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.66 155.29 31.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.53 -161.04 16.97 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -176.89 138.64 0.27 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.503 -0.999 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.25 -85.05 0.05 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.02 -176.83 2.79 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.91 1.74 . . . . 0.0 109.9 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -135.97 136.42 40.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.16 47.56 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.154 0.978 . . . . 0.0 110.966 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -162.92 136.27 5.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.3 p-90 -140.54 174.68 10.28 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.31 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -138.83 171.21 14.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.598 0.713 . . . . 0.0 109.855 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.8 ptp -153.04 136.48 15.86 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -132.99 149.93 52.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.703 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.99 143.73 43.79 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.9 p -92.75 161.02 14.7 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.58 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -60.42 -21.67 62.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.624 -0.672 . . . . 0.0 110.214 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.42 -28.45 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 109.32 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.35 -9.84 7.34 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -56.16 172.28 0.22 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.148 -1.207 . . . . 0.0 109.212 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.495 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.7 tt -146.84 111.46 5.25 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.405 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.06 156.45 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.72 133.67 32.56 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.354 -0.841 . . . . 0.0 109.515 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 166.76 11.23 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 7.4 mtp -144.93 163.13 35.09 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.243 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -147.01 151.17 36.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.407 0.622 . . . . 0.0 109.331 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -157.54 95.13 1.42 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.564 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.27 -79.12 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.63 23.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.519 -0.738 . . . . 0.0 109.319 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.22 -179.88 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.52 118.4 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.744 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -98.32 113.0 24.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.6 m -107.14 148.34 28.95 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.911 0.862 . . . . 0.0 109.985 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -152.81 119.02 5.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.0 138.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.571 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -126.53 131.07 51.67 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.3 139.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.47 125.58 11.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.262 -0.899 . . . . 0.0 111.21 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.59 179.473 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.973 0 N-CA-C 110.317 -0.686 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.65 141.03 0.15 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.116 0.96 . . . . 0.0 110.197 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 3.1 m-85 -104.49 -3.79 23.52 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.7 p -68.15 118.81 11.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 112.132 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.06 -173.33 38.37 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.2 m120 -95.75 170.22 9.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.22 122.86 7.98 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.814 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -114.36 114.03 25.34 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.3 tt -54.4 157.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.97 0.89 . . . . 0.0 111.46 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -130.72 -32.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.34 169.57 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.3 p -176.94 160.84 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -0.794 . . . . 0.0 109.824 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.45 166.58 32.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 110.016 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.28 29.67 18.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CD1' ' CG2' ' A' ' 33' ' ' VAL . 4.4 t80 -64.19 -64.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 109.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 36.2 tt0 -60.4 -26.39 66.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.721 -0.612 . . . . 0.0 109.623 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.36 -41.56 96.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 0.0 109.922 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 46.5 tp -81.13 -12.84 59.14 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -91.1 -20.59 21.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.95 -1.094 . . . . 0.0 109.102 179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.2 mmmt -84.5 -30.05 25.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -77.4 -40.9 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.7 mp -67.41 -53.02 32.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.19 0.995 . . . . 0.0 109.075 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.63 21.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -150.91 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.861 -0.788 . . . . 0.0 110.343 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -58.21 -169.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.261 -0.899 . . . . 0.0 109.786 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.7 -43.59 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.594 -0.692 . . . . 0.0 110.121 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 7.5 ttm -68.46 -28.02 66.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.753 . . . . 0.0 109.03 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.98 -50.29 73.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.734 -0.604 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -44.46 92.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 110.22 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -59.87 -25.63 65.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.624 -0.672 . . . . 0.0 111.219 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -80.27 -28.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.165 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -82.43 -23.36 34.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.61 -0.681 . . . . 0.0 109.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' CG2' ' CD1' ' A' ' 15' ' ' PHE . 3.0 t -82.25 -47.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.24 96.82 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 15' ' ' PHE . . . -83.49 37.39 0.57 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 p -63.69 -33.19 75.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.694 -1.254 . . . . 0.0 108.224 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -163.12 71.58 1.96 Allowed Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.23 -176.31 2.85 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 122.033 1.822 . . . . 0.0 110.793 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.21 172.11 10.34 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 41.4 t -155.57 164.95 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 39.6 tt0 -153.72 112.4 3.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.6 mp -98.73 133.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 109.99 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.3 mttt -113.92 103.59 11.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 59.1 tt0 -97.49 127.18 43.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.143 -0.973 . . . . 0.0 111.156 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.54 55.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.05 -126.05 8.34 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.34 -0.07 24.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.434 -1.039 . . . . 0.0 110.148 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 m -97.48 140.64 31.63 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.745 -1.222 . . . . 0.0 108.545 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -136.4 118.09 15.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.693 0.759 . . . . 0.0 109.547 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.8 t80 -102.47 145.78 29.06 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.434 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 3.9 mt -140.34 99.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 120.987 -1.071 . . . . 0.0 110.663 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -98.79 113.46 25.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.756 . . . . 0.0 109.764 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.6 m -106.18 143.3 34.5 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 p -148.8 123.44 9.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.837 . . . . 0.0 109.195 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 m -97.96 -66.83 0.88 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.96 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -175.94 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.16 -14.85 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -130.36 162.46 29.03 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.7 m -162.0 108.1 1.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -109.28 177.22 4.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.576 -0.703 . . . . 0.0 109.939 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -170.66 136.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.714 -0.616 . . . . 0.0 109.342 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.97 172.54 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.0 109.292 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -162.45 130.34 3.91 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 108.882 179.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.465 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.2 p90 -161.97 -172.72 3.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.313 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 152.79 48.54 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.23 95.69 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.89 1.57 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.911 -1.137 . . . . 0.0 110.666 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -111.2 154.91 23.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.302 -1.117 . . . . 0.0 110.065 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.46 167.38 14.72 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.0 p90 -162.43 173.28 14.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 110.005 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.84 145.54 29.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.1 -177.8 5.98 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -99.82 155.51 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -91.14 -142.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.3 -20.22 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.205 . . . . 0.0 110.618 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -89.19 -41.91 11.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.78 45.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -131.91 151.51 78.64 Favored Pre-proline 0 N--CA 1.485 1.322 0 O-C-N 121.618 -0.931 . . . . 0.0 109.31 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.69 141.55 17.41 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.715 1.61 . . . . 0.0 110.482 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.21 141.07 10.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.676 -0.64 . . . . 0.0 109.772 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.5 115.22 27.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -103.04 176.43 5.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.754 -0.591 . . . . 0.0 110.136 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -151.18 152.97 34.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 5.7 t -140.17 130.27 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -124.43 159.31 30.74 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.443 ' CE2' HG23 ' A' ' 67' ' ' VAL . 87.2 m95 -84.54 170.19 13.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.266 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -133.53 -46.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.7 p -131.63 -154.75 0.64 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -76.74 -24.44 53.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.677 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -144.49 27.07 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.2 tttm -130.81 108.1 9.61 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.918 -1.114 . . . . 0.0 107.995 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 87' ' ' TRP . 1.1 ptp -115.84 148.85 39.47 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.63 0.729 . . . . 0.0 110.497 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.03 171.01 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.63 129.95 14.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.197 -0.939 . . . . 0.0 110.675 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.49 164.46 11.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.48 143.49 13.35 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.773 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -146.28 149.24 33.48 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.74 166.17 3.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.054 -1.029 . . . . 0.0 110.84 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.0 mt -98.54 -5.49 32.01 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -151.52 139.6 20.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 108.958 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.71 -159.19 42.97 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -176.86 140.59 0.33 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.492 -1.005 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.8 -84.66 0.05 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.53 -177.11 3.04 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.86 1.707 . . . . 0.0 110.12 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -136.11 135.8 39.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.97 145.67 46.56 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.119 0.961 . . . . 0.0 110.793 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 m -162.64 130.4 3.82 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -133.41 168.68 18.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 p -134.25 174.6 10.33 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.412 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.6 ptp -159.13 130.23 6.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -123.66 151.5 43.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.81 142.78 46.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.6 159.15 15.35 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.761 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -59.65 -21.59 60.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.692 . . . . 0.0 110.234 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.38 -30.23 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.77 -9.48 6.79 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -56.67 171.8 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.146 -1.208 . . . . 0.0 109.08 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.8 tt -147.18 111.2 5.08 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.189 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.6 tt -105.24 156.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -135.76 153.89 51.41 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.461 -0.775 . . . . 0.0 109.302 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.12 169.05 18.24 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.6 mtp -150.15 165.82 31.68 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.669 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -148.34 151.24 34.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -158.16 95.93 1.41 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.4 -79.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.13 23.87 1.17 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.539 -0.726 . . . . 0.0 109.311 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.77 -179.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -157.88 118.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -98.15 121.13 39.71 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.8 m -119.55 145.95 45.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -150.56 121.24 7.5 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.23 139.8 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.1 m-85 -128.3 126.77 41.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.89 139.03 31.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.07 125.62 10.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.212 -0.93 . . . . 0.0 111.289 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.699 179.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 110.34 -0.677 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -153.69 125.56 7.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 3.9 m-85 -99.39 -5.43 29.55 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.627 -0.67 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 p -71.92 117.8 13.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.147 -0.97 . . . . 0.0 111.805 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.26 -173.58 39.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.0 m120 -95.61 172.27 8.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -150.6 124.51 9.25 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.643 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -116.46 113.7 23.2 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 6.3 tt -53.05 152.76 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.73 0.776 . . . . 0.0 111.183 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.16 -25.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.99 -0.444 . . . . 0.0 110.543 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -152.42 -179.85 7.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 110.72 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 170.22 168.91 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.81 29.33 0.06 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.941 -1.1 . . . . 0.0 112.252 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -162.21 37.79 0.12 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.16 -0.962 . . . . 0.0 108.999 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' CE1' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.76 -63.33 1.41 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.562 -0.712 . . . . 0.0 109.558 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 17.3 mt-10 -57.52 -30.67 65.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.382 -0.824 . . . . 0.0 110.581 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -30.58 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.243 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.1 tp -78.71 -17.1 56.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.25 -19.97 23.51 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.067 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.1 mtmt -81.14 -30.6 34.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.72 -41.4 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.977 0.894 . . . . 0.0 108.848 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -66.59 -50.94 61.43 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.081 0.943 . . . . 0.0 109.279 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.23 -153.01 24.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -150.42 -37.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.956 -0.732 . . . . 0.0 110.335 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -60.9 -159.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.6 t -127.93 -47.34 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 0.0 109.471 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.3 ttt -65.82 -30.42 71.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.18 -28.19 67.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.724 -0.61 . . . . 0.0 110.49 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -89.49 -44.95 9.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.379 -0.825 . . . . 0.0 110.145 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -61.56 -25.08 67.08 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.632 -0.667 . . . . 0.0 110.895 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.5 -26.73 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 108.914 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.09 -25.89 36.66 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.631 -0.668 . . . . 0.0 109.232 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 3.0 t -80.67 -45.64 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.13 85.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.99 49.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.73 50.62 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.854 -0.529 . . . . 0.0 110.467 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.4 p -61.99 -34.03 75.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.707 -1.246 . . . . 0.0 108.236 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -162.93 74.31 2.0 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 32.9 Cg_endo -73.5 134.25 20.27 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.941 1.761 . . . . 0.0 111.267 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.08 177.3 7.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 19.1 t -155.98 164.58 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -153.51 113.17 3.85 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -105.71 141.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.705 0.764 . . . . 0.0 110.676 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HE3' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.84 117.09 27.24 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.3 tt0 -99.04 118.17 35.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.115 -0.99 . . . . 0.0 110.996 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -119.69 45.8 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.31 -128.56 9.57 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -74.35 -3.48 30.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -1.066 . . . . 0.0 110.006 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -96.45 133.86 40.35 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.81 -1.181 . . . . 0.0 108.142 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.8 m-85 -129.54 114.87 16.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.758 0.79 . . . . 0.0 109.7 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.4 t80 -99.67 148.02 24.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.5 mt -140.81 143.45 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.096 -1.002 . . . . 0.0 108.745 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -139.58 107.24 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.402 -0.811 . . . . 0.0 109.247 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 m -98.74 147.89 24.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -145.64 118.58 8.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.327 -0.858 . . . . 0.0 110.37 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 76.1 p -98.87 -149.65 0.35 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 p -72.19 -41.94 66.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.928 -1.107 . . . . 0.0 110.286 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.5 t -128.68 -6.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.437 -0.789 . . . . 0.0 111.649 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -104.94 165.6 10.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.122 -0.986 . . . . 0.0 110.271 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 m -163.82 99.87 0.88 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.655 -0.653 . . . . 0.0 109.281 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 156.49 18.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.449 -0.782 . . . . 0.0 109.877 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -151.05 103.08 3.01 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.8 pt -102.85 165.46 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.328 -0.857 . . . . 0.0 108.945 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.18 129.15 3.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.075 -1.015 . . . . 0.0 109.201 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 85' ' ' VAL . 48.3 p90 -161.48 -172.4 3.35 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.344 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -128.86 153.37 47.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.4 95.52 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.145 -0.972 . . . . 0.0 109.755 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.05 -33.89 1.58 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.672 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.99 154.99 23.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -1.088 . . . . 0.0 109.978 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -86.12 168.02 14.41 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.65 175.27 11.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.0 109.567 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.33 144.67 31.31 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.11 -177.71 5.93 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -99.6 155.47 17.58 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.9 t -93.26 -142.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.4 -0.812 . . . . 0.0 109.306 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.9 t -111.39 -20.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -87.21 -39.23 15.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.186 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.31 44.82 0.14 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -132.36 151.82 78.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.739 -0.859 . . . . 0.0 109.311 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.81 142.13 17.54 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.603 1.535 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 p -161.04 142.32 11.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.673 -0.642 . . . . 0.0 109.81 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.55 113.69 25.75 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.3 t -102.08 175.2 5.61 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.139 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 84' ' ' LEU . 50.6 tp -151.32 152.92 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 6.1 t -140.81 126.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.762 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -119.51 155.62 31.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.437 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.2 m95 -77.46 173.3 12.12 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.018 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -136.07 -46.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.9 p -131.52 -152.61 0.51 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -78.06 -25.92 47.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -142.96 26.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 110.782 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -132.16 111.2 11.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.937 -1.102 . . . . 0.0 108.084 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.437 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.4 ptm -117.94 149.58 40.67 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.388 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.66 172.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.7 t -149.13 128.71 13.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 0.0 110.731 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -99.9 163.5 12.42 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -160.35 142.15 12.65 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.963 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -146.82 148.92 32.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -58.94 166.49 1.96 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.985 . . . . 0.0 110.972 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.3 mt -97.44 -6.5 33.77 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -152.27 141.13 21.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 108.962 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.91 -159.78 39.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -176.8 141.19 0.35 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.998 . . . . 0.0 109.665 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.68 -84.77 0.05 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.04 -176.54 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.89 1.727 . . . . 0.0 110.022 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -136.08 137.59 41.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.41 145.3 48.41 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.101 0.953 . . . . 0.0 110.676 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.77 130.08 3.66 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -134.13 172.1 13.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.041 -1.037 . . . . 0.0 110.121 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 p -135.15 175.21 9.79 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 111' ' ' MET . 8.4 ptp -158.08 133.8 9.06 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -131.81 147.68 52.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.386 -0.821 . . . . 0.0 109.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.96 143.17 38.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.406 ' N ' HD11 ' A' ' 113' ' ' LEU . 16.3 p -90.97 160.29 15.72 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.648 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -60.19 -21.54 61.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.666 -0.646 . . . . 0.0 110.064 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.59 -29.81 25.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.97 -8.97 7.14 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.11 174.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.0 tt -146.04 110.27 5.0 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.914 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 tt -106.11 146.32 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.76 141.96 51.44 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.639 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.49 171.99 7.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.3 mtp -152.75 165.11 36.35 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.583 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.23 152.99 39.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.48 97.46 1.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.627 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.95 -79.83 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.33 24.26 1.02 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 109.387 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.75 -179.72 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.83 117.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.374 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 6.4 t -98.93 133.95 42.47 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -125.61 125.73 43.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -122.38 101.54 7.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.18 136.95 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.409 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 28.3 m-85 -127.9 130.79 49.08 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.416 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.5 137.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -49.12 128.63 16.71 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.211 -0.931 . . . . 0.0 111.634 -178.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.688 179.643 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.03 0 N-CA-C 110.685 -0.544 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.88 124.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.751 0.786 . . . . 0.0 110.213 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 2.6 m-85 -99.59 -2.74 34.9 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.634 -0.666 . . . . 0.0 109.441 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -70.53 118.5 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.944 . . . . 0.0 112.186 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.46 -172.08 38.46 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.77 170.48 9.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.23 122.17 7.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.609 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -114.13 114.49 26.13 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.4 tt -57.68 153.64 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.928 0.87 . . . . 0.0 111.326 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.25 -31.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 173.08 12.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.338 -0.851 . . . . 0.0 108.842 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.8 t 179.94 165.29 1.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.303 -0.873 . . . . 0.0 109.715 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -159.99 163.12 34.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.748 -0.595 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 26.6 m-80 62.64 33.3 15.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.72 . . . . 0.0 109.719 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -75.7 -64.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 110.165 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 18.7 mt-10 -56.91 -33.82 67.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.869 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.7 66.04 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.467 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.61 -21.4 52.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.037 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -88.99 -16.13 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.036 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -86.14 -32.6 21.2 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -75.14 -38.91 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -69.28 -45.63 69.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.797 0.808 . . . . 0.0 109.476 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.8 -159.56 27.66 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.4 m -146.63 -38.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.963 -0.728 . . . . 0.0 110.051 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -61.28 -156.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.422 -0.799 . . . . 0.0 109.138 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.45 -47.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.429 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.5 ttt -68.01 -27.98 67.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.94 -16.96 34.17 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.684 -0.635 . . . . 0.0 111.243 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.11 -50.14 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.009 . . . . 0.0 110.048 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -23.38 67.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.73 . . . . 0.0 110.717 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.3 mt -77.17 -28.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 108.768 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.91 -25.15 35.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 13.5 t -76.06 -37.98 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.88 46.33 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.57 92.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -70.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t 48.51 52.62 13.41 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.497 0.665 . . . . 0.0 109.763 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 66.23 70.39 0.52 Allowed Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.87 164.55 35.25 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.988 1.792 . . . . 0.0 111.027 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.36 173.77 6.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -154.8 166.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -154.38 110.24 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.8 mt -97.33 133.52 38.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.845 0.831 . . . . 0.0 110.298 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 6.8 mttm -107.94 93.79 4.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.72 125.53 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.4 -0.813 . . . . 0.0 110.373 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.45 59.36 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.64 -130.05 10.15 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 1.1 p30 -74.65 -2.42 26.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.394 -1.062 . . . . 0.0 110.209 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -96.93 137.05 36.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.571 -1.331 . . . . 0.0 108.269 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE2' ' NE2' ' A' ' 45' ' ' GLN . 97.5 m-85 -135.35 125.97 27.05 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.69 0.757 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.3 t80 -108.74 143.06 38.37 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' CG1' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -130.05 106.54 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 106.21 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.1 m -99.22 146.82 25.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 108.896 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.7 p -142.69 134.31 26.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.433 -0.792 . . . . 0.0 110.323 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.53 -65.1 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.87 0.843 . . . . 0.0 108.829 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t 175.78 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.66 -10.2 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.663 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -101.12 -85.89 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.994 -1.066 . . . . 0.0 109.322 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 3.2 m 67.81 90.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.887 . . . . 0.0 110.104 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -119.65 171.44 8.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -160.93 157.09 25.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' CG1' HG12 ' A' ' 52' ' ' ILE . 29.7 pt -144.22 170.72 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.56 -0.712 . . . . 0.0 109.157 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -161.6 134.65 6.23 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 45.8 p90 -162.96 -173.23 3.37 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.289 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -127.88 153.0 47.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.72 95.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.257 -0.902 . . . . 0.0 109.666 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.85 -24.57 1.63 Allowed Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.815 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -124.57 155.57 38.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.296 -1.12 . . . . 0.0 110.229 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.18 168.02 14.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.47 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.58 174.35 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.617 -0.677 . . . . 0.0 109.717 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -103.04 144.93 30.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -176.04 4.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.655 -0.653 . . . . 0.0 109.513 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.88 156.98 16.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -94.58 -143.82 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.375 -0.828 . . . . 0.0 109.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.4 t -111.59 -21.07 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.825 -1.172 . . . . 0.0 110.876 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -89.03 -39.84 13.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.649 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 46.89 0.09 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -136.3 151.99 74.28 Favored Pre-proline 0 C--N 1.306 -1.308 0 O-C-N 121.759 -0.847 . . . . 0.0 109.353 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.07 141.76 16.73 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.764 1.643 . . . . 0.0 110.512 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 p -161.01 142.26 11.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.666 -0.646 . . . . 0.0 109.707 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -86.68 117.65 25.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.24 164.48 12.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.845 -0.534 . . . . 0.0 109.731 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.5 tp -144.24 153.81 42.44 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' A' ' 65' ' ' PHE . 29.0 t -147.09 130.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 118.5 -1.28 . . . . 0.0 112.108 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -125.04 157.85 35.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.428 ' CE2' HG23 ' A' ' 67' ' ' VAL . 79.8 m95 -79.82 172.26 14.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -135.68 -45.85 0.67 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.8 p -131.47 -154.18 0.61 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -76.59 -25.13 53.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.666 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -144.36 26.88 1.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.823 . . . . 0.0 110.817 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -130.75 110.86 11.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.901 -1.124 . . . . 0.0 108.154 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.434 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 1.5 ptp -115.5 146.96 41.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.446 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.18 170.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 52.2 t -146.38 140.94 26.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.739 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.7 162.8 14.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -160.21 135.74 8.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 149.97 41.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.87 167.63 2.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.64 -6.55 29.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.02 143.66 19.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.77 -162.66 34.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.99 139.38 0.38 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.44 -1.035 . . . . 0.0 109.975 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.18 -85.84 0.05 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.86 -176.94 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.811 1.674 . . . . 0.0 109.721 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -135.29 139.67 44.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.14 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.139 0.971 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.3 m -163.01 139.1 7.1 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -142.64 173.25 11.71 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.037 -1.039 . . . . 0.0 110.568 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.0 p -137.58 172.65 12.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.909 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.402 ' HE1' ' CZ3' ' A' ' 109' ' ' TRP . 11.6 ptp -160.11 136.34 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.6 pt-20 -135.41 154.76 51.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.237 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.71 144.36 42.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.7 p -91.18 159.95 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.406 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.73 -19.45 50.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.591 -0.693 . . . . 0.0 110.45 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.98 -28.54 21.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.3 -9.16 7.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -57.63 172.67 0.34 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.082 -1.246 . . . . 0.0 109.11 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 8.0 tt -147.13 112.15 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.251 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 120' ' ' ILE . 14.3 tt -108.52 148.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -131.35 137.99 48.99 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.363 -0.836 . . . . 0.0 109.684 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.54 170.75 8.02 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.8 mtp -147.65 168.19 22.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.573 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.1 m -151.85 150.94 30.67 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.9 94.21 1.42 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.534 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.9 -78.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -146.88 24.62 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.13 -179.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.4 t -157.33 119.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.827 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -99.46 123.25 43.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.4 m -116.61 148.04 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -151.94 120.37 6.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 50.3 t -82.38 137.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.005 . . . . 0.0 108.351 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.8 m-85 -127.28 124.99 40.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.351 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.64 139.85 28.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.12 125.72 11.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.176 -0.952 . . . . 0.0 111.193 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.942 -1.028 . . . . 0.0 111.607 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.0 0 N-CA-C 110.455 -0.633 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -154.2 123.67 6.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.5 m-85 -98.86 -1.78 39.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.712 -0.617 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 t -70.9 116.61 11.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.144 -0.972 . . . . 0.0 112.011 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.45 -172.83 39.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.8 168.23 10.78 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.67 124.65 8.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.566 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -118.83 112.59 19.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.7 tt -54.25 143.92 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.626 0.727 . . . . 0.0 110.882 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.61 -24.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.999 -0.438 . . . . 0.0 109.936 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.05 174.24 10.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.282 -0.886 . . . . 0.0 110.069 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t 170.2 168.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.62 28.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.91 -1.119 . . . . 0.0 111.654 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.53 29.65 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -178.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -64.05 -66.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -0.851 . . . . 0.0 108.752 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 15.4 mt-10 -55.97 -31.1 62.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -61.29 -38.46 86.88 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.129 0.49 . . . . 0.0 110.469 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 tp -80.17 -17.45 52.41 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.717 -0.614 . . . . 0.0 110.137 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 mt -89.67 -17.65 27.96 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.088 -1.007 . . . . 0.0 109.013 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -84.05 -32.19 24.98 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.28 -40.21 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.84 -46.28 72.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.838 0.827 . . . . 0.0 109.6 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.16 -157.01 27.16 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.341 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -148.78 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 122.037 -0.684 . . . . 0.0 109.687 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -61.65 -156.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.474 -0.767 . . . . 0.0 109.132 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.97 -47.09 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 109.695 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 ttp -68.16 -28.36 67.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.49 -23.79 63.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.811 -0.556 . . . . 0.0 110.64 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' CZ ' ' HD2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -91.33 -46.91 7.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.905 . . . . 0.0 109.727 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -62.15 -20.88 64.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.664 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.54 -28.92 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.261 -0.9 . . . . 0.0 108.925 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.95 -26.05 34.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 9.8 t -76.48 -41.21 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.62 64.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.92 97.47 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.43 -66.19 0.59 Allowed 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.566 -0.708 . . . . 0.0 109.289 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m 52.83 57.64 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 66.71 73.61 0.38 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.0 Cg_endo -70.91 153.39 63.69 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 122.167 1.912 . . . . 0.0 111.003 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.28 174.02 6.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.698 -0.626 . . . . 0.0 109.464 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 47.2 t -154.86 165.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 43.1 tt0 -149.7 112.47 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mp -97.81 133.88 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.806 0.812 . . . . 0.0 110.264 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.05 106.29 14.23 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 61.2 tt0 -97.55 126.43 42.83 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.078 -1.014 . . . . 0.0 111.36 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -125.76 55.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -126.94 8.62 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.53 -0.33 22.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 110.12 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -97.22 139.98 32.38 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.72 -1.237 . . . . 0.0 108.498 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 96.7 m-85 -134.57 118.27 17.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.536 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.2 t80 -102.78 144.98 30.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 3.3 mt -140.67 101.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -98.92 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.572 -0.705 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 m -99.38 141.01 32.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.55 118.92 17.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 110.434 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -99.2 -170.75 1.96 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -52.68 -42.66 64.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.571 -0.706 . . . . 0.0 111.33 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.09 -6.83 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.395 -0.815 . . . . 0.0 112.168 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -109.32 173.13 6.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.011 -1.056 . . . . 0.0 110.447 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -164.69 95.17 0.71 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -95.66 175.43 6.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.3 pm0 -171.35 142.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.04 171.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.524 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.89 130.58 4.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.178 -0.951 . . . . 0.0 109.217 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 44.5 p90 -162.07 -172.17 3.14 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 153.35 48.28 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.35 89.26 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.143 -0.973 . . . . 0.0 109.661 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.1 -23.26 0.99 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.938 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -122.02 154.94 36.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -86.26 165.56 16.37 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.18 173.93 13.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.866 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -102.28 146.74 27.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -162.53 -175.49 4.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 109.408 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -101.01 155.65 17.86 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -93.89 -143.75 0.24 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.354 -0.841 . . . . 0.0 109.12 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -112.67 -19.87 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.807 -1.183 . . . . 0.0 110.638 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -88.04 -40.89 13.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.44 44.77 0.1 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -135.98 154.13 77.42 Favored Pre-proline 0 C--N 1.308 -1.229 0 O-C-N 121.654 -0.91 . . . . 0.0 109.095 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 144.61 20.92 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.7 1.6 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.5 p -161.24 141.75 11.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.688 -0.633 . . . . 0.0 109.616 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -88.02 117.21 26.73 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 4.0 t -99.94 168.11 10.07 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.207 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -150.61 152.99 34.89 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 25.9 t -144.08 135.88 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.236 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -128.3 159.23 35.93 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.434 ' CE2' HG23 ' A' ' 67' ' ' VAL . 88.6 m95 -84.97 167.3 16.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 110.062 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -129.79 -45.61 1.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.6 p -131.83 -154.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.31 -25.38 51.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -142.67 26.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.898 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -131.41 104.96 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 108.302 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.417 ' HE2' ' CH2' ' A' ' 87' ' ' TRP . 1.2 ptp -112.22 147.55 35.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.581 -0.699 . . . . 0.0 110.221 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 t -103.57 169.05 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.9 t -144.55 140.76 29.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.169 -0.957 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.55 160.73 15.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -158.95 139.6 12.57 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.433 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -143.53 150.56 39.07 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.42 166.39 3.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.7 mt -99.74 -4.24 31.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.95 130.68 15.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 108.672 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.49 -159.46 45.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -176.82 141.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.469 -1.018 . . . . 0.0 109.713 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.29 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.46 -176.78 2.91 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.804 1.669 . . . . 0.0 109.752 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -131.95 142.8 49.74 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.2 146.32 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.85 126.75 2.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -130.86 163.94 26.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.136 -0.977 . . . . 0.0 110.39 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.6 p -130.02 166.44 20.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.2 ptp -150.01 117.75 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 151.98 28.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.433 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -117.06 143.12 46.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.4 p -94.35 178.46 5.61 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.932 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -75.76 -24.15 56.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.641 -0.662 . . . . 0.0 110.448 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.73 -19.64 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.741 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 119.41 -5.13 13.27 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.1 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.48 177.99 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 118.924 1.362 . . . . 0.0 108.439 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.8 tt -153.4 115.89 4.43 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.965 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.27 154.59 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.61 109.2 7.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.09 167.21 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 38.4 mtp -145.93 164.35 32.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.552 -0.717 . . . . 0.0 109.603 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.9 m -146.89 152.67 39.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.73 94.94 1.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.537 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.52 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -148.11 23.72 1.06 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.57 -0.706 . . . . 0.0 109.382 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.23 -179.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.423 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -157.46 117.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.456 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.7 t -99.37 111.7 24.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 75.1 m -99.26 152.74 19.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.866 0.841 . . . . 0.0 109.469 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.41 ' O ' ' CD2' ' A' ' 134' ' ' TYR . 27.7 mtm180 -151.88 94.83 2.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.61 128.74 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.5 m-85 -115.82 133.88 55.58 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.491 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.85 137.75 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.479 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.9 mtm180 -47.38 124.22 6.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.387 -0.821 . . . . 0.0 111.468 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.755 179.816 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.502 1.983 0 N-CA-C 110.207 -0.728 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -143.15 115.17 8.31 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.708 0.766 . . . . 0.0 110.436 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 m-85 -111.58 0.54 16.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -72.95 117.5 14.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 112.13 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.86 -171.74 37.86 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 169.39 10.05 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.5 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -150.38 118.6 6.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.591 -177.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -110.51 113.74 26.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE2' ' A' ' 134' ' ' TYR . 11.1 tt -55.61 157.78 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.921 0.867 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 -32.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.497 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -146.13 170.33 16.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 108.812 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.6 t 177.64 141.24 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -136.58 178.44 7.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.701 -0.625 . . . . 0.0 109.875 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 72.2 m-20 58.86 26.59 15.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.728 . . . . 0.0 109.99 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' CZ ' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t80 -65.55 -62.95 1.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.822 . . . . 0.0 109.072 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 8.4 pt-20 -58.73 -29.13 66.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.643 -0.661 . . . . 0.0 109.565 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.01 -39.61 93.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.738 -0.601 . . . . 0.0 110.235 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 47.6 tp -82.02 -13.97 56.6 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.708 -0.62 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -91.34 -20.27 22.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.931 -1.106 . . . . 0.0 109.11 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.5 mtmt -83.32 -29.58 28.18 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.79 -41.82 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.66 -56.39 10.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 122.381 1.086 . . . . 0.0 108.523 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.59 -145.84 15.6 Favored Glycine 0 N--CA 1.489 2.221 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.79 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 m -156.29 -37.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.706 . . . . 0.0 110.364 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.51 -175.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.204 -0.935 . . . . 0.0 110.126 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -116.3 -44.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.554 -0.716 . . . . 0.0 109.574 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 37.1 ttp -65.41 -24.75 67.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.11 -40.14 95.56 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.675 -0.64 . . . . 0.0 110.57 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -70.54 -48.33 55.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.379 -0.825 . . . . 0.0 110.139 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -55.72 -46.65 77.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.1 -26.07 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.801 . . . . 0.0 109.688 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -81.25 -21.95 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.353 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -82.12 -44.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.29 91.63 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.63 -53.28 56.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -83.93 37.71 0.61 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.868 -0.52 . . . . 0.0 110.511 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 t -66.02 -34.09 77.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.796 -1.19 . . . . 0.0 108.501 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -157.27 69.68 4.37 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -74.24 137.37 23.47 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 121.948 1.765 . . . . 0.0 110.2 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.57 166.86 15.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.583 -0.698 . . . . 0.0 109.37 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG21 ' CG2' ' A' ' 54' ' ' THR . 16.0 t -154.34 127.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -117.9 111.02 18.45 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.5 mt -98.33 132.16 43.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.728 0.775 . . . . 0.0 110.334 -178.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttm -106.48 94.15 4.98 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.68 123.85 40.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.344 -0.848 . . . . 0.0 110.366 -177.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -132.61 68.17 1.51 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.11 -130.59 10.26 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -75.43 -1.6 24.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.357 -1.084 . . . . 0.0 110.388 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -95.98 139.28 32.4 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.701 -1.249 . . . . 0.0 109.003 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.9 m-85 -136.31 118.81 15.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.753 0.787 . . . . 0.0 108.951 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 52' ' ' ILE . 16.2 t80 -104.41 150.85 24.17 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -149.35 104.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.895 -1.128 . . . . 0.0 111.288 -176.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -103.23 102.44 12.41 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.419 ' CG2' HG21 ' A' ' 41' ' ' VAL . 32.5 m -98.09 127.1 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.849 . . . . 0.0 109.359 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.11 130.48 53.76 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.799 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -98.64 -165.45 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.745 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -57.57 -42.58 83.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.564 -0.71 . . . . 0.0 110.338 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.35 -2.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.534 -0.729 . . . . 0.0 111.87 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -109.44 -178.42 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.92 -1.113 . . . . 0.0 109.804 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -162.13 162.17 28.41 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.692 -0.63 . . . . 0.0 109.677 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.1 p -156.86 156.41 33.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.45 109.19 2.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 110.247 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.0 pt -113.5 164.32 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p-10 -162.44 132.25 4.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.131 -0.981 . . . . 0.0 109.497 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 50.7 p90 -161.87 -171.42 2.89 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.224 1.011 . . . . 0.0 111.83 -178.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.85 154.72 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.28 93.9 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.09 -1.006 . . . . 0.0 109.657 -178.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.26 -19.46 0.63 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.683 -1.246 . . . . 0.0 111.298 179.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.9 160.7 37.42 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.121 -1.223 . . . . 0.0 111.205 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -86.63 164.83 16.6 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.1 p90 -162.2 173.62 14.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -102.1 144.53 30.56 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.36 -176.67 5.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.62 . . . . 0.0 109.363 -179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.27 157.3 16.7 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.4 t -93.05 -144.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -0.867 . . . . 0.0 109.258 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.2 t -107.75 -22.2 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.856 -1.152 . . . . 0.0 110.571 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -86.62 -47.71 8.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 108.955 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.1 151.69 78.86 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.671 -0.899 . . . . 0.0 109.226 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.35 140.5 17.36 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.618 1.545 . . . . 0.0 110.374 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.3 p -161.05 142.38 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -88.25 118.56 27.93 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -99.57 168.08 10.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.496 0.665 . . . . 0.0 110.459 -178.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.2 tp -148.0 149.95 33.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 5.3 t -141.78 134.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.111 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -130.47 161.83 30.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.426 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 85.0 m95 -85.44 170.27 12.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -133.63 -45.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -132.9 -153.18 0.53 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.97 -23.78 44.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -143.0 22.26 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.834 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -130.78 111.81 12.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.832 -1.167 . . . . 0.0 108.639 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.46 ' CE ' ' CE2' ' A' ' 50' ' ' PHE . 3.7 ptp -116.0 154.97 28.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.601 -0.687 . . . . 0.0 109.981 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.8 t -108.92 168.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.41 132.81 20.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -104.02 158.11 16.64 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -154.76 142.04 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.91 -177.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -144.0 150.87 38.94 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.59 168.17 2.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 110.783 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.2 mt -99.79 -5.29 28.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -153.99 138.7 17.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 108.84 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.63 -158.79 39.56 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -176.33 140.55 0.39 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.475 -1.015 . . . . 0.0 109.888 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.83 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.96 -176.7 2.75 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.822 1.681 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -134.31 137.24 44.07 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.69 145.81 47.64 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.123 0.963 . . . . 0.0 110.854 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.41 131.56 4.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -134.98 169.78 16.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.364 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.7 p -134.34 170.17 16.13 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.5 0.667 . . . . 0.0 109.817 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.426 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 6.6 ptm -153.05 124.38 7.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -119.05 152.39 36.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.431 -0.793 . . . . 0.0 110.185 -178.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.77 144.43 44.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.8 p -89.87 167.12 13.08 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.802 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -63.81 -20.36 65.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.647 -0.658 . . . . 0.0 110.687 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.35 -32.66 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.06 -13.24 2.84 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.704 -1.236 . . . . 0.0 111.336 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -53.11 170.89 0.08 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 118.828 1.314 . . . . 0.0 109.345 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.9 tt -147.36 114.23 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.725 -178.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.19 158.62 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.81 134.37 30.08 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.393 -0.817 . . . . 0.0 109.57 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.0 170.04 8.57 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 17.6 mtp -147.8 164.53 33.34 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.178 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 m -148.46 151.97 36.11 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.448 0.642 . . . . 0.0 109.434 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -158.35 96.88 1.45 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.518 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.86 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.44 24.41 1.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.559 -0.713 . . . . 0.0 109.268 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.2 m -118.87 -179.29 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.78 118.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.651 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -98.33 115.57 28.72 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.6 m -110.8 147.63 34.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 -179.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 120.74 6.34 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.78 142.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -129.39 133.28 47.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.59 139.31 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.1 125.29 10.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.244 -0.91 . . . . 0.0 111.33 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.602 179.466 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.009 0 N-CA-C 110.306 -0.69 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -152.84 124.28 7.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.747 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 6.3 m-85 -99.37 -10.92 21.66 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.712 -0.617 . . . . 0.0 109.576 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 t -65.71 115.39 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.219 -0.925 . . . . 0.0 111.819 -177.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.78 -172.71 39.73 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.71 168.49 10.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 178.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.72 124.63 8.57 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.375 -177.288 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -118.91 112.95 20.29 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.11 140.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.41 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.95 -23.18 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.9 -0.5 . . . . 0.0 110.055 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -139.42 172.81 12.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t 171.29 168.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.15 29.97 0.12 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.948 -1.095 . . . . 0.0 111.713 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.09 33.55 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.285 -0.884 . . . . 0.0 109.082 -178.51 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -65.7 -66.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -0.784 . . . . 0.0 108.979 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 pt-20 -57.5 -26.73 61.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -64.3 -39.66 94.36 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.65 -0.656 . . . . 0.0 109.706 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -80.17 -15.3 57.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.697 -0.627 . . . . 0.0 110.016 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.05 -19.8 23.96 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.976 179.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmt -84.98 -28.15 25.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.82 -41.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.93 -53.71 35.79 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.04 0.924 . . . . 0.0 109.114 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 -151.62 23.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.56 -42.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.981 -0.717 . . . . 0.0 109.407 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -56.37 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.793 . . . . 0.0 109.681 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.2 -43.77 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.03 -26.69 66.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.532 -0.73 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.61 -45.26 85.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.681 -0.637 . . . . 0.0 110.491 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 4.2 mtp180 -67.34 -40.95 85.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -62.75 -24.38 67.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.678 -0.639 . . . . 0.0 110.838 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.2 mt -78.67 -28.81 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.062 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.42 -24.92 34.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 109.237 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.9 t -79.22 -38.72 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.67 -35.65 62.81 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.03 -37.58 81.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.1 -67.7 0.43 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t 49.87 50.46 18.38 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm 66.3 74.19 0.37 Allowed Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -71.72 146.21 48.09 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 122.01 1.807 . . . . 0.0 110.797 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.56 175.48 6.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.765 -0.584 . . . . 0.0 109.778 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 24.7 t -155.31 165.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.9 tt0 -149.88 112.87 4.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.44 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.7 mt -99.85 140.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.806 0.812 . . . . 0.0 110.443 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.9 mttt -119.14 114.37 22.36 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 57.1 tt0 -98.9 111.61 23.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.0 110.786 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -115.57 47.95 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.18 -127.57 9.07 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -74.85 -3.28 31.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.444 -1.033 . . . . 0.0 110.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 m -96.39 134.9 38.97 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.689 -1.257 . . . . 0.0 108.309 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 95.9 m-85 -131.37 119.2 21.34 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.875 0.845 . . . . 0.0 109.22 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.0 t80 -104.61 133.16 49.92 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.5 mm -115.45 137.18 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -132.4 98.65 4.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.0 108.704 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 17.8 m -98.45 145.37 26.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.446 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.59 136.42 24.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.853 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -66.54 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.848 0.832 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -179.61 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.77 -10.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -124.01 164.01 20.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.299 -0.876 . . . . 0.0 109.06 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.6 m -163.49 106.7 1.0 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.678 -0.639 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 152.83 19.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.409 -0.807 . . . . 0.0 109.123 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -150.98 101.7 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.563 -0.711 . . . . 0.0 109.735 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.403 ' CG1' HG12 ' A' ' 52' ' ' ILE . 26.2 pt -104.71 167.35 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.632 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.78 132.49 5.07 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.483 -0.761 . . . . 0.0 109.064 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.3 p90 -161.88 -172.46 3.29 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.061 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.45 154.27 46.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.27 95.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -33.77 1.68 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.712 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.42 153.77 23.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.367 -1.078 . . . . 0.0 109.977 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.96 166.95 15.51 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.24 173.3 14.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.875 -178.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.13 145.04 30.52 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.11 -178.21 6.24 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.62 155.2 17.72 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 t -91.66 -152.2 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 109.331 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.29 -20.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.992 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.61 -50.86 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.211 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.06 44.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 -130.67 152.01 79.72 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 121.613 -0.933 . . . . 0.0 109.127 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.54 141.05 17.36 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.581 1.521 . . . . 0.0 110.431 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 p -161.07 142.02 11.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -90.65 115.08 27.48 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -102.95 176.66 5.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.36 152.15 31.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 6.5 t -140.87 125.54 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.543 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -120.47 156.0 32.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 83.8 m95 -77.91 172.28 13.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.805 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -134.52 -46.61 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.9 p -129.27 -152.79 0.53 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.17 -24.98 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -143.3 25.68 1.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -131.06 108.29 9.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.82 -1.175 . . . . 0.0 108.211 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.46 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 1.6 ptm -114.47 148.21 38.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.366 -0.834 . . . . 0.0 110.239 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.66 172.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.37 129.81 14.82 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.754 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.21 141.35 12.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.9 -178.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -145.75 148.4 32.94 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 110.872 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.98 -7.09 33.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -154.18 146.31 23.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.839 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.73 -162.51 34.23 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -176.94 140.14 0.3 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -1.033 . . . . 0.0 109.798 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.92 -84.79 0.05 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.93 -176.79 2.8 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.883 1.722 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -137.74 139.22 39.99 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.24 146.04 47.65 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.072 0.939 . . . . 0.0 110.669 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -162.61 131.27 4.07 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -135.85 170.05 16.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.968 -1.082 . . . . 0.0 110.362 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 p -133.55 165.33 25.14 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.462 0.649 . . . . 0.0 109.395 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.415 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 8.3 ptm -152.72 124.86 8.04 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.5 pt-20 -129.98 158.8 38.58 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.965 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.65 145.2 41.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 p -92.38 161.26 14.73 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.425 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.72 -18.62 55.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.528 -0.732 . . . . 0.0 110.515 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -88.39 -27.02 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.17 -7.87 8.58 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.97 172.33 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.243 . . . . 0.0 108.579 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -145.64 113.11 6.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.065 -178.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 12.5 tt -99.76 151.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.87 112.14 11.05 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.22 166.51 11.19 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 31.1 mtp -145.4 163.97 32.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.543 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 m -146.12 152.35 39.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.56 95.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.548 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 78.08 -79.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -147.64 23.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.25 -179.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.3 t -157.16 117.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.594 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.7 t -99.6 112.64 24.84 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -99.2 153.81 18.64 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.847 0.832 . . . . 0.0 109.139 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.408 ' O ' ' CD2' ' A' ' 134' ' ' TYR . 36.5 mtm180 -151.42 93.6 1.91 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.54 127.39 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.7 m-85 -114.79 130.34 56.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.239 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.24 138.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.57 124.12 6.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.307 -0.871 . . . . 0.0 111.391 -178.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.702 179.907 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.979 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -154.67 122.22 5.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.531 -0.73 . . . . 0.0 109.794 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 5.3 m-85 -99.59 -18.08 17.52 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -60.65 116.21 4.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 111.827 -177.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.33 -173.06 39.43 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -96.03 169.53 9.91 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.498 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -151.95 126.21 9.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.718 -176.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -117.36 113.08 21.59 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -61.59 140.99 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.711 0.767 . . . . 0.0 110.236 -178.929 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.36 -22.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.597 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -133.22 167.29 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.159 -0.963 . . . . 0.0 110.442 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 170.05 167.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -161.04 29.3 0.14 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.019 -1.05 . . . . 0.0 111.289 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.85 34.3 0.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.06 -65.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.534 -0.729 . . . . 0.0 109.235 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.2 mt-10 -58.65 -26.44 63.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.429 -0.795 . . . . 0.0 109.138 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.11 -38.12 89.92 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.717 -0.614 . . . . 0.0 109.841 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.58 -16.28 52.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.686 -0.634 . . . . 0.0 110.033 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mt -89.67 -19.25 25.07 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.947 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -85.84 -29.09 24.01 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.651 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.5 -41.25 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.0 -52.51 48.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.001 0.905 . . . . 0.0 108.905 179.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.32 -147.58 19.63 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -154.91 -41.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.927 -0.749 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -57.68 -171.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.536 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.14 -43.91 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 110.077 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.81 -29.52 68.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.39 -46.31 76.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.641 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -64.49 -39.75 94.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.429 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -63.41 -15.68 58.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.575 . . . . 0.0 111.22 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mm -84.2 -30.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 108.709 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.99 -25.36 32.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 4.0 t -80.4 -44.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.49 85.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -48.95 77.65 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.87 -72.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.954 -0.466 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t 47.39 48.56 16.41 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.574 0.702 . . . . 0.0 109.171 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.2 mttp 71.19 73.23 0.26 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -177.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -71.4 -179.54 3.72 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.053 1.836 . . . . 0.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.36 172.56 8.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.464 -0.773 . . . . 0.0 110.401 -178.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 41.2 t -155.31 166.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 12.7 tm-20 -155.47 111.33 3.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 108.768 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mp -96.48 143.16 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.964 0.888 . . . . 0.0 110.151 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 2.7 mttm -119.73 108.66 14.69 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.3 tt0 -98.52 117.41 32.89 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.05 . . . . 0.0 110.993 -178.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -119.43 45.92 2.02 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.44 -127.41 9.13 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.93 -3.05 26.66 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -1.079 . . . . 0.0 110.045 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -96.73 133.98 40.58 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.623 -1.298 . . . . 0.0 108.196 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.5 m-85 -130.41 122.86 28.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.763 0.792 . . . . 0.0 109.164 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.2 t80 -106.03 140.46 38.99 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.429 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.3 mm -123.95 110.88 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -107.79 100.56 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -99.65 143.57 29.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 0.0 109.01 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 p -156.56 125.88 6.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.6 m -99.51 -64.77 1.01 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.705 -0.622 . . . . 0.0 110.021 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t 179.94 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.2 t -109.12 -16.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -127.74 162.42 26.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.444 -0.785 . . . . 0.0 108.984 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.0 m -162.71 115.75 1.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.301 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.6 p -106.76 160.87 15.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.04 136.62 14.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.314 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.429 ' CG1' HG12 ' A' ' 52' ' ' ILE . 27.2 pt -138.81 168.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.554 -0.716 . . . . 0.0 109.394 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.51 132.78 5.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 43.5 p90 -162.05 -173.61 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.948 -1.101 . . . . 0.0 112.095 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -127.94 154.25 45.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.43 93.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.069 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.15 -23.64 1.58 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.727 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.87 156.99 35.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.279 -1.13 . . . . 0.0 110.119 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.61 169.58 12.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.693 -0.629 . . . . 0.0 109.357 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 11.8 p90 -162.41 174.24 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.371 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -111.43 143.11 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.4 pm0 -162.43 -168.66 1.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.449 0.642 . . . . 0.0 109.341 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -99.9 159.52 15.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -94.77 -144.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 109.02 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.1 t -107.33 -19.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.841 -1.162 . . . . 0.0 110.74 -179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.24 -44.93 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.17 45.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -132.67 152.57 80.17 Favored Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.634 -0.921 . . . . 0.0 109.232 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.73 140.41 16.48 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.707 1.605 . . . . 0.0 110.471 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.5 p -160.76 143.41 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.632 -0.667 . . . . 0.0 109.822 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -90.9 120.3 31.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -103.52 168.43 9.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.671 -0.643 . . . . 0.0 110.299 -178.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -147.54 153.2 39.17 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.453 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 13.3 t -145.46 126.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.962 -178.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -120.2 155.54 32.95 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.44 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 79.4 m95 -77.89 173.88 11.66 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.857 0.837 . . . . 0.0 110.27 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -136.73 -45.98 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -131.83 -153.41 0.55 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -25.6 52.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 110.042 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -143.93 27.38 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.817 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -132.39 110.73 10.76 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.44 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -117.41 149.86 39.85 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.285 -179.229 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.43 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.412 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 42.0 t -147.71 141.12 25.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.976 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.06 162.3 14.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.27 135.52 8.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.82 -178.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -142.47 154.21 44.34 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.21 169.38 5.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.041 -1.037 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.1 mt -101.47 -5.64 25.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.38 135.11 12.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.904 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.78 -160.46 37.62 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -175.86 139.2 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.426 -1.044 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.42 -88.38 0.09 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.13 -176.78 2.75 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.677 1.585 . . . . 0.0 109.368 178.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -131.53 141.31 49.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.94 145.02 48.85 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.141 0.972 . . . . 0.0 110.686 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -162.96 136.75 6.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.412 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.8 p-90 -144.54 175.57 10.04 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.522 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.8 p -139.61 171.83 13.68 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.499 0.666 . . . . 0.0 109.636 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.8 ptp -153.56 139.29 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -136.94 150.18 48.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 109.522 -178.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.423 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.1 140.91 48.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.464 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.2 p -89.72 160.15 16.72 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.471 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -60.18 -20.59 59.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 110.29 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.18 -29.74 24.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.232 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.52 -9.31 6.9 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -57.34 171.9 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.108 -1.231 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.498 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.2 tt -144.73 107.95 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.973 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -103.4 147.65 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.72 145.33 51.91 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.55 162.34 19.77 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 22.0 mtp -143.99 162.1 37.05 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.324 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.2 m -145.89 152.41 39.42 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.73 97.24 1.3 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.489 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.78 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.12 23.85 0.94 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.5 -0.75 . . . . 0.0 109.506 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.2 179.34 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.98 116.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.63 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.73 113.7 26.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.625 . . . . 0.0 109.576 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -103.11 128.92 49.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.413 -0.805 . . . . 0.0 109.312 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -126.56 102.89 7.3 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.19 132.59 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.432 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -122.08 121.69 37.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.513 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.08 140.24 22.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.18 125.31 10.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.269 -0.894 . . . . 0.0 111.303 -178.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.667 179.582 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.501 1.966 0 N-CA-C 110.324 -0.683 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -175.36 126.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.691 . . . . 0.0 109.784 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.8 m-85 -99.16 -15.17 19.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -63.17 115.54 4.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -0.819 . . . . 0.0 111.597 -177.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.04 -172.04 39.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -96.14 169.2 10.12 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -151.1 120.89 7.04 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.619 -177.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -112.75 112.22 23.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.3 tt -56.0 141.67 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.667 0.746 . . . . 0.0 110.842 -178.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.71 -23.55 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.959 -0.463 . . . . 0.0 110.171 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.6 mtt-85 -143.73 170.64 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.877 . . . . 0.0 110.393 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t 170.65 167.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.02 31.83 0.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 111.988 -179.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.13 29.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.075 -1.016 . . . . 0.0 109.803 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.59 -60.03 3.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.775 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 24.3 mt-10 -58.09 -29.07 65.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 111.283 -178.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.421 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 1.7 pt-20 -72.63 -27.39 62.11 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.734 -178.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 2.2 tp -83.34 -18.81 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 15' ' ' PHE . 14.1 mt -90.25 -16.18 29.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.11 -0.994 . . . . 0.0 109.094 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.8 -33.01 21.49 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.634 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.09 -40.53 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -66.95 -48.06 69.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.883 0.849 . . . . 0.0 108.921 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.11 21.09 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -154.8 -42.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.825 -0.809 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -57.14 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 0.0 109.66 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.47 -43.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.813 . . . . 0.0 110.096 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -27.12 65.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.29 -48.13 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.669 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.793 . . . . 0.0 110.213 -178.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.23 -23.49 64.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 111.615 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.78 -27.5 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.42 -26.41 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.265 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 3.5 t -79.1 -46.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.1 75.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.95 92.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' HA ' HG23 ' A' ' 56' ' ' THR . . . -64.46 -66.96 0.47 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.4 -0.812 . . . . 0.0 109.161 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 p 51.83 61.61 3.13 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.87 70.85 0.46 Allowed Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 30.2 Cg_endo -71.53 139.73 34.9 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 122.102 1.868 . . . . 0.0 110.857 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.39 176.5 7.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 25.5 t -154.86 165.67 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.5 tt0 -154.05 113.2 3.72 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.3 mp -100.17 149.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.759 0.79 . . . . 0.0 110.19 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 4.3 mttt -129.01 106.4 8.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 66.7 tt0 -98.22 120.44 38.64 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 111.191 -177.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -123.76 49.14 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -130.17 10.14 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -2.96 30.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.201 178.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -97.43 118.59 34.25 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.857 -1.152 . . . . 0.0 108.782 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 85.3 m-85 -114.11 127.57 55.98 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.867 0.842 . . . . 0.0 109.126 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 19.8 t80 -109.58 147.13 33.54 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -133.46 138.07 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.234 -0.916 . . . . 0.0 108.636 -178.891 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.28 103.66 5.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -98.41 143.13 29.19 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -140.46 118.14 11.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.206 -179.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.433 HG23 ' HA ' ' A' ' 36' ' ' ALA . 70.5 p -99.17 -158.52 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 t -56.2 -45.62 79.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 0.0 110.863 -179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.07 -7.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.33 -0.857 . . . . 0.0 111.974 -179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 ttp-105 -98.03 166.27 11.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.014 -1.053 . . . . 0.0 109.777 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -163.21 94.69 0.82 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.562 -0.711 . . . . 0.0 109.603 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -85.27 158.99 20.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -155.8 100.75 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 0.0 109.86 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.5 pt -101.78 168.27 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.516 -0.74 . . . . 0.0 109.33 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.02 135.3 5.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.438 -0.789 . . . . 0.0 109.603 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.486 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 42.2 p90 -162.61 -171.82 2.89 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.35 1.071 . . . . 0.0 112.358 -178.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -129.79 153.24 48.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.44 95.5 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.157 -0.964 . . . . 0.0 109.542 -179.135 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.98 -31.65 1.45 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.684 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -117.09 157.34 26.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -1.077 . . . . 0.0 110.127 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -86.05 169.42 13.19 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.06 172.85 15.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 -179.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -104.11 144.35 31.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.25 -176.86 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.99 158.73 15.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.6 t -92.6 -144.07 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.418 -0.801 . . . . 0.0 109.109 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -106.42 -21.61 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.857 -1.152 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.51 -46.93 8.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.414 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.47 44.71 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -129.95 152.41 79.9 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.572 -0.958 . . . . 0.0 108.994 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.83 140.69 16.48 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 121.696 1.597 . . . . 0.0 110.875 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.05 141.81 11.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -88.2 117.07 26.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 4.1 t -99.63 166.53 11.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.847 -0.533 . . . . 0.0 109.809 -178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -145.83 155.41 42.89 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' CE2' ' A' ' 65' ' ' PHE . 25.3 t -146.46 129.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.088 -178.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -123.85 161.74 24.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.422 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 83.9 m95 -84.29 171.38 12.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.499 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -136.12 -45.31 0.64 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -132.78 -154.51 0.62 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.19 -26.49 56.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.786 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -143.68 29.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.794 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -132.3 109.26 9.76 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.422 ' HE2' ' CH2' ' A' ' 87' ' ' TRP . 1.2 ptp -115.09 147.69 39.88 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.665 0.745 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.88 172.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 44.4 t -146.79 141.88 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.922 . . . . 0.0 110.951 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.72 162.04 14.83 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -160.45 133.87 6.82 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.597 -178.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 150.05 39.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.07 167.3 1.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.869 -178.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 mt -94.35 -9.28 36.34 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -156.93 156.28 32.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 108.927 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.31 -160.15 17.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -176.24 139.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.484 -1.01 . . . . 0.0 109.837 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.64 -84.13 0.05 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.54 -177.05 3.0 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 121.938 1.758 . . . . 0.0 110.177 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -139.74 137.9 35.48 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.37 145.89 49.18 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.109 0.957 . . . . 0.0 110.831 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.7 m -162.76 135.48 5.64 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.414 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.4 p-90 -141.92 175.62 9.58 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.942 -1.099 . . . . 0.0 110.686 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -138.01 173.23 11.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.479 0.657 . . . . 0.0 109.987 -179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.425 ' HE2' ' CD2' ' A' ' 3' ' ' PHE . 8.5 ptm -157.17 126.63 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -124.65 153.75 41.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.82 142.73 46.16 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.032 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.423 ' N ' HD11 ' A' ' 113' ' ' LEU . 17.9 p -91.2 160.78 15.36 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.525 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -60.21 -21.0 61.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.457 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.07 -28.31 24.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -8.46 7.52 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.19 171.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -1.223 . . . . 0.0 109.032 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.503 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -144.28 109.77 5.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.0 109.963 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -104.35 150.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.27 145.25 51.17 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.479 -179.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 169.26 10.88 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.1 mtp -150.3 165.87 31.7 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.51 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.5 m -147.81 152.53 37.82 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.431 0.634 . . . . 0.0 109.367 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.17 97.92 1.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.607 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.57 -79.34 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.23 24.77 0.91 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.527 -0.733 . . . . 0.0 109.252 178.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.89 -179.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.413 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.2 t -156.36 118.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.754 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.5 t -99.67 118.81 37.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.5 m -111.37 130.38 55.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.908 . . . . 0.0 109.55 -179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -129.77 103.95 7.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 136.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -125.88 127.47 46.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.499 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.12 139.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 177.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.03 125.35 10.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.0 111.219 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.599 179.574 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.978 0 N-CA-C 110.28 -0.7 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.77 124.41 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 109.754 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 m-85 -98.86 -3.91 34.28 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.9 p -72.13 119.98 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.112 -0.992 . . . . 0.0 112.194 -177.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.74 -173.56 37.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 8.8 m120 -95.22 171.77 8.52 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 177.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -151.9 126.11 9.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.336 -176.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -116.28 111.52 20.25 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -62.86 140.64 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.607 0.718 . . . . 0.0 109.711 -179.378 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.13 -23.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.19 162.77 32.02 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.195 -0.941 . . . . 0.0 110.745 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p 178.26 168.88 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.35 26.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.91 -1.119 . . . . 0.0 111.443 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -161.65 29.06 0.13 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.488 -0.757 . . . . 0.0 108.986 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.56 -64.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.3 tt0 -57.0 -28.74 62.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.19 -35.96 82.69 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.773 -0.579 . . . . 0.0 110.375 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.5 tp -82.46 -17.34 45.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.637 -0.665 . . . . 0.0 110.363 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD13 ' CE1' ' A' ' 15' ' ' PHE . 8.1 mt -90.61 -18.29 25.41 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.763 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.4 mmmm -85.32 -29.54 24.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 22' ' ' LEU . 14.7 p -77.69 -39.46 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 21' ' ' VAL . 4.6 mp -69.03 -46.56 67.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.781 0.801 . . . . 0.0 110.008 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -156.58 27.14 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.708 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -149.67 -36.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.985 -0.715 . . . . 0.0 110.477 -179.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -62.86 -148.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.473 -0.767 . . . . 0.0 109.466 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.28 -46.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.661 -1.274 . . . . 0.0 109.151 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.7 ttt -67.59 -33.52 75.17 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -57.31 -24.36 54.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.811 -0.555 . . . . 0.0 110.544 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -92.69 -48.4 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 110.181 -179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -63.93 -16.87 62.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.549 -0.719 . . . . 0.0 111.447 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.6 mm -85.7 -28.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.944 . . . . 0.0 108.634 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.9 -25.73 34.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 3.8 t -80.17 -48.22 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.16 60.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.68 57.06 4.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.722 -0.611 . . . . 0.0 110.68 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -66.27 -36.22 82.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.7 -1.25 . . . . 0.0 107.793 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -155.14 72.51 5.68 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 33.5 Cg_endo -72.37 163.16 39.47 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.138 1.892 . . . . 0.0 111.168 -178.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.37 173.41 6.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.696 -0.627 . . . . 0.0 109.668 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.2 t -155.4 165.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -152.52 109.12 3.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.5 mt -97.98 135.78 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.667 0.746 . . . . 0.0 110.22 -178.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -114.33 111.44 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.878 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.437 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -98.2 121.93 40.74 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.031 -1.043 . . . . 0.0 110.974 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -123.02 51.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.04 -127.96 9.16 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -74.97 -2.0 25.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 110.124 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -96.51 134.69 39.4 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.724 -1.235 . . . . 0.0 108.12 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.445 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 97.6 m-85 -130.09 116.69 18.86 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.931 0.872 . . . . 0.0 109.416 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.6 t80 -102.29 148.2 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.2 mt -145.45 101.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.991 -1.068 . . . . 0.0 110.459 -177.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -99.47 113.74 26.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.673 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.4 m -101.42 143.29 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 115.45 11.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 109.955 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -98.47 -171.7 2.18 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.518 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.3 t -58.95 -37.55 77.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.671 -0.643 . . . . 0.0 111.186 -179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -126.23 -7.34 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.339 -0.85 . . . . 0.0 112.161 -177.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -116.4 172.23 7.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.876 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.5 m -165.33 94.9 0.64 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.8 p -103.7 176.0 5.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -171.34 120.7 0.5 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.743 -0.598 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 pt -109.01 171.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.493 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.6 p-10 -162.58 134.61 5.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.165 -0.96 . . . . 0.0 109.361 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.479 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.1 p90 -161.95 -171.43 2.87 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.395 1.093 . . . . 0.0 112.5 -178.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -129.76 152.66 49.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.3 95.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -178.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -35.14 1.58 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.681 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -110.56 155.33 22.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -1.065 . . . . 0.0 109.999 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.16 169.2 13.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.567 -0.708 . . . . 0.0 109.245 -179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.08 173.92 13.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.63 144.04 32.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -177.34 5.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.298 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.96 155.95 17.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -92.86 -143.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 0.0 109.158 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -110.92 -20.44 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.789 -1.195 . . . . 0.0 110.608 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.02 -40.99 13.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.92 . . . . 0.0 109.26 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.16 44.69 0.1 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -133.02 151.89 78.75 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.619 -0.93 . . . . 0.0 109.323 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.97 141.76 16.91 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.737 1.625 . . . . 0.0 110.519 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -161.03 143.26 12.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.734 -0.604 . . . . 0.0 109.46 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.67 117.16 27.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.9 t -99.78 166.36 11.13 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.283 0.564 . . . . 0.0 109.749 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.2 tp -148.77 150.76 33.65 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 10.7 t -141.92 127.18 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.024 -177.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.73 156.03 28.97 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.465 ' CH2' ' CE ' ' A' ' 93' ' ' MET . 75.8 m95 -76.87 -175.04 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.576 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -142.68 -53.76 0.4 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.0 p -131.36 -152.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.54 -24.15 45.81 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 110.003 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -138.82 22.26 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 0.0 111.167 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -130.49 129.65 43.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.746 -1.221 . . . . 0.0 108.325 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -134.96 151.09 50.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.918 -179.622 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.31 171.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.2 t -147.91 133.2 18.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.3 -0.875 . . . . 0.0 110.82 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -105.95 153.28 22.2 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -151.36 140.53 21.24 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.939 -177.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -144.92 148.45 33.89 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.11 168.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.049 -1.032 . . . . 0.0 110.886 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.78 -10.1 35.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.95 160.19 35.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.74 -161.58 22.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -176.72 138.62 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.427 -1.043 . . . . 0.0 109.941 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.94 -85.42 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.91 -176.73 2.54 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.932 1.755 . . . . 0.0 110.142 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -139.97 138.8 35.82 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.81 146.01 47.92 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.071 0.939 . . . . 0.0 110.778 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 m -162.38 129.89 3.84 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -136.39 171.05 15.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.092 -1.005 . . . . 0.0 110.608 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -134.06 176.0 8.98 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.472 0.653 . . . . 0.0 109.884 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.23 124.07 3.62 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -120.06 146.6 45.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.679 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.92 143.52 38.05 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.101 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.401 ' N ' HD11 ' A' ' 113' ' ' LEU . 18.9 p -92.73 160.94 14.74 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.676 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.39 -22.67 63.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.646 . . . . 0.0 110.21 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.49 -29.22 28.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.164 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.29 7.22 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -56.2 171.7 0.25 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.145 -1.209 . . . . 0.0 109.333 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.1 tt -146.4 110.16 4.9 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.995 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.5 tt -106.24 145.01 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -126.59 142.08 51.65 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.322 -0.861 . . . . 0.0 109.604 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.01 170.67 8.85 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 68.1 mtp -152.18 166.09 32.79 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.659 -178.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.1 m -147.07 152.54 38.69 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -159.35 96.74 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.14 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.1 23.96 1.05 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 178.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.14 -179.2 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.3 t -157.27 117.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.589 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 5.6 t -99.25 132.64 44.43 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.7 m -124.96 126.16 45.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.36 -0.838 . . . . 0.0 109.436 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -123.15 100.4 6.85 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.58 130.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.7 m-85 -120.1 132.25 55.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.404 -179.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.81 137.18 47.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.14 127.63 14.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.215 -0.928 . . . . 0.0 111.867 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.992 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.501 1.968 0 N-CA-C 110.3 -0.692 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -153.08 126.13 8.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.479 -0.763 . . . . 0.0 109.638 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 4.9 m-85 -99.11 -5.34 30.35 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.714 -0.616 . . . . 0.0 109.509 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 p -72.15 118.66 15.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 111.945 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.87 -173.36 38.21 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.4 m120 -95.45 171.87 8.43 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.2 m95 -150.73 125.35 9.64 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.482 -176.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -118.9 114.76 23.1 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.0 tt -58.15 143.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.414 -179.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.15 -24.44 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.893 -0.504 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -150.16 176.32 10.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -0.912 . . . . 0.0 110.383 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t 176.56 167.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.56 26.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.2 m-20 -160.53 27.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.752 -0.592 . . . . 0.0 109.851 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -63.19 -66.36 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.854 . . . . 0.0 109.053 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.9 mt-10 -55.53 -31.56 62.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.446 -0.784 . . . . 0.0 109.476 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.61 -39.54 91.61 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.157 0.504 . . . . 0.0 110.506 -179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 22' ' ' LEU . 17.0 tp -79.0 -16.88 56.3 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 15' ' ' PHE . 4.8 mt -90.14 -18.92 24.91 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.055 -1.028 . . . . 0.0 109.077 179.23 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mtmm -82.3 -31.48 29.97 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -77.84 -40.37 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.011 0.91 . . . . 0.0 108.714 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.6 mp -67.32 -47.17 71.33 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.884 0.849 . . . . 0.0 109.428 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -151.31 24.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.1 m -153.74 -41.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.968 -0.725 . . . . 0.0 109.506 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -60.89 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.525 -0.734 . . . . 0.0 109.444 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.62 -46.84 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.809 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.58 -29.39 68.73 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.34 -32.17 68.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.788 -0.57 . . . . 0.0 110.63 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -82.69 -44.29 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 109.903 -179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -61.96 -22.3 65.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 110.682 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mt -79.48 -28.54 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.0 109.04 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.06 -26.21 33.9 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 8.8 t -77.94 -39.83 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.65 -33.59 60.45 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.69 94.45 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.87 -67.48 0.43 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.618 -0.676 . . . . 0.0 109.253 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 m 51.64 55.3 9.56 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mttm 66.69 73.51 0.38 Allowed Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HB3' HG21 ' A' ' 56' ' ' THR . 28.4 Cg_endo -70.99 153.92 63.08 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.024 1.816 . . . . 0.0 110.605 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.95 173.2 6.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 54' ' ' THR . 53.9 t -154.99 164.49 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 12.3 tm-20 -149.43 109.49 4.11 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -98.61 139.7 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 121.802 0.81 . . . . 0.0 110.605 -178.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.0 116.47 27.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.666 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.0 tt0 -98.77 116.52 31.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.123 -0.985 . . . . 0.0 110.837 -178.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -116.9 49.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.3 -125.84 8.19 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.78 -1.83 26.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -1.04 . . . . 0.0 110.023 178.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.56 138.91 33.43 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.787 -1.196 . . . . 0.0 108.434 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 92.5 m-85 -134.06 116.31 15.32 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.865 0.84 . . . . 0.0 109.431 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.9 147.75 26.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -143.45 105.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.289 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.23 112.09 24.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 109.466 179.041 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.404 ' CG2' HG21 ' A' ' 41' ' ' VAL . 34.4 m -102.54 141.09 35.93 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.48 140.99 39.42 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.129 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -110.41 -65.36 1.17 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.841 0.829 . . . . 0.0 109.466 -179.825 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 t 179.21 -42.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.2 t -113.87 -11.37 12.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -123.65 163.99 19.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.253 -0.904 . . . . 0.0 109.028 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m -163.0 100.02 0.97 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.59 -0.694 . . . . 0.0 109.258 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.55 165.27 16.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.731 . . . . 0.0 109.679 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -159.57 123.51 3.79 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.641 -0.662 . . . . 0.0 109.307 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.7 pt -123.98 166.34 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.02 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.505 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.19 129.45 3.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 109.052 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.461 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 46.0 p90 -161.65 -173.0 3.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.689 -1.204 . . . . 0.0 112.273 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 153.6 47.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.44 94.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.649 -178.997 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.72 -34.1 1.37 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.495 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -112.42 156.61 22.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.403 -1.057 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -86.39 169.16 13.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.461 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.26 173.47 14.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.563 -0.711 . . . . 0.0 109.816 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.28 145.2 29.79 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.32 -176.17 4.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 109.528 -179.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -100.71 157.51 16.64 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 t -95.2 -143.13 0.26 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.862 . . . . 0.0 109.24 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.3 t -110.1 -22.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.754 -1.216 . . . . 0.0 110.814 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -88.12 -40.27 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.589 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.38 45.1 0.1 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 152.1 78.76 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.714 -0.874 . . . . 0.0 109.046 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.42 142.38 18.63 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.655 1.57 . . . . 0.0 110.876 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.14 141.12 10.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 109.552 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -86.67 116.13 24.58 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.91 165.42 11.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.735 -0.603 . . . . 0.0 110.268 -178.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 tp -145.69 153.84 41.43 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 14.7 t -146.17 125.13 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.728 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.1 156.05 29.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CE3' ' HB3' ' A' ' 93' ' ' MET . 81.4 m95 -78.03 174.84 10.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.876 0.846 . . . . 0.0 110.126 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -137.84 -46.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.2 p -130.51 -152.68 0.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.67 -28.35 51.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -141.04 28.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -132.69 111.52 11.23 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.43 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -118.36 150.17 39.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.25 -0.906 . . . . 0.0 110.398 -179.295 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -99.47 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.423 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 49.8 t -147.45 140.3 24.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 110.895 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.68 163.01 13.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -160.3 135.38 7.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.781 -1.167 . . . . 0.0 111.642 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -143.63 150.55 38.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.94 168.94 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.005 . . . . 0.0 110.842 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 mt -99.04 -5.98 29.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.68 133.72 14.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.669 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.86 -157.37 38.94 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -176.15 139.97 0.39 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.438 -1.036 . . . . 0.0 109.915 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.0 -87.9 0.09 OUTLIER Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.36 -176.69 2.89 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.682 1.588 . . . . 0.0 109.474 178.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -130.46 136.31 48.87 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.95 144.41 48.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.151 0.977 . . . . 0.0 110.749 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.7 m -163.04 136.88 6.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.8 p-90 -142.49 174.83 10.28 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.436 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.0 p -138.36 170.53 15.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.556 0.693 . . . . 0.0 109.801 -179.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 ptp -153.37 137.0 15.99 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -133.19 149.42 52.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.388 -0.82 . . . . 0.0 109.413 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -111.84 141.44 45.47 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 p -90.4 161.12 15.72 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.763 -179.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.33 -22.01 62.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -84.35 -29.19 26.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.284 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.63 -9.85 7.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.55 172.62 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.158 -1.201 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.2 tt -145.08 108.38 4.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 109.974 -179.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.6 137.52 42.02 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.248 -0.907 . . . . 0.0 109.771 -178.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.65 168.59 9.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.7 mtp -147.55 167.86 23.43 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.636 -179.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.0 m -150.65 150.2 30.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.25 93.84 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.522 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.83 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -146.69 23.52 1.25 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.576 -0.702 . . . . 0.0 109.286 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.2 m -117.14 -178.52 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.79 118.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.436 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.6 t -97.66 116.98 30.92 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.5 m -114.45 126.26 54.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -0.999 . . . . 0.0 110.17 -179.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -133.22 107.76 8.36 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.04 135.4 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -123.36 126.12 46.26 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.274 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.48 138.48 33.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.496 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -49.96 128.22 18.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.242 -0.911 . . . . 0.0 111.559 -178.617 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.6 tm-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.762 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.001 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -157.08 126.82 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.532 -0.73 . . . . 0.0 109.666 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 4.3 m-85 -98.84 -9.8 23.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -65.37 118.09 8.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 112.293 -177.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.24 -172.84 37.57 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.63 171.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.9 m95 -150.22 120.01 7.08 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.891 -1.123 . . . . 0.0 112.613 -177.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -111.43 114.11 27.02 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 7.2 tt -56.26 155.45 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.907 0.861 . . . . 0.0 111.195 -178.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.41 -32.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.436 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -145.0 171.04 15.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.029 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t 179.52 157.44 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 109.335 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 170.74 19.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.616 . . . . 0.0 110.049 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 37.5 m-80 61.04 29.99 19.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.476 -0.765 . . . . 0.0 109.887 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.431 ' CZ ' ' HB1' ' A' ' 36' ' ' ALA . 3.7 t80 -65.55 -63.17 1.16 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.282 -0.886 . . . . 0.0 108.85 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 2.5 pt-20 -59.76 -28.35 67.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.736 -0.603 . . . . 0.0 109.641 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.73 -38.97 90.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.626 -0.671 . . . . 0.0 110.411 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' CD1' ' CB ' ' A' ' 125' ' ' ALA . 47.8 tp -83.12 -13.39 55.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.686 -0.634 . . . . 0.0 109.711 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.82 -20.96 20.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.959 -1.088 . . . . 0.0 108.952 179.572 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmm -83.37 -30.04 27.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -77.43 -41.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' LEU . 4.6 mp -66.41 -53.55 34.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.25 1.024 . . . . 0.0 108.865 179.251 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.06 -144.9 14.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -154.99 -38.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.901 -0.764 . . . . 0.0 110.244 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.29 -171.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.248 -0.907 . . . . 0.0 109.779 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.12 -43.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.77 . . . . 0.0 110.112 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.0 ttm -67.83 -26.35 66.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.57 -0.706 . . . . 0.0 109.131 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.74 -49.2 78.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.704 -0.622 . . . . 0.0 110.525 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -66.03 -42.3 89.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.463 -0.773 . . . . 0.0 110.029 -178.87 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -57.52 -38.98 75.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.567 -0.708 . . . . 0.0 110.705 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.03 -26.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.429 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' ' CZ ' ' A' ' 15' ' ' PHE . . . -81.51 -22.1 38.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.66 -0.65 . . . . 0.0 110.169 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.408 HG12 ' CG ' ' A' ' 15' ' ' PHE . 3.5 t -81.99 -45.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.25 91.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.27 71.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.35 42.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.547 179.15 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.8 t -64.97 -35.39 81.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.841 -1.162 . . . . 0.0 108.313 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -157.4 71.22 4.43 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 30.5 Cg_endo -73.57 146.33 38.89 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 122.012 1.808 . . . . 0.0 110.545 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.04 173.22 7.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.664 -0.648 . . . . 0.0 109.618 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 4.7 t -153.53 165.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.2 tt0 -156.87 116.98 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.653 -0.654 . . . . 0.0 109.427 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.1 mp -107.21 138.04 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.582 0.706 . . . . 0.0 109.769 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.432 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 3.8 mttt -117.53 109.16 16.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.2 tt0 -98.1 117.07 31.63 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.07 -1.019 . . . . 0.0 111.113 -177.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.84 56.01 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.08 -126.37 8.39 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -77.79 -0.4 26.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.418 -1.048 . . . . 0.0 109.954 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 m -96.19 139.99 31.54 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.781 -1.2 . . . . 0.0 108.862 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' CE1' ' HE2' ' A' ' 93' ' ' MET . 95.4 m-85 -136.66 117.44 14.06 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.774 0.797 . . . . 0.0 108.92 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 4.5 t80 -104.53 119.12 38.24 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.7 mm -99.84 146.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 120.785 -1.197 . . . . 0.0 107.991 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -145.11 102.58 3.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.93 . . . . 0.0 108.785 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 25.0 m -99.56 154.9 17.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.723 . . . . 0.0 109.486 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.69 116.0 6.59 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -98.53 -172.14 2.26 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.861 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -58.13 -38.1 75.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 111.214 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.75 -6.03 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.382 -0.824 . . . . 0.0 112.216 -177.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -117.18 175.26 5.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.034 -1.041 . . . . 0.0 110.763 -178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.6 m -164.72 105.12 0.82 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.01 169.53 8.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.395 -0.816 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.1 pt-20 -173.44 113.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' CG1' HG12 ' A' ' 52' ' ' ILE . 37.5 pt -103.65 173.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.467 -0.77 . . . . 0.0 110.052 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -160.68 130.34 5.02 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.479 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 43.2 p90 -162.38 -171.62 2.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.089 0.947 . . . . 0.0 111.448 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -132.31 154.67 49.47 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.59 94.3 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -178.541 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.74 -23.02 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.865 -1.159 . . . . 0.0 110.607 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 163.59 30.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.296 -1.12 . . . . 0.0 110.727 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.16 171.2 11.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.765 -0.584 . . . . 0.0 109.578 -179.511 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.0 p90 -162.63 175.32 11.51 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.03 143.62 39.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.7 pm0 -162.16 -169.18 2.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 109.343 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -99.6 160.07 14.57 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.348 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -97.84 -143.72 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.386 -0.821 . . . . 0.0 109.227 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 t -110.78 -20.99 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.731 -1.23 . . . . 0.0 110.897 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -90.39 -40.39 12.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.821 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.89 46.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -137.28 154.01 75.24 Favored Pre-proline 0 C--N 1.306 -1.292 0 O-C-N 121.743 -0.857 . . . . 0.0 109.269 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.34 142.94 17.05 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.6 p -160.66 142.41 12.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -90.71 120.76 32.03 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 2.6 t -100.31 172.8 6.93 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.516 0.674 . . . . 0.0 110.347 -178.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.7 tp -148.7 152.72 37.14 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' CE2' ' A' ' 65' ' ' PHE . 15.5 t -147.74 131.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 118.441 -1.304 . . . . 0.0 112.266 -178.059 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.64 161.23 29.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.43 ' CE2' HG23 ' A' ' 67' ' ' VAL . 86.0 m95 -84.36 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.923 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -134.84 -46.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -132.25 -153.66 0.57 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -24.77 47.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -142.16 24.76 1.95 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -130.77 111.85 12.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 0.0 108.522 179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.431 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.06 149.42 38.96 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.628 0.728 . . . . 0.0 110.39 -178.876 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.88 171.74 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.416 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 47.4 t -149.12 138.29 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.915 . . . . 0.0 110.966 -179.498 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -108.59 163.39 13.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.65 139.69 10.46 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.873 -178.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -141.42 157.13 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.75 168.81 12.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 110.612 -179.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 mt -101.65 -6.07 24.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 138.73 18.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.46 -156.86 41.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -176.87 140.08 0.31 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.567 -0.961 . . . . 0.0 109.603 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.46 -85.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.43 -177.11 3.06 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.88 1.72 . . . . 0.0 109.936 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -135.92 139.02 42.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.84 145.09 48.42 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.16 0.981 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.1 p -163.07 137.71 6.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CZ3' ' CE ' ' A' ' 111' ' ' MET . 61.7 p-90 -142.32 176.0 9.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.023 -1.048 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -140.41 174.46 10.49 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.817 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.452 ' CE ' ' CZ3' ' A' ' 109' ' ' TRP . 2.4 mtm -157.16 128.5 6.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -124.35 146.83 48.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.529 -0.732 . . . . 0.0 109.63 -179.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.46 144.25 39.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.349 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.406 ' N ' HD11 ' A' ' 113' ' ' LEU . 19.2 p -93.18 160.52 14.81 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.6 -179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.66 -21.61 62.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.171 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.99 -29.23 27.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 109.106 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.45 -9.39 7.34 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.65 171.68 0.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -1.227 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.496 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -146.25 112.03 5.63 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.149 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 120' ' ' ILE . 12.1 tt -106.72 147.7 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.329 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.401 ' CD1' ' CE ' ' A' ' 111' ' ' MET . 7.5 tt -129.43 147.96 51.3 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.193 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.96 163.37 24.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 20.0 mtp -143.13 163.34 33.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.368 -179.23 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 m -146.7 152.05 38.21 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . -158.33 96.75 1.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.98 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.73 23.91 1.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.546 -0.721 . . . . 0.0 109.407 178.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.0 m -119.3 -179.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -158.03 117.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.3 t -98.89 112.08 24.29 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -107.92 148.9 29.0 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.767 0.794 . . . . 0.0 110.074 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -151.0 118.18 5.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.32 138.97 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.123 -0.986 . . . . 0.0 108.385 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 22.5 m-85 -127.49 125.3 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.367 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.03 139.59 28.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.36 125.63 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.215 -0.928 . . . . 0.0 111.207 -178.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.515 179.578 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.971 0 N-CA-C 110.287 -0.697 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -152.59 128.12 10.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 m-85 -98.85 -8.1 26.29 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.7 p -69.6 118.09 12.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.209 -0.932 . . . . 0.0 111.938 -177.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.3 -171.54 37.34 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.1 m120 -95.59 169.94 9.69 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 177.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.486 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.9 m95 -150.67 120.43 7.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.643 -177.344 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -112.66 120.76 42.64 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 11.7 tt -64.56 151.97 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.845 0.831 . . . . 0.0 111.116 -178.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.03 -31.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -139.73 168.84 18.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 108.985 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -176.82 149.61 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.489 -0.757 . . . . 0.0 109.606 -179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -148.2 163.64 36.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.86 27.48 16.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -64.85 -65.47 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.588 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.8 pt-20 -58.01 -27.89 63.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.39 -34.83 79.22 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.553 -0.717 . . . . 0.0 110.018 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.9 -18.58 39.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.729 -0.607 . . . . 0.0 110.254 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD13 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -91.37 -16.81 26.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.909 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 mmmt -87.94 -28.49 21.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.156 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.77 -41.14 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.1 -54.6 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.99 -148.2 19.86 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.8 m -157.28 -43.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.815 -0.815 . . . . 0.0 109.407 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.28 176.07 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.472 -0.767 . . . . 0.0 109.516 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.68 -43.68 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.6 ttm -62.74 -26.38 68.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.8 -69.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.634 -0.666 . . . . 0.0 109.993 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -38.32 57.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 110.62 -179.299 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -61.01 -39.33 89.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.61 -0.681 . . . . 0.0 110.373 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.82 -26.8 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.6 -26.02 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 10.6 t -75.9 -35.98 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.01 41.74 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.52 93.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.41 -69.49 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m 49.19 51.19 16.71 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.495 0.664 . . . . 0.0 109.46 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.3 mttt 65.38 72.31 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -72.1 156.96 55.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.05 1.833 . . . . 0.0 110.613 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.95 174.38 5.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.355 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.8 t -154.23 164.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -149.68 108.61 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD13 ' CD1' ' A' ' 7' ' ' TRP . 4.2 mt -98.45 139.13 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.19 113.1 21.74 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.711 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.421 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.2 tt0 -98.48 118.38 35.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.07 -1.019 . . . . 0.0 110.976 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.38 52.45 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -124.44 7.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -178.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -76.31 -1.25 25.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 178.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.33 141.77 29.26 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 120.808 -1.183 . . . . 0.0 108.807 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -137.3 115.52 11.73 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.839 0.828 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -101.43 147.5 26.28 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.4 mt -142.09 107.52 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.197 -177.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.7 109.84 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.091 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -99.36 135.86 40.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.37 121.01 26.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.25 -0.906 . . . . 0.0 110.314 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.29 -168.99 1.69 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 t -51.06 -42.54 60.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.504 -0.747 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.14 -7.02 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.345 -178.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.98 174.96 5.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.905 -1.122 . . . . 0.0 110.377 -179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 m -164.3 93.03 0.67 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.75 160.97 22.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -152.51 125.21 8.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 0.0 109.791 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.73 165.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.72 129.03 3.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.001 -1.062 . . . . 0.0 109.887 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 49.0 p90 -162.25 -171.87 2.98 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.734 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' CG ' ' HG2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -132.06 155.91 47.24 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.689 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -83.47 91.63 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.109 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.78 -27.08 0.65 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.124 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' HG2' ' CG ' ' A' ' 66' ' ' LYS . 4.9 pt-20 -124.77 159.09 31.73 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.182 -1.187 . . . . 0.0 110.3 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.82 166.23 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.2 173.6 14.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.686 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.97 146.12 28.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.37 -177.52 5.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.667 -0.645 . . . . 0.0 109.342 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.44 155.83 17.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.0 t -94.49 -142.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.71 -18.64 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.218 . . . . 0.0 110.64 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.39 -36.59 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.42 44.84 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -134.23 151.85 77.15 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.779 -0.836 . . . . 0.0 109.224 -179.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.8 143.4 18.49 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.658 1.572 . . . . 0.0 110.553 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -161.14 141.65 11.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.717 -0.615 . . . . 0.0 109.625 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -88.32 116.74 26.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.4 t -99.47 168.08 10.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.428 0.632 . . . . 0.0 110.458 -178.241 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.2 tp -151.12 153.77 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 65' ' ' PHE . 38.7 t -146.04 134.63 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.214 -177.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -126.17 157.4 38.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.432 ' CE2' HG23 ' A' ' 67' ' ' VAL . 84.6 m95 -81.58 171.05 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.098 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -134.17 -45.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -132.31 -154.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -76.56 -25.52 54.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.18 27.69 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.825 . . . . 0.0 110.717 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -130.84 106.87 8.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 108.16 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.422 ' HE2' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 ptp -115.18 145.88 41.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.12 171.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.6 t -145.47 138.74 26.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.268 -0.895 . . . . 0.0 110.475 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -109.62 154.35 22.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -152.46 142.02 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.905 -177.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -143.6 153.32 42.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.66 169.3 3.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.092 -1.005 . . . . 0.0 110.527 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 mt -98.07 -7.93 28.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -155.14 145.31 21.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 108.946 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.04 -158.71 37.51 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.54 140.41 0.36 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.505 -0.997 . . . . 0.0 109.743 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.43 -85.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.99 -176.9 2.83 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.872 1.714 . . . . 0.0 109.905 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -137.92 138.95 39.52 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.99 145.97 48.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.024 0.916 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -162.49 131.1 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.426 ' CZ3' ' HE1' ' A' ' 111' ' ' MET . 46.4 p-90 -136.16 167.26 21.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.123 -0.986 . . . . 0.0 110.839 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 p -131.63 169.77 15.7 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.386 0.612 . . . . 0.0 109.9 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.426 ' HE1' ' CZ3' ' A' ' 109' ' ' TRP . 11.4 ptp -154.98 123.44 6.01 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.31 155.68 29.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 110.412 -178.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.45 141.65 48.95 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.823 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.5 p -93.86 161.03 14.48 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.804 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -60.79 -22.01 63.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.678 . . . . 0.0 110.142 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.65 -28.9 28.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.67 -10.36 7.15 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -54.97 170.89 0.16 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.159 -1.201 . . . . 0.0 109.275 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.486 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.8 tt -147.42 110.12 4.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 120' ' ' ILE . 12.3 tt -103.49 161.07 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.08 132.22 20.43 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.41 171.55 7.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.219 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 16.0 mtp -149.76 163.91 36.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.093 -179.514 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 m -147.51 152.7 38.44 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.436 0.636 . . . . 0.0 109.415 179.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.72 96.53 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.645 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.76 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 24.12 1.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.563 -0.711 . . . . 0.0 109.312 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.09 -179.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.56 117.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 4.0 t -98.21 117.33 32.35 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -111.35 149.77 30.68 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.882 0.848 . . . . 0.0 109.925 -179.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -152.49 118.2 5.38 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.17 137.8 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.434 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.8 m-85 -126.93 124.87 40.51 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.446 -179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.55 140.78 24.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -50.02 125.99 13.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.176 -0.952 . . . . 0.0 111.131 -178.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.544 179.569 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.006 0 N-CA-C 110.746 -0.521 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.91 123.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.706 0.765 . . . . 0.0 110.216 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 113' ' ' LEU . 3.3 m-85 -99.59 -1.09 39.06 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.66 -0.65 . . . . 0.0 109.44 179.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -72.37 120.56 18.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.123 -0.986 . . . . 0.0 112.122 -177.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.54 -171.97 36.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -95.86 169.78 9.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.501 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -150.47 120.97 7.41 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.639 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -113.69 115.7 28.27 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.0 tt -55.6 156.61 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.994 0.902 . . . . 0.0 111.418 -178.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.21 -32.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.527 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -143.82 169.61 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.254 -0.904 . . . . 0.0 108.938 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -177.19 145.37 0.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -141.18 165.7 26.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.759 -0.588 . . . . 0.0 109.657 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.1 m-80 58.77 22.54 10.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.474 -0.766 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -65.19 -64.2 0.92 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 108.943 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 42.9 tt0 -57.5 -29.12 64.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -65.36 -34.19 77.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.664 -0.648 . . . . 0.0 110.167 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.72 -19.0 38.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.758 -0.589 . . . . 0.0 110.375 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -90.86 -17.03 27.2 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -87.33 -29.28 21.69 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.216 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.06 -41.01 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.73 -50.8 63.49 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -143.93 14.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 m -154.5 -43.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.697 -0.884 . . . . 0.0 109.985 179.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.97 -172.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.483 -0.761 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.46 -42.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -61.45 -23.34 65.79 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.82 -39.63 30.31 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.736 -0.602 . . . . 0.0 110.086 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -37.39 85.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.701 -0.624 . . . . 0.0 109.502 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -11.97 57.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 111.043 -179.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.84 -30.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 108.459 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.28 -27.25 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' HA ' ' CE2' ' A' ' 15' ' ' PHE . 2.7 t -79.52 -46.13 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.65 89.86 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.98 88.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -83.47 40.69 0.74 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.824 -0.547 . . . . 0.0 111.56 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.4 p -58.31 -26.66 63.3 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.487 -1.383 . . . . 0.0 108.679 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.19 73.01 0.23 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -73.18 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.996 1.798 . . . . 0.0 111.089 -178.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.96 173.43 11.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.1 t -156.43 163.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -150.47 111.0 4.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -99.37 133.37 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.636 0.731 . . . . 0.0 110.366 -178.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -112.72 111.92 23.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.666 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.44 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 61.8 tt0 -98.57 119.39 37.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.11 -0.994 . . . . 0.0 111.002 -178.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -120.69 54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.9 -126.74 8.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -0.44 25.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.387 -1.066 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.65 140.75 30.8 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.653 -1.279 . . . . 0.0 108.512 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.7 m-85 -136.67 116.39 13.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.8 0.81 . . . . 0.0 109.465 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.67 147.45 26.42 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.6 mt -142.27 104.8 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.25 -177.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.44 109.35 21.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.067 178.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.6 m -103.21 141.8 35.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -148.88 124.88 10.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 109.592 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 m -98.24 -65.15 0.98 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.532 -0.73 . . . . 0.0 109.634 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.7 t -174.36 -41.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -109.24 -17.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 ttm105 -124.21 162.24 24.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.502 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.2 m -161.24 104.66 1.29 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.42 169.06 10.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.554 -0.716 . . . . 0.0 110.079 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -160.42 123.32 3.37 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 pt -124.49 168.85 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.376 -0.827 . . . . 0.0 109.407 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.54 129.32 3.61 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.234 -0.916 . . . . 0.0 109.08 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 51.2 p90 -162.14 -172.16 3.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.388 -179.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -130.54 153.12 49.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.42 95.15 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 109.79 -178.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.3 -33.58 1.57 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.772 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -110.88 153.59 25.23 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.356 -1.085 . . . . 0.0 109.869 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 167.21 15.13 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.463 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.39 173.61 13.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.818 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -103.94 143.66 32.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -162.09 -176.86 5.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.82 155.67 17.53 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -91.19 -142.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.46 -0.775 . . . . 0.0 109.194 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.02 -20.63 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.74 -1.225 . . . . 0.0 110.624 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.43 -39.96 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.57 44.88 0.11 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 150.82 77.43 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.629 -0.924 . . . . 0.0 109.342 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.92 140.29 15.98 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.7 1.6 . . . . 0.0 110.26 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.4 p -161.36 141.86 10.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.637 -0.664 . . . . 0.0 109.811 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -90.57 114.32 26.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.81 177.5 4.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.715 -0.615 . . . . 0.0 110.235 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 96' ' ' GLU . 64.4 tp -151.75 152.01 32.15 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 3.4 t -140.74 130.25 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.516 -177.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -125.89 162.48 25.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.426 ' CZ2' ' HE2' ' A' ' 93' ' ' MET . 88.3 m95 -85.69 167.35 15.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.969 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -129.93 -45.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 p -132.01 -154.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.29 -24.65 50.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.733 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -143.91 27.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -132.27 106.4 7.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 107.977 179.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.435 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 1.4 ptp -113.18 149.89 33.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.316 -178.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.7 172.11 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.8 t -149.58 129.79 13.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 110.747 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -100.68 163.99 12.08 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 176.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.41 142.91 13.09 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.945 -178.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -147.08 149.25 32.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.43 167.9 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.065 -1.022 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.0 -7.44 29.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -152.44 141.14 20.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 108.922 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.07 -159.72 36.04 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -176.37 139.91 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.493 -1.004 . . . . 0.0 109.829 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.45 -86.67 0.06 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.1 -176.97 2.83 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.834 1.689 . . . . 0.0 109.774 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -135.5 138.53 43.2 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 146.05 47.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.068 0.937 . . . . 0.0 110.872 -179.362 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -162.7 128.79 3.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -133.34 166.01 23.49 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.098 -1.001 . . . . 0.0 110.85 -179.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.8 p -130.4 174.69 9.61 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.415 0.626 . . . . 0.0 109.692 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.09 122.33 3.31 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -116.95 154.1 31.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -115.22 142.73 46.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.282 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -95.03 160.34 14.61 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.987 -179.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.9 -23.19 63.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.688 -0.632 . . . . 0.0 110.139 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -81.69 -31.06 32.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.16 -8.6 7.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -58.12 170.73 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.124 -1.221 . . . . 0.0 108.97 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.501 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.3 tt -143.87 113.74 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.123 -178.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.81 152.45 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.01 132.78 38.71 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.46 -0.775 . . . . 0.0 109.557 -179.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.29 170.65 8.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 34.4 mtp -150.01 165.04 33.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.418 -179.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 m -146.9 152.22 38.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.94 96.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.561 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.45 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -146.38 24.23 1.27 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.456 -0.778 . . . . 0.0 109.393 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.4 m -119.59 -178.29 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.39 117.49 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.665 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 13.9 t -98.41 119.4 37.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.0 m -115.5 149.79 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 110.075 -179.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -152.07 118.27 5.57 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.52 138.38 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.96 . . . . 0.0 108.446 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.4 m-85 -126.88 124.48 39.67 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.019 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.35 139.94 26.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -49.2 125.67 11.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.228 -0.92 . . . . 0.0 111.214 -178.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.628 179.573 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.503 2.03 0 N-CA-C 110.368 -0.666 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -165.87 124.76 1.61 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.736 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.43 ' CG ' HD22 ' A' ' 113' ' ' LEU . 5.0 m-85 -99.18 -8.87 24.48 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.744 -0.598 . . . . 0.0 109.478 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.6 p -68.73 118.05 11.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.225 -0.922 . . . . 0.0 111.869 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.4 -174.41 38.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.2 m120 -95.45 172.24 8.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.0 m95 -151.72 124.66 8.59 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.964 -1.094 . . . . 0.0 112.54 -176.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -116.8 117.77 30.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 13.9 tt -61.73 151.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.914 0.864 . . . . 0.0 111.082 -178.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.28 -31.37 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -141.72 172.1 13.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -179.7 145.68 0.24 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.456 -0.777 . . . . 0.0 109.443 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -142.19 163.11 33.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.0 109.992 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.2 m-20 62.87 32.8 15.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.607 -0.683 . . . . 0.0 109.754 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 33' ' ' VAL . 1.0 OUTLIER -74.88 -64.11 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.139 -179.728 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 tt0 -57.22 -35.87 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.815 . . . . 0.0 110.919 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.7 68.79 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.179 -178.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.2 tp -77.49 -22.28 51.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 15' ' ' PHE . 6.3 mt -89.95 -15.97 30.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.301 -0.875 . . . . 0.0 109.14 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -87.58 -31.4 19.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -74.59 -39.03 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -69.2 -45.8 69.02 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.736 0.779 . . . . 0.0 109.492 179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.88 -161.63 27.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -146.29 -35.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.891 -0.77 . . . . 0.0 110.463 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -62.21 -149.72 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 109.372 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.98 -47.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.7 -1.25 . . . . 0.0 109.323 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 ttt -71.27 -26.89 63.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.73 -18.8 34.57 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.74 -0.6 . . . . 0.0 111.054 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -96.19 -47.9 5.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.754 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -21.32 65.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.662 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.21 -29.09 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -0.904 . . . . 0.0 108.728 179.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 15' ' ' PHE . 14.4 t -76.56 -37.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -31.73 45.98 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.49 -39.18 91.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.46 -69.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 p 48.33 50.79 16.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.467 0.651 . . . . 0.0 109.662 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 64.63 72.3 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.06 159.32 47.98 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 122.059 1.84 . . . . 0.0 110.714 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.88 174.34 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.561 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.402 HG21 ' CG2' ' A' ' 54' ' ' THR . 53.7 t -155.58 164.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -151.23 110.53 3.95 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mp -98.62 140.14 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.753 0.787 . . . . 0.0 110.376 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -118.18 111.09 18.38 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.478 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.25 120.62 38.98 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.068 -1.02 . . . . 0.0 111.091 -177.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.03 54.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.89 -127.55 8.89 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.211 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.36 -0.85 24.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.403 -1.057 . . . . 0.0 110.079 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 m -97.02 138.74 34.09 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.753 -1.217 . . . . 0.0 108.489 -179.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.1 m-85 -133.98 118.02 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 0.0 109.446 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.98 147.97 26.27 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.337 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.8 mt -144.57 103.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.884 -1.135 . . . . 0.0 111.585 -177.488 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 113.02 25.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 ' CG2' HG21 ' A' ' 41' ' ' VAL . 57.1 m -104.44 141.83 35.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.96 144.33 41.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.323 -0.86 . . . . 0.0 110.059 -179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.8 -65.95 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.934 0.873 . . . . 0.0 109.291 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t 178.92 -41.76 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.89 -11.28 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -124.62 164.64 19.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.277 -0.889 . . . . 0.0 108.939 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m -162.44 95.97 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.599 -0.688 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.59 164.97 23.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.787 . . . . 0.0 109.585 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -165.41 119.41 1.23 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 pt -123.44 168.61 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 109.341 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.26 129.23 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.186 -0.946 . . . . 0.0 108.937 179.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.484 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 45.3 p90 -162.03 -172.44 3.25 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.394 -179.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -129.56 153.33 48.15 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.64 90.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.121 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.41 -24.68 1.09 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.795 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.88 156.89 33.72 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.266 -1.137 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.3 167.47 14.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.705 -0.622 . . . . 0.0 109.489 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.484 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.41 175.81 11.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.698 -0.626 . . . . 0.0 109.49 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.39 145.81 29.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -162.26 -175.81 4.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.69 -0.631 . . . . 0.0 109.375 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -100.19 158.3 15.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 t -97.96 -144.34 0.31 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.396 -0.815 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -109.93 -24.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.86 -1.15 . . . . 0.0 110.841 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.5 -40.74 17.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.75 45.41 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -135.4 154.66 78.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.731 -0.864 . . . . 0.0 108.971 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.89 144.29 18.98 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.703 1.602 . . . . 0.0 110.703 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 p -160.86 141.81 11.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.718 -0.614 . . . . 0.0 109.549 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.05 116.75 25.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.48 166.45 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 -178.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 tp -146.25 154.51 41.81 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 65' ' ' PHE . 25.4 t -146.24 131.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.319 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -125.57 160.55 29.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.427 ' CE2' HG23 ' A' ' 67' ' ' VAL . 85.8 m95 -83.65 171.76 12.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.193 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -134.87 -46.16 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -131.9 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.66 -24.58 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 109.745 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -143.65 26.45 1.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 110.788 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -131.44 110.48 11.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.902 -1.124 . . . . 0.0 108.085 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.424 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 1.1 ptp -116.13 148.29 40.46 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.297 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.88 170.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.419 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 49.9 t -146.36 142.46 28.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -109.77 163.47 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -160.36 135.34 7.79 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.528 -178.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -143.1 148.94 37.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.59 166.37 2.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.052 -1.03 . . . . 0.0 110.94 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.5 mt -98.45 -5.99 31.33 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -150.91 133.87 15.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.72 -161.21 36.26 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.95 140.79 0.44 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.43 -1.041 . . . . 0.0 109.874 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.04 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.25 -176.71 2.93 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.712 1.608 . . . . 0.0 109.536 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -129.94 137.65 50.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.95 145.04 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.118 0.961 . . . . 0.0 110.608 -179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -163.13 143.44 9.14 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.3 p-90 -144.05 173.47 11.7 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 p -139.51 170.33 16.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.6 ptp -154.56 137.1 15.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -131.11 151.37 51.51 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.371 -0.831 . . . . 0.0 109.468 -179.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.7 142.09 46.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -90.63 161.47 15.39 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.36 -22.1 62.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.653 . . . . 0.0 110.182 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.9 -28.69 25.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.07 -9.24 7.51 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -57.02 172.99 0.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.079 -1.248 . . . . 0.0 109.455 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.499 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.4 tt -146.1 112.47 5.85 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.923 -178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -105.06 158.43 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.41 134.02 26.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -178.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.38 166.91 10.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 75.2 mmm -141.27 165.86 26.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 108.992 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -151.72 149.78 29.47 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.446 0.641 . . . . 0.0 109.338 178.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -156.77 94.58 1.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.9 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -147.67 24.14 1.1 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.533 -0.73 . . . . 0.0 109.137 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.38 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' MET . 2.3 t -157.68 119.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 1.8 t -99.44 114.15 26.93 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.067 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.0 m -104.08 149.51 25.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.16 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -153.21 120.13 5.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.6 137.07 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.0 m-85 -126.0 125.36 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.082 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.54 137.08 40.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.426 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.48 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.2 127.98 15.72 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.011 0.91 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 6.8 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.725 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.983 0 N-CA-C 110.396 -0.655 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -168.11 124.89 1.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.525 -0.734 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 113' ' ' LEU . 5.0 m-85 -99.01 -13.47 19.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -63.21 117.67 6.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.359 -0.838 . . . . 0.0 112.033 -177.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.57 -175.06 38.17 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.0 m120 -95.5 172.2 8.22 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.592 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.9 m95 -150.7 120.4 7.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.753 -176.404 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -109.08 117.15 33.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 7.2 tt -60.4 154.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.921 0.867 . . . . 0.0 111.072 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.79 -32.3 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.207 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -149.49 169.25 21.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.108 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.7 p -177.46 139.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.528 -0.733 . . . . 0.0 109.301 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.66 174.83 10.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.622 -0.674 . . . . 0.0 109.868 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 69.4 m-20 59.17 25.43 13.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.066 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' CE1' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -64.8 -64.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 108.718 179.582 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 pt-20 -56.78 -28.06 60.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 0.0 109.509 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -65.14 -39.88 93.64 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.052 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -80.91 -14.33 58.09 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.748 -0.595 . . . . 0.0 109.821 179.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 15' ' ' PHE . 1.3 mt -91.41 -20.16 22.09 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.063 -1.023 . . . . 0.0 109.173 178.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mmmt -83.65 -28.62 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.172 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -78.81 -41.48 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.456 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.6 mp -66.18 -53.54 36.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.198 0.999 . . . . 0.0 108.908 179.323 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.64 -145.5 15.87 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 m -155.35 -39.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.914 -0.757 . . . . 0.0 110.234 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -57.93 -171.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.43 -43.44 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.593 -0.692 . . . . 0.0 110.244 -179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 6.7 ttt -68.23 -28.15 66.98 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.77 -52.04 67.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.758 -0.589 . . . . 0.0 110.553 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' NE ' ' CD ' ' A' ' 20' ' ' LYS . 1.5 mpp_? -60.35 -39.51 87.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.506 -0.746 . . . . 0.0 110.262 -178.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -60.33 -29.24 68.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 110.667 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.8 mt -77.54 -27.76 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.115 179.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -82.21 -22.54 35.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 t -81.01 -42.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.22 81.79 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.34 -49.79 75.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 15' ' ' PHE . . . -84.49 48.63 1.54 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.783 -0.573 . . . . 0.0 110.6 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -63.33 -33.1 74.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.777 -1.202 . . . . 0.0 108.55 179.441 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 72.12 2.01 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.01 141.05 29.25 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.909 1.739 . . . . 0.0 111.085 -178.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.96 177.07 5.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.879 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 42' ' ' GLU . 50.4 t -155.74 165.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 42.9 tt0 -151.62 110.18 3.8 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.428 HD13 ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -97.93 138.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.849 0.833 . . . . 0.0 110.124 -178.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 12.7 mttt -116.56 108.93 16.58 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.1 tt0 -98.56 114.72 27.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -178.483 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -120.45 60.64 0.88 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.71 -127.93 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.02 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -78.56 0.74 25.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -1.085 . . . . 0.0 110.014 178.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -97.05 142.11 29.39 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.713 -1.242 . . . . 0.0 108.778 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 45' ' ' GLN . 96.9 m-85 -138.45 120.1 15.13 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.808 0.813 . . . . 0.0 109.288 179.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.424 ' CG ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 t80 -102.9 139.91 37.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.447 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG12 ' CG1' ' A' ' 63' ' ' ILE . 1.3 mm -123.34 116.97 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.022 -1.048 . . . . 0.0 109.292 -179.518 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -115.08 101.08 8.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.523 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 m -100.0 144.89 28.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 109.056 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.16 125.94 14.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.429 -0.794 . . . . 0.0 110.028 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.8 p -98.55 -121.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.551 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.9 p -108.77 -36.85 6.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.526 -1.359 . . . . 0.0 108.326 179.397 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 t -125.11 -5.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.916 -0.49 . . . . 0.0 110.692 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -115.84 165.38 13.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 0.0 110.118 -179.177 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 m -163.51 105.3 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.654 -0.654 . . . . 0.0 109.333 179.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -95.88 156.14 16.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.397 -0.815 . . . . 0.0 109.322 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -151.03 137.58 18.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.594 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' CG1' HG12 ' A' ' 52' ' ' ILE . 24.4 pt -142.85 169.5 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.557 -0.715 . . . . 0.0 109.519 179.39 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -162.6 135.95 6.01 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.46 -0.775 . . . . 0.0 108.945 179.325 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' CB ' ' CE1' ' A' ' 71' ' ' PHE . 52.5 p90 -161.85 -173.45 3.71 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.93 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 152.87 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.722 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 92.2 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -178.881 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.91 -29.8 1.25 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.841 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -116.33 155.84 27.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.308 -1.113 . . . . 0.0 110.26 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.72 167.35 15.35 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.1 p90 -162.84 174.74 12.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.894 -178.514 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -104.38 144.89 31.03 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.1 -177.27 5.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.42 156.21 17.14 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.011 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 t -93.53 -142.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.366 -179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.64 -23.23 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.751 -1.218 . . . . 0.0 110.875 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.38 -40.86 14.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.397 -179.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.35 44.53 0.1 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -130.72 152.11 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.676 -0.896 . . . . 0.0 109.146 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.09 142.24 19.3 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.643 1.562 . . . . 0.0 110.413 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.0 p -160.91 141.47 11.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.672 -0.643 . . . . 0.0 109.782 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.56 114.05 26.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.5 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -101.78 177.22 4.97 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.88 -178.756 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.3 tp -151.83 152.92 33.26 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 65' ' ' PHE . 9.1 t -140.36 131.99 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.843 -177.916 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -126.83 159.89 32.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.433 ' CH2' ' HE2' ' A' ' 93' ' ' MET . 86.5 m95 -83.8 170.13 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.025 -179.602 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -132.99 -45.7 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -133.19 -153.94 0.58 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -77.6 -24.87 49.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 109.792 179.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -143.03 26.74 1.66 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -131.21 107.96 9.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.943 -1.098 . . . . 0.0 108.113 179.59 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.436 ' HE2' ' CE1' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -115.61 147.29 40.95 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.501 -0.749 . . . . 0.0 110.175 -179.141 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 t -102.55 172.16 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.572 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.0 t -149.38 130.5 14.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.789 -179.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -101.35 163.62 12.18 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -160.18 143.25 13.65 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.962 -178.222 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -147.37 150.74 35.28 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.83 167.1 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.861 -179.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.5 -7.61 31.08 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 134.26 18.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.8 -158.39 44.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.414 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -176.35 141.37 0.41 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.501 -1.0 . . . . 0.0 109.808 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.65 -86.23 0.05 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.26 -176.87 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.841 1.694 . . . . 0.0 109.911 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -132.46 135.04 45.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.56 145.49 47.92 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.068 0.937 . . . . 0.0 110.774 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 p -163.14 134.27 4.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -135.6 169.29 17.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.086 -1.009 . . . . 0.0 110.202 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -134.95 171.4 14.46 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.429 0.633 . . . . 0.0 109.791 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.1 ptp -154.46 130.82 10.47 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 154.04 39.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.246 -178.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.47 141.71 48.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.032 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.5 p -93.77 160.55 14.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.682 -179.477 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -60.74 -21.48 63.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.104 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.22 -29.33 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.16 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.36 -9.18 7.39 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 170.32 0.4 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.256 . . . . 0.0 108.944 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 7.6 tt -146.75 112.54 5.69 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.228 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.9 tt -104.45 160.3 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.69 132.63 27.67 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.359 -0.838 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.75 170.8 7.99 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.362 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 27.9 mtp -148.4 166.0 29.42 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.353 -179.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 5.7 m -150.11 151.96 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.44 0.638 . . . . 0.0 109.369 179.212 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -158.85 96.08 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.501 179.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.13 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -147.37 24.03 1.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.495 -0.753 . . . . 0.0 109.22 178.516 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.7 m -117.87 -179.07 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' THR . 2.3 t -157.81 118.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.628 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 2.0 t -97.36 121.32 39.13 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -116.72 148.17 41.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.007 0.908 . . . . 0.0 110.283 -178.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -153.1 121.82 6.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.95 139.19 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.087 -1.008 . . . . 0.0 108.697 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 21.7 m-85 -127.65 133.38 49.65 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.232 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.15 138.32 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.24 128.25 16.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.204 -0.935 . . . . 0.0 111.644 -178.482 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.656 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.42 0.628 . . . . 1.29 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.653 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -99.73 -8.15 24.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.915 -0.772 . . . . 0.18 108.915 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 23.0 t -66.62 116.39 7.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.405 -0.81 . . . . 1.22 111.352 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -169.89 37.65 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.609 -1.796 . . . . 0.14 108.609 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 6.4 m120 -96.62 169.88 9.58 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.537 -1.653 . . . . 0.58 106.537 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.927 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.84 119.78 6.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.474 -1.29 . . . . 0.21 112.385 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -114.12 113.72 25.09 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.829 -1.175 . . . . 1.75 107.829 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.3 tt -56.52 154.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.847 0.832 . . . . 0.69 110.907 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.99 -31.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.979 -0.748 . . . . 0.46 108.979 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HB2' HD12 ' A' ' 10' ' ' ILE . 5.5 mtt180 -139.88 168.1 20.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 2.86 108.753 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 9' ' ' ILE . 4.2 t 177.74 152.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.04 109.689 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.54 171.01 16.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.579 -0.701 . . . . 1.25 109.456 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.0 m120 61.34 32.11 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 1.78 109.865 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.18 -62.65 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.42 110.084 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -59.2 -36.51 75.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.268 -0.895 . . . . 2.28 110.354 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 8.1 pt-20 -68.02 -28.62 67.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.274 -0.97 . . . . 2.08 109.795 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD22 ' HB2' ' A' ' 130' ' ' CYS . 43.4 tp -79.41 -21.34 45.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.191 -0.943 . . . . 0.6 108.998 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 32' ' ' ALA . 3.9 mt -89.5 -18.45 26.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.161 -0.962 . . . . 0.72 108.596 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -84.13 -30.3 26.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.738 -1.208 . . . . 1.11 107.738 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.7 p -77.48 -41.02 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.875 -1.157 . . . . 0.45 107.875 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.4 mp -65.51 -50.62 64.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.608 -0.886 . . . . 0.57 108.608 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.704 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.72 -142.25 12.46 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.136 -1.186 . . . . 0.72 110.136 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -164.67 -34.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.655 -0.909 . . . . 1.53 109.415 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.0 t30 -61.71 -159.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.806 . . . . 1.54 109.497 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.6 HG12 HH12 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -120.97 -48.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.24 109.397 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.9 ttt -68.96 -24.46 64.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.54 -0.911 . . . . 2.21 108.54 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -60.8 -27.75 68.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.763 -0.586 . . . . 1.4 110.219 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -87.38 -45.19 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 2.44 109.901 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -61.43 -25.09 66.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 2.77 110.526 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.9 mt -76.5 -29.66 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.989 . . . . 1.45 108.85 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.22 -26.04 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.561 -0.712 . . . . 0.42 109.166 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.1 t -77.15 -36.15 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.768 -1.197 . . . . 0.44 107.768 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -33.57 48.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.13 -1.063 . . . . 0.68 108.13 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.31 94.91 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.912 -0.773 . . . . 0.8 108.912 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.84 -69.07 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.741 -0.837 . . . . 1.69 108.741 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 44.18 46.78 7.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.608 -0.683 . . . . 1.6 109.348 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 67.34 73.46 0.36 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.436 -0.95 . . . . 3.08 108.436 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.3 Cg_endo -74.58 157.13 44.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.596 2.198 . . . . 0.58 110.437 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -99.67 173.15 6.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.447 -0.783 . . . . 0.24 109.488 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 54' ' ' THR . 13.3 t -156.15 160.74 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.89 -0.781 . . . . 0.28 108.89 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 35.3 tt0 -146.68 113.11 5.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 1.47 108.746 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.9 mt -99.94 136.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.395 -0.816 . . . . 0.31 110.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.23 111.06 20.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.297 -1.371 . . . . 1.23 107.297 178.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.5 tt0 -98.52 122.33 41.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.985 -1.072 . . . . 1.61 110.781 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -125.47 46.72 2.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.565 -0.902 . . . . 1.97 108.565 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.47 -131.33 10.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.749 -1.74 . . . . 0.38 108.749 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.26 -0.31 19.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -1.179 . . . . 1.13 109.555 179.047 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.3 m -98.81 131.53 44.86 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.897 -1.127 . . . . 0.25 108.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.591 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.3 m-85 -128.25 118.62 23.62 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.22 110.049 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.0 t80 -102.24 144.71 30.42 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.082 -1.451 . . . . 0.31 107.082 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.851 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -141.79 107.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.684 -1.26 . . . . 0.56 110.562 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 1.6 tttt -104.72 115.46 30.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 1.8 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' CG2' ' A' ' 41' ' ' VAL . 44.4 m -104.2 144.79 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.38 109.1 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -140.65 134.57 30.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 0.54 109.615 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.93 0.871 . . . . 1.05 109.329 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 55' ' ' SER . 20.4 m . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.301 -0.629 . . . . 0.63 109.301 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -101.71 172.69 6.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.77 109.504 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 3.7 pt-20 -171.87 125.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 1.85 109.332 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.851 HD11 HD12 ' A' ' 52' ' ' ILE . 38.0 pt -117.57 170.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.35 109.289 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.6 p-10 -161.25 130.53 4.68 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.942 . . . . 1.17 108.939 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -161.54 -172.93 3.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.16 111.484 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 11.6 ptpt -128.91 152.74 48.21 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.027 -1.101 . . . . 1.84 108.027 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.2 92.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 0.18 109.734 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.67 -26.97 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.519 -1.324 . . . . 0.27 110.579 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -124.65 159.51 30.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.246 . . . . 2.38 109.995 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG2' HD22 ' A' ' 84' ' ' LEU . 27.2 mt-10 -87.51 167.96 13.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 1.65 109.207 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 18.3 p90 -161.38 178.36 9.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.419 -0.801 . . . . 0.2 109.713 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -107.56 143.31 36.17 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.374 -0.973 . . . . 1.14 108.374 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.698 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.1 pt-20 -161.99 -176.21 5.07 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.462 -0.774 . . . . 1.59 109.46 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -99.55 153.06 19.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.817 -0.808 . . . . 1.92 108.817 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.71 HG23 ' H ' ' A' ' 77' ' ' ASP . 9.2 t -90.18 -144.99 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 1.04 109.529 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 21.5 t -107.96 -19.21 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.78 -1.2 . . . . 2.02 110.56 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.71 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.6 -44.21 10.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.063 -1.023 . . . . 2.03 109.305 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.88 39.65 0.09 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.425 . . . . 0.45 109.536 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 1.5 mmm180 -129.41 152.91 80.36 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.469 -1.019 . . . . 2.66 109.052 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD2' ' HD2' ' A' ' 79' ' ' ARG . 35.9 Cg_endo -78.41 139.71 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.164 1.909 . . . . 0.29 110.537 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 13.1 p -160.58 144.06 13.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.24 109.559 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -86.4 117.28 25.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.293 -1.003 . . . . 1.5 108.293 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 97' ' ' GLN . 1.9 t -99.88 165.63 11.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -0.787 . . . . 0.75 109.971 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.0 tp -144.94 155.63 43.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.473 -1.306 . . . . 0.53 107.473 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.8 t -148.41 128.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.37 -1.332 . . . . 0.2 111.855 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.66 158.48 28.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.274 -1.38 . . . . 1.91 107.274 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.54 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.6 m95 -81.36 166.53 20.36 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.959 -1.088 . . . . 0.15 110.178 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.7 tp10 -130.99 -42.2 1.11 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.845 -1.169 . . . . 1.11 107.845 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -136.71 -153.31 0.49 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.75 -1.204 . . . . 0.16 107.75 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.94 -18.94 49.17 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.118 -0.989 . . . . 2.15 109.594 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -147.93 26.84 0.99 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.091 -1.005 . . . . 0.25 110.355 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 57.5 tttt -134.38 109.33 8.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.73 -1.231 . . . . 1.34 108.617 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.591 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -115.17 148.02 39.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.404 -0.81 . . . . 0.67 110.073 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.6 t -100.32 172.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.2 108.774 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 53.6 t -147.99 140.12 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.018 . . . . 0.21 111.078 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -107.57 164.49 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.867 -1.531 . . . . 2.11 106.867 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 4.5 tt0 -160.2 135.84 8.29 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.412 -1.315 . . . . 0.78 111.554 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 56.0 pttt -145.16 144.28 30.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.134 -1.061 . . . . 2.45 108.134 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 168.14 1.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.898 -1.126 . . . . 0.87 110.808 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 82' ' ' LYS . 67.3 mt -102.78 -3.83 25.83 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.931 -1.137 . . . . 0.98 107.931 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -153.88 148.2 25.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.942 -0.762 . . . . 2.85 108.942 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.16 -162.71 22.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.079 -1.609 . . . . 1.94 109.079 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.94 141.73 0.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.266 -1.138 . . . . 5.26 109.645 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.45 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.856 -1.697 . . . . 1.32 108.856 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.17 -176.15 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.448 2.099 . . . . 0.84 110.056 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -137.18 136.8 38.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.232 -1.025 . . . . 1.28 108.232 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.91 145.2 46.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 0.36 110.753 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.8 m -162.73 136.59 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.819 -1.178 . . . . 0.85 107.819 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.441 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 53.4 p-90 -142.96 176.7 8.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.24 110.323 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.43 171.83 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.462 0.649 . . . . 0.23 109.599 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.539 ' HE2' ' HB2' ' A' ' 111' ' ' MET . 13.3 ptm -153.97 125.83 7.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.584 -0.895 . . . . 1.93 108.584 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -120.53 154.12 35.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 1.97 110.232 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.93 144.78 41.91 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.839 -1.171 . . . . 0.17 107.839 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.403 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 41.4 p -93.26 161.55 14.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.854 -1.154 . . . . 0.24 109.715 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -62.14 -19.49 63.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 2.15 109.794 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.21 -26.46 23.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.86 109.184 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.1 -9.68 8.4 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.847 -1.301 . . . . 0.18 109.847 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.426 ' O ' HD13 ' A' ' 113' ' ' LEU . 62.0 mt-10 -55.88 172.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 1.48 109.03 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.764 HD13 HD13 ' A' ' 43' ' ' ILE . 7.9 tt -144.84 113.21 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.15 110.18 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.74 154.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.914 -1.143 . . . . 0.68 107.914 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -137.91 131.3 30.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.023 -1.048 . . . . 1.38 109.893 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -109.02 162.32 14.34 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.835 -1.172 . . . . 0.27 107.835 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 13.9 mtp -142.4 159.09 42.92 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.164 -0.96 . . . . 0.81 109.774 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 129' ' ' VAL . 3.4 m -143.87 152.56 41.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.15 -0.685 . . . . 0.31 109.15 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 128' ' ' VAL . . . -155.94 91.14 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.31 109.586 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER 78.72 -76.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.924 -0.769 . . . . 1.21 108.924 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.25 22.67 1.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.751 -0.833 . . . . 2.14 108.751 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 125' ' ' ALA . 16.6 m -117.36 179.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.85 117.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.132 -1.027 . . . . 0.29 110.077 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.915 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.14 107.74 20.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 0.4 109.321 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 122' ' ' THR . 93.7 m -99.71 145.98 27.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.37 109.507 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -151.02 122.69 8.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.503 -0.925 . . . . 1.81 108.503 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.54 135.52 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.911 -1.118 . . . . 0.24 108.767 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.477 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.1 m-85 -124.37 124.35 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.508 -0.877 . . . . 0.4 109.916 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.575 -1.269 . . . . 0.18 107.575 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -44.52 125.88 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.14 110.565 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' ARG . 9.1 tt0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.101 -0.952 . . . . 2.3 111.057 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.425 0.631 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.4 m-85 -99.4 -11.46 21.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -66.12 117.08 7.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 111.958 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.11 -174.09 38.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 24.7 m-20 -95.02 171.73 8.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.868 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.3 m95 -151.22 128.79 11.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.513 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -120.41 115.82 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.801 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.1 tt -58.51 153.56 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.918 0.866 . . . . 0.0 111.2 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.48 -32.89 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -140.77 168.69 19.19 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.801 ' HB2' HD11 ' A' ' 9' ' ' ILE . 13.4 t 177.95 147.09 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -144.39 168.79 19.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.433 0.635 . . . . 0.0 109.951 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 12.7 m120 61.66 31.38 18.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.672 . . . . 0.0 109.66 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.969 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.11 -64.72 0.99 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.528 -0.732 . . . . 0.0 110.111 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.709 ' HG2' HG21 ' A' ' 33' ' ' VAL . 46.8 mt-10 -56.51 -34.83 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 110.959 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -69.81 -29.97 67.39 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.469 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 130' ' ' CYS . 22.3 tp -77.46 -19.8 55.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 109.908 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -89.99 -16.85 28.99 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.97 . . . . 0.0 109.291 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mtmm -86.19 -33.69 20.72 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -72.07 -39.76 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -68.56 -46.26 69.92 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.832 0.825 . . . . 0.0 109.266 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.12 -163.44 27.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 25' ' ' ASN . 27.1 m -140.21 -40.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.894 -0.768 . . . . 0.0 109.75 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 t-20 -59.74 -165.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.483 -0.761 . . . . 0.0 109.482 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.484 HG13 ' NH1' ' A' ' 29' ' ' ARG . 1.7 t -115.45 -48.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.29 -28.17 67.79 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.9 mm? -56.98 -20.31 23.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -91.78 -50.48 5.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.787 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -62.35 -19.84 63.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.7 . . . . 0.0 111.076 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.58 -29.86 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.195 -0.941 . . . . 0.0 108.752 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.66 -25.1 33.38 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.9 t -76.89 -37.08 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.61 49.04 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.03 93.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.36 -69.93 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m 47.79 49.84 16.17 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.498 0.666 . . . . 0.0 109.626 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mttp 66.37 72.49 0.43 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -72.9 166.4 30.11 Favored 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.974 1.782 . . . . 0.0 110.811 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.53 173.02 6.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.65 -0.657 . . . . 0.0 109.536 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 54' ' ' THR . 53.5 t -154.55 165.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.4 tt0 -151.82 110.92 3.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.868 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.6 mt -97.83 138.43 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.806 0.812 . . . . 0.0 110.084 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttt -116.95 104.96 11.81 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.2 tt0 -97.34 125.37 41.9 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.33 54.15 1.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -126.18 8.35 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.619 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -75.5 -1.36 23.86 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.252 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -97.14 136.49 37.6 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.741 -1.224 . . . . 0.0 108.338 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -131.16 116.48 17.76 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.857 0.837 . . . . 0.0 109.297 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.8 t80 -102.29 148.95 24.83 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.882 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -146.31 99.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.996 -1.065 . . . . 0.0 110.426 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 62' ' ' GLU . 1.7 tttp -99.98 114.23 27.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 109.883 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 41' ' ' VAL . 31.6 m -101.96 144.69 30.26 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.4 OUTLIER -142.57 131.65 23.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.408 -0.807 . . . . 0.0 109.777 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.665 . . . . 0.0 109.446 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 55' ' ' SER . 15.1 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -102.07 172.85 6.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.767 . . . . 0.0 109.329 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . 2.6 pt-20 -171.94 119.58 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.69 . . . . 0.0 109.736 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.882 HD11 HD12 ' A' ' 52' ' ' ILE . 37.7 pt -110.43 170.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.528 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.3 p30 -162.35 133.87 5.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.292 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.1 p90 -161.98 -172.37 3.23 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.637 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -129.19 153.01 48.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.39 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.139 -0.976 . . . . 0.0 109.825 -178.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.12 -27.36 1.72 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.013 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -119.39 156.19 30.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.676 ' HG2' HD13 ' A' ' 84' ' ' LEU . 14.1 mt-10 -86.28 167.27 14.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.7 p90 -162.72 174.46 12.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.698 . . . . 0.0 109.634 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.94 147.5 26.85 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.671 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.4 pt-20 -161.74 179.49 8.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.679 -0.638 . . . . 0.0 109.324 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.72 128.1 55.05 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.265 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -63.86 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' N ' HG23 ' A' ' 75' ' ' THR . 12.3 p -103.1 -16.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 111.322 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.7 ' H ' HG23 ' A' ' 75' ' ' THR . 3.9 t70 -86.66 -40.85 14.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.28 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.51 43.49 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 75' ' ' THR . 6.9 mmm180 -130.52 148.89 71.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.661 -0.905 . . . . 0.0 108.937 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 140.51 17.15 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.454 1.436 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.6 p -160.86 141.69 11.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.682 -0.636 . . . . 0.0 109.633 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.828 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -90.45 114.27 26.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.21 176.21 5.33 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.947 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -152.93 153.32 32.76 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.6 t -140.75 127.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.989 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.07 155.3 34.7 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.687 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.6 m95 -78.01 173.16 12.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.058 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.3 tp10 -135.11 -46.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -129.99 -152.67 0.52 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.25 -25.71 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -143.78 25.27 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 110.981 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 34.7 tttm -130.08 110.93 12.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.893 -1.13 . . . . 0.0 108.065 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.446 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.41 150.17 38.22 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.661 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -99.52 172.15 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.492 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.2 t -149.15 129.76 14.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.88 . . . . 0.0 110.752 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -101.04 162.37 12.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 9.0 tt0 -160.44 139.76 10.78 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.878 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.05 149.74 37.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.69 165.59 3.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 111.085 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.828 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.3 mt -100.49 -2.97 31.77 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -153.36 134.31 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 108.807 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.87 -160.7 41.46 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -176.26 141.41 0.43 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.467 -1.019 . . . . 0.0 109.841 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.0 -85.39 0.05 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.53 -177.14 3.05 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.82 1.68 . . . . 0.0 109.857 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -134.44 138.51 44.83 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.03 145.25 48.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.008 0.909 . . . . 0.0 110.69 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.5 m -163.39 132.53 4.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -135.96 170.45 15.98 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.037 -1.039 . . . . 0.0 110.422 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 HG13 ' A' ' 94' ' ' VAL . 14.1 p -134.54 173.12 12.0 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.532 0.682 . . . . 0.0 109.722 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.7 ptp -158.6 139.57 12.97 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.0 pt-20 -140.64 144.87 35.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.366 -0.834 . . . . 0.0 109.1 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -105.02 144.79 31.34 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.8 p -91.75 160.38 15.36 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.15 -19.87 55.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.62 -0.675 . . . . 0.0 110.337 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.11 -28.56 22.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.29 -8.79 7.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 113' ' ' LEU . 8.1 mt-10 -57.94 171.3 0.53 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.046 -1.267 . . . . 0.0 108.95 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD13 HD13 ' A' ' 43' ' ' ILE . 7.5 tt -146.01 110.87 5.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.883 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.407 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -107.34 148.47 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -132.87 138.56 47.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.378 -0.826 . . . . 0.0 109.59 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.44 169.04 9.46 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.2 mtp -146.96 165.25 30.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.197 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -147.63 151.11 35.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.715 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.67 92.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.559 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.78 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -146.57 24.11 1.25 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.6 m -117.74 -179.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.69 118.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.722 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.911 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.53 113.67 26.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 122' ' ' THR . 85.8 m -109.34 147.94 31.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.737 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -152.59 117.59 5.15 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.9 t -80.18 139.17 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 108.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.7 m-85 -127.68 123.51 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.315 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.03 138.45 31.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.495 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.15 128.56 16.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.181 -0.95 . . . . 0.0 111.543 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 4.1 tt0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.322 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.517 0.675 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -98.69 1.38 46.11 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 120.12 18.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 111.925 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -174.19 38.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 46.8 m-20 -95.58 172.03 8.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.543 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -151.49 125.23 9.05 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.573 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -117.54 114.04 22.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' A' ' 39' ' ' PRO . 4.6 tt -52.63 147.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.661 0.744 . . . . 0.0 111.13 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.67 -25.11 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 122.003 -0.436 . . . . 0.0 110.24 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -152.57 177.43 10.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.164 -0.96 . . . . 0.0 110.469 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -179.47 166.05 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.79 24.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 111.708 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 61.1 m-20 -161.14 27.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.607 -0.683 . . . . 0.0 110.197 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.815 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -65.44 -66.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 108.738 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 14.9 pt-20 -56.52 -28.64 60.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.35 -38.9 91.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.677 -0.639 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 130' ' ' CYS . 36.7 tp -79.4 -16.13 56.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.773 -0.58 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.83 -20.29 22.47 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.954 -1.091 . . . . 0.0 109.18 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.7 mmmt -83.03 -28.17 29.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -80.42 -40.64 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 122.127 0.965 . . . . 0.0 108.477 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.3 mp -67.76 -50.02 59.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.919 0.866 . . . . 0.0 109.87 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.77 -154.21 25.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.79 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.0 t -150.7 -39.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 122.029 -0.689 . . . . 0.0 110.029 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.8 -160.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.38 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.09 -45.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.892 . . . . 0.0 109.775 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.423 ' O ' HD12 ' A' ' 31' ' ' ILE . 4.1 ttt -66.12 -30.9 71.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.857 -0.527 . . . . 0.0 110.213 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 33' ' ' VAL . 43.4 mtt180 -84.87 -47.48 10.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.499 -0.751 . . . . 0.0 109.968 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -61.61 -21.86 64.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.691 -0.63 . . . . 0.0 111.06 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 27' ' ' MET . 29.5 mt -81.26 -28.8 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.22 -25.87 36.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.665 -0.647 . . . . 0.0 109.354 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.33 -44.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.21 85.54 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.41 -56.23 23.9 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.775 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.9 57.96 4.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.757 -0.589 . . . . 0.0 110.287 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 t -64.21 -43.11 96.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.697 -1.252 . . . . 0.0 107.726 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -151.36 74.19 8.2 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.948 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.1 Cg_endo -71.5 142.11 39.83 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.846 1.697 . . . . 0.0 111.262 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -98.94 174.73 6.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 54' ' ' THR . 50.8 t -155.74 163.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -151.31 111.6 4.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HG23 ' A' ' 52' ' ' ILE . 2.6 mp -98.08 135.81 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.019 0.914 . . . . 0.0 110.442 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 4.4 mttm -109.91 93.45 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.65 125.44 41.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.31 -0.869 . . . . 0.0 110.42 -176.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -132.65 56.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.55 -132.29 10.97 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.5 p30 -71.71 -4.36 27.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.384 -1.068 . . . . 0.0 110.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 m -96.79 134.08 40.54 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.656 -1.278 . . . . 0.0 108.476 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.685 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.7 m-85 -131.15 119.06 21.36 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.687 0.756 . . . . 0.0 109.336 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 15.0 t80 -103.15 150.46 23.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.094 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -148.58 104.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.94 -1.1 . . . . 0.0 110.97 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -104.81 113.11 26.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 108.864 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 41' ' ' VAL . 41.6 m -102.49 145.5 29.49 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.459 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.9 p -142.77 119.15 10.91 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.674 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.948 HG22 ' HB3' ' A' ' 39' ' ' PRO . 82.8 p . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 55' ' ' SER . 7.1 m . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 169.17 12.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.772 . . . . 0.0 109.724 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.34 111.35 1.22 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.489 -0.757 . . . . 0.0 109.699 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 52' ' ' ILE . 42.7 pt -116.53 165.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.6 p30 -162.58 132.51 4.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.3 p90 -161.67 -172.7 3.43 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.404 1.097 . . . . 0.0 112.445 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.76 153.54 48.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.32 93.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.133 -0.98 . . . . 0.0 109.681 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.31 -22.91 1.55 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.906 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.69 155.63 37.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.22 -1.165 . . . . 0.0 110.219 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.566 ' HG2' HD13 ' A' ' 84' ' ' LEU . 32.3 mt-10 -86.64 166.41 15.38 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.17 174.57 12.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -105.55 144.22 32.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.709 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.31 -174.79 4.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -99.75 159.91 14.7 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.9 t -97.31 -142.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.5 t -111.13 -19.2 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.783 -1.198 . . . . 0.0 110.824 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t70 -90.67 -37.11 13.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.486 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.71 45.14 0.15 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 7.1 mtm-85 -133.3 153.54 80.65 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 121.691 -0.888 . . . . 0.0 109.447 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -79.0 142.04 17.05 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.767 1.645 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -161.26 143.06 11.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.657 -0.652 . . . . 0.0 109.517 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.598 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -89.46 117.33 28.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.48 166.54 11.11 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.266 0.555 . . . . 0.0 109.988 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' A' ' 70' ' ' GLU . 49.1 tp -148.77 153.02 37.56 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.695 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.8 t -143.4 136.13 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.417 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.21 157.22 41.45 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.556 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.6 m95 -81.15 172.83 13.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.019 0.914 . . . . 0.0 110.627 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -136.69 -45.98 0.6 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.9 p -131.81 -153.63 0.57 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -76.47 -26.97 55.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.801 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -143.46 28.53 1.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 48.7 tttt -130.54 110.37 11.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.989 -1.069 . . . . 0.0 108.188 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.685 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.3 ptp -117.43 147.5 42.64 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.728 0.775 . . . . 0.0 110.572 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 110' ' ' THR . 2.2 t -100.73 171.5 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.423 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.0 t -146.83 137.43 23.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' OE2' HD23 ' A' ' 84' ' ' LEU . 7.4 pt-20 -108.77 156.13 19.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -154.65 142.2 19.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.974 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -143.73 152.05 40.78 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.499 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.17 168.03 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.755 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.6 mt -99.6 -5.75 28.51 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 137.2 14.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 108.621 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.85 -163.12 37.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -175.96 140.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.43 -1.041 . . . . 0.0 109.995 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.35 -86.83 0.06 OUTLIER Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.83 -176.91 2.87 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.783 1.655 . . . . 0.0 109.643 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -131.41 139.87 49.52 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.12 144.63 48.46 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.172 0.987 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 m -162.92 131.8 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 48.9 p-90 -137.12 172.79 12.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.143 -0.973 . . . . 0.0 110.231 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.813 HG22 HG13 ' A' ' 94' ' ' VAL . 19.8 p -135.92 174.16 10.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.542 0.687 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.497 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.9 ptm -157.95 124.31 4.79 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -119.54 147.64 44.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.488 -0.758 . . . . 0.0 109.889 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.01 143.52 39.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 p -93.55 159.48 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -59.28 -21.9 60.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.96 -30.19 24.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.3 -9.82 6.56 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.9 173.91 0.13 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.084 -1.245 . . . . 0.0 109.349 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.5 tt -148.17 111.14 4.83 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.124 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.409 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.1 tt -106.82 151.47 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.94 147.08 52.44 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.423 -0.798 . . . . 0.0 109.439 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.559 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -127.73 170.36 12.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.5 mtp -150.6 167.77 26.29 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.675 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.5 m -149.31 151.31 33.94 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.82 94.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.53 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.15 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.19 23.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.808 HG21 HG11 ' A' ' 21' ' ' VAL . 24.7 m -117.23 -178.86 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.5 t -157.86 118.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.589 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.755 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -97.9 121.52 39.92 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.559 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.6 m -119.93 134.62 55.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.224 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -139.86 108.43 5.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 120' ' ' ILE . 43.5 t -72.39 140.38 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.2 m-85 -129.07 128.79 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.2 137.63 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -49.48 128.33 17.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.233 -0.917 . . . . 0.0 111.687 -178.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.4 tm-20 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.807 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.45 0.643 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.543 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -99.06 -2.13 37.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.7 p -71.82 118.74 15.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.955 . . . . 0.0 111.943 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.64 -173.62 38.04 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 27.7 m-20 -95.36 170.67 9.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -150.91 128.12 11.23 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.488 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -121.66 116.36 24.42 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 132' ' ' ARG . 9.4 tt -59.48 141.84 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.525 0.678 . . . . 0.0 110.294 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -119.52 -23.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.875 -0.516 . . . . 0.0 110.101 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -145.66 176.73 9.41 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 176.29 165.43 0.43 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -159.32 25.77 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.091 -1.006 . . . . 0.0 111.292 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.4 m-20 -160.85 29.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.665 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.49 -65.66 0.65 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 0.0 109.008 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.6 mt-10 -56.68 -27.07 58.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.81 -40.9 97.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.667 -0.645 . . . . 0.0 109.791 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.781 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.8 tp -77.75 -16.73 58.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.662 -0.649 . . . . 0.0 110.091 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.7 mt -89.43 -19.24 25.39 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.055 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.1 mmmt -85.57 -28.6 24.76 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 128' ' ' VAL . 14.9 p -79.57 -41.06 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.69 -53.13 45.29 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.018 0.913 . . . . 0.0 108.935 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.75 -146.26 17.13 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 25' ' ' ASN . 19.3 m -155.93 -43.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.0 t-20 -56.95 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.518 -0.739 . . . . 0.0 109.56 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' NH2' ' A' ' 29' ' ' ARG . 2.1 m -109.83 -44.49 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.416 -0.802 . . . . 0.0 109.899 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.1 ttm -66.3 -27.27 67.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.8 mm? -57.71 -41.9 82.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.675 -0.641 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.844 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.2 mtp180 -71.36 -42.66 68.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -62.44 -20.24 64.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.755 -0.59 . . . . 0.0 111.115 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 28' ' ' LEU . 45.4 mt -79.47 -30.04 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 108.879 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.6 32.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.7 t -79.13 -35.93 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.69 -36.17 51.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.91 79.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' A' ' 39' ' ' PRO . . . -69.42 -67.56 0.47 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 49.23 52.08 15.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 67.36 73.7 0.36 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.46 158.35 54.23 Favored 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.017 1.811 . . . . 0.0 110.795 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.51 173.13 6.45 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.743 -0.598 . . . . 0.0 109.528 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 54' ' ' THR . 48.8 t -155.0 164.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 tt0 -148.68 111.53 4.82 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -97.9 132.59 42.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.786 0.803 . . . . 0.0 110.054 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -111.78 106.49 15.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -97.47 123.97 41.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.064 -1.022 . . . . 0.0 111.176 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -123.62 55.22 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -126.03 8.15 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.97 -1.09 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -1.034 . . . . 0.0 110.143 178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.44 136.05 37.47 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.782 -1.199 . . . . 0.0 108.551 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.9 m-85 -130.96 115.66 16.8 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.6 t80 -102.29 148.17 25.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.964 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -145.17 99.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.019 -1.05 . . . . 0.0 110.389 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -99.25 113.71 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.766 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 41' ' ' VAL . 34.0 m -100.53 144.7 29.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.799 . . . . 0.0 108.964 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 136.9 32.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.46 -0.775 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.916 0.865 . . . . 0.0 109.708 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -101.84 173.87 6.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.8 . . . . 0.0 109.55 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -172.27 118.96 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.773 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 52' ' ' ILE . 40.2 pt -108.56 169.55 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.517 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.4 p30 -162.56 132.82 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.764 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.92 -172.21 3.18 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.069 0.938 . . . . 0.0 111.739 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -131.53 154.53 48.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.58 95.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.187 -0.945 . . . . 0.0 109.636 -178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.66 -21.8 0.62 Allowed Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.606 -1.283 . . . . 0.0 111.038 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -135.82 163.57 29.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -1.144 . . . . 0.0 110.714 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.1 mt-10 -86.28 169.31 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.4 p90 -162.6 174.39 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -103.14 144.78 30.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -161.89 178.65 8.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.84 151.61 21.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.4 t -88.26 -142.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.485 -0.759 . . . . 0.0 109.125 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 22.5 t -112.2 -19.77 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.741 -1.224 . . . . 0.0 110.657 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t70 -88.75 -41.31 12.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 44.25 0.1 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mtp180 -131.63 147.19 65.04 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.666 -0.902 . . . . 0.0 108.89 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD11 ' A' ' 100' ' ' LEU . 37.8 Cg_endo -79.8 142.72 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.441 1.427 . . . . 0.0 110.237 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.3 p -161.05 143.24 12.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.645 -0.66 . . . . 0.0 109.569 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -89.64 114.36 25.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.6 t -98.91 176.29 5.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.706 -0.621 . . . . 0.0 109.71 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -150.32 154.41 37.79 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.1 t -143.33 129.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.089 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.94 155.46 39.55 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.9 m95 -79.67 173.16 12.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -135.39 -46.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -130.7 -153.61 0.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.08 -25.77 52.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.08 26.85 1.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 110.892 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 78.8 tttt -132.15 109.58 10.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.0 108.078 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.46 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.6 OUTLIER -115.66 150.36 36.87 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.243 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -100.09 173.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.522 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.4 t -149.81 135.84 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.04 163.3 12.65 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -160.92 138.69 9.42 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.798 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -152.46 144.55 23.82 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.576 HD22 HH21 ' A' ' 79' ' ' ARG . 7.5 mt -58.74 164.27 2.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 110.651 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -107.87 5.6 26.58 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.412 ' N ' HD12 ' A' ' 100' ' ' LEU . 22.9 tptt -153.75 113.14 3.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.99 -163.83 45.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -176.34 140.97 0.4 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.393 -1.063 . . . . 0.0 110.066 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.67 -86.95 0.06 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.31 -176.49 2.59 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.846 1.697 . . . . 0.0 109.695 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -131.55 139.87 49.33 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 145.15 49.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.121 0.963 . . . . 0.0 110.84 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.88 137.04 6.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -142.79 175.44 9.82 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.986 -1.085 . . . . 0.0 110.56 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.643 HG22 HG13 ' A' ' 94' ' ' VAL . 13.2 p -137.91 172.67 12.59 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.551 0.691 . . . . 0.0 110.028 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.492 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 21.8 ptm -157.84 128.59 6.43 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.9 pt-20 -131.67 154.89 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.586 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.13 144.71 41.05 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -91.99 162.19 14.48 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.585 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -61.36 -21.1 63.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.22 -26.58 24.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.15 -8.13 8.57 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 48.6 mt-10 -58.7 172.94 0.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.113 -1.227 . . . . 0.0 109.234 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.727 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.92 110.36 5.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.501 -0.749 . . . . 0.0 109.618 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' A' ' 133' ' ' VAL . 14.0 tt -106.08 145.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -130.22 133.07 46.28 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.713 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.78 165.97 11.28 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.468 ' O ' HG22 ' A' ' 129' ' ' VAL . 12.1 mtp -144.14 164.52 30.46 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.383 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 m -147.4 151.4 36.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.68 95.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.17 -80.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.33 24.89 1.25 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.525 -0.734 . . . . 0.0 109.168 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -118.34 -178.93 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.94 118.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.781 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.49 112.18 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -106.32 143.61 34.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 9' ' ' ILE . 20.7 mtt180 -150.5 105.23 3.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 120' ' ' ILE . 53.7 t -69.47 133.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 30.1 m-85 -121.2 123.5 42.41 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.075 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.32 139.71 26.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.59 128.08 16.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.221 -0.925 . . . . 0.0 111.351 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.245 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.606 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.9 m-85 -99.42 -11.36 21.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -67.78 117.42 9.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 111.841 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.45 -173.46 38.73 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.9 m120 -95.45 170.84 9.08 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.45 128.12 10.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.666 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 12.4 mmtt -122.48 116.32 23.74 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 132' ' ' ARG . 10.0 tt -58.94 142.07 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.587 0.708 . . . . 0.0 110.474 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.3 -24.26 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.959 -0.463 . . . . 0.0 110.068 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -143.25 174.83 10.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.277 -0.889 . . . . 0.0 110.08 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 178.42 163.1 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.34 24.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 111.457 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 76.0 m-20 -160.59 27.37 0.15 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.981 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.1 t80 -65.16 -64.76 0.79 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 110.192 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 27.2 tt0 -55.86 -31.0 62.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.581 -0.699 . . . . 0.0 111.296 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 7.0 pt-20 -73.1 -31.51 64.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.51 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.856 HD22 ' CB ' ' A' ' 130' ' ' CYS . 27.4 tp -75.58 -19.42 59.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.828 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.02 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -90.17 -18.18 26.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 109.388 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.8 mtmt -84.6 -32.63 23.64 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 128' ' ' VAL . 14.2 p -74.61 -39.96 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -68.04 -45.59 73.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.756 0.788 . . . . 0.0 109.458 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.94 -159.97 27.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 t -144.61 -41.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.982 -0.717 . . . . 0.0 109.722 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.4 t-20 -60.64 -162.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG13 ' NH1' ' A' ' 29' ' ' ARG . 2.2 t -117.63 -49.02 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.409 ' O ' HD12 ' A' ' 31' ' ' ILE . 1.4 ttt -67.41 -27.73 67.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -58.15 -19.62 34.25 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.79 -0.569 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -92.72 -49.26 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.16 -0.962 . . . . 0.0 109.59 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -62.25 -20.25 64.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.645 -0.659 . . . . 0.0 110.793 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 27' ' ' MET . 19.6 mt -78.42 -29.64 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.16 -25.62 34.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.2 t -77.52 -36.98 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.41 -34.16 48.2 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.64 93.97 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.463 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.33 -67.87 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.67 52.41 14.96 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 67.25 73.41 0.37 Allowed Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.61 155.9 58.44 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 C-N-CA 122.055 1.837 . . . . 0.0 110.829 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . . . -102.47 172.99 6.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 HG23 ' A' ' 54' ' ' THR . 53.4 t -155.49 164.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.465 ' N ' HG12 ' A' ' 41' ' ' VAL . 48.5 tt0 -151.11 110.6 3.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.79 HG13 HG23 ' A' ' 52' ' ' ILE . 1.8 mp -98.65 141.99 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.817 0.818 . . . . 0.0 110.543 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.36 111.93 18.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.36 117.73 33.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.97 -1.081 . . . . 0.0 111.026 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.63 50.05 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -125.43 8.11 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.8 p30 -75.66 -1.82 26.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.431 -1.04 . . . . 0.0 110.052 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 m -96.35 138.4 34.01 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.816 -1.177 . . . . 0.0 108.636 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -134.18 117.68 16.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.795 0.807 . . . . 0.0 109.217 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -103.43 147.98 26.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -144.01 104.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 C-N-CA 118.974 -1.091 . . . . 0.0 111.445 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.13 113.61 26.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.514 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.665 HG23 HG22 ' A' ' 41' ' ' VAL . 31.9 m -103.28 142.35 34.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.87 143.16 38.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.917 0.865 . . . . 0.0 109.43 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 165.31 23.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 109.974 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -164.12 118.69 1.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 52' ' ' ILE . 31.9 pt -121.87 165.99 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 108.93 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.6 p-10 -162.15 127.59 3.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.9 p90 -162.18 -172.64 3.29 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.009 -1.076 . . . . 0.0 111.763 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -131.12 154.65 48.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.57 95.05 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.92 . . . . 0.0 109.828 -178.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.87 -20.04 0.67 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.13 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -135.02 162.18 33.19 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.185 -1.185 . . . . 0.0 110.841 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.43 165.63 16.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.7 p90 -161.75 173.84 14.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -101.73 144.77 30.01 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.1 pt-20 -162.18 -178.28 6.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -99.66 155.69 17.48 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.7 t -92.91 -142.33 0.21 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 109.325 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -111.2 -21.01 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.717 -1.239 . . . . 0.0 110.837 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -88.75 -40.0 13.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.67 45.19 0.11 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 34.8 mtp180 -131.96 150.62 76.64 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.708 -0.878 . . . . 0.0 109.161 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.79 141.68 17.26 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.676 1.584 . . . . 0.0 110.408 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.7 p -161.19 141.46 10.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.645 -0.659 . . . . 0.0 109.862 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.796 ' HB2' HD21 ' A' ' 100' ' ' LEU . 10.3 ttmt -89.7 114.17 25.79 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -99.68 174.05 6.42 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.301 0.572 . . . . 0.0 110.416 -178.271 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 85' ' ' VAL . 44.4 tp -148.05 152.39 37.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.742 HG21 ' CE2' ' A' ' 65' ' ' PHE . 7.0 t -142.36 126.89 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.976 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -122.33 155.2 36.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.555 ' CE2' HG21 ' A' ' 67' ' ' VAL . 79.0 m95 -77.42 176.22 9.06 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.892 0.854 . . . . 0.0 110.242 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.2 tp10 -138.44 -46.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.1 p -131.01 -152.51 0.51 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.6 -25.42 45.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -142.8 27.63 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.4 tttp -132.98 113.31 12.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.935 -1.103 . . . . 0.0 108.283 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.494 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -120.37 150.44 40.75 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.521 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.82 172.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.5 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.0 t -149.89 134.81 17.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -103.95 165.21 11.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -160.87 138.93 9.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.84 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -144.84 148.9 34.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.5 mt -60.86 166.86 3.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 0.0 110.994 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.5 mt -101.54 -3.56 28.28 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -150.8 130.34 13.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 108.892 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.93 -157.4 42.66 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -176.43 140.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.47 -1.018 . . . . 0.0 109.863 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.39 -87.3 0.06 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.64 -176.82 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 C-N-CA 121.8 1.666 . . . . 0.0 109.645 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -130.66 138.52 50.1 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.67 144.83 48.88 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.189 0.995 . . . . 0.0 110.734 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.9 m -163.44 136.67 5.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -139.21 172.38 12.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.707 HG22 HG13 ' A' ' 94' ' ' VAL . 16.8 p -136.43 170.16 16.5 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.476 0.655 . . . . 0.0 109.848 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.424 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 7.1 ptp -154.01 137.16 15.6 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -134.01 146.26 50.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.392 -0.817 . . . . 0.0 109.225 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.7 141.53 42.18 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -90.27 160.65 16.05 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.791 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -21.45 61.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.657 -0.652 . . . . 0.0 110.078 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -85.08 -29.49 24.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.99 -9.21 7.12 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.12 172.2 0.31 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.158 -1.201 . . . . 0.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -145.14 107.98 4.49 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.097 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -101.87 150.73 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -135.03 133.68 39.64 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.59 8.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 129' ' ' VAL . 11.8 mtp -148.41 166.78 27.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.742 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.1 m -150.07 148.07 28.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.668 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.56 93.05 1.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.521 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.79 -78.26 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -147.07 23.72 1.18 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.6 m -118.31 -179.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.7 t -156.41 119.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.46 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.856 ' CB ' HD22 ' A' ' 18' ' ' LEU . 2.2 t -98.39 118.46 35.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -112.92 143.37 44.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.762 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 9' ' ' ILE . 24.0 mtm180 -150.82 105.01 3.22 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.2 133.05 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.4 m-85 -120.83 120.81 36.65 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.154 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.14 139.98 22.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.98 128.48 18.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.196 -0.94 . . . . 0.0 111.322 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.3 tp10 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.332 0.587 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.7 m-85 -99.26 -7.85 25.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.3 p -69.11 117.54 10.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.955 . . . . 0.0 111.9 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.12 38.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.0 m120 -95.72 169.39 10.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.924 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.08 122.23 7.73 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.687 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -114.28 112.82 23.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.9 tt -56.53 146.93 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 110.67 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -127.64 -23.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.62 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -143.46 173.46 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t 169.57 168.51 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.66 28.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.013 -1.054 . . . . 0.0 112.02 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.01 31.69 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.205 -0.934 . . . . 0.0 109.106 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.916 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.0 -62.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 110.019 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.49 -31.15 67.59 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 111.097 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -71.18 -26.55 63.01 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.696 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.9 tp -81.76 -21.38 37.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.424 -0.797 . . . . 0.0 109.975 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.936 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -86.94 -17.62 32.72 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.099 -1.001 . . . . 0.0 109.305 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.6 mtmt -85.05 -34.64 22.24 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -73.69 -40.54 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 77' ' ' ASP . 5.0 mp -67.32 -46.11 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.828 0.823 . . . . 0.0 108.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -162.59 27.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.98 -37.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.831 -0.805 . . . . 0.0 110.183 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.2 t30 -62.0 -158.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.443 -0.786 . . . . 0.0 109.163 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.646 HG13 HH21 ' A' ' 29' ' ' ARG . 1.8 t -125.07 -47.56 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 109.316 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 ttt -68.08 -28.42 67.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -59.39 -19.26 45.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.737 -0.602 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -95.58 -47.4 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 109.876 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -62.73 -22.58 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.612 -0.68 . . . . 0.0 110.569 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.42 -28.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.842 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.936 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.88 -25.59 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.3 t -76.67 -38.9 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.62 57.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.4 95.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.544 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -66.63 -65.57 0.66 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.627 -0.671 . . . . 0.0 109.237 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p 47.89 55.3 8.76 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.671 0.748 . . . . 0.0 109.082 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 69.29 72.73 0.32 Allowed Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.67 162.66 41.42 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.146 1.898 . . . . 0.0 110.808 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.97 172.8 6.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.711 -0.618 . . . . 0.0 109.432 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.762 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -154.07 165.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 47.3 tt0 -150.69 110.75 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.924 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mt -98.34 137.1 26.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.677 0.751 . . . . 0.0 110.335 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.63 112.08 21.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.4 tt0 -98.24 121.7 40.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.008 -1.057 . . . . 0.0 111.106 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -121.52 51.77 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -125.4 7.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -76.27 -0.95 24.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.415 -1.05 . . . . 0.0 110.102 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 m -96.68 140.93 30.56 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.789 -1.194 . . . . 0.0 108.353 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.8 m-85 -136.07 115.33 12.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.923 0.868 . . . . 0.0 109.718 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.1 t80 -101.04 147.03 26.67 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 63' ' ' ILE . 3.0 mt -142.31 100.92 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.989 -1.07 . . . . 0.0 110.327 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 2.2 tttt -98.8 114.64 27.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.535 -0.728 . . . . 0.0 109.961 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.762 HG23 HG22 ' A' ' 41' ' ' VAL . 7.1 m -99.22 142.2 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 p -136.54 118.32 15.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.357 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.3 p -92.43 176.04 6.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.102 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.7 pt-20 -172.4 139.81 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 52' ' ' ILE . 31.2 pt -128.66 170.07 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.1 p-10 -162.55 130.76 3.96 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.9 p90 -161.58 -172.2 3.25 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.896 -1.121 . . . . 0.0 112.062 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -128.89 153.31 47.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 96.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.529 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.6 -32.28 1.61 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.56 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -113.64 155.8 24.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -1.069 . . . . 0.0 109.893 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.0 mt-10 -86.33 167.72 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 17.2 p90 -162.14 173.08 14.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.551 -0.718 . . . . 0.0 109.809 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -104.24 144.52 31.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.13 -175.75 4.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -99.53 156.88 16.81 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.4 t -94.39 -142.1 0.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 109.22 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.45 -20.57 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.712 -1.242 . . . . 0.0 110.828 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.82 -38.18 13.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 109.428 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 44.13 0.15 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.682 ' H ' HG22 ' A' ' 75' ' ' THR . 2.1 mtm-85 -130.28 151.9 79.26 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 121.656 -0.908 . . . . 0.0 109.256 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.66 141.06 17.1 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.644 1.563 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.6 p -160.75 140.79 11.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.683 -0.636 . . . . 0.0 109.692 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.758 ' HB2' HD21 ' A' ' 100' ' ' LEU . 26.7 ttpt -90.85 113.96 26.26 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -102.74 177.76 4.76 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.224 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 85' ' ' VAL . 50.3 tp -152.94 153.15 32.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.7 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.0 t -141.37 127.72 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.874 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 155.78 33.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.536 ' NE1' HG21 ' A' ' 67' ' ' VAL . 84.2 m95 -78.69 172.38 13.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 109.851 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -133.44 -47.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 p -132.17 -151.69 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.98 -26.87 48.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.308 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -140.2 23.93 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 111.466 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 53.0 tttp -131.83 111.69 11.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.749 -1.22 . . . . 0.0 108.451 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.477 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.71 149.26 40.13 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.119 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.63 173.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.517 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -149.45 130.35 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 110.887 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -101.97 163.45 12.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -160.34 143.8 13.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.006 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -146.18 151.38 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.405 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.23 166.66 5.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.935 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 82' ' ' LYS . 50.6 mt -101.03 -4.11 28.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 108.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.6 -157.03 42.09 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -177.34 140.43 0.28 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.514 -0.992 . . . . 0.0 109.529 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.19 -85.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.59 -176.84 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.82 1.68 . . . . 0.0 109.956 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -136.12 141.26 44.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.05 145.09 48.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.125 0.964 . . . . 0.0 110.596 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 p -162.79 129.65 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -136.57 173.69 11.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.226 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 94' ' ' VAL . 9.2 p -135.84 172.43 13.03 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.54 0.686 . . . . 0.0 109.901 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.464 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 9.8 ptm -155.91 124.84 6.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.94 152.7 39.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.899 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.55 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.75 142.13 46.93 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.8 p -91.77 160.09 15.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -60.45 -21.8 62.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -83.76 -29.7 27.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.137 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.47 -9.01 7.36 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -57.32 172.44 0.32 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.12 -1.223 . . . . 0.0 109.061 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.697 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.62 110.13 5.04 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.86 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.6 tt -105.99 148.97 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.58 145.95 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.668 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.59 169.65 11.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.419 -1.696 . . . . 0.0 106.419 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 35.4 mtp -151.66 164.26 37.32 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.574 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 129' ' ' VAL . 7.6 m -146.34 152.51 39.22 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.653 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.94 97.61 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.635 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.97 -79.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.43 24.27 1.01 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.566 -0.709 . . . . 0.0 109.342 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.1 m -119.54 -179.73 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.05 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.593 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 5.8 t -99.27 131.65 45.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.2 m -123.39 127.58 48.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -125.18 102.56 7.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.68 134.13 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.5 m-85 -124.15 129.99 51.77 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.604 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.91 138.45 40.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -48.73 125.28 9.81 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 0.0 111.285 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.6 179.647 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 45' ' ' GLN . 5.8 m120 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.62 -0.85 42.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -71.12 117.14 12.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.128 -0.983 . . . . 0.0 112.023 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.5 -172.18 38.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 32.3 m-20 -95.78 168.26 10.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -151.88 125.0 8.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.493 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -120.86 115.36 23.09 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.5 tt -56.29 139.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.556 0.693 . . . . 0.0 110.582 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.15 -24.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.852 -0.53 . . . . 0.0 109.823 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -142.93 174.41 10.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.356 -0.84 . . . . 0.0 110.075 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.535 ' HB2' HD11 ' A' ' 9' ' ' ILE . 20.7 t 178.86 164.51 0.84 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.45 25.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 74.8 m-20 -160.5 27.76 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.709 -0.619 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.905 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.49 -66.94 0.47 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.1 tt0 -55.54 -27.78 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.488 -0.757 . . . . 0.0 109.672 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -63.6 -40.56 97.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.674 -0.641 . . . . 0.0 110.205 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.7 tp -79.59 -16.44 55.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.2 mt -90.67 -17.49 26.72 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.97 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.3 mmmt -85.6 -30.45 23.3 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -77.55 -40.2 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.37 -47.5 70.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.86 0.838 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -156.12 26.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.2 -36.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.925 -0.75 . . . . 0.0 110.311 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.937 ' HB2' HD22 ' A' ' 28' ' ' LEU . 1.9 t-20 -62.41 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 27' ' ' MET . 5.1 m -132.0 -47.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.661 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.408 ' N ' HG23 ' A' ' 26' ' ' VAL . 9.7 ttt -69.58 -33.13 72.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.1 mp -48.05 -34.62 9.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.937 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 -42.88 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -61.96 -19.8 63.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.687 -0.633 . . . . 0.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.31 -29.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 108.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.47 -25.77 33.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.7 t -77.33 -39.86 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.5 62.88 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.57 94.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.01 -67.62 0.44 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.36 55.22 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.4 mttm 65.08 73.35 0.43 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.5 Cg_endo -71.46 151.95 59.8 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.031 1.821 . . . . 0.0 110.822 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -101.87 173.64 6.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 54' ' ' THR . 46.4 t -155.8 164.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.8 tt0 -147.77 111.98 5.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -98.01 131.47 44.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.805 0.812 . . . . 0.0 110.348 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -110.82 107.83 17.45 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.452 ' OE1' ' ND2' ' A' ' 2' ' ' ASN . 60.6 tt0 -97.63 123.81 41.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.114 -0.991 . . . . 0.0 111.177 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -124.17 54.43 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.41 -126.93 8.65 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.18 -1.09 24.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -1.049 . . . . 0.0 110.088 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m -96.81 136.8 36.84 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.763 -1.211 . . . . 0.0 108.394 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.5 m-85 -131.81 116.04 16.73 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.877 0.846 . . . . 0.0 109.346 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.1 t80 -101.42 147.98 25.71 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.88 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -144.77 100.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.982 -1.074 . . . . 0.0 110.328 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 112.1 24.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 41' ' ' VAL . 29.9 m -99.1 146.31 26.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.8 p -139.3 132.16 29.26 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.4 m . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.229 0.538 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.19 176.97 4.9 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.0 pt-20 -168.4 124.25 0.99 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.908 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.88 HD11 HD12 ' A' ' 52' ' ' ILE . 37.6 pt -111.68 170.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.1 p30 -162.74 133.99 5.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.133 -0.98 . . . . 0.0 109.467 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.3 p90 -161.92 -171.66 2.97 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.372 1.082 . . . . 0.0 112.615 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -129.62 152.65 48.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 95.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.19 -29.86 1.49 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.733 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -119.24 157.32 28.27 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.302 -1.117 . . . . 0.0 110.035 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HG2' HD22 ' A' ' 84' ' ' LEU . 21.1 mt-10 -86.14 169.15 13.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.594 -0.691 . . . . 0.0 109.22 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.5 p90 -162.13 174.09 13.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 0.0 109.765 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.55 145.87 29.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.14 -177.71 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.472 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -104.66 157.75 16.97 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.211 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.859 HG23 ' SG ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -95.36 -170.4 2.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.333 -0.854 . . . . 0.0 110.19 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.92 -20.71 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.89 -0.506 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.54 -41.66 13.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.73 43.63 0.2 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -127.9 152.19 76.89 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 121.628 -0.925 . . . . 0.0 109.142 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.61 137.36 14.43 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.336 1.357 . . . . 0.0 110.21 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' HG23 ' A' ' 75' ' ' THR . 12.8 p -160.69 142.47 12.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.656 -0.653 . . . . 0.0 109.466 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.763 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -86.79 117.35 25.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.5 t -99.14 166.52 11.2 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.494 HD22 ' HG2' ' A' ' 70' ' ' GLU . 56.3 tp -147.28 153.97 40.4 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 65' ' ' PHE . 21.3 t -145.79 131.16 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.019 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.1 pttt -125.63 159.9 31.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.572 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.3 m95 -82.86 170.04 15.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -133.4 -46.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 p -131.18 -154.28 0.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -77.66 -25.53 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.594 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -141.85 26.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 31.8 tttm -131.42 108.77 9.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.885 -1.134 . . . . 0.0 108.316 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.522 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -113.88 145.96 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.513 -0.742 . . . . 0.0 110.286 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 110' ' ' THR . 2.5 t -99.91 172.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.526 ' H ' HG12 ' A' ' 94' ' ' VAL . 54.0 t -148.4 139.59 23.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.29 163.15 13.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 7.3 tt0 -160.5 137.99 9.45 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.729 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -144.5 147.52 33.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.46 166.83 2.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 82' ' ' LYS . 58.0 mt -101.17 -3.43 29.13 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -156.01 139.94 16.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 108.79 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.17 -162.68 35.68 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -176.49 139.33 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.41 -1.053 . . . . 0.0 109.947 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.75 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.67 -176.88 2.65 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.824 1.683 . . . . 0.0 109.663 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -132.61 141.38 48.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.44 144.42 49.52 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.163 0.982 . . . . 0.0 110.861 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -163.67 138.66 6.19 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -140.66 172.52 12.6 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.953 -1.092 . . . . 0.0 110.729 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.723 HG22 HG13 ' A' ' 94' ' ' VAL . 17.9 p -134.16 169.16 17.59 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 109.422 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.635 ' HG3' HD23 ' A' ' 121' ' ' LEU . 2.1 ttt -154.53 122.01 5.74 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -118.82 154.62 32.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.478 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -118.7 144.96 45.88 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.3 p -96.83 161.36 13.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.791 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -22.38 63.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -84.36 -27.94 27.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.295 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.52 -11.1 7.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.87 172.12 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.067 -1.255 . . . . 0.0 109.073 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.585 HD11 ' HD2' ' A' ' 3' ' ' PHE . 8.0 tt -149.72 113.64 5.1 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.648 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -98.62 155.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.81 111.72 8.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -101.35 168.63 9.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.451 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.9 mtp -145.73 169.19 18.97 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.64 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.0 m -151.31 150.48 30.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.34 91.41 1.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.448 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -78.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.24 23.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.572 -0.705 . . . . 0.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.5 m -117.68 -179.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.8 t -156.7 119.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.474 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.722 ' CB ' HD22 ' A' ' 18' ' ' LEU . 3.2 t -98.08 109.92 22.59 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 122' ' ' THR . 39.1 m -101.48 147.0 26.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 9' ' ' ILE . 60.8 mtm180 -152.19 97.26 2.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.48 129.97 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -116.47 124.3 49.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.49 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.83 139.0 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.474 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -48.1 125.15 8.69 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.051 -0.976 . . . . 0.0 111.66 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.653 0.74 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.5 m-85 -99.56 1.22 43.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.665 -0.647 . . . . 0.0 109.573 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -73.04 118.19 15.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.117 -0.989 . . . . 0.0 111.939 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.47 -172.52 38.57 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 28.9 m-20 -95.16 168.29 10.84 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -150.11 123.23 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.552 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -118.58 113.5 21.35 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 132' ' ' ARG . 8.8 tt -56.93 145.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.711 0.767 . . . . 0.0 110.806 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.4 pp -126.55 -23.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.331 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HG3' HD12 ' A' ' 10' ' ' ILE . 2.3 mtt180 -141.54 175.62 9.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 0.0 110.468 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 169.15 168.04 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.06 30.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.877 -1.139 . . . . 0.0 112.036 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 32.95 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.195 -0.941 . . . . 0.0 108.975 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.994 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -66.35 -63.73 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.55 -0.719 . . . . 0.0 110.331 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 3.7 mt-10 -58.23 -27.17 63.71 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.497 -0.752 . . . . 0.0 111.25 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -73.08 -28.07 62.09 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.423 -178.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.6 tp -84.82 -17.69 37.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 110.277 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 15' ' ' PHE . 7.8 mt -90.33 -16.8 28.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.014 -1.054 . . . . 0.0 109.049 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' NE ' ' A' ' 29' ' ' ARG . 1.3 mmmm -86.52 -33.09 20.41 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -74.17 -40.36 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.48 -48.45 67.11 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.867 0.841 . . . . 0.0 109.05 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.65 -150.61 23.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.0 m -155.19 -43.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.922 -0.752 . . . . 0.0 109.275 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.1 t-20 -56.72 -175.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.529 -0.732 . . . . 0.0 109.576 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.1 m -108.35 -44.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 0.0 110.034 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttt -68.23 -25.83 65.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 108.933 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.6 mm? -58.46 -34.97 71.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.63 -0.669 . . . . 0.0 110.66 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -76.37 -47.47 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.08 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -24.8 67.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 111.149 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.97 -28.47 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.304 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.978 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.76 -26.03 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 0.0 109.266 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.5 t -77.57 -39.43 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.1 60.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.68 97.06 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.449 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.38 -68.84 0.29 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m 50.13 52.3 15.0 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 64.22 73.33 0.47 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.4 Cg_endo -71.32 153.22 61.55 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.051 1.834 . . . . 0.0 110.728 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.36 174.15 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.686 -0.634 . . . . 0.0 109.532 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 54' ' ' THR . 48.3 t -154.98 164.21 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 6.8 tp10 -145.71 110.86 5.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -99.05 132.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.442 -0.786 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -112.38 114.45 27.18 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.77 119.55 37.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -119.06 52.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 -125.24 7.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.626 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.2 p30 -76.88 -0.43 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.388 -1.066 . . . . 0.0 109.953 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.5 m -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.841 -1.162 . . . . 0.0 108.648 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -135.71 115.5 13.0 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.842 0.829 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.0 147.52 26.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.95 105.09 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.983 -1.073 . . . . 0.0 111.196 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.67 112.07 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.654 HG23 HG22 ' A' ' 41' ' ' VAL . 23.9 m -99.52 141.73 31.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.77 120.22 18.07 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.246 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 167.55 16.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 109.315 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -160.22 124.17 3.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 109.785 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 52' ' ' ILE . 36.4 pt -123.71 165.56 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.545 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.1 p-10 -162.3 128.13 3.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.043 -1.035 . . . . 0.0 109.669 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.5 p90 -162.04 -172.02 3.08 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.622 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.04 154.6 49.23 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.63 93.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -178.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.49 -24.16 0.51 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -132.43 161.93 32.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -1.075 . . . . 0.0 110.47 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.68 168.8 13.25 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.671 -0.643 . . . . 0.0 109.359 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 16.6 p90 -162.06 173.59 14.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.699 -0.626 . . . . 0.0 109.456 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.25 144.18 31.1 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.722 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.9 pt-20 -162.24 -175.98 4.87 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -100.07 157.6 16.44 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 79' ' ' ARG . 9.7 t -93.59 -141.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.345 -0.847 . . . . 0.0 108.856 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' N ' HG23 ' A' ' 75' ' ' THR . 25.9 t -112.81 -18.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.695 -1.253 . . . . 0.0 110.77 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -91.37 -37.41 13.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.97 45.64 0.12 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.7 151.03 76.34 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.883 . . . . 0.0 109.193 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.76 141.06 16.89 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.675 1.583 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -161.05 142.18 11.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.655 -0.653 . . . . 0.0 109.592 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.8 ttpt -87.97 117.31 26.74 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -99.32 162.27 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.733 -0.605 . . . . 0.0 109.837 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.6 tp -139.87 153.5 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.1 t -146.98 128.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.379 -1.329 . . . . 0.0 112.171 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 155.46 37.48 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE2' HG21 ' A' ' 67' ' ' VAL . 80.7 m95 -78.18 174.64 10.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 109.89 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -137.45 -46.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.1 p -130.9 -153.23 0.55 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.55 -24.87 45.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.725 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -143.09 28.13 1.56 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 110.502 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.1 tttm -133.79 110.43 9.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.888 -1.133 . . . . 0.0 108.277 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.512 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -117.47 149.68 40.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.861 . . . . 0.0 110.141 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.7 172.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.511 ' H ' HG12 ' A' ' 94' ' ' VAL . 45.7 t -148.55 138.32 22.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -105.22 164.02 12.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -160.06 132.99 6.65 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.515 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -141.18 149.25 41.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.16 167.51 3.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.641 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.0 mt -96.19 -8.42 33.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -158.08 156.19 30.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.67 -162.74 20.34 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -176.85 139.06 0.28 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.512 -0.993 . . . . 0.0 109.829 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.77 -84.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.42 -176.95 2.74 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.938 1.758 . . . . 0.0 109.994 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -137.12 139.94 41.57 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 146.32 48.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.092 0.948 . . . . 0.0 110.759 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.18 137.86 6.34 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.9 p-90 -144.18 175.96 9.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.74 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 94' ' ' VAL . 13.1 p -138.33 169.85 17.06 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.532 0.682 . . . . 0.0 109.955 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.519 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 20.5 ptm -152.8 124.16 7.65 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -124.38 153.04 42.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.957 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.9 45.33 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.4 p -91.06 161.11 15.25 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.5 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.91 -20.72 62.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -28.3 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.48 -8.36 7.85 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 44.0 mt-10 -58.25 172.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -1.202 . . . . 0.0 109.146 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.84 110.46 5.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.151 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 133' ' ' VAL . 11.1 tt -105.35 143.9 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -128.23 131.49 48.8 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.48 163.71 12.83 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 21.6 mtp -142.49 160.13 40.87 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.039 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 129' ' ' VAL . 7.7 m -143.4 152.88 42.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.62 98.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.54 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.21 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.62 23.86 0.99 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.517 -0.74 . . . . 0.0 109.534 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.2 m -120.15 -179.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.54 116.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.659 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.713 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.0 t -99.65 112.06 24.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.8 m -100.85 151.47 21.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.9 mtm180 -150.63 102.43 3.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 120' ' ' ILE . 52.5 t -67.02 133.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.3 m-85 -121.55 120.29 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.907 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.89 142.86 16.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.475 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -50.08 126.14 13.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.303 -0.873 . . . . 0.0 111.146 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.961 -1.018 . . . . 0.0 111.752 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 m120 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.523 0.677 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -98.01 -2.49 40.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -71.96 118.01 14.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 112.028 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.52 -173.84 38.83 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.3 m120 -95.16 171.45 8.73 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.874 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -151.13 126.95 10.29 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.014 -1.075 . . . . 0.0 112.777 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.49 118.04 31.1 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.833 HD11 ' HB3' ' A' ' 12' ' ' SER . 13.6 tt -61.85 150.86 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.871 0.843 . . . . 0.0 111.016 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.65 -30.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.627 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -141.96 165.8 26.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 108.917 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 9' ' ' ILE . 56.9 p -177.01 147.19 0.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 0.0 109.469 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -145.61 165.65 28.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 109.953 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 14.5 m120 62.64 32.69 16.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.581 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.937 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.35 -64.22 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.472 -0.767 . . . . 0.0 110.188 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.727 ' CD ' HG21 ' A' ' 33' ' ' VAL . 4.5 mm-40 -57.41 -36.08 70.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 110.903 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.28 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.889 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.7 tp -78.89 -22.04 46.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.941 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.0 mt -89.33 -16.26 31.48 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.204 -0.935 . . . . 0.0 109.143 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.2 mmmm -87.02 -32.61 19.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.2 p -73.42 -38.3 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.6 mp -70.43 -45.12 66.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 109.562 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.84 -161.45 27.74 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.301 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.36 -36.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.925 -0.75 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.3 t30 -62.28 -148.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.462 -0.774 . . . . 0.0 109.617 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.48 -45.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.744 -1.223 . . . . 0.0 109.237 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -72.35 -26.91 62.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.3 mm? -60.22 -17.14 39.43 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.706 -0.621 . . . . 0.0 111.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -98.15 -47.77 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.578 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -62.8 -22.33 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.636 -0.665 . . . . 0.0 110.516 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 27' ' ' MET . 35.1 mt -78.05 -28.59 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 108.934 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.47 34.95 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -77.38 -37.67 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.77 -31.62 46.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.33 83.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -69.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.514 -0.741 . . . . 0.0 109.139 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m 48.79 49.09 19.49 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.658 -0.652 . . . . 0.0 109.677 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.3 mttt 65.27 72.17 0.48 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -73.15 151.26 49.18 Favored 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 122.026 1.817 . . . . 0.0 110.726 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -88.8 174.75 7.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.655 -0.653 . . . . 0.0 109.466 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 40' ' ' ALA . 10.1 t -153.58 164.91 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.0 tt0 -154.94 115.14 3.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 109.236 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -106.15 138.83 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.764 0.792 . . . . 0.0 110.279 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.44 113.51 21.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.7 tt0 -98.53 115.34 28.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.162 -0.961 . . . . 0.0 110.796 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -118.52 56.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.54 8.78 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -77.69 -0.13 25.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.366 -1.079 . . . . 0.0 110.047 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.91 137.01 36.65 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.706 -1.246 . . . . 0.0 108.555 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -132.56 117.0 17.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.783 0.802 . . . . 0.0 108.871 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.9 t80 -104.46 125.51 50.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.795 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -108.0 141.06 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.948 -1.095 . . . . 0.0 108.658 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 2.2 tttt -138.55 101.44 4.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.171 -0.956 . . . . 0.0 108.946 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 31.5 m -99.76 147.25 25.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.63 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.949 0.881 . . . . 0.0 109.451 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.9 153.29 29.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.106 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG2' ' HG3' ' A' ' 53' ' ' LYS . 10.7 mt-10 -156.23 97.78 1.8 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.51 -0.744 . . . . 0.0 109.689 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 52' ' ' ILE . 24.2 pt -105.34 167.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.506 -0.746 . . . . 0.0 109.052 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.2 p30 -162.19 135.13 5.97 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.374 -0.829 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.6 p90 -162.74 -172.29 3.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.388 1.089 . . . . 0.0 112.545 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.11 152.75 48.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.81 95.07 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.102 -0.999 . . . . 0.0 109.833 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.8 -25.06 1.63 Allowed Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.929 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.5 156.95 34.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.295 -1.12 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.748 ' HG3' HD13 ' A' ' 84' ' ' LEU . 6.2 mp0 -85.8 167.98 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.31 174.0 13.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.565 -0.709 . . . . 0.0 109.42 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.31 144.59 31.42 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.14 -177.19 5.58 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -99.65 156.99 16.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.2 -142.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.418 -0.801 . . . . 0.0 108.98 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 t -109.72 -21.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.723 -1.236 . . . . 0.0 110.672 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 2.3 t70 -88.35 -39.97 13.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 109.354 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.97 44.73 0.12 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.97 151.87 79.7 Favored Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 121.669 -0.901 . . . . 0.0 109.283 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.71 141.38 17.24 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.665 1.577 . . . . 0.0 110.604 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.2 p -161.12 141.26 10.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.5 ttmm -90.2 113.63 25.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -100.58 174.48 6.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.768 -0.582 . . . . 0.0 109.933 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.748 HD13 ' HG3' ' A' ' 70' ' ' GLU . 44.5 tp -147.92 153.47 39.11 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.9 t -141.86 128.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.465 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.2 ptpt -125.97 164.5 20.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -86.09 169.58 13.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.097 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.8 tp10 -133.19 -45.2 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -133.46 -154.25 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.81 -25.66 53.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.219 -0.925 . . . . 0.0 110.062 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -143.26 27.47 1.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 110.774 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 24.4 tttm -132.92 110.0 9.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.885 -1.134 . . . . 0.0 108.114 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.484 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 1.5 ptp -114.87 151.98 33.02 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.481 -0.762 . . . . 0.0 110.13 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.839 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -105.04 171.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.491 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.0 t -148.29 131.97 16.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 110.621 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.7 165.07 11.41 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -160.96 138.67 9.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.818 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -144.85 150.3 36.86 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.29 167.48 2.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 80' ' ' PRO . 34.6 mt -98.4 -6.88 29.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 137.95 18.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.13 -158.85 41.3 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -175.8 142.64 0.55 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.414 -1.05 . . . . 0.0 109.759 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 -85.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.5 -176.96 2.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.922 1.748 . . . . 0.0 109.93 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -136.54 135.14 38.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 145.98 47.39 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.163 0.982 . . . . 0.0 110.712 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.3 p -163.01 133.02 4.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -136.7 169.41 17.77 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.049 -1.061 . . . . 0.0 110.727 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 94' ' ' VAL . 13.5 p -134.43 170.72 15.33 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.561 0.696 . . . . 0.0 109.935 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 1.7 ptp -153.38 134.35 13.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -129.71 152.9 48.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.93 143.55 44.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.3 162.14 14.12 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.29 -22.63 65.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.077 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.13 -27.68 27.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.432 -0.793 . . . . 0.0 109.236 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.93 -9.75 7.96 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 52.5 mt-10 -56.49 172.35 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.166 -1.197 . . . . 0.0 109.18 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.6 109.69 4.89 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.919 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.4 tt -103.61 160.7 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.52 153.64 46.25 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.374 -0.829 . . . . 0.0 109.218 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.578 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.24 165.86 24.44 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 26.7 mtp -147.27 165.24 30.69 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.491 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 m -147.09 150.42 35.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.33 93.86 1.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.0 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.84 24.84 1.33 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.1 m -118.68 -179.65 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.54 117.81 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.017 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.889 ' HB2' HD22 ' A' ' 18' ' ' LEU . 8.4 t -99.93 112.5 24.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 122' ' ' THR . 91.7 m -107.39 146.73 31.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 119.74 6.29 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 120' ' ' ILE . 42.0 t -84.12 143.61 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.141 -0.974 . . . . 0.0 108.666 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -130.99 127.94 39.39 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.477 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.54 138.39 37.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.62 128.21 17.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.204 -0.935 . . . . 0.0 111.518 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.346 0.593 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -99.1 -5.74 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.1 p -68.3 117.23 9.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 111.939 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.85 -172.13 37.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.7 m120 -95.69 168.08 10.89 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.88 124.97 8.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.485 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -120.01 113.7 20.91 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.5 tt -56.42 143.21 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.563 0.697 . . . . 0.0 110.381 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -123.8 -23.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.942 -0.474 . . . . 0.0 110.181 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.544 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -141.4 178.3 7.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 t 169.13 168.81 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.76 28.93 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.898 -1.126 . . . . 0.0 112.093 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 34.99 0.11 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.816 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.18 -60.38 2.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.442 -0.786 . . . . 0.0 110.097 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.8 pt-20 -58.42 -26.86 63.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 111.082 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 2.1 pt-20 -72.79 -29.37 63.23 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.493 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.903 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.2 tp -82.28 -18.3 42.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.917 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 32' ' ' ALA . 22.9 mt -90.28 -16.35 29.47 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.149 -0.969 . . . . 0.0 109.397 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.9 mmmm -87.21 -31.76 20.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -75.54 -40.74 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 76' ' ' VAL . 4.7 mp -66.75 -49.58 65.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.953 0.882 . . . . 0.0 108.776 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.8 -147.5 19.99 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.1 m -155.34 -42.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.852 -0.793 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.7 t-20 -57.42 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 109.615 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.35 -43.71 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.362 -0.836 . . . . 0.0 110.116 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -69.88 -25.6 63.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.2 mm? -57.07 -43.9 82.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.603 -0.685 . . . . 0.0 110.694 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.2 mpp_? -63.29 -41.73 99.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.577 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -61.31 -21.5 64.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.658 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.68 -29.31 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 109.059 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.4 -26.41 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.3 t -76.52 -40.39 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.01 65.0 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.19 90.16 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -65.68 -68.69 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.1 t 49.19 51.05 16.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.432 0.634 . . . . 0.0 109.376 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm 63.75 72.36 0.55 Allowed Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -72.11 157.38 54.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.973 1.782 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -104.99 174.07 6.04 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 47.8 t -156.18 163.94 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.7 tt0 -147.24 112.26 5.45 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.3 mt -98.54 134.2 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.798 0.808 . . . . 0.0 110.497 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -113.78 109.16 18.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -97.89 120.82 38.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.035 -1.041 . . . . 0.0 111.146 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -120.93 53.57 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.44 -126.43 8.35 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.594 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -75.59 -1.25 23.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.4 -1.059 . . . . 0.0 110.095 178.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 m -96.08 137.37 35.24 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.795 -1.19 . . . . 0.0 108.619 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.4 m-85 -132.83 114.45 14.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.826 0.822 . . . . 0.0 109.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.2 t80 -100.93 148.73 24.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.115 HD12 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -144.95 103.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.009 -1.057 . . . . 0.0 110.844 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -99.81 111.49 23.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.508 -0.745 . . . . 0.0 109.023 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 22.8 m -99.53 148.27 24.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -143.41 128.82 18.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.357 -0.839 . . . . 0.0 110.45 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.583 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.457 HG22 ' OE2' ' A' ' 62' ' ' GLU . 2.6 m . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.07 168.82 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 60' ' ' THR . 2.6 mp0 -158.7 112.37 2.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.637 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.115 HD11 HD12 ' A' ' 52' ' ' ILE . 41.6 pt -115.32 165.06 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.5 p30 -162.68 131.83 4.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.4 p90 -161.6 -171.68 3.04 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.175 0.988 . . . . 0.0 111.769 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 4.0 ptpt -132.96 155.34 49.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.8 96.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.31 -20.97 0.74 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.923 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 1.2 pt-20 -138.06 163.53 31.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.188 -1.184 . . . . 0.0 110.941 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.7 ' HG2' HD13 ' A' ' 84' ' ' LEU . 20.8 mt-10 -86.99 168.8 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.17 174.48 12.86 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -101.5 145.02 29.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.693 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.4 pt-20 -162.17 -177.11 5.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -104.62 154.17 20.28 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.374 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 77' ' ' ASP . 13.9 t -91.75 -170.28 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 HD21 ' A' ' 22' ' ' LEU . 9.8 p -87.63 -6.27 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 0.0 111.21 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.796 ' H ' HG23 ' A' ' 75' ' ' THR . 1.3 t0 -98.18 -55.07 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.997 -1.065 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.7 46.22 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 75' ' ' THR . 8.0 mmm180 -137.08 152.6 74.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.73 -0.865 . . . . 0.0 109.214 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.85 141.14 16.75 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.533 1.489 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -160.82 141.17 11.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.64 -0.663 . . . . 0.0 109.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.8 tttp -87.63 118.94 27.46 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -99.7 167.16 10.74 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' HG2' ' A' ' 70' ' ' GLU . 45.0 tp -146.03 152.25 39.05 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 65' ' ' PHE . 11.3 t -144.74 127.68 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.112 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -123.13 155.97 35.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.549 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.4 m95 -78.76 173.69 12.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.779 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.73 -46.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.7 p -131.43 -153.55 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.76 -25.43 49.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.777 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -142.72 27.43 1.67 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.588 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 66.0 tttt -132.85 109.68 9.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.962 -1.086 . . . . 0.0 108.376 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.517 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.38 148.89 40.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.828 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.64 172.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.498 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.9 t -148.54 134.58 19.19 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.693 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -103.05 165.15 11.19 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.45 135.31 7.68 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.293 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.67 40.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.95 166.7 3.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.065 -1.022 . . . . 0.0 110.722 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.5 mt -98.76 -5.51 31.18 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -152.45 137.2 17.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 108.962 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.47 -158.72 42.71 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.14 141.05 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.461 -1.023 . . . . 0.0 109.795 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.97 -85.47 0.05 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.35 -176.83 2.95 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.883 1.722 . . . . 0.0 109.752 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -136.18 137.03 40.47 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.9 146.08 47.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.051 0.929 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.3 m -163.03 136.48 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.0 p-90 -138.91 175.11 9.84 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.891 -1.13 . . . . 0.0 110.343 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.671 HG22 HG13 ' A' ' 94' ' ' VAL . 12.6 p -137.7 166.45 23.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.547 0.689 . . . . 0.0 109.831 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.452 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 10.8 ptm -149.2 119.74 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -118.46 152.77 35.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.589 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -116.26 143.3 45.71 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -97.13 161.07 13.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.907 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.89 -21.39 63.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.675 -0.64 . . . . 0.0 110.217 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.37 -29.13 28.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.75 -7.59 8.86 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.96 171.27 0.98 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -1.233 . . . . 0.0 108.643 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.623 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.01 114.7 7.69 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.343 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.8 tt -99.17 148.32 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.746 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -129.29 110.32 11.85 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.423 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -98.97 171.3 8.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 129' ' ' VAL . 45.3 mtp -150.35 165.87 31.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.596 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.516 HG23 HG23 ' A' ' 129' ' ' VAL . 5.3 m -148.85 151.92 35.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 96.39 1.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.51 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.83 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -148.38 23.57 1.03 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.539 -0.726 . . . . 0.0 109.617 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.0 m -122.17 179.64 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -155.48 118.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.903 ' CB ' HD22 ' A' ' 18' ' ' LEU . 35.7 t -99.11 133.38 43.46 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 132' ' ' ARG . 38.6 m -120.44 156.02 32.31 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.865 0.841 . . . . 0.0 109.818 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HB3' HD12 ' A' ' 9' ' ' ILE . 15.3 mtm180 -151.97 92.35 1.72 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.16 117.03 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 42.6 m-85 -102.13 133.92 46.2 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.562 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.77 138.08 47.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.83 124.49 7.42 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.3 -0.875 . . . . 0.0 111.331 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.757 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.425 0.631 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.724 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.2 m-85 -99.29 -17.38 18.1 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 t -60.97 113.94 2.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.85 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 -172.64 40.96 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 36.5 m-20 -96.01 170.44 9.28 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -150.86 123.11 8.32 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.601 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -116.02 113.33 23.07 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.813 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.0 tt -56.06 154.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 122.09 0.947 . . . . 0.0 111.37 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.19 -32.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.382 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -137.08 167.49 21.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.865 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.813 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.8 p -177.12 152.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -0.773 . . . . 0.0 109.792 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -151.45 168.42 24.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.833 -0.542 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 16.8 m120 59.85 26.48 15.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.749 . . . . 0.0 110.059 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -63.75 -62.87 1.37 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.31 -0.869 . . . . 0.0 108.686 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.1 mt-10 -57.03 -28.42 62.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.278 -0.889 . . . . 0.0 109.281 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.08 -38.69 92.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.729 -0.607 . . . . 0.0 109.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.1 tp -79.43 -17.96 53.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.8 mt -89.59 -17.32 28.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.194 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.3 mmmm -87.44 -29.63 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -77.71 -41.15 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -66.62 -52.63 43.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.038 0.923 . . . . 0.0 108.667 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.17 -148.36 20.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 23' ' ' GLY . 18.2 m -155.87 -34.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.958 -0.731 . . . . 0.0 110.387 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.902 ' HB2' HD22 ' A' ' 28' ' ' LEU . 1.7 t-20 -60.96 -153.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.574 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.6 m -129.61 -48.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.024 -1.047 . . . . 0.0 109.652 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.406 ' H ' HG23 ' A' ' 26' ' ' VAL . 17.0 ttp -68.11 -30.24 69.35 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -51.61 -35.35 41.36 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.913 -0.492 . . . . 0.0 110.698 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.7 mtp180 -77.21 -38.54 51.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.561 -0.712 . . . . 0.0 109.59 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -64.88 -24.35 67.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.69 -0.631 . . . . 0.0 110.297 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.63 -29.56 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 108.956 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.23 34.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.0 t -76.22 -37.77 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.36 -35.51 61.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.69 88.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.59 -69.63 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t 47.82 50.04 15.98 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.465 0.65 . . . . 0.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 mttt 65.47 72.81 0.44 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -72.11 153.98 57.28 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.083 1.856 . . . . 0.0 110.769 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.59 175.66 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 109.741 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ALA . 23.7 t -155.07 166.25 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -157.41 113.68 2.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.725 . . . . 0.0 109.384 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.724 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.8 mp -101.33 144.3 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.894 0.854 . . . . 0.0 110.303 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 7.3 mttt -123.7 104.35 8.94 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.4 tt0 -98.06 121.93 40.58 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.178 -0.951 . . . . 0.0 111.219 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -124.07 52.35 1.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -129.14 9.79 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -75.4 -2.45 28.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -1.063 . . . . 0.0 110.111 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.9 m -96.7 124.49 40.7 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.821 -1.174 . . . . 0.0 108.516 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 87.9 m-85 -120.5 122.98 41.84 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.857 0.836 . . . . 0.0 108.9 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.4 t80 -107.09 138.2 43.72 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.576 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -122.54 137.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -137.75 105.92 5.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.77 147.12 25.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.255 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.12 116.86 10.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.19 169.04 8.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -168.09 112.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 110.516 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 52' ' ' ILE . 29.5 pt -98.94 172.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.545 -0.722 . . . . 0.0 109.1 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.7 p30 -163.0 134.81 5.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.0 110.05 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 41.4 p90 -163.04 -171.26 2.59 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.437 1.113 . . . . 0.0 112.508 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -130.7 153.15 49.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.71 94.82 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.099 -1.001 . . . . 0.0 109.557 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.46 -27.65 1.35 Allowed Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.699 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -122.99 157.49 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -1.105 . . . . 0.0 110.131 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' CA ' HD13 ' A' ' 84' ' ' LEU . 8.8 pm0 -86.72 169.61 12.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.635 -0.666 . . . . 0.0 109.359 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 16.2 p90 -161.94 -172.89 3.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.6 -0.687 . . . . 0.0 109.386 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 20.3 mt-10 -115.83 147.76 40.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.7 pt-20 -161.64 179.74 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.682 -0.636 . . . . 0.0 109.596 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -105.73 159.18 16.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.327 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -92.38 -143.73 0.21 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.577 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 t -117.78 -17.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.161 . . . . 0.0 110.67 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.61 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -87.95 -34.64 18.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.75 45.99 0.18 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.653 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.6 146.85 62.2 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.749 -0.854 . . . . 0.0 109.268 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -80.02 136.09 11.5 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.687 1.591 . . . . 0.0 110.284 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.0 p -161.0 141.48 11.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB3' HD21 ' A' ' 100' ' ' LEU . 9.2 ptmt -80.41 161.71 24.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.5 t -141.88 160.69 39.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.0 tp -142.07 154.27 44.81 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 20.3 t -144.25 129.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.358 -1.337 . . . . 0.0 112.222 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -124.24 159.58 29.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.648 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.8 m95 -82.82 172.06 13.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 0.0 110.498 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.5 tp10 -135.99 -45.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.7 p -132.65 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.74 -26.35 54.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.858 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -143.09 27.82 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 19.4 tttt -131.8 111.12 11.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.7 ptp -116.23 148.86 40.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.45 -0.781 . . . . 0.0 110.239 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.652 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -100.26 171.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.478 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.46 141.75 26.25 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.41 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -107.4 164.12 12.46 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -162.15 131.31 4.38 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.616 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -138.74 155.12 48.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.76 169.29 4.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 82' ' ' LYS . 62.5 mt -102.59 -2.66 28.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.73 133.93 10.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 108.968 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.57 -155.71 43.89 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -175.7 140.5 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.439 -1.036 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.8 -87.0 0.06 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.6 -176.9 2.92 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.816 1.677 . . . . 0.0 109.697 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -132.84 138.44 47.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 144.8 49.82 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.215 1.007 . . . . 0.0 110.867 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.9 m -163.13 139.32 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.409 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.3 p-90 -142.62 175.73 9.58 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.956 -1.09 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.652 HG22 HG13 ' A' ' 94' ' ' VAL . 14.9 p -140.05 171.39 14.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.529 0.68 . . . . 0.0 109.838 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.455 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.1 ptp -154.14 140.52 18.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.15 149.44 47.28 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.324 -0.86 . . . . 0.0 109.501 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.3 46.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.67 160.9 14.78 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.725 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -60.45 -21.75 62.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.643 -0.66 . . . . 0.0 110.218 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.98 -28.67 25.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.9 -9.13 7.6 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.76 171.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.097 -1.237 . . . . 0.0 108.966 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.9 tt -146.62 110.11 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.19 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.77 153.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 133.3 36.84 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.496 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.508 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -112.88 167.2 10.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 24.7 mtp -146.49 164.74 31.55 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.399 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.2 m -147.86 152.27 37.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.67 95.93 1.35 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.595 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.21 -79.25 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -147.6 24.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.248 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.9 m -118.97 -179.25 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.61 117.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.696 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.841 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.4 t -98.46 113.81 25.96 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.508 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.3 m -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 0.0 109.715 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.46 118.74 5.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.19 136.98 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -125.77 121.74 34.22 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.16 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.39 141.13 20.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.76 126.25 13.45 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.23 -0.919 . . . . 0.0 111.189 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.635 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.5 m120 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.45 0.643 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.5 m-85 -99.22 -8.11 25.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -67.01 115.64 6.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.301 -0.874 . . . . 0.0 111.893 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.32 -173.38 41.08 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 36.5 m-20 -96.16 169.99 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.3 m95 -152.38 131.4 12.61 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.079 -1.049 . . . . 0.0 113.038 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -122.82 116.72 24.16 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.0 tt -58.57 145.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.603 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.15 -24.43 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.961 -0.462 . . . . 0.0 110.324 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -149.66 168.02 24.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.221 -0.924 . . . . 0.0 110.602 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p 178.0 170.11 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.19 30.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.903 -1.123 . . . . 0.0 111.635 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.9 33.49 0.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.284 -0.885 . . . . 0.0 109.134 -178.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.66 -64.99 0.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 21.7 tt0 -57.09 -27.12 61.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.58 -39.66 94.97 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.756 -0.59 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.9 tp -80.03 -15.8 56.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.675 -0.641 . . . . 0.0 110.016 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.971 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.6 mt -90.22 -18.97 24.75 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.054 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.22 -28.66 25.25 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.7 p -79.46 -41.22 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.97 -51.71 56.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.05 0.929 . . . . 0.0 109.041 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.15 -147.76 20.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 25' ' ' ASN . 23.1 m -155.74 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.978 -0.719 . . . . 0.0 109.721 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.3 t-20 -60.46 -159.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.682 . . . . 0.0 109.885 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG13 ' NH2' ' A' ' 29' ' ' ARG . 2.5 t -122.18 -49.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.875 . . . . 0.0 109.429 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -66.39 -29.79 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -57.05 -25.68 59.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.827 -0.545 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.5 mtp180 -87.24 -42.7 12.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.785 . . . . 0.0 109.272 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -22.37 66.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.753 -0.592 . . . . 0.0 110.54 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.68 -29.99 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 108.774 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.971 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.17 -24.97 34.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.9 t -77.11 -35.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.52 -35.89 52.97 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.34 -35.51 80.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -71.19 -67.14 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.6 m 49.23 51.37 16.41 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.8 mttt 65.64 73.73 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.5 Cg_endo -72.37 154.28 55.96 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 111.063 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.54 176.37 5.88 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 42.9 t -155.57 164.59 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.6 tt0 -152.21 112.49 4.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.664 HG13 HG23 ' A' ' 52' ' ' ILE . 2.4 mp -98.04 136.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.767 0.794 . . . . 0.0 110.002 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.445 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.35 106.38 13.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.9 tt0 -97.7 124.3 41.97 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.112 -0.993 . . . . 0.0 111.193 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -124.44 53.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.3 -127.26 8.87 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.03 -1.13 24.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -1.029 . . . . 0.0 110.074 178.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.7 m -97.14 138.58 34.43 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.706 -1.246 . . . . 0.0 108.31 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 93.6 m-85 -134.11 118.11 17.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.764 0.793 . . . . 0.0 109.464 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.5 t80 -102.65 146.97 27.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.98 HD12 HD11 ' A' ' 63' ' ' ILE . 2.9 mt -141.73 100.81 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.947 -1.096 . . . . 0.0 110.45 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -99.39 114.07 26.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.393 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 18.0 m -99.87 144.76 28.55 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.9 p -135.51 144.19 46.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.2 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.878 0.847 . . . . 0.0 108.738 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.8 m . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.224 0.535 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.01 177.58 4.8 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.2 pm0 -171.37 143.75 1.88 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.69 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 52' ' ' ILE . 33.3 pt -128.18 170.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.5 p-10 -162.0 132.69 4.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.987 -1.071 . . . . 0.0 109.457 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.7 p90 -162.25 -172.39 3.18 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.409 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.81 152.6 48.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.64 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.97 96.89 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.36 -34.88 1.48 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.559 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.76 157.34 21.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -1.046 . . . . 0.0 109.968 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.2 mt-10 -85.8 168.88 13.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 22.3 p90 -161.21 -172.9 3.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 21.8 mt-10 -116.39 148.86 40.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.651 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.9 pt-20 -161.29 179.8 8.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.444 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.8 144.14 42.85 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 79' ' ' ARG . 7.9 t -81.54 177.62 8.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.407 -0.808 . . . . 0.0 108.985 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 76' ' ' VAL . 13.5 p -84.7 -0.35 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.6 -0.688 . . . . 0.0 111.396 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 75' ' ' THR . 5.2 t0 -95.68 -44.61 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.89 -1.132 . . . . 0.0 109.955 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 75' ' ' THR . . . 134.19 45.3 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mmm180 -139.9 149.88 60.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.796 -0.826 . . . . 0.0 109.088 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HB2' HD12 ' A' ' 100' ' ' LEU . 37.2 Cg_endo -80.46 135.03 10.33 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.49 1.46 . . . . 0.0 110.048 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.1 p -160.45 141.45 12.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.701 -0.624 . . . . 0.0 109.55 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 2.1 ptmm? -80.69 163.34 23.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.9 t -144.56 160.52 40.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD22 ' HG2' ' A' ' 70' ' ' GLU . 58.2 tp -142.13 153.57 44.2 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.6 t -144.7 125.77 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.772 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -120.58 162.28 19.89 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.64 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.1 m95 -85.51 168.7 14.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' OE1' HG21 ' A' ' 94' ' ' VAL . 5.4 tp10 -131.81 -45.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.6 p -133.04 -153.81 0.57 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -77.14 -25.14 51.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -143.83 26.6 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.877 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 15.5 tttt -131.5 109.65 10.43 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' CZ2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.25 150.67 35.82 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -102.8 171.36 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.3 t -148.93 140.41 23.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.185 -0.947 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -107.17 164.75 11.9 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -161.96 133.41 5.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.988 -1.07 . . . . 0.0 110.752 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -140.89 153.67 45.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.35 169.59 3.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 0.0 110.684 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 80' ' ' PRO . 40.7 mt -98.01 -7.48 29.83 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -159.98 157.03 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 108.774 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.69 -158.5 18.94 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -176.73 139.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.514 -0.992 . . . . 0.0 109.691 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.35 -85.35 0.06 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.48 -176.75 2.65 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.95 1.767 . . . . 0.0 110.17 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -138.67 141.19 39.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.81 145.28 50.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.163 0.982 . . . . 0.0 110.839 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 m -162.99 137.23 6.22 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.7 p-90 -143.21 174.55 10.61 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.674 HG22 HG13 ' A' ' 94' ' ' VAL . 12.2 p -139.29 175.31 9.67 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.512 0.672 . . . . 0.0 109.674 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.7 ptp -158.34 141.1 14.62 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -136.09 150.28 49.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.451 -0.78 . . . . 0.0 109.158 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.42 143.3 44.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -93.03 160.49 14.84 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.809 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -60.01 -21.04 60.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 110.229 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.0 -29.7 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.838 . . . . 0.0 109.177 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.07 -9.84 7.03 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.9 172.88 0.23 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.215 -1.168 . . . . 0.0 109.432 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.596 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -146.12 108.57 4.46 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.225 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.8 tt -103.62 147.87 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tt -129.93 147.75 51.72 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.263 -0.898 . . . . 0.0 109.637 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.469 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.22 164.57 18.48 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.5 mtp -146.88 164.49 32.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.534 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 8.4 m -146.52 153.08 39.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -161.5 98.72 1.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.51 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.43 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.27 24.19 1.03 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.519 -0.738 . . . . 0.0 109.426 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.1 m -119.15 -179.22 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.07 116.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.423 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.864 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.0 t -99.68 114.49 27.62 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.79 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.469 ' OG1' HG22 ' A' ' 122' ' ' THR . 76.9 m -104.57 126.61 51.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.36 -0.838 . . . . 0.0 109.296 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -126.39 101.96 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.15 136.17 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.413 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.3 m-85 -125.43 127.59 46.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.0 137.56 41.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.494 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.57 127.57 15.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 111.405 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.604 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.246 0.546 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.5 m-85 -99.33 -8.79 24.38 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.732 -0.605 . . . . 0.0 109.61 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p -68.87 116.91 9.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.207 -0.933 . . . . 0.0 111.895 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.61 -171.95 39.39 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.89 169.04 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.56 121.55 7.67 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.717 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -115.25 113.7 24.24 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.6 tt -56.55 144.88 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.686 0.755 . . . . 0.0 110.804 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -125.21 -23.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.934 -0.479 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 10' ' ' ILE . 10.9 mtt180 -144.98 173.5 11.83 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.225 -0.922 . . . . 0.0 110.527 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t 170.29 168.79 0.06 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.78 31.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.961 -1.087 . . . . 0.0 111.893 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.38 32.11 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.167 -0.958 . . . . 0.0 109.237 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.832 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -66.92 -61.86 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.462 -0.774 . . . . 0.0 110.174 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.3 mm-40 -58.07 -30.08 65.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.357 -0.839 . . . . 0.0 110.988 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -71.69 -27.45 63.05 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.621 -178.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.7 tp -81.52 -20.65 39.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 13.7 mt -88.43 -16.68 32.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 109.187 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.9 mtmt -85.56 -32.86 21.91 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.47 -40.58 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -67.52 -48.74 66.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.886 0.85 . . . . 0.0 109.099 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.86 -160.52 26.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.61 -44.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.896 -0.767 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.9 t-20 -58.69 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 109.141 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.5 m -111.86 -43.52 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.6 ttp -66.92 -28.53 68.38 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm? -59.6 -23.57 63.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.729 -0.607 . . . . 0.0 110.57 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 33' ' ' VAL . 56.4 mtt180 -86.82 -47.59 8.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.641 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.74 -23.61 65.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 110.696 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.1 mt -77.25 -29.18 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.306 -0.871 . . . . 0.0 109.086 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.62 -26.44 34.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.7 t -76.86 -37.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 -33.47 55.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.55 92.77 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.92 -67.83 0.4 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m 51.13 53.4 13.05 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mttt 66.04 73.32 0.41 Allowed Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.2 Cg_endo -71.22 143.41 43.85 Favored 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 121.939 1.759 . . . . 0.0 110.632 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.1 176.13 6.21 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 54' ' ' THR . 54.2 t -155.36 163.97 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 31.0 tt0 -148.15 111.53 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.8 mt -99.68 140.9 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.81 0.814 . . . . 0.0 110.75 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -118.86 116.12 25.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -98.92 116.91 32.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.085 -1.009 . . . . 0.0 110.948 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -118.5 52.11 1.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.75 -125.97 8.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -76.91 -0.65 24.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.395 -1.062 . . . . 0.0 110.029 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.63 139.97 31.92 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.772 -1.205 . . . . 0.0 108.371 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CD2' ' HE1' ' A' ' 93' ' ' MET . 94.7 m-85 -135.02 116.94 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.879 0.847 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -102.18 148.72 25.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -147.24 105.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 O-C-N 120.909 -1.119 . . . . 0.0 111.665 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -102.17 115.36 30.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.331 -0.856 . . . . 0.0 108.836 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 41' ' ' VAL . 60.1 m -103.08 137.15 41.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.34 143.16 50.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.303 -0.873 . . . . 0.0 110.032 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.593 0.711 . . . . 0.0 109.27 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.83 HG22 ' OE2' ' A' ' 62' ' ' GLU . 13.1 m . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.5 p -79.37 162.87 25.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.707 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.83 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.9 mp0 -156.12 122.92 5.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.69 -0.631 . . . . 0.0 109.499 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 52' ' ' ILE . 37.2 pt -121.56 165.66 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.9 p-10 -162.48 129.34 3.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.144 -0.972 . . . . 0.0 108.833 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.2 p90 -161.33 -172.43 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -128.55 153.38 47.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.54 95.3 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.554 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.91 -35.55 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -112.05 155.86 23.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.411 -1.052 . . . . 0.0 109.909 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -86.61 170.51 11.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.56 173.7 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.0 109.811 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -103.18 143.98 31.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.22 -175.4 4.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 109.445 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -102.55 154.87 18.7 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.2 t -90.19 -142.34 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.4 -0.813 . . . . 0.0 108.958 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 14.9 t -110.95 -20.8 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.733 -1.229 . . . . 0.0 110.445 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -88.57 -42.62 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.0 109.438 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.4 44.66 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.691 ' H ' HG22 ' A' ' 75' ' ' THR . 12.2 mtp180 -131.07 150.03 75.43 Favored Pre-proline 0 C--N 1.308 -1.237 0 O-C-N 121.696 -0.885 . . . . 0.0 109.003 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -77.94 140.72 18.4 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.615 1.543 . . . . 0.0 110.674 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -160.84 141.48 11.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.683 -0.636 . . . . 0.0 109.668 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.632 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.1 ttmt -87.23 116.35 25.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -99.48 164.58 12.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.295 0.569 . . . . 0.0 110.117 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.9 tp -143.98 153.18 41.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.3 t -145.58 124.94 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.656 -1.218 . . . . 0.0 111.761 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -119.17 155.34 31.81 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.526 ' NE1' HG21 ' A' ' 67' ' ' VAL . 80.6 m95 -77.19 175.15 9.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.881 0.848 . . . . 0.0 110.163 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -138.08 -46.41 0.52 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.9 p -131.22 -152.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -78.14 -25.56 47.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -142.99 27.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 110.571 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.7 tttm -133.34 113.34 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.891 -1.131 . . . . 0.0 108.288 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.38 150.82 39.53 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.493 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.71 172.21 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.506 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.7 t -147.79 139.66 24.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.781 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.93 162.84 13.65 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.23 133.59 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.552 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -141.93 151.13 42.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.23 167.93 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.98 . . . . 0.0 110.718 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 80' ' ' PRO . 50.9 mt -98.41 -6.27 30.95 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -155.09 141.1 18.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.99 -158.07 38.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -175.97 140.98 0.44 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.458 -1.024 . . . . 0.0 109.871 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.13 -85.51 0.05 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.19 -176.52 2.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.905 1.737 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -137.17 136.21 38.02 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.55 145.51 48.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.123 0.964 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.1 m -162.84 135.75 5.69 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.408 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.4 p-90 -141.73 175.41 9.72 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.669 HG22 HG13 ' A' ' 94' ' ' VAL . 11.8 p -138.15 174.38 10.62 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.696 . . . . 0.0 109.888 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 1.5 ptt? -156.77 133.35 10.06 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -131.07 146.45 52.37 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.393 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.3 143.07 39.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -92.65 161.41 14.58 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.833 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -60.27 -21.27 61.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.18 -29.62 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 0.0 109.179 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.15 -7.91 8.05 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 113' ' ' LEU . 36.2 mt-10 -59.37 172.37 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -1.167 . . . . 0.0 109.05 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -143.41 108.96 5.09 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.122 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.3 tt -103.13 148.48 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.68 145.35 51.9 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.489 -0.885 . . . . 0.0 109.489 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.14 167.19 12.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 14.2 mtp -148.32 164.65 33.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.474 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 128' ' ' VAL . 7.3 m -146.71 152.38 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.1 97.73 1.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.547 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.87 -79.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -149.65 24.47 0.87 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.398 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.3 m -120.92 -179.3 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -156.85 117.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.689 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.838 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.9 t -99.92 116.71 32.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.581 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -108.11 130.28 55.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.561 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 104.01 7.18 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.76 135.58 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.6 m-85 -124.52 122.08 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.394 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.34 140.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.45 126.0 12.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.254 -0.904 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.64 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.532 0.682 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.679 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 m-85 -99.56 -11.44 21.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 116.81 6.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.25 -0.906 . . . . 0.0 111.689 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.72 -172.95 39.74 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.02 170.11 9.51 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.11 122.83 8.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.547 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -115.75 112.07 21.48 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.778 HG21 ' HD2' ' A' ' 39' ' ' PRO . 9.1 tt -52.47 156.5 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.994 0.902 . . . . 0.0 111.547 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -128.8 -33.31 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 10' ' ' ILE . 40.1 mtt180 -146.69 170.14 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.407 ' HB2' HD11 ' A' ' 9' ' ' ILE . 6.4 t -179.35 155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.3 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -152.08 171.95 17.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.688 -0.633 . . . . 0.0 110.048 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 15.7 m120 60.31 27.77 17.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 109.798 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -66.32 -64.27 0.89 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 108.976 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 tt0 -59.1 -28.53 66.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.613 -0.679 . . . . 0.0 109.719 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.77 -37.63 84.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 130' ' ' CYS . 48.2 tp -83.58 -13.61 53.98 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.684 -0.635 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.46 -21.7 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.003 -1.061 . . . . 0.0 108.946 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mmmt -82.64 -29.28 30.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.25 -41.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 122.098 0.951 . . . . 0.0 108.472 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.505 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -65.66 -53.56 39.63 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.149 0.976 . . . . 0.0 108.99 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.95 -146.37 17.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.5 m -155.58 -37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.014 -0.698 . . . . 0.0 110.175 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.52 -170.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 109.744 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH2' ' A' ' 29' ' ' ARG . 3.0 m -119.78 -43.8 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 110.084 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 31' ' ' ILE . 16.6 ttp -68.68 -23.02 64.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 0.0 109.281 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -65.35 -30.59 71.44 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.522 -0.736 . . . . 0.0 110.921 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -85.11 -45.31 12.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 0.0 110.65 -178.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -25.43 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.0 110.834 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.558 HD11 ' HG2' ' A' ' 27' ' ' MET . 96.0 mt -80.04 -27.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.365 -0.835 . . . . 0.0 108.879 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.99 -24.45 35.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.686 -0.634 . . . . 0.0 109.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.5 t -82.23 -49.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.95 97.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.25 86.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.58 40.72 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.684 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -64.25 -54.46 32.97 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.777 -1.202 . . . . 0.0 108.12 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -139.21 71.06 40.42 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.96 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.9 Cg_endo -72.89 147.95 44.88 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.947 1.765 . . . . 0.0 110.954 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -94.31 172.52 8.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.618 ' CG2' HG23 ' A' ' 54' ' ' THR . 17.0 t -155.3 166.34 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.0 tt0 -156.77 112.44 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.331 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.5 mp -100.07 141.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.753 0.787 . . . . 0.0 110.105 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 29.7 mttt -117.03 91.28 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.21 126.28 42.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -177.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -135.54 64.88 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.43 -131.62 10.85 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -74.75 -2.34 26.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -1.044 . . . . 0.0 110.418 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -96.44 132.09 42.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.543 -1.348 . . . . 0.0 108.31 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.04 121.11 25.8 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.811 0.815 . . . . 0.0 109.047 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.74 ' O ' HD13 ' A' ' 52' ' ' ILE . 13.3 t80 -105.78 151.41 24.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -138.55 135.48 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -138.89 105.35 5.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.315 -0.866 . . . . 0.0 108.797 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.618 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.2 m -98.74 148.43 23.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 108.975 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.01 113.02 5.79 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.037 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.96 HG22 ' HB3' ' A' ' 39' ' ' PRO . 35.6 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.61 168.53 9.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -165.73 113.37 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.545 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -99.84 172.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.463 -0.773 . . . . 0.0 109.059 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.7 p30 -163.4 135.66 5.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -163.02 -171.69 2.76 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.354 1.073 . . . . 0.0 112.661 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 153.68 47.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.68 96.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.095 -1.003 . . . . 0.0 109.615 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.1 -22.69 1.92 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.941 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -126.03 156.95 39.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.256 -1.144 . . . . 0.0 110.261 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' HD13 ' A' ' 84' ' ' LEU . 4.5 mt-10 -86.65 168.3 13.73 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.5 p90 -161.93 175.17 12.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' HD11 ' A' ' 100' ' ' LEU . 7.3 mt-10 -110.32 142.75 41.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 4.9 pm0 -162.08 -169.69 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -99.71 159.79 14.78 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.17 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.748 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.8 t -96.85 -143.04 0.29 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.379 -0.825 . . . . 0.0 109.242 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 21.9 t -106.44 -23.86 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.762 -1.211 . . . . 0.0 110.914 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 p30 -88.87 -41.61 12.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.43 45.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.748 ' H ' HG22 ' A' ' 75' ' ' THR . 5.3 mmm180 -131.45 153.08 81.49 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.683 -0.892 . . . . 0.0 109.188 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.52 140.09 14.82 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.76 1.64 . . . . 0.0 110.439 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.2 p -160.57 144.65 13.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.517 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.793 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.1 tppt? -90.48 122.09 33.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 11.9 t -104.52 168.92 8.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.543 . . . . 0.0 110.206 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.605 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.2 tp -148.24 153.43 38.72 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.636 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.6 t -144.92 126.48 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.908 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.57 ' CD1' HG11 ' A' ' 67' ' ' VAL . 76.6 m95 -76.94 174.01 11.1 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.913 0.863 . . . . 0.0 110.769 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -136.65 -45.68 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.4 p -134.89 -150.66 0.4 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.87 -26.59 49.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -142.36 24.03 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 11.0 tttt -131.13 113.86 14.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.93 -1.106 . . . . 0.0 108.289 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.464 ' HE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.24 149.96 40.89 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.512 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.15 173.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.53 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.5 t -147.57 141.09 25.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.2 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.55 163.25 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -160.33 138.83 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.654 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -145.59 150.73 36.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.55 166.56 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.032 -1.043 . . . . 0.0 110.775 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.1 mt -98.68 -5.48 31.53 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -147.76 129.79 15.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 108.945 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.18 -155.83 45.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -176.27 141.82 0.45 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.524 -0.986 . . . . 0.0 109.686 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.76 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -82.18 -176.89 3.19 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.749 1.632 . . . . 0.0 109.925 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -130.42 133.83 46.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.4 144.16 46.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.115 0.96 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -163.34 135.55 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -142.78 177.66 8.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.061 -1.024 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.67 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -139.23 166.86 23.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.516 0.674 . . . . 0.0 109.956 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.56 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 19.2 ptm -148.92 124.72 10.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -122.64 151.14 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.38 144.48 43.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 18.7 p -93.87 161.77 14.18 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.859 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -60.65 -23.05 64.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.635 -0.666 . . . . 0.0 110.114 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.4 -27.95 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.67 -10.08 7.6 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 114' ' ' THR . 25.4 mt-10 -55.47 173.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.156 -1.202 . . . . 0.0 109.412 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.5 tt -147.71 114.63 6.12 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.45 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.25 150.92 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 132.98 42.16 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.49 -0.756 . . . . 0.0 109.546 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.67 165.23 13.27 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 129' ' ' VAL . 32.4 mtp -144.73 163.45 33.98 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.649 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 129' ' ' VAL . 2.6 m -146.86 149.09 32.59 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.99 93.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.52 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -147.47 23.16 1.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.665 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -118.47 -179.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.57 118.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.893 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.651 ' HB2' HD22 ' A' ' 18' ' ' LEU . 28.1 t -98.96 112.8 24.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.7 m -110.77 147.64 34.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -151.37 120.29 6.64 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.1 t -81.31 138.71 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.098 -1.001 . . . . 0.0 108.428 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.3 m-85 -127.07 125.98 42.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.153 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.99 139.92 28.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.2 125.72 11.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.224 -0.922 . . . . 0.0 111.102 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.48 179.662 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.389 0.614 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 2.6 m-85 -98.65 0.59 45.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -73.25 118.5 16.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 111.97 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.66 -171.77 38.56 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.82 170.03 9.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.891 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.52 121.77 7.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.508 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -115.25 113.22 23.6 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 12' ' ' SER . 8.6 tt -52.22 157.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.012 0.911 . . . . 0.0 111.684 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.57 -32.72 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.441 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.722 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.1 ttp180 -146.52 171.3 15.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.877 . . . . 0.0 109.034 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 9' ' ' ILE . 81.7 p -177.52 158.15 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.781 . . . . 0.0 109.641 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.64 169.86 22.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.678 -0.638 . . . . 0.0 110.034 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 17.1 m120 58.68 23.88 11.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.538 -0.726 . . . . 0.0 110.194 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -66.42 -63.39 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -56.88 -27.8 61.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.57 -39.02 93.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.634 -0.666 . . . . 0.0 109.681 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 8.4 tp -78.49 -18.04 55.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.717 -0.614 . . . . 0.0 110.157 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.5 mt -90.23 -17.76 26.9 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -86.29 -28.32 23.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.5 p -80.21 -40.96 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 76' ' ' VAL . 4.6 mp -67.28 -52.31 42.23 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.097 0.951 . . . . 0.0 109.314 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.1 -149.34 22.06 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.462 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 23' ' ' GLY . 21.1 m -155.71 -34.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 122.104 -0.645 . . . . 0.0 110.375 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.93 ' HB2' HD22 ' A' ' 28' ' ' LEU . 1.7 t-20 -61.71 -152.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 110.033 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.12 -50.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.977 -1.077 . . . . 0.0 109.051 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 8.9 ttm -65.95 -30.98 71.64 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -52.82 -33.93 51.46 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.465 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.4 mtp180 -83.31 -46.55 12.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -62.88 -15.19 53.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.691 -0.631 . . . . 0.0 111.206 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.6 -30.46 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.094 -1.004 . . . . 0.0 108.474 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.75 -24.14 33.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.5 t -80.45 -44.33 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.06 -41.33 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.07 83.49 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.21 45.21 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.844 -0.535 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -60.66 -34.72 74.72 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.572 -1.33 . . . . 0.0 108.37 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -165.68 72.88 1.32 Allowed Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.731 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.2 Cg_endo -73.15 149.78 46.67 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.811 1.674 . . . . 0.0 110.759 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.73 175.07 5.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 54' ' ' THR . 55.8 t -155.61 164.43 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 41' ' ' VAL . 44.2 tt0 -150.58 110.82 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.891 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -98.25 133.38 40.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.786 0.803 . . . . 0.0 110.161 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -113.03 106.9 15.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.7 tt0 -97.48 122.99 41.17 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.14 -0.975 . . . . 0.0 111.017 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -122.58 56.42 1.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.86 -126.06 8.13 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.77 -0.42 23.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.378 -1.072 . . . . 0.0 110.163 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 65' ' ' PHE . 14.4 m -96.89 138.06 35.02 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 120.712 -1.243 . . . . 0.0 108.556 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.6 m-85 -132.49 116.01 16.22 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.891 0.853 . . . . 0.0 109.342 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.4 t80 -101.77 146.98 27.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -143.15 99.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.026 -1.046 . . . . 0.0 110.161 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 14.6 tttt -99.45 111.82 24.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.449 -0.782 . . . . 0.0 109.718 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 41' ' ' VAL . 24.4 m -99.51 146.4 26.42 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.2 p -139.9 119.5 13.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.997 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.731 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.3 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.766 0.793 . . . . 0.0 108.917 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.6 m . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.239 0.543 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 p -108.25 176.96 4.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.0 109.34 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 2.5 pt-20 -170.26 124.05 0.71 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 109.849 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 52' ' ' ILE . 35.6 pt -114.87 170.91 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.2 p30 -162.56 133.88 5.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.949 . . . . 0.0 109.51 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.5 p90 -161.91 -171.52 2.92 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.44 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.09 152.81 49.13 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -83.0 94.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.129 -0.982 . . . . 0.0 109.64 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.08 -27.56 1.26 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.662 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.38 156.81 34.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.322 -1.105 . . . . 0.0 110.177 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -86.39 169.78 12.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.592 -0.692 . . . . 0.0 109.395 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.9 p90 -163.0 174.42 12.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.616 -0.678 . . . . 0.0 109.612 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -103.65 144.33 31.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -162.35 -174.93 4.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.564 -0.71 . . . . 0.0 109.443 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -99.83 159.25 15.21 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.3 t -95.13 -150.05 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 22' ' ' LEU . 13.7 p -98.54 -21.18 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.976 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -91.99 -51.21 5.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.64 44.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.742 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mtm180 -128.88 152.63 79.38 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.584 -0.951 . . . . 0.0 109.05 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.07 139.88 17.46 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.599 1.532 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.82 140.96 11.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.745 -0.597 . . . . 0.0 109.445 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.683 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.3 ttmt -86.4 117.28 25.1 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.0 t -99.41 168.25 10.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.18 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 70' ' ' GLU . 61.5 tp -147.01 154.08 40.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.6 t -146.65 130.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 118.441 -1.303 . . . . 0.0 112.153 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -125.51 160.04 30.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.9 m95 -83.63 169.83 14.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.129 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.446 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -132.45 -46.22 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.0 p -130.6 -153.47 0.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.11 -26.35 47.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -142.2 27.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.806 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 1.2 tttt -132.03 108.58 9.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.822 -1.173 . . . . 0.0 107.933 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.7 ptp -114.77 149.74 36.47 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.43 -0.794 . . . . 0.0 110.509 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -102.21 171.5 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.2 t -146.71 141.5 26.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.756 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.66 162.91 13.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -160.69 136.96 8.53 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.655 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -142.25 149.8 40.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.62 166.06 4.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 110.805 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 82' ' ' LYS . 48.2 mt -101.07 -3.15 29.82 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 132.41 13.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 108.796 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.77 -159.86 42.24 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.25 141.33 0.43 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.396 -1.061 . . . . 0.0 109.857 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.98 -85.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.18 -177.05 3.1 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.816 1.677 . . . . 0.0 109.793 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -132.55 138.14 47.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.37 144.47 48.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.106 0.955 . . . . 0.0 110.698 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.96 135.82 5.61 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -139.21 173.71 11.27 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.056 -1.028 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.709 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -137.57 174.05 11.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.482 0.658 . . . . 0.0 110.073 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.453 ' HB3' ' HE2' ' A' ' 111' ' ' MET . 11.0 ptp -160.35 132.83 6.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 15.3 pt-20 -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.62 145.23 40.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -92.95 161.0 14.64 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -60.14 -21.92 62.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.655 -0.653 . . . . 0.0 110.323 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -85.31 -28.37 25.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.87 -8.84 7.64 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 113' ' ' LEU . 46.3 mt-10 -57.18 172.53 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.095 -1.238 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -147.29 112.13 5.39 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.111 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.1 tt -108.04 146.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 139.8 52.3 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.536 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -118.47 169.9 9.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.8 mtp -148.81 166.25 29.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.355 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' VAL . 4.9 m -149.0 151.75 35.08 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.434 0.635 . . . . 0.0 109.459 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.36 95.07 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -147.42 24.0 1.13 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.54 -0.725 . . . . 0.0 109.282 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -118.78 -178.75 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.61 117.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.841 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.4 t -98.38 120.08 38.18 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.536 ' OG1' HG22 ' A' ' 122' ' ' THR . 90.0 m -117.85 145.51 44.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.25 118.0 7.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.56 138.48 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.0 108.398 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.7 m-85 -127.13 123.84 37.74 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.226 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 140.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.25 125.69 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.239 -0.913 . . . . 0.0 111.137 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.593 179.645 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.305 0.574 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.96 -2.42 37.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.704 -0.623 . . . . 0.0 109.366 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 t -72.15 117.71 14.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 111.936 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.6 -172.25 38.62 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 32.7 m-20 -95.68 170.08 9.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.5 m95 -149.97 118.93 6.67 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.653 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -110.65 115.28 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.832 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.4 tt -56.67 158.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.01 0.91 . . . . 0.0 111.117 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -130.7 -33.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.421 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB2' HD12 ' A' ' 10' ' ' ILE . 43.3 mtt85 -146.23 168.4 21.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 108.844 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.684 ' HB3' HD11 ' A' ' 9' ' ' ILE . 97.0 p -177.56 139.76 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.512 -0.743 . . . . 0.0 109.406 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.9 169.71 16.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.672 -0.642 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 16.4 m120 61.24 29.4 18.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.735 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.8 t80 -64.68 -63.64 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.0 109.074 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.1 pt-20 -60.53 -26.58 66.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.675 -0.641 . . . . 0.0 109.629 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -64.57 -41.48 96.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.6 tp -80.67 -13.24 59.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.0 -20.33 22.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.038 -1.038 . . . . 0.0 109.207 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.6 mmmm -84.23 -29.54 26.45 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 18' ' ' LEU . 14.3 p -78.61 -40.78 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.88 -53.1 29.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.139 0.971 . . . . 0.0 109.159 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.73 -148.72 20.8 Favored Glycine 0 N--CA 1.491 2.364 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.265 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.96 -36.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.982 -0.716 . . . . 0.0 110.418 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.865 . . . . 0.0 109.993 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 HG13 HH12 ' A' ' 29' ' ' ARG . 2.2 t -126.43 -48.24 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.362 -0.836 . . . . 0.0 109.705 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HG2' HD11 ' A' ' 31' ' ' ILE . 1.5 ttt -67.2 -25.95 66.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -62.96 -28.83 70.35 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.697 -0.627 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.5 mtp180 -87.71 -46.88 9.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 0.0 110.449 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -60.44 -30.77 69.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.505 -0.747 . . . . 0.0 110.656 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 27' ' ' MET . 80.5 mt -76.18 -27.34 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.474 -0.766 . . . . 0.0 109.188 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.2 -22.3 36.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.1 t -81.21 -43.41 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.86 85.38 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.0 -46.17 88.92 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.2 41.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -65.69 -32.73 74.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.908 -1.12 . . . . 0.0 108.293 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -159.11 70.54 3.47 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.937 ' HB3' HG23 ' A' ' 56' ' ' THR . 29.8 Cg_endo -73.92 135.2 20.9 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.897 1.731 . . . . 0.0 109.741 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -86.55 170.29 12.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.581 -0.7 . . . . 0.0 109.803 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 54' ' ' THR . 20.2 t -156.76 130.91 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.18 112.03 18.14 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.919 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.0 mt -99.21 136.13 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.657 0.741 . . . . 0.0 110.106 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -113.59 114.99 27.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.87 117.15 32.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.1 -1.0 . . . . 0.0 110.9 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -118.21 52.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 -125.1 7.67 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -77.75 0.04 25.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.366 -1.079 . . . . 0.0 109.991 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.7 m -96.42 140.2 31.43 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.763 -1.21 . . . . 0.0 108.424 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.9 m-85 -136.02 116.57 13.82 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.85 0.834 . . . . 0.0 109.488 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.7 t80 -102.36 148.44 25.47 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.126 HD12 HD11 ' A' ' 63' ' ' ILE . 1.7 mt -144.46 105.59 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 120.937 -1.102 . . . . 0.0 111.275 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.35 106.29 18.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 108.928 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 41' ' ' VAL . 14.4 m -98.17 144.61 27.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 108.559 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 118.79 12.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.852 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.413 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 p -91.11 166.87 12.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.367 -0.833 . . . . 0.0 109.99 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.04 123.06 4.36 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.126 HD11 HD12 ' A' ' 52' ' ' ILE . 35.4 pt -123.06 167.59 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.0 p-10 -162.49 128.98 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.184 -0.947 . . . . 0.0 109.26 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.68 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.4 p90 -162.09 -172.24 3.16 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.281 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -129.75 153.57 48.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.95 93.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 109.668 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.87 -26.44 1.3 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.741 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -122.82 157.68 31.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.321 -1.105 . . . . 0.0 110.079 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' HG2' HD22 ' A' ' 84' ' ' LEU . 30.6 mt-10 -86.63 168.08 13.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.12 173.33 14.47 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.708 -0.62 . . . . 0.0 109.398 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -102.68 143.11 32.76 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.8 pt-20 -162.34 -175.74 4.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.628 . . . . 0.0 109.433 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.92 157.63 16.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -91.88 -142.97 0.19 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.406 -0.809 . . . . 0.0 109.005 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.27 -19.56 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.785 -1.197 . . . . 0.0 110.649 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.676 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t0 -91.89 -44.52 8.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.557 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.99 45.1 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 0.6 OUTLIER -131.79 151.17 78.1 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 121.617 -0.931 . . . . 0.0 109.019 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.775 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.51 140.26 16.84 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.618 1.546 . . . . 0.0 110.677 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.94 141.72 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.657 -0.652 . . . . 0.0 109.606 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.7 ttmt -87.03 116.26 24.96 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -99.54 166.39 11.17 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.499 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.09 153.07 40.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.68 HG21 ' CE2' ' A' ' 65' ' ' PHE . 12.0 t -145.03 126.65 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.861 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.39 155.46 33.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.517 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.5 m95 -78.0 173.62 11.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.78 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.29 -46.26 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.8 p -131.47 -153.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.91 -23.09 44.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.85 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -144.3 26.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 20.8 tttm -133.82 112.25 11.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.905 -1.122 . . . . 0.0 108.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.495 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 ptm -118.18 149.84 40.39 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.26 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.84 172.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.497 ' H ' HG12 ' A' ' 94' ' ' VAL . 46.4 t -147.78 137.78 22.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.818 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.98 163.48 12.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -160.23 135.41 7.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.563 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -141.22 148.41 39.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.69 167.3 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.3 mt -94.98 -8.81 35.85 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.66 155.29 31.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.53 -161.04 16.97 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -176.89 138.64 0.27 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.503 -0.999 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.25 -85.05 0.05 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.02 -176.83 2.79 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.91 1.74 . . . . 0.0 109.9 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -135.97 136.42 40.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.16 47.56 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.154 0.978 . . . . 0.0 110.966 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -162.92 136.27 5.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.3 p-90 -140.54 174.68 10.28 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.31 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 94' ' ' VAL . 12.3 p -138.83 171.21 14.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.598 0.713 . . . . 0.0 109.855 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.441 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 9.8 ptp -153.04 136.48 15.86 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -132.99 149.93 52.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.703 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.99 143.73 43.79 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.9 p -92.75 161.02 14.7 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.58 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -60.42 -21.67 62.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.624 -0.672 . . . . 0.0 110.214 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.42 -28.45 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 109.32 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.35 -9.84 7.34 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 56.3 mt-10 -56.16 172.28 0.22 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.148 -1.207 . . . . 0.0 109.212 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -146.84 111.46 5.25 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.405 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.06 156.45 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.72 133.67 32.56 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.354 -0.841 . . . . 0.0 109.515 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 166.76 11.23 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.448 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.4 mtp -144.93 163.13 35.09 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.243 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -147.01 151.17 36.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.407 0.622 . . . . 0.0 109.331 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 95.13 1.42 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.564 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.27 -79.12 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.63 23.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.519 -0.738 . . . . 0.0 109.319 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.1 m -118.22 -179.88 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.52 118.4 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.744 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.741 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.32 113.0 24.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.6 m -107.14 148.34 28.95 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.911 0.862 . . . . 0.0 109.985 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -152.81 119.02 5.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.0 138.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.571 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -126.53 131.07 51.67 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.3 139.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.47 125.58 11.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.262 -0.899 . . . . 0.0 111.21 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.59 179.473 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 122.116 0.96 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.1 m-85 -104.49 -3.79 23.52 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.7 p -68.15 118.81 11.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 112.132 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.06 -173.33 38.37 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.2 m120 -95.75 170.22 9.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.22 122.86 7.98 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.814 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -114.36 114.03 25.34 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.79 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.3 tt -54.4 157.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.97 0.89 . . . . 0.0 111.46 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.778 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -130.72 -32.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -147.34 169.57 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 9' ' ' ILE . 93.3 p -176.94 160.84 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -0.794 . . . . 0.0 109.824 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.45 166.58 32.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 110.016 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 14.0 m120 61.28 29.67 18.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.965 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.4 t80 -64.19 -64.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 109.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 36.2 tt0 -60.4 -26.39 66.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.721 -0.612 . . . . 0.0 109.623 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.36 -41.56 96.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 0.0 109.922 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.5 tp -81.13 -12.84 59.14 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.1 -20.59 21.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.95 -1.094 . . . . 0.0 109.102 179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.2 mmmt -84.5 -30.05 25.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' ' 125' ' ' ALA . 14.5 p -77.4 -40.9 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.582 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -67.41 -53.02 32.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.19 0.995 . . . . 0.0 109.075 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.63 21.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -150.91 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.861 -0.788 . . . . 0.0 110.343 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.21 -169.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.261 -0.899 . . . . 0.0 109.786 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG12 ' NH2' ' A' ' 29' ' ' ARG . 14.1 m -121.7 -43.59 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.594 -0.692 . . . . 0.0 110.121 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.402 ' N ' HG23 ' A' ' 26' ' ' VAL . 7.5 ttm -68.46 -28.02 66.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.753 . . . . 0.0 109.03 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.98 -50.29 73.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.734 -0.604 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -64.0 -44.46 92.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 110.22 -178.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -59.87 -25.63 65.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.624 -0.672 . . . . 0.0 111.219 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -80.27 -28.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.165 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.43 -23.36 34.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.61 -0.681 . . . . 0.0 109.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.965 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.0 t -82.25 -47.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.24 96.82 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.49 37.39 0.57 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 p -63.69 -33.19 75.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.694 -1.254 . . . . 0.0 108.224 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -163.12 71.58 1.96 Allowed Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' HG21 ' A' ' 9' ' ' ILE . 33.3 Cg_endo -75.23 -176.31 2.85 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 122.033 1.822 . . . . 0.0 110.793 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -126.21 172.11 10.34 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 54' ' ' THR . 41.4 t -155.57 164.95 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.6 tt0 -153.72 112.4 3.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.599 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.6 mp -98.73 133.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 109.99 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.3 mttt -113.92 103.59 11.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 59.1 tt0 -97.49 127.18 43.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.143 -0.973 . . . . 0.0 111.156 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.54 55.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.05 -126.05 8.34 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.34 -0.07 24.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.434 -1.039 . . . . 0.0 110.148 178.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 m -97.48 140.64 31.63 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.745 -1.222 . . . . 0.0 108.545 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 94.1 m-85 -136.4 118.09 15.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.693 0.759 . . . . 0.0 109.547 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.8 t80 -102.47 145.78 29.06 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 63' ' ' ILE . 3.9 mt -140.34 99.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 120.987 -1.071 . . . . 0.0 110.663 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -98.79 113.46 25.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.756 . . . . 0.0 109.764 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 41' ' ' VAL . 58.6 m -106.18 143.3 34.5 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 60' ' ' THR . 2.2 p -148.8 123.44 9.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.837 . . . . 0.0 109.195 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.96 -179.295 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.727 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.7 m . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -109.28 177.22 4.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.576 -0.703 . . . . 0.0 109.939 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 pt-20 -170.66 136.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.714 -0.616 . . . . 0.0 109.342 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 52' ' ' ILE . 28.8 pt -125.97 172.54 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.0 109.292 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.535 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.3 p-10 -162.45 130.34 3.91 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 108.882 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.2 p90 -161.97 -172.72 3.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.313 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 152.79 48.54 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.726 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.23 95.69 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.89 1.57 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.911 -1.137 . . . . 0.0 110.666 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -111.2 154.91 23.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.302 -1.117 . . . . 0.0 110.065 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.459 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -86.46 167.38 14.72 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.0 p90 -162.43 173.28 14.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 110.005 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.84 145.54 29.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.683 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.1 -177.8 5.98 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -99.82 155.51 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.713 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -91.14 -142.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HB ' HD21 ' A' ' 22' ' ' LEU . 24.5 t -110.3 -20.22 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.205 . . . . 0.0 110.618 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.64 ' H ' HG23 ' A' ' 75' ' ' THR . 2.1 t70 -89.19 -41.91 11.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.78 45.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.713 ' H ' HG22 ' A' ' 75' ' ' THR . 4.8 mmm180 -131.91 151.51 78.64 Favored Pre-proline 0 N--CA 1.485 1.322 0 O-C-N 121.618 -0.931 . . . . 0.0 109.31 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.69 141.55 17.41 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.715 1.61 . . . . 0.0 110.482 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.21 141.07 10.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.676 -0.64 . . . . 0.0 109.772 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.7 ttmm -90.5 115.22 27.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -103.04 176.43 5.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.754 -0.591 . . . . 0.0 110.136 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.5 tp -151.18 152.97 34.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.709 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.7 t -140.17 130.27 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -124.43 159.31 30.74 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.726 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.2 m95 -84.54 170.19 13.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.266 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.53 -46.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.7 p -131.63 -154.75 0.64 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -76.74 -24.44 53.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.677 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -144.49 27.07 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.2 tttm -130.81 108.1 9.61 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.918 -1.114 . . . . 0.0 107.995 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.541 ' HE1' HG13 ' A' ' 67' ' ' VAL . 1.1 ptp -115.84 148.85 39.47 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.63 0.729 . . . . 0.0 110.497 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 110' ' ' THR . 1.0 OUTLIER -103.03 171.01 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 85' ' ' VAL . 42.6 t -148.63 129.95 14.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.197 -0.939 . . . . 0.0 110.675 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -100.49 164.46 11.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.48 143.49 13.35 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.773 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -146.28 149.24 33.48 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.74 166.17 3.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.054 -1.029 . . . . 0.0 110.84 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.0 mt -98.54 -5.49 32.01 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -151.52 139.6 20.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 108.958 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.71 -159.19 42.97 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -176.86 140.59 0.33 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.492 -1.005 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.8 -84.66 0.05 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.53 -177.11 3.04 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.86 1.707 . . . . 0.0 110.12 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -136.11 135.8 39.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.97 145.67 46.56 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.119 0.961 . . . . 0.0 110.793 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 m -162.64 130.4 3.82 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -133.41 168.68 18.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.765 HG22 HG13 ' A' ' 94' ' ' VAL . 17.8 p -134.25 174.6 10.33 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.449 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.6 ptp -159.13 130.23 6.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -123.66 151.5 43.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.511 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.81 142.78 46.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.6 159.15 15.35 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.761 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -59.65 -21.59 60.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.692 . . . . 0.0 110.234 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.38 -30.23 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.77 -9.48 6.79 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -56.67 171.8 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.146 -1.208 . . . . 0.0 109.08 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.8 tt -147.18 111.2 5.08 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.189 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.6 tt -105.24 156.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -135.76 153.89 51.41 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.461 -0.775 . . . . 0.0 109.302 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.64 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -136.12 169.05 18.24 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.492 ' O ' HG22 ' A' ' 129' ' ' VAL . 13.6 mtp -150.15 165.82 31.68 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.669 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -148.34 151.24 34.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.16 95.93 1.41 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.4 -79.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.13 23.87 1.17 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.539 -0.726 . . . . 0.0 109.311 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -117.77 -179.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.88 118.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.813 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -98.15 121.13 39.71 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.64 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.8 m -119.55 145.95 45.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -150.56 121.24 7.5 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.23 139.8 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.1 m-85 -128.3 126.77 41.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.89 139.03 31.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.486 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.07 125.62 10.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.212 -0.93 . . . . 0.0 111.289 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.699 179.684 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.327 0.584 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.531 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.9 m-85 -99.39 -5.43 29.55 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.627 -0.67 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 p -71.92 117.8 13.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.147 -0.97 . . . . 0.0 111.805 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.26 -173.58 39.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.0 m120 -95.61 172.27 8.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.6 124.51 9.25 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.643 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -116.46 113.7 23.2 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 6.3 tt -53.05 152.76 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.73 0.776 . . . . 0.0 111.183 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.16 -25.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.99 -0.444 . . . . 0.0 110.543 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.493 ' HB2' HD12 ' A' ' 10' ' ' ILE . 21.5 mtm-85 -152.42 -179.85 7.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 110.72 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 170.22 168.91 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.81 29.33 0.06 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.941 -1.1 . . . . 0.0 112.252 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.21 37.79 0.12 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.16 -0.962 . . . . 0.0 108.999 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.779 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.76 -63.33 1.41 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.562 -0.712 . . . . 0.0 109.558 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.3 mt-10 -57.52 -30.67 65.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.382 -0.824 . . . . 0.0 110.581 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -73.49 -30.58 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.243 -179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 130' ' ' CYS . 34.1 tp -78.71 -17.1 56.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.779 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.25 -19.97 23.51 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.067 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.1 mtmt -81.14 -30.6 34.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.72 -41.4 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.977 0.894 . . . . 0.0 108.848 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.59 -50.94 61.43 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.081 0.943 . . . . 0.0 109.279 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.23 -153.01 24.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -150.42 -37.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.956 -0.732 . . . . 0.0 110.335 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.9 -159.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.6 t -127.93 -47.34 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 0.0 109.471 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.3 ttt -65.82 -30.42 71.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.1 mm? -60.18 -28.19 67.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.724 -0.61 . . . . 0.0 110.49 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -89.49 -44.95 9.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.379 -0.825 . . . . 0.0 110.145 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -61.56 -25.08 67.08 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.632 -0.667 . . . . 0.0 110.895 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.5 -26.73 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 108.914 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -81.09 -25.89 36.66 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.631 -0.668 . . . . 0.0 109.232 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.67 -45.64 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.13 85.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.99 49.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.73 50.62 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.854 -0.529 . . . . 0.0 110.467 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.4 p -61.99 -34.03 75.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.707 -1.246 . . . . 0.0 108.236 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -162.93 74.31 2.0 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.936 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.9 Cg_endo -73.5 134.25 20.27 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.941 1.761 . . . . 0.0 111.267 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.08 177.3 7.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.651 ' CG2' HG23 ' A' ' 54' ' ' THR . 19.1 t -155.98 164.58 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -153.51 113.17 3.85 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.905 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -105.71 141.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.705 0.764 . . . . 0.0 110.676 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HE3' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.84 117.09 27.24 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.3 tt0 -99.04 118.17 35.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.115 -0.99 . . . . 0.0 110.996 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -119.69 45.8 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.31 -128.56 9.57 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.35 -3.48 30.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -1.066 . . . . 0.0 110.006 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -96.45 133.86 40.35 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.81 -1.181 . . . . 0.0 108.142 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.8 m-85 -129.54 114.87 16.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.758 0.79 . . . . 0.0 109.7 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.4 t80 -99.67 148.02 24.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.066 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -140.81 143.45 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.096 -1.002 . . . . 0.0 108.745 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -139.58 107.24 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.402 -0.811 . . . . 0.0 109.247 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.651 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.9 m -98.74 147.89 24.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -145.64 118.58 8.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.327 -0.858 . . . . 0.0 110.37 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 39' ' ' PRO . 76.1 p . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 156.49 18.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.449 -0.782 . . . . 0.0 109.877 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -151.05 103.08 3.01 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.066 HD11 HD12 ' A' ' 52' ' ' ILE . 38.8 pt -102.85 165.46 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.328 -0.857 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.2 p-10 -162.18 129.15 3.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.075 -1.015 . . . . 0.0 109.201 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.69 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.3 p90 -161.48 -172.4 3.35 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.344 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -128.86 153.37 47.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.4 95.52 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.145 -0.972 . . . . 0.0 109.755 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.05 -33.89 1.58 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.672 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.99 154.99 23.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -1.088 . . . . 0.0 109.978 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.603 ' HG3' HD13 ' A' ' 84' ' ' LEU . 7.5 mp0 -86.12 168.02 14.41 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.65 175.27 11.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.0 109.567 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.33 144.67 31.31 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -177.71 5.93 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -99.6 155.47 17.58 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.26 -142.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.4 -0.812 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.572 ' N ' HG23 ' A' ' 75' ' ' THR . 24.9 t -111.39 -20.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 110.657 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' H ' HG23 ' A' ' 75' ' ' THR . 2.7 t0 -87.21 -39.23 15.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.186 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.31 44.82 0.14 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 35.2 mtp180 -132.36 151.82 78.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.739 -0.859 . . . . 0.0 109.311 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.81 142.13 17.54 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.603 1.535 . . . . 0.0 110.348 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 p -161.04 142.32 11.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.673 -0.642 . . . . 0.0 109.81 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -90.55 113.69 25.75 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.3 t -102.08 175.2 5.61 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.139 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.6 tp -151.32 152.92 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.1 t -140.81 126.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.762 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -119.51 155.62 31.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.523 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.2 m95 -77.46 173.3 12.12 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.018 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.07 -46.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.9 p -131.52 -152.61 0.51 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -78.06 -25.92 47.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -142.96 26.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 110.782 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 79.0 tttt -132.16 111.2 11.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.937 -1.102 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.488 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.4 ptm -117.94 149.58 40.67 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.388 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.66 172.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.505 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.7 t -149.13 128.71 13.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 0.0 110.731 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -99.9 163.5 12.42 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -160.35 142.15 12.65 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.963 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -146.82 148.92 32.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.521 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.3 mt -58.94 166.49 1.96 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.985 . . . . 0.0 110.972 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.3 mt -97.44 -6.5 33.77 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -152.27 141.13 21.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 108.962 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.91 -159.78 39.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -176.8 141.19 0.35 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.998 . . . . 0.0 109.665 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.68 -84.77 0.05 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.04 -176.54 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.89 1.727 . . . . 0.0 110.022 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -136.08 137.59 41.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.41 145.3 48.41 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.101 0.953 . . . . 0.0 110.676 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.77 130.08 3.66 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -134.13 172.1 13.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.041 -1.037 . . . . 0.0 110.121 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.749 HG22 HG13 ' A' ' 94' ' ' VAL . 14.0 p -135.15 175.21 9.79 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.4 ptp -158.08 133.8 9.06 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -131.81 147.68 52.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.386 -0.821 . . . . 0.0 109.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.96 143.17 38.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 160.29 15.72 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.648 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -60.19 -21.54 61.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.666 -0.646 . . . . 0.0 110.064 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.59 -29.81 25.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.97 -8.97 7.14 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.8 mp0 -58.11 174.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.698 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -146.04 110.27 5.0 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.914 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.665 ' CD1' HG22 ' A' ' 133' ' ' VAL . 9.0 tt -106.11 146.32 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.76 141.96 51.44 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.639 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.49 171.99 7.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.3 mtp -152.75 165.11 36.35 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.583 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.23 152.99 39.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.48 97.46 1.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.627 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.95 -79.83 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.33 24.26 1.02 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 109.387 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -119.75 -179.72 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.83 117.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.374 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.59 ' HB2' HD22 ' A' ' 18' ' ' LEU . 6.4 t -98.93 133.95 42.47 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -125.61 125.73 43.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -122.38 101.54 7.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' A' ' 120' ' ' ILE . 48.8 t -68.18 136.95 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.403 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 28.3 m-85 -127.9 130.79 49.08 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.416 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.5 137.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -49.12 128.63 16.71 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.211 -0.931 . . . . 0.0 111.634 -178.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 tm-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.751 0.786 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.556 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.6 m-85 -99.59 -2.74 34.9 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.634 -0.666 . . . . 0.0 109.441 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -70.53 118.5 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.944 . . . . 0.0 112.186 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.46 -172.08 38.46 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 36.0 m-20 -95.77 170.48 9.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.888 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.23 122.17 7.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.609 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -114.13 114.49 26.13 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.4 tt -57.68 153.64 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.928 0.87 . . . . 0.0 111.326 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.731 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.1 pp -127.25 -31.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.731 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -144.26 173.08 12.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.338 -0.851 . . . . 0.0 108.842 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.63 ' HB2' HD11 ' A' ' 9' ' ' ILE . 11.8 t 179.94 165.29 1.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.303 -0.873 . . . . 0.0 109.715 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -159.99 163.12 34.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.748 -0.595 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 12.0 m120 62.64 33.3 15.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.72 . . . . 0.0 109.719 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.949 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.7 -64.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 110.165 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 18.7 mt-10 -56.91 -33.82 67.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.869 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -70.71 -29.7 66.04 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.467 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' HB2' ' A' ' 130' ' ' CYS . 15.4 tp -77.61 -21.4 52.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.037 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.982 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -88.99 -16.13 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.036 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -86.14 -32.6 21.2 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -75.14 -38.91 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.7 mp -69.28 -45.63 69.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.797 0.808 . . . . 0.0 109.476 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.8 -159.56 27.66 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.4 m -146.63 -38.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.963 -0.728 . . . . 0.0 110.051 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.6 t-20 -61.28 -156.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.422 -0.799 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.45 -47.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.429 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 31' ' ' ILE . 2.5 ttt -68.01 -27.98 67.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -59.94 -16.96 34.17 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.684 -0.635 . . . . 0.0 111.243 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.4 mpt_? -97.11 -50.14 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.009 . . . . 0.0 110.048 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -23.38 67.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.73 . . . . 0.0 110.717 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.57 HD11 ' HG2' ' A' ' 27' ' ' MET . 74.3 mt -77.17 -28.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 108.768 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.91 -25.15 35.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.5 t -76.06 -37.98 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.88 46.33 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.57 92.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -70.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t 48.51 52.62 13.41 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.497 0.665 . . . . 0.0 109.763 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 66.23 70.39 0.52 Allowed Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.0 Cg_endo -72.87 164.55 35.25 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.988 1.792 . . . . 0.0 111.027 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.36 173.77 6.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 HG23 ' A' ' 54' ' ' THR . 47.9 t -154.8 166.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.9 tt0 -154.38 110.24 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.888 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.8 mt -97.33 133.52 38.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.845 0.831 . . . . 0.0 110.298 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 6.8 mttm -107.94 93.79 4.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.72 125.53 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.4 -0.813 . . . . 0.0 110.373 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.45 59.36 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.64 -130.05 10.15 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.65 -2.42 26.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.394 -1.062 . . . . 0.0 110.209 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -96.93 137.05 36.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.571 -1.331 . . . . 0.0 108.269 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.648 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 97.5 m-85 -135.35 125.97 27.05 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.69 0.757 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.3 t80 -108.74 143.06 38.37 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -130.05 106.54 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 106.21 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 41' ' ' VAL . 15.1 m -99.22 146.82 25.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 108.896 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.7 p -142.69 134.31 26.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.433 -0.792 . . . . 0.0 110.323 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.87 0.843 . . . . 0.0 108.829 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 3.2 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.292 0.567 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -119.65 171.44 8.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -160.93 157.09 25.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.717 HD11 HG13 ' A' ' 52' ' ' ILE . 29.7 pt -144.22 170.72 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.56 -0.712 . . . . 0.0 109.157 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.1 p-10 -161.6 134.65 6.23 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.8 p90 -162.96 -173.23 3.37 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.289 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -127.88 153.0 47.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.72 95.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.257 -0.902 . . . . 0.0 109.666 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.85 -24.57 1.63 Allowed Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.815 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -124.57 155.57 38.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.296 -1.12 . . . . 0.0 110.229 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -86.18 168.02 14.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.47 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.58 174.35 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.617 -0.677 . . . . 0.0 109.717 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -103.04 144.93 30.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -176.04 4.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.655 -0.653 . . . . 0.0 109.513 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -99.88 156.98 16.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.721 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.58 -143.82 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.375 -0.828 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.4 t -111.59 -21.07 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.825 -1.172 . . . . 0.0 110.876 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.594 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -89.03 -39.84 13.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.649 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 46.89 0.09 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 75' ' ' THR . 7.4 mmm180 -136.3 151.99 74.28 Favored Pre-proline 0 C--N 1.306 -1.308 0 O-C-N 121.759 -0.847 . . . . 0.0 109.353 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.643 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -79.07 141.76 16.73 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.764 1.643 . . . . 0.0 110.512 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 p -161.01 142.26 11.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.666 -0.646 . . . . 0.0 109.707 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.579 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.8 ttpt -86.68 117.65 25.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.24 164.48 12.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.845 -0.534 . . . . 0.0 109.731 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' CA ' ' A' ' 70' ' ' GLU . 62.5 tp -144.24 153.81 42.44 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG21 ' CE2' ' A' ' 65' ' ' PHE . 29.0 t -147.09 130.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 118.5 -1.28 . . . . 0.0 112.108 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -125.04 157.85 35.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.544 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.8 m95 -79.82 172.26 14.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -135.68 -45.85 0.67 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.8 p -131.47 -154.18 0.61 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -76.59 -25.13 53.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.666 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -144.36 26.88 1.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.823 . . . . 0.0 110.817 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 51.9 tttt -130.75 110.86 11.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.901 -1.124 . . . . 0.0 108.154 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.657 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -115.5 146.96 41.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.446 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -100.18 170.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.467 ' H ' HG12 ' A' ' 94' ' ' VAL . 52.2 t -146.38 140.94 26.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.739 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.7 162.8 14.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -160.21 135.74 8.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 149.97 41.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.87 167.63 2.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 80' ' ' PRO . 46.7 mt -98.64 -6.55 29.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.02 143.66 19.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.77 -162.66 34.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.99 139.38 0.38 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.44 -1.035 . . . . 0.0 109.975 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.18 -85.84 0.05 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.86 -176.94 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.811 1.674 . . . . 0.0 109.721 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -135.29 139.67 44.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.14 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.139 0.971 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.3 m -163.01 139.1 7.1 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -142.64 173.25 11.71 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.037 -1.039 . . . . 0.0 110.568 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.746 HG22 HG13 ' A' ' 94' ' ' VAL . 16.0 p -137.58 172.65 12.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.909 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.408 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 11.6 ptp -160.11 136.34 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.406 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.6 pt-20 -135.41 154.76 51.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.237 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.551 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.71 144.36 42.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.7 p -91.18 159.95 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.406 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.73 -19.45 50.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.591 -0.693 . . . . 0.0 110.45 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.98 -28.54 21.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.3 -9.16 7.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 113' ' ' LEU . 60.8 mt-10 -57.63 172.67 0.34 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.082 -1.246 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.803 HD13 HD13 ' A' ' 43' ' ' ILE . 8.0 tt -147.13 112.15 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.251 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -108.52 148.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -131.35 137.99 48.99 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.363 -0.836 . . . . 0.0 109.684 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.54 170.75 8.02 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.8 mtp -147.65 168.19 22.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.573 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.1 m -151.85 150.94 30.67 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.712 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.9 94.21 1.42 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.534 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.9 -78.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -146.88 24.62 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.7 m -118.13 -179.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.33 119.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.827 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.875 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.46 123.25 43.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.4 m -116.61 148.04 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -151.94 120.37 6.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 50.3 t -82.38 137.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.005 . . . . 0.0 108.351 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.8 m-85 -127.28 124.99 40.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.351 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.64 139.85 28.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.483 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.12 125.72 11.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.176 -0.952 . . . . 0.0 111.193 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.942 -1.028 . . . . 0.0 111.607 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.322 0.582 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.5 m-85 -98.86 -1.78 39.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.712 -0.617 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 t -70.9 116.61 11.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.144 -0.972 . . . . 0.0 112.011 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.45 -172.83 39.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 32.9 m-20 -95.8 168.23 10.78 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.67 124.65 8.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.566 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -118.83 112.59 19.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.436 HD12 ' HD2' ' A' ' 132' ' ' ARG . 5.7 tt -54.25 143.92 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.626 0.727 . . . . 0.0 110.882 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.61 -24.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.999 -0.438 . . . . 0.0 109.936 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.05 174.24 10.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.282 -0.886 . . . . 0.0 110.069 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t 170.2 168.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.62 28.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.91 -1.119 . . . . 0.0 111.654 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.53 29.65 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -178.418 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.869 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.05 -66.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -0.851 . . . . 0.0 108.752 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' HG21 ' A' ' 33' ' ' VAL . 15.4 mt-10 -55.97 -31.1 62.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -61.29 -38.46 86.88 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.129 0.49 . . . . 0.0 110.469 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.675 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.3 tp -80.17 -17.45 52.41 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.717 -0.614 . . . . 0.0 110.137 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.3 mt -89.67 -17.65 27.96 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.088 -1.007 . . . . 0.0 109.013 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -84.05 -32.19 24.98 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -76.28 -40.21 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.84 -46.28 72.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.838 0.827 . . . . 0.0 109.6 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.16 -157.01 27.16 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.341 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.8 m -148.78 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 122.037 -0.684 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.5 t-20 -61.65 -156.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.474 -0.767 . . . . 0.0 109.132 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.97 -47.09 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 109.695 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 ttp -68.16 -28.36 67.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -59.49 -23.79 63.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.811 -0.556 . . . . 0.0 110.64 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -91.33 -46.91 7.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.905 . . . . 0.0 109.727 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -62.15 -20.88 64.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.664 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.54 -28.92 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.261 -0.9 . . . . 0.0 108.925 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.95 -26.05 34.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -76.48 -41.21 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.62 64.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.92 97.47 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.554 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.43 -66.19 0.59 Allowed 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.566 -0.708 . . . . 0.0 109.289 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m 52.83 57.64 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 66.71 73.61 0.38 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.0 Cg_endo -70.91 153.39 63.69 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 122.167 1.912 . . . . 0.0 111.003 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -105.28 174.02 6.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.698 -0.626 . . . . 0.0 109.464 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.691 HG22 HG23 ' A' ' 54' ' ' THR . 47.2 t -154.86 165.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.1 tt0 -149.7 112.47 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.612 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -97.81 133.88 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.806 0.812 . . . . 0.0 110.264 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.05 106.29 14.23 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 61.2 tt0 -97.55 126.43 42.83 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.078 -1.014 . . . . 0.0 111.36 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -125.76 55.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -126.94 8.62 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.53 -0.33 22.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 110.12 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -97.22 139.98 32.38 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.72 -1.237 . . . . 0.0 108.498 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.7 m-85 -134.57 118.27 17.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.536 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.2 t80 -102.78 144.98 30.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 63' ' ' ILE . 3.3 mt -140.67 101.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -98.92 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.572 -0.705 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.691 HG23 HG22 ' A' ' 41' ' ' VAL . 12.8 m -99.38 141.01 32.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.55 118.92 17.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 110.434 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -95.66 175.43 6.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.3 pm0 -171.35 142.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.045 HD11 HD12 ' A' ' 52' ' ' ILE . 31.7 pt -129.04 171.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.5 p-10 -161.89 130.58 4.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.178 -0.951 . . . . 0.0 109.217 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -162.07 -172.17 3.14 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 153.35 48.28 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.35 89.26 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.143 -0.973 . . . . 0.0 109.661 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.1 -23.26 0.99 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.938 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -122.02 154.94 36.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.55 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.4 mt-10 -86.26 165.56 16.37 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.18 173.93 13.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.866 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -102.28 146.74 27.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.5 pt-20 -162.53 -175.49 4.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 109.408 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -101.01 155.65 17.86 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.9 t -93.89 -143.75 0.24 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.354 -0.841 . . . . 0.0 109.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 23.3 t -112.67 -19.87 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.807 -1.183 . . . . 0.0 110.638 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.631 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t70 -88.04 -40.89 13.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.44 44.77 0.1 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.698 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mmm180 -135.98 154.13 77.42 Favored Pre-proline 0 C--N 1.308 -1.229 0 O-C-N 121.654 -0.91 . . . . 0.0 109.095 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.23 144.61 20.92 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.7 1.6 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.5 p -161.24 141.75 11.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.688 -0.633 . . . . 0.0 109.616 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.677 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.4 tttp -88.02 117.21 26.73 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.0 t -99.94 168.11 10.07 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.207 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' HG2' ' A' ' 70' ' ' GLU . 62.0 tp -150.61 152.99 34.89 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.9 t -144.08 135.88 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.236 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -128.3 159.23 35.93 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.598 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.6 m95 -84.97 167.3 16.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 110.062 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.4 tp10 -129.79 -45.61 1.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.6 p -131.83 -154.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.31 -25.38 51.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -142.67 26.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.898 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 46.4 tttm -131.41 104.96 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 108.302 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.2 ptp -112.22 147.55 35.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.581 -0.699 . . . . 0.0 110.221 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 110' ' ' THR . 1.6 t -103.57 169.05 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.9 t -144.55 140.76 29.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.169 -0.957 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -109.55 160.73 15.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 176.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -158.95 139.6 12.57 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.433 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -143.53 150.56 39.07 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.42 166.39 3.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.7 mt -99.74 -4.24 31.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.95 130.68 15.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 108.672 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.49 -159.46 45.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -176.82 141.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.469 -1.018 . . . . 0.0 109.713 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.29 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.46 -176.78 2.91 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.804 1.669 . . . . 0.0 109.752 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -131.95 142.8 49.74 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.2 146.32 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.85 126.75 2.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -130.86 163.94 26.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.136 -0.977 . . . . 0.0 110.39 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 94' ' ' VAL . 21.6 p -130.02 166.44 20.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.548 ' HE3' HD11 ' A' ' 52' ' ' ILE . 11.2 ptp -150.01 117.75 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 151.98 28.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.433 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.499 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -117.06 143.12 46.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.4 p -94.35 178.46 5.61 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.932 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -75.76 -24.15 56.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.641 -0.662 . . . . 0.0 110.448 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.73 -19.64 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.741 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 119.41 -5.13 13.27 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.1 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.48 177.99 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 118.924 1.362 . . . . 0.0 108.439 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.605 HD11 ' HD2' ' A' ' 3' ' ' PHE . 7.8 tt -153.4 115.89 4.43 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.965 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.27 154.59 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.767 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -136.61 109.2 7.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -99.09 167.21 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 129' ' ' VAL . 38.4 mtp -145.93 164.35 32.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.552 -0.717 . . . . 0.0 109.603 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.89 152.67 39.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.73 94.94 1.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.537 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.52 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -148.11 23.72 1.06 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.57 -0.706 . . . . 0.0 109.382 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.3 m -120.23 -179.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.46 117.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.456 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.675 ' CB ' HD22 ' A' ' 18' ' ' LEU . 10.7 t -99.37 111.7 24.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 122' ' ' THR . 75.1 m -99.26 152.74 19.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.866 0.841 . . . . 0.0 109.469 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.436 ' HD2' HD12 ' A' ' 9' ' ' ILE . 27.7 mtm180 -151.88 94.83 2.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.61 128.74 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.5 m-85 -115.82 133.88 55.58 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.491 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.85 137.75 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.479 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.9 mtm180 -47.38 124.22 6.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.387 -0.821 . . . . 0.0 111.468 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.755 179.816 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.708 0.766 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.5 m-85 -111.58 0.54 16.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -72.95 117.5 14.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 112.13 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.86 -171.74 37.86 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.446 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 169.39 10.05 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.38 118.6 6.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.591 -177.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -110.51 113.74 26.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.736 HG21 ' HD2' ' A' ' 39' ' ' PRO . 11.1 tt -55.61 157.78 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.921 0.867 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.798 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.81 -32.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.497 179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.798 ' HB2' HD12 ' A' ' 10' ' ' ILE . 4.1 ttp180 -146.13 170.33 16.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 108.812 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.6 t 177.64 141.24 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -136.58 178.44 7.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.701 -0.625 . . . . 0.0 109.875 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.1 m120 58.86 26.59 15.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.728 . . . . 0.0 109.99 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -65.55 -62.95 1.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.822 . . . . 0.0 109.072 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 8.4 pt-20 -58.73 -29.13 66.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.643 -0.661 . . . . 0.0 109.565 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.01 -39.61 93.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.738 -0.601 . . . . 0.0 110.235 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.748 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.6 tp -82.02 -13.97 56.6 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.708 -0.62 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.34 -20.27 22.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.931 -1.106 . . . . 0.0 109.11 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.5 mtmt -83.32 -29.58 28.18 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 14.6 p -78.79 -41.82 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.66 -56.39 10.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 122.381 1.086 . . . . 0.0 108.523 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -103.59 -145.84 15.6 Favored Glycine 0 N--CA 1.489 2.221 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.79 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.0 m -156.29 -37.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.706 . . . . 0.0 110.364 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.51 -175.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.204 -0.935 . . . . 0.0 110.126 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.5 t -116.3 -44.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.554 -0.716 . . . . 0.0 109.574 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.449 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.1 ttp -65.41 -24.75 67.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.8 mm? -64.11 -40.14 95.56 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.675 -0.64 . . . . 0.0 110.57 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 33' ' ' VAL . 10.3 mtp180 -70.54 -48.33 55.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.379 -0.825 . . . . 0.0 110.139 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -55.72 -46.65 77.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.449 HD11 ' HG2' ' A' ' 27' ' ' MET . 48.7 mt -67.1 -26.07 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.801 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.25 -21.95 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.353 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.6 t -82.12 -44.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.29 91.63 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.63 -53.28 56.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.93 37.71 0.61 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.868 -0.52 . . . . 0.0 110.511 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 t -66.02 -34.09 77.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.796 -1.19 . . . . 0.0 108.501 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -157.27 69.68 4.37 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.736 ' HD2' HG21 ' A' ' 9' ' ' ILE . 29.7 Cg_endo -74.24 137.37 23.47 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 121.948 1.765 . . . . 0.0 110.2 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -85.57 166.86 15.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.583 -0.698 . . . . 0.0 109.37 -179.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.704 ' CG2' HG23 ' A' ' 54' ' ' THR . 16.0 t -154.34 127.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -117.9 111.02 18.45 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.5 mt -98.33 132.16 43.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.728 0.775 . . . . 0.0 110.334 -178.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttm -106.48 94.15 4.98 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.68 123.85 40.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.344 -0.848 . . . . 0.0 110.366 -177.251 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -132.61 68.17 1.51 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.11 -130.59 10.26 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.1 p30 -75.43 -1.6 24.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.357 -1.084 . . . . 0.0 110.388 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -95.98 139.28 32.4 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.701 -1.249 . . . . 0.0 109.003 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.9 m-85 -136.31 118.81 15.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.753 0.787 . . . . 0.0 108.951 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 16.2 t80 -104.41 150.85 24.17 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -149.35 104.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.895 -1.128 . . . . 0.0 111.288 -176.866 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -103.23 102.44 12.41 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.704 HG23 ' CG2' ' A' ' 41' ' ' VAL . 32.5 m -98.09 127.1 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.849 . . . . 0.0 109.359 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.8 OUTLIER -121.11 130.48 53.76 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.799 -179.455 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' THR . 12.1 m . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.267 0.556 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 60' ' ' THR . 3.1 p -156.86 156.41 33.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.45 109.19 2.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 110.247 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 52' ' ' ILE . 40.0 pt -113.5 164.32 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.8 p30 -162.44 132.25 4.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.131 -0.981 . . . . 0.0 109.497 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.764 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.7 p90 -161.87 -171.42 2.89 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.224 1.011 . . . . 0.0 111.83 -178.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.85 154.72 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.28 93.9 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.09 -1.006 . . . . 0.0 109.657 -178.415 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.26 -19.46 0.63 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.683 -1.246 . . . . 0.0 111.298 179.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -134.9 160.7 37.42 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.121 -1.223 . . . . 0.0 111.205 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.769 ' HG3' HD13 ' A' ' 84' ' ' LEU . 3.7 mt-10 -86.63 164.83 16.6 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.1 p90 -162.2 173.62 14.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -102.1 144.53 30.56 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.617 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.36 -176.67 5.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.62 . . . . 0.0 109.363 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.27 157.3 16.7 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.4 t -93.05 -144.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -0.867 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.2 t -107.75 -22.2 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.856 -1.152 . . . . 0.0 110.571 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.637 ' H ' HG23 ' A' ' 75' ' ' THR . 19.9 t0 -86.62 -47.71 8.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 108.955 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -132.1 151.69 78.86 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.671 -0.899 . . . . 0.0 109.226 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.3 Cg_endo -78.35 140.5 17.36 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.618 1.545 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.3 p -161.05 142.38 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HB2' HD21 ' A' ' 100' ' ' LEU . 4.5 tttt -88.25 118.56 27.93 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -99.57 168.08 10.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.496 0.665 . . . . 0.0 110.459 -178.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.769 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.2 tp -148.0 149.95 33.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.764 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.3 t -141.78 134.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.111 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.9 pttt -130.47 161.83 30.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.582 ' CE2' HG21 ' A' ' 67' ' ' VAL . 85.0 m95 -85.44 170.27 12.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.63 -45.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -132.9 -153.18 0.53 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.97 -23.78 44.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -143.0 22.26 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.834 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 73.1 tttt -130.78 111.81 12.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.832 -1.167 . . . . 0.0 108.639 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.489 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 3.7 ptp -116.0 154.97 28.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.601 -0.687 . . . . 0.0 109.981 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 110' ' ' THR . 1.8 t -108.92 168.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.41 132.81 20.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -104.02 158.11 16.64 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -154.76 142.04 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.91 -177.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -144.0 150.87 38.94 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.59 168.17 2.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 110.783 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 80' ' ' PRO . 33.2 mt -99.79 -5.29 28.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -153.99 138.7 17.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 108.84 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.63 -158.79 39.56 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -176.33 140.55 0.39 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.475 -1.015 . . . . 0.0 109.888 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.83 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.96 -176.7 2.75 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.822 1.681 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -134.31 137.24 44.07 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.69 145.81 47.64 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.123 0.963 . . . . 0.0 110.854 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.41 131.56 4.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.23 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -134.98 169.78 16.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.364 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 94' ' ' VAL . 22.7 p -134.34 170.17 16.13 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.5 0.667 . . . . 0.0 109.817 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.552 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.6 ptm -153.05 124.38 7.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -119.05 152.39 36.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.431 -0.793 . . . . 0.0 110.185 -178.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.77 144.43 44.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.937 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.8 p -89.87 167.12 13.08 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.802 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -63.81 -20.36 65.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.647 -0.658 . . . . 0.0 110.687 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.35 -32.66 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.06 -13.24 2.84 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.704 -1.236 . . . . 0.0 111.336 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -53.11 170.89 0.08 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 118.828 1.314 . . . . 0.0 109.345 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.9 tt -147.36 114.23 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.725 -178.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.19 158.62 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.81 134.37 30.08 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.393 -0.817 . . . . 0.0 109.57 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.0 170.04 8.57 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.496 ' O ' HG22 ' A' ' 129' ' ' VAL . 17.6 mtp -147.8 164.53 33.34 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.178 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.4 m -148.46 151.97 36.11 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.448 0.642 . . . . 0.0 109.434 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.35 96.88 1.45 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.518 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.86 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.44 24.41 1.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.559 -0.713 . . . . 0.0 109.268 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -118.87 -179.29 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.78 118.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.651 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.748 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.33 115.57 28.72 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.6 m -110.8 147.63 34.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 -179.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 120.74 6.34 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.78 142.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -129.39 133.28 47.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.59 139.31 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.1 125.29 10.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.244 -0.91 . . . . 0.0 111.33 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.602 179.466 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.261 0.553 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.702 ' HB3' HG21 ' A' ' 43' ' ' ILE . 6.3 m-85 -99.37 -10.92 21.66 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.712 -0.617 . . . . 0.0 109.576 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 t -65.71 115.39 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.219 -0.925 . . . . 0.0 111.819 -177.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.78 -172.71 39.73 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.71 168.49 10.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 178.062 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.926 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.72 124.63 8.57 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.375 -177.288 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -118.91 112.95 20.29 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.571 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.6 tt -57.11 140.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.41 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -120.95 -23.18 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.9 -0.5 . . . . 0.0 110.055 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -139.42 172.81 12.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t 171.29 168.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.15 29.97 0.12 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.948 -1.095 . . . . 0.0 111.713 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.09 33.55 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.285 -0.884 . . . . 0.0 109.082 -178.51 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -65.7 -66.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -0.784 . . . . 0.0 108.979 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 pt-20 -57.5 -26.73 61.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -64.3 -39.66 94.36 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.65 -0.656 . . . . 0.0 109.706 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.4 tp -80.17 -15.3 57.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.697 -0.627 . . . . 0.0 110.016 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.6 mt -90.05 -19.8 23.96 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.976 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmt -84.98 -28.15 25.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -79.82 -41.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.716 HD21 HG13 ' A' ' 76' ' ' VAL . 4.4 mp -65.93 -53.71 35.79 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.04 0.924 . . . . 0.0 109.114 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 -151.62 23.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.56 -42.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.981 -0.717 . . . . 0.0 109.407 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -56.37 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.793 . . . . 0.0 109.681 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.618 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.2 m -113.2 -43.77 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.03 -26.69 66.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.532 -0.73 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -57.61 -45.26 85.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.681 -0.637 . . . . 0.0 110.491 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.904 ' O ' HG23 ' A' ' 33' ' ' VAL . 4.2 mtp180 -67.34 -40.95 85.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -62.75 -24.38 67.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.678 -0.639 . . . . 0.0 110.838 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 28' ' ' LEU . 34.2 mt -78.67 -28.81 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.062 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.952 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.92 34.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 109.237 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.9 t -79.22 -38.72 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.67 -35.65 62.81 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.03 -37.58 81.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.1 -67.7 0.43 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t 49.87 50.46 18.38 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm 66.3 74.19 0.37 Allowed Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.6 Cg_endo -71.72 146.21 48.09 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 122.01 1.807 . . . . 0.0 110.797 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -92.56 175.48 6.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.765 -0.584 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.547 ' CG2' HG23 ' A' ' 54' ' ' THR . 24.7 t -155.31 165.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.9 tt0 -149.88 112.87 4.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.926 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.7 mt -99.85 140.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.806 0.812 . . . . 0.0 110.443 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.9 mttt -119.14 114.37 22.36 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 57.1 tt0 -98.9 111.61 23.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.0 110.786 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -115.57 47.95 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.18 -127.57 9.07 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.4 p30 -74.85 -3.28 31.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.444 -1.033 . . . . 0.0 110.048 178.672 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 m -96.39 134.9 38.97 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.689 -1.257 . . . . 0.0 108.309 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.9 m-85 -131.37 119.2 21.34 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.875 0.845 . . . . 0.0 109.22 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.0 t80 -104.61 133.16 49.92 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.791 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 mm -115.45 137.18 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.1 tttt -132.4 98.65 4.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.0 108.704 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.547 HG23 ' CG2' ' A' ' 41' ' ' VAL . 17.8 m -98.45 145.37 26.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.446 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.59 136.42 24.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.853 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.848 0.832 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 152.83 19.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.409 -0.807 . . . . 0.0 109.123 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG3' ' CG ' ' A' ' 53' ' ' LYS . 1.2 mp0 -150.98 101.7 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.563 -0.711 . . . . 0.0 109.735 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -104.71 167.35 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.632 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.0 p-10 -161.78 132.49 5.07 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.483 -0.761 . . . . 0.0 109.064 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.3 p90 -161.88 -172.46 3.29 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.061 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.45 154.27 46.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.27 95.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -33.77 1.68 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.712 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.42 153.77 23.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.367 -1.078 . . . . 0.0 109.977 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' CA ' HD13 ' A' ' 84' ' ' LEU . 20.1 mt-10 -85.96 166.95 15.51 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.24 173.3 14.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.875 -178.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.13 145.04 30.52 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -178.21 6.24 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.573 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.62 155.2 17.72 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.8 t -91.66 -152.2 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 109.331 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.716 HG13 HD21 ' A' ' 22' ' ' LEU . 14.7 p -99.29 -20.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.992 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.716 ' H ' HG23 ' A' ' 75' ' ' THR . 1.8 t70 -88.61 -50.86 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.211 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.06 44.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 3.0 mmm-85 -130.67 152.01 79.72 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 121.613 -0.933 . . . . 0.0 109.127 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.54 141.05 17.36 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.581 1.521 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 p -161.07 142.02 11.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.7 ttmm -90.65 115.08 27.48 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -102.95 176.66 5.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.411 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.4 tp -152.36 152.15 31.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.5 t -140.87 125.54 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.543 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -120.47 156.0 32.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.525 ' NE1' HG21 ' A' ' 67' ' ' VAL . 83.8 m95 -77.91 172.28 13.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.805 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 6.9 tp10 -134.52 -46.61 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.9 p -129.27 -152.79 0.53 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.17 -24.98 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -143.3 25.68 1.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 29.0 tttm -131.06 108.29 9.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.82 -1.175 . . . . 0.0 108.211 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.506 ' HE3' HG13 ' A' ' 67' ' ' VAL . 1.6 ptm -114.47 148.21 38.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.366 -0.834 . . . . 0.0 110.239 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.861 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.66 172.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.502 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -148.37 129.81 14.82 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.21 141.35 12.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.9 -178.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -145.75 148.4 32.94 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 110.872 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 80' ' ' PRO . 35.6 mt -96.98 -7.09 33.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -154.18 146.31 23.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.839 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.73 -162.51 34.23 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -176.94 140.14 0.3 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -1.033 . . . . 0.0 109.798 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.92 -84.79 0.05 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.93 -176.79 2.8 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.883 1.722 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -137.74 139.22 39.99 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.24 146.04 47.65 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.072 0.939 . . . . 0.0 110.669 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -162.61 131.27 4.07 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -135.85 170.05 16.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.968 -1.082 . . . . 0.0 110.362 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 94' ' ' VAL . 18.5 p -133.55 165.33 25.14 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.462 0.649 . . . . 0.0 109.395 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.437 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.3 ptm -152.72 124.86 8.04 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.5 pt-20 -129.98 158.8 38.58 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.965 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -113.65 145.2 41.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.348 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 p -92.38 161.26 14.73 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.425 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.72 -18.62 55.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.528 -0.732 . . . . 0.0 110.515 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -88.39 -27.02 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.17 -7.87 8.58 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 113' ' ' LEU . 27.1 mt-10 -59.97 172.33 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.243 . . . . 0.0 108.579 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -145.64 113.11 6.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.065 -178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 12.5 tt -99.76 151.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -133.87 112.14 11.05 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.007 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.438 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -99.22 166.51 11.19 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.1 mtp -145.4 163.97 32.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.543 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.12 152.35 39.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.56 95.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.548 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 78.08 -79.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -147.64 23.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.7 m -120.25 -179.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.16 117.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.594 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.825 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.7 t -99.6 112.64 24.84 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -99.2 153.81 18.64 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.847 0.832 . . . . 0.0 109.139 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.571 ' HB3' HD12 ' A' ' 9' ' ' ILE . 36.5 mtm180 -151.42 93.6 1.91 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.54 127.39 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.7 m-85 -114.79 130.34 56.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.239 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.24 138.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.57 124.12 6.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.307 -0.871 . . . . 0.0 111.391 -178.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.702 179.907 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.34 0.591 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.3 m-85 -99.59 -18.08 17.52 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -60.65 116.21 4.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 111.827 -177.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.33 -173.06 39.43 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -96.03 169.53 9.91 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -151.95 126.21 9.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.718 -176.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -117.36 113.08 21.59 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.54 ' C ' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -61.59 140.99 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.711 0.767 . . . . 0.0 110.236 -178.929 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 11' ' ' ARG . 2.5 pp -126.36 -22.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 10' ' ' ILE . 1.9 mmm180 -133.22 167.29 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.159 -0.963 . . . . 0.0 110.442 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 170.05 167.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -161.04 29.3 0.14 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.019 -1.05 . . . . 0.0 111.289 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.85 34.3 0.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.06 -65.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.534 -0.729 . . . . 0.0 109.235 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.2 mt-10 -58.65 -26.44 63.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.429 -0.795 . . . . 0.0 109.138 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.11 -38.12 89.92 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.717 -0.614 . . . . 0.0 109.841 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.5 tp -81.58 -16.28 52.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.686 -0.634 . . . . 0.0 110.033 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' HB3' ' A' ' 32' ' ' ALA . 9.4 mt -89.67 -19.25 25.07 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -85.84 -29.09 24.01 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.651 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.9 p -78.5 -41.25 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.0 -52.51 48.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.001 0.905 . . . . 0.0 108.905 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.32 -147.58 19.63 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.4 m -154.91 -41.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.927 -0.749 . . . . 0.0 109.531 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.4 t-20 -57.68 -171.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.536 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH1' ' A' ' 29' ' ' ARG . 7.0 m -116.14 -43.91 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 110.077 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.81 -29.52 68.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -55.39 -46.31 76.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 mtp180 -64.49 -39.75 94.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.429 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -63.41 -15.68 58.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.575 . . . . 0.0 111.22 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mm -84.2 -30.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 108.709 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.36 32.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.0 t -80.4 -44.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.49 85.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -48.95 77.65 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 56' ' ' THR . . . -49.87 -72.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.954 -0.466 . . . . 0.0 110.439 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t 47.39 48.56 16.41 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.574 0.702 . . . . 0.0 109.171 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.2 mttp 71.19 73.23 0.26 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -177.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.6 Cg_endo -71.4 -179.54 3.72 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.053 1.836 . . . . 0.0 110.623 -178.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -123.36 172.56 8.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.464 -0.773 . . . . 0.0 110.401 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 54' ' ' THR . 41.2 t -155.31 166.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 tm-20 -155.47 111.33 3.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 108.768 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.2 mp -96.48 143.16 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.964 0.888 . . . . 0.0 110.151 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 2.7 mttm -119.73 108.66 14.69 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.42 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.3 tt0 -98.52 117.41 32.89 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.05 . . . . 0.0 110.993 -178.287 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -119.43 45.92 2.02 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.44 -127.41 9.13 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 p30 -73.93 -3.05 26.66 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -1.079 . . . . 0.0 110.045 178.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -96.73 133.98 40.58 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.623 -1.298 . . . . 0.0 108.196 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.5 m-85 -130.41 122.86 28.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.763 0.792 . . . . 0.0 109.164 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.2 t80 -106.03 140.46 38.99 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.835 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.95 110.88 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -107.79 100.56 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 41' ' ' VAL . 17.8 m -99.65 143.57 29.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 0.0 109.01 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.8 p -156.56 125.88 6.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 36' ' ' ALA . 19.6 m . . . . . 0 C--N 1.306 -1.312 0 O-C-N 121.705 -0.622 . . . . 0.0 110.021 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 55' ' ' SER . 88.0 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.6 p -106.76 160.87 15.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.04 136.62 14.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.314 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.835 HD11 HG13 ' A' ' 52' ' ' ILE . 27.2 pt -138.81 168.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.554 -0.716 . . . . 0.0 109.394 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.513 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.6 p-10 -161.51 132.78 5.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.5 p90 -162.05 -173.61 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.948 -1.101 . . . . 0.0 112.095 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -127.94 154.25 45.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.43 93.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.069 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.15 -23.64 1.58 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.727 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.87 156.99 35.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.279 -1.13 . . . . 0.0 110.119 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.593 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.1 mt-10 -86.61 169.58 12.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.693 -0.629 . . . . 0.0 109.357 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 11.8 p90 -162.41 174.24 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.371 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -111.43 143.11 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.4 pm0 -162.43 -168.66 1.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.449 0.642 . . . . 0.0 109.341 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -99.9 159.52 15.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.77 -144.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 109.02 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -107.33 -19.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.841 -1.162 . . . . 0.0 110.74 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.708 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -93.24 -44.93 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.17 45.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.739 ' H ' HG22 ' A' ' 75' ' ' THR . 4.6 mmm180 -132.67 152.57 80.17 Favored Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.634 -0.921 . . . . 0.0 109.232 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.73 140.41 16.48 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.707 1.605 . . . . 0.0 110.471 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.5 p -160.76 143.41 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.632 -0.667 . . . . 0.0 109.822 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.786 ' HB2' HD21 ' A' ' 100' ' ' LEU . 18.0 ttmt -90.9 120.3 31.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -103.52 168.43 9.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.671 -0.643 . . . . 0.0 110.299 -178.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.8 tp -147.54 153.2 39.17 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 13.3 t -145.46 126.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.962 -178.328 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -120.2 155.54 32.95 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.58 ' CD1' HG11 ' A' ' 67' ' ' VAL . 79.4 m95 -77.89 173.88 11.66 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.857 0.837 . . . . 0.0 110.27 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.73 -45.98 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -131.83 -153.41 0.55 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -25.6 52.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 110.042 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -143.93 27.38 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.817 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 9.3 tttt -132.39 110.73 10.76 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.448 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -117.41 149.86 39.85 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.285 -179.229 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.43 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.71 141.12 25.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.976 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.06 162.3 14.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.27 135.52 8.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.82 -178.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -142.47 154.21 44.34 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.21 169.38 5.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.041 -1.037 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.1 mt -101.47 -5.64 25.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.38 135.11 12.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.904 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.78 -160.46 37.62 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -175.86 139.2 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.426 -1.044 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.42 -88.38 0.09 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.13 -176.78 2.75 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.677 1.585 . . . . 0.0 109.368 178.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -131.53 141.31 49.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.94 145.02 48.85 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.141 0.972 . . . . 0.0 110.686 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -162.96 136.75 6.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.8 p-90 -144.54 175.57 10.04 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.522 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 7.8 p -139.61 171.83 13.68 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.499 0.666 . . . . 0.0 109.636 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.8 ptp -153.56 139.29 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -136.94 150.18 48.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 109.522 -178.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.1 140.91 48.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.464 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.2 p -89.72 160.15 16.72 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.471 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -60.18 -20.59 59.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 110.29 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.18 -29.74 24.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.232 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.52 -9.31 6.9 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -57.34 171.9 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.108 -1.231 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.2 tt -144.73 107.95 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.973 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.44 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.0 tt -103.4 147.65 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.72 145.33 51.91 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.467 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -120.55 162.34 19.77 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.185 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 22.0 mtp -143.99 162.1 37.05 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.324 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 129' ' ' VAL . 7.2 m -145.89 152.41 39.42 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.73 97.24 1.3 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.489 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.78 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.12 23.85 0.94 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.5 -0.75 . . . . 0.0 109.506 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -120.2 179.34 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.98 116.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.63 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.875 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.2 t -100.73 113.7 26.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.625 . . . . 0.0 109.576 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.0 m -103.11 128.92 49.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.413 -0.805 . . . . 0.0 109.312 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -126.56 102.89 7.3 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 120' ' ' ILE . 57.5 t -67.19 132.59 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -122.08 121.69 37.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.513 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.08 140.24 22.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.18 125.31 10.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.269 -0.894 . . . . 0.0 111.303 -178.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.667 179.582 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.36 0.6 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.8 m-85 -99.16 -15.17 19.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -63.17 115.54 4.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -0.819 . . . . 0.0 111.597 -177.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.04 -172.04 39.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -96.14 169.2 10.12 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.842 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.1 120.89 7.04 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.619 -177.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -112.75 112.22 23.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.3 tt -56.0 141.67 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.667 0.746 . . . . 0.0 110.842 -178.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -121.71 -23.55 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.959 -0.463 . . . . 0.0 110.171 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.598 ' HG3' HD12 ' A' ' 10' ' ' ILE . 18.6 mtt-85 -143.73 170.64 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.877 . . . . 0.0 110.393 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t 170.65 167.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.02 31.83 0.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 111.988 -179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.13 29.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.075 -1.016 . . . . 0.0 109.803 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.97 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.59 -60.03 3.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.775 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' HG21 ' A' ' 33' ' ' VAL . 24.3 mt-10 -58.09 -29.07 65.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 111.283 -178.102 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 1.7 pt-20 -72.63 -27.39 62.11 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.734 -178.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.8 HD22 ' CB ' ' A' ' 130' ' ' CYS . 2.2 tp -83.34 -18.81 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 32' ' ' ALA . 14.1 mt -90.25 -16.18 29.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.11 -0.994 . . . . 0.0 109.094 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.8 -33.01 21.49 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.634 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.09 -40.53 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.8 mp -66.95 -48.06 69.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.883 0.849 . . . . 0.0 108.921 179.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.11 21.09 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' ASN . 24.3 m -154.8 -42.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.825 -0.809 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.7 t-20 -57.14 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 0.0 109.66 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.698 HG12 ' NH1' ' A' ' 29' ' ' ARG . 2.5 m -112.47 -43.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.813 . . . . 0.0 110.096 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -27.12 65.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -56.29 -48.13 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.669 . . . . 0.0 110.871 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.793 . . . . 0.0 110.213 -178.931 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.23 -23.49 64.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 111.615 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 48.1 mm -82.78 -27.5 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.052 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -26.41 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.265 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -79.1 -46.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.1 75.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' ILE . . . -63.62 -44.95 92.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.46 -66.96 0.47 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.4 -0.812 . . . . 0.0 109.161 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 p 51.83 61.61 3.13 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.87 70.85 0.46 Allowed Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.972 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.2 Cg_endo -71.53 139.73 34.9 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 122.102 1.868 . . . . 0.0 110.857 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.39 176.5 7.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 HG23 ' A' ' 54' ' ' THR . 25.5 t -154.86 165.67 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.5 tt0 -154.05 113.2 3.72 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.842 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.3 mp -100.17 149.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.759 0.79 . . . . 0.0 110.19 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 4.3 mttt -129.01 106.4 8.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 66.7 tt0 -98.22 120.44 38.64 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 111.191 -177.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -123.76 49.14 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -130.17 10.14 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.62 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -75.15 -2.96 30.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.201 178.747 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -97.43 118.59 34.25 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.857 -1.152 . . . . 0.0 108.782 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 85.3 m-85 -114.11 127.57 55.98 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.867 0.842 . . . . 0.0 109.126 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' ILE . 19.8 t80 -109.58 147.13 33.54 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.792 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -133.46 138.07 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.234 -0.916 . . . . 0.0 108.636 -178.891 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.28 103.66 5.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.183 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.568 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.41 143.13 29.19 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.7 p -140.46 118.14 11.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.206 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 39' ' ' PRO . 70.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 55' ' ' SER . 9.4 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -85.27 158.99 20.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -155.8 100.75 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 0.0 109.86 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.792 HD11 HG13 ' A' ' 52' ' ' ILE . 24.5 pt -101.78 168.27 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.516 -0.74 . . . . 0.0 109.33 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.509 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.6 p30 -163.02 135.3 5.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.438 -0.789 . . . . 0.0 109.603 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -162.61 -171.82 2.89 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.35 1.071 . . . . 0.0 112.358 -178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -129.79 153.24 48.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.637 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.44 95.5 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.157 -0.964 . . . . 0.0 109.542 -179.135 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.98 -31.65 1.45 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.684 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -117.09 157.34 26.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -1.077 . . . . 0.0 110.127 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG2' HD22 ' A' ' 84' ' ' LEU . 17.7 mt-10 -86.05 169.42 13.19 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.06 172.85 15.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 -179.079 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -104.11 144.35 31.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.25 -176.86 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.99 158.73 15.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.6 t -92.6 -144.07 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.418 -0.801 . . . . 0.0 109.109 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -106.42 -21.61 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.857 -1.152 . . . . 0.0 110.611 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.675 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 t70 -89.51 -46.93 8.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.414 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.47 44.71 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 75' ' ' THR . 3.9 mmm180 -129.95 152.41 79.9 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.572 -0.958 . . . . 0.0 108.994 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.83 140.69 16.48 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 121.696 1.597 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.05 141.81 11.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.514 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.2 ttpm? -88.2 117.07 26.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.1 t -99.63 166.53 11.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.847 -0.533 . . . . 0.0 109.809 -178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' HG2' ' A' ' 70' ' ' GLU . 52.1 tp -145.83 155.41 42.89 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.3 t -146.46 129.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.088 -178.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' HG12 ' A' ' 67' ' ' VAL . 2.7 ptpp? -123.85 161.74 24.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 67' ' ' VAL . 83.9 m95 -84.29 171.38 12.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.499 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -136.12 -45.31 0.64 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -132.78 -154.51 0.62 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.19 -26.49 56.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.786 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -143.68 29.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.794 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 28.5 tttt -132.3 109.26 9.76 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.637 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.2 ptp -115.09 147.69 39.88 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.665 0.745 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 110' ' ' THR . 2.9 t -99.88 172.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.504 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.4 t -146.79 141.88 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.922 . . . . 0.0 110.951 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.72 162.04 14.83 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -160.45 133.87 6.82 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.597 -178.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 150.05 39.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.07 167.3 1.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.869 -178.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD12 ' HB2' ' A' ' 80' ' ' PRO . 37.2 mt -94.35 -9.28 36.34 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -156.93 156.28 32.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 108.927 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.31 -160.15 17.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -176.24 139.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.484 -1.01 . . . . 0.0 109.837 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.64 -84.13 0.05 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.54 -177.05 3.0 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 121.938 1.758 . . . . 0.0 110.177 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -139.74 137.9 35.48 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.37 145.89 49.18 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.109 0.957 . . . . 0.0 110.831 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.7 m -162.76 135.48 5.64 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.405 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.4 p-90 -141.92 175.62 9.58 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.942 -1.099 . . . . 0.0 110.686 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.684 HG22 HG13 ' A' ' 94' ' ' VAL . 11.4 p -138.01 173.23 11.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.479 0.657 . . . . 0.0 109.987 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.509 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.5 ptm -157.17 126.63 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -124.65 153.75 41.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.82 142.73 46.16 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.032 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.9 p -91.2 160.78 15.36 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.525 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -60.21 -21.0 61.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.457 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.07 -28.31 24.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -8.46 7.52 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 113' ' ' LEU . 47.1 mt-10 -58.19 171.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -1.223 . . . . 0.0 109.032 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.814 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.28 109.77 5.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.0 109.963 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -104.35 150.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -132.27 145.25 51.17 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.479 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.408 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -121.65 169.26 10.88 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.272 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.523 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.1 mtp -150.3 165.87 31.7 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.51 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.81 152.53 37.82 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.431 0.634 . . . . 0.0 109.367 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.17 97.92 1.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.607 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.57 -79.34 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.23 24.77 0.91 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.527 -0.733 . . . . 0.0 109.252 178.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.0 m -120.89 -179.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -156.36 118.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.754 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.8 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.5 t -99.67 118.81 37.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.5 m -111.37 130.38 55.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.908 . . . . 0.0 109.55 -179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -129.77 103.95 7.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 136.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -125.88 127.47 46.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.499 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.12 139.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 177.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.03 125.35 10.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.0 111.219 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.599 179.574 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.354 0.597 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -98.86 -3.91 34.28 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.9 p -72.13 119.98 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.112 -0.992 . . . . 0.0 112.194 -177.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.74 -173.56 37.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 43.9 m-20 -95.22 171.77 8.52 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 177.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.9 126.11 9.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.336 -176.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -116.28 111.52 20.25 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' C ' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -62.86 140.64 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.607 0.718 . . . . 0.0 109.711 -179.378 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.13 -23.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.19 162.77 32.02 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.195 -0.941 . . . . 0.0 110.745 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p 178.26 168.88 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 14' ' ' ASN . 2.6 pt-20 -161.35 26.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.91 -1.119 . . . . 0.0 111.443 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -161.65 29.06 0.13 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.488 -0.757 . . . . 0.0 108.986 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.897 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.56 -64.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.3 tt0 -57.0 -28.74 62.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.19 -35.96 82.69 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.773 -0.579 . . . . 0.0 110.375 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.671 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.5 tp -82.46 -17.34 45.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.637 -0.665 . . . . 0.0 110.363 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD11 ' CE1' ' A' ' 15' ' ' PHE . 8.1 mt -90.61 -18.29 25.41 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.763 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.4 mmmm -85.32 -29.54 24.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -77.69 -39.46 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -69.03 -46.56 67.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.781 0.801 . . . . 0.0 110.008 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -156.58 27.14 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.708 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -149.67 -36.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.985 -0.715 . . . . 0.0 110.477 -179.434 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -62.86 -148.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.473 -0.767 . . . . 0.0 109.466 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.28 -46.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.661 -1.274 . . . . 0.0 109.151 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.7 ttt -67.59 -33.52 75.17 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.7 mm? -57.31 -24.36 54.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.811 -0.555 . . . . 0.0 110.544 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.892 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.7 mtt180 -92.69 -48.4 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 110.181 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -63.93 -16.87 62.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.549 -0.719 . . . . 0.0 111.447 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.6 mm -85.7 -28.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.944 . . . . 0.0 108.634 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.73 34.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.8 t -80.17 -48.22 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.16 60.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.785 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.68 57.06 4.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.722 -0.611 . . . . 0.0 110.68 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -66.27 -36.22 82.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.7 -1.25 . . . . 0.0 107.793 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -155.14 72.51 5.68 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.75 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 33.5 Cg_endo -72.37 163.16 39.47 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.138 1.892 . . . . 0.0 111.168 -178.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -117.37 173.41 6.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.696 -0.627 . . . . 0.0 109.668 -179.424 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -155.4 165.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 41' ' ' VAL . 29.5 tt0 -152.52 109.12 3.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.5 mt -97.98 135.78 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.667 0.746 . . . . 0.0 110.22 -178.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -114.33 111.44 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.878 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -98.2 121.93 40.74 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.031 -1.043 . . . . 0.0 110.974 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -123.02 51.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.04 -127.96 9.16 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.9 p30 -74.97 -2.0 25.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 110.124 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -96.51 134.69 39.4 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.724 -1.235 . . . . 0.0 108.12 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.09 116.69 18.86 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.931 0.872 . . . . 0.0 109.416 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.6 t80 -102.29 148.2 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.655 HD12 HD11 ' A' ' 63' ' ' ILE . 1.2 mt -145.45 101.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.991 -1.068 . . . . 0.0 110.459 -177.397 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 3.3 ttmt -99.47 113.74 26.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.673 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 41' ' ' VAL . 29.4 m -101.42 143.29 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 115.45 11.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 109.955 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.8 p -103.7 176.0 5.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -171.34 120.7 0.5 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.743 -0.598 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 73' ' ' GLU . 41.2 pt -109.01 171.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.1 p30 -162.58 134.61 5.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.165 -0.96 . . . . 0.0 109.361 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.95 -171.43 2.87 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.395 1.093 . . . . 0.0 112.5 -178.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -129.76 152.66 49.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.3 95.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -178.992 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -35.14 1.58 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.681 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -110.56 155.33 22.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -1.065 . . . . 0.0 109.999 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HD22 ' A' ' 84' ' ' LEU . 32.8 mt-10 -86.16 169.2 13.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.567 -0.708 . . . . 0.0 109.245 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.08 173.92 13.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.63 144.04 32.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -162.24 -177.34 5.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.298 -179.526 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.96 155.95 17.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -92.86 -143.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 28.6 t -110.92 -20.44 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.789 -1.195 . . . . 0.0 110.608 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.62 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 t70 -88.02 -40.99 13.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.92 . . . . 0.0 109.26 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.16 44.69 0.1 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mmm180 -133.02 151.89 78.75 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.619 -0.93 . . . . 0.0 109.323 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.732 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.97 141.76 16.91 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.737 1.625 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -161.03 143.26 12.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.734 -0.604 . . . . 0.0 109.46 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -88.67 117.16 27.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.9 t -99.78 166.36 11.13 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.283 0.564 . . . . 0.0 109.749 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG2' ' A' ' 70' ' ' GLU . 63.2 tp -148.77 150.76 33.65 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.7 t -141.92 127.18 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.024 -177.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.73 156.03 28.97 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.617 ' CD1' HG11 ' A' ' 67' ' ' VAL . 75.8 m95 -76.87 -175.04 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.576 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -142.68 -53.76 0.4 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.0 p -131.36 -152.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.54 -24.15 45.81 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 110.003 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -138.82 22.26 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 0.0 111.167 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -130.49 129.65 43.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.746 -1.221 . . . . 0.0 108.325 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -134.96 151.09 50.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.918 -179.622 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.752 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -103.31 171.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.2 t -147.91 133.2 18.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.3 -0.875 . . . . 0.0 110.82 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 4.7 pt-20 -105.95 153.28 22.2 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -151.36 140.53 21.24 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.939 -177.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -144.92 148.45 33.89 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.11 168.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.049 -1.032 . . . . 0.0 110.886 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.2 mt -93.78 -10.1 35.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.95 160.19 35.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.74 -161.58 22.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -176.72 138.62 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.427 -1.043 . . . . 0.0 109.941 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.94 -85.42 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.91 -176.73 2.54 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.932 1.755 . . . . 0.0 110.142 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -139.97 138.8 35.82 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.81 146.01 47.92 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.071 0.939 . . . . 0.0 110.778 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 m -162.38 129.89 3.84 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.083 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -136.39 171.05 15.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.092 -1.005 . . . . 0.0 110.608 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.752 HG22 HG13 ' A' ' 94' ' ' VAL . 13.3 p -134.06 176.0 8.98 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.472 0.653 . . . . 0.0 109.884 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.4 ' CE ' ' HG3' ' A' ' 93' ' ' MET . 3.0 ptt? -160.23 124.07 3.62 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.182 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -120.06 146.6 45.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.679 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.92 143.52 38.05 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.101 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.73 160.94 14.74 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.676 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.39 -22.67 63.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.646 . . . . 0.0 110.21 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.49 -29.22 28.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.164 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.29 7.22 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' O ' HD13 ' A' ' 113' ' ' LEU . 22.6 mt-10 -56.2 171.7 0.25 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.145 -1.209 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.697 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -146.4 110.16 4.9 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.995 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.5 tt -106.24 145.01 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -126.59 142.08 51.65 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.322 -0.861 . . . . 0.0 109.604 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -119.01 170.67 8.85 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.252 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 68.1 mtp -152.18 166.09 32.79 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.659 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.1 m -147.07 152.54 38.69 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.35 96.74 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.14 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.1 23.96 1.05 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 178.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.8 m -120.14 -179.2 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.27 117.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.589 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.671 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.6 t -99.25 132.64 44.43 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.424 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.7 m -124.96 126.16 45.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.36 -0.838 . . . . 0.0 109.436 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -123.15 100.4 6.85 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 120' ' ' ILE . 59.2 t -66.58 130.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.7 m-85 -120.1 132.25 55.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.404 -179.15 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.81 137.18 47.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.14 127.63 14.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.215 -0.928 . . . . 0.0 111.867 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.992 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.342 0.591 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.9 m-85 -99.11 -5.34 30.35 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.714 -0.616 . . . . 0.0 109.509 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 p -72.15 118.66 15.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 111.945 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.87 -173.36 38.21 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.4 m120 -95.45 171.87 8.43 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.918 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.2 m95 -150.73 125.35 9.64 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.482 -176.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -118.9 114.76 23.1 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.018 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 132' ' ' ARG . 11.0 tt -58.15 143.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.414 -179.063 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.15 -24.44 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.893 -0.504 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -150.16 176.32 10.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -0.912 . . . . 0.0 110.383 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t 176.56 167.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.56 26.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.2 m-20 -160.53 27.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.752 -0.592 . . . . 0.0 109.851 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.871 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.19 -66.36 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.854 . . . . 0.0 109.053 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.9 mt-10 -55.53 -31.56 62.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.446 -0.784 . . . . 0.0 109.476 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.61 -39.54 91.61 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.157 0.504 . . . . 0.0 110.506 -179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.769 HD22 ' HB2' ' A' ' 130' ' ' CYS . 17.0 tp -79.0 -16.88 56.3 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' A' ' 32' ' ' ALA . 4.8 mt -90.14 -18.92 24.91 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.055 -1.028 . . . . 0.0 109.077 179.23 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mtmm -82.3 -31.48 29.97 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 128' ' ' VAL . 13.6 p -77.84 -40.37 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.011 0.91 . . . . 0.0 108.714 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.32 -47.17 71.33 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.884 0.849 . . . . 0.0 109.428 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -151.31 24.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.323 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.1 m -153.74 -41.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.968 -0.725 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.3 t-20 -60.89 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.525 -0.734 . . . . 0.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 m -123.62 -46.84 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.809 179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.58 -29.39 68.73 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.0 mm? -58.34 -32.17 68.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.788 -0.57 . . . . 0.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.9 mpp_? -82.69 -44.29 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 109.903 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -61.96 -22.3 65.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 110.682 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mt -79.48 -28.54 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.0 109.04 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.925 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.06 -26.21 33.9 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.342 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.8 t -77.94 -39.83 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.65 -33.59 60.45 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.69 94.45 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.87 -67.48 0.43 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.618 -0.676 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 m 51.64 55.3 9.56 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mttm 66.69 73.51 0.38 Allowed Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.462 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.4 Cg_endo -70.99 153.92 63.08 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.024 1.816 . . . . 0.0 110.605 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.95 173.2 6.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.015 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 53.9 t -154.99 164.49 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.3 tm-20 -149.43 109.49 4.11 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.918 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -98.61 139.7 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 121.802 0.81 . . . . 0.0 110.605 -178.212 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.0 116.47 27.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.666 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.0 tt0 -98.77 116.52 31.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.123 -0.985 . . . . 0.0 110.837 -178.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -116.9 49.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.3 -125.84 8.19 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.6 p30 -75.78 -1.83 26.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -1.04 . . . . 0.0 110.023 178.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.56 138.91 33.43 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.787 -1.196 . . . . 0.0 108.434 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 92.5 m-85 -134.06 116.31 15.32 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.865 0.84 . . . . 0.0 109.431 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.9 147.75 26.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -143.45 105.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.289 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.23 112.09 24.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 109.466 179.041 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 34.4 m -102.54 141.09 35.93 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.48 140.99 39.42 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.129 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.841 0.829 . . . . 0.0 109.466 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.55 165.27 16.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.731 . . . . 0.0 109.679 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -159.57 123.51 3.79 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.641 -0.662 . . . . 0.0 109.307 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 52' ' ' ILE . 39.7 pt -123.98 166.34 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.02 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.531 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.9 p-10 -162.19 129.45 3.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 109.052 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.0 p90 -161.65 -173.0 3.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.689 -1.204 . . . . 0.0 112.273 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 153.6 47.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 94.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.649 -178.997 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.72 -34.1 1.37 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.495 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -112.42 156.61 22.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.403 -1.057 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.498 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.1 mt-10 -86.39 169.16 13.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 -179.572 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 15.9 p90 -162.26 173.47 14.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.563 -0.711 . . . . 0.0 109.816 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.28 145.2 29.79 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -162.32 -176.17 4.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 109.528 -179.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -100.71 157.51 16.64 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -95.2 -143.13 0.26 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.862 . . . . 0.0 109.24 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' THR . 24.3 t -110.1 -22.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.754 -1.216 . . . . 0.0 110.814 -179.051 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.581 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -88.12 -40.27 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.589 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.38 45.1 0.1 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.709 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.32 152.1 78.76 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.714 -0.874 . . . . 0.0 109.046 -179.649 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.766 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.42 142.38 18.63 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.655 1.57 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.14 141.12 10.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 109.552 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 100' ' ' LEU . 8.7 ttmm -86.67 116.13 24.58 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.91 165.42 11.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.735 -0.603 . . . . 0.0 110.268 -178.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 70' ' ' GLU . 57.7 tp -145.69 153.84 41.43 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.7 t -146.17 125.13 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.728 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.1 156.05 29.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.4 m95 -78.03 174.84 10.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.876 0.846 . . . . 0.0 110.126 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -137.84 -46.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.2 p -130.51 -152.68 0.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.67 -28.35 51.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -141.04 28.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 27.3 tttt -132.69 111.52 11.23 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.439 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -118.36 150.17 39.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.25 -0.906 . . . . 0.0 110.398 -179.295 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.47 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.494 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.8 t -147.45 140.3 24.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 110.895 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.68 163.01 13.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -160.3 135.38 7.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.781 -1.167 . . . . 0.0 111.642 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -143.63 150.55 38.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.94 168.94 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.005 . . . . 0.0 110.842 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 80' ' ' PRO . 39.1 mt -99.04 -5.98 29.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.68 133.72 14.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.669 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.86 -157.37 38.94 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -176.15 139.97 0.39 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.438 -1.036 . . . . 0.0 109.915 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.0 -87.9 0.09 OUTLIER Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.018 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.36 -176.69 2.89 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.682 1.588 . . . . 0.0 109.474 178.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -130.46 136.31 48.87 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.95 144.41 48.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.151 0.977 . . . . 0.0 110.749 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.7 m -163.04 136.88 6.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.8 p-90 -142.49 174.83 10.28 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.436 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 94' ' ' VAL . 13.0 p -138.36 170.53 15.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.556 0.693 . . . . 0.0 109.801 -179.344 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.42 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.9 ptp -153.37 137.0 15.99 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -133.19 149.42 52.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.388 -0.82 . . . . 0.0 109.413 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -111.84 141.44 45.47 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 p -90.4 161.12 15.72 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.763 -179.295 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.33 -22.01 62.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -84.35 -29.19 26.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.284 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.63 -9.85 7.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.55 172.62 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.158 -1.201 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 43' ' ' ILE . 7.2 tt -145.08 108.38 4.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 109.974 -179.19 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -135.6 137.52 42.02 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.248 -0.907 . . . . 0.0 109.771 -178.986 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -114.65 168.59 9.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.974 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.505 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.7 mtp -147.55 167.86 23.43 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.636 -179.203 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.0 m -150.65 150.2 30.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.692 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.25 93.84 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.83 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -146.69 23.52 1.25 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.576 -0.702 . . . . 0.0 109.286 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 125' ' ' ALA . 23.2 m -117.14 -178.52 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.012 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.79 118.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.436 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.769 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.6 t -97.66 116.98 30.92 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.5 m -114.45 126.26 54.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -0.999 . . . . 0.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 9' ' ' ILE . 1.1 mtt-85 -133.22 107.76 8.36 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.04 135.4 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -123.36 126.12 46.26 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.274 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.48 138.48 33.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.496 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -49.96 128.22 18.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.242 -0.911 . . . . 0.0 111.559 -178.617 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.6 tm-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.762 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.348 0.594 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.688 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.3 m-85 -98.84 -9.8 23.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -65.37 118.09 8.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 112.293 -177.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.24 -172.84 37.57 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.63 171.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.818 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.22 120.01 7.08 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.891 -1.123 . . . . 0.0 112.613 -177.122 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -111.43 114.11 27.02 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' HD2' ' A' ' 39' ' ' PRO . 7.2 tt -56.26 155.45 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.907 0.861 . . . . 0.0 111.195 -178.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.41 -32.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.436 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -145.0 171.04 15.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.029 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t 179.52 157.44 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 109.335 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 170.74 19.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.616 . . . . 0.0 110.049 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 17.5 m120 61.04 29.99 19.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.476 -0.765 . . . . 0.0 109.887 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.812 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.7 t80 -65.55 -63.17 1.16 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.282 -0.886 . . . . 0.0 108.85 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 2.5 pt-20 -59.76 -28.35 67.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.736 -0.603 . . . . 0.0 109.641 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.73 -38.97 90.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.626 -0.671 . . . . 0.0 110.411 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.8 tp -83.12 -13.39 55.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.686 -0.634 . . . . 0.0 109.711 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -91.82 -20.96 20.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.959 -1.088 . . . . 0.0 108.952 179.572 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmm -83.37 -30.04 27.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.508 HG11 HD12 ' A' ' 18' ' ' LEU . 14.4 p -77.43 -41.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -66.41 -53.55 34.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.25 1.024 . . . . 0.0 108.865 179.251 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.06 -144.9 14.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.6 m -154.99 -38.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.901 -0.764 . . . . 0.0 110.244 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.1 t-20 -57.29 -171.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.248 -0.907 . . . . 0.0 109.779 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.677 HG12 ' NH1' ' A' ' 29' ' ' ARG . 4.8 m -121.12 -43.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.77 . . . . 0.0 110.112 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.0 ttm -67.83 -26.35 66.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.57 -0.706 . . . . 0.0 109.131 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.74 -49.2 78.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.704 -0.622 . . . . 0.0 110.525 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.886 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -66.03 -42.3 89.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.463 -0.773 . . . . 0.0 110.029 -178.87 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -57.52 -38.98 75.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.567 -0.708 . . . . 0.0 110.705 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.03 -26.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.429 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.51 -22.1 38.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.66 -0.65 . . . . 0.0 110.169 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -81.99 -45.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.25 91.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.27 71.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.35 42.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.547 179.15 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.8 t -64.97 -35.39 81.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.841 -1.162 . . . . 0.0 108.313 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -157.4 71.22 4.43 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.091 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.5 Cg_endo -73.57 146.33 38.89 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 122.012 1.808 . . . . 0.0 110.545 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -93.04 173.22 7.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.664 -0.648 . . . . 0.0 109.618 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 40' ' ' ALA . 4.7 t -153.53 165.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.2 tt0 -156.87 116.98 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.653 -0.654 . . . . 0.0 109.427 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.818 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.1 mp -107.21 138.04 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.582 0.706 . . . . 0.0 109.769 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 3.8 mttt -117.53 109.16 16.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.636 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.2 tt0 -98.1 117.07 31.63 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.07 -1.019 . . . . 0.0 111.113 -177.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.84 56.01 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.08 -126.37 8.39 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -77.79 -0.4 26.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.418 -1.048 . . . . 0.0 109.954 178.541 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 m -96.19 139.99 31.54 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.781 -1.2 . . . . 0.0 108.862 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.4 m-85 -136.66 117.44 14.06 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.774 0.797 . . . . 0.0 108.92 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 4.5 t80 -104.53 119.12 38.24 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 HG13 HD11 ' A' ' 63' ' ' ILE . 1.7 mm -99.84 146.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 120.785 -1.197 . . . . 0.0 107.991 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.8 tttt -145.11 102.58 3.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.93 . . . . 0.0 108.785 179.329 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 25.0 m -99.56 154.9 17.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.723 . . . . 0.0 109.486 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.69 116.0 6.59 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.01 169.53 8.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.395 -0.816 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.1 pt-20 -173.44 113.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 73' ' ' GLU . 37.5 pt -103.65 173.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.467 -0.77 . . . . 0.0 110.052 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.7 p-10 -160.68 130.34 5.02 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.2 p90 -162.38 -171.62 2.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.089 0.947 . . . . 0.0 111.448 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 15.4 ptmt -132.31 154.67 49.47 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.14 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.59 94.3 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -178.541 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.74 -23.02 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.865 -1.159 . . . . 0.0 110.607 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -136.41 163.59 30.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.296 -1.12 . . . . 0.0 110.727 -179.6 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.16 171.2 11.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.765 -0.584 . . . . 0.0 109.578 -179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.0 p90 -162.63 175.32 11.51 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.03 143.62 39.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 5.7 pm0 -162.16 -169.18 2.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 109.343 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -99.6 160.07 14.57 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.348 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -97.84 -143.72 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.386 -0.821 . . . . 0.0 109.227 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 27.4 t -110.78 -20.99 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.731 -1.23 . . . . 0.0 110.897 -179.143 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.603 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -90.39 -40.39 12.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.821 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.89 46.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 8.4 mmm180 -137.28 154.01 75.24 Favored Pre-proline 0 C--N 1.306 -1.292 0 O-C-N 121.743 -0.857 . . . . 0.0 109.269 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.734 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -79.34 142.94 17.05 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 110.439 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.6 p -160.66 142.41 12.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.0 ttpt -90.71 120.76 32.03 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 2.6 t -100.31 172.8 6.93 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.516 0.674 . . . . 0.0 110.347 -178.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.7 tp -148.7 152.72 37.14 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 65' ' ' PHE . 15.5 t -147.74 131.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 118.441 -1.304 . . . . 0.0 112.266 -178.059 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.64 161.23 29.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.0 m95 -84.36 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.923 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -134.84 -46.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -132.25 -153.66 0.57 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -24.77 47.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -142.16 24.76 1.95 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.8 tttm -130.77 111.85 12.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 0.0 108.522 179.622 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.576 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.06 149.42 38.96 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.628 0.728 . . . . 0.0 110.39 -178.876 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.608 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -101.88 171.74 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.495 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.4 t -149.12 138.29 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.915 . . . . 0.0 110.966 -179.498 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -108.59 163.39 13.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.154 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.65 139.69 10.46 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.873 -178.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -141.42 157.13 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.75 168.81 12.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 110.612 -179.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 80' ' ' PRO . 52.9 mt -101.65 -6.07 24.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 138.73 18.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.46 -156.86 41.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -176.87 140.08 0.31 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.567 -0.961 . . . . 0.0 109.603 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.46 -85.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.43 -177.11 3.06 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.88 1.72 . . . . 0.0 109.936 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -135.92 139.02 42.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.84 145.09 48.42 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.16 0.981 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.1 p -163.07 137.71 6.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CZ3' ' CE ' ' A' ' 111' ' ' MET . 61.7 p-90 -142.32 176.0 9.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.023 -1.048 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.608 HG22 HG13 ' A' ' 94' ' ' VAL . 7.3 p -140.41 174.46 10.49 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.817 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.602 ' CE ' HD12 ' A' ' 121' ' ' LEU . 2.4 mtm -157.16 128.5 6.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -124.35 146.83 48.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.529 -0.732 . . . . 0.0 109.63 -179.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.46 144.25 39.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.349 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.18 160.52 14.81 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.6 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.66 -21.61 62.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.171 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.99 -29.23 27.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 109.106 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.45 -9.39 7.34 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' O ' HD13 ' A' ' 113' ' ' LEU . 54.3 mt-10 -56.65 171.68 0.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -1.227 . . . . 0.0 109.293 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.738 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -146.25 112.03 5.63 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.149 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -106.72 147.7 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.329 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.602 HD12 ' CE ' ' A' ' 111' ' ' MET . 7.5 tt -129.43 147.96 51.3 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.193 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -127.96 163.37 24.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.616 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.474 ' O ' HG22 ' A' ' 129' ' ' VAL . 20.0 mtp -143.13 163.34 33.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.368 -179.23 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 129' ' ' VAL . 6.6 m -146.7 152.05 38.21 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.33 96.75 1.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.98 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.73 23.91 1.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.546 -0.721 . . . . 0.0 109.407 178.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -119.3 -179.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.03 117.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.716 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.3 t -98.89 112.08 24.29 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.455 ' OG1' HG22 ' A' ' 122' ' ' THR . 77.7 m -107.92 148.9 29.0 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.767 0.794 . . . . 0.0 110.074 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -151.0 118.18 5.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.32 138.97 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.123 -0.986 . . . . 0.0 108.385 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 22.5 m-85 -127.49 125.3 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.367 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.03 139.59 28.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.36 125.63 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.215 -0.928 . . . . 0.0 111.207 -178.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.515 179.578 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.383 0.611 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 5.1 m-85 -98.85 -8.1 26.29 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.7 p -69.6 118.09 12.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.209 -0.932 . . . . 0.0 111.938 -177.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.3 -171.54 37.34 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.1 m120 -95.59 169.94 9.69 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 177.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.945 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.67 120.43 7.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.643 -177.344 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -112.66 120.76 42.64 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.7 tt -64.56 151.97 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.845 0.831 . . . . 0.0 111.116 -178.142 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.03 -31.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -139.73 168.84 18.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 108.985 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.821 ' HB3' HD11 ' A' ' 9' ' ' ILE . 83.8 p -176.82 149.61 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.489 -0.757 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -148.2 163.64 36.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 14.8 m120 61.86 27.48 16.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.917 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.85 -65.47 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.588 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.8 pt-20 -58.01 -27.89 63.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.39 -34.83 79.22 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.553 -0.717 . . . . 0.0 110.018 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' A' ' 130' ' ' CYS . 18.4 tp -82.9 -18.58 39.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.729 -0.607 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.917 HD11 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -91.37 -16.81 26.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.909 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 mmmt -87.94 -28.49 21.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.156 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 12.6 p -76.77 -41.14 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.1 -54.6 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.99 -148.2 19.86 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 23' ' ' GLY . 15.8 m -157.28 -43.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.815 -0.815 . . . . 0.0 109.407 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.607 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 t-20 -54.28 176.07 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.472 -0.767 . . . . 0.0 109.516 179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.68 -43.68 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.6 ttm -62.74 -26.38 68.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 25' ' ' ASN . 3.8 mm? -64.8 -69.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.634 -0.666 . . . . 0.0 109.993 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.914 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -52.21 -38.32 57.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 110.62 -179.299 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -61.01 -39.33 89.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.61 -0.681 . . . . 0.0 110.373 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.82 -26.8 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.6 -26.02 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.6 t -75.9 -35.98 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.01 41.74 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.52 93.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.41 -69.49 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m 49.19 51.19 16.71 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.495 0.664 . . . . 0.0 109.46 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.3 mttt 65.38 72.31 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.3 Cg_endo -72.1 156.96 55.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.05 1.833 . . . . 0.0 110.613 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 41' ' ' VAL . . . -105.95 174.38 5.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.355 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 71.8 t -154.23 164.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.8 tt0 -149.68 108.61 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.2 mt -98.45 139.13 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.19 113.1 21.74 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.711 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.2 tt0 -98.48 118.38 35.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.07 -1.019 . . . . 0.0 110.976 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.38 52.45 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -124.44 7.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -178.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.4 p30 -76.31 -1.25 25.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.33 141.77 29.26 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 120.808 -1.183 . . . . 0.0 108.807 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 97.8 m-85 -137.3 115.52 11.73 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.839 0.828 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -101.43 147.5 26.28 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.09 107.52 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.197 -177.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.7 109.84 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.091 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 41' ' ' VAL . 22.6 m -99.36 135.86 40.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.37 121.01 26.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.25 -0.906 . . . . 0.0 110.314 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.75 160.97 22.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -152.51 125.21 8.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 0.0 109.791 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 52' ' ' ILE . 37.9 pt -124.73 165.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.124 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.6 p-10 -162.72 129.03 3.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.001 -1.062 . . . . 0.0 109.887 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 85' ' ' VAL . 49.0 p90 -162.25 -171.87 2.98 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.734 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -132.06 155.91 47.24 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.689 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -83.47 91.63 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.109 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.78 -27.08 0.65 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.124 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HG2' ' CG ' ' A' ' 66' ' ' LYS . 4.9 pt-20 -124.77 159.09 31.73 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.182 -1.187 . . . . 0.0 110.3 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD22 ' A' ' 84' ' ' LEU . 33.8 mt-10 -86.82 166.23 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.2 173.6 14.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.686 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.97 146.12 28.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.37 -177.52 5.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.667 -0.645 . . . . 0.0 109.342 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.44 155.83 17.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.0 t -94.49 -142.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 39.5 t -113.71 -18.64 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.218 . . . . 0.0 110.64 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -89.39 -36.59 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.42 44.84 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.679 ' H ' HG22 ' A' ' 75' ' ' THR . 48.2 mtp180 -134.23 151.85 77.15 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.779 -0.836 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.809 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.8 143.4 18.49 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.658 1.572 . . . . 0.0 110.553 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -161.14 141.65 11.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.717 -0.615 . . . . 0.0 109.625 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.1 ttmm -88.32 116.74 26.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.4 t -99.47 168.08 10.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.428 0.632 . . . . 0.0 110.458 -178.241 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.56 HD22 ' HG2' ' A' ' 70' ' ' GLU . 60.2 tp -151.12 153.77 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.7 t -146.04 134.63 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.214 -177.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -126.17 157.4 38.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.558 ' CE2' HG21 ' A' ' 67' ' ' VAL . 84.6 m95 -81.58 171.05 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.098 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 19.2 tp10 -134.17 -45.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -132.31 -154.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -76.56 -25.52 54.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.18 27.69 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.825 . . . . 0.0 110.717 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 38.8 tttt -130.84 106.87 8.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 108.16 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.608 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.2 ptp -115.18 145.88 41.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 110' ' ' THR . 1.5 t -102.12 171.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.6 t -145.47 138.74 26.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.268 -0.895 . . . . 0.0 110.475 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 7.3 pt-20 -109.62 154.35 22.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.454 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -152.46 142.02 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.905 -177.757 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -143.6 153.32 42.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.66 169.3 3.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.092 -1.005 . . . . 0.0 110.527 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 80' ' ' PRO . 47.2 mt -98.07 -7.93 28.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.637 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -155.14 145.31 21.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 108.946 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.04 -158.71 37.51 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.54 140.41 0.36 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.505 -0.997 . . . . 0.0 109.743 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.43 -85.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.99 -176.9 2.83 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.872 1.714 . . . . 0.0 109.905 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -137.92 138.95 39.52 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.99 145.97 48.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.024 0.916 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -162.49 131.1 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -136.16 167.26 21.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.123 -0.986 . . . . 0.0 110.839 -179.366 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 HG13 ' A' ' 94' ' ' VAL . 21.5 p -131.63 169.77 15.7 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.386 0.612 . . . . 0.0 109.9 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.629 ' HB3' HD12 ' A' ' 121' ' ' LEU . 11.4 ptp -154.98 123.44 6.01 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.31 155.68 29.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 110.412 -178.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.45 141.65 48.95 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.823 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.5 p -93.86 161.03 14.48 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.804 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -60.79 -22.01 63.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.678 . . . . 0.0 110.142 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.65 -28.9 28.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.67 -10.36 7.15 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -54.97 170.89 0.16 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.159 -1.201 . . . . 0.0 109.275 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.605 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.8 tt -147.42 110.12 4.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.49 161.07 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -145.08 132.22 20.43 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.215 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.41 171.55 7.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.219 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.0 mtp -149.76 163.91 36.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.093 -179.514 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.6 m -147.51 152.7 38.44 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.436 0.636 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.669 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.72 96.53 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.645 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.76 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 24.12 1.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.563 -0.711 . . . . 0.0 109.312 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -119.09 -179.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.56 117.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.765 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.21 117.33 32.35 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -111.35 149.77 30.68 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.882 0.848 . . . . 0.0 109.925 -179.05 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -152.49 118.2 5.38 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.17 137.8 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.8 m-85 -126.93 124.87 40.51 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.446 -179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.55 140.78 24.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -50.02 125.99 13.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.176 -0.952 . . . . 0.0 111.131 -178.736 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.544 179.569 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.706 0.765 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.581 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.3 m-85 -99.59 -1.09 39.06 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.66 -0.65 . . . . 0.0 109.44 179.436 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -72.37 120.56 18.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.123 -0.986 . . . . 0.0 112.122 -177.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.54 -171.97 36.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -95.86 169.78 9.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.47 120.97 7.41 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.639 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -113.69 115.7 28.27 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.784 HG21 ' HD2' ' A' ' 39' ' ' PRO . 8.0 tt -55.6 156.61 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.994 0.902 . . . . 0.0 111.418 -178.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -132.21 -32.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.527 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 10' ' ' ILE . 1.3 mtt180 -143.82 169.61 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.254 -0.904 . . . . 0.0 108.938 179.776 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.57 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.0 p -177.19 145.37 0.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 109.754 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -141.18 165.7 26.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.759 -0.588 . . . . 0.0 109.657 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 13.0 m120 58.77 22.54 10.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.474 -0.766 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -65.19 -64.2 0.92 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 108.943 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 42.9 tt0 -57.5 -29.12 64.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -65.36 -34.19 77.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.664 -0.648 . . . . 0.0 110.167 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.808 HD22 ' HB2' ' A' ' 130' ' ' CYS . 12.5 tp -82.72 -19.0 38.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.758 -0.589 . . . . 0.0 110.375 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -90.86 -17.03 27.2 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -87.33 -29.28 21.69 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.216 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.1 p -77.06 -41.01 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.7 mp -65.73 -50.8 63.49 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -143.93 14.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.0 m -154.5 -43.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.697 -0.884 . . . . 0.0 109.985 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.1 t-20 -61.97 -172.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.483 -0.761 . . . . 0.0 109.033 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.46 -42.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -61.45 -23.34 65.79 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.9 mm? -79.82 -39.63 30.31 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.736 -0.602 . . . . 0.0 110.086 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.895 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.1 -37.39 85.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.701 -0.624 . . . . 0.0 109.502 -179.223 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -11.97 57.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 111.043 -179.521 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' ILE . 42.4 mm -85.84 -30.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.897 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.28 -27.25 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.7 t -79.52 -46.13 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.65 89.86 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.98 88.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.693 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.47 40.69 0.74 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.824 -0.547 . . . . 0.0 111.56 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.4 p -58.31 -26.66 63.3 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.487 -1.383 . . . . 0.0 108.679 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.19 73.01 0.23 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.784 ' HD2' HG21 ' A' ' 9' ' ' ILE . 32.4 Cg_endo -73.18 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.996 1.798 . . . . 0.0 111.089 -178.23 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -138.96 173.43 11.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 55.1 t -156.43 163.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.9 tt0 -150.47 111.0 4.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -99.37 133.37 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.636 0.731 . . . . 0.0 110.366 -178.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -112.72 111.92 23.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.666 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 61.8 tt0 -98.57 119.39 37.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.11 -0.994 . . . . 0.0 111.002 -178.226 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -120.69 54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.9 -126.74 8.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.23 -0.44 25.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.387 -1.066 . . . . 0.0 109.987 178.663 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.65 140.75 30.8 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.653 -1.279 . . . . 0.0 108.512 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.7 m-85 -136.67 116.39 13.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.8 0.81 . . . . 0.0 109.465 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.67 147.45 26.42 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.141 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -142.27 104.8 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.25 -177.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.44 109.35 21.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.067 178.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 60.6 m -103.21 141.8 35.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.6 p -148.88 124.88 10.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 109.592 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.532 -0.73 . . . . 0.0 109.634 -179.703 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.2 m . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.42 169.06 10.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.554 -0.716 . . . . 0.0 110.079 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -160.42 123.32 3.37 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.141 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -124.49 168.85 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.376 -0.827 . . . . 0.0 109.407 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.4 p-10 -162.54 129.32 3.61 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.234 -0.916 . . . . 0.0 109.08 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.2 p90 -162.14 -172.16 3.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.388 -179.629 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -130.54 153.12 49.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.42 95.15 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 109.79 -178.871 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.3 -33.58 1.57 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.772 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -110.88 153.59 25.23 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.356 -1.085 . . . . 0.0 109.869 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.15 167.21 15.13 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.684 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.463 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.39 173.61 13.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.818 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -103.94 143.66 32.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.7 pt-20 -162.09 -176.86 5.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.82 155.67 17.53 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.6 t -91.19 -142.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.46 -0.775 . . . . 0.0 109.194 -179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 25.4 t -110.02 -20.63 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.74 -1.225 . . . . 0.0 110.624 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.638 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.43 -39.96 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.57 44.88 0.11 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -130.61 150.82 77.43 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.629 -0.924 . . . . 0.0 109.342 -179.628 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.92 140.29 15.98 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.7 1.6 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.4 p -161.36 141.86 10.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.637 -0.664 . . . . 0.0 109.811 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.3 ttmm -90.57 114.32 26.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.647 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.81 177.5 4.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.715 -0.615 . . . . 0.0 110.235 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' ' 70' ' ' GLU . 64.4 tp -151.75 152.01 32.15 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.4 t -140.74 130.25 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.516 -177.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.5 ptmt -125.89 162.48 25.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.562 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.3 m95 -85.69 167.35 15.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.969 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -129.93 -45.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 p -132.01 -154.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.039 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.29 -24.65 50.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.733 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -143.91 27.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.5 tttt -132.27 106.4 7.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 107.977 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.496 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.4 ptp -113.18 149.89 33.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.316 -178.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.946 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -104.7 172.11 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.49 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.8 t -149.58 129.79 13.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 110.747 -179.412 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -100.68 163.99 12.08 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 176.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.41 142.91 13.09 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.945 -178.222 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -147.08 149.25 32.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.43 167.9 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.065 -1.022 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 80' ' ' PRO . 30.3 mt -98.0 -7.44 29.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -152.44 141.14 20.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 108.922 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.07 -159.72 36.04 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -176.37 139.91 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.493 -1.004 . . . . 0.0 109.829 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.45 -86.67 0.06 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.1 -176.97 2.83 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.834 1.689 . . . . 0.0 109.774 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -135.5 138.53 43.2 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 146.05 47.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.068 0.937 . . . . 0.0 110.872 -179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -162.7 128.79 3.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -133.34 166.01 23.49 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.098 -1.001 . . . . 0.0 110.85 -179.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.946 HG22 HG13 ' A' ' 94' ' ' VAL . 18.8 p -130.4 174.69 9.61 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.415 0.626 . . . . 0.0 109.692 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -160.09 122.33 3.31 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.112 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -116.95 154.1 31.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -115.22 142.73 46.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.282 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -95.03 160.34 14.61 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.987 -179.342 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.9 -23.19 63.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.688 -0.632 . . . . 0.0 110.139 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -81.69 -31.06 32.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.16 -8.6 7.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -58.12 170.73 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.124 -1.221 . . . . 0.0 108.97 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.737 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -143.87 113.74 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.123 -178.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.81 152.45 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -135.01 132.78 38.71 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.46 -0.775 . . . . 0.0 109.557 -179.156 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.487 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -113.29 170.65 8.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.242 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.4 mtp -150.01 165.04 33.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.418 -179.341 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.7 m -146.9 152.22 38.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.674 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.94 96.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.561 179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.45 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -146.38 24.23 1.27 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.456 -0.778 . . . . 0.0 109.393 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 125' ' ' ALA . 24.4 m -119.59 -178.29 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.035 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.39 117.49 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.665 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.808 ' HB2' HD22 ' A' ' 18' ' ' LEU . 13.9 t -98.41 119.4 37.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.066 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' HG22 ' A' ' 122' ' ' THR . 92.0 m -115.5 149.79 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 110.075 -179.085 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -152.07 118.27 5.57 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.52 138.38 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.96 . . . . 0.0 108.446 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.4 m-85 -126.88 124.48 39.67 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.019 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.35 139.94 26.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.205 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -49.2 125.67 11.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.228 -0.92 . . . . 0.0 111.214 -178.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.628 179.573 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.576 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.58 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.18 -8.87 24.48 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.744 -0.598 . . . . 0.0 109.478 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.6 p -68.73 118.05 11.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.225 -0.922 . . . . 0.0 111.869 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.4 -174.41 38.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.119 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 45.4 m-20 -95.45 172.24 8.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.51 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.72 124.66 8.59 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.964 -1.094 . . . . 0.0 112.54 -176.644 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -116.8 117.77 30.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 12' ' ' SER . 13.9 tt -61.73 151.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.914 0.864 . . . . 0.0 111.082 -178.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.28 -31.37 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -141.72 172.1 13.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.768 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.1 t -179.7 145.68 0.24 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.456 -0.777 . . . . 0.0 109.443 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -142.19 163.11 33.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.0 109.992 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 13.5 m120 62.87 32.8 15.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.607 -0.683 . . . . 0.0 109.754 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.955 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.88 -64.11 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.139 -179.728 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 tt0 -57.22 -35.87 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.815 . . . . 0.0 110.919 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -67.97 -29.7 68.79 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.179 -178.848 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.2 tp -77.49 -22.28 51.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.3 mt -89.95 -15.97 30.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.301 -0.875 . . . . 0.0 109.14 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -87.58 -31.4 19.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.0 p -74.59 -39.03 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.848 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -69.2 -45.8 69.02 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.736 0.779 . . . . 0.0 109.492 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.88 -161.63 27.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -146.29 -35.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.891 -0.77 . . . . 0.0 110.463 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.8 t-20 -62.21 -149.72 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 109.372 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.98 -47.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.7 -1.25 . . . . 0.0 109.323 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.484 ' HG2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttt -71.27 -26.89 63.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.2 mm? -58.73 -18.8 34.57 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.74 -0.6 . . . . 0.0 111.054 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.9 mpt_? -96.19 -47.9 5.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.754 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -21.32 65.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.662 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.484 HD11 ' HG2' ' A' ' 27' ' ' MET . 58.9 mt -78.21 -29.09 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -0.904 . . . . 0.0 108.728 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.973 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 14.4 t -76.56 -37.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.545 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -31.73 45.98 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.49 -39.18 91.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.46 -69.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 p 48.33 50.79 16.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.467 0.651 . . . . 0.0 109.662 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 64.63 72.3 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.145 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -73.06 159.32 47.98 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 122.059 1.84 . . . . 0.0 110.714 -179.293 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.88 174.34 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.561 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 54' ' ' THR . 53.7 t -155.58 164.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 41' ' ' VAL . 55.0 tt0 -151.23 110.53 3.95 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -98.62 140.14 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.753 0.787 . . . . 0.0 110.376 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -118.18 111.09 18.38 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.478 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.25 120.62 38.98 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.068 -1.02 . . . . 0.0 111.091 -177.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.03 54.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.89 -127.55 8.89 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.211 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.36 -0.85 24.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.403 -1.057 . . . . 0.0 110.079 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 m -97.02 138.74 34.09 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.753 -1.217 . . . . 0.0 108.489 -179.147 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.1 m-85 -133.98 118.02 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 0.0 109.446 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.98 147.97 26.27 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.337 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.069 HD12 HD11 ' A' ' 63' ' ' ILE . 1.8 mt -144.57 103.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.884 -1.135 . . . . 0.0 111.585 -177.488 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 113.02 25.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 41' ' ' VAL . 57.1 m -104.44 141.83 35.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.96 144.33 41.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.323 -0.86 . . . . 0.0 110.059 -179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.934 0.873 . . . . 0.0 109.291 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.59 164.97 23.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.787 . . . . 0.0 109.585 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -165.41 119.41 1.23 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.069 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -123.44 168.61 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 109.341 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.6 p-10 -162.26 129.23 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.186 -0.946 . . . . 0.0 108.937 179.452 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.3 p90 -162.03 -172.44 3.25 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.394 -179.465 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -129.56 153.33 48.15 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 90.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.121 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.41 -24.68 1.09 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.795 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.88 156.89 33.72 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.266 -1.137 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG2' HD22 ' A' ' 84' ' ' LEU . 49.2 mt-10 -86.3 167.47 14.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.705 -0.622 . . . . 0.0 109.489 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.484 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.41 175.81 11.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.698 -0.626 . . . . 0.0 109.49 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.39 145.81 29.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.8 pt-20 -162.26 -175.81 4.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.69 -0.631 . . . . 0.0 109.375 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -100.19 158.3 15.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.3 t -97.96 -144.34 0.31 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.396 -0.815 . . . . 0.0 109.326 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.581 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -109.93 -24.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.86 -1.15 . . . . 0.0 110.841 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -84.5 -40.74 17.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.75 45.41 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 mmm180 -135.4 154.66 78.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.731 -0.864 . . . . 0.0 108.971 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -78.89 144.29 18.98 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.703 1.602 . . . . 0.0 110.703 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 p -160.86 141.81 11.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.718 -0.614 . . . . 0.0 109.549 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -87.05 116.75 25.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.825 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.48 166.45 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 -178.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.25 154.51 41.81 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.4 t -146.24 131.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.319 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.5 pttt -125.57 160.55 29.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.518 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.8 m95 -83.65 171.76 12.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.193 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 10.9 tp10 -134.87 -46.16 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -131.9 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.66 -24.58 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 109.745 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -143.65 26.45 1.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 110.788 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 14.0 tttt -131.44 110.48 11.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.902 -1.124 . . . . 0.0 108.085 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.1 ptp -116.13 148.29 40.46 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.297 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -100.88 170.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.479 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.9 t -146.36 142.46 28.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -109.77 163.47 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -160.36 135.34 7.79 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.528 -178.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -143.1 148.94 37.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.59 166.37 2.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.052 -1.03 . . . . 0.0 110.94 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.716 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.5 mt -98.45 -5.99 31.33 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -150.91 133.87 15.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.72 -161.21 36.26 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.95 140.79 0.44 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.43 -1.041 . . . . 0.0 109.874 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.04 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.25 -176.71 2.93 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.712 1.608 . . . . 0.0 109.536 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -129.94 137.65 50.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.95 145.04 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.118 0.961 . . . . 0.0 110.608 -179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -163.13 143.44 9.14 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.3 p-90 -144.05 173.47 11.7 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 15.2 p -139.51 170.33 16.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 121' ' ' LEU . 9.6 ptp -154.56 137.1 15.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -131.11 151.37 51.51 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.371 -0.831 . . . . 0.0 109.468 -179.097 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.7 142.09 46.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -90.63 161.47 15.39 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.36 -22.1 62.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.653 . . . . 0.0 110.182 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.9 -28.69 25.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.07 -9.24 7.51 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.699 ' OE1' HG22 ' A' ' 135' ' ' VAL . 67.8 mm-40 -57.02 172.99 0.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.079 -1.248 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -146.1 112.47 5.85 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.923 -178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -105.06 158.43 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD21 ' SD ' ' A' ' 123' ' ' MET . 0.7 OUTLIER -142.41 134.02 26.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -178.995 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.38 166.91 10.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.248 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 121' ' ' LEU . 75.2 mmm -141.27 165.86 26.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 108.992 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -151.72 149.78 29.47 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.446 0.641 . . . . 0.0 109.338 178.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.77 94.58 1.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.9 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -147.67 24.14 1.1 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.533 -0.73 . . . . 0.0 109.137 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -117.38 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.084 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.68 119.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.9 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.44 114.15 26.93 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.067 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.0 m -104.08 149.51 25.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.16 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.498 ' HD2' HD12 ' A' ' 9' ' ' ILE . 18.9 mtm180 -153.21 120.13 5.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.6 137.07 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.0 m-85 -126.0 125.36 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.082 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.699 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -107.54 137.08 40.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.426 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.48 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.2 127.98 15.72 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.011 0.91 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 6.8 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.725 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.348 0.594 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.795 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.01 -13.47 19.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -63.21 117.67 6.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.359 -0.838 . . . . 0.0 112.033 -177.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.57 -175.06 38.17 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 44.9 m-20 -95.5 172.2 8.22 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.592 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.854 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.7 120.4 7.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.753 -176.404 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -109.08 117.15 33.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.682 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 12' ' ' SER . 7.2 tt -60.4 154.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.921 0.867 . . . . 0.0 111.072 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -126.79 -32.3 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.207 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.754 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.8 ttp85 -149.49 169.25 21.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.108 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 9' ' ' ILE . 94.7 p -177.46 139.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.528 -0.733 . . . . 0.0 109.301 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.66 174.83 10.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.622 -0.674 . . . . 0.0 109.868 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 18.9 m120 59.17 25.43 13.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.066 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.657 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -64.8 -64.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 108.718 179.582 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 pt-20 -56.78 -28.06 60.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 0.0 109.509 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' OE1' ' ND2' ' A' ' 14' ' ' ASN . 13.0 mt-10 -65.14 -39.88 93.64 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.052 -179.761 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 130' ' ' CYS . 37.2 tp -80.91 -14.33 58.09 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.748 -0.595 . . . . 0.0 109.821 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 1.3 mt -91.41 -20.16 22.09 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.063 -1.023 . . . . 0.0 109.173 178.97 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mmmt -83.65 -28.62 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.172 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 HD12 ' A' ' 18' ' ' LEU . 14.7 p -78.81 -41.48 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.456 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.471 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.18 -53.54 36.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.198 0.999 . . . . 0.0 108.908 179.323 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.64 -145.5 15.87 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 23' ' ' GLY . 20.9 m -155.35 -39.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.914 -0.757 . . . . 0.0 110.234 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -57.93 -171.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 0.0 109.724 -179.834 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.481 HG12 ' NH1' ' A' ' 29' ' ' ARG . 15.6 m -121.43 -43.44 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.593 -0.692 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.416 ' N ' HG23 ' A' ' 26' ' ' VAL . 6.7 ttt -68.23 -28.15 66.98 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.682 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.4 mm? -58.77 -52.04 67.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.758 -0.589 . . . . 0.0 110.553 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.893 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 mpp_? -60.35 -39.51 87.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.506 -0.746 . . . . 0.0 110.262 -178.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -60.33 -29.24 68.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 110.667 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.8 mt -77.54 -27.76 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.115 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.21 -22.54 35.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.2 t -81.01 -42.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.657 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.22 81.79 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.34 -49.79 75.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.087 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.49 48.63 1.54 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.783 -0.573 . . . . 0.0 110.6 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -63.33 -33.1 74.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.777 -1.202 . . . . 0.0 108.55 179.441 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 72.12 2.01 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.863 ' HB3' HG22 ' A' ' 56' ' ' THR . 33.5 Cg_endo -74.01 141.05 29.25 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.909 1.739 . . . . 0.0 111.085 -178.32 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.96 177.07 5.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 54' ' ' THR . 50.4 t -155.74 165.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 42.9 tt0 -151.62 110.18 3.8 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.724 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -97.93 138.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.849 0.833 . . . . 0.0 110.124 -178.707 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 12.7 mttt -116.56 108.93 16.58 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.1 tt0 -98.56 114.72 27.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -178.483 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -120.45 60.64 0.88 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.16 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.71 -127.93 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.02 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -78.56 0.74 25.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -1.085 . . . . 0.0 110.014 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -97.05 142.11 29.39 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.713 -1.242 . . . . 0.0 108.778 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.9 m-85 -138.45 120.1 15.13 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.808 0.813 . . . . 0.0 109.288 179.639 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' CE2' ' ND2' ' A' ' 64' ' ' ASN . 5.8 t80 -102.9 139.91 37.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.447 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.34 116.97 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.022 -1.048 . . . . 0.0 109.292 -179.518 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.7 tttt -115.08 101.08 8.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.523 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.69 HG23 HG22 ' A' ' 41' ' ' VAL . 16.5 m -100.0 144.89 28.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 109.056 179.5 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -145.16 125.94 14.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.429 -0.794 . . . . 0.0 110.028 -179.721 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 39' ' ' PRO . 21.8 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.551 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.773 HG22 ' OE2' ' A' ' 62' ' ' GLU . 12.3 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -95.88 156.14 16.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.397 -0.815 . . . . 0.0 109.322 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.773 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.1 mp0 -151.03 137.58 18.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.594 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.865 HD11 HG13 ' A' ' 52' ' ' ILE . 24.4 pt -142.85 169.5 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.557 -0.715 . . . . 0.0 109.519 179.39 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.559 ' ND2' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -162.6 135.95 6.01 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.46 -0.775 . . . . 0.0 108.945 179.325 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 52.5 p90 -161.85 -173.45 3.71 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.93 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 152.87 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.722 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 92.2 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -178.881 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.91 -29.8 1.25 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.841 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -116.33 155.84 27.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.308 -1.113 . . . . 0.0 110.26 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' HD22 ' A' ' 84' ' ' LEU . 37.1 mt-10 -85.72 167.35 15.35 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.84 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 17.1 p90 -162.84 174.74 12.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.894 -178.514 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -104.38 144.89 31.03 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.642 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.1 -177.27 5.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.42 156.21 17.14 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.011 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.1 t -93.53 -142.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.366 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' N ' HG23 ' A' ' 75' ' ' THR . 24.0 t -108.64 -23.23 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.751 -1.218 . . . . 0.0 110.875 -179.039 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.583 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -87.38 -40.86 14.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.397 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.35 44.53 0.1 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 13.5 mtp180 -130.72 152.11 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.676 -0.896 . . . . 0.0 109.146 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.09 142.24 19.3 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.643 1.562 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.0 p -160.91 141.47 11.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.672 -0.643 . . . . 0.0 109.782 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.603 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -90.56 114.05 26.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.5 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -101.78 177.22 4.97 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.88 -178.756 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' HG2' ' A' ' 70' ' ' GLU . 59.3 tp -151.83 152.92 33.26 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.29 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.1 t -140.36 131.99 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.843 -177.916 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -126.83 159.89 32.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.753 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.671 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -83.8 170.13 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.025 -179.602 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.4 tp10 -132.99 -45.7 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.092 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -133.19 -153.94 0.58 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.08 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -77.6 -24.87 49.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 109.792 179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -143.03 26.74 1.66 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 60.7 tttt -131.21 107.96 9.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.943 -1.098 . . . . 0.0 108.113 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.509 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -115.61 147.29 40.95 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.501 -0.749 . . . . 0.0 110.175 -179.141 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -102.55 172.16 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.0 t -149.38 130.5 14.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.789 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.0 pt-20 -101.35 163.62 12.18 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.152 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 8.4 tt0 -160.18 143.25 13.65 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.962 -178.222 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -147.37 150.74 35.28 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.83 167.1 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.861 -179.149 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.1 mt -97.5 -7.61 31.08 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.428 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 134.26 18.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.8 -158.39 44.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.414 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -176.35 141.37 0.41 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.501 -1.0 . . . . 0.0 109.808 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.65 -86.23 0.05 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.317 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.26 -176.87 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.841 1.694 . . . . 0.0 109.911 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -132.46 135.04 45.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.56 145.49 47.92 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.068 0.937 . . . . 0.0 110.774 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 p -163.14 134.27 4.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -135.6 169.29 17.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.086 -1.009 . . . . 0.0 110.202 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.842 HG22 HG13 ' A' ' 94' ' ' VAL . 17.6 p -134.95 171.4 14.46 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.429 0.633 . . . . 0.0 109.791 -179.566 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.436 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 2.1 ptp -154.46 130.82 10.47 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 154.04 39.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.246 -178.296 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.47 141.71 48.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.032 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.5 p -93.77 160.55 14.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.682 -179.477 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -60.74 -21.48 63.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.104 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.22 -29.33 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.16 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.36 -9.18 7.39 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 170.32 0.4 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.256 . . . . 0.0 108.944 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.836 HD13 HD13 ' A' ' 43' ' ' ILE . 7.6 tt -146.75 112.54 5.69 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.228 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.9 tt -104.45 160.3 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.69 132.63 27.67 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.359 -0.838 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.75 170.8 7.99 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.362 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 27.9 mtp -148.4 166.0 29.42 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.353 -179.333 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 5.7 m -150.11 151.96 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.44 0.638 . . . . 0.0 109.369 179.212 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.85 96.08 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.501 179.722 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.13 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -147.37 24.03 1.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.495 -0.753 . . . . 0.0 109.22 178.516 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.7 m -117.87 -179.07 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.81 118.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.628 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.704 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -97.36 121.32 39.13 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -116.72 148.17 41.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.007 0.908 . . . . 0.0 110.283 -178.751 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -153.1 121.82 6.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.95 139.19 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.087 -1.008 . . . . 0.0 108.697 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 21.7 m-85 -127.65 133.38 49.65 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.232 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.15 138.32 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.24 128.25 16.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.204 -0.935 . . . . 0.0 111.644 -178.482 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.656 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.498 1.741 0 N-CA-C 109.868 -0.858 . . . . 1.72 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -162.78 123.0 2.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 1.29 109.564 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.653 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -99.73 -8.15 24.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.915 -0.772 . . . . 0.18 108.915 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 23.0 t -66.62 116.39 7.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.405 -0.81 . . . . 1.22 111.352 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -169.89 37.65 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.609 -1.796 . . . . 0.14 108.609 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 6.4 m120 -96.62 169.88 9.58 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.537 -1.653 . . . . 0.58 106.537 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.927 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.84 119.78 6.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.474 -1.29 . . . . 0.21 112.385 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -114.12 113.72 25.09 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.829 -1.175 . . . . 1.75 107.829 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.3 tt -56.52 154.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.847 0.832 . . . . 0.69 110.907 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.99 -31.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.979 -0.748 . . . . 0.46 108.979 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HB2' HD12 ' A' ' 10' ' ' ILE . 5.5 mtt180 -139.88 168.1 20.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 2.86 108.753 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 9' ' ' ILE . 4.2 t 177.74 152.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.04 109.689 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.54 171.01 16.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.579 -0.701 . . . . 1.25 109.456 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.0 m120 61.34 32.11 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 1.78 109.865 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.18 -62.65 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.42 110.084 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -59.2 -36.51 75.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.268 -0.895 . . . . 2.28 110.354 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 8.1 pt-20 -68.02 -28.62 67.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.274 -0.97 . . . . 2.08 109.795 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD22 ' HB2' ' A' ' 130' ' ' CYS . 43.4 tp -79.41 -21.34 45.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.191 -0.943 . . . . 0.6 108.998 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 32' ' ' ALA . 3.9 mt -89.5 -18.45 26.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.161 -0.962 . . . . 0.72 108.596 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -84.13 -30.3 26.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.738 -1.208 . . . . 1.11 107.738 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.7 p -77.48 -41.02 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.875 -1.157 . . . . 0.45 107.875 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.4 mp -65.51 -50.62 64.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.608 -0.886 . . . . 0.57 108.608 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.704 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.72 -142.25 12.46 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.136 -1.186 . . . . 0.72 110.136 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -164.67 -34.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.655 -0.909 . . . . 1.53 109.415 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.0 t30 -61.71 -159.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.806 . . . . 1.54 109.497 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.6 HG12 HH12 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -120.97 -48.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.24 109.397 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.9 ttt -68.96 -24.46 64.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.54 -0.911 . . . . 2.21 108.54 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -60.8 -27.75 68.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.763 -0.586 . . . . 1.4 110.219 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -87.38 -45.19 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 2.44 109.901 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -61.43 -25.09 66.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 2.77 110.526 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.9 mt -76.5 -29.66 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.989 . . . . 1.45 108.85 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.22 -26.04 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.561 -0.712 . . . . 0.42 109.166 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.1 t -77.15 -36.15 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.768 -1.197 . . . . 0.44 107.768 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -33.57 48.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.13 -1.063 . . . . 0.68 108.13 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.31 94.91 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.912 -0.773 . . . . 0.8 108.912 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.84 -69.07 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.741 -0.837 . . . . 1.69 108.741 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 44.18 46.78 7.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.608 -0.683 . . . . 1.6 109.348 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 67.34 73.46 0.36 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.436 -0.95 . . . . 3.08 108.436 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.3 Cg_endo -74.58 157.13 44.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.596 2.198 . . . . 0.58 110.437 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -99.67 173.15 6.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.447 -0.783 . . . . 0.24 109.488 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 54' ' ' THR . 13.3 t -156.15 160.74 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.89 -0.781 . . . . 0.28 108.89 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 35.3 tt0 -146.68 113.11 5.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 1.47 108.746 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.9 mt -99.94 136.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.395 -0.816 . . . . 0.31 110.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.23 111.06 20.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.297 -1.371 . . . . 1.23 107.297 178.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.5 tt0 -98.52 122.33 41.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.985 -1.072 . . . . 1.61 110.781 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -125.47 46.72 2.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.565 -0.902 . . . . 1.97 108.565 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.47 -131.33 10.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.749 -1.74 . . . . 0.38 108.749 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.26 -0.31 19.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -1.179 . . . . 1.13 109.555 179.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.3 m -98.81 131.53 44.86 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.897 -1.127 . . . . 0.25 108.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.591 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.3 m-85 -128.25 118.62 23.62 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.22 110.049 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.0 t80 -102.24 144.71 30.42 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.082 -1.451 . . . . 0.31 107.082 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.851 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -141.79 107.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.684 -1.26 . . . . 0.56 110.562 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 1.6 tttt -104.72 115.46 30.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 1.8 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' CG2' ' A' ' 41' ' ' VAL . 44.4 m -104.2 144.79 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.38 109.1 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -140.65 134.57 30.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 0.54 109.615 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -102.8 -71.73 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.93 0.871 . . . . 1.05 109.329 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.819 HG23 HG23 ' A' ' 58' ' ' VAL . 5.1 t -172.95 -41.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.809 -1.552 . . . . 1.26 106.809 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.819 HG23 HG23 ' A' ' 57' ' ' THR . 38.1 t -113.96 -9.85 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.701 -0.851 . . . . 1.36 108.701 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' CG ' ' N ' ' A' ' 60' ' ' THR . 35.8 ttm180 -123.3 163.81 20.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.278 -0.889 . . . . 3.29 109.411 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 55' ' ' SER . 20.4 m -164.31 102.96 0.85 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.545 -0.722 . . . . 0.63 109.301 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -101.71 172.69 6.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.77 109.504 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 3.7 pt-20 -171.87 125.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 1.85 109.332 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.851 HD11 HD12 ' A' ' 52' ' ' ILE . 38.0 pt -117.57 170.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.35 109.289 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.6 p-10 -161.25 130.53 4.68 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.942 . . . . 1.17 108.939 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -161.54 -172.93 3.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.16 111.484 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 11.6 ptpt -128.91 152.74 48.21 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.027 -1.101 . . . . 1.84 108.027 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.2 92.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 0.18 109.734 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.67 -26.97 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.519 -1.324 . . . . 0.27 110.579 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -124.65 159.51 30.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.246 . . . . 2.38 109.995 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG2' HD22 ' A' ' 84' ' ' LEU . 27.2 mt-10 -87.51 167.96 13.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 1.65 109.207 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 18.3 p90 -161.38 178.36 9.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.419 -0.801 . . . . 0.2 109.713 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -107.56 143.31 36.17 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.374 -0.973 . . . . 1.14 108.374 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.698 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.1 pt-20 -161.99 -176.21 5.07 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.462 -0.774 . . . . 1.59 109.46 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -99.55 153.06 19.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.817 -0.808 . . . . 1.92 108.817 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.71 HG23 ' H ' ' A' ' 77' ' ' ASP . 9.2 t -90.18 -144.99 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 1.04 109.529 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 21.5 t -107.96 -19.21 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.78 -1.2 . . . . 2.02 110.56 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.71 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.6 -44.21 10.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.063 -1.023 . . . . 2.03 109.305 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.88 39.65 0.09 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.425 . . . . 0.45 109.536 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 1.5 mmm180 -129.41 152.91 80.36 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.469 -1.019 . . . . 2.66 109.052 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD2' ' HD2' ' A' ' 79' ' ' ARG . 35.9 Cg_endo -78.41 139.71 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.164 1.909 . . . . 0.29 110.537 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 13.1 p -160.58 144.06 13.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.24 109.559 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -86.4 117.28 25.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.293 -1.003 . . . . 1.5 108.293 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 97' ' ' GLN . 1.9 t -99.88 165.63 11.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -0.787 . . . . 0.75 109.971 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.0 tp -144.94 155.63 43.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.473 -1.306 . . . . 0.53 107.473 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.8 t -148.41 128.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.37 -1.332 . . . . 0.2 111.855 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.66 158.48 28.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.274 -1.38 . . . . 1.91 107.274 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.54 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.6 m95 -81.36 166.53 20.36 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.959 -1.088 . . . . 0.15 110.178 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.7 tp10 -130.99 -42.2 1.11 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.845 -1.169 . . . . 1.11 107.845 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -136.71 -153.31 0.49 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.75 -1.204 . . . . 0.16 107.75 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.94 -18.94 49.17 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.118 -0.989 . . . . 2.15 109.594 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -147.93 26.84 0.99 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.091 -1.005 . . . . 0.25 110.355 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 57.5 tttt -134.38 109.33 8.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.73 -1.231 . . . . 1.34 108.617 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.591 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -115.17 148.02 39.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.404 -0.81 . . . . 0.67 110.073 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.6 t -100.32 172.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.2 108.774 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 53.6 t -147.99 140.12 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.018 . . . . 0.21 111.078 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -107.57 164.49 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.867 -1.531 . . . . 2.11 106.867 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 4.5 tt0 -160.2 135.84 8.29 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.412 -1.315 . . . . 0.78 111.554 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 56.0 pttt -145.16 144.28 30.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.134 -1.061 . . . . 2.45 108.134 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 168.14 1.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.898 -1.126 . . . . 0.87 110.808 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 82' ' ' LYS . 67.3 mt -102.78 -3.83 25.83 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.931 -1.137 . . . . 0.98 107.931 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -153.88 148.2 25.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.942 -0.762 . . . . 2.85 108.942 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.16 -162.71 22.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.079 -1.609 . . . . 1.94 109.079 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.94 141.73 0.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.266 -1.138 . . . . 5.26 109.645 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.45 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.856 -1.697 . . . . 1.32 108.856 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.17 -176.15 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.448 2.099 . . . . 0.84 110.056 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -137.18 136.8 38.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.232 -1.025 . . . . 1.28 108.232 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.91 145.2 46.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 0.36 110.753 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.8 m -162.73 136.59 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.819 -1.178 . . . . 0.85 107.819 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.441 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 53.4 p-90 -142.96 176.7 8.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.24 110.323 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.43 171.83 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.462 0.649 . . . . 0.23 109.599 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.539 ' HE2' ' HB2' ' A' ' 111' ' ' MET . 13.3 ptm -153.97 125.83 7.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.584 -0.895 . . . . 1.93 108.584 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -120.53 154.12 35.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 1.97 110.232 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.93 144.78 41.91 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.839 -1.171 . . . . 0.17 107.839 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.403 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 41.4 p -93.26 161.55 14.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.854 -1.154 . . . . 0.24 109.715 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -62.14 -19.49 63.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 2.15 109.794 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.21 -26.46 23.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.86 109.184 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.1 -9.68 8.4 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.847 -1.301 . . . . 0.18 109.847 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.426 ' O ' HD13 ' A' ' 113' ' ' LEU . 62.0 mt-10 -55.88 172.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 1.48 109.03 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.764 HD13 HD13 ' A' ' 43' ' ' ILE . 7.9 tt -144.84 113.21 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.15 110.18 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.74 154.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.914 -1.143 . . . . 0.68 107.914 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -137.91 131.3 30.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.023 -1.048 . . . . 1.38 109.893 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -109.02 162.32 14.34 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.835 -1.172 . . . . 0.27 107.835 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 13.9 mtp -142.4 159.09 42.92 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.164 -0.96 . . . . 0.81 109.774 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 129' ' ' VAL . 3.4 m -143.87 152.56 41.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.15 -0.685 . . . . 0.31 109.15 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 128' ' ' VAL . . . -155.94 91.14 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.31 109.586 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER 78.72 -76.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.924 -0.769 . . . . 1.21 108.924 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.25 22.67 1.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.751 -0.833 . . . . 2.14 108.751 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 125' ' ' ALA . 16.6 m -117.36 179.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.85 117.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.132 -1.027 . . . . 0.29 110.077 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.915 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.14 107.74 20.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 0.4 109.321 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 122' ' ' THR . 93.7 m -99.71 145.98 27.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.37 109.507 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -151.02 122.69 8.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.503 -0.925 . . . . 1.81 108.503 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.54 135.52 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.911 -1.118 . . . . 0.24 108.767 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.477 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.1 m-85 -124.37 124.35 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.508 -0.877 . . . . 0.4 109.916 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.575 -1.269 . . . . 0.18 107.575 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -44.52 125.88 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.14 110.565 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' ARG . 9.1 tt0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.101 -0.952 . . . . 2.3 111.057 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.972 0 N-CA-C 110.359 -0.67 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -153.65 121.64 6.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.506 -0.747 . . . . 0.0 109.707 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.4 m-85 -99.4 -11.46 21.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -66.12 117.08 7.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 111.958 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.11 -174.09 38.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 24.7 m-20 -95.02 171.73 8.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.868 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.3 m95 -151.22 128.79 11.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.513 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -120.41 115.82 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.801 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.1 tt -58.51 153.56 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.918 0.866 . . . . 0.0 111.2 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.48 -32.89 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -140.77 168.69 19.19 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.801 ' HB2' HD11 ' A' ' 9' ' ' ILE . 13.4 t 177.95 147.09 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -144.39 168.79 19.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.433 0.635 . . . . 0.0 109.951 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 12.7 m120 61.66 31.38 18.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.672 . . . . 0.0 109.66 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.969 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.11 -64.72 0.99 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.528 -0.732 . . . . 0.0 110.111 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.709 ' HG2' HG21 ' A' ' 33' ' ' VAL . 46.8 mt-10 -56.51 -34.83 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 110.959 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -69.81 -29.97 67.39 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.469 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 130' ' ' CYS . 22.3 tp -77.46 -19.8 55.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 109.908 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -89.99 -16.85 28.99 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.97 . . . . 0.0 109.291 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mtmm -86.19 -33.69 20.72 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -72.07 -39.76 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -68.56 -46.26 69.92 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.832 0.825 . . . . 0.0 109.266 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.12 -163.44 27.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 25' ' ' ASN . 27.1 m -140.21 -40.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.894 -0.768 . . . . 0.0 109.75 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 t-20 -59.74 -165.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.483 -0.761 . . . . 0.0 109.482 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.484 HG13 ' NH1' ' A' ' 29' ' ' ARG . 1.7 t -115.45 -48.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.29 -28.17 67.79 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.9 mm? -56.98 -20.31 23.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -91.78 -50.48 5.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.787 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -62.35 -19.84 63.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.7 . . . . 0.0 111.076 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.58 -29.86 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.195 -0.941 . . . . 0.0 108.752 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.66 -25.1 33.38 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.9 t -76.89 -37.08 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.61 49.04 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.03 93.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.36 -69.93 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m 47.79 49.84 16.17 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.498 0.666 . . . . 0.0 109.626 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mttp 66.37 72.49 0.43 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -72.9 166.4 30.11 Favored 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.974 1.782 . . . . 0.0 110.811 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.53 173.02 6.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.65 -0.657 . . . . 0.0 109.536 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 54' ' ' THR . 53.5 t -154.55 165.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.4 tt0 -151.82 110.92 3.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.868 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.6 mt -97.83 138.43 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.806 0.812 . . . . 0.0 110.084 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttt -116.95 104.96 11.81 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.2 tt0 -97.34 125.37 41.9 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.33 54.15 1.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -126.18 8.35 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.619 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -75.5 -1.36 23.86 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.252 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -97.14 136.49 37.6 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.741 -1.224 . . . . 0.0 108.338 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -131.16 116.48 17.76 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.857 0.837 . . . . 0.0 109.297 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.8 t80 -102.29 148.95 24.83 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.882 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -146.31 99.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.996 -1.065 . . . . 0.0 110.426 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 62' ' ' GLU . 1.7 tttp -99.98 114.23 27.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 109.883 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 41' ' ' VAL . 31.6 m -101.96 144.69 30.26 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.4 OUTLIER -142.57 131.65 23.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.408 -0.807 . . . . 0.0 109.777 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -100.37 -80.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.665 . . . . 0.0 109.446 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.4 HG23 ' C ' ' A' ' 56' ' ' THR . 77.5 p -158.06 -46.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 t -112.7 -10.45 12.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -117.24 162.02 18.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 55' ' ' SER . 15.1 m -163.83 103.47 0.9 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -102.07 172.85 6.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.767 . . . . 0.0 109.329 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . 2.6 pt-20 -171.94 119.58 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.69 . . . . 0.0 109.736 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.882 HD11 HD12 ' A' ' 52' ' ' ILE . 37.7 pt -110.43 170.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.528 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.3 p30 -162.35 133.87 5.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.292 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.1 p90 -161.98 -172.37 3.23 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.637 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -129.19 153.01 48.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.39 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.139 -0.976 . . . . 0.0 109.825 -178.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.12 -27.36 1.72 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.013 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -119.39 156.19 30.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.676 ' HG2' HD13 ' A' ' 84' ' ' LEU . 14.1 mt-10 -86.28 167.27 14.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.7 p90 -162.72 174.46 12.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.698 . . . . 0.0 109.634 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.94 147.5 26.85 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.671 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.4 pt-20 -161.74 179.49 8.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.679 -0.638 . . . . 0.0 109.324 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.72 128.1 55.05 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.265 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -63.86 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' N ' HG23 ' A' ' 75' ' ' THR . 12.3 p -103.1 -16.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 111.322 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.7 ' H ' HG23 ' A' ' 75' ' ' THR . 3.9 t70 -86.66 -40.85 14.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.28 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.51 43.49 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 75' ' ' THR . 6.9 mmm180 -130.52 148.89 71.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.661 -0.905 . . . . 0.0 108.937 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 140.51 17.15 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.454 1.436 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.6 p -160.86 141.69 11.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.682 -0.636 . . . . 0.0 109.633 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.828 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -90.45 114.27 26.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.21 176.21 5.33 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.947 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -152.93 153.32 32.76 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.6 t -140.75 127.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.989 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.07 155.3 34.7 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.687 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.6 m95 -78.01 173.16 12.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.058 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.3 tp10 -135.11 -46.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -129.99 -152.67 0.52 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.25 -25.71 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -143.78 25.27 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 110.981 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 34.7 tttm -130.08 110.93 12.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.893 -1.13 . . . . 0.0 108.065 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.446 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.41 150.17 38.22 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.661 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -99.52 172.15 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.492 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.2 t -149.15 129.76 14.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.88 . . . . 0.0 110.752 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -101.04 162.37 12.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 9.0 tt0 -160.44 139.76 10.78 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.878 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.05 149.74 37.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.69 165.59 3.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 111.085 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.828 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.3 mt -100.49 -2.97 31.77 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -153.36 134.31 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 108.807 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.87 -160.7 41.46 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -176.26 141.41 0.43 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.467 -1.019 . . . . 0.0 109.841 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.0 -85.39 0.05 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.53 -177.14 3.05 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.82 1.68 . . . . 0.0 109.857 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -134.44 138.51 44.83 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.03 145.25 48.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.008 0.909 . . . . 0.0 110.69 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.5 m -163.39 132.53 4.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -135.96 170.45 15.98 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.037 -1.039 . . . . 0.0 110.422 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 HG13 ' A' ' 94' ' ' VAL . 14.1 p -134.54 173.12 12.0 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.532 0.682 . . . . 0.0 109.722 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.7 ptp -158.6 139.57 12.97 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.0 pt-20 -140.64 144.87 35.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.366 -0.834 . . . . 0.0 109.1 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -105.02 144.79 31.34 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.8 p -91.75 160.38 15.36 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.15 -19.87 55.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.62 -0.675 . . . . 0.0 110.337 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.11 -28.56 22.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.29 -8.79 7.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 113' ' ' LEU . 8.1 mt-10 -57.94 171.3 0.53 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.046 -1.267 . . . . 0.0 108.95 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD13 HD13 ' A' ' 43' ' ' ILE . 7.5 tt -146.01 110.87 5.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.883 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.407 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -107.34 148.47 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -132.87 138.56 47.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.378 -0.826 . . . . 0.0 109.59 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.44 169.04 9.46 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.2 mtp -146.96 165.25 30.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.197 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -147.63 151.11 35.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.715 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.67 92.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.559 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.78 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -146.57 24.11 1.25 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.6 m -117.74 -179.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.69 118.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.722 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.911 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.53 113.67 26.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 122' ' ' THR . 85.8 m -109.34 147.94 31.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.737 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -152.59 117.59 5.15 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.9 t -80.18 139.17 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 108.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.7 m-85 -127.68 123.51 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.315 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.03 138.45 31.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.495 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.15 128.56 16.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.181 -0.95 . . . . 0.0 111.543 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 4.1 tt0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.322 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.502 1.987 0 N-CA-C 110.381 -0.661 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -132.49 135.41 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.503 -0.748 . . . . 0.0 110.143 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -98.69 1.38 46.11 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 120.12 18.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 111.925 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -174.19 38.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 46.8 m-20 -95.58 172.03 8.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.543 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -151.49 125.23 9.05 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.573 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -117.54 114.04 22.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' A' ' 39' ' ' PRO . 4.6 tt -52.63 147.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.661 0.744 . . . . 0.0 111.13 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.67 -25.11 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 122.003 -0.436 . . . . 0.0 110.24 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -152.57 177.43 10.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.164 -0.96 . . . . 0.0 110.469 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -179.47 166.05 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.79 24.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 111.708 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 61.1 m-20 -161.14 27.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.607 -0.683 . . . . 0.0 110.197 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.815 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -65.44 -66.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 108.738 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 14.9 pt-20 -56.52 -28.64 60.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.35 -38.9 91.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.677 -0.639 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 130' ' ' CYS . 36.7 tp -79.4 -16.13 56.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.773 -0.58 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.83 -20.29 22.47 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.954 -1.091 . . . . 0.0 109.18 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.7 mmmt -83.03 -28.17 29.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -80.42 -40.64 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 122.127 0.965 . . . . 0.0 108.477 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.3 mp -67.76 -50.02 59.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.919 0.866 . . . . 0.0 109.87 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.77 -154.21 25.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.79 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.0 t -150.7 -39.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 122.029 -0.689 . . . . 0.0 110.029 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.8 -160.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.38 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.09 -45.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.892 . . . . 0.0 109.775 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.423 ' O ' HD12 ' A' ' 31' ' ' ILE . 4.1 ttt -66.12 -30.9 71.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.857 -0.527 . . . . 0.0 110.213 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 33' ' ' VAL . 43.4 mtt180 -84.87 -47.48 10.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.499 -0.751 . . . . 0.0 109.968 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -61.61 -21.86 64.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.691 -0.63 . . . . 0.0 111.06 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 27' ' ' MET . 29.5 mt -81.26 -28.8 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.22 -25.87 36.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.665 -0.647 . . . . 0.0 109.354 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.33 -44.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.21 85.54 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.41 -56.23 23.9 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.775 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.9 57.96 4.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.757 -0.589 . . . . 0.0 110.287 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 t -64.21 -43.11 96.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.697 -1.252 . . . . 0.0 107.726 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -151.36 74.19 8.2 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.948 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.1 Cg_endo -71.5 142.11 39.83 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.846 1.697 . . . . 0.0 111.262 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -98.94 174.73 6.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 54' ' ' THR . 50.8 t -155.74 163.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -151.31 111.6 4.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HG23 ' A' ' 52' ' ' ILE . 2.6 mp -98.08 135.81 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.019 0.914 . . . . 0.0 110.442 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 4.4 mttm -109.91 93.45 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.65 125.44 41.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.31 -0.869 . . . . 0.0 110.42 -176.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -132.65 56.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.55 -132.29 10.97 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.5 p30 -71.71 -4.36 27.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.384 -1.068 . . . . 0.0 110.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 m -96.79 134.08 40.54 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.656 -1.278 . . . . 0.0 108.476 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.685 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.7 m-85 -131.15 119.06 21.36 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.687 0.756 . . . . 0.0 109.336 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 15.0 t80 -103.15 150.46 23.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.094 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -148.58 104.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.94 -1.1 . . . . 0.0 110.97 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -104.81 113.11 26.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 108.864 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 41' ' ' VAL . 41.6 m -102.49 145.5 29.49 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.459 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.9 p -142.77 119.15 10.91 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.674 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.948 HG22 ' HB3' ' A' ' 39' ' ' PRO . 82.8 p -99.26 -158.87 0.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.498 HG23 ' N ' ' A' ' 58' ' ' VAL . 5.6 t -57.39 -45.11 84.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.942 . . . . 0.0 110.923 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.498 ' N ' HG23 ' A' ' 57' ' ' THR . 33.0 t -131.42 -7.67 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.314 -0.866 . . . . 0.0 111.975 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -98.94 165.75 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.072 -1.017 . . . . 0.0 110.008 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 55' ' ' SER . 7.1 m -163.71 95.44 0.81 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 169.17 12.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.772 . . . . 0.0 109.724 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.34 111.35 1.22 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.489 -0.757 . . . . 0.0 109.699 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 52' ' ' ILE . 42.7 pt -116.53 165.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.6 p30 -162.58 132.51 4.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.3 p90 -161.67 -172.7 3.43 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.404 1.097 . . . . 0.0 112.445 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.76 153.54 48.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.32 93.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.133 -0.98 . . . . 0.0 109.681 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.31 -22.91 1.55 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.906 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.69 155.63 37.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.22 -1.165 . . . . 0.0 110.219 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' HG2' HD13 ' A' ' 84' ' ' LEU . 32.3 mt-10 -86.64 166.41 15.38 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.17 174.57 12.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -105.55 144.22 32.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.709 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.31 -174.79 4.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -99.75 159.91 14.7 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.9 t -97.31 -142.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.5 t -111.13 -19.2 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.783 -1.198 . . . . 0.0 110.824 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t70 -90.67 -37.11 13.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.486 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.71 45.14 0.15 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 7.1 mtm-85 -133.3 153.54 80.65 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 121.691 -0.888 . . . . 0.0 109.447 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -79.0 142.04 17.05 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.767 1.645 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -161.26 143.06 11.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.657 -0.652 . . . . 0.0 109.517 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.598 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -89.46 117.33 28.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.48 166.54 11.11 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.266 0.555 . . . . 0.0 109.988 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' A' ' 70' ' ' GLU . 49.1 tp -148.77 153.02 37.56 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.695 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.8 t -143.4 136.13 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.417 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.21 157.22 41.45 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.556 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.6 m95 -81.15 172.83 13.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.019 0.914 . . . . 0.0 110.627 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -136.69 -45.98 0.6 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.9 p -131.81 -153.63 0.57 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -76.47 -26.97 55.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.801 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -143.46 28.53 1.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 48.7 tttt -130.54 110.37 11.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.989 -1.069 . . . . 0.0 108.188 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.685 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.3 ptp -117.43 147.5 42.64 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.728 0.775 . . . . 0.0 110.572 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 110' ' ' THR . 2.2 t -100.73 171.5 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.423 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.0 t -146.83 137.43 23.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' OE2' HD23 ' A' ' 84' ' ' LEU . 7.4 pt-20 -108.77 156.13 19.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -154.65 142.2 19.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.974 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -143.73 152.05 40.78 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.17 168.03 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.755 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.6 mt -99.6 -5.75 28.51 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 137.2 14.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 108.621 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.85 -163.12 37.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -175.96 140.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.43 -1.041 . . . . 0.0 109.995 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.35 -86.83 0.06 OUTLIER Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.83 -176.91 2.87 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.783 1.655 . . . . 0.0 109.643 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -131.41 139.87 49.52 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.12 144.63 48.46 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.172 0.987 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 m -162.92 131.8 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 48.9 p-90 -137.12 172.79 12.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.143 -0.973 . . . . 0.0 110.231 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.813 HG22 HG13 ' A' ' 94' ' ' VAL . 19.8 p -135.92 174.16 10.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.542 0.687 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.497 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.9 ptm -157.95 124.31 4.79 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -119.54 147.64 44.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.488 -0.758 . . . . 0.0 109.889 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.01 143.52 39.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 p -93.55 159.48 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -59.28 -21.9 60.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.96 -30.19 24.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.3 -9.82 6.56 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.9 173.91 0.13 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.084 -1.245 . . . . 0.0 109.349 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.5 tt -148.17 111.14 4.83 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.124 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.409 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.1 tt -106.82 151.47 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.94 147.08 52.44 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.423 -0.798 . . . . 0.0 109.439 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.559 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -127.73 170.36 12.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.5 mtp -150.6 167.77 26.29 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.675 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.5 m -149.31 151.31 33.94 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.82 94.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.53 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.15 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.19 23.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.808 HG21 HG11 ' A' ' 21' ' ' VAL . 24.7 m -117.23 -178.86 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.5 t -157.86 118.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.589 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.755 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -97.9 121.52 39.92 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.559 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.6 m -119.93 134.62 55.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.224 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -139.86 108.43 5.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 120' ' ' ILE . 43.5 t -72.39 140.38 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.2 m-85 -129.07 128.79 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.2 137.63 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -49.48 128.33 17.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.233 -0.917 . . . . 0.0 111.687 -178.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.4 tm-20 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.807 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.624 ' HD2' HD12 ' A' ' 113' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.501 1.931 0 N-CA-C 110.58 -0.585 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.34 128.96 38.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 110.044 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.543 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -99.06 -2.13 37.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.7 p -71.82 118.74 15.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.955 . . . . 0.0 111.943 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.64 -173.62 38.04 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 27.7 m-20 -95.36 170.67 9.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -150.91 128.12 11.23 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.488 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -121.66 116.36 24.42 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 132' ' ' ARG . 9.4 tt -59.48 141.84 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.525 0.678 . . . . 0.0 110.294 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -119.52 -23.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.875 -0.516 . . . . 0.0 110.101 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -145.66 176.73 9.41 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 176.29 165.43 0.43 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -159.32 25.77 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.091 -1.006 . . . . 0.0 111.292 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.4 m-20 -160.85 29.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.665 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.49 -65.66 0.65 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 0.0 109.008 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.6 mt-10 -56.68 -27.07 58.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.81 -40.9 97.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.667 -0.645 . . . . 0.0 109.791 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.781 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.8 tp -77.75 -16.73 58.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.662 -0.649 . . . . 0.0 110.091 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.7 mt -89.43 -19.24 25.39 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.055 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.1 mmmt -85.57 -28.6 24.76 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 128' ' ' VAL . 14.9 p -79.57 -41.06 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.69 -53.13 45.29 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.018 0.913 . . . . 0.0 108.935 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.75 -146.26 17.13 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 25' ' ' ASN . 19.3 m -155.93 -43.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.0 t-20 -56.95 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.518 -0.739 . . . . 0.0 109.56 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' NH2' ' A' ' 29' ' ' ARG . 2.1 m -109.83 -44.49 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.416 -0.802 . . . . 0.0 109.899 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.1 ttm -66.3 -27.27 67.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.8 mm? -57.71 -41.9 82.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.675 -0.641 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.844 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.2 mtp180 -71.36 -42.66 68.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -62.44 -20.24 64.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.755 -0.59 . . . . 0.0 111.115 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 28' ' ' LEU . 45.4 mt -79.47 -30.04 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 108.879 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.6 32.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.7 t -79.13 -35.93 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.69 -36.17 51.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.91 79.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' A' ' 39' ' ' PRO . . . -69.42 -67.56 0.47 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 49.23 52.08 15.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 67.36 73.7 0.36 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.46 158.35 54.23 Favored 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.017 1.811 . . . . 0.0 110.795 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.51 173.13 6.45 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.743 -0.598 . . . . 0.0 109.528 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 54' ' ' THR . 48.8 t -155.0 164.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 tt0 -148.68 111.53 4.82 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -97.9 132.59 42.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.786 0.803 . . . . 0.0 110.054 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -111.78 106.49 15.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -97.47 123.97 41.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.064 -1.022 . . . . 0.0 111.176 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -123.62 55.22 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -126.03 8.15 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.97 -1.09 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -1.034 . . . . 0.0 110.143 178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.44 136.05 37.47 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.782 -1.199 . . . . 0.0 108.551 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.9 m-85 -130.96 115.66 16.8 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.6 t80 -102.29 148.17 25.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.964 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -145.17 99.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.019 -1.05 . . . . 0.0 110.389 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -99.25 113.71 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.766 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 41' ' ' VAL . 34.0 m -100.53 144.7 29.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.799 . . . . 0.0 108.964 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 136.9 32.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.46 -0.775 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -106.27 -65.93 1.04 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.916 0.865 . . . . 0.0 109.708 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.637 HG23 HG23 ' A' ' 58' ' ' VAL . 2.6 t 178.64 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG23 HG23 ' A' ' 57' ' ' THR . 45.4 t -112.93 -11.64 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -124.37 163.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.083 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 m -163.28 103.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -101.84 173.87 6.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.8 . . . . 0.0 109.55 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -172.27 118.96 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.773 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 52' ' ' ILE . 40.2 pt -108.56 169.55 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.517 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.4 p30 -162.56 132.82 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.764 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.92 -172.21 3.18 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.069 0.938 . . . . 0.0 111.739 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -131.53 154.53 48.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.58 95.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.187 -0.945 . . . . 0.0 109.636 -178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.66 -21.8 0.62 Allowed Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.606 -1.283 . . . . 0.0 111.038 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -135.82 163.57 29.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -1.144 . . . . 0.0 110.714 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.1 mt-10 -86.28 169.31 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.4 p90 -162.6 174.39 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -103.14 144.78 30.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -161.89 178.65 8.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.84 151.61 21.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.4 t -88.26 -142.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.485 -0.759 . . . . 0.0 109.125 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 22.5 t -112.2 -19.77 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.741 -1.224 . . . . 0.0 110.657 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t70 -88.75 -41.31 12.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 44.25 0.1 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mtp180 -131.63 147.19 65.04 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.666 -0.902 . . . . 0.0 108.89 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD11 ' A' ' 100' ' ' LEU . 37.8 Cg_endo -79.8 142.72 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.441 1.427 . . . . 0.0 110.237 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.3 p -161.05 143.24 12.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.645 -0.66 . . . . 0.0 109.569 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -89.64 114.36 25.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.6 t -98.91 176.29 5.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.706 -0.621 . . . . 0.0 109.71 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -150.32 154.41 37.79 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.1 t -143.33 129.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.089 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.94 155.46 39.55 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.9 m95 -79.67 173.16 12.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -135.39 -46.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -130.7 -153.61 0.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.08 -25.77 52.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.08 26.85 1.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 110.892 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 78.8 tttt -132.15 109.58 10.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.0 108.078 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.46 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.6 OUTLIER -115.66 150.36 36.87 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.243 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -100.09 173.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.522 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.4 t -149.81 135.84 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.04 163.3 12.65 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -160.92 138.69 9.42 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.798 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -152.46 144.55 23.82 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.576 HD22 HH21 ' A' ' 79' ' ' ARG . 7.5 mt -58.74 164.27 2.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 110.651 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -107.87 5.6 26.58 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.412 ' N ' HD12 ' A' ' 100' ' ' LEU . 22.9 tptt -153.75 113.14 3.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.99 -163.83 45.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -176.34 140.97 0.4 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.393 -1.063 . . . . 0.0 110.066 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.67 -86.95 0.06 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.31 -176.49 2.59 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.846 1.697 . . . . 0.0 109.695 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -131.55 139.87 49.33 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 145.15 49.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.121 0.963 . . . . 0.0 110.84 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.88 137.04 6.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -142.79 175.44 9.82 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.986 -1.085 . . . . 0.0 110.56 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.643 HG22 HG13 ' A' ' 94' ' ' VAL . 13.2 p -137.91 172.67 12.59 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.551 0.691 . . . . 0.0 110.028 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.492 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 21.8 ptm -157.84 128.59 6.43 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.9 pt-20 -131.67 154.89 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.586 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.624 HD12 ' HD2' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -112.13 144.71 41.05 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -91.99 162.19 14.48 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.585 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -61.36 -21.1 63.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.22 -26.58 24.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.15 -8.13 8.57 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 48.6 mt-10 -58.7 172.94 0.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.113 -1.227 . . . . 0.0 109.234 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.727 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.92 110.36 5.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.501 -0.749 . . . . 0.0 109.618 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' A' ' 133' ' ' VAL . 14.0 tt -106.08 145.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -130.22 133.07 46.28 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.713 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.78 165.97 11.28 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.468 ' O ' HG22 ' A' ' 129' ' ' VAL . 12.1 mtp -144.14 164.52 30.46 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.383 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 m -147.4 151.4 36.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.68 95.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.17 -80.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.33 24.89 1.25 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.525 -0.734 . . . . 0.0 109.168 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -118.34 -178.93 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.94 118.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.781 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.49 112.18 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -106.32 143.61 34.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 9' ' ' ILE . 20.7 mtt180 -150.5 105.23 3.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 120' ' ' ILE . 53.7 t -69.47 133.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 30.1 m-85 -121.2 123.5 42.41 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.075 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.32 139.71 26.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.59 128.08 16.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.221 -0.925 . . . . 0.0 111.351 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.245 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.023 0 N-CA-C 110.362 -0.668 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -150.66 126.38 10.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.724 . . . . 0.0 109.361 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.606 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.9 m-85 -99.42 -11.36 21.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -67.78 117.42 9.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 111.841 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.45 -173.46 38.73 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.9 m120 -95.45 170.84 9.08 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.45 128.12 10.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.666 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 12.4 mmtt -122.48 116.32 23.74 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 132' ' ' ARG . 10.0 tt -58.94 142.07 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.587 0.708 . . . . 0.0 110.474 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.3 -24.26 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.959 -0.463 . . . . 0.0 110.068 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -143.25 174.83 10.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.277 -0.889 . . . . 0.0 110.08 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 178.42 163.1 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.34 24.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 111.457 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 76.0 m-20 -160.59 27.37 0.15 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.981 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.1 t80 -65.16 -64.76 0.79 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 110.192 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 27.2 tt0 -55.86 -31.0 62.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.581 -0.699 . . . . 0.0 111.296 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 7.0 pt-20 -73.1 -31.51 64.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.51 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.856 HD22 ' CB ' ' A' ' 130' ' ' CYS . 27.4 tp -75.58 -19.42 59.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.828 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.02 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -90.17 -18.18 26.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 109.388 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.8 mtmt -84.6 -32.63 23.64 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 128' ' ' VAL . 14.2 p -74.61 -39.96 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -68.04 -45.59 73.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.756 0.788 . . . . 0.0 109.458 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.94 -159.97 27.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 t -144.61 -41.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.982 -0.717 . . . . 0.0 109.722 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.4 t-20 -60.64 -162.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG13 ' NH1' ' A' ' 29' ' ' ARG . 2.2 t -117.63 -49.02 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.409 ' O ' HD12 ' A' ' 31' ' ' ILE . 1.4 ttt -67.41 -27.73 67.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -58.15 -19.62 34.25 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.79 -0.569 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -92.72 -49.26 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.16 -0.962 . . . . 0.0 109.59 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -62.25 -20.25 64.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.645 -0.659 . . . . 0.0 110.793 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 27' ' ' MET . 19.6 mt -78.42 -29.64 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.16 -25.62 34.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.2 t -77.52 -36.98 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.41 -34.16 48.2 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.64 93.97 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.463 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.33 -67.87 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.67 52.41 14.96 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 67.25 73.41 0.37 Allowed Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.61 155.9 58.44 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 C-N-CA 122.055 1.837 . . . . 0.0 110.829 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . . . -102.47 172.99 6.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 HG23 ' A' ' 54' ' ' THR . 53.4 t -155.49 164.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.465 ' N ' HG12 ' A' ' 41' ' ' VAL . 48.5 tt0 -151.11 110.6 3.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.79 HG13 HG23 ' A' ' 52' ' ' ILE . 1.8 mp -98.65 141.99 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.817 0.818 . . . . 0.0 110.543 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.36 111.93 18.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.36 117.73 33.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.97 -1.081 . . . . 0.0 111.026 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.63 50.05 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -125.43 8.11 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.8 p30 -75.66 -1.82 26.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.431 -1.04 . . . . 0.0 110.052 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 m -96.35 138.4 34.01 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.816 -1.177 . . . . 0.0 108.636 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -134.18 117.68 16.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.795 0.807 . . . . 0.0 109.217 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -103.43 147.98 26.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -144.01 104.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 C-N-CA 118.974 -1.091 . . . . 0.0 111.445 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.13 113.61 26.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.514 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.665 HG23 HG22 ' A' ' 41' ' ' VAL . 31.9 m -103.28 142.35 34.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.87 143.16 38.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -115.55 -65.91 1.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.917 0.865 . . . . 0.0 109.43 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.671 HG23 HG23 ' A' ' 58' ' ' VAL . 2.8 t 178.82 -41.76 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.671 HG23 HG23 ' A' ' 57' ' ' THR . 40.3 t -113.58 -10.83 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -125.08 164.71 19.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 109.103 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.9 m -162.44 96.25 0.95 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.697 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 165.31 23.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 109.974 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -164.12 118.69 1.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 52' ' ' ILE . 31.9 pt -121.87 165.99 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 108.93 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.6 p-10 -162.15 127.59 3.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.9 p90 -162.18 -172.64 3.29 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.009 -1.076 . . . . 0.0 111.763 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -131.12 154.65 48.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.57 95.05 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.92 . . . . 0.0 109.828 -178.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.87 -20.04 0.67 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.13 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -135.02 162.18 33.19 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.185 -1.185 . . . . 0.0 110.841 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.43 165.63 16.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.7 p90 -161.75 173.84 14.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -101.73 144.77 30.01 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.1 pt-20 -162.18 -178.28 6.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -99.66 155.69 17.48 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.7 t -92.91 -142.33 0.21 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 109.325 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -111.2 -21.01 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.717 -1.239 . . . . 0.0 110.837 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -88.75 -40.0 13.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.67 45.19 0.11 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 34.8 mtp180 -131.96 150.62 76.64 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.708 -0.878 . . . . 0.0 109.161 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.79 141.68 17.26 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.676 1.584 . . . . 0.0 110.408 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.7 p -161.19 141.46 10.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.645 -0.659 . . . . 0.0 109.862 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.796 ' HB2' HD21 ' A' ' 100' ' ' LEU . 10.3 ttmt -89.7 114.17 25.79 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -99.68 174.05 6.42 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.301 0.572 . . . . 0.0 110.416 -178.271 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 85' ' ' VAL . 44.4 tp -148.05 152.39 37.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.742 HG21 ' CE2' ' A' ' 65' ' ' PHE . 7.0 t -142.36 126.89 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.976 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -122.33 155.2 36.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.555 ' CE2' HG21 ' A' ' 67' ' ' VAL . 79.0 m95 -77.42 176.22 9.06 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.892 0.854 . . . . 0.0 110.242 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.2 tp10 -138.44 -46.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.1 p -131.01 -152.51 0.51 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.6 -25.42 45.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -142.8 27.63 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.4 tttp -132.98 113.31 12.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.935 -1.103 . . . . 0.0 108.283 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.494 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -120.37 150.44 40.75 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.521 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.82 172.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.5 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.0 t -149.89 134.81 17.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -103.95 165.21 11.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -160.87 138.93 9.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.84 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -144.84 148.9 34.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.5 mt -60.86 166.86 3.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 0.0 110.994 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.5 mt -101.54 -3.56 28.28 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -150.8 130.34 13.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 108.892 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.93 -157.4 42.66 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -176.43 140.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.47 -1.018 . . . . 0.0 109.863 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.39 -87.3 0.06 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.64 -176.82 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 C-N-CA 121.8 1.666 . . . . 0.0 109.645 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -130.66 138.52 50.1 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.67 144.83 48.88 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.189 0.995 . . . . 0.0 110.734 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.9 m -163.44 136.67 5.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -139.21 172.38 12.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.707 HG22 HG13 ' A' ' 94' ' ' VAL . 16.8 p -136.43 170.16 16.5 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.476 0.655 . . . . 0.0 109.848 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.424 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 7.1 ptp -154.01 137.16 15.6 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -134.01 146.26 50.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.392 -0.817 . . . . 0.0 109.225 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.7 141.53 42.18 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -90.27 160.65 16.05 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.791 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -21.45 61.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.657 -0.652 . . . . 0.0 110.078 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -85.08 -29.49 24.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.99 -9.21 7.12 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.12 172.2 0.31 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.158 -1.201 . . . . 0.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -145.14 107.98 4.49 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.097 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -101.87 150.73 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -135.03 133.68 39.64 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.59 8.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 129' ' ' VAL . 11.8 mtp -148.41 166.78 27.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.742 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.1 m -150.07 148.07 28.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.668 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.56 93.05 1.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.521 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.79 -78.26 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -147.07 23.72 1.18 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.6 m -118.31 -179.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.7 t -156.41 119.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.46 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.856 ' CB ' HD22 ' A' ' 18' ' ' LEU . 2.2 t -98.39 118.46 35.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -112.92 143.37 44.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.762 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 9' ' ' ILE . 24.0 mtm180 -150.82 105.01 3.22 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.2 133.05 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.4 m-85 -120.83 120.81 36.65 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.154 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.14 139.98 22.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.98 128.48 18.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.196 -0.94 . . . . 0.0 111.322 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.3 tp10 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.009 0 N-CA-C 110.222 -0.722 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -152.39 124.07 7.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.555 -0.716 . . . . 0.0 109.766 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.7 m-85 -99.26 -7.85 25.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.3 p -69.11 117.54 10.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.955 . . . . 0.0 111.9 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.12 38.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.0 m120 -95.72 169.39 10.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.924 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.08 122.23 7.73 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.687 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -114.28 112.82 23.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.9 tt -56.53 146.93 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 110.67 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -127.64 -23.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.62 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -143.46 173.46 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t 169.57 168.51 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.66 28.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.013 -1.054 . . . . 0.0 112.02 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.01 31.69 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.205 -0.934 . . . . 0.0 109.106 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.916 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.0 -62.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 110.019 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.49 -31.15 67.59 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 111.097 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -71.18 -26.55 63.01 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.696 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.9 tp -81.76 -21.38 37.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.424 -0.797 . . . . 0.0 109.975 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.936 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -86.94 -17.62 32.72 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.099 -1.001 . . . . 0.0 109.305 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.6 mtmt -85.05 -34.64 22.24 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -73.69 -40.54 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 77' ' ' ASP . 5.0 mp -67.32 -46.11 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.828 0.823 . . . . 0.0 108.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -162.59 27.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.98 -37.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.831 -0.805 . . . . 0.0 110.183 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.2 t30 -62.0 -158.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.443 -0.786 . . . . 0.0 109.163 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.646 HG13 HH21 ' A' ' 29' ' ' ARG . 1.8 t -125.07 -47.56 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 109.316 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 ttt -68.08 -28.42 67.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -59.39 -19.26 45.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.737 -0.602 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -95.58 -47.4 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 109.876 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -62.73 -22.58 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.612 -0.68 . . . . 0.0 110.569 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.42 -28.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.842 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.936 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.88 -25.59 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.3 t -76.67 -38.9 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.62 57.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.4 95.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.544 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -66.63 -65.57 0.66 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.627 -0.671 . . . . 0.0 109.237 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p 47.89 55.3 8.76 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.671 0.748 . . . . 0.0 109.082 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 69.29 72.73 0.32 Allowed Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.67 162.66 41.42 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.146 1.898 . . . . 0.0 110.808 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.97 172.8 6.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.711 -0.618 . . . . 0.0 109.432 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.762 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -154.07 165.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 47.3 tt0 -150.69 110.75 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.924 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mt -98.34 137.1 26.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.677 0.751 . . . . 0.0 110.335 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.63 112.08 21.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.4 tt0 -98.24 121.7 40.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.008 -1.057 . . . . 0.0 111.106 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -121.52 51.77 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -125.4 7.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -76.27 -0.95 24.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.415 -1.05 . . . . 0.0 110.102 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 m -96.68 140.93 30.56 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.789 -1.194 . . . . 0.0 108.353 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.8 m-85 -136.07 115.33 12.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.923 0.868 . . . . 0.0 109.718 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.1 t80 -101.04 147.03 26.67 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 63' ' ' ILE . 3.0 mt -142.31 100.92 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.989 -1.07 . . . . 0.0 110.327 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 2.2 tttt -98.8 114.64 27.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.535 -0.728 . . . . 0.0 109.961 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.762 HG23 HG22 ' A' ' 41' ' ' VAL . 7.1 m -99.22 142.2 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 p -136.54 118.32 15.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.357 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -99.28 -169.7 1.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.572 HG23 HG23 ' A' ' 58' ' ' VAL . 5.8 t -51.66 -42.35 62.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.493 -0.755 . . . . 0.0 111.204 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 57' ' ' THR . 22.9 t -132.36 -7.36 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.274 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -106.13 173.33 6.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.917 -1.114 . . . . 0.0 110.228 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -164.39 93.91 0.69 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.3 p -92.43 176.04 6.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.102 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.7 pt-20 -172.4 139.81 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 52' ' ' ILE . 31.2 pt -128.66 170.07 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.1 p-10 -162.55 130.76 3.96 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.9 p90 -161.58 -172.2 3.25 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.896 -1.121 . . . . 0.0 112.062 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -128.89 153.31 47.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 96.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.529 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.6 -32.28 1.61 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.56 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -113.64 155.8 24.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -1.069 . . . . 0.0 109.893 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.0 mt-10 -86.33 167.72 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 17.2 p90 -162.14 173.08 14.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.551 -0.718 . . . . 0.0 109.809 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -104.24 144.52 31.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.13 -175.75 4.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -99.53 156.88 16.81 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.4 t -94.39 -142.1 0.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 109.22 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.45 -20.57 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.712 -1.242 . . . . 0.0 110.828 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.82 -38.18 13.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 109.428 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 44.13 0.15 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.682 ' H ' HG22 ' A' ' 75' ' ' THR . 2.1 mtm-85 -130.28 151.9 79.26 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 121.656 -0.908 . . . . 0.0 109.256 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.66 141.06 17.1 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.644 1.563 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.6 p -160.75 140.79 11.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.683 -0.636 . . . . 0.0 109.692 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.758 ' HB2' HD21 ' A' ' 100' ' ' LEU . 26.7 ttpt -90.85 113.96 26.26 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -102.74 177.76 4.76 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.224 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 85' ' ' VAL . 50.3 tp -152.94 153.15 32.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.7 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.0 t -141.37 127.72 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.874 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 155.78 33.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.536 ' NE1' HG21 ' A' ' 67' ' ' VAL . 84.2 m95 -78.69 172.38 13.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 109.851 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -133.44 -47.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 p -132.17 -151.69 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.98 -26.87 48.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.308 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -140.2 23.93 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 111.466 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 53.0 tttp -131.83 111.69 11.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.749 -1.22 . . . . 0.0 108.451 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.477 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.71 149.26 40.13 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.119 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.63 173.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.517 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -149.45 130.35 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 110.887 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -101.97 163.45 12.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -160.34 143.8 13.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.006 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -146.18 151.38 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.405 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.23 166.66 5.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.935 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 82' ' ' LYS . 50.6 mt -101.03 -4.11 28.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 108.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.6 -157.03 42.09 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -177.34 140.43 0.28 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.514 -0.992 . . . . 0.0 109.529 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.19 -85.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.59 -176.84 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.82 1.68 . . . . 0.0 109.956 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -136.12 141.26 44.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.05 145.09 48.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.125 0.964 . . . . 0.0 110.596 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 p -162.79 129.65 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -136.57 173.69 11.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.226 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 94' ' ' VAL . 9.2 p -135.84 172.43 13.03 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.54 0.686 . . . . 0.0 109.901 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.464 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 9.8 ptm -155.91 124.84 6.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.94 152.7 39.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.899 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.55 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.75 142.13 46.93 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.8 p -91.77 160.09 15.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -60.45 -21.8 62.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -83.76 -29.7 27.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.137 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.47 -9.01 7.36 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -57.32 172.44 0.32 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.12 -1.223 . . . . 0.0 109.061 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.697 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.62 110.13 5.04 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.86 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.6 tt -105.99 148.97 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.58 145.95 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.668 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.59 169.65 11.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.419 -1.696 . . . . 0.0 106.419 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 35.4 mtp -151.66 164.26 37.32 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.574 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 129' ' ' VAL . 7.6 m -146.34 152.51 39.22 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.653 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.94 97.61 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.635 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.97 -79.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.43 24.27 1.01 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.566 -0.709 . . . . 0.0 109.342 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.1 m -119.54 -179.73 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.05 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.593 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 5.8 t -99.27 131.65 45.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.2 m -123.39 127.58 48.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -125.18 102.56 7.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.68 134.13 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.5 m-85 -124.15 129.99 51.77 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.604 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.91 138.45 40.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -48.73 125.28 9.81 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 0.0 111.285 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.6 179.647 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.011 0 N-CA-C 110.35 -0.673 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 45' ' ' GLN . 5.8 m120 -163.53 123.11 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.574 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.62 -0.85 42.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -71.12 117.14 12.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.128 -0.983 . . . . 0.0 112.023 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.5 -172.18 38.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 32.3 m-20 -95.78 168.26 10.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -151.88 125.0 8.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.493 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -120.86 115.36 23.09 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.5 tt -56.29 139.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.556 0.693 . . . . 0.0 110.582 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.15 -24.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.852 -0.53 . . . . 0.0 109.823 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -142.93 174.41 10.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.356 -0.84 . . . . 0.0 110.075 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.535 ' HB2' HD11 ' A' ' 9' ' ' ILE . 20.7 t 178.86 164.51 0.84 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.45 25.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 74.8 m-20 -160.5 27.76 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.709 -0.619 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.905 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.49 -66.94 0.47 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.1 tt0 -55.54 -27.78 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.488 -0.757 . . . . 0.0 109.672 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -63.6 -40.56 97.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.674 -0.641 . . . . 0.0 110.205 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.7 tp -79.59 -16.44 55.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.2 mt -90.67 -17.49 26.72 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.97 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.3 mmmt -85.6 -30.45 23.3 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -77.55 -40.2 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.37 -47.5 70.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.86 0.838 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -156.12 26.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.2 -36.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.925 -0.75 . . . . 0.0 110.311 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.937 ' HB2' HD22 ' A' ' 28' ' ' LEU . 1.9 t-20 -62.41 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 27' ' ' MET . 5.1 m -132.0 -47.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.661 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.408 ' N ' HG23 ' A' ' 26' ' ' VAL . 9.7 ttt -69.58 -33.13 72.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.1 mp -48.05 -34.62 9.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.937 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 -42.88 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -61.96 -19.8 63.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.687 -0.633 . . . . 0.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.31 -29.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 108.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.47 -25.77 33.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.7 t -77.33 -39.86 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.5 62.88 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.57 94.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.01 -67.62 0.44 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.36 55.22 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.4 mttm 65.08 73.35 0.43 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.5 Cg_endo -71.46 151.95 59.8 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.031 1.821 . . . . 0.0 110.822 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -101.87 173.64 6.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 54' ' ' THR . 46.4 t -155.8 164.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.8 tt0 -147.77 111.98 5.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -98.01 131.47 44.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.805 0.812 . . . . 0.0 110.348 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -110.82 107.83 17.45 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.452 ' OE1' ' ND2' ' A' ' 2' ' ' ASN . 60.6 tt0 -97.63 123.81 41.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.114 -0.991 . . . . 0.0 111.177 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -124.17 54.43 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.41 -126.93 8.65 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.18 -1.09 24.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -1.049 . . . . 0.0 110.088 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m -96.81 136.8 36.84 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.763 -1.211 . . . . 0.0 108.394 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.5 m-85 -131.81 116.04 16.73 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.877 0.846 . . . . 0.0 109.346 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.1 t80 -101.42 147.98 25.71 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.88 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -144.77 100.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.982 -1.074 . . . . 0.0 110.328 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 112.1 24.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 41' ' ' VAL . 29.9 m -99.1 146.31 26.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.8 p -139.3 132.16 29.26 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -111.75 -63.14 1.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.702 HG23 HG23 ' A' ' 58' ' ' VAL . 3.7 t 177.37 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.702 HG23 HG23 ' A' ' 57' ' ' THR . 41.2 t -122.81 -9.64 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.753 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -97.47 -83.25 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.044 . . . . 0.0 109.473 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.4 m 69.36 85.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.0 110.105 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.19 176.97 4.9 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.0 pt-20 -168.4 124.25 0.99 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.908 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.88 HD11 HD12 ' A' ' 52' ' ' ILE . 37.6 pt -111.68 170.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.1 p30 -162.74 133.99 5.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.133 -0.98 . . . . 0.0 109.467 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.3 p90 -161.92 -171.66 2.97 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.372 1.082 . . . . 0.0 112.615 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -129.62 152.65 48.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 95.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.19 -29.86 1.49 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.733 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -119.24 157.32 28.27 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.302 -1.117 . . . . 0.0 110.035 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HG2' HD22 ' A' ' 84' ' ' LEU . 21.1 mt-10 -86.14 169.15 13.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.594 -0.691 . . . . 0.0 109.22 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.5 p90 -162.13 174.09 13.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 0.0 109.765 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.55 145.87 29.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.14 -177.71 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.472 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -104.66 157.75 16.97 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.211 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.859 HG23 ' SG ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -95.36 -170.4 2.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.333 -0.854 . . . . 0.0 110.19 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.92 -20.71 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.89 -0.506 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.54 -41.66 13.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.73 43.63 0.2 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -127.9 152.19 76.89 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 121.628 -0.925 . . . . 0.0 109.142 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.61 137.36 14.43 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.336 1.357 . . . . 0.0 110.21 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' HG23 ' A' ' 75' ' ' THR . 12.8 p -160.69 142.47 12.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.656 -0.653 . . . . 0.0 109.466 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.763 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -86.79 117.35 25.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.5 t -99.14 166.52 11.2 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.494 HD22 ' HG2' ' A' ' 70' ' ' GLU . 56.3 tp -147.28 153.97 40.4 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 65' ' ' PHE . 21.3 t -145.79 131.16 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.019 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.1 pttt -125.63 159.9 31.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.572 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.3 m95 -82.86 170.04 15.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -133.4 -46.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 p -131.18 -154.28 0.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -77.66 -25.53 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.594 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -141.85 26.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 31.8 tttm -131.42 108.77 9.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.885 -1.134 . . . . 0.0 108.316 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.522 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -113.88 145.96 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.513 -0.742 . . . . 0.0 110.286 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 110' ' ' THR . 2.5 t -99.91 172.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.526 ' H ' HG12 ' A' ' 94' ' ' VAL . 54.0 t -148.4 139.59 23.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.29 163.15 13.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 7.3 tt0 -160.5 137.99 9.45 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.729 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -144.5 147.52 33.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.46 166.83 2.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 82' ' ' LYS . 58.0 mt -101.17 -3.43 29.13 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -156.01 139.94 16.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 108.79 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.17 -162.68 35.68 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -176.49 139.33 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.41 -1.053 . . . . 0.0 109.947 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.75 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.67 -176.88 2.65 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.824 1.683 . . . . 0.0 109.663 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -132.61 141.38 48.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.44 144.42 49.52 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.163 0.982 . . . . 0.0 110.861 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -163.67 138.66 6.19 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -140.66 172.52 12.6 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.953 -1.092 . . . . 0.0 110.729 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.723 HG22 HG13 ' A' ' 94' ' ' VAL . 17.9 p -134.16 169.16 17.59 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 109.422 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.635 ' HG3' HD23 ' A' ' 121' ' ' LEU . 2.1 ttt -154.53 122.01 5.74 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -118.82 154.62 32.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.478 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -118.7 144.96 45.88 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.3 p -96.83 161.36 13.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.791 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -22.38 63.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -84.36 -27.94 27.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.295 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.52 -11.1 7.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.87 172.12 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.067 -1.255 . . . . 0.0 109.073 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.585 HD11 ' HD2' ' A' ' 3' ' ' PHE . 8.0 tt -149.72 113.64 5.1 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.648 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -98.62 155.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.81 111.72 8.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -101.35 168.63 9.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.451 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.9 mtp -145.73 169.19 18.97 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.64 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.0 m -151.31 150.48 30.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.34 91.41 1.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.448 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -78.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.24 23.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.572 -0.705 . . . . 0.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.5 m -117.68 -179.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.8 t -156.7 119.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.474 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.722 ' CB ' HD22 ' A' ' 18' ' ' LEU . 3.2 t -98.08 109.92 22.59 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 122' ' ' THR . 39.1 m -101.48 147.0 26.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 9' ' ' ILE . 60.8 mtm180 -152.19 97.26 2.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.48 129.97 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -116.47 124.3 49.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.49 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.83 139.0 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.474 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -48.1 125.15 8.69 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.051 -0.976 . . . . 0.0 111.66 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.31 123.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.653 0.74 . . . . 0.0 110.236 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.5 m-85 -99.56 1.22 43.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.665 -0.647 . . . . 0.0 109.573 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -73.04 118.19 15.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.117 -0.989 . . . . 0.0 111.939 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.47 -172.52 38.57 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 28.9 m-20 -95.16 168.29 10.84 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -150.11 123.23 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.552 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -118.58 113.5 21.35 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 132' ' ' ARG . 8.8 tt -56.93 145.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.711 0.767 . . . . 0.0 110.806 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.4 pp -126.55 -23.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.331 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HG3' HD12 ' A' ' 10' ' ' ILE . 2.3 mtt180 -141.54 175.62 9.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 0.0 110.468 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 169.15 168.04 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.06 30.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.877 -1.139 . . . . 0.0 112.036 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 32.95 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.195 -0.941 . . . . 0.0 108.975 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.994 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -66.35 -63.73 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.55 -0.719 . . . . 0.0 110.331 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 3.7 mt-10 -58.23 -27.17 63.71 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.497 -0.752 . . . . 0.0 111.25 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -73.08 -28.07 62.09 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.423 -178.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.6 tp -84.82 -17.69 37.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 110.277 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 15' ' ' PHE . 7.8 mt -90.33 -16.8 28.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.014 -1.054 . . . . 0.0 109.049 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' NE ' ' A' ' 29' ' ' ARG . 1.3 mmmm -86.52 -33.09 20.41 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -74.17 -40.36 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.48 -48.45 67.11 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.867 0.841 . . . . 0.0 109.05 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.65 -150.61 23.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.0 m -155.19 -43.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.922 -0.752 . . . . 0.0 109.275 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.1 t-20 -56.72 -175.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.529 -0.732 . . . . 0.0 109.576 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.1 m -108.35 -44.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 0.0 110.034 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttt -68.23 -25.83 65.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 108.933 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.6 mm? -58.46 -34.97 71.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.63 -0.669 . . . . 0.0 110.66 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -76.37 -47.47 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.08 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -24.8 67.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 111.149 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.97 -28.47 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.304 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.978 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.76 -26.03 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 0.0 109.266 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.5 t -77.57 -39.43 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.1 60.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.68 97.06 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.449 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.38 -68.84 0.29 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m 50.13 52.3 15.0 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 64.22 73.33 0.47 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.4 Cg_endo -71.32 153.22 61.55 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.051 1.834 . . . . 0.0 110.728 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.36 174.15 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.686 -0.634 . . . . 0.0 109.532 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 54' ' ' THR . 48.3 t -154.98 164.21 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 6.8 tp10 -145.71 110.86 5.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -99.05 132.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.442 -0.786 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -112.38 114.45 27.18 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.77 119.55 37.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -119.06 52.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 -125.24 7.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.626 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.2 p30 -76.88 -0.43 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.388 -1.066 . . . . 0.0 109.953 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.5 m -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.841 -1.162 . . . . 0.0 108.648 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -135.71 115.5 13.0 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.842 0.829 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.0 147.52 26.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.95 105.09 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.983 -1.073 . . . . 0.0 111.196 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.67 112.07 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.654 HG23 HG22 ' A' ' 41' ' ' VAL . 23.9 m -99.52 141.73 31.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.77 120.22 18.07 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.246 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -99.22 -169.45 1.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 58' ' ' VAL . 5.4 t -51.49 -42.36 61.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.55 HG23 HG23 ' A' ' 57' ' ' THR . 22.0 t -133.82 -6.9 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.382 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -106.29 175.98 5.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.955 -1.09 . . . . 0.0 110.223 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -164.57 96.56 0.76 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.765 -0.584 . . . . 0.0 109.646 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 167.55 16.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 109.315 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -160.22 124.17 3.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 109.785 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 52' ' ' ILE . 36.4 pt -123.71 165.56 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.545 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.1 p-10 -162.3 128.13 3.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.043 -1.035 . . . . 0.0 109.669 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.5 p90 -162.04 -172.02 3.08 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.622 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.04 154.6 49.23 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.63 93.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -178.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.49 -24.16 0.51 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -132.43 161.93 32.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -1.075 . . . . 0.0 110.47 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.68 168.8 13.25 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.671 -0.643 . . . . 0.0 109.359 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 16.6 p90 -162.06 173.59 14.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.699 -0.626 . . . . 0.0 109.456 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.25 144.18 31.1 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.722 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.9 pt-20 -162.24 -175.98 4.87 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -100.07 157.6 16.44 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 79' ' ' ARG . 9.7 t -93.59 -141.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.345 -0.847 . . . . 0.0 108.856 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' N ' HG23 ' A' ' 75' ' ' THR . 25.9 t -112.81 -18.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.695 -1.253 . . . . 0.0 110.77 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -91.37 -37.41 13.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.97 45.64 0.12 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.7 151.03 76.34 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.883 . . . . 0.0 109.193 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.76 141.06 16.89 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.675 1.583 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -161.05 142.18 11.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.655 -0.653 . . . . 0.0 109.592 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.8 ttpt -87.97 117.31 26.74 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -99.32 162.27 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.733 -0.605 . . . . 0.0 109.837 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.6 tp -139.87 153.5 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.1 t -146.98 128.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.379 -1.329 . . . . 0.0 112.171 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 155.46 37.48 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE2' HG21 ' A' ' 67' ' ' VAL . 80.7 m95 -78.18 174.64 10.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 109.89 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -137.45 -46.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.1 p -130.9 -153.23 0.55 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.55 -24.87 45.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.725 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -143.09 28.13 1.56 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 110.502 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.1 tttm -133.79 110.43 9.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.888 -1.133 . . . . 0.0 108.277 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.512 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -117.47 149.68 40.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.861 . . . . 0.0 110.141 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.7 172.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.511 ' H ' HG12 ' A' ' 94' ' ' VAL . 45.7 t -148.55 138.32 22.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -105.22 164.02 12.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -160.06 132.99 6.65 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.515 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -141.18 149.25 41.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.16 167.51 3.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.641 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.0 mt -96.19 -8.42 33.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -158.08 156.19 30.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.67 -162.74 20.34 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -176.85 139.06 0.28 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.512 -0.993 . . . . 0.0 109.829 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.77 -84.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.42 -176.95 2.74 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.938 1.758 . . . . 0.0 109.994 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -137.12 139.94 41.57 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 146.32 48.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.092 0.948 . . . . 0.0 110.759 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.18 137.86 6.34 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.9 p-90 -144.18 175.96 9.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.74 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 94' ' ' VAL . 13.1 p -138.33 169.85 17.06 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.532 0.682 . . . . 0.0 109.955 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.519 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 20.5 ptm -152.8 124.16 7.65 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -124.38 153.04 42.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.957 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.9 45.33 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.4 p -91.06 161.11 15.25 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.5 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.91 -20.72 62.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -28.3 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.48 -8.36 7.85 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 44.0 mt-10 -58.25 172.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -1.202 . . . . 0.0 109.146 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.84 110.46 5.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.151 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 133' ' ' VAL . 11.1 tt -105.35 143.9 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -128.23 131.49 48.8 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.48 163.71 12.83 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 21.6 mtp -142.49 160.13 40.87 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.039 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 129' ' ' VAL . 7.7 m -143.4 152.88 42.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.62 98.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.54 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.21 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.62 23.86 0.99 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.517 -0.74 . . . . 0.0 109.534 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.2 m -120.15 -179.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.54 116.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.659 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.713 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.0 t -99.65 112.06 24.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.8 m -100.85 151.47 21.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.9 mtm180 -150.63 102.43 3.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 120' ' ' ILE . 52.5 t -67.02 133.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.3 m-85 -121.55 120.29 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.907 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.89 142.86 16.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -50.08 126.14 13.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.303 -0.873 . . . . 0.0 111.146 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.961 -1.018 . . . . 0.0 111.752 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.832 ' HD2' HD12 ' A' ' 113' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.499 1.847 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -156.29 141.1 17.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.509 -0.744 . . . . 0.0 110.169 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -98.01 -2.49 40.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -71.96 118.01 14.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 112.028 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.52 -173.84 38.83 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.3 m120 -95.16 171.45 8.73 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.874 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -151.13 126.95 10.29 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.014 -1.075 . . . . 0.0 112.777 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.49 118.04 31.1 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.833 HD11 ' HB3' ' A' ' 12' ' ' SER . 13.6 tt -61.85 150.86 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.871 0.843 . . . . 0.0 111.016 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.65 -30.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.627 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -141.96 165.8 26.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 108.917 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 9' ' ' ILE . 56.9 p -177.01 147.19 0.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 0.0 109.469 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -145.61 165.65 28.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 109.953 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 14.5 m120 62.64 32.69 16.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.581 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.937 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.35 -64.22 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.472 -0.767 . . . . 0.0 110.188 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.727 ' CD ' HG21 ' A' ' 33' ' ' VAL . 4.5 mm-40 -57.41 -36.08 70.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 110.903 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.28 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.889 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.7 tp -78.89 -22.04 46.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.941 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.0 mt -89.33 -16.26 31.48 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.204 -0.935 . . . . 0.0 109.143 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.2 mmmm -87.02 -32.61 19.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.2 p -73.42 -38.3 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.6 mp -70.43 -45.12 66.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 109.562 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.84 -161.45 27.74 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.301 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.36 -36.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.925 -0.75 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.3 t30 -62.28 -148.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.462 -0.774 . . . . 0.0 109.617 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.48 -45.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.744 -1.223 . . . . 0.0 109.237 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -72.35 -26.91 62.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.3 mm? -60.22 -17.14 39.43 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.706 -0.621 . . . . 0.0 111.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -98.15 -47.77 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.578 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -62.8 -22.33 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.636 -0.665 . . . . 0.0 110.516 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 27' ' ' MET . 35.1 mt -78.05 -28.59 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 108.934 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.47 34.95 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -77.38 -37.67 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.77 -31.62 46.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.33 83.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -69.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.514 -0.741 . . . . 0.0 109.139 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m 48.79 49.09 19.49 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.658 -0.652 . . . . 0.0 109.677 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.3 mttt 65.27 72.17 0.48 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -73.15 151.26 49.18 Favored 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 122.026 1.817 . . . . 0.0 110.726 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -88.8 174.75 7.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.655 -0.653 . . . . 0.0 109.466 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 40' ' ' ALA . 10.1 t -153.58 164.91 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.0 tt0 -154.94 115.14 3.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 109.236 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -106.15 138.83 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.764 0.792 . . . . 0.0 110.279 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.44 113.51 21.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.7 tt0 -98.53 115.34 28.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.162 -0.961 . . . . 0.0 110.796 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -118.52 56.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.54 8.78 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -77.69 -0.13 25.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.366 -1.079 . . . . 0.0 110.047 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.91 137.01 36.65 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.706 -1.246 . . . . 0.0 108.555 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -132.56 117.0 17.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.783 0.802 . . . . 0.0 108.871 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.9 t80 -104.46 125.51 50.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.795 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -108.0 141.06 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.948 -1.095 . . . . 0.0 108.658 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 2.2 tttt -138.55 101.44 4.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.171 -0.956 . . . . 0.0 108.946 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 31.5 m -99.76 147.25 25.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.63 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -112.01 -63.93 1.36 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.949 0.881 . . . . 0.0 109.451 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.609 HG23 HG23 ' A' ' 58' ' ' VAL . 2.5 t 179.2 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.609 HG23 HG23 ' A' ' 57' ' ' THR . 40.9 t -114.99 -11.66 11.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -122.31 165.03 16.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.896 . . . . 0.0 109.026 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -162.63 100.48 1.03 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.499 -0.75 . . . . 0.0 109.423 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.9 153.29 29.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.106 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG2' ' HG3' ' A' ' 53' ' ' LYS . 10.7 mt-10 -156.23 97.78 1.8 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.51 -0.744 . . . . 0.0 109.689 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 52' ' ' ILE . 24.2 pt -105.34 167.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.506 -0.746 . . . . 0.0 109.052 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.2 p30 -162.19 135.13 5.97 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.374 -0.829 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.6 p90 -162.74 -172.29 3.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.388 1.089 . . . . 0.0 112.545 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.11 152.75 48.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.81 95.07 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.102 -0.999 . . . . 0.0 109.833 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.8 -25.06 1.63 Allowed Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.929 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.5 156.95 34.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.295 -1.12 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.748 ' HG3' HD13 ' A' ' 84' ' ' LEU . 6.2 mp0 -85.8 167.98 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.31 174.0 13.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.565 -0.709 . . . . 0.0 109.42 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.31 144.59 31.42 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.14 -177.19 5.58 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -99.65 156.99 16.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.2 -142.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.418 -0.801 . . . . 0.0 108.98 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 t -109.72 -21.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.723 -1.236 . . . . 0.0 110.672 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 2.3 t70 -88.35 -39.97 13.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 109.354 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.97 44.73 0.12 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.97 151.87 79.7 Favored Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 121.669 -0.901 . . . . 0.0 109.283 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.71 141.38 17.24 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.665 1.577 . . . . 0.0 110.604 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.2 p -161.12 141.26 10.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.5 ttmm -90.2 113.63 25.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -100.58 174.48 6.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.768 -0.582 . . . . 0.0 109.933 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.748 HD13 ' HG3' ' A' ' 70' ' ' GLU . 44.5 tp -147.92 153.47 39.11 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.9 t -141.86 128.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.465 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.2 ptpt -125.97 164.5 20.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -86.09 169.58 13.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.097 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.8 tp10 -133.19 -45.2 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -133.46 -154.25 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.81 -25.66 53.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.219 -0.925 . . . . 0.0 110.062 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -143.26 27.47 1.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 110.774 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 24.4 tttm -132.92 110.0 9.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.885 -1.134 . . . . 0.0 108.114 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.484 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 1.5 ptp -114.87 151.98 33.02 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.481 -0.762 . . . . 0.0 110.13 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.839 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -105.04 171.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.491 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.0 t -148.29 131.97 16.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 110.621 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.7 165.07 11.41 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -160.96 138.67 9.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.818 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -144.85 150.3 36.86 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.29 167.48 2.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 80' ' ' PRO . 34.6 mt -98.4 -6.88 29.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 137.95 18.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.13 -158.85 41.3 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -175.8 142.64 0.55 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.414 -1.05 . . . . 0.0 109.759 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 -85.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.5 -176.96 2.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.922 1.748 . . . . 0.0 109.93 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -136.54 135.14 38.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 145.98 47.39 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.163 0.982 . . . . 0.0 110.712 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.3 p -163.01 133.02 4.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -136.7 169.41 17.77 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.049 -1.061 . . . . 0.0 110.727 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 94' ' ' VAL . 13.5 p -134.43 170.72 15.33 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.561 0.696 . . . . 0.0 109.935 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 1.7 ptp -153.38 134.35 13.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -129.71 152.9 48.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.832 HD12 ' HD2' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -114.93 143.55 44.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.3 162.14 14.12 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.29 -22.63 65.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.077 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.13 -27.68 27.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.432 -0.793 . . . . 0.0 109.236 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.93 -9.75 7.96 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 52.5 mt-10 -56.49 172.35 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.166 -1.197 . . . . 0.0 109.18 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.6 109.69 4.89 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.919 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.4 tt -103.61 160.7 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.52 153.64 46.25 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.374 -0.829 . . . . 0.0 109.218 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.578 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.24 165.86 24.44 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 26.7 mtp -147.27 165.24 30.69 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.491 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 m -147.09 150.42 35.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.33 93.86 1.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.0 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.84 24.84 1.33 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.1 m -118.68 -179.65 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.54 117.81 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.017 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.889 ' HB2' HD22 ' A' ' 18' ' ' LEU . 8.4 t -99.93 112.5 24.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 122' ' ' THR . 91.7 m -107.39 146.73 31.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 119.74 6.29 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 120' ' ' ILE . 42.0 t -84.12 143.61 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.141 -0.974 . . . . 0.0 108.666 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -130.99 127.94 39.39 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.477 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.54 138.39 37.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.62 128.21 17.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.204 -0.935 . . . . 0.0 111.518 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.019 0 N-CA-C 110.318 -0.686 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -156.12 124.52 5.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.756 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -99.1 -5.74 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.1 p -68.3 117.23 9.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 111.939 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.85 -172.13 37.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.7 m120 -95.69 168.08 10.89 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.88 124.97 8.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.485 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -120.01 113.7 20.91 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.5 tt -56.42 143.21 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.563 0.697 . . . . 0.0 110.381 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -123.8 -23.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.942 -0.474 . . . . 0.0 110.181 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.544 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -141.4 178.3 7.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 t 169.13 168.81 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.76 28.93 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.898 -1.126 . . . . 0.0 112.093 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 34.99 0.11 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.816 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.18 -60.38 2.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.442 -0.786 . . . . 0.0 110.097 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.8 pt-20 -58.42 -26.86 63.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 111.082 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 2.1 pt-20 -72.79 -29.37 63.23 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.493 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.903 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.2 tp -82.28 -18.3 42.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.917 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 32' ' ' ALA . 22.9 mt -90.28 -16.35 29.47 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.149 -0.969 . . . . 0.0 109.397 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.9 mmmm -87.21 -31.76 20.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -75.54 -40.74 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 76' ' ' VAL . 4.7 mp -66.75 -49.58 65.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.953 0.882 . . . . 0.0 108.776 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.8 -147.5 19.99 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.1 m -155.34 -42.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.852 -0.793 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.7 t-20 -57.42 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 109.615 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.35 -43.71 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.362 -0.836 . . . . 0.0 110.116 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -69.88 -25.6 63.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.2 mm? -57.07 -43.9 82.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.603 -0.685 . . . . 0.0 110.694 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.2 mpp_? -63.29 -41.73 99.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.577 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -61.31 -21.5 64.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.658 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.68 -29.31 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 109.059 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.4 -26.41 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.3 t -76.52 -40.39 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.01 65.0 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.19 90.16 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -65.68 -68.69 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.1 t 49.19 51.05 16.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.432 0.634 . . . . 0.0 109.376 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm 63.75 72.36 0.55 Allowed Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -72.11 157.38 54.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.973 1.782 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -104.99 174.07 6.04 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 47.8 t -156.18 163.94 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.7 tt0 -147.24 112.26 5.45 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.3 mt -98.54 134.2 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.798 0.808 . . . . 0.0 110.497 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -113.78 109.16 18.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -97.89 120.82 38.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.035 -1.041 . . . . 0.0 111.146 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -120.93 53.57 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.44 -126.43 8.35 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.594 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -75.59 -1.25 23.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.4 -1.059 . . . . 0.0 110.095 178.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 m -96.08 137.37 35.24 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.795 -1.19 . . . . 0.0 108.619 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.4 m-85 -132.83 114.45 14.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.826 0.822 . . . . 0.0 109.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.2 t80 -100.93 148.73 24.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.115 HD12 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -144.95 103.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.009 -1.057 . . . . 0.0 110.844 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -99.81 111.49 23.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.508 -0.745 . . . . 0.0 109.023 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 22.8 m -99.53 148.27 24.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -143.41 128.82 18.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.357 -0.839 . . . . 0.0 110.45 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.583 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -109.4 -63.12 1.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.677 HG23 HG23 ' A' ' 58' ' ' VAL . 3.3 t 176.4 -39.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 57' ' ' THR . 39.6 t -123.61 -8.94 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.884 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -99.0 -80.73 0.46 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.965 -1.084 . . . . 0.0 109.684 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.457 HG22 ' OE2' ' A' ' 62' ' ' GLU . 2.6 m 69.89 90.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 109.643 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.07 168.82 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 60' ' ' THR . 2.6 mp0 -158.7 112.37 2.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.637 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.115 HD11 HD12 ' A' ' 52' ' ' ILE . 41.6 pt -115.32 165.06 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.5 p30 -162.68 131.83 4.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.4 p90 -161.6 -171.68 3.04 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.175 0.988 . . . . 0.0 111.769 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 4.0 ptpt -132.96 155.34 49.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.8 96.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.31 -20.97 0.74 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.923 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 1.2 pt-20 -138.06 163.53 31.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.188 -1.184 . . . . 0.0 110.941 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.7 ' HG2' HD13 ' A' ' 84' ' ' LEU . 20.8 mt-10 -86.99 168.8 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.17 174.48 12.86 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -101.5 145.02 29.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.693 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.4 pt-20 -162.17 -177.11 5.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -104.62 154.17 20.28 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.374 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 77' ' ' ASP . 13.9 t -91.75 -170.28 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 HD21 ' A' ' 22' ' ' LEU . 9.8 p -87.63 -6.27 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 0.0 111.21 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.796 ' H ' HG23 ' A' ' 75' ' ' THR . 1.3 t0 -98.18 -55.07 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.997 -1.065 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.7 46.22 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 75' ' ' THR . 8.0 mmm180 -137.08 152.6 74.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.73 -0.865 . . . . 0.0 109.214 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.85 141.14 16.75 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.533 1.489 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -160.82 141.17 11.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.64 -0.663 . . . . 0.0 109.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.8 tttp -87.63 118.94 27.46 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -99.7 167.16 10.74 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' HG2' ' A' ' 70' ' ' GLU . 45.0 tp -146.03 152.25 39.05 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 65' ' ' PHE . 11.3 t -144.74 127.68 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.112 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -123.13 155.97 35.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.549 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.4 m95 -78.76 173.69 12.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.779 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.73 -46.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.7 p -131.43 -153.55 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.76 -25.43 49.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.777 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -142.72 27.43 1.67 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.588 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 66.0 tttt -132.85 109.68 9.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.962 -1.086 . . . . 0.0 108.376 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.517 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.38 148.89 40.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.828 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.64 172.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.498 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.9 t -148.54 134.58 19.19 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.693 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -103.05 165.15 11.19 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.45 135.31 7.68 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.293 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.67 40.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.95 166.7 3.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.065 -1.022 . . . . 0.0 110.722 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.5 mt -98.76 -5.51 31.18 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -152.45 137.2 17.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 108.962 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.47 -158.72 42.71 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.14 141.05 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.461 -1.023 . . . . 0.0 109.795 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.97 -85.47 0.05 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.35 -176.83 2.95 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.883 1.722 . . . . 0.0 109.752 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -136.18 137.03 40.47 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.9 146.08 47.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.051 0.929 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.3 m -163.03 136.48 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.0 p-90 -138.91 175.11 9.84 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.891 -1.13 . . . . 0.0 110.343 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.671 HG22 HG13 ' A' ' 94' ' ' VAL . 12.6 p -137.7 166.45 23.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.547 0.689 . . . . 0.0 109.831 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.452 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 10.8 ptm -149.2 119.74 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -118.46 152.77 35.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.589 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -116.26 143.3 45.71 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -97.13 161.07 13.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.907 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.89 -21.39 63.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.675 -0.64 . . . . 0.0 110.217 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.37 -29.13 28.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.75 -7.59 8.86 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.96 171.27 0.98 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -1.233 . . . . 0.0 108.643 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.623 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.01 114.7 7.69 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.343 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.8 tt -99.17 148.32 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.746 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -129.29 110.32 11.85 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.423 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -98.97 171.3 8.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 129' ' ' VAL . 45.3 mtp -150.35 165.87 31.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.596 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.516 HG23 HG23 ' A' ' 129' ' ' VAL . 5.3 m -148.85 151.92 35.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 96.39 1.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.51 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.83 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -148.38 23.57 1.03 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.539 -0.726 . . . . 0.0 109.617 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.0 m -122.17 179.64 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -155.48 118.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.903 ' CB ' HD22 ' A' ' 18' ' ' LEU . 35.7 t -99.11 133.38 43.46 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 132' ' ' ARG . 38.6 m -120.44 156.02 32.31 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.865 0.841 . . . . 0.0 109.818 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HB3' HD12 ' A' ' 9' ' ' ILE . 15.3 mtm180 -151.97 92.35 1.72 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.16 117.03 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 42.6 m-85 -102.13 133.92 46.2 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.562 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.77 138.08 47.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.83 124.49 7.42 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.3 -0.875 . . . . 0.0 111.331 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.757 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 2.029 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.8 127.46 13.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.543 -0.723 . . . . 0.0 109.605 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.724 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.2 m-85 -99.29 -17.38 18.1 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 t -60.97 113.94 2.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.85 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 -172.64 40.96 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 36.5 m-20 -96.01 170.44 9.28 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -150.86 123.11 8.32 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.601 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -116.02 113.33 23.07 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.813 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.0 tt -56.06 154.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 122.09 0.947 . . . . 0.0 111.37 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.19 -32.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.382 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -137.08 167.49 21.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.865 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.813 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.8 p -177.12 152.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -0.773 . . . . 0.0 109.792 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -151.45 168.42 24.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.833 -0.542 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 16.8 m120 59.85 26.48 15.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.749 . . . . 0.0 110.059 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -63.75 -62.87 1.37 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.31 -0.869 . . . . 0.0 108.686 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.1 mt-10 -57.03 -28.42 62.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.278 -0.889 . . . . 0.0 109.281 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.08 -38.69 92.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.729 -0.607 . . . . 0.0 109.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.841 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.1 tp -79.43 -17.96 53.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.8 mt -89.59 -17.32 28.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.194 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.3 mmmm -87.44 -29.63 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -77.71 -41.15 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -66.62 -52.63 43.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.038 0.923 . . . . 0.0 108.667 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.17 -148.36 20.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 23' ' ' GLY . 18.2 m -155.87 -34.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.958 -0.731 . . . . 0.0 110.387 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.902 ' HB2' HD22 ' A' ' 28' ' ' LEU . 1.7 t-20 -60.96 -153.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.574 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.6 m -129.61 -48.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.024 -1.047 . . . . 0.0 109.652 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.406 ' H ' HG23 ' A' ' 26' ' ' VAL . 17.0 ttp -68.11 -30.24 69.35 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -51.61 -35.35 41.36 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.913 -0.492 . . . . 0.0 110.698 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.7 mtp180 -77.21 -38.54 51.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.561 -0.712 . . . . 0.0 109.59 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -64.88 -24.35 67.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.69 -0.631 . . . . 0.0 110.297 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.63 -29.56 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 108.956 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.23 34.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.0 t -76.22 -37.77 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.36 -35.51 61.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.69 88.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.59 -69.63 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t 47.82 50.04 15.98 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.465 0.65 . . . . 0.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 mttt 65.47 72.81 0.44 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -72.11 153.98 57.28 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.083 1.856 . . . . 0.0 110.769 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.59 175.66 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 109.741 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ALA . 23.7 t -155.07 166.25 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -157.41 113.68 2.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.725 . . . . 0.0 109.384 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.724 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.8 mp -101.33 144.3 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.894 0.854 . . . . 0.0 110.303 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 7.3 mttt -123.7 104.35 8.94 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.4 tt0 -98.06 121.93 40.58 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.178 -0.951 . . . . 0.0 111.219 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -124.07 52.35 1.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -129.14 9.79 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -75.4 -2.45 28.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -1.063 . . . . 0.0 110.111 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.9 m -96.7 124.49 40.7 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.821 -1.174 . . . . 0.0 108.516 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 87.9 m-85 -120.5 122.98 41.84 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.857 0.836 . . . . 0.0 108.9 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.4 t80 -107.09 138.2 43.72 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.576 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -122.54 137.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -137.75 105.92 5.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.77 147.12 25.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.255 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.12 116.86 10.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.08 -169.78 1.87 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 58' ' ' VAL . 5.5 t -52.93 -43.15 66.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 111.293 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' N ' HG23 ' A' ' 57' ' ' THR . 39.5 t -130.44 -6.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.363 -0.836 . . . . 0.0 112.093 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -109.07 172.86 6.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.963 -1.086 . . . . 0.0 110.473 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 m -165.1 100.79 0.75 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.19 169.04 8.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -168.09 112.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 110.516 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 52' ' ' ILE . 29.5 pt -98.94 172.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.545 -0.722 . . . . 0.0 109.1 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.7 p30 -163.0 134.81 5.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.0 110.05 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 41.4 p90 -163.04 -171.26 2.59 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.437 1.113 . . . . 0.0 112.508 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -130.7 153.15 49.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.71 94.82 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.099 -1.001 . . . . 0.0 109.557 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.46 -27.65 1.35 Allowed Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.699 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -122.99 157.49 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -1.105 . . . . 0.0 110.131 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' CA ' HD13 ' A' ' 84' ' ' LEU . 8.8 pm0 -86.72 169.61 12.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.635 -0.666 . . . . 0.0 109.359 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 16.2 p90 -161.94 -172.89 3.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.6 -0.687 . . . . 0.0 109.386 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 20.3 mt-10 -115.83 147.76 40.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.7 pt-20 -161.64 179.74 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.682 -0.636 . . . . 0.0 109.596 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -105.73 159.18 16.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.327 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -92.38 -143.73 0.21 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.577 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 t -117.78 -17.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.161 . . . . 0.0 110.67 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.61 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -87.95 -34.64 18.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.75 45.99 0.18 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.653 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.6 146.85 62.2 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.749 -0.854 . . . . 0.0 109.268 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -80.02 136.09 11.5 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.687 1.591 . . . . 0.0 110.284 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.0 p -161.0 141.48 11.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB3' HD21 ' A' ' 100' ' ' LEU . 9.2 ptmt -80.41 161.71 24.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.5 t -141.88 160.69 39.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.0 tp -142.07 154.27 44.81 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 20.3 t -144.25 129.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.358 -1.337 . . . . 0.0 112.222 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -124.24 159.58 29.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.648 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.8 m95 -82.82 172.06 13.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 0.0 110.498 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.5 tp10 -135.99 -45.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.7 p -132.65 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.74 -26.35 54.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.858 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -143.09 27.82 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 19.4 tttt -131.8 111.12 11.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.7 ptp -116.23 148.86 40.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.45 -0.781 . . . . 0.0 110.239 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.652 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -100.26 171.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.478 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.46 141.75 26.25 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.41 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -107.4 164.12 12.46 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -162.15 131.31 4.38 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.616 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -138.74 155.12 48.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.76 169.29 4.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 82' ' ' LYS . 62.5 mt -102.59 -2.66 28.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.73 133.93 10.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 108.968 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.57 -155.71 43.89 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -175.7 140.5 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.439 -1.036 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.8 -87.0 0.06 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.6 -176.9 2.92 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.816 1.677 . . . . 0.0 109.697 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -132.84 138.44 47.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 144.8 49.82 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.215 1.007 . . . . 0.0 110.867 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.9 m -163.13 139.32 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.409 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.3 p-90 -142.62 175.73 9.58 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.956 -1.09 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.652 HG22 HG13 ' A' ' 94' ' ' VAL . 14.9 p -140.05 171.39 14.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.529 0.68 . . . . 0.0 109.838 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.455 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.1 ptp -154.14 140.52 18.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.15 149.44 47.28 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.324 -0.86 . . . . 0.0 109.501 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.3 46.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.67 160.9 14.78 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.725 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -60.45 -21.75 62.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.643 -0.66 . . . . 0.0 110.218 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.98 -28.67 25.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.9 -9.13 7.6 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.76 171.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.097 -1.237 . . . . 0.0 108.966 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.583 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.9 tt -146.62 110.11 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.19 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.77 153.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 133.3 36.84 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.496 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.508 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -112.88 167.2 10.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 24.7 mtp -146.49 164.74 31.55 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.399 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.2 m -147.86 152.27 37.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.67 95.93 1.35 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.595 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.21 -79.25 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -147.6 24.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.248 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.9 m -118.97 -179.25 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.61 117.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.696 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.841 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.4 t -98.46 113.81 25.96 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.508 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.3 m -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 0.0 109.715 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.46 118.74 5.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.19 136.98 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -125.77 121.74 34.22 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.16 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.39 141.13 20.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.76 126.25 13.45 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.23 -0.919 . . . . 0.0 111.189 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.635 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.021 0 N-CA-C 110.307 -0.689 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -154.7 125.43 7.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.549 -0.72 . . . . 0.0 109.727 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.5 m-85 -99.22 -8.11 25.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -67.01 115.64 6.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.301 -0.874 . . . . 0.0 111.893 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.32 -173.38 41.08 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 36.5 m-20 -96.16 169.99 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.3 m95 -152.38 131.4 12.61 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.079 -1.049 . . . . 0.0 113.038 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -122.82 116.72 24.16 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.0 tt -58.57 145.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.603 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.15 -24.43 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.961 -0.462 . . . . 0.0 110.324 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -149.66 168.02 24.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.221 -0.924 . . . . 0.0 110.602 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p 178.0 170.11 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.19 30.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.903 -1.123 . . . . 0.0 111.635 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.9 33.49 0.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.284 -0.885 . . . . 0.0 109.134 -178.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.66 -64.99 0.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 21.7 tt0 -57.09 -27.12 61.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.58 -39.66 94.97 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.756 -0.59 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.9 tp -80.03 -15.8 56.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.675 -0.641 . . . . 0.0 110.016 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.971 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.6 mt -90.22 -18.97 24.75 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.054 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.22 -28.66 25.25 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.7 p -79.46 -41.22 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.97 -51.71 56.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.05 0.929 . . . . 0.0 109.041 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.15 -147.76 20.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 25' ' ' ASN . 23.1 m -155.74 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.978 -0.719 . . . . 0.0 109.721 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.3 t-20 -60.46 -159.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.682 . . . . 0.0 109.885 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG13 ' NH2' ' A' ' 29' ' ' ARG . 2.5 t -122.18 -49.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.875 . . . . 0.0 109.429 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -66.39 -29.79 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -57.05 -25.68 59.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.827 -0.545 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.5 mtp180 -87.24 -42.7 12.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.785 . . . . 0.0 109.272 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -22.37 66.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.753 -0.592 . . . . 0.0 110.54 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.68 -29.99 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 108.774 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.971 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.17 -24.97 34.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.9 t -77.11 -35.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.52 -35.89 52.97 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.34 -35.51 80.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -71.19 -67.14 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.6 m 49.23 51.37 16.41 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.8 mttt 65.64 73.73 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.5 Cg_endo -72.37 154.28 55.96 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 111.063 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.54 176.37 5.88 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 42.9 t -155.57 164.59 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.6 tt0 -152.21 112.49 4.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.664 HG13 HG23 ' A' ' 52' ' ' ILE . 2.4 mp -98.04 136.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.767 0.794 . . . . 0.0 110.002 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.445 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.35 106.38 13.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.9 tt0 -97.7 124.3 41.97 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.112 -0.993 . . . . 0.0 111.193 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -124.44 53.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.3 -127.26 8.87 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.03 -1.13 24.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -1.029 . . . . 0.0 110.074 178.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.7 m -97.14 138.58 34.43 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.706 -1.246 . . . . 0.0 108.31 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 93.6 m-85 -134.11 118.11 17.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.764 0.793 . . . . 0.0 109.464 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.5 t80 -102.65 146.97 27.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.98 HD12 HD11 ' A' ' 63' ' ' ILE . 2.9 mt -141.73 100.81 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.947 -1.096 . . . . 0.0 110.45 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -99.39 114.07 26.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.393 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 18.0 m -99.87 144.76 28.55 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.9 p -135.51 144.19 46.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.2 p -123.78 -62.18 1.32 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.878 0.847 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.688 HG23 HG23 ' A' ' 58' ' ' VAL . 3.0 t 176.49 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.688 HG23 HG23 ' A' ' 57' ' ' THR . 24.4 t -125.15 -8.23 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -82.81 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.0 109.604 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.8 m 69.85 84.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.452 -0.78 . . . . 0.0 109.913 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.01 177.58 4.8 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.2 pm0 -171.37 143.75 1.88 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.69 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 52' ' ' ILE . 33.3 pt -128.18 170.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.5 p-10 -162.0 132.69 4.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.987 -1.071 . . . . 0.0 109.457 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.7 p90 -162.25 -172.39 3.18 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.409 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.81 152.6 48.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.64 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.97 96.89 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.36 -34.88 1.48 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.559 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.76 157.34 21.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -1.046 . . . . 0.0 109.968 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.2 mt-10 -85.8 168.88 13.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 22.3 p90 -161.21 -172.9 3.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 21.8 mt-10 -116.39 148.86 40.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.651 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.9 pt-20 -161.29 179.8 8.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.444 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.8 144.14 42.85 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 79' ' ' ARG . 7.9 t -81.54 177.62 8.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.407 -0.808 . . . . 0.0 108.985 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 76' ' ' VAL . 13.5 p -84.7 -0.35 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.6 -0.688 . . . . 0.0 111.396 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 75' ' ' THR . 5.2 t0 -95.68 -44.61 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.89 -1.132 . . . . 0.0 109.955 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 75' ' ' THR . . . 134.19 45.3 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mmm180 -139.9 149.88 60.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.796 -0.826 . . . . 0.0 109.088 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HB2' HD12 ' A' ' 100' ' ' LEU . 37.2 Cg_endo -80.46 135.03 10.33 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.49 1.46 . . . . 0.0 110.048 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.1 p -160.45 141.45 12.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.701 -0.624 . . . . 0.0 109.55 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 2.1 ptmm? -80.69 163.34 23.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.9 t -144.56 160.52 40.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD22 ' HG2' ' A' ' 70' ' ' GLU . 58.2 tp -142.13 153.57 44.2 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.6 t -144.7 125.77 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.772 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -120.58 162.28 19.89 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.64 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.1 m95 -85.51 168.7 14.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' OE1' HG21 ' A' ' 94' ' ' VAL . 5.4 tp10 -131.81 -45.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.6 p -133.04 -153.81 0.57 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -77.14 -25.14 51.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -143.83 26.6 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.877 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 15.5 tttt -131.5 109.65 10.43 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' CZ2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.25 150.67 35.82 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -102.8 171.36 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.3 t -148.93 140.41 23.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.185 -0.947 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -107.17 164.75 11.9 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -161.96 133.41 5.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.988 -1.07 . . . . 0.0 110.752 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -140.89 153.67 45.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.35 169.59 3.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 0.0 110.684 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 80' ' ' PRO . 40.7 mt -98.01 -7.48 29.83 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -159.98 157.03 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 108.774 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.69 -158.5 18.94 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -176.73 139.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.514 -0.992 . . . . 0.0 109.691 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.35 -85.35 0.06 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.48 -176.75 2.65 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.95 1.767 . . . . 0.0 110.17 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -138.67 141.19 39.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.81 145.28 50.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.163 0.982 . . . . 0.0 110.839 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 m -162.99 137.23 6.22 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.7 p-90 -143.21 174.55 10.61 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.674 HG22 HG13 ' A' ' 94' ' ' VAL . 12.2 p -139.29 175.31 9.67 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.512 0.672 . . . . 0.0 109.674 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.7 ptp -158.34 141.1 14.62 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -136.09 150.28 49.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.451 -0.78 . . . . 0.0 109.158 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.42 143.3 44.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -93.03 160.49 14.84 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.809 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -60.01 -21.04 60.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 110.229 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.0 -29.7 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.838 . . . . 0.0 109.177 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.07 -9.84 7.03 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.9 172.88 0.23 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.215 -1.168 . . . . 0.0 109.432 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.596 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -146.12 108.57 4.46 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.225 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.8 tt -103.62 147.87 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tt -129.93 147.75 51.72 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.263 -0.898 . . . . 0.0 109.637 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.469 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.22 164.57 18.48 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.5 mtp -146.88 164.49 32.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.534 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 8.4 m -146.52 153.08 39.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -161.5 98.72 1.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.51 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.43 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.27 24.19 1.03 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.519 -0.738 . . . . 0.0 109.426 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.1 m -119.15 -179.22 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.07 116.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.423 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.864 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.0 t -99.68 114.49 27.62 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.79 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.469 ' OG1' HG22 ' A' ' 122' ' ' THR . 76.9 m -104.57 126.61 51.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.36 -0.838 . . . . 0.0 109.296 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -126.39 101.96 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.15 136.17 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.413 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.3 m-85 -125.43 127.59 46.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.0 137.56 41.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.494 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.57 127.57 15.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 111.405 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.604 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.98 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -161.13 122.39 2.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.766 . . . . 0.0 109.819 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.5 m-85 -99.33 -8.79 24.38 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.732 -0.605 . . . . 0.0 109.61 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p -68.87 116.91 9.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.207 -0.933 . . . . 0.0 111.895 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.61 -171.95 39.39 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.89 169.04 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.56 121.55 7.67 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.717 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -115.25 113.7 24.24 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.6 tt -56.55 144.88 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.686 0.755 . . . . 0.0 110.804 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -125.21 -23.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.934 -0.479 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 10' ' ' ILE . 10.9 mtt180 -144.98 173.5 11.83 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.225 -0.922 . . . . 0.0 110.527 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t 170.29 168.79 0.06 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.78 31.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.961 -1.087 . . . . 0.0 111.893 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.38 32.11 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.167 -0.958 . . . . 0.0 109.237 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.832 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -66.92 -61.86 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.462 -0.774 . . . . 0.0 110.174 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.3 mm-40 -58.07 -30.08 65.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.357 -0.839 . . . . 0.0 110.988 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -71.69 -27.45 63.05 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.621 -178.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.7 tp -81.52 -20.65 39.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 13.7 mt -88.43 -16.68 32.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 109.187 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.9 mtmt -85.56 -32.86 21.91 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.47 -40.58 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -67.52 -48.74 66.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.886 0.85 . . . . 0.0 109.099 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.86 -160.52 26.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.61 -44.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.896 -0.767 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.9 t-20 -58.69 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 109.141 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.5 m -111.86 -43.52 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.6 ttp -66.92 -28.53 68.38 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm? -59.6 -23.57 63.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.729 -0.607 . . . . 0.0 110.57 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 33' ' ' VAL . 56.4 mtt180 -86.82 -47.59 8.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.641 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.74 -23.61 65.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 110.696 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.1 mt -77.25 -29.18 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.306 -0.871 . . . . 0.0 109.086 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.62 -26.44 34.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.7 t -76.86 -37.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 -33.47 55.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.55 92.77 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.92 -67.83 0.4 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m 51.13 53.4 13.05 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mttt 66.04 73.32 0.41 Allowed Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.2 Cg_endo -71.22 143.41 43.85 Favored 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 121.939 1.759 . . . . 0.0 110.632 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.1 176.13 6.21 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 54' ' ' THR . 54.2 t -155.36 163.97 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 31.0 tt0 -148.15 111.53 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.8 mt -99.68 140.9 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.81 0.814 . . . . 0.0 110.75 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -118.86 116.12 25.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -98.92 116.91 32.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.085 -1.009 . . . . 0.0 110.948 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -118.5 52.11 1.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.75 -125.97 8.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -76.91 -0.65 24.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.395 -1.062 . . . . 0.0 110.029 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.63 139.97 31.92 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.772 -1.205 . . . . 0.0 108.371 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CD2' ' HE1' ' A' ' 93' ' ' MET . 94.7 m-85 -135.02 116.94 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.879 0.847 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -102.18 148.72 25.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -147.24 105.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 O-C-N 120.909 -1.119 . . . . 0.0 111.665 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -102.17 115.36 30.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.331 -0.856 . . . . 0.0 108.836 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 41' ' ' VAL . 60.1 m -103.08 137.15 41.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.34 143.16 50.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.303 -0.873 . . . . 0.0 110.032 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -110.9 -77.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.593 0.711 . . . . 0.0 109.27 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 56' ' ' THR . 66.9 p -157.73 -47.58 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.62 -9.56 12.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.522 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -115.87 163.65 15.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.83 HG22 ' OE2' ' A' ' 62' ' ' GLU . 13.1 m -162.81 94.17 0.84 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.5 p -79.37 162.87 25.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.707 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.83 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.9 mp0 -156.12 122.92 5.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.69 -0.631 . . . . 0.0 109.499 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 52' ' ' ILE . 37.2 pt -121.56 165.66 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.9 p-10 -162.48 129.34 3.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.144 -0.972 . . . . 0.0 108.833 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.2 p90 -161.33 -172.43 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -128.55 153.38 47.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.54 95.3 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.554 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.91 -35.55 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -112.05 155.86 23.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.411 -1.052 . . . . 0.0 109.909 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -86.61 170.51 11.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.56 173.7 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.0 109.811 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -103.18 143.98 31.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.22 -175.4 4.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 109.445 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -102.55 154.87 18.7 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.2 t -90.19 -142.34 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.4 -0.813 . . . . 0.0 108.958 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 14.9 t -110.95 -20.8 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.733 -1.229 . . . . 0.0 110.445 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -88.57 -42.62 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.0 109.438 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.4 44.66 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.691 ' H ' HG22 ' A' ' 75' ' ' THR . 12.2 mtp180 -131.07 150.03 75.43 Favored Pre-proline 0 C--N 1.308 -1.237 0 O-C-N 121.696 -0.885 . . . . 0.0 109.003 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -77.94 140.72 18.4 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.615 1.543 . . . . 0.0 110.674 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -160.84 141.48 11.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.683 -0.636 . . . . 0.0 109.668 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.632 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.1 ttmt -87.23 116.35 25.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -99.48 164.58 12.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.295 0.569 . . . . 0.0 110.117 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.9 tp -143.98 153.18 41.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.3 t -145.58 124.94 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.656 -1.218 . . . . 0.0 111.761 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -119.17 155.34 31.81 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.526 ' NE1' HG21 ' A' ' 67' ' ' VAL . 80.6 m95 -77.19 175.15 9.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.881 0.848 . . . . 0.0 110.163 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -138.08 -46.41 0.52 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.9 p -131.22 -152.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -78.14 -25.56 47.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -142.99 27.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 110.571 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.7 tttm -133.34 113.34 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.891 -1.131 . . . . 0.0 108.288 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.38 150.82 39.53 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.493 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.71 172.21 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.506 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.7 t -147.79 139.66 24.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.781 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.93 162.84 13.65 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.23 133.59 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.552 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -141.93 151.13 42.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.23 167.93 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.98 . . . . 0.0 110.718 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 80' ' ' PRO . 50.9 mt -98.41 -6.27 30.95 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -155.09 141.1 18.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.99 -158.07 38.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -175.97 140.98 0.44 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.458 -1.024 . . . . 0.0 109.871 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.13 -85.51 0.05 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.19 -176.52 2.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.905 1.737 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -137.17 136.21 38.02 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.55 145.51 48.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.123 0.964 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.1 m -162.84 135.75 5.69 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.408 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.4 p-90 -141.73 175.41 9.72 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.669 HG22 HG13 ' A' ' 94' ' ' VAL . 11.8 p -138.15 174.38 10.62 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.696 . . . . 0.0 109.888 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 1.5 ptt? -156.77 133.35 10.06 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -131.07 146.45 52.37 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.393 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.3 143.07 39.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -92.65 161.41 14.58 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.833 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -60.27 -21.27 61.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.18 -29.62 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 0.0 109.179 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.15 -7.91 8.05 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 113' ' ' LEU . 36.2 mt-10 -59.37 172.37 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -1.167 . . . . 0.0 109.05 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -143.41 108.96 5.09 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.122 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.3 tt -103.13 148.48 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.68 145.35 51.9 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.489 -0.885 . . . . 0.0 109.489 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.14 167.19 12.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 14.2 mtp -148.32 164.65 33.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.474 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 128' ' ' VAL . 7.3 m -146.71 152.38 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.1 97.73 1.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.547 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.87 -79.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -149.65 24.47 0.87 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.398 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.3 m -120.92 -179.3 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -156.85 117.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.689 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.838 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.9 t -99.92 116.71 32.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.581 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -108.11 130.28 55.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.561 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 104.01 7.18 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.76 135.58 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.6 m-85 -124.52 122.08 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.394 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.34 140.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.45 126.0 12.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.254 -0.904 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.64 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 110.336 -0.678 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -170.63 128.73 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.576 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 m-85 -99.56 -11.44 21.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 116.81 6.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.25 -0.906 . . . . 0.0 111.689 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.72 -172.95 39.74 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.02 170.11 9.51 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.11 122.83 8.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.547 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -115.75 112.07 21.48 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.778 HG21 ' HD2' ' A' ' 39' ' ' PRO . 9.1 tt -52.47 156.5 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.994 0.902 . . . . 0.0 111.547 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -128.8 -33.31 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 10' ' ' ILE . 40.1 mtt180 -146.69 170.14 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.407 ' HB2' HD11 ' A' ' 9' ' ' ILE . 6.4 t -179.35 155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.3 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -152.08 171.95 17.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.688 -0.633 . . . . 0.0 110.048 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 15.7 m120 60.31 27.77 17.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 109.798 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -66.32 -64.27 0.89 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 108.976 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 tt0 -59.1 -28.53 66.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.613 -0.679 . . . . 0.0 109.719 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.77 -37.63 84.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 130' ' ' CYS . 48.2 tp -83.58 -13.61 53.98 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.684 -0.635 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.46 -21.7 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.003 -1.061 . . . . 0.0 108.946 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mmmt -82.64 -29.28 30.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.25 -41.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 122.098 0.951 . . . . 0.0 108.472 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.505 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -65.66 -53.56 39.63 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.149 0.976 . . . . 0.0 108.99 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.95 -146.37 17.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.5 m -155.58 -37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.014 -0.698 . . . . 0.0 110.175 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.52 -170.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 109.744 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH2' ' A' ' 29' ' ' ARG . 3.0 m -119.78 -43.8 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 110.084 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 31' ' ' ILE . 16.6 ttp -68.68 -23.02 64.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 0.0 109.281 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -65.35 -30.59 71.44 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.522 -0.736 . . . . 0.0 110.921 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -85.11 -45.31 12.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 0.0 110.65 -178.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -25.43 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.0 110.834 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.558 HD11 ' HG2' ' A' ' 27' ' ' MET . 96.0 mt -80.04 -27.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.365 -0.835 . . . . 0.0 108.879 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.99 -24.45 35.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.686 -0.634 . . . . 0.0 109.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.5 t -82.23 -49.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.95 97.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.25 86.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.58 40.72 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.684 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -64.25 -54.46 32.97 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.777 -1.202 . . . . 0.0 108.12 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -139.21 71.06 40.42 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.96 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.9 Cg_endo -72.89 147.95 44.88 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.947 1.765 . . . . 0.0 110.954 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -94.31 172.52 8.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.618 ' CG2' HG23 ' A' ' 54' ' ' THR . 17.0 t -155.3 166.34 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.0 tt0 -156.77 112.44 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.331 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.5 mp -100.07 141.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.753 0.787 . . . . 0.0 110.105 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 29.7 mttt -117.03 91.28 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.21 126.28 42.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -177.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -135.54 64.88 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.43 -131.62 10.85 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -74.75 -2.34 26.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -1.044 . . . . 0.0 110.418 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -96.44 132.09 42.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.543 -1.348 . . . . 0.0 108.31 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.04 121.11 25.8 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.811 0.815 . . . . 0.0 109.047 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.74 ' O ' HD13 ' A' ' 52' ' ' ILE . 13.3 t80 -105.78 151.41 24.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -138.55 135.48 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -138.89 105.35 5.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.315 -0.866 . . . . 0.0 108.797 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.618 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.2 m -98.74 148.43 23.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 108.975 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.01 113.02 5.79 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.037 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.96 HG22 ' HB3' ' A' ' 39' ' ' PRO . 35.6 p -98.22 -169.01 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.822 HG23 HG23 ' A' ' 58' ' ' VAL . 8.1 t -58.23 -39.76 79.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.6 -0.687 . . . . 0.0 111.517 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.822 HG23 HG23 ' A' ' 57' ' ' THR . 25.6 t -125.67 -7.25 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.225 -0.922 . . . . 0.0 112.204 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -113.3 166.18 11.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 0.0 110.618 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -164.83 101.25 0.78 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.61 168.53 9.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -165.73 113.37 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.545 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -99.84 172.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.463 -0.773 . . . . 0.0 109.059 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.7 p30 -163.4 135.66 5.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -163.02 -171.69 2.76 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.354 1.073 . . . . 0.0 112.661 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 153.68 47.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.68 96.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.095 -1.003 . . . . 0.0 109.615 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.1 -22.69 1.92 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.941 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -126.03 156.95 39.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.256 -1.144 . . . . 0.0 110.261 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' HD13 ' A' ' 84' ' ' LEU . 4.5 mt-10 -86.65 168.3 13.73 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.5 p90 -161.93 175.17 12.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' HD11 ' A' ' 100' ' ' LEU . 7.3 mt-10 -110.32 142.75 41.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 4.9 pm0 -162.08 -169.69 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -99.71 159.79 14.78 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.17 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.748 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.8 t -96.85 -143.04 0.29 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.379 -0.825 . . . . 0.0 109.242 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 21.9 t -106.44 -23.86 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.762 -1.211 . . . . 0.0 110.914 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 p30 -88.87 -41.61 12.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.43 45.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.748 ' H ' HG22 ' A' ' 75' ' ' THR . 5.3 mmm180 -131.45 153.08 81.49 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.683 -0.892 . . . . 0.0 109.188 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.52 140.09 14.82 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.76 1.64 . . . . 0.0 110.439 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.2 p -160.57 144.65 13.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.517 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.793 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.1 tppt? -90.48 122.09 33.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 11.9 t -104.52 168.92 8.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.543 . . . . 0.0 110.206 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.605 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.2 tp -148.24 153.43 38.72 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.636 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.6 t -144.92 126.48 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.908 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.57 ' CD1' HG11 ' A' ' 67' ' ' VAL . 76.6 m95 -76.94 174.01 11.1 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.913 0.863 . . . . 0.0 110.769 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -136.65 -45.68 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.4 p -134.89 -150.66 0.4 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.87 -26.59 49.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -142.36 24.03 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 11.0 tttt -131.13 113.86 14.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.93 -1.106 . . . . 0.0 108.289 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.464 ' HE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.24 149.96 40.89 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.512 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.15 173.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.53 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.5 t -147.57 141.09 25.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.2 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.55 163.25 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -160.33 138.83 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.654 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -145.59 150.73 36.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.55 166.56 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.032 -1.043 . . . . 0.0 110.775 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.1 mt -98.68 -5.48 31.53 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -147.76 129.79 15.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 108.945 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.18 -155.83 45.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -176.27 141.82 0.45 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.524 -0.986 . . . . 0.0 109.686 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.76 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -82.18 -176.89 3.19 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.749 1.632 . . . . 0.0 109.925 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -130.42 133.83 46.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.4 144.16 46.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.115 0.96 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -163.34 135.55 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -142.78 177.66 8.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.061 -1.024 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.67 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -139.23 166.86 23.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.516 0.674 . . . . 0.0 109.956 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.56 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 19.2 ptm -148.92 124.72 10.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -122.64 151.14 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.38 144.48 43.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 18.7 p -93.87 161.77 14.18 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.859 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -60.65 -23.05 64.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.635 -0.666 . . . . 0.0 110.114 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.4 -27.95 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.67 -10.08 7.6 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 114' ' ' THR . 25.4 mt-10 -55.47 173.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.156 -1.202 . . . . 0.0 109.412 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.5 tt -147.71 114.63 6.12 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.45 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.25 150.92 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 132.98 42.16 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.49 -0.756 . . . . 0.0 109.546 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.67 165.23 13.27 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 129' ' ' VAL . 32.4 mtp -144.73 163.45 33.98 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.649 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 129' ' ' VAL . 2.6 m -146.86 149.09 32.59 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.99 93.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.52 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -147.47 23.16 1.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.665 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -118.47 -179.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.57 118.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.893 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.651 ' HB2' HD22 ' A' ' 18' ' ' LEU . 28.1 t -98.96 112.8 24.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.7 m -110.77 147.64 34.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -151.37 120.29 6.64 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.1 t -81.31 138.71 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.098 -1.001 . . . . 0.0 108.428 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.3 m-85 -127.07 125.98 42.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.153 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.99 139.92 28.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.2 125.72 11.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.224 -0.922 . . . . 0.0 111.102 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.48 179.662 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 113' ' ' LEU . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.029 0 N-CA-C 110.389 -0.658 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -133.64 132.01 40.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 2.6 m-85 -98.65 0.59 45.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -73.25 118.5 16.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 111.97 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.66 -171.77 38.56 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.82 170.03 9.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.891 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.52 121.77 7.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.508 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -115.25 113.22 23.6 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 12' ' ' SER . 8.6 tt -52.22 157.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.012 0.911 . . . . 0.0 111.684 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.57 -32.72 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.441 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.722 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.1 ttp180 -146.52 171.3 15.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.877 . . . . 0.0 109.034 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 9' ' ' ILE . 81.7 p -177.52 158.15 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.781 . . . . 0.0 109.641 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.64 169.86 22.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.678 -0.638 . . . . 0.0 110.034 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 17.1 m120 58.68 23.88 11.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.538 -0.726 . . . . 0.0 110.194 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -66.42 -63.39 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -56.88 -27.8 61.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.57 -39.02 93.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.634 -0.666 . . . . 0.0 109.681 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 8.4 tp -78.49 -18.04 55.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.717 -0.614 . . . . 0.0 110.157 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.5 mt -90.23 -17.76 26.9 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -86.29 -28.32 23.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.5 p -80.21 -40.96 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 76' ' ' VAL . 4.6 mp -67.28 -52.31 42.23 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.097 0.951 . . . . 0.0 109.314 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.1 -149.34 22.06 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.462 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 23' ' ' GLY . 21.1 m -155.71 -34.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 122.104 -0.645 . . . . 0.0 110.375 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.93 ' HB2' HD22 ' A' ' 28' ' ' LEU . 1.7 t-20 -61.71 -152.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 110.033 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.12 -50.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.977 -1.077 . . . . 0.0 109.051 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 8.9 ttm -65.95 -30.98 71.64 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -52.82 -33.93 51.46 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.465 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.4 mtp180 -83.31 -46.55 12.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -62.88 -15.19 53.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.691 -0.631 . . . . 0.0 111.206 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.6 -30.46 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.094 -1.004 . . . . 0.0 108.474 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.75 -24.14 33.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.5 t -80.45 -44.33 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.06 -41.33 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.07 83.49 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.21 45.21 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.844 -0.535 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -60.66 -34.72 74.72 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.572 -1.33 . . . . 0.0 108.37 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -165.68 72.88 1.32 Allowed Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.731 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.2 Cg_endo -73.15 149.78 46.67 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.811 1.674 . . . . 0.0 110.759 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.73 175.07 5.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 54' ' ' THR . 55.8 t -155.61 164.43 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 41' ' ' VAL . 44.2 tt0 -150.58 110.82 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.891 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -98.25 133.38 40.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.786 0.803 . . . . 0.0 110.161 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -113.03 106.9 15.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.7 tt0 -97.48 122.99 41.17 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.14 -0.975 . . . . 0.0 111.017 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -122.58 56.42 1.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.86 -126.06 8.13 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.77 -0.42 23.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.378 -1.072 . . . . 0.0 110.163 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 65' ' ' PHE . 14.4 m -96.89 138.06 35.02 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 120.712 -1.243 . . . . 0.0 108.556 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.6 m-85 -132.49 116.01 16.22 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.891 0.853 . . . . 0.0 109.342 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.4 t80 -101.77 146.98 27.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -143.15 99.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.026 -1.046 . . . . 0.0 110.161 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 14.6 tttt -99.45 111.82 24.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.449 -0.782 . . . . 0.0 109.718 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 41' ' ' VAL . 24.4 m -99.51 146.4 26.42 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.2 p -139.9 119.5 13.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.997 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.731 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.3 p -99.84 -63.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.766 0.793 . . . . 0.0 108.917 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.777 HG23 HG23 ' A' ' 58' ' ' VAL . 2.8 t 174.94 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.777 HG23 HG23 ' A' ' 57' ' ' THR . 25.7 t -120.6 -9.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -100.19 -81.89 0.46 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 109.599 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.6 m 69.63 85.12 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 109.752 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 p -108.25 176.96 4.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.0 109.34 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 2.5 pt-20 -170.26 124.05 0.71 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 109.849 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 52' ' ' ILE . 35.6 pt -114.87 170.91 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.2 p30 -162.56 133.88 5.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.949 . . . . 0.0 109.51 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.5 p90 -161.91 -171.52 2.92 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.44 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.09 152.81 49.13 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -83.0 94.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.129 -0.982 . . . . 0.0 109.64 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.08 -27.56 1.26 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.662 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.38 156.81 34.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.322 -1.105 . . . . 0.0 110.177 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -86.39 169.78 12.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.592 -0.692 . . . . 0.0 109.395 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.9 p90 -163.0 174.42 12.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.616 -0.678 . . . . 0.0 109.612 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -103.65 144.33 31.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -162.35 -174.93 4.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.564 -0.71 . . . . 0.0 109.443 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -99.83 159.25 15.21 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.3 t -95.13 -150.05 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 22' ' ' LEU . 13.7 p -98.54 -21.18 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.976 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -91.99 -51.21 5.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.64 44.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.742 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mtm180 -128.88 152.63 79.38 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.584 -0.951 . . . . 0.0 109.05 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.07 139.88 17.46 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.599 1.532 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.82 140.96 11.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.745 -0.597 . . . . 0.0 109.445 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.683 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.3 ttmt -86.4 117.28 25.1 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.0 t -99.41 168.25 10.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.18 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 70' ' ' GLU . 61.5 tp -147.01 154.08 40.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.6 t -146.65 130.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 118.441 -1.303 . . . . 0.0 112.153 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -125.51 160.04 30.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.9 m95 -83.63 169.83 14.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.129 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.446 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -132.45 -46.22 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.0 p -130.6 -153.47 0.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.11 -26.35 47.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -142.2 27.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.806 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 1.2 tttt -132.03 108.58 9.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.822 -1.173 . . . . 0.0 107.933 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.7 ptp -114.77 149.74 36.47 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.43 -0.794 . . . . 0.0 110.509 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -102.21 171.5 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.2 t -146.71 141.5 26.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.756 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.66 162.91 13.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -160.69 136.96 8.53 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.655 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -142.25 149.8 40.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.62 166.06 4.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 110.805 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 82' ' ' LYS . 48.2 mt -101.07 -3.15 29.82 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 132.41 13.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 108.796 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.77 -159.86 42.24 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.25 141.33 0.43 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.396 -1.061 . . . . 0.0 109.857 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.98 -85.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.18 -177.05 3.1 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.816 1.677 . . . . 0.0 109.793 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -132.55 138.14 47.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.37 144.47 48.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.106 0.955 . . . . 0.0 110.698 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.96 135.82 5.61 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -139.21 173.71 11.27 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.056 -1.028 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.709 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -137.57 174.05 11.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.482 0.658 . . . . 0.0 110.073 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.453 ' HB3' ' HE2' ' A' ' 111' ' ' MET . 11.0 ptp -160.35 132.83 6.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 15.3 pt-20 -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -112.62 145.23 40.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -92.95 161.0 14.64 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -60.14 -21.92 62.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.655 -0.653 . . . . 0.0 110.323 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -85.31 -28.37 25.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.87 -8.84 7.64 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 113' ' ' LEU . 46.3 mt-10 -57.18 172.53 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.095 -1.238 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -147.29 112.13 5.39 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.111 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.1 tt -108.04 146.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 139.8 52.3 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.536 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -118.47 169.9 9.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.8 mtp -148.81 166.25 29.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.355 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' VAL . 4.9 m -149.0 151.75 35.08 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.434 0.635 . . . . 0.0 109.459 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.36 95.07 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -147.42 24.0 1.13 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.54 -0.725 . . . . 0.0 109.282 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -118.78 -178.75 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.61 117.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.841 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.4 t -98.38 120.08 38.18 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.536 ' OG1' HG22 ' A' ' 122' ' ' THR . 90.0 m -117.85 145.51 44.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.25 118.0 7.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.56 138.48 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.0 108.398 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.7 m-85 -127.13 123.84 37.74 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.226 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 140.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.25 125.69 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.239 -0.913 . . . . 0.0 111.137 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.593 179.645 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.501 1.969 0 N-CA-C 110.347 -0.674 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -159.86 122.33 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.749 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.96 -2.42 37.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.704 -0.623 . . . . 0.0 109.366 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 t -72.15 117.71 14.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 111.936 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.6 -172.25 38.62 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 32.7 m-20 -95.68 170.08 9.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.5 m95 -149.97 118.93 6.67 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.653 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -110.65 115.28 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.832 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.4 tt -56.67 158.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.01 0.91 . . . . 0.0 111.117 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -130.7 -33.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.421 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB2' HD12 ' A' ' 10' ' ' ILE . 43.3 mtt85 -146.23 168.4 21.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 108.844 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.684 ' HB3' HD11 ' A' ' 9' ' ' ILE . 97.0 p -177.56 139.76 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.512 -0.743 . . . . 0.0 109.406 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.9 169.71 16.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.672 -0.642 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 16.4 m120 61.24 29.4 18.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.735 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.8 t80 -64.68 -63.64 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.0 109.074 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.1 pt-20 -60.53 -26.58 66.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.675 -0.641 . . . . 0.0 109.629 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -64.57 -41.48 96.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.6 tp -80.67 -13.24 59.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.0 -20.33 22.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.038 -1.038 . . . . 0.0 109.207 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.6 mmmm -84.23 -29.54 26.45 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 18' ' ' LEU . 14.3 p -78.61 -40.78 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.88 -53.1 29.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.139 0.971 . . . . 0.0 109.159 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.73 -148.72 20.8 Favored Glycine 0 N--CA 1.491 2.364 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.265 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.96 -36.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.982 -0.716 . . . . 0.0 110.418 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.865 . . . . 0.0 109.993 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 HG13 HH12 ' A' ' 29' ' ' ARG . 2.2 t -126.43 -48.24 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.362 -0.836 . . . . 0.0 109.705 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HG2' HD11 ' A' ' 31' ' ' ILE . 1.5 ttt -67.2 -25.95 66.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -62.96 -28.83 70.35 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.697 -0.627 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.5 mtp180 -87.71 -46.88 9.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 0.0 110.449 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -60.44 -30.77 69.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.505 -0.747 . . . . 0.0 110.656 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 27' ' ' MET . 80.5 mt -76.18 -27.34 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.474 -0.766 . . . . 0.0 109.188 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.2 -22.3 36.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.1 t -81.21 -43.41 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.86 85.38 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HB1' HG22 ' A' ' 57' ' ' THR . . . -63.0 -46.17 88.92 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.2 41.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -65.69 -32.73 74.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.908 -1.12 . . . . 0.0 108.293 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -159.11 70.54 3.47 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.937 ' HB3' HG23 ' A' ' 56' ' ' THR . 29.8 Cg_endo -73.92 135.2 20.9 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.897 1.731 . . . . 0.0 109.741 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -86.55 170.29 12.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.581 -0.7 . . . . 0.0 109.803 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 54' ' ' THR . 20.2 t -156.76 130.91 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.18 112.03 18.14 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.919 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.0 mt -99.21 136.13 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.657 0.741 . . . . 0.0 110.106 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -113.59 114.99 27.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.87 117.15 32.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.1 -1.0 . . . . 0.0 110.9 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -118.21 52.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 -125.1 7.67 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -77.75 0.04 25.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.366 -1.079 . . . . 0.0 109.991 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.7 m -96.42 140.2 31.43 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.763 -1.21 . . . . 0.0 108.424 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.9 m-85 -136.02 116.57 13.82 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.85 0.834 . . . . 0.0 109.488 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.7 t80 -102.36 148.44 25.47 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.126 HD12 HD11 ' A' ' 63' ' ' ILE . 1.7 mt -144.46 105.59 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 120.937 -1.102 . . . . 0.0 111.275 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.35 106.29 18.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 108.928 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 41' ' ' VAL . 14.4 m -98.17 144.61 27.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 108.559 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 118.79 12.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.852 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -97.44 -159.04 0.71 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.724 HG23 HG23 ' A' ' 58' ' ' VAL . 8.5 t -62.23 -43.09 99.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.063 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.724 HG23 HG23 ' A' ' 57' ' ' THR . 21.8 t -130.24 -6.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.529 -0.732 . . . . 0.0 111.892 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 -102.54 168.2 9.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.066 -1.021 . . . . 0.0 110.07 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 m -163.85 93.89 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 p -91.11 166.87 12.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.367 -0.833 . . . . 0.0 109.99 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.04 123.06 4.36 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.126 HD11 HD12 ' A' ' 52' ' ' ILE . 35.4 pt -123.06 167.59 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.0 p-10 -162.49 128.98 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.184 -0.947 . . . . 0.0 109.26 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.68 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.4 p90 -162.09 -172.24 3.16 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.281 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -129.75 153.57 48.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.95 93.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 109.668 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.87 -26.44 1.3 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.741 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -122.82 157.68 31.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.321 -1.105 . . . . 0.0 110.079 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' HG2' HD22 ' A' ' 84' ' ' LEU . 30.6 mt-10 -86.63 168.08 13.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.12 173.33 14.47 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.708 -0.62 . . . . 0.0 109.398 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -102.68 143.11 32.76 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.8 pt-20 -162.34 -175.74 4.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.628 . . . . 0.0 109.433 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.92 157.63 16.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -91.88 -142.97 0.19 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.406 -0.809 . . . . 0.0 109.005 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.27 -19.56 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.785 -1.197 . . . . 0.0 110.649 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.676 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t0 -91.89 -44.52 8.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.557 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.99 45.1 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 0.6 OUTLIER -131.79 151.17 78.1 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 121.617 -0.931 . . . . 0.0 109.019 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.775 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.51 140.26 16.84 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.618 1.546 . . . . 0.0 110.677 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.94 141.72 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.657 -0.652 . . . . 0.0 109.606 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.7 ttmt -87.03 116.26 24.96 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -99.54 166.39 11.17 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.499 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.09 153.07 40.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.68 HG21 ' CE2' ' A' ' 65' ' ' PHE . 12.0 t -145.03 126.65 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.861 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.39 155.46 33.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.517 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.5 m95 -78.0 173.62 11.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.78 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.29 -46.26 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.8 p -131.47 -153.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.91 -23.09 44.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.85 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -144.3 26.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 20.8 tttm -133.82 112.25 11.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.905 -1.122 . . . . 0.0 108.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.495 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 ptm -118.18 149.84 40.39 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.26 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.84 172.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.497 ' H ' HG12 ' A' ' 94' ' ' VAL . 46.4 t -147.78 137.78 22.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.818 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.98 163.48 12.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -160.23 135.41 7.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.563 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -141.22 148.41 39.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.69 167.3 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.3 mt -94.98 -8.81 35.85 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.66 155.29 31.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.53 -161.04 16.97 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -176.89 138.64 0.27 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.503 -0.999 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.25 -85.05 0.05 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.02 -176.83 2.79 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.91 1.74 . . . . 0.0 109.9 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -135.97 136.42 40.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.16 47.56 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.154 0.978 . . . . 0.0 110.966 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -162.92 136.27 5.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.3 p-90 -140.54 174.68 10.28 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.31 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 94' ' ' VAL . 12.3 p -138.83 171.21 14.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.598 0.713 . . . . 0.0 109.855 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.441 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 9.8 ptp -153.04 136.48 15.86 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -132.99 149.93 52.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.703 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.99 143.73 43.79 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.9 p -92.75 161.02 14.7 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.58 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -60.42 -21.67 62.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.624 -0.672 . . . . 0.0 110.214 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.42 -28.45 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 109.32 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.35 -9.84 7.34 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 56.3 mt-10 -56.16 172.28 0.22 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.148 -1.207 . . . . 0.0 109.212 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -146.84 111.46 5.25 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.405 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.06 156.45 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.72 133.67 32.56 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.354 -0.841 . . . . 0.0 109.515 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 166.76 11.23 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.448 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.4 mtp -144.93 163.13 35.09 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.243 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -147.01 151.17 36.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.407 0.622 . . . . 0.0 109.331 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 95.13 1.42 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.564 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.27 -79.12 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.63 23.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.519 -0.738 . . . . 0.0 109.319 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.1 m -118.22 -179.88 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.52 118.4 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.744 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.741 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.32 113.0 24.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.6 m -107.14 148.34 28.95 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.911 0.862 . . . . 0.0 109.985 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -152.81 119.02 5.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.0 138.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.571 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -126.53 131.07 51.67 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.3 139.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.47 125.58 11.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.262 -0.899 . . . . 0.0 111.21 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.59 179.473 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.973 0 N-CA-C 110.317 -0.686 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.65 141.03 0.15 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.116 0.96 . . . . 0.0 110.197 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.1 m-85 -104.49 -3.79 23.52 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.7 p -68.15 118.81 11.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 112.132 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.06 -173.33 38.37 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.2 m120 -95.75 170.22 9.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.22 122.86 7.98 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.814 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -114.36 114.03 25.34 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.79 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.3 tt -54.4 157.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.97 0.89 . . . . 0.0 111.46 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.778 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -130.72 -32.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -147.34 169.57 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 9' ' ' ILE . 93.3 p -176.94 160.84 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -0.794 . . . . 0.0 109.824 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.45 166.58 32.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 110.016 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 14.0 m120 61.28 29.67 18.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.965 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.4 t80 -64.19 -64.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 109.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 36.2 tt0 -60.4 -26.39 66.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.721 -0.612 . . . . 0.0 109.623 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.36 -41.56 96.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 0.0 109.922 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.5 tp -81.13 -12.84 59.14 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.1 -20.59 21.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.95 -1.094 . . . . 0.0 109.102 179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.2 mmmt -84.5 -30.05 25.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' ' 125' ' ' ALA . 14.5 p -77.4 -40.9 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.582 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -67.41 -53.02 32.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.19 0.995 . . . . 0.0 109.075 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.63 21.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -150.91 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.861 -0.788 . . . . 0.0 110.343 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.21 -169.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.261 -0.899 . . . . 0.0 109.786 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG12 ' NH2' ' A' ' 29' ' ' ARG . 14.1 m -121.7 -43.59 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.594 -0.692 . . . . 0.0 110.121 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.402 ' N ' HG23 ' A' ' 26' ' ' VAL . 7.5 ttm -68.46 -28.02 66.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.753 . . . . 0.0 109.03 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.98 -50.29 73.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.734 -0.604 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -64.0 -44.46 92.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 110.22 -178.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -59.87 -25.63 65.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.624 -0.672 . . . . 0.0 111.219 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -80.27 -28.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.165 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.43 -23.36 34.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.61 -0.681 . . . . 0.0 109.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.965 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.0 t -82.25 -47.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.24 96.82 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.49 37.39 0.57 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 p -63.69 -33.19 75.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.694 -1.254 . . . . 0.0 108.224 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -163.12 71.58 1.96 Allowed Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' HG21 ' A' ' 9' ' ' ILE . 33.3 Cg_endo -75.23 -176.31 2.85 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 122.033 1.822 . . . . 0.0 110.793 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -126.21 172.11 10.34 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 54' ' ' THR . 41.4 t -155.57 164.95 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.6 tt0 -153.72 112.4 3.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.599 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.6 mp -98.73 133.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 109.99 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.3 mttt -113.92 103.59 11.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 59.1 tt0 -97.49 127.18 43.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.143 -0.973 . . . . 0.0 111.156 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.54 55.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.05 -126.05 8.34 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.34 -0.07 24.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.434 -1.039 . . . . 0.0 110.148 178.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 m -97.48 140.64 31.63 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.745 -1.222 . . . . 0.0 108.545 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 94.1 m-85 -136.4 118.09 15.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.693 0.759 . . . . 0.0 109.547 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.8 t80 -102.47 145.78 29.06 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 63' ' ' ILE . 3.9 mt -140.34 99.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 120.987 -1.071 . . . . 0.0 110.663 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -98.79 113.46 25.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.756 . . . . 0.0 109.764 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 41' ' ' VAL . 58.6 m -106.18 143.3 34.5 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 60' ' ' THR . 2.2 p -148.8 123.44 9.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.837 . . . . 0.0 109.195 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.603 HG22 HG22 ' A' ' 57' ' ' THR . 62.0 m -97.96 -66.83 0.88 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.96 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.838 HG23 HG23 ' A' ' 58' ' ' VAL . 5.0 t -175.94 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.838 HG23 HG23 ' A' ' 57' ' ' THR . 25.3 t -107.16 -14.85 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -130.36 162.46 29.03 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.727 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.7 m -162.0 108.1 1.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -109.28 177.22 4.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.576 -0.703 . . . . 0.0 109.939 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 pt-20 -170.66 136.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.714 -0.616 . . . . 0.0 109.342 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 52' ' ' ILE . 28.8 pt -125.97 172.54 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.0 109.292 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.535 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.3 p-10 -162.45 130.34 3.91 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 108.882 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.2 p90 -161.97 -172.72 3.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.313 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 152.79 48.54 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.726 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.23 95.69 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.89 1.57 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.911 -1.137 . . . . 0.0 110.666 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -111.2 154.91 23.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.302 -1.117 . . . . 0.0 110.065 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.459 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -86.46 167.38 14.72 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.0 p90 -162.43 173.28 14.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 110.005 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.84 145.54 29.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.683 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.1 -177.8 5.98 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -99.82 155.51 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.713 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -91.14 -142.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HB ' HD21 ' A' ' 22' ' ' LEU . 24.5 t -110.3 -20.22 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.205 . . . . 0.0 110.618 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.64 ' H ' HG23 ' A' ' 75' ' ' THR . 2.1 t70 -89.19 -41.91 11.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.78 45.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.713 ' H ' HG22 ' A' ' 75' ' ' THR . 4.8 mmm180 -131.91 151.51 78.64 Favored Pre-proline 0 N--CA 1.485 1.322 0 O-C-N 121.618 -0.931 . . . . 0.0 109.31 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.69 141.55 17.41 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.715 1.61 . . . . 0.0 110.482 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.21 141.07 10.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.676 -0.64 . . . . 0.0 109.772 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.7 ttmm -90.5 115.22 27.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -103.04 176.43 5.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.754 -0.591 . . . . 0.0 110.136 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.5 tp -151.18 152.97 34.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.709 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.7 t -140.17 130.27 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -124.43 159.31 30.74 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.726 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.2 m95 -84.54 170.19 13.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.266 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.53 -46.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.7 p -131.63 -154.75 0.64 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -76.74 -24.44 53.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.677 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -144.49 27.07 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.2 tttm -130.81 108.1 9.61 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.918 -1.114 . . . . 0.0 107.995 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.541 ' HE1' HG13 ' A' ' 67' ' ' VAL . 1.1 ptp -115.84 148.85 39.47 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.63 0.729 . . . . 0.0 110.497 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 110' ' ' THR . 1.0 OUTLIER -103.03 171.01 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 85' ' ' VAL . 42.6 t -148.63 129.95 14.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.197 -0.939 . . . . 0.0 110.675 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -100.49 164.46 11.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.48 143.49 13.35 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.773 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -146.28 149.24 33.48 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.74 166.17 3.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.054 -1.029 . . . . 0.0 110.84 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.0 mt -98.54 -5.49 32.01 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -151.52 139.6 20.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 108.958 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.71 -159.19 42.97 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -176.86 140.59 0.33 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.492 -1.005 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.8 -84.66 0.05 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.53 -177.11 3.04 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.86 1.707 . . . . 0.0 110.12 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -136.11 135.8 39.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.97 145.67 46.56 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.119 0.961 . . . . 0.0 110.793 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 m -162.64 130.4 3.82 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -133.41 168.68 18.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.765 HG22 HG13 ' A' ' 94' ' ' VAL . 17.8 p -134.25 174.6 10.33 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.449 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.6 ptp -159.13 130.23 6.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -123.66 151.5 43.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.511 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.81 142.78 46.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.6 159.15 15.35 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.761 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -59.65 -21.59 60.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.692 . . . . 0.0 110.234 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.38 -30.23 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.77 -9.48 6.79 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -56.67 171.8 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.146 -1.208 . . . . 0.0 109.08 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.8 tt -147.18 111.2 5.08 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.189 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.6 tt -105.24 156.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -135.76 153.89 51.41 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.461 -0.775 . . . . 0.0 109.302 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.64 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -136.12 169.05 18.24 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.492 ' O ' HG22 ' A' ' 129' ' ' VAL . 13.6 mtp -150.15 165.82 31.68 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.669 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -148.34 151.24 34.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.16 95.93 1.41 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.4 -79.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.13 23.87 1.17 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.539 -0.726 . . . . 0.0 109.311 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -117.77 -179.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.88 118.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.813 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -98.15 121.13 39.71 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.64 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.8 m -119.55 145.95 45.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -150.56 121.24 7.5 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.23 139.8 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.1 m-85 -128.3 126.77 41.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.89 139.03 31.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.07 125.62 10.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.212 -0.93 . . . . 0.0 111.289 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.699 179.684 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 110.34 -0.677 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -153.69 125.56 7.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.531 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.9 m-85 -99.39 -5.43 29.55 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.627 -0.67 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 p -71.92 117.8 13.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.147 -0.97 . . . . 0.0 111.805 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.26 -173.58 39.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.0 m120 -95.61 172.27 8.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.6 124.51 9.25 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.643 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -116.46 113.7 23.2 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 6.3 tt -53.05 152.76 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.73 0.776 . . . . 0.0 111.183 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.16 -25.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.99 -0.444 . . . . 0.0 110.543 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.493 ' HB2' HD12 ' A' ' 10' ' ' ILE . 21.5 mtm-85 -152.42 -179.85 7.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 110.72 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 170.22 168.91 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.81 29.33 0.06 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.941 -1.1 . . . . 0.0 112.252 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.21 37.79 0.12 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.16 -0.962 . . . . 0.0 108.999 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.779 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.76 -63.33 1.41 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.562 -0.712 . . . . 0.0 109.558 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.3 mt-10 -57.52 -30.67 65.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.382 -0.824 . . . . 0.0 110.581 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -73.49 -30.58 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.243 -179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 130' ' ' CYS . 34.1 tp -78.71 -17.1 56.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.779 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.25 -19.97 23.51 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.067 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.1 mtmt -81.14 -30.6 34.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.72 -41.4 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.977 0.894 . . . . 0.0 108.848 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.59 -50.94 61.43 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.081 0.943 . . . . 0.0 109.279 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.23 -153.01 24.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -150.42 -37.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.956 -0.732 . . . . 0.0 110.335 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.9 -159.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.6 t -127.93 -47.34 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 0.0 109.471 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.3 ttt -65.82 -30.42 71.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.1 mm? -60.18 -28.19 67.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.724 -0.61 . . . . 0.0 110.49 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -89.49 -44.95 9.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.379 -0.825 . . . . 0.0 110.145 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -61.56 -25.08 67.08 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.632 -0.667 . . . . 0.0 110.895 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.5 -26.73 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 108.914 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -81.09 -25.89 36.66 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.631 -0.668 . . . . 0.0 109.232 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.67 -45.64 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.13 85.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.99 49.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.73 50.62 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.854 -0.529 . . . . 0.0 110.467 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.4 p -61.99 -34.03 75.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.707 -1.246 . . . . 0.0 108.236 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -162.93 74.31 2.0 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.936 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.9 Cg_endo -73.5 134.25 20.27 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.941 1.761 . . . . 0.0 111.267 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.08 177.3 7.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.651 ' CG2' HG23 ' A' ' 54' ' ' THR . 19.1 t -155.98 164.58 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -153.51 113.17 3.85 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.905 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -105.71 141.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.705 0.764 . . . . 0.0 110.676 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HE3' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.84 117.09 27.24 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.3 tt0 -99.04 118.17 35.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.115 -0.99 . . . . 0.0 110.996 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -119.69 45.8 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.31 -128.56 9.57 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.35 -3.48 30.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -1.066 . . . . 0.0 110.006 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -96.45 133.86 40.35 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.81 -1.181 . . . . 0.0 108.142 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.8 m-85 -129.54 114.87 16.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.758 0.79 . . . . 0.0 109.7 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.4 t80 -99.67 148.02 24.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.066 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -140.81 143.45 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.096 -1.002 . . . . 0.0 108.745 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -139.58 107.24 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.402 -0.811 . . . . 0.0 109.247 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.651 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.9 m -98.74 147.89 24.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -145.64 118.58 8.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.327 -0.858 . . . . 0.0 110.37 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 39' ' ' PRO . 76.1 p -98.87 -149.65 0.35 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 p -72.19 -41.94 66.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.928 -1.107 . . . . 0.0 110.286 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 58' ' ' VAL . 24.5 t -128.68 -6.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.437 -0.789 . . . . 0.0 111.649 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -104.94 165.6 10.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.122 -0.986 . . . . 0.0 110.271 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 m -163.82 99.87 0.88 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.655 -0.653 . . . . 0.0 109.281 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 156.49 18.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.449 -0.782 . . . . 0.0 109.877 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -151.05 103.08 3.01 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.066 HD11 HD12 ' A' ' 52' ' ' ILE . 38.8 pt -102.85 165.46 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.328 -0.857 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.2 p-10 -162.18 129.15 3.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.075 -1.015 . . . . 0.0 109.201 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.69 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.3 p90 -161.48 -172.4 3.35 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.344 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -128.86 153.37 47.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.4 95.52 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.145 -0.972 . . . . 0.0 109.755 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.05 -33.89 1.58 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.672 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.99 154.99 23.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -1.088 . . . . 0.0 109.978 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.603 ' HG3' HD13 ' A' ' 84' ' ' LEU . 7.5 mp0 -86.12 168.02 14.41 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.65 175.27 11.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.0 109.567 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.33 144.67 31.31 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -177.71 5.93 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -99.6 155.47 17.58 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.26 -142.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.4 -0.812 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.572 ' N ' HG23 ' A' ' 75' ' ' THR . 24.9 t -111.39 -20.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 110.657 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' H ' HG23 ' A' ' 75' ' ' THR . 2.7 t0 -87.21 -39.23 15.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.186 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.31 44.82 0.14 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 35.2 mtp180 -132.36 151.82 78.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.739 -0.859 . . . . 0.0 109.311 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.81 142.13 17.54 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.603 1.535 . . . . 0.0 110.348 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 p -161.04 142.32 11.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.673 -0.642 . . . . 0.0 109.81 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -90.55 113.69 25.75 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.3 t -102.08 175.2 5.61 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.139 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.6 tp -151.32 152.92 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.1 t -140.81 126.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.762 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -119.51 155.62 31.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.523 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.2 m95 -77.46 173.3 12.12 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.018 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.07 -46.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.9 p -131.52 -152.61 0.51 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -78.06 -25.92 47.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -142.96 26.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 110.782 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 79.0 tttt -132.16 111.2 11.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.937 -1.102 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.488 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.4 ptm -117.94 149.58 40.67 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.388 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.66 172.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.505 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.7 t -149.13 128.71 13.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 0.0 110.731 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -99.9 163.5 12.42 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -160.35 142.15 12.65 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.963 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -146.82 148.92 32.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.521 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.3 mt -58.94 166.49 1.96 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.985 . . . . 0.0 110.972 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.3 mt -97.44 -6.5 33.77 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -152.27 141.13 21.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 108.962 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.91 -159.78 39.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -176.8 141.19 0.35 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.998 . . . . 0.0 109.665 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.68 -84.77 0.05 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.04 -176.54 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.89 1.727 . . . . 0.0 110.022 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -136.08 137.59 41.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.41 145.3 48.41 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.101 0.953 . . . . 0.0 110.676 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.77 130.08 3.66 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -134.13 172.1 13.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.041 -1.037 . . . . 0.0 110.121 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.749 HG22 HG13 ' A' ' 94' ' ' VAL . 14.0 p -135.15 175.21 9.79 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.4 ptp -158.08 133.8 9.06 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -131.81 147.68 52.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.386 -0.821 . . . . 0.0 109.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.96 143.17 38.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 160.29 15.72 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.648 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -60.19 -21.54 61.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.666 -0.646 . . . . 0.0 110.064 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.59 -29.81 25.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.97 -8.97 7.14 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.8 mp0 -58.11 174.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.698 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -146.04 110.27 5.0 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.914 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.665 ' CD1' HG22 ' A' ' 133' ' ' VAL . 9.0 tt -106.11 146.32 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.76 141.96 51.44 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.639 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.49 171.99 7.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.3 mtp -152.75 165.11 36.35 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.583 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.23 152.99 39.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.48 97.46 1.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.627 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.95 -79.83 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.33 24.26 1.02 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 109.387 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -119.75 -179.72 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.83 117.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.374 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.59 ' HB2' HD22 ' A' ' 18' ' ' LEU . 6.4 t -98.93 133.95 42.47 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -125.61 125.73 43.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -122.38 101.54 7.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' A' ' 120' ' ' ILE . 48.8 t -68.18 136.95 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.403 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 28.3 m-85 -127.9 130.79 49.08 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.416 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.5 137.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -49.12 128.63 16.71 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.211 -0.931 . . . . 0.0 111.634 -178.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 tm-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.03 0 N-CA-C 110.685 -0.544 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.88 124.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.751 0.786 . . . . 0.0 110.213 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.556 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.6 m-85 -99.59 -2.74 34.9 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.634 -0.666 . . . . 0.0 109.441 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -70.53 118.5 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.944 . . . . 0.0 112.186 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.46 -172.08 38.46 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 36.0 m-20 -95.77 170.48 9.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.888 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.23 122.17 7.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.609 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -114.13 114.49 26.13 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.4 tt -57.68 153.64 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.928 0.87 . . . . 0.0 111.326 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.731 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.1 pp -127.25 -31.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.731 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -144.26 173.08 12.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.338 -0.851 . . . . 0.0 108.842 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.63 ' HB2' HD11 ' A' ' 9' ' ' ILE . 11.8 t 179.94 165.29 1.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.303 -0.873 . . . . 0.0 109.715 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -159.99 163.12 34.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.748 -0.595 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 12.0 m120 62.64 33.3 15.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.72 . . . . 0.0 109.719 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.949 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.7 -64.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 110.165 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 18.7 mt-10 -56.91 -33.82 67.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.869 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -70.71 -29.7 66.04 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.467 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' HB2' ' A' ' 130' ' ' CYS . 15.4 tp -77.61 -21.4 52.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.037 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.982 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -88.99 -16.13 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.036 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -86.14 -32.6 21.2 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -75.14 -38.91 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.7 mp -69.28 -45.63 69.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.797 0.808 . . . . 0.0 109.476 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.8 -159.56 27.66 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.4 m -146.63 -38.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.963 -0.728 . . . . 0.0 110.051 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.6 t-20 -61.28 -156.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.422 -0.799 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.45 -47.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.429 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 31' ' ' ILE . 2.5 ttt -68.01 -27.98 67.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -59.94 -16.96 34.17 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.684 -0.635 . . . . 0.0 111.243 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.4 mpt_? -97.11 -50.14 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.009 . . . . 0.0 110.048 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -23.38 67.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.73 . . . . 0.0 110.717 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.57 HD11 ' HG2' ' A' ' 27' ' ' MET . 74.3 mt -77.17 -28.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 108.768 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.91 -25.15 35.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.5 t -76.06 -37.98 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.88 46.33 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.57 92.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -70.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t 48.51 52.62 13.41 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.497 0.665 . . . . 0.0 109.763 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 66.23 70.39 0.52 Allowed Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.0 Cg_endo -72.87 164.55 35.25 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.988 1.792 . . . . 0.0 111.027 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.36 173.77 6.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 HG23 ' A' ' 54' ' ' THR . 47.9 t -154.8 166.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.9 tt0 -154.38 110.24 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.888 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.8 mt -97.33 133.52 38.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.845 0.831 . . . . 0.0 110.298 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 6.8 mttm -107.94 93.79 4.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.72 125.53 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.4 -0.813 . . . . 0.0 110.373 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.45 59.36 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.64 -130.05 10.15 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.65 -2.42 26.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.394 -1.062 . . . . 0.0 110.209 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -96.93 137.05 36.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.571 -1.331 . . . . 0.0 108.269 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.648 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 97.5 m-85 -135.35 125.97 27.05 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.69 0.757 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.3 t80 -108.74 143.06 38.37 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -130.05 106.54 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 106.21 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 41' ' ' VAL . 15.1 m -99.22 146.82 25.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 108.896 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.7 p -142.69 134.31 26.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.433 -0.792 . . . . 0.0 110.323 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -115.53 -65.1 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.87 0.843 . . . . 0.0 108.829 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.75 HG23 HG23 ' A' ' 58' ' ' VAL . 3.1 t 175.78 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.75 HG23 HG23 ' A' ' 57' ' ' THR . 35.0 t -118.66 -10.2 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.663 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -101.12 -85.89 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.994 -1.066 . . . . 0.0 109.322 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 3.2 m 67.81 90.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.887 . . . . 0.0 110.104 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -119.65 171.44 8.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -160.93 157.09 25.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.717 HD11 HG13 ' A' ' 52' ' ' ILE . 29.7 pt -144.22 170.72 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.56 -0.712 . . . . 0.0 109.157 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.1 p-10 -161.6 134.65 6.23 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.8 p90 -162.96 -173.23 3.37 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.289 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -127.88 153.0 47.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.72 95.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.257 -0.902 . . . . 0.0 109.666 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.85 -24.57 1.63 Allowed Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.815 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -124.57 155.57 38.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.296 -1.12 . . . . 0.0 110.229 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -86.18 168.02 14.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.47 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.58 174.35 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.617 -0.677 . . . . 0.0 109.717 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -103.04 144.93 30.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -176.04 4.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.655 -0.653 . . . . 0.0 109.513 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -99.88 156.98 16.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.721 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.58 -143.82 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.375 -0.828 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.4 t -111.59 -21.07 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.825 -1.172 . . . . 0.0 110.876 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.594 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -89.03 -39.84 13.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.649 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 46.89 0.09 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 75' ' ' THR . 7.4 mmm180 -136.3 151.99 74.28 Favored Pre-proline 0 C--N 1.306 -1.308 0 O-C-N 121.759 -0.847 . . . . 0.0 109.353 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.643 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -79.07 141.76 16.73 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.764 1.643 . . . . 0.0 110.512 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 p -161.01 142.26 11.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.666 -0.646 . . . . 0.0 109.707 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.579 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.8 ttpt -86.68 117.65 25.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.24 164.48 12.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.845 -0.534 . . . . 0.0 109.731 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' CA ' ' A' ' 70' ' ' GLU . 62.5 tp -144.24 153.81 42.44 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG21 ' CE2' ' A' ' 65' ' ' PHE . 29.0 t -147.09 130.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 118.5 -1.28 . . . . 0.0 112.108 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -125.04 157.85 35.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.544 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.8 m95 -79.82 172.26 14.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -135.68 -45.85 0.67 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.8 p -131.47 -154.18 0.61 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -76.59 -25.13 53.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.666 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -144.36 26.88 1.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.823 . . . . 0.0 110.817 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 51.9 tttt -130.75 110.86 11.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.901 -1.124 . . . . 0.0 108.154 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.657 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -115.5 146.96 41.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.446 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -100.18 170.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.467 ' H ' HG12 ' A' ' 94' ' ' VAL . 52.2 t -146.38 140.94 26.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.739 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.7 162.8 14.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -160.21 135.74 8.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 149.97 41.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.87 167.63 2.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 80' ' ' PRO . 46.7 mt -98.64 -6.55 29.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.02 143.66 19.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.77 -162.66 34.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.99 139.38 0.38 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.44 -1.035 . . . . 0.0 109.975 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.18 -85.84 0.05 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.86 -176.94 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.811 1.674 . . . . 0.0 109.721 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -135.29 139.67 44.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.14 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.139 0.971 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.3 m -163.01 139.1 7.1 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -142.64 173.25 11.71 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.037 -1.039 . . . . 0.0 110.568 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.746 HG22 HG13 ' A' ' 94' ' ' VAL . 16.0 p -137.58 172.65 12.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.909 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.408 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 11.6 ptp -160.11 136.34 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.6 pt-20 -135.41 154.76 51.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.237 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.551 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.71 144.36 42.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.7 p -91.18 159.95 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.406 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.73 -19.45 50.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.591 -0.693 . . . . 0.0 110.45 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.98 -28.54 21.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.3 -9.16 7.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 113' ' ' LEU . 60.8 mt-10 -57.63 172.67 0.34 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.082 -1.246 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.803 HD13 HD13 ' A' ' 43' ' ' ILE . 8.0 tt -147.13 112.15 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.251 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -108.52 148.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -131.35 137.99 48.99 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.363 -0.836 . . . . 0.0 109.684 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.54 170.75 8.02 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.8 mtp -147.65 168.19 22.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.573 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.1 m -151.85 150.94 30.67 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.712 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.9 94.21 1.42 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.534 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.9 -78.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -146.88 24.62 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.7 m -118.13 -179.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.33 119.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.827 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.875 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.46 123.25 43.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.4 m -116.61 148.04 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -151.94 120.37 6.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 50.3 t -82.38 137.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.005 . . . . 0.0 108.351 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.8 m-85 -127.28 124.99 40.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.351 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.64 139.85 28.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.12 125.72 11.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.176 -0.952 . . . . 0.0 111.193 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.942 -1.028 . . . . 0.0 111.607 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.0 0 N-CA-C 110.455 -0.633 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -154.2 123.67 6.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.5 m-85 -98.86 -1.78 39.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.712 -0.617 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 t -70.9 116.61 11.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.144 -0.972 . . . . 0.0 112.011 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.45 -172.83 39.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 32.9 m-20 -95.8 168.23 10.78 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.67 124.65 8.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.566 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -118.83 112.59 19.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.436 HD12 ' HD2' ' A' ' 132' ' ' ARG . 5.7 tt -54.25 143.92 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.626 0.727 . . . . 0.0 110.882 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.61 -24.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.999 -0.438 . . . . 0.0 109.936 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.05 174.24 10.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.282 -0.886 . . . . 0.0 110.069 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t 170.2 168.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.62 28.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.91 -1.119 . . . . 0.0 111.654 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.53 29.65 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -178.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.869 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.05 -66.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -0.851 . . . . 0.0 108.752 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' HG21 ' A' ' 33' ' ' VAL . 15.4 mt-10 -55.97 -31.1 62.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -61.29 -38.46 86.88 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.129 0.49 . . . . 0.0 110.469 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.675 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.3 tp -80.17 -17.45 52.41 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.717 -0.614 . . . . 0.0 110.137 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.3 mt -89.67 -17.65 27.96 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.088 -1.007 . . . . 0.0 109.013 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -84.05 -32.19 24.98 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -76.28 -40.21 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.84 -46.28 72.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.838 0.827 . . . . 0.0 109.6 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.16 -157.01 27.16 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.341 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.8 m -148.78 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 122.037 -0.684 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.5 t-20 -61.65 -156.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.474 -0.767 . . . . 0.0 109.132 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.97 -47.09 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 109.695 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 ttp -68.16 -28.36 67.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -59.49 -23.79 63.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.811 -0.556 . . . . 0.0 110.64 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -91.33 -46.91 7.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.905 . . . . 0.0 109.727 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -62.15 -20.88 64.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.664 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.54 -28.92 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.261 -0.9 . . . . 0.0 108.925 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.95 -26.05 34.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -76.48 -41.21 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.62 64.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 57' ' ' THR . . . -63.99 -40.92 97.47 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.554 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.43 -66.19 0.59 Allowed 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.566 -0.708 . . . . 0.0 109.289 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m 52.83 57.64 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 66.71 73.61 0.38 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.0 Cg_endo -70.91 153.39 63.69 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 122.167 1.912 . . . . 0.0 111.003 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -105.28 174.02 6.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.698 -0.626 . . . . 0.0 109.464 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.691 HG22 HG23 ' A' ' 54' ' ' THR . 47.2 t -154.86 165.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.1 tt0 -149.7 112.47 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -97.81 133.88 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.806 0.812 . . . . 0.0 110.264 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.05 106.29 14.23 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 61.2 tt0 -97.55 126.43 42.83 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.078 -1.014 . . . . 0.0 111.36 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -125.76 55.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -126.94 8.62 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.53 -0.33 22.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 110.12 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -97.22 139.98 32.38 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.72 -1.237 . . . . 0.0 108.498 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.7 m-85 -134.57 118.27 17.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.536 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.2 t80 -102.78 144.98 30.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 63' ' ' ILE . 3.3 mt -140.67 101.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -98.92 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.572 -0.705 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.691 HG23 HG22 ' A' ' 41' ' ' VAL . 12.8 m -99.38 141.01 32.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.55 118.92 17.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 110.434 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -99.2 -170.75 1.96 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 58' ' ' VAL . 5.7 t -52.68 -42.66 64.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.571 -0.706 . . . . 0.0 111.33 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.519 HG23 HG23 ' A' ' 57' ' ' THR . 39.9 t -130.09 -6.83 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.395 -0.815 . . . . 0.0 112.168 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -109.32 173.13 6.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.011 -1.056 . . . . 0.0 110.447 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -164.69 95.17 0.71 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -95.66 175.43 6.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.3 pm0 -171.35 142.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.045 HD11 HD12 ' A' ' 52' ' ' ILE . 31.7 pt -129.04 171.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.5 p-10 -161.89 130.58 4.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.178 -0.951 . . . . 0.0 109.217 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -162.07 -172.17 3.14 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 153.35 48.28 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.35 89.26 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.143 -0.973 . . . . 0.0 109.661 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.1 -23.26 0.99 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.938 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -122.02 154.94 36.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.55 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.4 mt-10 -86.26 165.56 16.37 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.18 173.93 13.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.866 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -102.28 146.74 27.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.5 pt-20 -162.53 -175.49 4.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 109.408 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -101.01 155.65 17.86 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.9 t -93.89 -143.75 0.24 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.354 -0.841 . . . . 0.0 109.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 23.3 t -112.67 -19.87 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.807 -1.183 . . . . 0.0 110.638 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.631 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t70 -88.04 -40.89 13.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.44 44.77 0.1 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.698 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mmm180 -135.98 154.13 77.42 Favored Pre-proline 0 C--N 1.308 -1.229 0 O-C-N 121.654 -0.91 . . . . 0.0 109.095 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.23 144.61 20.92 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.7 1.6 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.5 p -161.24 141.75 11.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.688 -0.633 . . . . 0.0 109.616 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.677 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.4 tttp -88.02 117.21 26.73 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.0 t -99.94 168.11 10.07 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.207 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' HG2' ' A' ' 70' ' ' GLU . 62.0 tp -150.61 152.99 34.89 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.9 t -144.08 135.88 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.236 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -128.3 159.23 35.93 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.598 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.6 m95 -84.97 167.3 16.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 110.062 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.4 tp10 -129.79 -45.61 1.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.6 p -131.83 -154.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.31 -25.38 51.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -142.67 26.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.898 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 46.4 tttm -131.41 104.96 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 108.302 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.2 ptp -112.22 147.55 35.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.581 -0.699 . . . . 0.0 110.221 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 110' ' ' THR . 1.6 t -103.57 169.05 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.9 t -144.55 140.76 29.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.169 -0.957 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -109.55 160.73 15.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 176.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -158.95 139.6 12.57 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.433 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -143.53 150.56 39.07 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.42 166.39 3.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.7 mt -99.74 -4.24 31.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.95 130.68 15.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 108.672 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.49 -159.46 45.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -176.82 141.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.469 -1.018 . . . . 0.0 109.713 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.29 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.46 -176.78 2.91 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.804 1.669 . . . . 0.0 109.752 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -131.95 142.8 49.74 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.2 146.32 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.85 126.75 2.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -130.86 163.94 26.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.136 -0.977 . . . . 0.0 110.39 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 94' ' ' VAL . 21.6 p -130.02 166.44 20.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.548 ' HE3' HD11 ' A' ' 52' ' ' ILE . 11.2 ptp -150.01 117.75 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 151.98 28.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.433 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.499 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -117.06 143.12 46.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.4 p -94.35 178.46 5.61 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.932 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -75.76 -24.15 56.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.641 -0.662 . . . . 0.0 110.448 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.73 -19.64 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.741 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 119.41 -5.13 13.27 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.1 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.48 177.99 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 118.924 1.362 . . . . 0.0 108.439 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.605 HD11 ' HD2' ' A' ' 3' ' ' PHE . 7.8 tt -153.4 115.89 4.43 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.965 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.27 154.59 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.767 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -136.61 109.2 7.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -99.09 167.21 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 129' ' ' VAL . 38.4 mtp -145.93 164.35 32.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.552 -0.717 . . . . 0.0 109.603 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.89 152.67 39.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.73 94.94 1.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.537 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.52 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -148.11 23.72 1.06 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.57 -0.706 . . . . 0.0 109.382 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.3 m -120.23 -179.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.46 117.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.456 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.675 ' CB ' HD22 ' A' ' 18' ' ' LEU . 10.7 t -99.37 111.7 24.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 122' ' ' THR . 75.1 m -99.26 152.74 19.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.866 0.841 . . . . 0.0 109.469 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.436 ' HD2' HD12 ' A' ' 9' ' ' ILE . 27.7 mtm180 -151.88 94.83 2.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.61 128.74 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.5 m-85 -115.82 133.88 55.58 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.491 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.85 137.75 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.479 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.9 mtm180 -47.38 124.22 6.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.387 -0.821 . . . . 0.0 111.468 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.755 179.816 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.502 1.983 0 N-CA-C 110.207 -0.728 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -143.15 115.17 8.31 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.708 0.766 . . . . 0.0 110.436 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.5 m-85 -111.58 0.54 16.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -72.95 117.5 14.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 112.13 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.86 -171.74 37.86 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 169.39 10.05 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.38 118.6 6.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.591 -177.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -110.51 113.74 26.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.736 HG21 ' HD2' ' A' ' 39' ' ' PRO . 11.1 tt -55.61 157.78 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.921 0.867 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.798 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.81 -32.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.497 179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.798 ' HB2' HD12 ' A' ' 10' ' ' ILE . 4.1 ttp180 -146.13 170.33 16.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 108.812 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.6 t 177.64 141.24 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -136.58 178.44 7.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.701 -0.625 . . . . 0.0 109.875 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.1 m120 58.86 26.59 15.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.728 . . . . 0.0 109.99 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -65.55 -62.95 1.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.822 . . . . 0.0 109.072 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 8.4 pt-20 -58.73 -29.13 66.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.643 -0.661 . . . . 0.0 109.565 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.01 -39.61 93.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.738 -0.601 . . . . 0.0 110.235 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.748 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.6 tp -82.02 -13.97 56.6 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.708 -0.62 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.34 -20.27 22.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.931 -1.106 . . . . 0.0 109.11 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.5 mtmt -83.32 -29.58 28.18 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 14.6 p -78.79 -41.82 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.66 -56.39 10.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 122.381 1.086 . . . . 0.0 108.523 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -103.59 -145.84 15.6 Favored Glycine 0 N--CA 1.489 2.221 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.79 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.0 m -156.29 -37.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.706 . . . . 0.0 110.364 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.51 -175.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.204 -0.935 . . . . 0.0 110.126 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.5 t -116.3 -44.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.554 -0.716 . . . . 0.0 109.574 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.449 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.1 ttp -65.41 -24.75 67.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.8 mm? -64.11 -40.14 95.56 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.675 -0.64 . . . . 0.0 110.57 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 33' ' ' VAL . 10.3 mtp180 -70.54 -48.33 55.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.379 -0.825 . . . . 0.0 110.139 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -55.72 -46.65 77.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.449 HD11 ' HG2' ' A' ' 27' ' ' MET . 48.7 mt -67.1 -26.07 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.801 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.25 -21.95 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.353 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.6 t -82.12 -44.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.29 91.63 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.63 -53.28 56.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.93 37.71 0.61 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.868 -0.52 . . . . 0.0 110.511 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 t -66.02 -34.09 77.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.796 -1.19 . . . . 0.0 108.501 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -157.27 69.68 4.37 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.736 ' HD2' HG21 ' A' ' 9' ' ' ILE . 29.7 Cg_endo -74.24 137.37 23.47 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 121.948 1.765 . . . . 0.0 110.2 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -85.57 166.86 15.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.583 -0.698 . . . . 0.0 109.37 -179.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.704 ' CG2' HG23 ' A' ' 54' ' ' THR . 16.0 t -154.34 127.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -117.9 111.02 18.45 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.5 mt -98.33 132.16 43.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.728 0.775 . . . . 0.0 110.334 -178.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttm -106.48 94.15 4.98 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.68 123.85 40.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.344 -0.848 . . . . 0.0 110.366 -177.251 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -132.61 68.17 1.51 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.11 -130.59 10.26 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.1 p30 -75.43 -1.6 24.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.357 -1.084 . . . . 0.0 110.388 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -95.98 139.28 32.4 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.701 -1.249 . . . . 0.0 109.003 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.9 m-85 -136.31 118.81 15.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.753 0.787 . . . . 0.0 108.951 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 16.2 t80 -104.41 150.85 24.17 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -149.35 104.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.895 -1.128 . . . . 0.0 111.288 -176.866 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -103.23 102.44 12.41 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.704 HG23 ' CG2' ' A' ' 41' ' ' VAL . 32.5 m -98.09 127.1 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.849 . . . . 0.0 109.359 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.8 OUTLIER -121.11 130.48 53.76 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.799 -179.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -98.64 -165.45 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.745 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 58' ' ' VAL . 6.8 t -57.57 -42.58 83.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.564 -0.71 . . . . 0.0 110.338 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 57' ' ' THR . 22.3 t -134.35 -2.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.534 -0.729 . . . . 0.0 111.87 -178.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -109.44 -178.42 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.92 -1.113 . . . . 0.0 109.804 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' THR . 12.1 m -162.13 162.17 28.41 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.692 -0.63 . . . . 0.0 109.677 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 60' ' ' THR . 3.1 p -156.86 156.41 33.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.45 109.19 2.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 110.247 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 52' ' ' ILE . 40.0 pt -113.5 164.32 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.8 p30 -162.44 132.25 4.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.131 -0.981 . . . . 0.0 109.497 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.764 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.7 p90 -161.87 -171.42 2.89 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.224 1.011 . . . . 0.0 111.83 -178.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.85 154.72 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.28 93.9 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.09 -1.006 . . . . 0.0 109.657 -178.415 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.26 -19.46 0.63 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.683 -1.246 . . . . 0.0 111.298 179.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -134.9 160.7 37.42 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.121 -1.223 . . . . 0.0 111.205 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.769 ' HG3' HD13 ' A' ' 84' ' ' LEU . 3.7 mt-10 -86.63 164.83 16.6 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.1 p90 -162.2 173.62 14.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -102.1 144.53 30.56 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.617 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.36 -176.67 5.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.62 . . . . 0.0 109.363 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.27 157.3 16.7 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.4 t -93.05 -144.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -0.867 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.2 t -107.75 -22.2 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.856 -1.152 . . . . 0.0 110.571 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.637 ' H ' HG23 ' A' ' 75' ' ' THR . 19.9 t0 -86.62 -47.71 8.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 108.955 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -132.1 151.69 78.86 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.671 -0.899 . . . . 0.0 109.226 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.3 Cg_endo -78.35 140.5 17.36 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.618 1.545 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.3 p -161.05 142.38 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HB2' HD21 ' A' ' 100' ' ' LEU . 4.5 tttt -88.25 118.56 27.93 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -99.57 168.08 10.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.496 0.665 . . . . 0.0 110.459 -178.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.769 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.2 tp -148.0 149.95 33.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.764 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.3 t -141.78 134.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.111 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.9 pttt -130.47 161.83 30.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.582 ' CE2' HG21 ' A' ' 67' ' ' VAL . 85.0 m95 -85.44 170.27 12.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.63 -45.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -132.9 -153.18 0.53 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.97 -23.78 44.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -143.0 22.26 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.834 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 73.1 tttt -130.78 111.81 12.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.832 -1.167 . . . . 0.0 108.639 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.489 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 3.7 ptp -116.0 154.97 28.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.601 -0.687 . . . . 0.0 109.981 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 110' ' ' THR . 1.8 t -108.92 168.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.41 132.81 20.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -104.02 158.11 16.64 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -154.76 142.04 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.91 -177.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -144.0 150.87 38.94 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.59 168.17 2.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 110.783 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 80' ' ' PRO . 33.2 mt -99.79 -5.29 28.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -153.99 138.7 17.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 108.84 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.63 -158.79 39.56 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -176.33 140.55 0.39 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.475 -1.015 . . . . 0.0 109.888 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.83 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.96 -176.7 2.75 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.822 1.681 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -134.31 137.24 44.07 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.69 145.81 47.64 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.123 0.963 . . . . 0.0 110.854 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.41 131.56 4.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.23 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -134.98 169.78 16.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.364 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 94' ' ' VAL . 22.7 p -134.34 170.17 16.13 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.5 0.667 . . . . 0.0 109.817 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.552 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.6 ptm -153.05 124.38 7.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -119.05 152.39 36.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.431 -0.793 . . . . 0.0 110.185 -178.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.77 144.43 44.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.8 p -89.87 167.12 13.08 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.802 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -63.81 -20.36 65.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.647 -0.658 . . . . 0.0 110.687 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.35 -32.66 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.06 -13.24 2.84 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.704 -1.236 . . . . 0.0 111.336 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -53.11 170.89 0.08 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 118.828 1.314 . . . . 0.0 109.345 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.9 tt -147.36 114.23 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.725 -178.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.19 158.62 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.81 134.37 30.08 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.393 -0.817 . . . . 0.0 109.57 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.0 170.04 8.57 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.496 ' O ' HG22 ' A' ' 129' ' ' VAL . 17.6 mtp -147.8 164.53 33.34 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.178 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.4 m -148.46 151.97 36.11 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.448 0.642 . . . . 0.0 109.434 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.35 96.88 1.45 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.518 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.86 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.44 24.41 1.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.559 -0.713 . . . . 0.0 109.268 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -118.87 -179.29 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.78 118.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.651 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.748 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.33 115.57 28.72 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.6 m -110.8 147.63 34.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 -179.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 120.74 6.34 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.78 142.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -129.39 133.28 47.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.59 139.31 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.1 125.29 10.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.244 -0.91 . . . . 0.0 111.33 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.602 179.466 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.009 0 N-CA-C 110.306 -0.69 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -152.84 124.28 7.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.747 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.702 ' HB3' HG21 ' A' ' 43' ' ' ILE . 6.3 m-85 -99.37 -10.92 21.66 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.712 -0.617 . . . . 0.0 109.576 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 t -65.71 115.39 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.219 -0.925 . . . . 0.0 111.819 -177.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.78 -172.71 39.73 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.71 168.49 10.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 178.062 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.926 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.72 124.63 8.57 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.375 -177.288 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -118.91 112.95 20.29 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.571 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.6 tt -57.11 140.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.41 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -120.95 -23.18 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.9 -0.5 . . . . 0.0 110.055 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -139.42 172.81 12.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t 171.29 168.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.15 29.97 0.12 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.948 -1.095 . . . . 0.0 111.713 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.09 33.55 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.285 -0.884 . . . . 0.0 109.082 -178.51 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -65.7 -66.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -0.784 . . . . 0.0 108.979 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 pt-20 -57.5 -26.73 61.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -64.3 -39.66 94.36 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.65 -0.656 . . . . 0.0 109.706 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.4 tp -80.17 -15.3 57.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.697 -0.627 . . . . 0.0 110.016 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.6 mt -90.05 -19.8 23.96 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.976 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmt -84.98 -28.15 25.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -79.82 -41.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.716 HD21 HG13 ' A' ' 76' ' ' VAL . 4.4 mp -65.93 -53.71 35.79 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.04 0.924 . . . . 0.0 109.114 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 -151.62 23.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.56 -42.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.981 -0.717 . . . . 0.0 109.407 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -56.37 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.793 . . . . 0.0 109.681 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.618 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.2 m -113.2 -43.77 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.03 -26.69 66.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.532 -0.73 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -57.61 -45.26 85.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.681 -0.637 . . . . 0.0 110.491 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.904 ' O ' HG23 ' A' ' 33' ' ' VAL . 4.2 mtp180 -67.34 -40.95 85.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -62.75 -24.38 67.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.678 -0.639 . . . . 0.0 110.838 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 28' ' ' LEU . 34.2 mt -78.67 -28.81 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.062 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.952 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.92 34.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 109.237 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.9 t -79.22 -38.72 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.67 -35.65 62.81 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.03 -37.58 81.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.1 -67.7 0.43 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t 49.87 50.46 18.38 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm 66.3 74.19 0.37 Allowed Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.6 Cg_endo -71.72 146.21 48.09 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 122.01 1.807 . . . . 0.0 110.797 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -92.56 175.48 6.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.765 -0.584 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.547 ' CG2' HG23 ' A' ' 54' ' ' THR . 24.7 t -155.31 165.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.9 tt0 -149.88 112.87 4.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.926 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.7 mt -99.85 140.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.806 0.812 . . . . 0.0 110.443 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.9 mttt -119.14 114.37 22.36 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 57.1 tt0 -98.9 111.61 23.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.0 110.786 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -115.57 47.95 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.18 -127.57 9.07 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.4 p30 -74.85 -3.28 31.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.444 -1.033 . . . . 0.0 110.048 178.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 m -96.39 134.9 38.97 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.689 -1.257 . . . . 0.0 108.309 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.9 m-85 -131.37 119.2 21.34 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.875 0.845 . . . . 0.0 109.22 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.0 t80 -104.61 133.16 49.92 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.791 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 mm -115.45 137.18 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.1 tttt -132.4 98.65 4.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.0 108.704 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.547 HG23 ' CG2' ' A' ' 41' ' ' VAL . 17.8 m -98.45 145.37 26.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.446 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.59 136.42 24.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.853 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -106.28 -66.54 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.848 0.832 . . . . 0.0 109.511 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.614 HG23 HG23 ' A' ' 58' ' ' VAL . 2.9 t -179.61 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.614 HG23 HG23 ' A' ' 57' ' ' THR . 46.4 t -113.77 -10.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -124.01 164.01 20.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.299 -0.876 . . . . 0.0 109.06 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.6 m -163.49 106.7 1.0 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.678 -0.639 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 152.83 19.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.409 -0.807 . . . . 0.0 109.123 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG3' ' CG ' ' A' ' 53' ' ' LYS . 1.2 mp0 -150.98 101.7 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.563 -0.711 . . . . 0.0 109.735 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -104.71 167.35 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.632 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.0 p-10 -161.78 132.49 5.07 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.483 -0.761 . . . . 0.0 109.064 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.3 p90 -161.88 -172.46 3.29 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.061 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.45 154.27 46.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.27 95.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -33.77 1.68 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.712 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.42 153.77 23.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.367 -1.078 . . . . 0.0 109.977 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' CA ' HD13 ' A' ' 84' ' ' LEU . 20.1 mt-10 -85.96 166.95 15.51 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.24 173.3 14.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.875 -178.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.13 145.04 30.52 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -178.21 6.24 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.573 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.62 155.2 17.72 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.8 t -91.66 -152.2 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 109.331 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.716 HG13 HD21 ' A' ' 22' ' ' LEU . 14.7 p -99.29 -20.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.992 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.716 ' H ' HG23 ' A' ' 75' ' ' THR . 1.8 t70 -88.61 -50.86 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.211 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.06 44.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 3.0 mmm-85 -130.67 152.01 79.72 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 121.613 -0.933 . . . . 0.0 109.127 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.54 141.05 17.36 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.581 1.521 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 p -161.07 142.02 11.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.7 ttmm -90.65 115.08 27.48 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -102.95 176.66 5.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.4 tp -152.36 152.15 31.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.5 t -140.87 125.54 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.543 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -120.47 156.0 32.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.525 ' NE1' HG21 ' A' ' 67' ' ' VAL . 83.8 m95 -77.91 172.28 13.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.805 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 6.9 tp10 -134.52 -46.61 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.9 p -129.27 -152.79 0.53 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.17 -24.98 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -143.3 25.68 1.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 29.0 tttm -131.06 108.29 9.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.82 -1.175 . . . . 0.0 108.211 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.506 ' HE3' HG13 ' A' ' 67' ' ' VAL . 1.6 ptm -114.47 148.21 38.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.366 -0.834 . . . . 0.0 110.239 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.861 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.66 172.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.502 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -148.37 129.81 14.82 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.21 141.35 12.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.9 -178.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -145.75 148.4 32.94 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 110.872 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 80' ' ' PRO . 35.6 mt -96.98 -7.09 33.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -154.18 146.31 23.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.839 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.73 -162.51 34.23 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -176.94 140.14 0.3 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -1.033 . . . . 0.0 109.798 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.92 -84.79 0.05 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.93 -176.79 2.8 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.883 1.722 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -137.74 139.22 39.99 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.24 146.04 47.65 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.072 0.939 . . . . 0.0 110.669 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -162.61 131.27 4.07 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -135.85 170.05 16.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.968 -1.082 . . . . 0.0 110.362 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 94' ' ' VAL . 18.5 p -133.55 165.33 25.14 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.462 0.649 . . . . 0.0 109.395 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.437 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.3 ptm -152.72 124.86 8.04 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.5 pt-20 -129.98 158.8 38.58 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.965 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -113.65 145.2 41.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.348 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 p -92.38 161.26 14.73 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.425 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.72 -18.62 55.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.528 -0.732 . . . . 0.0 110.515 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -88.39 -27.02 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.17 -7.87 8.58 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 113' ' ' LEU . 27.1 mt-10 -59.97 172.33 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.243 . . . . 0.0 108.579 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -145.64 113.11 6.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.065 -178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 12.5 tt -99.76 151.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -133.87 112.14 11.05 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.007 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.438 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -99.22 166.51 11.19 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.1 mtp -145.4 163.97 32.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.543 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.12 152.35 39.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.56 95.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.548 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 78.08 -79.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -147.64 23.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.7 m -120.25 -179.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.16 117.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.594 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.825 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.7 t -99.6 112.64 24.84 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -99.2 153.81 18.64 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.847 0.832 . . . . 0.0 109.139 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.571 ' HB3' HD12 ' A' ' 9' ' ' ILE . 36.5 mtm180 -151.42 93.6 1.91 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.54 127.39 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.7 m-85 -114.79 130.34 56.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.239 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.24 138.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.57 124.12 6.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.307 -0.871 . . . . 0.0 111.391 -178.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.702 179.907 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.979 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -154.67 122.22 5.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.531 -0.73 . . . . 0.0 109.794 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.3 m-85 -99.59 -18.08 17.52 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -60.65 116.21 4.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 111.827 -177.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.33 -173.06 39.43 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -96.03 169.53 9.91 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -151.95 126.21 9.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.718 -176.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -117.36 113.08 21.59 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.54 ' C ' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -61.59 140.99 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.711 0.767 . . . . 0.0 110.236 -178.929 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 11' ' ' ARG . 2.5 pp -126.36 -22.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 10' ' ' ILE . 1.9 mmm180 -133.22 167.29 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.159 -0.963 . . . . 0.0 110.442 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 170.05 167.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -161.04 29.3 0.14 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.019 -1.05 . . . . 0.0 111.289 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.85 34.3 0.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.06 -65.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.534 -0.729 . . . . 0.0 109.235 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.2 mt-10 -58.65 -26.44 63.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.429 -0.795 . . . . 0.0 109.138 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.11 -38.12 89.92 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.717 -0.614 . . . . 0.0 109.841 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.5 tp -81.58 -16.28 52.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.686 -0.634 . . . . 0.0 110.033 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' HB3' ' A' ' 32' ' ' ALA . 9.4 mt -89.67 -19.25 25.07 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -85.84 -29.09 24.01 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.651 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.9 p -78.5 -41.25 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.0 -52.51 48.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.001 0.905 . . . . 0.0 108.905 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.32 -147.58 19.63 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.4 m -154.91 -41.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.927 -0.749 . . . . 0.0 109.531 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.4 t-20 -57.68 -171.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.536 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH1' ' A' ' 29' ' ' ARG . 7.0 m -116.14 -43.91 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 110.077 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.81 -29.52 68.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -55.39 -46.31 76.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 mtp180 -64.49 -39.75 94.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.429 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -63.41 -15.68 58.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.575 . . . . 0.0 111.22 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mm -84.2 -30.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 108.709 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.36 32.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.0 t -80.4 -44.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.49 85.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -48.95 77.65 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 56' ' ' THR . . . -49.87 -72.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.954 -0.466 . . . . 0.0 110.439 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t 47.39 48.56 16.41 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.574 0.702 . . . . 0.0 109.171 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.2 mttp 71.19 73.23 0.26 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -177.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.6 Cg_endo -71.4 -179.54 3.72 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.053 1.836 . . . . 0.0 110.623 -178.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -123.36 172.56 8.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.464 -0.773 . . . . 0.0 110.401 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 54' ' ' THR . 41.2 t -155.31 166.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 tm-20 -155.47 111.33 3.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 108.768 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.2 mp -96.48 143.16 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.964 0.888 . . . . 0.0 110.151 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 2.7 mttm -119.73 108.66 14.69 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.42 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.3 tt0 -98.52 117.41 32.89 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.05 . . . . 0.0 110.993 -178.287 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -119.43 45.92 2.02 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.44 -127.41 9.13 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 p30 -73.93 -3.05 26.66 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -1.079 . . . . 0.0 110.045 178.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -96.73 133.98 40.58 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.623 -1.298 . . . . 0.0 108.196 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.5 m-85 -130.41 122.86 28.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.763 0.792 . . . . 0.0 109.164 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.2 t80 -106.03 140.46 38.99 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.835 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.95 110.88 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -107.79 100.56 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 41' ' ' VAL . 17.8 m -99.65 143.57 29.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 0.0 109.01 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.8 p -156.56 125.88 6.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 57' ' ' THR . 19.6 m -99.51 -64.77 1.01 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.705 -0.622 . . . . 0.0 110.021 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.771 HG23 HG23 ' A' ' 58' ' ' VAL . 3.8 t 179.94 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.771 HG23 HG23 ' A' ' 57' ' ' THR . 28.2 t -109.12 -16.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -127.74 162.42 26.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.444 -0.785 . . . . 0.0 108.984 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 55' ' ' SER . 88.0 m -162.71 115.75 1.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.301 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.6 p -106.76 160.87 15.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.04 136.62 14.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.314 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.835 HD11 HG13 ' A' ' 52' ' ' ILE . 27.2 pt -138.81 168.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.554 -0.716 . . . . 0.0 109.394 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.513 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.6 p-10 -161.51 132.78 5.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.5 p90 -162.05 -173.61 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.948 -1.101 . . . . 0.0 112.095 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -127.94 154.25 45.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.43 93.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.069 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.15 -23.64 1.58 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.727 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.87 156.99 35.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.279 -1.13 . . . . 0.0 110.119 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.593 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.1 mt-10 -86.61 169.58 12.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.693 -0.629 . . . . 0.0 109.357 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 11.8 p90 -162.41 174.24 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.371 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -111.43 143.11 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.4 pm0 -162.43 -168.66 1.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.449 0.642 . . . . 0.0 109.341 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -99.9 159.52 15.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.77 -144.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 109.02 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -107.33 -19.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.841 -1.162 . . . . 0.0 110.74 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.708 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -93.24 -44.93 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.17 45.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.739 ' H ' HG22 ' A' ' 75' ' ' THR . 4.6 mmm180 -132.67 152.57 80.17 Favored Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.634 -0.921 . . . . 0.0 109.232 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.73 140.41 16.48 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.707 1.605 . . . . 0.0 110.471 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.5 p -160.76 143.41 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.632 -0.667 . . . . 0.0 109.822 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.786 ' HB2' HD21 ' A' ' 100' ' ' LEU . 18.0 ttmt -90.9 120.3 31.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -103.52 168.43 9.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.671 -0.643 . . . . 0.0 110.299 -178.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.8 tp -147.54 153.2 39.17 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 13.3 t -145.46 126.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.962 -178.328 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -120.2 155.54 32.95 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.58 ' CD1' HG11 ' A' ' 67' ' ' VAL . 79.4 m95 -77.89 173.88 11.66 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.857 0.837 . . . . 0.0 110.27 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.73 -45.98 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -131.83 -153.41 0.55 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -25.6 52.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 110.042 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -143.93 27.38 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.817 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 9.3 tttt -132.39 110.73 10.76 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.448 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -117.41 149.86 39.85 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.285 -179.229 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.43 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.71 141.12 25.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.976 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.06 162.3 14.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.27 135.52 8.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.82 -178.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -142.47 154.21 44.34 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.21 169.38 5.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.041 -1.037 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.1 mt -101.47 -5.64 25.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.38 135.11 12.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.904 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.78 -160.46 37.62 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -175.86 139.2 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.426 -1.044 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.42 -88.38 0.09 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.13 -176.78 2.75 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.677 1.585 . . . . 0.0 109.368 178.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -131.53 141.31 49.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.94 145.02 48.85 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.141 0.972 . . . . 0.0 110.686 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -162.96 136.75 6.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.8 p-90 -144.54 175.57 10.04 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.522 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 7.8 p -139.61 171.83 13.68 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.499 0.666 . . . . 0.0 109.636 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.8 ptp -153.56 139.29 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -136.94 150.18 48.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 109.522 -178.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.1 140.91 48.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.464 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.2 p -89.72 160.15 16.72 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.471 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -60.18 -20.59 59.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 110.29 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.18 -29.74 24.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.232 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.52 -9.31 6.9 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -57.34 171.9 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.108 -1.231 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.2 tt -144.73 107.95 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.973 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.44 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.0 tt -103.4 147.65 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.72 145.33 51.91 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.467 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -120.55 162.34 19.77 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.185 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 22.0 mtp -143.99 162.1 37.05 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.324 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 129' ' ' VAL . 7.2 m -145.89 152.41 39.42 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.73 97.24 1.3 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.489 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.78 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.12 23.85 0.94 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.5 -0.75 . . . . 0.0 109.506 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -120.2 179.34 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.98 116.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.63 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.875 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.2 t -100.73 113.7 26.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.625 . . . . 0.0 109.576 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.0 m -103.11 128.92 49.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.413 -0.805 . . . . 0.0 109.312 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -126.56 102.89 7.3 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 120' ' ' ILE . 57.5 t -67.19 132.59 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -122.08 121.69 37.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.513 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.08 140.24 22.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.18 125.31 10.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.269 -0.894 . . . . 0.0 111.303 -178.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.667 179.582 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.501 1.966 0 N-CA-C 110.324 -0.683 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -175.36 126.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.691 . . . . 0.0 109.784 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.8 m-85 -99.16 -15.17 19.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -63.17 115.54 4.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -0.819 . . . . 0.0 111.597 -177.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.04 -172.04 39.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -96.14 169.2 10.12 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.842 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.1 120.89 7.04 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.619 -177.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -112.75 112.22 23.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.3 tt -56.0 141.67 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.667 0.746 . . . . 0.0 110.842 -178.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -121.71 -23.55 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.959 -0.463 . . . . 0.0 110.171 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.598 ' HG3' HD12 ' A' ' 10' ' ' ILE . 18.6 mtt-85 -143.73 170.64 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.877 . . . . 0.0 110.393 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t 170.65 167.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.02 31.83 0.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 111.988 -179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.13 29.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.075 -1.016 . . . . 0.0 109.803 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.97 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.59 -60.03 3.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.775 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' HG21 ' A' ' 33' ' ' VAL . 24.3 mt-10 -58.09 -29.07 65.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 111.283 -178.102 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 1.7 pt-20 -72.63 -27.39 62.11 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.734 -178.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.8 HD22 ' CB ' ' A' ' 130' ' ' CYS . 2.2 tp -83.34 -18.81 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 32' ' ' ALA . 14.1 mt -90.25 -16.18 29.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.11 -0.994 . . . . 0.0 109.094 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.8 -33.01 21.49 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.634 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.09 -40.53 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.8 mp -66.95 -48.06 69.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.883 0.849 . . . . 0.0 108.921 179.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.11 21.09 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' ASN . 24.3 m -154.8 -42.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.825 -0.809 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.7 t-20 -57.14 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 0.0 109.66 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.698 HG12 ' NH1' ' A' ' 29' ' ' ARG . 2.5 m -112.47 -43.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.813 . . . . 0.0 110.096 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -27.12 65.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -56.29 -48.13 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.669 . . . . 0.0 110.871 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.793 . . . . 0.0 110.213 -178.931 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.23 -23.49 64.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 111.615 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 48.1 mm -82.78 -27.5 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.052 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -26.41 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.265 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -79.1 -46.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.1 75.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 57' ' ' THR . . . -63.62 -44.95 92.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.46 -66.96 0.47 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.4 -0.812 . . . . 0.0 109.161 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 p 51.83 61.61 3.13 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.87 70.85 0.46 Allowed Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.972 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.2 Cg_endo -71.53 139.73 34.9 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 122.102 1.868 . . . . 0.0 110.857 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.39 176.5 7.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 HG23 ' A' ' 54' ' ' THR . 25.5 t -154.86 165.67 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.5 tt0 -154.05 113.2 3.72 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.842 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.3 mp -100.17 149.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.759 0.79 . . . . 0.0 110.19 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 4.3 mttt -129.01 106.4 8.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 66.7 tt0 -98.22 120.44 38.64 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 111.191 -177.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -123.76 49.14 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -130.17 10.14 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.62 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -75.15 -2.96 30.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.201 178.747 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -97.43 118.59 34.25 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.857 -1.152 . . . . 0.0 108.782 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 85.3 m-85 -114.11 127.57 55.98 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.867 0.842 . . . . 0.0 109.126 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' ILE . 19.8 t80 -109.58 147.13 33.54 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.792 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -133.46 138.07 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.234 -0.916 . . . . 0.0 108.636 -178.891 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.28 103.66 5.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.183 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.568 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.41 143.13 29.19 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.7 p -140.46 118.14 11.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.206 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 39' ' ' PRO . 70.5 p -99.17 -158.52 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 58' ' ' VAL . 6.7 t -56.2 -45.62 79.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 0.0 110.863 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 57' ' ' THR . 22.0 t -133.07 -7.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.33 -0.857 . . . . 0.0 111.974 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 ttp-105 -98.03 166.27 11.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.014 -1.053 . . . . 0.0 109.777 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 55' ' ' SER . 9.4 m -163.21 94.69 0.82 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.562 -0.711 . . . . 0.0 109.603 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -85.27 158.99 20.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -155.8 100.75 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 0.0 109.86 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.792 HD11 HG13 ' A' ' 52' ' ' ILE . 24.5 pt -101.78 168.27 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.516 -0.74 . . . . 0.0 109.33 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.509 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 10.6 p30 -163.02 135.3 5.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.438 -0.789 . . . . 0.0 109.603 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -162.61 -171.82 2.89 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.35 1.071 . . . . 0.0 112.358 -178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -129.79 153.24 48.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.637 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.44 95.5 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.157 -0.964 . . . . 0.0 109.542 -179.135 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.98 -31.65 1.45 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.684 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -117.09 157.34 26.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -1.077 . . . . 0.0 110.127 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG2' HD22 ' A' ' 84' ' ' LEU . 17.7 mt-10 -86.05 169.42 13.19 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.06 172.85 15.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 -179.079 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -104.11 144.35 31.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.25 -176.86 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.99 158.73 15.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.6 t -92.6 -144.07 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.418 -0.801 . . . . 0.0 109.109 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -106.42 -21.61 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.857 -1.152 . . . . 0.0 110.611 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.675 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 t70 -89.51 -46.93 8.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.414 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.47 44.71 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 75' ' ' THR . 3.9 mmm180 -129.95 152.41 79.9 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.572 -0.958 . . . . 0.0 108.994 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.83 140.69 16.48 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 121.696 1.597 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.05 141.81 11.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.514 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.2 ttpm? -88.2 117.07 26.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.1 t -99.63 166.53 11.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.847 -0.533 . . . . 0.0 109.809 -178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' HG2' ' A' ' 70' ' ' GLU . 52.1 tp -145.83 155.41 42.89 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.3 t -146.46 129.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.088 -178.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' HG12 ' A' ' 67' ' ' VAL . 2.7 ptpp? -123.85 161.74 24.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 67' ' ' VAL . 83.9 m95 -84.29 171.38 12.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.499 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -136.12 -45.31 0.64 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -132.78 -154.51 0.62 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.19 -26.49 56.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.786 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -143.68 29.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.794 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 28.5 tttt -132.3 109.26 9.76 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.637 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.2 ptp -115.09 147.69 39.88 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.665 0.745 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 110' ' ' THR . 2.9 t -99.88 172.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.504 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.4 t -146.79 141.88 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.922 . . . . 0.0 110.951 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.72 162.04 14.83 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -160.45 133.87 6.82 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.597 -178.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 150.05 39.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.07 167.3 1.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.869 -178.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD12 ' HB2' ' A' ' 80' ' ' PRO . 37.2 mt -94.35 -9.28 36.34 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -156.93 156.28 32.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 108.927 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.31 -160.15 17.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -176.24 139.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.484 -1.01 . . . . 0.0 109.837 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.64 -84.13 0.05 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.54 -177.05 3.0 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 121.938 1.758 . . . . 0.0 110.177 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -139.74 137.9 35.48 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.37 145.89 49.18 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.109 0.957 . . . . 0.0 110.831 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.7 m -162.76 135.48 5.64 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.405 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.4 p-90 -141.92 175.62 9.58 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.942 -1.099 . . . . 0.0 110.686 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.684 HG22 HG13 ' A' ' 94' ' ' VAL . 11.4 p -138.01 173.23 11.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.479 0.657 . . . . 0.0 109.987 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.509 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.5 ptm -157.17 126.63 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -124.65 153.75 41.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.82 142.73 46.16 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.032 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.9 p -91.2 160.78 15.36 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.525 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -60.21 -21.0 61.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.457 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.07 -28.31 24.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -8.46 7.52 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 113' ' ' LEU . 47.1 mt-10 -58.19 171.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -1.223 . . . . 0.0 109.032 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.814 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.28 109.77 5.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.0 109.963 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -104.35 150.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -132.27 145.25 51.17 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.479 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.408 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -121.65 169.26 10.88 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.272 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.523 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.1 mtp -150.3 165.87 31.7 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.51 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.81 152.53 37.82 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.431 0.634 . . . . 0.0 109.367 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.17 97.92 1.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.607 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.57 -79.34 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.23 24.77 0.91 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.527 -0.733 . . . . 0.0 109.252 178.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.0 m -120.89 -179.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -156.36 118.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.754 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.8 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.5 t -99.67 118.81 37.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.5 m -111.37 130.38 55.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.908 . . . . 0.0 109.55 -179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -129.77 103.95 7.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 136.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -125.88 127.47 46.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.499 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.12 139.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 177.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.03 125.35 10.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.0 111.219 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.599 179.574 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.978 0 N-CA-C 110.28 -0.7 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.77 124.41 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 109.754 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -98.86 -3.91 34.28 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.9 p -72.13 119.98 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.112 -0.992 . . . . 0.0 112.194 -177.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.74 -173.56 37.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 43.9 m-20 -95.22 171.77 8.52 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 177.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.9 126.11 9.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.336 -176.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -116.28 111.52 20.25 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' C ' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -62.86 140.64 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.607 0.718 . . . . 0.0 109.711 -179.378 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.13 -23.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.19 162.77 32.02 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.195 -0.941 . . . . 0.0 110.745 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p 178.26 168.88 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 14' ' ' ASN . 2.6 pt-20 -161.35 26.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.91 -1.119 . . . . 0.0 111.443 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -161.65 29.06 0.13 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.488 -0.757 . . . . 0.0 108.986 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.897 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.56 -64.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.3 tt0 -57.0 -28.74 62.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.19 -35.96 82.69 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.773 -0.579 . . . . 0.0 110.375 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.671 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.5 tp -82.46 -17.34 45.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.637 -0.665 . . . . 0.0 110.363 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD11 ' CE1' ' A' ' 15' ' ' PHE . 8.1 mt -90.61 -18.29 25.41 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.763 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.4 mmmm -85.32 -29.54 24.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -77.69 -39.46 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -69.03 -46.56 67.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.781 0.801 . . . . 0.0 110.008 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -156.58 27.14 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.708 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -149.67 -36.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.985 -0.715 . . . . 0.0 110.477 -179.434 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -62.86 -148.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.473 -0.767 . . . . 0.0 109.466 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.28 -46.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.661 -1.274 . . . . 0.0 109.151 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.7 ttt -67.59 -33.52 75.17 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.7 mm? -57.31 -24.36 54.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.811 -0.555 . . . . 0.0 110.544 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.892 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.7 mtt180 -92.69 -48.4 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 110.181 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -63.93 -16.87 62.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.549 -0.719 . . . . 0.0 111.447 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.6 mm -85.7 -28.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.944 . . . . 0.0 108.634 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.73 34.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.8 t -80.17 -48.22 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.16 60.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.785 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.68 57.06 4.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.722 -0.611 . . . . 0.0 110.68 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -66.27 -36.22 82.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.7 -1.25 . . . . 0.0 107.793 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -155.14 72.51 5.68 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.75 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 33.5 Cg_endo -72.37 163.16 39.47 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.138 1.892 . . . . 0.0 111.168 -178.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -117.37 173.41 6.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.696 -0.627 . . . . 0.0 109.668 -179.424 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -155.4 165.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 41' ' ' VAL . 29.5 tt0 -152.52 109.12 3.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.5 mt -97.98 135.78 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.667 0.746 . . . . 0.0 110.22 -178.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -114.33 111.44 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.878 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -98.2 121.93 40.74 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.031 -1.043 . . . . 0.0 110.974 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -123.02 51.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.04 -127.96 9.16 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.9 p30 -74.97 -2.0 25.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 110.124 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -96.51 134.69 39.4 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.724 -1.235 . . . . 0.0 108.12 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.09 116.69 18.86 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.931 0.872 . . . . 0.0 109.416 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.6 t80 -102.29 148.2 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.655 HD12 HD11 ' A' ' 63' ' ' ILE . 1.2 mt -145.45 101.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.991 -1.068 . . . . 0.0 110.459 -177.397 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 3.3 ttmt -99.47 113.74 26.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.673 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 41' ' ' VAL . 29.4 m -101.42 143.29 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 115.45 11.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 109.955 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -98.47 -171.7 2.18 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.518 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.872 HG23 HG23 ' A' ' 58' ' ' VAL . 8.3 t -58.95 -37.55 77.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.671 -0.643 . . . . 0.0 111.186 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.872 HG23 HG23 ' A' ' 57' ' ' THR . 22.1 t -126.23 -7.34 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.339 -0.85 . . . . 0.0 112.161 -177.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -116.4 172.23 7.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.876 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.5 m -165.33 94.9 0.64 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.8 p -103.7 176.0 5.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -171.34 120.7 0.5 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.743 -0.598 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 73' ' ' GLU . 41.2 pt -109.01 171.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 11.1 p30 -162.58 134.61 5.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.165 -0.96 . . . . 0.0 109.361 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.95 -171.43 2.87 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.395 1.093 . . . . 0.0 112.5 -178.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -129.76 152.66 49.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.3 95.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -178.992 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -35.14 1.58 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.681 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -110.56 155.33 22.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -1.065 . . . . 0.0 109.999 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HD22 ' A' ' 84' ' ' LEU . 32.8 mt-10 -86.16 169.2 13.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.567 -0.708 . . . . 0.0 109.245 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.08 173.92 13.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.63 144.04 32.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -162.24 -177.34 5.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.298 -179.526 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.96 155.95 17.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -92.86 -143.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 28.6 t -110.92 -20.44 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.789 -1.195 . . . . 0.0 110.608 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.62 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 t70 -88.02 -40.99 13.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.92 . . . . 0.0 109.26 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.16 44.69 0.1 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mmm180 -133.02 151.89 78.75 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.619 -0.93 . . . . 0.0 109.323 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.732 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.97 141.76 16.91 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.737 1.625 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -161.03 143.26 12.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.734 -0.604 . . . . 0.0 109.46 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -88.67 117.16 27.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.9 t -99.78 166.36 11.13 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.283 0.564 . . . . 0.0 109.749 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG2' ' A' ' 70' ' ' GLU . 63.2 tp -148.77 150.76 33.65 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.7 t -141.92 127.18 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.024 -177.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.73 156.03 28.97 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.617 ' CD1' HG11 ' A' ' 67' ' ' VAL . 75.8 m95 -76.87 -175.04 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.576 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -142.68 -53.76 0.4 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.0 p -131.36 -152.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.54 -24.15 45.81 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 110.003 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -138.82 22.26 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 0.0 111.167 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -130.49 129.65 43.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.746 -1.221 . . . . 0.0 108.325 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -134.96 151.09 50.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.918 -179.622 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.752 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -103.31 171.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.2 t -147.91 133.2 18.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.3 -0.875 . . . . 0.0 110.82 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 4.7 pt-20 -105.95 153.28 22.2 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -151.36 140.53 21.24 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.939 -177.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -144.92 148.45 33.89 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.11 168.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.049 -1.032 . . . . 0.0 110.886 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.2 mt -93.78 -10.1 35.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.95 160.19 35.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.74 -161.58 22.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -176.72 138.62 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.427 -1.043 . . . . 0.0 109.941 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.94 -85.42 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.91 -176.73 2.54 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.932 1.755 . . . . 0.0 110.142 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -139.97 138.8 35.82 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.81 146.01 47.92 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.071 0.939 . . . . 0.0 110.778 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 m -162.38 129.89 3.84 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -136.39 171.05 15.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.092 -1.005 . . . . 0.0 110.608 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.752 HG22 HG13 ' A' ' 94' ' ' VAL . 13.3 p -134.06 176.0 8.98 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.472 0.653 . . . . 0.0 109.884 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.4 ' CE ' ' HG3' ' A' ' 93' ' ' MET . 3.0 ptt? -160.23 124.07 3.62 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.182 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -120.06 146.6 45.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.679 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.92 143.52 38.05 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.101 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.73 160.94 14.74 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.676 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.39 -22.67 63.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.646 . . . . 0.0 110.21 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.49 -29.22 28.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.164 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.29 7.22 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' O ' HD13 ' A' ' 113' ' ' LEU . 22.6 mt-10 -56.2 171.7 0.25 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.145 -1.209 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.697 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -146.4 110.16 4.9 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.995 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.5 tt -106.24 145.01 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -126.59 142.08 51.65 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.322 -0.861 . . . . 0.0 109.604 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -119.01 170.67 8.85 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.252 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 68.1 mtp -152.18 166.09 32.79 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.659 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.1 m -147.07 152.54 38.69 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.35 96.74 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.14 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.1 23.96 1.05 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 178.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.8 m -120.14 -179.2 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.27 117.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.589 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.671 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.6 t -99.25 132.64 44.43 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.424 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.7 m -124.96 126.16 45.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.36 -0.838 . . . . 0.0 109.436 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -123.15 100.4 6.85 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 120' ' ' ILE . 59.2 t -66.58 130.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.7 m-85 -120.1 132.25 55.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.404 -179.15 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.81 137.18 47.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.14 127.63 14.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.215 -0.928 . . . . 0.0 111.867 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.992 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.501 1.968 0 N-CA-C 110.3 -0.692 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -153.08 126.13 8.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.479 -0.763 . . . . 0.0 109.638 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.9 m-85 -99.11 -5.34 30.35 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.714 -0.616 . . . . 0.0 109.509 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 p -72.15 118.66 15.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 111.945 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.87 -173.36 38.21 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.4 m120 -95.45 171.87 8.43 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.918 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.2 m95 -150.73 125.35 9.64 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.482 -176.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -118.9 114.76 23.1 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.018 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 132' ' ' ARG . 11.0 tt -58.15 143.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.414 -179.063 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.15 -24.44 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.893 -0.504 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -150.16 176.32 10.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -0.912 . . . . 0.0 110.383 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t 176.56 167.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.56 26.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.2 m-20 -160.53 27.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.752 -0.592 . . . . 0.0 109.851 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.871 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.19 -66.36 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.854 . . . . 0.0 109.053 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.9 mt-10 -55.53 -31.56 62.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.446 -0.784 . . . . 0.0 109.476 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.61 -39.54 91.61 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.157 0.504 . . . . 0.0 110.506 -179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.769 HD22 ' HB2' ' A' ' 130' ' ' CYS . 17.0 tp -79.0 -16.88 56.3 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' A' ' 32' ' ' ALA . 4.8 mt -90.14 -18.92 24.91 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.055 -1.028 . . . . 0.0 109.077 179.23 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mtmm -82.3 -31.48 29.97 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 128' ' ' VAL . 13.6 p -77.84 -40.37 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.011 0.91 . . . . 0.0 108.714 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.32 -47.17 71.33 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.884 0.849 . . . . 0.0 109.428 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -151.31 24.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.323 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.1 m -153.74 -41.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.968 -0.725 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.3 t-20 -60.89 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.525 -0.734 . . . . 0.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 m -123.62 -46.84 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.809 179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.58 -29.39 68.73 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.0 mm? -58.34 -32.17 68.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.788 -0.57 . . . . 0.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.9 mpp_? -82.69 -44.29 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 109.903 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -61.96 -22.3 65.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 110.682 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mt -79.48 -28.54 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.0 109.04 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.925 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.06 -26.21 33.9 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.342 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.8 t -77.94 -39.83 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.65 -33.59 60.45 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.69 94.45 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.87 -67.48 0.43 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.618 -0.676 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 m 51.64 55.3 9.56 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mttm 66.69 73.51 0.38 Allowed Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.462 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.4 Cg_endo -70.99 153.92 63.08 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.024 1.816 . . . . 0.0 110.605 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.95 173.2 6.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.015 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 53.9 t -154.99 164.49 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.3 tm-20 -149.43 109.49 4.11 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.918 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -98.61 139.7 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 121.802 0.81 . . . . 0.0 110.605 -178.212 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.0 116.47 27.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.666 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.0 tt0 -98.77 116.52 31.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.123 -0.985 . . . . 0.0 110.837 -178.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -116.9 49.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.3 -125.84 8.19 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.6 p30 -75.78 -1.83 26.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -1.04 . . . . 0.0 110.023 178.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.56 138.91 33.43 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.787 -1.196 . . . . 0.0 108.434 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 92.5 m-85 -134.06 116.31 15.32 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.865 0.84 . . . . 0.0 109.431 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.9 147.75 26.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -143.45 105.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.289 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.23 112.09 24.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 109.466 179.041 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 34.4 m -102.54 141.09 35.93 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.48 140.99 39.42 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.129 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -110.41 -65.36 1.17 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.841 0.829 . . . . 0.0 109.466 -179.825 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.622 HG23 HG23 ' A' ' 58' ' ' VAL . 2.4 t 179.21 -42.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.622 HG23 HG23 ' A' ' 57' ' ' THR . 40.2 t -113.87 -11.37 12.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -123.65 163.99 19.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.253 -0.904 . . . . 0.0 109.028 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m -163.0 100.02 0.97 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.59 -0.694 . . . . 0.0 109.258 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.55 165.27 16.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.731 . . . . 0.0 109.679 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -159.57 123.51 3.79 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.641 -0.662 . . . . 0.0 109.307 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 52' ' ' ILE . 39.7 pt -123.98 166.34 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.02 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.531 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.9 p-10 -162.19 129.45 3.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 109.052 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.0 p90 -161.65 -173.0 3.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.689 -1.204 . . . . 0.0 112.273 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 153.6 47.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 94.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.649 -178.997 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.72 -34.1 1.37 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.495 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -112.42 156.61 22.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.403 -1.057 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.498 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.1 mt-10 -86.39 169.16 13.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 -179.572 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 15.9 p90 -162.26 173.47 14.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.563 -0.711 . . . . 0.0 109.816 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.28 145.2 29.79 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -162.32 -176.17 4.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 109.528 -179.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -100.71 157.51 16.64 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -95.2 -143.13 0.26 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.862 . . . . 0.0 109.24 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' THR . 24.3 t -110.1 -22.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.754 -1.216 . . . . 0.0 110.814 -179.051 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.581 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -88.12 -40.27 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.589 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.38 45.1 0.1 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.709 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.32 152.1 78.76 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.714 -0.874 . . . . 0.0 109.046 -179.649 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.766 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.42 142.38 18.63 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.655 1.57 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.14 141.12 10.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 109.552 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 100' ' ' LEU . 8.7 ttmm -86.67 116.13 24.58 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.91 165.42 11.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.735 -0.603 . . . . 0.0 110.268 -178.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 70' ' ' GLU . 57.7 tp -145.69 153.84 41.43 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.7 t -146.17 125.13 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.728 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.1 156.05 29.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.4 m95 -78.03 174.84 10.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.876 0.846 . . . . 0.0 110.126 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -137.84 -46.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.2 p -130.51 -152.68 0.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.67 -28.35 51.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -141.04 28.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 27.3 tttt -132.69 111.52 11.23 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.439 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -118.36 150.17 39.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.25 -0.906 . . . . 0.0 110.398 -179.295 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.47 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.494 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.8 t -147.45 140.3 24.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 110.895 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.68 163.01 13.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -160.3 135.38 7.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.781 -1.167 . . . . 0.0 111.642 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -143.63 150.55 38.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.94 168.94 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.005 . . . . 0.0 110.842 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 80' ' ' PRO . 39.1 mt -99.04 -5.98 29.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.68 133.72 14.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.669 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.86 -157.37 38.94 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -176.15 139.97 0.39 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.438 -1.036 . . . . 0.0 109.915 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.0 -87.9 0.09 OUTLIER Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.018 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.36 -176.69 2.89 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.682 1.588 . . . . 0.0 109.474 178.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -130.46 136.31 48.87 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.95 144.41 48.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.151 0.977 . . . . 0.0 110.749 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.7 m -163.04 136.88 6.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.8 p-90 -142.49 174.83 10.28 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.436 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 94' ' ' VAL . 13.0 p -138.36 170.53 15.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.556 0.693 . . . . 0.0 109.801 -179.344 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.42 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.9 ptp -153.37 137.0 15.99 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -133.19 149.42 52.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.388 -0.82 . . . . 0.0 109.413 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -111.84 141.44 45.47 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 p -90.4 161.12 15.72 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.763 -179.295 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.33 -22.01 62.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -84.35 -29.19 26.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.284 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.63 -9.85 7.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.55 172.62 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.158 -1.201 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 43' ' ' ILE . 7.2 tt -145.08 108.38 4.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 109.974 -179.19 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -135.6 137.52 42.02 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.248 -0.907 . . . . 0.0 109.771 -178.986 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -114.65 168.59 9.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.974 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.505 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.7 mtp -147.55 167.86 23.43 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.636 -179.203 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.0 m -150.65 150.2 30.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.692 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.25 93.84 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.83 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -146.69 23.52 1.25 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.576 -0.702 . . . . 0.0 109.286 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 125' ' ' ALA . 23.2 m -117.14 -178.52 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.012 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.79 118.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.436 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.769 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.6 t -97.66 116.98 30.92 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.5 m -114.45 126.26 54.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -0.999 . . . . 0.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 9' ' ' ILE . 1.1 mtt-85 -133.22 107.76 8.36 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.04 135.4 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -123.36 126.12 46.26 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.274 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.48 138.48 33.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.496 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -49.96 128.22 18.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.242 -0.911 . . . . 0.0 111.559 -178.617 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.6 tm-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.762 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.001 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -157.08 126.82 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.532 -0.73 . . . . 0.0 109.666 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.3 m-85 -98.84 -9.8 23.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -65.37 118.09 8.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 112.293 -177.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.24 -172.84 37.57 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.63 171.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.818 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.22 120.01 7.08 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.891 -1.123 . . . . 0.0 112.613 -177.122 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -111.43 114.11 27.02 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' HD2' ' A' ' 39' ' ' PRO . 7.2 tt -56.26 155.45 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.907 0.861 . . . . 0.0 111.195 -178.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.41 -32.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.436 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -145.0 171.04 15.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.029 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t 179.52 157.44 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 109.335 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 170.74 19.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.616 . . . . 0.0 110.049 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 17.5 m120 61.04 29.99 19.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.476 -0.765 . . . . 0.0 109.887 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.812 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.7 t80 -65.55 -63.17 1.16 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.282 -0.886 . . . . 0.0 108.85 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 2.5 pt-20 -59.76 -28.35 67.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.736 -0.603 . . . . 0.0 109.641 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.73 -38.97 90.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.626 -0.671 . . . . 0.0 110.411 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.8 tp -83.12 -13.39 55.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.686 -0.634 . . . . 0.0 109.711 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -91.82 -20.96 20.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.959 -1.088 . . . . 0.0 108.952 179.572 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmm -83.37 -30.04 27.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 HG11 HD12 ' A' ' 18' ' ' LEU . 14.4 p -77.43 -41.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -66.41 -53.55 34.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.25 1.024 . . . . 0.0 108.865 179.251 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.06 -144.9 14.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.6 m -154.99 -38.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.901 -0.764 . . . . 0.0 110.244 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.1 t-20 -57.29 -171.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.248 -0.907 . . . . 0.0 109.779 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.677 HG12 ' NH1' ' A' ' 29' ' ' ARG . 4.8 m -121.12 -43.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.77 . . . . 0.0 110.112 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.0 ttm -67.83 -26.35 66.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.57 -0.706 . . . . 0.0 109.131 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.74 -49.2 78.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.704 -0.622 . . . . 0.0 110.525 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.886 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -66.03 -42.3 89.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.463 -0.773 . . . . 0.0 110.029 -178.87 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -57.52 -38.98 75.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.567 -0.708 . . . . 0.0 110.705 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.03 -26.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.429 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.51 -22.1 38.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.66 -0.65 . . . . 0.0 110.169 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -81.99 -45.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.25 91.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.27 71.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.35 42.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.547 179.15 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.8 t -64.97 -35.39 81.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.841 -1.162 . . . . 0.0 108.313 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -157.4 71.22 4.43 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.091 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.5 Cg_endo -73.57 146.33 38.89 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 122.012 1.808 . . . . 0.0 110.545 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -93.04 173.22 7.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.664 -0.648 . . . . 0.0 109.618 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 40' ' ' ALA . 4.7 t -153.53 165.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.2 tt0 -156.87 116.98 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.653 -0.654 . . . . 0.0 109.427 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.818 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.1 mp -107.21 138.04 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.582 0.706 . . . . 0.0 109.769 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 3.8 mttt -117.53 109.16 16.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.636 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.2 tt0 -98.1 117.07 31.63 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.07 -1.019 . . . . 0.0 111.113 -177.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.84 56.01 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.08 -126.37 8.39 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -77.79 -0.4 26.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.418 -1.048 . . . . 0.0 109.954 178.541 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 m -96.19 139.99 31.54 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.781 -1.2 . . . . 0.0 108.862 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.4 m-85 -136.66 117.44 14.06 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.774 0.797 . . . . 0.0 108.92 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 4.5 t80 -104.53 119.12 38.24 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG13 HD11 ' A' ' 63' ' ' ILE . 1.7 mm -99.84 146.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 120.785 -1.197 . . . . 0.0 107.991 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.8 tttt -145.11 102.58 3.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.93 . . . . 0.0 108.785 179.329 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 25.0 m -99.56 154.9 17.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.723 . . . . 0.0 109.486 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.69 116.0 6.59 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -98.53 -172.14 2.26 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.861 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.887 HG23 HG23 ' A' ' 58' ' ' VAL . 7.5 t -58.13 -38.1 75.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 111.214 -179.148 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.887 HG23 HG23 ' A' ' 57' ' ' THR . 21.4 t -127.75 -6.03 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.382 -0.824 . . . . 0.0 112.216 -177.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -117.18 175.26 5.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.034 -1.041 . . . . 0.0 110.763 -178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.6 m -164.72 105.12 0.82 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.01 169.53 8.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.395 -0.816 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.1 pt-20 -173.44 113.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 73' ' ' GLU . 37.5 pt -103.65 173.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.467 -0.77 . . . . 0.0 110.052 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.7 p-10 -160.68 130.34 5.02 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.2 p90 -162.38 -171.62 2.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.089 0.947 . . . . 0.0 111.448 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 15.4 ptmt -132.31 154.67 49.47 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.14 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.59 94.3 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -178.541 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.74 -23.02 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.865 -1.159 . . . . 0.0 110.607 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -136.41 163.59 30.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.296 -1.12 . . . . 0.0 110.727 -179.6 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.16 171.2 11.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.765 -0.584 . . . . 0.0 109.578 -179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.0 p90 -162.63 175.32 11.51 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.03 143.62 39.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 5.7 pm0 -162.16 -169.18 2.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 109.343 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -99.6 160.07 14.57 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.348 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -97.84 -143.72 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.386 -0.821 . . . . 0.0 109.227 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 27.4 t -110.78 -20.99 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.731 -1.23 . . . . 0.0 110.897 -179.143 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.603 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -90.39 -40.39 12.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.821 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.89 46.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 8.4 mmm180 -137.28 154.01 75.24 Favored Pre-proline 0 C--N 1.306 -1.292 0 O-C-N 121.743 -0.857 . . . . 0.0 109.269 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.734 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -79.34 142.94 17.05 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 110.439 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.6 p -160.66 142.41 12.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.0 ttpt -90.71 120.76 32.03 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 2.6 t -100.31 172.8 6.93 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.516 0.674 . . . . 0.0 110.347 -178.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.7 tp -148.7 152.72 37.14 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 65' ' ' PHE . 15.5 t -147.74 131.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 118.441 -1.304 . . . . 0.0 112.266 -178.059 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.64 161.23 29.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.0 m95 -84.36 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.923 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -134.84 -46.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -132.25 -153.66 0.57 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -24.77 47.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -142.16 24.76 1.95 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.8 tttm -130.77 111.85 12.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 0.0 108.522 179.622 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.576 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.06 149.42 38.96 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.628 0.728 . . . . 0.0 110.39 -178.876 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.608 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -101.88 171.74 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.495 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.4 t -149.12 138.29 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.915 . . . . 0.0 110.966 -179.498 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -108.59 163.39 13.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.154 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.65 139.69 10.46 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.873 -178.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -141.42 157.13 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.75 168.81 12.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 110.612 -179.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 80' ' ' PRO . 52.9 mt -101.65 -6.07 24.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 138.73 18.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.46 -156.86 41.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -176.87 140.08 0.31 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.567 -0.961 . . . . 0.0 109.603 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.46 -85.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.43 -177.11 3.06 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.88 1.72 . . . . 0.0 109.936 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -135.92 139.02 42.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.84 145.09 48.42 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.16 0.981 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.1 p -163.07 137.71 6.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CZ3' ' CE ' ' A' ' 111' ' ' MET . 61.7 p-90 -142.32 176.0 9.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.023 -1.048 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.608 HG22 HG13 ' A' ' 94' ' ' VAL . 7.3 p -140.41 174.46 10.49 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.817 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.602 ' CE ' HD12 ' A' ' 121' ' ' LEU . 2.4 mtm -157.16 128.5 6.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -124.35 146.83 48.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.529 -0.732 . . . . 0.0 109.63 -179.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.46 144.25 39.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.349 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.18 160.52 14.81 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.6 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.66 -21.61 62.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.171 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.99 -29.23 27.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 109.106 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.45 -9.39 7.34 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' O ' HD13 ' A' ' 113' ' ' LEU . 54.3 mt-10 -56.65 171.68 0.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -1.227 . . . . 0.0 109.293 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.738 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -146.25 112.03 5.63 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.149 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -106.72 147.7 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.602 HD12 ' CE ' ' A' ' 111' ' ' MET . 7.5 tt -129.43 147.96 51.3 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.193 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -127.96 163.37 24.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.616 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.474 ' O ' HG22 ' A' ' 129' ' ' VAL . 20.0 mtp -143.13 163.34 33.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.368 -179.23 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 129' ' ' VAL . 6.6 m -146.7 152.05 38.21 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.33 96.75 1.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.98 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.73 23.91 1.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.546 -0.721 . . . . 0.0 109.407 178.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -119.3 -179.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.03 117.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.716 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.3 t -98.89 112.08 24.29 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.455 ' OG1' HG22 ' A' ' 122' ' ' THR . 77.7 m -107.92 148.9 29.0 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.767 0.794 . . . . 0.0 110.074 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -151.0 118.18 5.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.32 138.97 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.123 -0.986 . . . . 0.0 108.385 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 22.5 m-85 -127.49 125.3 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.367 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.03 139.59 28.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.36 125.63 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.215 -0.928 . . . . 0.0 111.207 -178.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.515 179.578 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.971 0 N-CA-C 110.287 -0.697 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -152.59 128.12 10.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 5.1 m-85 -98.85 -8.1 26.29 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.7 p -69.6 118.09 12.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.209 -0.932 . . . . 0.0 111.938 -177.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.3 -171.54 37.34 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.1 m120 -95.59 169.94 9.69 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 177.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.945 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.67 120.43 7.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.643 -177.344 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -112.66 120.76 42.64 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.7 tt -64.56 151.97 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.845 0.831 . . . . 0.0 111.116 -178.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.03 -31.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -139.73 168.84 18.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 108.985 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.821 ' HB3' HD11 ' A' ' 9' ' ' ILE . 83.8 p -176.82 149.61 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.489 -0.757 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -148.2 163.64 36.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 14.8 m120 61.86 27.48 16.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.917 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.85 -65.47 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.588 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.8 pt-20 -58.01 -27.89 63.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.39 -34.83 79.22 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.553 -0.717 . . . . 0.0 110.018 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' A' ' 130' ' ' CYS . 18.4 tp -82.9 -18.58 39.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.729 -0.607 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.917 HD11 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -91.37 -16.81 26.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.909 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 mmmt -87.94 -28.49 21.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.156 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 12.6 p -76.77 -41.14 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.1 -54.6 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.99 -148.2 19.86 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 23' ' ' GLY . 15.8 m -157.28 -43.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.815 -0.815 . . . . 0.0 109.407 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.607 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 t-20 -54.28 176.07 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.472 -0.767 . . . . 0.0 109.516 179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.68 -43.68 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.6 ttm -62.74 -26.38 68.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 25' ' ' ASN . 3.8 mm? -64.8 -69.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.634 -0.666 . . . . 0.0 109.993 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.914 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -52.21 -38.32 57.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 110.62 -179.299 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -61.01 -39.33 89.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.61 -0.681 . . . . 0.0 110.373 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.82 -26.8 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.6 -26.02 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.6 t -75.9 -35.98 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.01 41.74 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.52 93.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.41 -69.49 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m 49.19 51.19 16.71 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.495 0.664 . . . . 0.0 109.46 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.3 mttt 65.38 72.31 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.3 Cg_endo -72.1 156.96 55.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.05 1.833 . . . . 0.0 110.613 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 41' ' ' VAL . . . -105.95 174.38 5.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.355 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 71.8 t -154.23 164.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.8 tt0 -149.68 108.61 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.2 mt -98.45 139.13 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.19 113.1 21.74 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.711 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.2 tt0 -98.48 118.38 35.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.07 -1.019 . . . . 0.0 110.976 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.38 52.45 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -124.44 7.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -178.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.4 p30 -76.31 -1.25 25.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.33 141.77 29.26 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 120.808 -1.183 . . . . 0.0 108.807 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 97.8 m-85 -137.3 115.52 11.73 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.839 0.828 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -101.43 147.5 26.28 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.09 107.52 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.197 -177.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.7 109.84 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.091 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 41' ' ' VAL . 22.6 m -99.36 135.86 40.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.37 121.01 26.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.25 -0.906 . . . . 0.0 110.314 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -99.29 -168.99 1.69 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.33 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.521 HG23 HG23 ' A' ' 58' ' ' VAL . 5.4 t -51.06 -42.54 60.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.504 -0.747 . . . . 0.0 111.008 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 57' ' ' THR . 22.1 t -134.14 -7.02 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.345 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.98 174.96 5.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.905 -1.122 . . . . 0.0 110.377 -179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 m -164.3 93.03 0.67 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.75 160.97 22.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -152.51 125.21 8.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 0.0 109.791 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 52' ' ' ILE . 37.9 pt -124.73 165.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.124 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.6 p-10 -162.72 129.03 3.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.001 -1.062 . . . . 0.0 109.887 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 85' ' ' VAL . 49.0 p90 -162.25 -171.87 2.98 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.734 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -132.06 155.91 47.24 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.689 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -83.47 91.63 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.109 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.78 -27.08 0.65 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.124 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HG2' ' CG ' ' A' ' 66' ' ' LYS . 4.9 pt-20 -124.77 159.09 31.73 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.182 -1.187 . . . . 0.0 110.3 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD22 ' A' ' 84' ' ' LEU . 33.8 mt-10 -86.82 166.23 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.2 173.6 14.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.686 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.97 146.12 28.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.37 -177.52 5.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.667 -0.645 . . . . 0.0 109.342 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.44 155.83 17.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.0 t -94.49 -142.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 39.5 t -113.71 -18.64 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.218 . . . . 0.0 110.64 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -89.39 -36.59 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.42 44.84 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.679 ' H ' HG22 ' A' ' 75' ' ' THR . 48.2 mtp180 -134.23 151.85 77.15 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.779 -0.836 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.809 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.8 143.4 18.49 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.658 1.572 . . . . 0.0 110.553 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -161.14 141.65 11.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.717 -0.615 . . . . 0.0 109.625 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.1 ttmm -88.32 116.74 26.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.4 t -99.47 168.08 10.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.428 0.632 . . . . 0.0 110.458 -178.241 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.56 HD22 ' HG2' ' A' ' 70' ' ' GLU . 60.2 tp -151.12 153.77 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.7 t -146.04 134.63 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.214 -177.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -126.17 157.4 38.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.558 ' CE2' HG21 ' A' ' 67' ' ' VAL . 84.6 m95 -81.58 171.05 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.098 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 19.2 tp10 -134.17 -45.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -132.31 -154.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -76.56 -25.52 54.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.18 27.69 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.825 . . . . 0.0 110.717 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 38.8 tttt -130.84 106.87 8.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 108.16 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.608 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.2 ptp -115.18 145.88 41.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 110' ' ' THR . 1.5 t -102.12 171.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.6 t -145.47 138.74 26.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.268 -0.895 . . . . 0.0 110.475 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 7.3 pt-20 -109.62 154.35 22.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.454 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -152.46 142.02 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.905 -177.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -143.6 153.32 42.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.66 169.3 3.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.092 -1.005 . . . . 0.0 110.527 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 80' ' ' PRO . 47.2 mt -98.07 -7.93 28.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -155.14 145.31 21.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 108.946 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.04 -158.71 37.51 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.54 140.41 0.36 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.505 -0.997 . . . . 0.0 109.743 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.43 -85.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.99 -176.9 2.83 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.872 1.714 . . . . 0.0 109.905 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -137.92 138.95 39.52 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.99 145.97 48.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.024 0.916 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -162.49 131.1 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -136.16 167.26 21.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.123 -0.986 . . . . 0.0 110.839 -179.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 HG13 ' A' ' 94' ' ' VAL . 21.5 p -131.63 169.77 15.7 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.386 0.612 . . . . 0.0 109.9 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.629 ' HB3' HD12 ' A' ' 121' ' ' LEU . 11.4 ptp -154.98 123.44 6.01 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.31 155.68 29.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 110.412 -178.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.45 141.65 48.95 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.823 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.5 p -93.86 161.03 14.48 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.804 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -60.79 -22.01 63.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.678 . . . . 0.0 110.142 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.65 -28.9 28.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.67 -10.36 7.15 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -54.97 170.89 0.16 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.159 -1.201 . . . . 0.0 109.275 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.605 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.8 tt -147.42 110.12 4.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.49 161.07 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -145.08 132.22 20.43 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.215 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.41 171.55 7.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.219 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.0 mtp -149.76 163.91 36.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.093 -179.514 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.6 m -147.51 152.7 38.44 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.436 0.636 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.669 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.72 96.53 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.645 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.76 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 24.12 1.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.563 -0.711 . . . . 0.0 109.312 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -119.09 -179.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.56 117.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.765 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.21 117.33 32.35 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -111.35 149.77 30.68 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.882 0.848 . . . . 0.0 109.925 -179.05 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -152.49 118.2 5.38 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.17 137.8 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.8 m-85 -126.93 124.87 40.51 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.446 -179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.55 140.78 24.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -50.02 125.99 13.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.176 -0.952 . . . . 0.0 111.131 -178.736 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.544 179.569 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.535 ' CA ' HD12 ' A' ' 113' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.006 0 N-CA-C 110.746 -0.521 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.91 123.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.706 0.765 . . . . 0.0 110.216 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.581 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.3 m-85 -99.59 -1.09 39.06 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.66 -0.65 . . . . 0.0 109.44 179.436 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -72.37 120.56 18.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.123 -0.986 . . . . 0.0 112.122 -177.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.54 -171.97 36.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -95.86 169.78 9.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.47 120.97 7.41 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.639 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -113.69 115.7 28.27 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.784 HG21 ' HD2' ' A' ' 39' ' ' PRO . 8.0 tt -55.6 156.61 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.994 0.902 . . . . 0.0 111.418 -178.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -132.21 -32.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.527 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 10' ' ' ILE . 1.3 mtt180 -143.82 169.61 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.254 -0.904 . . . . 0.0 108.938 179.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.57 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.0 p -177.19 145.37 0.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 109.754 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -141.18 165.7 26.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.759 -0.588 . . . . 0.0 109.657 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 13.0 m120 58.77 22.54 10.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.474 -0.766 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -65.19 -64.2 0.92 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 108.943 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 42.9 tt0 -57.5 -29.12 64.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -65.36 -34.19 77.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.664 -0.648 . . . . 0.0 110.167 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.808 HD22 ' HB2' ' A' ' 130' ' ' CYS . 12.5 tp -82.72 -19.0 38.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.758 -0.589 . . . . 0.0 110.375 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -90.86 -17.03 27.2 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -87.33 -29.28 21.69 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.216 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.1 p -77.06 -41.01 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.7 mp -65.73 -50.8 63.49 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -143.93 14.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.0 m -154.5 -43.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.697 -0.884 . . . . 0.0 109.985 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.1 t-20 -61.97 -172.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.483 -0.761 . . . . 0.0 109.033 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.46 -42.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -61.45 -23.34 65.79 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.9 mm? -79.82 -39.63 30.31 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.736 -0.602 . . . . 0.0 110.086 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.895 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.1 -37.39 85.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.701 -0.624 . . . . 0.0 109.502 -179.223 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -11.97 57.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 111.043 -179.521 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' ILE . 42.4 mm -85.84 -30.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.897 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.28 -27.25 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.7 t -79.52 -46.13 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.65 89.86 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.98 88.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.693 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.47 40.69 0.74 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.824 -0.547 . . . . 0.0 111.56 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.4 p -58.31 -26.66 63.3 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.487 -1.383 . . . . 0.0 108.679 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.19 73.01 0.23 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.784 ' HD2' HG21 ' A' ' 9' ' ' ILE . 32.4 Cg_endo -73.18 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.996 1.798 . . . . 0.0 111.089 -178.23 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -138.96 173.43 11.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 55.1 t -156.43 163.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.9 tt0 -150.47 111.0 4.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -99.37 133.37 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.636 0.731 . . . . 0.0 110.366 -178.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -112.72 111.92 23.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.666 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 61.8 tt0 -98.57 119.39 37.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.11 -0.994 . . . . 0.0 111.002 -178.226 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -120.69 54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.9 -126.74 8.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.23 -0.44 25.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.387 -1.066 . . . . 0.0 109.987 178.663 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.65 140.75 30.8 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.653 -1.279 . . . . 0.0 108.512 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.7 m-85 -136.67 116.39 13.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.8 0.81 . . . . 0.0 109.465 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.67 147.45 26.42 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.141 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -142.27 104.8 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.25 -177.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.44 109.35 21.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.067 178.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 60.6 m -103.21 141.8 35.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.6 p -148.88 124.88 10.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 109.592 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 57' ' ' THR . 67.1 m -98.24 -65.15 0.98 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.532 -0.73 . . . . 0.0 109.634 -179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.822 HG23 HG23 ' A' ' 58' ' ' VAL . 4.7 t -174.36 -41.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.822 HG23 HG23 ' A' ' 57' ' ' THR . 23.8 t -109.24 -17.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 ttm105 -124.21 162.24 24.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.502 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.2 m -161.24 104.66 1.29 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.42 169.06 10.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.554 -0.716 . . . . 0.0 110.079 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -160.42 123.32 3.37 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.141 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -124.49 168.85 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.376 -0.827 . . . . 0.0 109.407 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 9.4 p-10 -162.54 129.32 3.61 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.234 -0.916 . . . . 0.0 109.08 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.2 p90 -162.14 -172.16 3.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.388 -179.629 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -130.54 153.12 49.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.42 95.15 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 109.79 -178.871 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.3 -33.58 1.57 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.772 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -110.88 153.59 25.23 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.356 -1.085 . . . . 0.0 109.869 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.15 167.21 15.13 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.684 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.463 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.39 173.61 13.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.818 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -103.94 143.66 32.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.7 pt-20 -162.09 -176.86 5.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.82 155.67 17.53 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.6 t -91.19 -142.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.46 -0.775 . . . . 0.0 109.194 -179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 25.4 t -110.02 -20.63 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.74 -1.225 . . . . 0.0 110.624 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.638 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.43 -39.96 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.57 44.88 0.11 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -130.61 150.82 77.43 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.629 -0.924 . . . . 0.0 109.342 -179.628 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.92 140.29 15.98 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.7 1.6 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.4 p -161.36 141.86 10.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.637 -0.664 . . . . 0.0 109.811 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.3 ttmm -90.57 114.32 26.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.81 177.5 4.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.715 -0.615 . . . . 0.0 110.235 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' ' 70' ' ' GLU . 64.4 tp -151.75 152.01 32.15 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.4 t -140.74 130.25 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.516 -177.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.5 ptmt -125.89 162.48 25.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.562 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.3 m95 -85.69 167.35 15.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.969 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -129.93 -45.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 p -132.01 -154.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.039 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.29 -24.65 50.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.733 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -143.91 27.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.5 tttt -132.27 106.4 7.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 107.977 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.496 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.4 ptp -113.18 149.89 33.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.316 -178.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.946 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -104.7 172.11 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.49 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.8 t -149.58 129.79 13.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 110.747 -179.412 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -100.68 163.99 12.08 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 176.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.41 142.91 13.09 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.945 -178.222 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -147.08 149.25 32.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.43 167.9 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.065 -1.022 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 80' ' ' PRO . 30.3 mt -98.0 -7.44 29.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -152.44 141.14 20.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 108.922 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.07 -159.72 36.04 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -176.37 139.91 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.493 -1.004 . . . . 0.0 109.829 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.45 -86.67 0.06 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.1 -176.97 2.83 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.834 1.689 . . . . 0.0 109.774 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -135.5 138.53 43.2 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 146.05 47.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.068 0.937 . . . . 0.0 110.872 -179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -162.7 128.79 3.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -133.34 166.01 23.49 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.098 -1.001 . . . . 0.0 110.85 -179.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.946 HG22 HG13 ' A' ' 94' ' ' VAL . 18.8 p -130.4 174.69 9.61 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.415 0.626 . . . . 0.0 109.692 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -160.09 122.33 3.31 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.112 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -116.95 154.1 31.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.535 HD12 ' CA ' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -115.22 142.73 46.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.282 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -95.03 160.34 14.61 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.987 -179.342 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.9 -23.19 63.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.688 -0.632 . . . . 0.0 110.139 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -81.69 -31.06 32.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.16 -8.6 7.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -58.12 170.73 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.124 -1.221 . . . . 0.0 108.97 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.737 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -143.87 113.74 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.123 -178.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.81 152.45 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -135.01 132.78 38.71 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.46 -0.775 . . . . 0.0 109.557 -179.156 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.487 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -113.29 170.65 8.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.242 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.4 mtp -150.01 165.04 33.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.418 -179.341 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.7 m -146.9 152.22 38.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.674 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.94 96.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.561 179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.45 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -146.38 24.23 1.27 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.456 -0.778 . . . . 0.0 109.393 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 125' ' ' ALA . 24.4 m -119.59 -178.29 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.035 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.39 117.49 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.665 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.808 ' HB2' HD22 ' A' ' 18' ' ' LEU . 13.9 t -98.41 119.4 37.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.066 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' HG22 ' A' ' 122' ' ' THR . 92.0 m -115.5 149.79 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 110.075 -179.085 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -152.07 118.27 5.57 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.52 138.38 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.96 . . . . 0.0 108.446 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.4 m-85 -126.88 124.48 39.67 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.019 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.35 139.94 26.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.205 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -49.2 125.67 11.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.228 -0.92 . . . . 0.0 111.214 -178.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.628 179.573 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.503 2.03 0 N-CA-C 110.368 -0.666 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.87 124.76 1.61 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.736 . . . . 0.0 109.668 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.58 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.18 -8.87 24.48 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.744 -0.598 . . . . 0.0 109.478 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.6 p -68.73 118.05 11.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.225 -0.922 . . . . 0.0 111.869 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.4 -174.41 38.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 45.4 m-20 -95.45 172.24 8.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.51 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.72 124.66 8.59 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.964 -1.094 . . . . 0.0 112.54 -176.644 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -116.8 117.77 30.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 12' ' ' SER . 13.9 tt -61.73 151.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.914 0.864 . . . . 0.0 111.082 -178.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.28 -31.37 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -141.72 172.1 13.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.768 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.1 t -179.7 145.68 0.24 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.456 -0.777 . . . . 0.0 109.443 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -142.19 163.11 33.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.0 109.992 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 13.5 m120 62.87 32.8 15.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.607 -0.683 . . . . 0.0 109.754 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.955 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.88 -64.11 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.139 -179.728 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 tt0 -57.22 -35.87 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.815 . . . . 0.0 110.919 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -67.97 -29.7 68.79 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.179 -178.848 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.2 tp -77.49 -22.28 51.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.3 mt -89.95 -15.97 30.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.301 -0.875 . . . . 0.0 109.14 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -87.58 -31.4 19.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.0 p -74.59 -39.03 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -69.2 -45.8 69.02 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.736 0.779 . . . . 0.0 109.492 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.88 -161.63 27.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -146.29 -35.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.891 -0.77 . . . . 0.0 110.463 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.8 t-20 -62.21 -149.72 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 109.372 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.98 -47.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.7 -1.25 . . . . 0.0 109.323 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.484 ' HG2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttt -71.27 -26.89 63.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.2 mm? -58.73 -18.8 34.57 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.74 -0.6 . . . . 0.0 111.054 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.9 mpt_? -96.19 -47.9 5.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.754 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -21.32 65.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.662 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.484 HD11 ' HG2' ' A' ' 27' ' ' MET . 58.9 mt -78.21 -29.09 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -0.904 . . . . 0.0 108.728 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.973 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 14.4 t -76.56 -37.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.545 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -31.73 45.98 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.49 -39.18 91.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.46 -69.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 p 48.33 50.79 16.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.467 0.651 . . . . 0.0 109.662 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 64.63 72.3 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -73.06 159.32 47.98 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 122.059 1.84 . . . . 0.0 110.714 -179.293 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.88 174.34 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.561 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 54' ' ' THR . 53.7 t -155.58 164.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 41' ' ' VAL . 55.0 tt0 -151.23 110.53 3.95 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -98.62 140.14 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.753 0.787 . . . . 0.0 110.376 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -118.18 111.09 18.38 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.478 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.25 120.62 38.98 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.068 -1.02 . . . . 0.0 111.091 -177.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.03 54.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.89 -127.55 8.89 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.211 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.36 -0.85 24.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.403 -1.057 . . . . 0.0 110.079 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 m -97.02 138.74 34.09 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.753 -1.217 . . . . 0.0 108.489 -179.147 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.1 m-85 -133.98 118.02 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 0.0 109.446 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.98 147.97 26.27 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.337 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.069 HD12 HD11 ' A' ' 63' ' ' ILE . 1.8 mt -144.57 103.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.884 -1.135 . . . . 0.0 111.585 -177.488 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 113.02 25.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 41' ' ' VAL . 57.1 m -104.44 141.83 35.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.96 144.33 41.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.323 -0.86 . . . . 0.0 110.059 -179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -115.8 -65.95 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.934 0.873 . . . . 0.0 109.291 -179.878 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 58' ' ' VAL . 2.8 t 178.92 -41.76 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG23 HG23 ' A' ' 57' ' ' THR . 45.3 t -113.89 -11.28 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -124.62 164.64 19.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.277 -0.889 . . . . 0.0 108.939 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m -162.44 95.97 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.599 -0.688 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.59 164.97 23.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.787 . . . . 0.0 109.585 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -165.41 119.41 1.23 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.069 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -123.44 168.61 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 109.341 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 8.6 p-10 -162.26 129.23 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.186 -0.946 . . . . 0.0 108.937 179.452 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.3 p90 -162.03 -172.44 3.25 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.394 -179.465 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -129.56 153.33 48.15 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 90.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.121 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.41 -24.68 1.09 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.795 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.88 156.89 33.72 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.266 -1.137 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG2' HD22 ' A' ' 84' ' ' LEU . 49.2 mt-10 -86.3 167.47 14.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.705 -0.622 . . . . 0.0 109.489 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.484 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.41 175.81 11.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.698 -0.626 . . . . 0.0 109.49 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.39 145.81 29.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.8 pt-20 -162.26 -175.81 4.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.69 -0.631 . . . . 0.0 109.375 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -100.19 158.3 15.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.3 t -97.96 -144.34 0.31 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.396 -0.815 . . . . 0.0 109.326 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.581 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -109.93 -24.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.86 -1.15 . . . . 0.0 110.841 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -84.5 -40.74 17.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.75 45.41 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 mmm180 -135.4 154.66 78.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.731 -0.864 . . . . 0.0 108.971 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -78.89 144.29 18.98 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.703 1.602 . . . . 0.0 110.703 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 p -160.86 141.81 11.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.718 -0.614 . . . . 0.0 109.549 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -87.05 116.75 25.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.825 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.48 166.45 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 -178.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.25 154.51 41.81 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.4 t -146.24 131.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.319 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.5 pttt -125.57 160.55 29.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.518 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.8 m95 -83.65 171.76 12.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.193 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 10.9 tp10 -134.87 -46.16 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -131.9 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.66 -24.58 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 109.745 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -143.65 26.45 1.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 110.788 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 14.0 tttt -131.44 110.48 11.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.902 -1.124 . . . . 0.0 108.085 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.1 ptp -116.13 148.29 40.46 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.297 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -100.88 170.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.479 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.9 t -146.36 142.46 28.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -109.77 163.47 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -160.36 135.34 7.79 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.528 -178.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -143.1 148.94 37.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.59 166.37 2.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.052 -1.03 . . . . 0.0 110.94 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.716 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.5 mt -98.45 -5.99 31.33 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -150.91 133.87 15.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.72 -161.21 36.26 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.95 140.79 0.44 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.43 -1.041 . . . . 0.0 109.874 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.04 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.25 -176.71 2.93 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.712 1.608 . . . . 0.0 109.536 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -129.94 137.65 50.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.95 145.04 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.118 0.961 . . . . 0.0 110.608 -179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -163.13 143.44 9.14 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.3 p-90 -144.05 173.47 11.7 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 15.2 p -139.51 170.33 16.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 121' ' ' LEU . 9.6 ptp -154.56 137.1 15.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -131.11 151.37 51.51 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.371 -0.831 . . . . 0.0 109.468 -179.097 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.7 142.09 46.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -90.63 161.47 15.39 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.36 -22.1 62.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.653 . . . . 0.0 110.182 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.9 -28.69 25.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.07 -9.24 7.51 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.699 ' OE1' HG22 ' A' ' 135' ' ' VAL . 67.8 mm-40 -57.02 172.99 0.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.079 -1.248 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -146.1 112.47 5.85 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.923 -178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -105.06 158.43 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD21 ' SD ' ' A' ' 123' ' ' MET . 0.7 OUTLIER -142.41 134.02 26.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -178.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.38 166.91 10.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.248 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 121' ' ' LEU . 75.2 mmm -141.27 165.86 26.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 108.992 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -151.72 149.78 29.47 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.446 0.641 . . . . 0.0 109.338 178.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.77 94.58 1.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.9 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -147.67 24.14 1.1 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.533 -0.73 . . . . 0.0 109.137 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -117.38 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.084 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.68 119.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.9 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.44 114.15 26.93 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.067 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.0 m -104.08 149.51 25.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.16 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.498 ' HD2' HD12 ' A' ' 9' ' ' ILE . 18.9 mtm180 -153.21 120.13 5.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.6 137.07 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.0 m-85 -126.0 125.36 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.082 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.699 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -107.54 137.08 40.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.426 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.48 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.2 127.98 15.72 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.011 0.91 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 6.8 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.725 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.983 0 N-CA-C 110.396 -0.655 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -168.11 124.89 1.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.525 -0.734 . . . . 0.0 109.739 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.795 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.01 -13.47 19.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -63.21 117.67 6.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.359 -0.838 . . . . 0.0 112.033 -177.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.57 -175.06 38.17 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 44.9 m-20 -95.5 172.2 8.22 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.592 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.854 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.7 120.4 7.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.753 -176.404 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -109.08 117.15 33.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.682 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 12' ' ' SER . 7.2 tt -60.4 154.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.921 0.867 . . . . 0.0 111.072 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -126.79 -32.3 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.207 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.754 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.8 ttp85 -149.49 169.25 21.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.108 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 9' ' ' ILE . 94.7 p -177.46 139.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.528 -0.733 . . . . 0.0 109.301 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.66 174.83 10.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.622 -0.674 . . . . 0.0 109.868 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 18.9 m120 59.17 25.43 13.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.066 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.657 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -64.8 -64.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 108.718 179.582 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 pt-20 -56.78 -28.06 60.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 0.0 109.509 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' OE1' ' ND2' ' A' ' 14' ' ' ASN . 13.0 mt-10 -65.14 -39.88 93.64 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.052 -179.761 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 130' ' ' CYS . 37.2 tp -80.91 -14.33 58.09 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.748 -0.595 . . . . 0.0 109.821 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 1.3 mt -91.41 -20.16 22.09 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.063 -1.023 . . . . 0.0 109.173 178.97 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mmmt -83.65 -28.62 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.172 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 HD12 ' A' ' 18' ' ' LEU . 14.7 p -78.81 -41.48 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.456 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.471 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.18 -53.54 36.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.198 0.999 . . . . 0.0 108.908 179.323 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.64 -145.5 15.87 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 23' ' ' GLY . 20.9 m -155.35 -39.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.914 -0.757 . . . . 0.0 110.234 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -57.93 -171.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 0.0 109.724 -179.834 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.481 HG12 ' NH1' ' A' ' 29' ' ' ARG . 15.6 m -121.43 -43.44 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.593 -0.692 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.416 ' N ' HG23 ' A' ' 26' ' ' VAL . 6.7 ttt -68.23 -28.15 66.98 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.682 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.4 mm? -58.77 -52.04 67.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.758 -0.589 . . . . 0.0 110.553 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.893 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 mpp_? -60.35 -39.51 87.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.506 -0.746 . . . . 0.0 110.262 -178.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -60.33 -29.24 68.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 110.667 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.8 mt -77.54 -27.76 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.115 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.21 -22.54 35.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.2 t -81.01 -42.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.657 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.22 81.79 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.34 -49.79 75.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.087 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.49 48.63 1.54 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.783 -0.573 . . . . 0.0 110.6 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -63.33 -33.1 74.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.777 -1.202 . . . . 0.0 108.55 179.441 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 72.12 2.01 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.863 ' HB3' HG22 ' A' ' 56' ' ' THR . 33.5 Cg_endo -74.01 141.05 29.25 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.909 1.739 . . . . 0.0 111.085 -178.32 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.96 177.07 5.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 54' ' ' THR . 50.4 t -155.74 165.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 42.9 tt0 -151.62 110.18 3.8 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.724 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -97.93 138.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.849 0.833 . . . . 0.0 110.124 -178.707 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 12.7 mttt -116.56 108.93 16.58 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.1 tt0 -98.56 114.72 27.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -178.483 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -120.45 60.64 0.88 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.16 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.71 -127.93 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.02 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -78.56 0.74 25.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -1.085 . . . . 0.0 110.014 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -97.05 142.11 29.39 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.713 -1.242 . . . . 0.0 108.778 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.9 m-85 -138.45 120.1 15.13 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.808 0.813 . . . . 0.0 109.288 179.639 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' CE2' ' ND2' ' A' ' 64' ' ' ASN . 5.8 t80 -102.9 139.91 37.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.447 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.34 116.97 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.022 -1.048 . . . . 0.0 109.292 -179.518 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.7 tttt -115.08 101.08 8.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.523 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.69 HG23 HG22 ' A' ' 41' ' ' VAL . 16.5 m -100.0 144.89 28.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 109.056 179.5 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -145.16 125.94 14.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.429 -0.794 . . . . 0.0 110.028 -179.721 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 39' ' ' PRO . 21.8 p -98.55 -121.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.9 p -108.77 -36.85 6.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.526 -1.359 . . . . 0.0 108.326 179.397 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 58' ' ' VAL . 23.4 t -125.11 -5.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.916 -0.49 . . . . 0.0 110.692 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -115.84 165.38 13.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 0.0 110.118 -179.177 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.773 HG22 ' OE2' ' A' ' 62' ' ' GLU . 12.3 m -163.51 105.3 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.654 -0.654 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -95.88 156.14 16.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.397 -0.815 . . . . 0.0 109.322 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.773 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.1 mp0 -151.03 137.58 18.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.594 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.865 HD11 HG13 ' A' ' 52' ' ' ILE . 24.4 pt -142.85 169.5 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.557 -0.715 . . . . 0.0 109.519 179.39 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.559 ' ND2' ' CE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -162.6 135.95 6.01 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.46 -0.775 . . . . 0.0 108.945 179.325 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 52.5 p90 -161.85 -173.45 3.71 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.93 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 152.87 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.722 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 92.2 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -178.881 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.91 -29.8 1.25 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.841 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -116.33 155.84 27.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.308 -1.113 . . . . 0.0 110.26 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' HD22 ' A' ' 84' ' ' LEU . 37.1 mt-10 -85.72 167.35 15.35 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.84 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 17.1 p90 -162.84 174.74 12.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.894 -178.514 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -104.38 144.89 31.03 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.642 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.1 -177.27 5.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.42 156.21 17.14 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.011 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.1 t -93.53 -142.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.366 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' N ' HG23 ' A' ' 75' ' ' THR . 24.0 t -108.64 -23.23 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.751 -1.218 . . . . 0.0 110.875 -179.039 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.583 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -87.38 -40.86 14.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.397 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.35 44.53 0.1 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 13.5 mtp180 -130.72 152.11 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.676 -0.896 . . . . 0.0 109.146 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.09 142.24 19.3 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.643 1.562 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.0 p -160.91 141.47 11.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.672 -0.643 . . . . 0.0 109.782 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.603 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -90.56 114.05 26.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.5 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -101.78 177.22 4.97 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.88 -178.756 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' HG2' ' A' ' 70' ' ' GLU . 59.3 tp -151.83 152.92 33.26 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.29 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.1 t -140.36 131.99 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.843 -177.916 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -126.83 159.89 32.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.753 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.671 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -83.8 170.13 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.025 -179.602 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.4 tp10 -132.99 -45.7 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.092 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -133.19 -153.94 0.58 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.08 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -77.6 -24.87 49.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 109.792 179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -143.03 26.74 1.66 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 60.7 tttt -131.21 107.96 9.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.943 -1.098 . . . . 0.0 108.113 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.509 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -115.61 147.29 40.95 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.501 -0.749 . . . . 0.0 110.175 -179.141 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -102.55 172.16 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.0 t -149.38 130.5 14.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.789 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.0 pt-20 -101.35 163.62 12.18 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.152 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 8.4 tt0 -160.18 143.25 13.65 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.962 -178.222 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -147.37 150.74 35.28 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.83 167.1 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.861 -179.149 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.1 mt -97.5 -7.61 31.08 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.428 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 134.26 18.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.8 -158.39 44.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.414 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -176.35 141.37 0.41 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.501 -1.0 . . . . 0.0 109.808 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.65 -86.23 0.05 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.317 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.26 -176.87 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.841 1.694 . . . . 0.0 109.911 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -132.46 135.04 45.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.56 145.49 47.92 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.068 0.937 . . . . 0.0 110.774 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 p -163.14 134.27 4.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -135.6 169.29 17.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.086 -1.009 . . . . 0.0 110.202 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.842 HG22 HG13 ' A' ' 94' ' ' VAL . 17.6 p -134.95 171.4 14.46 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.429 0.633 . . . . 0.0 109.791 -179.566 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.436 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 2.1 ptp -154.46 130.82 10.47 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 154.04 39.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.246 -178.296 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.47 141.71 48.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.032 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.5 p -93.77 160.55 14.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.682 -179.477 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -60.74 -21.48 63.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.104 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.22 -29.33 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.16 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.36 -9.18 7.39 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 170.32 0.4 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.256 . . . . 0.0 108.944 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.836 HD13 HD13 ' A' ' 43' ' ' ILE . 7.6 tt -146.75 112.54 5.69 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.228 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.9 tt -104.45 160.3 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.69 132.63 27.67 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.359 -0.838 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.75 170.8 7.99 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.362 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 27.9 mtp -148.4 166.0 29.42 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.353 -179.333 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 5.7 m -150.11 151.96 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.44 0.638 . . . . 0.0 109.369 179.212 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.85 96.08 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.501 179.722 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.13 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -147.37 24.03 1.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.495 -0.753 . . . . 0.0 109.22 178.516 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.7 m -117.87 -179.07 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.81 118.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.628 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.704 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -97.36 121.32 39.13 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -116.72 148.17 41.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.007 0.908 . . . . 0.0 110.283 -178.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -153.1 121.82 6.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.95 139.19 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.087 -1.008 . . . . 0.0 108.697 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 21.7 m-85 -127.65 133.38 49.65 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.232 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.15 138.32 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.24 128.25 16.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.204 -0.935 . . . . 0.0 111.644 -178.482 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.656 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.42 0.628 . . . . 1.29 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.653 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -99.73 -8.15 24.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.915 -0.772 . . . . 0.17999999999999999 108.915 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 23.0 t -66.62 116.39 7.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.405 -0.81 . . . . 1.22 111.352 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -169.89 37.65 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.609 -1.796 . . . . 0.14000000000000001 108.609 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 6.4 m120 -96.62 169.88 9.58 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.537 -1.653 . . . . 0.57999999999999996 106.537 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.927 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.84 119.78 6.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.474 -1.29 . . . . 0.20999999999999999 112.385 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -114.12 113.72 25.09 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.829 -1.175 . . . . 1.75 107.829 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.3 tt -56.52 154.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.847 0.832 . . . . 0.68999999999999995 110.907 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.99 -31.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.979 -0.748 . . . . 0.46000000000000002 108.979 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HB2' HD12 ' A' ' 10' ' ' ILE . 5.5 mtt180 -139.88 168.1 20.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 2.8599999999999999 108.753 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 9' ' ' ILE . 4.2 t 177.74 152.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.04 109.689 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.54 171.01 16.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.579 -0.701 . . . . 1.25 109.456 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 62.7 m-20 61.34 32.11 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 1.78 109.865 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.18 -62.65 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.41999999999999998 110.084 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -59.2 -36.51 75.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.268 -0.895 . . . . 2.2799999999999998 110.354 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 8.1 pt-20 -68.02 -28.62 67.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.274 -0.97 . . . . 2.0800000000000001 109.795 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD22 ' HB2' ' A' ' 130' ' ' CYS . 43.4 tp -79.41 -21.34 45.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.191 -0.943 . . . . 0.59999999999999998 108.998 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 32' ' ' ALA . 3.9 mt -89.5 -18.45 26.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.161 -0.962 . . . . 0.71999999999999997 108.596 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -84.13 -30.3 26.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.738 -1.208 . . . . 1.1100000000000001 107.738 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.7 p -77.48 -41.02 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.875 -1.157 . . . . 0.45000000000000001 107.875 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.4 mp -65.51 -50.62 64.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.608 -0.886 . . . . 0.56999999999999995 108.608 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.704 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.72 -142.25 12.46 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.136 -1.186 . . . . 0.71999999999999997 110.136 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -164.67 -34.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.655 -0.909 . . . . 1.53 109.415 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.0 t30 -61.71 -159.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.806 . . . . 1.54 109.497 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.6 HG12 HH12 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -120.97 -48.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.24 109.397 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.9 ttt -68.96 -24.46 64.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.54 -0.911 . . . . 2.21 108.54 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -60.8 -27.75 68.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.763 -0.586 . . . . 1.3999999999999999 110.219 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -87.38 -45.19 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 2.4399999999999999 109.901 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -61.43 -25.09 66.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 2.77 110.526 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.9 mt -76.5 -29.66 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.989 . . . . 1.45 108.85 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.22 -26.04 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.561 -0.712 . . . . 0.41999999999999998 109.166 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.1 t -77.15 -36.15 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.768 -1.197 . . . . 0.44 107.768 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -33.57 48.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.13 -1.063 . . . . 0.68000000000000005 108.13 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.31 94.91 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.912 -0.773 . . . . 0.80000000000000004 108.912 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.84 -69.07 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.741 -0.837 . . . . 1.6899999999999999 108.741 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 44.18 46.78 7.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.608 -0.683 . . . . 1.6000000000000001 109.348 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 67.34 73.46 0.36 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.436 -0.95 . . . . 3.0800000000000001 108.436 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.3 Cg_endo -74.58 157.13 44.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.596 2.198 . . . . 0.57999999999999996 110.437 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -99.67 173.15 6.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.447 -0.783 . . . . 0.23999999999999999 109.488 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 54' ' ' THR . 13.3 t -156.15 160.74 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.89 -0.781 . . . . 0.28000000000000003 108.89 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 35.3 tt0 -146.68 113.11 5.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 1.47 108.746 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.9 mt -99.94 136.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.395 -0.816 . . . . 0.31 110.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.23 111.06 20.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.297 -1.371 . . . . 1.23 107.297 178.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.5 tt0 -98.52 122.33 41.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.985 -1.072 . . . . 1.6100000000000001 110.781 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -125.47 46.72 2.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.565 -0.902 . . . . 1.97 108.565 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.47 -131.33 10.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.749 -1.74 . . . . 0.38 108.749 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.26 -0.31 19.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -1.179 . . . . 1.1299999999999999 109.555 179.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.3 m -98.81 131.53 44.86 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.897 -1.127 . . . . 0.25 108.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.591 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.3 m-85 -128.25 118.62 23.62 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.22 110.049 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.0 t80 -102.24 144.71 30.42 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.082 -1.451 . . . . 0.31 107.082 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.851 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -141.79 107.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.684 -1.26 . . . . 0.56000000000000005 110.562 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 1.6 tttt -104.72 115.46 30.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 1.8 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' CG2' ' A' ' 41' ' ' VAL . 44.4 m -104.2 144.79 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.38 109.1 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -140.65 134.57 30.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 0.54000000000000004 109.615 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.93 0.871 . . . . 1.05 109.329 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 55' ' ' SER . 20.4 m . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.301 -0.629 . . . . 0.63 109.301 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -101.71 172.69 6.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.77000000000000002 109.504 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 3.7 pt-20 -171.87 125.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 1.8500000000000001 109.332 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.851 HD11 HD12 ' A' ' 52' ' ' ILE . 38.0 pt -117.57 170.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.34999999999999998 109.289 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -161.25 130.53 4.68 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.942 . . . . 1.1699999999999999 108.939 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -161.54 -172.93 3.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.16 111.484 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 11.6 ptpt -128.91 152.74 48.21 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.027 -1.101 . . . . 1.8400000000000001 108.027 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.2 92.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 0.17999999999999999 109.734 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.67 -26.97 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.519 -1.324 . . . . 0.27000000000000002 110.579 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -124.65 159.51 30.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.246 . . . . 2.3799999999999999 109.995 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG2' HD22 ' A' ' 84' ' ' LEU . 27.2 mt-10 -87.51 167.96 13.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 1.6499999999999999 109.207 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 18.3 p90 -161.38 178.36 9.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.419 -0.801 . . . . 0.20000000000000001 109.713 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -107.56 143.31 36.17 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.374 -0.973 . . . . 1.1399999999999999 108.374 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.698 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.1 pt-20 -161.99 -176.21 5.07 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.462 -0.774 . . . . 1.5900000000000001 109.46 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -99.55 153.06 19.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.817 -0.808 . . . . 1.9199999999999999 108.817 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.71 HG23 ' H ' ' A' ' 77' ' ' ASP . 9.2 t -90.18 -144.99 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 1.04 109.529 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 21.5 t -107.96 -19.21 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.78 -1.2 . . . . 2.02 110.56 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.71 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.6 -44.21 10.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.063 -1.023 . . . . 2.0299999999999998 109.305 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.88 39.65 0.09 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.425 . . . . 0.45000000000000001 109.536 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 1.5 mmm180 -129.41 152.91 80.36 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.469 -1.019 . . . . 2.6600000000000001 109.052 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD2' ' HD2' ' A' ' 79' ' ' ARG . 35.9 Cg_endo -78.41 139.71 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.164 1.909 . . . . 0.28999999999999998 110.537 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.416 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 13.1 p -160.58 144.06 13.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.23999999999999999 109.559 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -86.4 117.28 25.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.293 -1.003 . . . . 1.5 108.293 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 97' ' ' GLN . 1.9 t -99.88 165.63 11.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -0.787 . . . . 0.75 109.971 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.0 tp -144.94 155.63 43.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.473 -1.306 . . . . 0.53000000000000003 107.473 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.8 t -148.41 128.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.37 -1.332 . . . . 0.20000000000000001 111.855 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.66 158.48 28.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.274 -1.38 . . . . 1.9099999999999999 107.274 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.54 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.6 m95 -81.36 166.53 20.36 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.959 -1.088 . . . . 0.14999999999999999 110.178 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.7 tp10 -130.99 -42.2 1.11 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.845 -1.169 . . . . 1.1100000000000001 107.845 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -136.71 -153.31 0.49 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.75 -1.204 . . . . 0.16 107.75 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.94 -18.94 49.17 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.118 -0.989 . . . . 2.1499999999999999 109.594 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -147.93 26.84 0.99 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.091 -1.005 . . . . 0.25 110.355 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 57.5 tttt -134.38 109.33 8.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.73 -1.231 . . . . 1.3400000000000001 108.617 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.591 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -115.17 148.02 39.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.404 -0.81 . . . . 0.67000000000000004 110.073 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.6 t -100.32 172.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.20000000000000001 108.774 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 53.6 t -147.99 140.12 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.018 . . . . 0.20999999999999999 111.078 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -107.57 164.49 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.867 -1.531 . . . . 2.1099999999999999 106.867 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 4.5 tt0 -160.2 135.84 8.29 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.412 -1.315 . . . . 0.78000000000000003 111.554 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 56.0 pttt -145.16 144.28 30.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.134 -1.061 . . . . 2.4500000000000002 108.134 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 168.14 1.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.898 -1.126 . . . . 0.87 110.808 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 82' ' ' LYS . 67.3 mt -102.78 -3.83 25.83 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.931 -1.137 . . . . 0.97999999999999998 107.931 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -153.88 148.2 25.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.942 -0.762 . . . . 2.8500000000000001 108.942 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.16 -162.71 22.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.079 -1.609 . . . . 1.9399999999999999 109.079 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.94 141.73 0.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.266 -1.138 . . . . 5.2599999999999998 109.645 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.45 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.856 -1.697 . . . . 1.3200000000000001 108.856 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.17 -176.15 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.448 2.099 . . . . 0.83999999999999997 110.056 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -137.18 136.8 38.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.232 -1.025 . . . . 1.28 108.232 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.91 145.2 46.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 0.35999999999999999 110.753 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.8 m -162.73 136.59 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.819 -1.178 . . . . 0.84999999999999998 107.819 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.441 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 53.4 p-90 -142.96 176.7 8.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.23999999999999999 110.323 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.43 171.83 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.462 0.649 . . . . 0.23000000000000001 109.599 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.539 ' HB2' ' HE2' ' A' ' 111' ' ' MET . 13.3 ptm -153.97 125.83 7.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.584 -0.895 . . . . 1.9299999999999999 108.584 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -120.53 154.12 35.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 1.97 110.232 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.93 144.78 41.91 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.839 -1.171 . . . . 0.17000000000000001 107.839 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.403 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 41.4 p -93.26 161.55 14.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.854 -1.154 . . . . 0.23999999999999999 109.715 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -62.14 -19.49 63.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 2.1499999999999999 109.794 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.21 -26.46 23.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.8600000000000001 109.184 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.1 -9.68 8.4 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.847 -1.301 . . . . 0.17999999999999999 109.847 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.426 ' O ' HD13 ' A' ' 113' ' ' LEU . 62.0 mt-10 -55.88 172.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 1.48 109.03 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.764 HD13 HD13 ' A' ' 43' ' ' ILE . 7.9 tt -144.84 113.21 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.14999999999999999 110.18 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.74 154.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.914 -1.143 . . . . 0.68000000000000005 107.914 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -137.91 131.3 30.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.023 -1.048 . . . . 1.3799999999999999 109.893 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -109.02 162.32 14.34 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.835 -1.172 . . . . 0.27000000000000002 107.835 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 13.9 mtp -142.4 159.09 42.92 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.164 -0.96 . . . . 0.81000000000000005 109.774 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 129' ' ' VAL . 3.4 m -143.87 152.56 41.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.15 -0.685 . . . . 0.31 109.15 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 128' ' ' VAL . . . -155.94 91.14 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.31 109.586 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER 78.72 -76.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.924 -0.769 . . . . 1.21 108.924 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.25 22.67 1.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 125' ' ' ALA . 16.6 m -117.36 179.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.85 117.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.132 -1.027 . . . . 0.28999999999999998 110.077 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.915 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.14 107.74 20.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 0.40000000000000002 109.321 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 122' ' ' THR . 93.7 m -99.71 145.98 27.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.37 109.507 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -151.02 122.69 8.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.503 -0.925 . . . . 1.8100000000000001 108.503 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.54 135.52 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.911 -1.118 . . . . 0.23999999999999999 108.767 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.477 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.1 m-85 -124.37 124.35 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.508 -0.877 . . . . 0.40000000000000002 109.916 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.575 -1.269 . . . . 0.17999999999999999 107.575 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -44.52 125.88 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.1399999999999999 110.565 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' ARG . 9.1 tt0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.101 -0.952 . . . . 2.2999999999999998 111.057 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.425 0.631 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.4 m-85 -99.4 -11.46 21.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -66.12 117.08 7.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 111.958 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.11 -174.09 38.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 3.9 m120 -95.02 171.73 8.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.868 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.3 m95 -151.22 128.79 11.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.513 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -120.41 115.82 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.801 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.1 tt -58.51 153.56 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.918 0.866 . . . . 0.0 111.2 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.48 -32.89 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -140.77 168.69 19.19 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.801 ' HB2' HD11 ' A' ' 9' ' ' ILE . 13.4 t 177.95 147.09 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -144.39 168.79 19.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.433 0.635 . . . . 0.0 109.951 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.4 m-80 61.66 31.38 18.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.672 . . . . 0.0 109.66 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.969 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.11 -64.72 0.99 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.528 -0.732 . . . . 0.0 110.111 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.709 ' HG2' HG21 ' A' ' 33' ' ' VAL . 46.8 mt-10 -56.51 -34.83 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 110.959 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -69.81 -29.97 67.39 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.469 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 130' ' ' CYS . 22.3 tp -77.46 -19.8 55.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 109.908 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -89.99 -16.85 28.99 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.97 . . . . 0.0 109.291 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mtmm -86.19 -33.69 20.72 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -72.07 -39.76 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -68.56 -46.26 69.92 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.832 0.825 . . . . 0.0 109.266 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.12 -163.44 27.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 25' ' ' ASN . 27.1 m -140.21 -40.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.894 -0.768 . . . . 0.0 109.75 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.5 t30 -59.74 -165.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.483 -0.761 . . . . 0.0 109.482 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.484 HG13 ' NH1' ' A' ' 29' ' ' ARG . 1.7 t -115.45 -48.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.29 -28.17 67.79 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.9 mm? -56.98 -20.31 23.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -91.78 -50.48 5.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.787 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -62.35 -19.84 63.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.7 . . . . 0.0 111.076 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.58 -29.86 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.195 -0.941 . . . . 0.0 108.752 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.66 -25.1 33.38 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.9 t -76.89 -37.08 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.61 49.04 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.03 93.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.36 -69.93 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m 47.79 49.84 16.17 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.498 0.666 . . . . 0.0 109.626 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mttp 66.37 72.49 0.43 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -72.9 166.4 30.11 Favored 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.974 1.782 . . . . 0.0 110.811 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.53 173.02 6.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.65 -0.657 . . . . 0.0 109.536 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 54' ' ' THR . 53.5 t -154.55 165.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.4 tt0 -151.82 110.92 3.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.868 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.6 mt -97.83 138.43 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.806 0.812 . . . . 0.0 110.084 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttt -116.95 104.96 11.81 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.2 tt0 -97.34 125.37 41.9 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.33 54.15 1.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -126.18 8.35 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.619 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -75.5 -1.36 23.86 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.252 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -97.14 136.49 37.6 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.741 -1.224 . . . . 0.0 108.338 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -131.16 116.48 17.76 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.857 0.837 . . . . 0.0 109.297 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.8 t80 -102.29 148.95 24.83 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.882 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -146.31 99.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.996 -1.065 . . . . 0.0 110.426 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 62' ' ' GLU . 1.7 tttp -99.98 114.23 27.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 109.883 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 41' ' ' VAL . 31.6 m -101.96 144.69 30.26 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.4 OUTLIER -142.57 131.65 23.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.408 -0.807 . . . . 0.0 109.777 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.665 . . . . 0.0 109.446 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 55' ' ' SER . 15.1 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -102.07 172.85 6.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.767 . . . . 0.0 109.329 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . 2.6 pt-20 -171.94 119.58 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.69 . . . . 0.0 109.736 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.882 HD11 HD12 ' A' ' 52' ' ' ILE . 37.7 pt -110.43 170.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.528 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.35 133.87 5.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.292 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.1 p90 -161.98 -172.37 3.23 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.637 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -129.19 153.01 48.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.39 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.139 -0.976 . . . . 0.0 109.825 -178.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.12 -27.36 1.72 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.013 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -119.39 156.19 30.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.676 ' HG2' HD13 ' A' ' 84' ' ' LEU . 14.1 mt-10 -86.28 167.27 14.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.7 p90 -162.72 174.46 12.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.698 . . . . 0.0 109.634 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.94 147.5 26.85 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.671 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.4 pt-20 -161.74 179.49 8.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.679 -0.638 . . . . 0.0 109.324 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.72 128.1 55.05 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.265 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -63.86 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' N ' HG23 ' A' ' 75' ' ' THR . 12.3 p -103.1 -16.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 111.322 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.7 ' H ' HG23 ' A' ' 75' ' ' THR . 3.9 t70 -86.66 -40.85 14.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.28 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.51 43.49 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 75' ' ' THR . 6.9 mmm180 -130.52 148.89 71.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.661 -0.905 . . . . 0.0 108.937 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 140.51 17.15 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.454 1.436 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.6 p -160.86 141.69 11.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.682 -0.636 . . . . 0.0 109.633 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.828 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -90.45 114.27 26.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.21 176.21 5.33 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.947 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -152.93 153.32 32.76 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.6 t -140.75 127.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.989 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.07 155.3 34.7 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.687 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.6 m95 -78.01 173.16 12.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.058 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.3 tp10 -135.11 -46.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -129.99 -152.67 0.52 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.25 -25.71 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -143.78 25.27 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 110.981 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 34.7 tttm -130.08 110.93 12.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.893 -1.13 . . . . 0.0 108.065 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.446 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.41 150.17 38.22 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.661 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -99.52 172.15 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.492 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.2 t -149.15 129.76 14.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.88 . . . . 0.0 110.752 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -101.04 162.37 12.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 9.0 tt0 -160.44 139.76 10.78 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.878 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.05 149.74 37.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.69 165.59 3.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 111.085 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.828 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.3 mt -100.49 -2.97 31.77 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -153.36 134.31 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 108.807 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.87 -160.7 41.46 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -176.26 141.41 0.43 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.467 -1.019 . . . . 0.0 109.841 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.0 -85.39 0.05 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.53 -177.14 3.05 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.82 1.68 . . . . 0.0 109.857 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -134.44 138.51 44.83 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.03 145.25 48.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.008 0.909 . . . . 0.0 110.69 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.5 m -163.39 132.53 4.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -135.96 170.45 15.98 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.037 -1.039 . . . . 0.0 110.422 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 HG13 ' A' ' 94' ' ' VAL . 14.1 p -134.54 173.12 12.0 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.532 0.682 . . . . 0.0 109.722 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.7 ptp -158.6 139.57 12.97 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.0 pt-20 -140.64 144.87 35.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.366 -0.834 . . . . 0.0 109.1 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -105.02 144.79 31.34 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.8 p -91.75 160.38 15.36 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.15 -19.87 55.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.62 -0.675 . . . . 0.0 110.337 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.11 -28.56 22.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.29 -8.79 7.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 113' ' ' LEU . 8.1 mt-10 -57.94 171.3 0.53 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.046 -1.267 . . . . 0.0 108.95 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD13 HD13 ' A' ' 43' ' ' ILE . 7.5 tt -146.01 110.87 5.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.883 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.407 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -107.34 148.47 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -132.87 138.56 47.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.378 -0.826 . . . . 0.0 109.59 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.44 169.04 9.46 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.2 mtp -146.96 165.25 30.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.197 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -147.63 151.11 35.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.715 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.67 92.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.559 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.78 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -146.57 24.11 1.25 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.6 m -117.74 -179.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.69 118.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.722 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.911 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.53 113.67 26.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 122' ' ' THR . 85.8 m -109.34 147.94 31.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.737 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -152.59 117.59 5.15 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.9 t -80.18 139.17 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 108.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.7 m-85 -127.68 123.51 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.315 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.03 138.45 31.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.495 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.15 128.56 16.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.181 -0.95 . . . . 0.0 111.543 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 4.1 tt0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.322 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.517 0.675 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -98.69 1.38 46.11 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 120.12 18.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 111.925 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -174.19 38.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.5 m120 -95.58 172.03 8.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.543 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -151.49 125.23 9.05 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.573 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -117.54 114.04 22.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' A' ' 39' ' ' PRO . 4.6 tt -52.63 147.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.661 0.744 . . . . 0.0 111.13 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.67 -25.11 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 122.003 -0.436 . . . . 0.0 110.24 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -152.57 177.43 10.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.164 -0.96 . . . . 0.0 110.469 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -179.47 166.05 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.79 24.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 111.708 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 61.1 m-20 -161.14 27.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.607 -0.683 . . . . 0.0 110.197 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.815 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -65.44 -66.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 108.738 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 14.9 pt-20 -56.52 -28.64 60.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.35 -38.9 91.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.677 -0.639 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 130' ' ' CYS . 36.7 tp -79.4 -16.13 56.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.773 -0.58 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.83 -20.29 22.47 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.954 -1.091 . . . . 0.0 109.18 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.7 mmmt -83.03 -28.17 29.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -80.42 -40.64 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 122.127 0.965 . . . . 0.0 108.477 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.3 mp -67.76 -50.02 59.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.919 0.866 . . . . 0.0 109.87 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.77 -154.21 25.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.79 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.0 t -150.7 -39.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 122.029 -0.689 . . . . 0.0 110.029 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -60.8 -160.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.38 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.09 -45.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.892 . . . . 0.0 109.775 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.423 ' O ' HD12 ' A' ' 31' ' ' ILE . 4.1 ttt -66.12 -30.9 71.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.4 mm? -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.857 -0.527 . . . . 0.0 110.213 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 33' ' ' VAL . 43.4 mtt180 -84.87 -47.48 10.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.499 -0.751 . . . . 0.0 109.968 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -61.61 -21.86 64.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.691 -0.63 . . . . 0.0 111.06 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 27' ' ' MET . 29.5 mt -81.26 -28.8 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.22 -25.87 36.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.665 -0.647 . . . . 0.0 109.354 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.33 -44.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.21 85.54 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.41 -56.23 23.9 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.775 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.9 57.96 4.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.757 -0.589 . . . . 0.0 110.287 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 t -64.21 -43.11 96.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.697 -1.252 . . . . 0.0 107.726 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -151.36 74.19 8.2 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.948 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.1 Cg_endo -71.5 142.11 39.83 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.846 1.697 . . . . 0.0 111.262 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -98.94 174.73 6.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 54' ' ' THR . 50.8 t -155.74 163.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -151.31 111.6 4.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HG23 ' A' ' 52' ' ' ILE . 2.6 mp -98.08 135.81 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.019 0.914 . . . . 0.0 110.442 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 4.4 mttm -109.91 93.45 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.65 125.44 41.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.31 -0.869 . . . . 0.0 110.42 -176.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -132.65 56.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.55 -132.29 10.97 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.5 p30 -71.71 -4.36 27.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.384 -1.068 . . . . 0.0 110.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 m -96.79 134.08 40.54 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.656 -1.278 . . . . 0.0 108.476 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.685 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.7 m-85 -131.15 119.06 21.36 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.687 0.756 . . . . 0.0 109.336 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 15.0 t80 -103.15 150.46 23.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.094 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -148.58 104.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.94 -1.1 . . . . 0.0 110.97 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -104.81 113.11 26.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 108.864 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 41' ' ' VAL . 41.6 m -102.49 145.5 29.49 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.459 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.9 p -142.77 119.15 10.91 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.674 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.948 HG22 ' HB3' ' A' ' 39' ' ' PRO . 82.8 p . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 55' ' ' SER . 7.1 m . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 169.17 12.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.772 . . . . 0.0 109.724 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.34 111.35 1.22 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.489 -0.757 . . . . 0.0 109.699 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 52' ' ' ILE . 42.7 pt -116.53 165.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.58 132.51 4.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.3 p90 -161.67 -172.7 3.43 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.404 1.097 . . . . 0.0 112.445 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.76 153.54 48.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.32 93.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.133 -0.98 . . . . 0.0 109.681 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.31 -22.91 1.55 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.906 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.69 155.63 37.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.22 -1.165 . . . . 0.0 110.219 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.566 ' HG2' HD13 ' A' ' 84' ' ' LEU . 32.3 mt-10 -86.64 166.41 15.38 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.17 174.57 12.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -105.55 144.22 32.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.709 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.31 -174.79 4.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -99.75 159.91 14.7 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.9 t -97.31 -142.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.5 t -111.13 -19.2 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.783 -1.198 . . . . 0.0 110.824 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t70 -90.67 -37.11 13.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.486 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.71 45.14 0.15 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 7.1 mtm-85 -133.3 153.54 80.65 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 121.691 -0.888 . . . . 0.0 109.447 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -79.0 142.04 17.05 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.767 1.645 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -161.26 143.06 11.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.657 -0.652 . . . . 0.0 109.517 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.598 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -89.46 117.33 28.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.48 166.54 11.11 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.266 0.555 . . . . 0.0 109.988 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' A' ' 70' ' ' GLU . 49.1 tp -148.77 153.02 37.56 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.695 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.8 t -143.4 136.13 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.417 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.21 157.22 41.45 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.556 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.6 m95 -81.15 172.83 13.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.019 0.914 . . . . 0.0 110.627 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -136.69 -45.98 0.6 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.9 p -131.81 -153.63 0.57 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -76.47 -26.97 55.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.801 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -143.46 28.53 1.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 48.7 tttt -130.54 110.37 11.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.989 -1.069 . . . . 0.0 108.188 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.685 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.3 ptp -117.43 147.5 42.64 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.728 0.775 . . . . 0.0 110.572 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 110' ' ' THR . 2.2 t -100.73 171.5 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.423 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.0 t -146.83 137.43 23.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' OE2' HD23 ' A' ' 84' ' ' LEU . 7.4 pt-20 -108.77 156.13 19.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -154.65 142.2 19.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.974 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -143.73 152.05 40.78 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.499 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.17 168.03 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.755 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.6 mt -99.6 -5.75 28.51 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 137.2 14.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 108.621 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.85 -163.12 37.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -175.96 140.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.43 -1.041 . . . . 0.0 109.995 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.35 -86.83 0.06 OUTLIER Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.83 -176.91 2.87 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.783 1.655 . . . . 0.0 109.643 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -131.41 139.87 49.52 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.12 144.63 48.46 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.172 0.987 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 m -162.92 131.8 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 48.9 p-90 -137.12 172.79 12.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.143 -0.973 . . . . 0.0 110.231 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.813 HG22 HG13 ' A' ' 94' ' ' VAL . 19.8 p -135.92 174.16 10.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.542 0.687 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.497 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.9 ptm -157.95 124.31 4.79 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -119.54 147.64 44.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.488 -0.758 . . . . 0.0 109.889 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.01 143.52 39.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 p -93.55 159.48 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -59.28 -21.9 60.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.96 -30.19 24.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.3 -9.82 6.56 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.9 173.91 0.13 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.084 -1.245 . . . . 0.0 109.349 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.597 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.5 tt -148.17 111.14 4.83 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.124 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.409 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.1 tt -106.82 151.47 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.94 147.08 52.44 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.423 -0.798 . . . . 0.0 109.439 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.559 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -127.73 170.36 12.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.5 mtp -150.6 167.77 26.29 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.675 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.5 m -149.31 151.31 33.94 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.82 94.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.53 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.15 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.19 23.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.808 HG21 HG11 ' A' ' 21' ' ' VAL . 24.7 m -117.23 -178.86 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.5 t -157.86 118.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.589 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.755 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -97.9 121.52 39.92 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.559 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.6 m -119.93 134.62 55.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.224 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -139.86 108.43 5.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 120' ' ' ILE . 43.5 t -72.39 140.38 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.2 m-85 -129.07 128.79 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.2 137.63 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -49.48 128.33 17.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.233 -0.917 . . . . 0.0 111.687 -178.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.4 tm-20 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.807 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.45 0.643 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.543 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -99.06 -2.13 37.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.7 p -71.82 118.74 15.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.955 . . . . 0.0 111.943 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.64 -173.62 38.04 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.6 m120 -95.36 170.67 9.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -150.91 128.12 11.23 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.488 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -121.66 116.36 24.42 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 132' ' ' ARG . 9.4 tt -59.48 141.84 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.525 0.678 . . . . 0.0 110.294 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -119.52 -23.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.875 -0.516 . . . . 0.0 110.101 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -145.66 176.73 9.41 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 176.29 165.43 0.43 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -159.32 25.77 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.091 -1.006 . . . . 0.0 111.292 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.4 m-20 -160.85 29.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.665 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.49 -65.66 0.65 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 0.0 109.008 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.6 mt-10 -56.68 -27.07 58.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.81 -40.9 97.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.667 -0.645 . . . . 0.0 109.791 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.781 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.8 tp -77.75 -16.73 58.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.662 -0.649 . . . . 0.0 110.091 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.7 mt -89.43 -19.24 25.39 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.055 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.1 mmmt -85.57 -28.6 24.76 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 128' ' ' VAL . 14.9 p -79.57 -41.06 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.69 -53.13 45.29 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.018 0.913 . . . . 0.0 108.935 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.75 -146.26 17.13 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 25' ' ' ASN . 19.3 m -155.93 -43.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' N ' HG23 ' A' ' 24' ' ' VAL . 5.1 t30 -56.95 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.518 -0.739 . . . . 0.0 109.56 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' NH2' ' A' ' 29' ' ' ARG . 2.1 m -109.83 -44.49 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.416 -0.802 . . . . 0.0 109.899 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.1 ttm -66.3 -27.27 67.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.8 mm? -57.71 -41.9 82.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.675 -0.641 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.844 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.2 mtp180 -71.36 -42.66 68.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -62.44 -20.24 64.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.755 -0.59 . . . . 0.0 111.115 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 28' ' ' LEU . 45.4 mt -79.47 -30.04 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 108.879 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.6 32.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.7 t -79.13 -35.93 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.69 -36.17 51.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.91 79.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' A' ' 39' ' ' PRO . . . -69.42 -67.56 0.47 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 49.23 52.08 15.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 67.36 73.7 0.36 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.46 158.35 54.23 Favored 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.017 1.811 . . . . 0.0 110.795 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.51 173.13 6.45 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.743 -0.598 . . . . 0.0 109.528 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 54' ' ' THR . 48.8 t -155.0 164.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 tt0 -148.68 111.53 4.82 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -97.9 132.59 42.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.786 0.803 . . . . 0.0 110.054 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -111.78 106.49 15.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -97.47 123.97 41.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.064 -1.022 . . . . 0.0 111.176 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -123.62 55.22 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -126.03 8.15 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.97 -1.09 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -1.034 . . . . 0.0 110.143 178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.44 136.05 37.47 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.782 -1.199 . . . . 0.0 108.551 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.9 m-85 -130.96 115.66 16.8 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.6 t80 -102.29 148.17 25.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.964 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -145.17 99.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.019 -1.05 . . . . 0.0 110.389 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -99.25 113.71 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.766 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 41' ' ' VAL . 34.0 m -100.53 144.7 29.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.799 . . . . 0.0 108.964 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 136.9 32.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.46 -0.775 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.916 0.865 . . . . 0.0 109.708 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -101.84 173.87 6.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.8 . . . . 0.0 109.55 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -172.27 118.96 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.773 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 52' ' ' ILE . 40.2 pt -108.56 169.55 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.517 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 132.82 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.764 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.92 -172.21 3.18 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.069 0.938 . . . . 0.0 111.739 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -131.53 154.53 48.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.58 95.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.187 -0.945 . . . . 0.0 109.636 -178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.66 -21.8 0.62 Allowed Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.606 -1.283 . . . . 0.0 111.038 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -135.82 163.57 29.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -1.144 . . . . 0.0 110.714 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.1 mt-10 -86.28 169.31 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.4 p90 -162.6 174.39 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -103.14 144.78 30.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -161.89 178.65 8.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.84 151.61 21.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.4 t -88.26 -142.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.485 -0.759 . . . . 0.0 109.125 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 22.5 t -112.2 -19.77 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.741 -1.224 . . . . 0.0 110.657 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t70 -88.75 -41.31 12.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 44.25 0.1 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mtp180 -131.63 147.19 65.04 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.666 -0.902 . . . . 0.0 108.89 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD11 ' A' ' 100' ' ' LEU . 37.8 Cg_endo -79.8 142.72 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.441 1.427 . . . . 0.0 110.237 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.3 p -161.05 143.24 12.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.645 -0.66 . . . . 0.0 109.569 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -89.64 114.36 25.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.6 t -98.91 176.29 5.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.706 -0.621 . . . . 0.0 109.71 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -150.32 154.41 37.79 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.1 t -143.33 129.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.089 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.94 155.46 39.55 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.9 m95 -79.67 173.16 12.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -135.39 -46.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -130.7 -153.61 0.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.08 -25.77 52.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.08 26.85 1.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 110.892 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 78.8 tttt -132.15 109.58 10.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.0 108.078 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.46 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.6 OUTLIER -115.66 150.36 36.87 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.243 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -100.09 173.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.522 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.4 t -149.81 135.84 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.04 163.3 12.65 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -160.92 138.69 9.42 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.798 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -152.46 144.55 23.82 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.576 HD22 HH21 ' A' ' 79' ' ' ARG . 7.5 mt -58.74 164.27 2.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 110.651 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -107.87 5.6 26.58 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.412 ' N ' HD12 ' A' ' 100' ' ' LEU . 22.9 tptt -153.75 113.14 3.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.99 -163.83 45.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -176.34 140.97 0.4 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.393 -1.063 . . . . 0.0 110.066 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.67 -86.95 0.06 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.31 -176.49 2.59 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.846 1.697 . . . . 0.0 109.695 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -131.55 139.87 49.33 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 145.15 49.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.121 0.963 . . . . 0.0 110.84 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.88 137.04 6.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -142.79 175.44 9.82 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.986 -1.085 . . . . 0.0 110.56 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.643 HG22 HG13 ' A' ' 94' ' ' VAL . 13.2 p -137.91 172.67 12.59 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.551 0.691 . . . . 0.0 110.028 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.492 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 21.8 ptm -157.84 128.59 6.43 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.9 pt-20 -131.67 154.89 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.586 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.13 144.71 41.05 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -91.99 162.19 14.48 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.585 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -61.36 -21.1 63.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.22 -26.58 24.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.15 -8.13 8.57 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 48.6 mt-10 -58.7 172.94 0.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.113 -1.227 . . . . 0.0 109.234 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.727 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.92 110.36 5.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.501 -0.749 . . . . 0.0 109.618 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' A' ' 133' ' ' VAL . 14.0 tt -106.08 145.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -130.22 133.07 46.28 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.713 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.78 165.97 11.28 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.468 ' O ' HG22 ' A' ' 129' ' ' VAL . 12.1 mtp -144.14 164.52 30.46 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.383 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 m -147.4 151.4 36.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.68 95.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.17 -80.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.33 24.89 1.25 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.525 -0.734 . . . . 0.0 109.168 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -118.34 -178.93 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.94 118.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.781 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.49 112.18 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -106.32 143.61 34.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 9' ' ' ILE . 20.7 mtt180 -150.5 105.23 3.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 120' ' ' ILE . 53.7 t -69.47 133.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 30.1 m-85 -121.2 123.5 42.41 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.075 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.32 139.71 26.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.59 128.08 16.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.221 -0.925 . . . . 0.0 111.351 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.245 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.606 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.9 m-85 -99.42 -11.36 21.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -67.78 117.42 9.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 111.841 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.45 -173.46 38.73 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.9 m120 -95.45 170.84 9.08 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.45 128.12 10.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.666 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 12.4 mmtt -122.48 116.32 23.74 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 132' ' ' ARG . 10.0 tt -58.94 142.07 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.587 0.708 . . . . 0.0 110.474 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.3 -24.26 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.959 -0.463 . . . . 0.0 110.068 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -143.25 174.83 10.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.277 -0.889 . . . . 0.0 110.08 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 178.42 163.1 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.34 24.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 111.457 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 76.0 m-20 -160.59 27.37 0.15 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.981 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.1 t80 -65.16 -64.76 0.79 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 110.192 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 27.2 tt0 -55.86 -31.0 62.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.581 -0.699 . . . . 0.0 111.296 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 7.0 pt-20 -73.1 -31.51 64.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.51 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.856 HD22 ' CB ' ' A' ' 130' ' ' CYS . 27.4 tp -75.58 -19.42 59.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.828 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.02 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -90.17 -18.18 26.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 109.388 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.8 mtmt -84.6 -32.63 23.64 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 128' ' ' VAL . 14.2 p -74.61 -39.96 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -68.04 -45.59 73.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.756 0.788 . . . . 0.0 109.458 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.94 -159.97 27.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 t -144.61 -41.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.982 -0.717 . . . . 0.0 109.722 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.4 t30 -60.64 -162.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG13 ' NH1' ' A' ' 29' ' ' ARG . 2.2 t -117.63 -49.02 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.409 ' O ' HD12 ' A' ' 31' ' ' ILE . 1.4 ttt -67.41 -27.73 67.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -58.15 -19.62 34.25 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.79 -0.569 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -92.72 -49.26 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.16 -0.962 . . . . 0.0 109.59 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -62.25 -20.25 64.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.645 -0.659 . . . . 0.0 110.793 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 27' ' ' MET . 19.6 mt -78.42 -29.64 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.16 -25.62 34.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.2 t -77.52 -36.98 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.41 -34.16 48.2 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.64 93.97 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.463 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.33 -67.87 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.67 52.41 14.96 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 67.25 73.41 0.37 Allowed Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.61 155.9 58.44 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 C-N-CA 122.055 1.837 . . . . 0.0 110.829 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . . . -102.47 172.99 6.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 HG23 ' A' ' 54' ' ' THR . 53.4 t -155.49 164.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.465 ' N ' HG12 ' A' ' 41' ' ' VAL . 48.5 tt0 -151.11 110.6 3.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.79 HG13 HG23 ' A' ' 52' ' ' ILE . 1.8 mp -98.65 141.99 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.817 0.818 . . . . 0.0 110.543 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.36 111.93 18.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.36 117.73 33.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.97 -1.081 . . . . 0.0 111.026 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.63 50.05 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -125.43 8.11 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.8 p30 -75.66 -1.82 26.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.431 -1.04 . . . . 0.0 110.052 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 m -96.35 138.4 34.01 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.816 -1.177 . . . . 0.0 108.636 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -134.18 117.68 16.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.795 0.807 . . . . 0.0 109.217 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -103.43 147.98 26.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -144.01 104.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 C-N-CA 118.974 -1.091 . . . . 0.0 111.445 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.13 113.61 26.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.514 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.665 HG23 HG22 ' A' ' 41' ' ' VAL . 31.9 m -103.28 142.35 34.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.87 143.16 38.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.917 0.865 . . . . 0.0 109.43 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 165.31 23.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 109.974 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -164.12 118.69 1.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 52' ' ' ILE . 31.9 pt -121.87 165.99 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 108.93 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.15 127.59 3.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.742 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.9 p90 -162.18 -172.64 3.29 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.009 -1.076 . . . . 0.0 111.763 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -131.12 154.65 48.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.57 95.05 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.92 . . . . 0.0 109.828 -178.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.87 -20.04 0.67 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.13 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -135.02 162.18 33.19 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.185 -1.185 . . . . 0.0 110.841 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.43 165.63 16.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.7 p90 -161.75 173.84 14.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -101.73 144.77 30.01 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.1 pt-20 -162.18 -178.28 6.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -99.66 155.69 17.48 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.7 t -92.91 -142.33 0.21 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 109.325 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -111.2 -21.01 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.717 -1.239 . . . . 0.0 110.837 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -88.75 -40.0 13.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.67 45.19 0.11 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 34.8 mtp180 -131.96 150.62 76.64 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.708 -0.878 . . . . 0.0 109.161 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.79 141.68 17.26 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.676 1.584 . . . . 0.0 110.408 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.7 p -161.19 141.46 10.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.645 -0.659 . . . . 0.0 109.862 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.796 ' HB2' HD21 ' A' ' 100' ' ' LEU . 10.3 ttmt -89.7 114.17 25.79 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -99.68 174.05 6.42 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.301 0.572 . . . . 0.0 110.416 -178.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 85' ' ' VAL . 44.4 tp -148.05 152.39 37.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.742 HG21 ' CE2' ' A' ' 65' ' ' PHE . 7.0 t -142.36 126.89 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.976 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -122.33 155.2 36.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.555 ' CE2' HG21 ' A' ' 67' ' ' VAL . 79.0 m95 -77.42 176.22 9.06 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.892 0.854 . . . . 0.0 110.242 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.2 tp10 -138.44 -46.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.1 p -131.01 -152.51 0.51 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.6 -25.42 45.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -142.8 27.63 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.4 tttp -132.98 113.31 12.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.935 -1.103 . . . . 0.0 108.283 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.494 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -120.37 150.44 40.75 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.521 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.82 172.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.5 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.0 t -149.89 134.81 17.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -103.95 165.21 11.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -160.87 138.93 9.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.84 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -144.84 148.9 34.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.5 mt -60.86 166.86 3.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 0.0 110.994 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.5 mt -101.54 -3.56 28.28 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -150.8 130.34 13.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 108.892 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.93 -157.4 42.66 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -176.43 140.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.47 -1.018 . . . . 0.0 109.863 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.39 -87.3 0.06 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.64 -176.82 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 C-N-CA 121.8 1.666 . . . . 0.0 109.645 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -130.66 138.52 50.1 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.67 144.83 48.88 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.189 0.995 . . . . 0.0 110.734 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.9 m -163.44 136.67 5.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -139.21 172.38 12.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.707 HG22 HG13 ' A' ' 94' ' ' VAL . 16.8 p -136.43 170.16 16.5 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.476 0.655 . . . . 0.0 109.848 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.424 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 7.1 ptp -154.01 137.16 15.6 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -134.01 146.26 50.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.392 -0.817 . . . . 0.0 109.225 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.7 141.53 42.18 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -90.27 160.65 16.05 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.791 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -21.45 61.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.657 -0.652 . . . . 0.0 110.078 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -85.08 -29.49 24.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.99 -9.21 7.12 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.12 172.2 0.31 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.158 -1.201 . . . . 0.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -145.14 107.98 4.49 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.097 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -101.87 150.73 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -135.03 133.68 39.64 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.59 8.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 129' ' ' VAL . 11.8 mtp -148.41 166.78 27.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.742 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.1 m -150.07 148.07 28.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.668 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.56 93.05 1.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.521 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.79 -78.26 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -147.07 23.72 1.18 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.6 m -118.31 -179.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.7 t -156.41 119.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.46 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.856 ' CB ' HD22 ' A' ' 18' ' ' LEU . 2.2 t -98.39 118.46 35.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -112.92 143.37 44.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.762 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 9' ' ' ILE . 24.0 mtm180 -150.82 105.01 3.22 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.2 133.05 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.4 m-85 -120.83 120.81 36.65 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.154 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.14 139.98 22.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.98 128.48 18.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.196 -0.94 . . . . 0.0 111.322 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.3 tp10 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.332 0.587 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.7 m-85 -99.26 -7.85 25.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.3 p -69.11 117.54 10.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.955 . . . . 0.0 111.9 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.12 38.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.0 m120 -95.72 169.39 10.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.924 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.08 122.23 7.73 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.687 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -114.28 112.82 23.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.9 tt -56.53 146.93 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 110.67 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -127.64 -23.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.62 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -143.46 173.46 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t 169.57 168.51 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.66 28.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.013 -1.054 . . . . 0.0 112.02 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.428 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.01 31.69 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.205 -0.934 . . . . 0.0 109.106 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.916 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.0 -62.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 110.019 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.49 -31.15 67.59 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 111.097 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -71.18 -26.55 63.01 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.696 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.9 tp -81.76 -21.38 37.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.424 -0.797 . . . . 0.0 109.975 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.936 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -86.94 -17.62 32.72 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.099 -1.001 . . . . 0.0 109.305 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.6 mtmt -85.05 -34.64 22.24 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -73.69 -40.54 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 77' ' ' ASP . 5.0 mp -67.32 -46.11 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.828 0.823 . . . . 0.0 108.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -162.59 27.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.98 -37.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.831 -0.805 . . . . 0.0 110.183 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.2 t30 -62.0 -158.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.443 -0.786 . . . . 0.0 109.163 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.646 HG13 HH21 ' A' ' 29' ' ' ARG . 1.8 t -125.07 -47.56 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 109.316 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 ttt -68.08 -28.42 67.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -59.39 -19.26 45.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.737 -0.602 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -95.58 -47.4 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 109.876 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -62.73 -22.58 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.612 -0.68 . . . . 0.0 110.569 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.42 -28.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.842 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.936 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.88 -25.59 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.3 t -76.67 -38.9 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.62 57.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.4 95.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.544 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -66.63 -65.57 0.66 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.627 -0.671 . . . . 0.0 109.237 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p 47.89 55.3 8.76 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.671 0.748 . . . . 0.0 109.082 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 69.29 72.73 0.32 Allowed Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.67 162.66 41.42 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.146 1.898 . . . . 0.0 110.808 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.97 172.8 6.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.711 -0.618 . . . . 0.0 109.432 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.762 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -154.07 165.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 47.3 tt0 -150.69 110.75 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.924 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mt -98.34 137.1 26.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.677 0.751 . . . . 0.0 110.335 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.63 112.08 21.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.4 tt0 -98.24 121.7 40.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.008 -1.057 . . . . 0.0 111.106 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -121.52 51.77 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -125.4 7.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -76.27 -0.95 24.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.415 -1.05 . . . . 0.0 110.102 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 m -96.68 140.93 30.56 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.789 -1.194 . . . . 0.0 108.353 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.8 m-85 -136.07 115.33 12.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.923 0.868 . . . . 0.0 109.718 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.1 t80 -101.04 147.03 26.67 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 63' ' ' ILE . 3.0 mt -142.31 100.92 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.989 -1.07 . . . . 0.0 110.327 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 2.2 tttt -98.8 114.64 27.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.535 -0.728 . . . . 0.0 109.961 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.762 HG23 HG22 ' A' ' 41' ' ' VAL . 7.1 m -99.22 142.2 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 p -136.54 118.32 15.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.357 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.3 p -92.43 176.04 6.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.102 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.7 pt-20 -172.4 139.81 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 52' ' ' ILE . 31.2 pt -128.66 170.07 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.55 130.76 3.96 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.9 p90 -161.58 -172.2 3.25 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.896 -1.121 . . . . 0.0 112.062 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -128.89 153.31 47.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 96.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.529 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.6 -32.28 1.61 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.56 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -113.64 155.8 24.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -1.069 . . . . 0.0 109.893 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.0 mt-10 -86.33 167.72 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 17.2 p90 -162.14 173.08 14.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.551 -0.718 . . . . 0.0 109.809 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -104.24 144.52 31.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.13 -175.75 4.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -99.53 156.88 16.81 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.4 t -94.39 -142.1 0.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 109.22 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.45 -20.57 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.712 -1.242 . . . . 0.0 110.828 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.82 -38.18 13.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 109.428 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 44.13 0.15 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.682 ' H ' HG22 ' A' ' 75' ' ' THR . 2.1 mtm-85 -130.28 151.9 79.26 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 121.656 -0.908 . . . . 0.0 109.256 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.66 141.06 17.1 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.644 1.563 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.6 p -160.75 140.79 11.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.683 -0.636 . . . . 0.0 109.692 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.758 ' HB2' HD21 ' A' ' 100' ' ' LEU . 26.7 ttpt -90.85 113.96 26.26 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -102.74 177.76 4.76 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.224 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 85' ' ' VAL . 50.3 tp -152.94 153.15 32.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.7 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.0 t -141.37 127.72 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.874 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 155.78 33.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.536 ' NE1' HG21 ' A' ' 67' ' ' VAL . 84.2 m95 -78.69 172.38 13.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 109.851 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -133.44 -47.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 p -132.17 -151.69 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.98 -26.87 48.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.308 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -140.2 23.93 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 111.466 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 53.0 tttp -131.83 111.69 11.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.749 -1.22 . . . . 0.0 108.451 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.477 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.71 149.26 40.13 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.119 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.63 173.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.517 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -149.45 130.35 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 110.887 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -101.97 163.45 12.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -160.34 143.8 13.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.006 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -146.18 151.38 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.405 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.23 166.66 5.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.935 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 82' ' ' LYS . 50.6 mt -101.03 -4.11 28.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 108.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.6 -157.03 42.09 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -177.34 140.43 0.28 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.514 -0.992 . . . . 0.0 109.529 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.19 -85.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.59 -176.84 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.82 1.68 . . . . 0.0 109.956 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -136.12 141.26 44.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.05 145.09 48.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.125 0.964 . . . . 0.0 110.596 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 p -162.79 129.65 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -136.57 173.69 11.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.226 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 94' ' ' VAL . 9.2 p -135.84 172.43 13.03 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.54 0.686 . . . . 0.0 109.901 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.464 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 9.8 ptm -155.91 124.84 6.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.94 152.7 39.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.899 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.55 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.75 142.13 46.93 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.8 p -91.77 160.09 15.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -60.45 -21.8 62.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -83.76 -29.7 27.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.137 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.47 -9.01 7.36 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -57.32 172.44 0.32 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.12 -1.223 . . . . 0.0 109.061 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.697 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.62 110.13 5.04 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.86 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.6 tt -105.99 148.97 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.58 145.95 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.668 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.59 169.65 11.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.419 -1.696 . . . . 0.0 106.419 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 35.4 mtp -151.66 164.26 37.32 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.574 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 129' ' ' VAL . 7.6 m -146.34 152.51 39.22 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.653 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.94 97.61 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.635 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.97 -79.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.43 24.27 1.01 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.566 -0.709 . . . . 0.0 109.342 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.1 m -119.54 -179.73 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.05 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.593 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 5.8 t -99.27 131.65 45.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.2 m -123.39 127.58 48.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -125.18 102.56 7.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.68 134.13 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.5 m-85 -124.15 129.99 51.77 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.604 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.91 138.45 40.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -48.73 125.28 9.81 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 0.0 111.285 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.6 179.647 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.62 -0.85 42.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -71.12 117.14 12.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.128 -0.983 . . . . 0.0 112.023 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.5 -172.18 38.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.78 168.26 10.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -151.88 125.0 8.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.493 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -120.86 115.36 23.09 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.5 tt -56.29 139.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.556 0.693 . . . . 0.0 110.582 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.15 -24.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.852 -0.53 . . . . 0.0 109.823 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -142.93 174.41 10.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.356 -0.84 . . . . 0.0 110.075 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.535 ' HB2' HD11 ' A' ' 9' ' ' ILE . 20.7 t 178.86 164.51 0.84 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.45 25.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 74.8 m-20 -160.5 27.76 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.709 -0.619 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.905 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.49 -66.94 0.47 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.1 tt0 -55.54 -27.78 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.488 -0.757 . . . . 0.0 109.672 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -63.6 -40.56 97.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.674 -0.641 . . . . 0.0 110.205 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.7 tp -79.59 -16.44 55.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.2 mt -90.67 -17.49 26.72 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.97 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.3 mmmt -85.6 -30.45 23.3 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -77.55 -40.2 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.37 -47.5 70.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.86 0.838 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -156.12 26.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.2 -36.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.925 -0.75 . . . . 0.0 110.311 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.937 ' HB2' HD22 ' A' ' 28' ' ' LEU . 4.7 t30 -62.41 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 27' ' ' MET . 5.1 m -132.0 -47.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.661 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.408 ' N ' HG23 ' A' ' 26' ' ' VAL . 9.7 ttt -69.58 -33.13 72.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.1 mp -48.05 -34.62 9.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.937 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 -42.88 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -61.96 -19.8 63.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.687 -0.633 . . . . 0.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.31 -29.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 108.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.47 -25.77 33.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.7 t -77.33 -39.86 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.5 62.88 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.57 94.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.01 -67.62 0.44 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.36 55.22 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.4 mttm 65.08 73.35 0.43 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.5 Cg_endo -71.46 151.95 59.8 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.031 1.821 . . . . 0.0 110.822 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -101.87 173.64 6.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 54' ' ' THR . 46.4 t -155.8 164.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.8 tt0 -147.77 111.98 5.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -98.01 131.47 44.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.805 0.812 . . . . 0.0 110.348 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -110.82 107.83 17.45 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.6 tt0 -97.63 123.81 41.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.114 -0.991 . . . . 0.0 111.177 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -124.17 54.43 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.41 -126.93 8.65 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.18 -1.09 24.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -1.049 . . . . 0.0 110.088 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m -96.81 136.8 36.84 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.763 -1.211 . . . . 0.0 108.394 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.5 m-85 -131.81 116.04 16.73 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.877 0.846 . . . . 0.0 109.346 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.1 t80 -101.42 147.98 25.71 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.88 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -144.77 100.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.982 -1.074 . . . . 0.0 110.328 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 112.1 24.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 41' ' ' VAL . 29.9 m -99.1 146.31 26.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.8 p -139.3 132.16 29.26 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.4 m . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.229 0.538 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.19 176.97 4.9 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.0 pt-20 -168.4 124.25 0.99 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.908 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.88 HD11 HD12 ' A' ' 52' ' ' ILE . 37.6 pt -111.68 170.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p-10 -162.74 133.99 5.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.133 -0.98 . . . . 0.0 109.467 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.3 p90 -161.92 -171.66 2.97 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.372 1.082 . . . . 0.0 112.615 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -129.62 152.65 48.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 95.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.19 -29.86 1.49 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.733 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -119.24 157.32 28.27 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.302 -1.117 . . . . 0.0 110.035 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HG2' HD22 ' A' ' 84' ' ' LEU . 21.1 mt-10 -86.14 169.15 13.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.594 -0.691 . . . . 0.0 109.22 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.5 p90 -162.13 174.09 13.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 0.0 109.765 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.55 145.87 29.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.14 -177.71 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.472 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -104.66 157.75 16.97 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.211 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.859 HG23 ' SG ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -95.36 -170.4 2.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.333 -0.854 . . . . 0.0 110.19 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.92 -20.71 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.89 -0.506 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.54 -41.66 13.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.73 43.63 0.2 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -127.9 152.19 76.89 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 121.628 -0.925 . . . . 0.0 109.142 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.61 137.36 14.43 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.336 1.357 . . . . 0.0 110.21 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' HG23 ' A' ' 75' ' ' THR . 12.8 p -160.69 142.47 12.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.656 -0.653 . . . . 0.0 109.466 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.763 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -86.79 117.35 25.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.5 t -99.14 166.52 11.2 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.494 HD22 ' HG2' ' A' ' 70' ' ' GLU . 56.3 tp -147.28 153.97 40.4 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 65' ' ' PHE . 21.3 t -145.79 131.16 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.019 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.1 pttt -125.63 159.9 31.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.572 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.3 m95 -82.86 170.04 15.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -133.4 -46.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 p -131.18 -154.28 0.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -77.66 -25.53 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.594 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -141.85 26.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 31.8 tttm -131.42 108.77 9.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.885 -1.134 . . . . 0.0 108.316 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.522 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -113.88 145.96 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.513 -0.742 . . . . 0.0 110.286 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 110' ' ' THR . 2.5 t -99.91 172.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.526 ' H ' HG12 ' A' ' 94' ' ' VAL . 54.0 t -148.4 139.59 23.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.29 163.15 13.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 7.3 tt0 -160.5 137.99 9.45 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.729 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -144.5 147.52 33.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.46 166.83 2.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 82' ' ' LYS . 58.0 mt -101.17 -3.43 29.13 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -156.01 139.94 16.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 108.79 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.17 -162.68 35.68 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -176.49 139.33 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.41 -1.053 . . . . 0.0 109.947 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.75 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.67 -176.88 2.65 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.824 1.683 . . . . 0.0 109.663 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -132.61 141.38 48.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.44 144.42 49.52 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.163 0.982 . . . . 0.0 110.861 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -163.67 138.66 6.19 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -140.66 172.52 12.6 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.953 -1.092 . . . . 0.0 110.729 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.723 HG22 HG13 ' A' ' 94' ' ' VAL . 17.9 p -134.16 169.16 17.59 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 109.422 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.635 ' HG3' HD23 ' A' ' 121' ' ' LEU . 2.1 ttt -154.53 122.01 5.74 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -118.82 154.62 32.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.478 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -118.7 144.96 45.88 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.3 p -96.83 161.36 13.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.791 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -22.38 63.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -84.36 -27.94 27.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.295 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.52 -11.1 7.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.87 172.12 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.067 -1.255 . . . . 0.0 109.073 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.585 HD11 ' HD2' ' A' ' 3' ' ' PHE . 8.0 tt -149.72 113.64 5.1 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.648 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -98.62 155.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.801 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.81 111.72 8.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -101.35 168.63 9.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.451 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.9 mtp -145.73 169.19 18.97 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.64 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.0 m -151.31 150.48 30.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.34 91.41 1.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.448 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -78.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.24 23.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.572 -0.705 . . . . 0.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.5 m -117.68 -179.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.8 t -156.7 119.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.474 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.722 ' CB ' HD22 ' A' ' 18' ' ' LEU . 3.2 t -98.08 109.92 22.59 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 122' ' ' THR . 39.1 m -101.48 147.0 26.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 9' ' ' ILE . 60.8 mtm180 -152.19 97.26 2.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.48 129.97 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -116.47 124.3 49.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.49 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.83 139.0 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.474 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -48.1 125.15 8.69 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.051 -0.976 . . . . 0.0 111.66 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.653 0.74 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.5 m-85 -99.56 1.22 43.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.665 -0.647 . . . . 0.0 109.573 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -73.04 118.19 15.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.117 -0.989 . . . . 0.0 111.939 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.47 -172.52 38.57 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.3 m120 -95.16 168.29 10.84 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -150.11 123.23 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.552 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -118.58 113.5 21.35 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 132' ' ' ARG . 8.8 tt -56.93 145.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.711 0.767 . . . . 0.0 110.806 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.4 pp -126.55 -23.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.331 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HG3' HD12 ' A' ' 10' ' ' ILE . 2.3 mtt180 -141.54 175.62 9.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 0.0 110.468 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 169.15 168.04 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.06 30.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.877 -1.139 . . . . 0.0 112.036 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 32.95 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.195 -0.941 . . . . 0.0 108.975 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.994 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -66.35 -63.73 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.55 -0.719 . . . . 0.0 110.331 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 3.7 mt-10 -58.23 -27.17 63.71 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.497 -0.752 . . . . 0.0 111.25 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -73.08 -28.07 62.09 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.423 -178.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.6 tp -84.82 -17.69 37.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 110.277 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 15' ' ' PHE . 7.8 mt -90.33 -16.8 28.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.014 -1.054 . . . . 0.0 109.049 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' NE ' ' A' ' 29' ' ' ARG . 1.3 mmmm -86.52 -33.09 20.41 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -74.17 -40.36 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.48 -48.45 67.11 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.867 0.841 . . . . 0.0 109.05 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.65 -150.61 23.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.0 m -155.19 -43.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.922 -0.752 . . . . 0.0 109.275 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 5.4 t30 -56.72 -175.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.529 -0.732 . . . . 0.0 109.576 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.1 m -108.35 -44.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 0.0 110.034 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttt -68.23 -25.83 65.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 108.933 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.6 mm? -58.46 -34.97 71.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.63 -0.669 . . . . 0.0 110.66 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -76.37 -47.47 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.08 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -24.8 67.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 111.149 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.97 -28.47 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.304 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.978 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.76 -26.03 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 0.0 109.266 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.5 t -77.57 -39.43 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.1 60.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.68 97.06 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.449 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.38 -68.84 0.29 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m 50.13 52.3 15.0 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 64.22 73.33 0.47 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.4 Cg_endo -71.32 153.22 61.55 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.051 1.834 . . . . 0.0 110.728 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.36 174.15 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.686 -0.634 . . . . 0.0 109.532 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 54' ' ' THR . 48.3 t -154.98 164.21 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 6.8 tp10 -145.71 110.86 5.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -99.05 132.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.442 -0.786 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -112.38 114.45 27.18 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.77 119.55 37.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -119.06 52.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 -125.24 7.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.626 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.2 p30 -76.88 -0.43 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.388 -1.066 . . . . 0.0 109.953 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.5 m -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.841 -1.162 . . . . 0.0 108.648 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -135.71 115.5 13.0 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.842 0.829 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.0 147.52 26.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.95 105.09 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.983 -1.073 . . . . 0.0 111.196 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.67 112.07 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.654 HG23 HG22 ' A' ' 41' ' ' VAL . 23.9 m -99.52 141.73 31.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.77 120.22 18.07 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.246 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 167.55 16.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 109.315 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -160.22 124.17 3.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 109.785 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 52' ' ' ILE . 36.4 pt -123.71 165.56 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.545 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.3 128.13 3.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.043 -1.035 . . . . 0.0 109.669 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.5 p90 -162.04 -172.02 3.08 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.622 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.04 154.6 49.23 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.63 93.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -178.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.49 -24.16 0.51 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -132.43 161.93 32.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -1.075 . . . . 0.0 110.47 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.68 168.8 13.25 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.671 -0.643 . . . . 0.0 109.359 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 16.6 p90 -162.06 173.59 14.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.699 -0.626 . . . . 0.0 109.456 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.25 144.18 31.1 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.722 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.9 pt-20 -162.24 -175.98 4.87 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -100.07 157.6 16.44 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 79' ' ' ARG . 9.7 t -93.59 -141.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.345 -0.847 . . . . 0.0 108.856 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' N ' HG23 ' A' ' 75' ' ' THR . 25.9 t -112.81 -18.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.695 -1.253 . . . . 0.0 110.77 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -91.37 -37.41 13.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.97 45.64 0.12 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.7 151.03 76.34 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.883 . . . . 0.0 109.193 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.76 141.06 16.89 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.675 1.583 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -161.05 142.18 11.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.655 -0.653 . . . . 0.0 109.592 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.8 ttpt -87.97 117.31 26.74 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -99.32 162.27 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.733 -0.605 . . . . 0.0 109.837 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.6 tp -139.87 153.5 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.1 t -146.98 128.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.379 -1.329 . . . . 0.0 112.171 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 155.46 37.48 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE2' HG21 ' A' ' 67' ' ' VAL . 80.7 m95 -78.18 174.64 10.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 109.89 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -137.45 -46.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.1 p -130.9 -153.23 0.55 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.55 -24.87 45.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.725 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -143.09 28.13 1.56 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 110.502 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.1 tttm -133.79 110.43 9.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.888 -1.133 . . . . 0.0 108.277 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.512 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -117.47 149.68 40.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.861 . . . . 0.0 110.141 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.7 172.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.511 ' H ' HG12 ' A' ' 94' ' ' VAL . 45.7 t -148.55 138.32 22.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -105.22 164.02 12.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -160.06 132.99 6.65 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.515 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -141.18 149.25 41.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.16 167.51 3.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.641 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.0 mt -96.19 -8.42 33.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -158.08 156.19 30.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.67 -162.74 20.34 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -176.85 139.06 0.28 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.512 -0.993 . . . . 0.0 109.829 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.77 -84.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.42 -176.95 2.74 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.938 1.758 . . . . 0.0 109.994 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -137.12 139.94 41.57 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 146.32 48.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.092 0.948 . . . . 0.0 110.759 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.18 137.86 6.34 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.9 p-90 -144.18 175.96 9.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.74 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 94' ' ' VAL . 13.1 p -138.33 169.85 17.06 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.532 0.682 . . . . 0.0 109.955 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.519 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 20.5 ptm -152.8 124.16 7.65 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -124.38 153.04 42.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.957 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.9 45.33 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.4 p -91.06 161.11 15.25 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.5 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.91 -20.72 62.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -28.3 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.48 -8.36 7.85 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 44.0 mt-10 -58.25 172.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -1.202 . . . . 0.0 109.146 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.84 110.46 5.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.151 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 133' ' ' VAL . 11.1 tt -105.35 143.9 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -128.23 131.49 48.8 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.48 163.71 12.83 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 21.6 mtp -142.49 160.13 40.87 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.039 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 129' ' ' VAL . 7.7 m -143.4 152.88 42.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.62 98.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.54 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.21 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.62 23.86 0.99 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.517 -0.74 . . . . 0.0 109.534 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.2 m -120.15 -179.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.54 116.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.659 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.713 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.0 t -99.65 112.06 24.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.8 m -100.85 151.47 21.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.9 mtm180 -150.63 102.43 3.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 120' ' ' ILE . 52.5 t -67.02 133.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.3 m-85 -121.55 120.29 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.907 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.89 142.86 16.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.475 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -50.08 126.14 13.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.303 -0.873 . . . . 0.0 111.146 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.961 -1.018 . . . . 0.0 111.752 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.523 0.677 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -98.01 -2.49 40.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -71.96 118.01 14.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 112.028 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.52 -173.84 38.83 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.3 m120 -95.16 171.45 8.73 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.874 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -151.13 126.95 10.29 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.014 -1.075 . . . . 0.0 112.777 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.49 118.04 31.1 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.833 HD11 ' HB3' ' A' ' 12' ' ' SER . 13.6 tt -61.85 150.86 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.871 0.843 . . . . 0.0 111.016 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.65 -30.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.627 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -141.96 165.8 26.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 108.917 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 9' ' ' ILE . 56.9 p -177.01 147.19 0.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 0.0 109.469 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -145.61 165.65 28.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 109.953 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.2 m-80 62.64 32.69 16.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.581 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.937 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.35 -64.22 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.472 -0.767 . . . . 0.0 110.188 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.727 ' CD ' HG21 ' A' ' 33' ' ' VAL . 4.5 mm-40 -57.41 -36.08 70.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 110.903 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.28 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.889 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.7 tp -78.89 -22.04 46.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.941 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.0 mt -89.33 -16.26 31.48 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.204 -0.935 . . . . 0.0 109.143 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.2 mmmm -87.02 -32.61 19.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.2 p -73.42 -38.3 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.6 mp -70.43 -45.12 66.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 109.562 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.84 -161.45 27.74 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.301 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.36 -36.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.925 -0.75 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.3 t30 -62.28 -148.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.462 -0.774 . . . . 0.0 109.617 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.48 -45.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.744 -1.223 . . . . 0.0 109.237 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -72.35 -26.91 62.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.3 mm? -60.22 -17.14 39.43 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.706 -0.621 . . . . 0.0 111.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -98.15 -47.77 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.578 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -62.8 -22.33 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.636 -0.665 . . . . 0.0 110.516 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 27' ' ' MET . 35.1 mt -78.05 -28.59 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 108.934 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.47 34.95 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -77.38 -37.67 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.77 -31.62 46.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.33 83.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -69.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.514 -0.741 . . . . 0.0 109.139 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m 48.79 49.09 19.49 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.658 -0.652 . . . . 0.0 109.677 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.3 mttt 65.27 72.17 0.48 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -73.15 151.26 49.18 Favored 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 122.026 1.817 . . . . 0.0 110.726 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -88.8 174.75 7.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.655 -0.653 . . . . 0.0 109.466 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 40' ' ' ALA . 10.1 t -153.58 164.91 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.0 tt0 -154.94 115.14 3.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 109.236 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -106.15 138.83 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.764 0.792 . . . . 0.0 110.279 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.44 113.51 21.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.7 tt0 -98.53 115.34 28.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.162 -0.961 . . . . 0.0 110.796 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -118.52 56.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.54 8.78 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -77.69 -0.13 25.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.366 -1.079 . . . . 0.0 110.047 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.91 137.01 36.65 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.706 -1.246 . . . . 0.0 108.555 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -132.56 117.0 17.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.783 0.802 . . . . 0.0 108.871 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.9 t80 -104.46 125.51 50.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.795 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -108.0 141.06 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.948 -1.095 . . . . 0.0 108.658 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 2.2 tttt -138.55 101.44 4.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.171 -0.956 . . . . 0.0 108.946 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 31.5 m -99.76 147.25 25.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.63 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.949 0.881 . . . . 0.0 109.451 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.9 153.29 29.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.106 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG2' ' HG3' ' A' ' 53' ' ' LYS . 10.7 mt-10 -156.23 97.78 1.8 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.51 -0.744 . . . . 0.0 109.689 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 52' ' ' ILE . 24.2 pt -105.34 167.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.506 -0.746 . . . . 0.0 109.052 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.19 135.13 5.97 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.374 -0.829 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.6 p90 -162.74 -172.29 3.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.388 1.089 . . . . 0.0 112.545 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.11 152.75 48.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.81 95.07 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.102 -0.999 . . . . 0.0 109.833 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.8 -25.06 1.63 Allowed Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.929 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.5 156.95 34.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.295 -1.12 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.748 ' HG3' HD13 ' A' ' 84' ' ' LEU . 6.2 mp0 -85.8 167.98 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.31 174.0 13.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.565 -0.709 . . . . 0.0 109.42 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.31 144.59 31.42 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.14 -177.19 5.58 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -99.65 156.99 16.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.2 -142.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.418 -0.801 . . . . 0.0 108.98 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 t -109.72 -21.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.723 -1.236 . . . . 0.0 110.672 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 2.3 t70 -88.35 -39.97 13.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 109.354 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.97 44.73 0.12 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.97 151.87 79.7 Favored Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 121.669 -0.901 . . . . 0.0 109.283 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.71 141.38 17.24 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.665 1.577 . . . . 0.0 110.604 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.2 p -161.12 141.26 10.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.5 ttmm -90.2 113.63 25.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -100.58 174.48 6.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.768 -0.582 . . . . 0.0 109.933 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.748 HD13 ' HG3' ' A' ' 70' ' ' GLU . 44.5 tp -147.92 153.47 39.11 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.9 t -141.86 128.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.465 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.2 ptpt -125.97 164.5 20.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -86.09 169.58 13.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.097 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.8 tp10 -133.19 -45.2 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -133.46 -154.25 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.81 -25.66 53.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.219 -0.925 . . . . 0.0 110.062 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -143.26 27.47 1.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 110.774 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 24.4 tttm -132.92 110.0 9.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.885 -1.134 . . . . 0.0 108.114 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.484 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 1.5 ptp -114.87 151.98 33.02 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.481 -0.762 . . . . 0.0 110.13 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.839 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -105.04 171.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.491 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.0 t -148.29 131.97 16.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 110.621 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.7 165.07 11.41 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -160.96 138.67 9.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.818 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -144.85 150.3 36.86 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.29 167.48 2.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 80' ' ' PRO . 34.6 mt -98.4 -6.88 29.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 137.95 18.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.13 -158.85 41.3 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -175.8 142.64 0.55 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.414 -1.05 . . . . 0.0 109.759 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 -85.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.5 -176.96 2.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.922 1.748 . . . . 0.0 109.93 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -136.54 135.14 38.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 145.98 47.39 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.163 0.982 . . . . 0.0 110.712 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.3 p -163.01 133.02 4.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -136.7 169.41 17.77 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.049 -1.061 . . . . 0.0 110.727 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 94' ' ' VAL . 13.5 p -134.43 170.72 15.33 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.561 0.696 . . . . 0.0 109.935 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 1.7 ptp -153.38 134.35 13.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -129.71 152.9 48.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.93 143.55 44.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.3 162.14 14.12 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.29 -22.63 65.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.077 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.13 -27.68 27.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.432 -0.793 . . . . 0.0 109.236 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.93 -9.75 7.96 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 52.5 mt-10 -56.49 172.35 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.166 -1.197 . . . . 0.0 109.18 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.6 109.69 4.89 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.919 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.4 tt -103.61 160.7 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.52 153.64 46.25 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.374 -0.829 . . . . 0.0 109.218 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.578 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.24 165.86 24.44 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 26.7 mtp -147.27 165.24 30.69 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.491 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 m -147.09 150.42 35.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.33 93.86 1.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.0 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.84 24.84 1.33 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.1 m -118.68 -179.65 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.54 117.81 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.017 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.889 ' HB2' HD22 ' A' ' 18' ' ' LEU . 8.4 t -99.93 112.5 24.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 122' ' ' THR . 91.7 m -107.39 146.73 31.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 119.74 6.29 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 120' ' ' ILE . 42.0 t -84.12 143.61 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.141 -0.974 . . . . 0.0 108.666 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -130.99 127.94 39.39 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.477 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.54 138.39 37.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.62 128.21 17.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.204 -0.935 . . . . 0.0 111.518 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.346 0.593 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -99.1 -5.74 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.1 p -68.3 117.23 9.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 111.939 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.85 -172.13 37.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.7 m120 -95.69 168.08 10.89 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.88 124.97 8.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.485 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -120.01 113.7 20.91 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.5 tt -56.42 143.21 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.563 0.697 . . . . 0.0 110.381 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -123.8 -23.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.942 -0.474 . . . . 0.0 110.181 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.544 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -141.4 178.3 7.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 t 169.13 168.81 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.76 28.93 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.898 -1.126 . . . . 0.0 112.093 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 34.99 0.11 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.816 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.18 -60.38 2.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.442 -0.786 . . . . 0.0 110.097 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.8 pt-20 -58.42 -26.86 63.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 111.082 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 2.1 pt-20 -72.79 -29.37 63.23 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.493 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.903 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.2 tp -82.28 -18.3 42.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.917 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 32' ' ' ALA . 22.9 mt -90.28 -16.35 29.47 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.149 -0.969 . . . . 0.0 109.397 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.9 mmmm -87.21 -31.76 20.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -75.54 -40.74 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 76' ' ' VAL . 4.7 mp -66.75 -49.58 65.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.953 0.882 . . . . 0.0 108.776 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.8 -147.5 19.99 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.1 m -155.34 -42.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.852 -0.793 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 24' ' ' VAL . 4.2 t30 -57.42 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 109.615 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.35 -43.71 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.362 -0.836 . . . . 0.0 110.116 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -69.88 -25.6 63.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.2 mm? -57.07 -43.9 82.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.603 -0.685 . . . . 0.0 110.694 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.2 mpp_? -63.29 -41.73 99.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.577 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -61.31 -21.5 64.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.658 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.68 -29.31 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 109.059 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.4 -26.41 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.3 t -76.52 -40.39 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.01 65.0 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.19 90.16 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -65.68 -68.69 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.1 t 49.19 51.05 16.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.432 0.634 . . . . 0.0 109.376 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm 63.75 72.36 0.55 Allowed Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -72.11 157.38 54.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.973 1.782 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -104.99 174.07 6.04 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 47.8 t -156.18 163.94 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.7 tt0 -147.24 112.26 5.45 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.3 mt -98.54 134.2 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.798 0.808 . . . . 0.0 110.497 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -113.78 109.16 18.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -97.89 120.82 38.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.035 -1.041 . . . . 0.0 111.146 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -120.93 53.57 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.44 -126.43 8.35 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.594 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -75.59 -1.25 23.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.4 -1.059 . . . . 0.0 110.095 178.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 m -96.08 137.37 35.24 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.795 -1.19 . . . . 0.0 108.619 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.4 m-85 -132.83 114.45 14.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.826 0.822 . . . . 0.0 109.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.2 t80 -100.93 148.73 24.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.115 HD12 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -144.95 103.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.009 -1.057 . . . . 0.0 110.844 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -99.81 111.49 23.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.508 -0.745 . . . . 0.0 109.023 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 22.8 m -99.53 148.27 24.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -143.41 128.82 18.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.357 -0.839 . . . . 0.0 110.45 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.583 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.457 HG22 ' OE2' ' A' ' 62' ' ' GLU . 2.6 m . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.07 168.82 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 60' ' ' THR . 2.6 mp0 -158.7 112.37 2.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.637 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.115 HD11 HD12 ' A' ' 52' ' ' ILE . 41.6 pt -115.32 165.06 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.4 p-10 -162.68 131.83 4.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.4 p90 -161.6 -171.68 3.04 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.175 0.988 . . . . 0.0 111.769 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 4.0 ptpt -132.96 155.34 49.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.8 96.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.31 -20.97 0.74 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.923 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 1.2 pt-20 -138.06 163.53 31.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.188 -1.184 . . . . 0.0 110.941 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.7 ' HG2' HD13 ' A' ' 84' ' ' LEU . 20.8 mt-10 -86.99 168.8 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.17 174.48 12.86 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -101.5 145.02 29.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.693 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.4 pt-20 -162.17 -177.11 5.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -104.62 154.17 20.28 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.374 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 77' ' ' ASP . 13.9 t -91.75 -170.28 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 HD21 ' A' ' 22' ' ' LEU . 9.8 p -87.63 -6.27 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 0.0 111.21 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.796 ' H ' HG23 ' A' ' 75' ' ' THR . 1.3 t0 -98.18 -55.07 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.997 -1.065 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.7 46.22 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 75' ' ' THR . 8.0 mmm180 -137.08 152.6 74.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.73 -0.865 . . . . 0.0 109.214 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.85 141.14 16.75 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.533 1.489 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -160.82 141.17 11.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.64 -0.663 . . . . 0.0 109.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.8 tttp -87.63 118.94 27.46 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -99.7 167.16 10.74 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' HG2' ' A' ' 70' ' ' GLU . 45.0 tp -146.03 152.25 39.05 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 65' ' ' PHE . 11.3 t -144.74 127.68 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.112 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -123.13 155.97 35.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.549 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.4 m95 -78.76 173.69 12.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.779 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.73 -46.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.7 p -131.43 -153.55 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.76 -25.43 49.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.777 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -142.72 27.43 1.67 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.588 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 66.0 tttt -132.85 109.68 9.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.962 -1.086 . . . . 0.0 108.376 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.517 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.38 148.89 40.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.828 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.64 172.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.498 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.9 t -148.54 134.58 19.19 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.693 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -103.05 165.15 11.19 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.45 135.31 7.68 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.293 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.67 40.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.95 166.7 3.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.065 -1.022 . . . . 0.0 110.722 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.5 mt -98.76 -5.51 31.18 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -152.45 137.2 17.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 108.962 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.47 -158.72 42.71 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.14 141.05 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.461 -1.023 . . . . 0.0 109.795 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.97 -85.47 0.05 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.35 -176.83 2.95 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.883 1.722 . . . . 0.0 109.752 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -136.18 137.03 40.47 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.9 146.08 47.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.051 0.929 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.3 m -163.03 136.48 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.0 p-90 -138.91 175.11 9.84 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.891 -1.13 . . . . 0.0 110.343 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.671 HG22 HG13 ' A' ' 94' ' ' VAL . 12.6 p -137.7 166.45 23.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.547 0.689 . . . . 0.0 109.831 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.452 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 10.8 ptm -149.2 119.74 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -118.46 152.77 35.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.589 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -116.26 143.3 45.71 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -97.13 161.07 13.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.907 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.89 -21.39 63.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.675 -0.64 . . . . 0.0 110.217 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.37 -29.13 28.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.75 -7.59 8.86 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.96 171.27 0.98 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -1.233 . . . . 0.0 108.643 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.623 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.01 114.7 7.69 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.343 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.8 tt -99.17 148.32 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.746 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -129.29 110.32 11.85 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.423 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -98.97 171.3 8.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 129' ' ' VAL . 45.3 mtp -150.35 165.87 31.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.596 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.516 HG23 HG23 ' A' ' 129' ' ' VAL . 5.3 m -148.85 151.92 35.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 96.39 1.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.51 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.83 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -148.38 23.57 1.03 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.539 -0.726 . . . . 0.0 109.617 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.0 m -122.17 179.64 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -155.48 118.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.903 ' CB ' HD22 ' A' ' 18' ' ' LEU . 35.7 t -99.11 133.38 43.46 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 132' ' ' ARG . 38.6 m -120.44 156.02 32.31 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.865 0.841 . . . . 0.0 109.818 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HB3' HD12 ' A' ' 9' ' ' ILE . 15.3 mtm180 -151.97 92.35 1.72 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.16 117.03 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 42.6 m-85 -102.13 133.92 46.2 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.562 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.77 138.08 47.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.83 124.49 7.42 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.3 -0.875 . . . . 0.0 111.331 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.757 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.425 0.631 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.724 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.2 m-85 -99.29 -17.38 18.1 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 t -60.97 113.94 2.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.85 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 -172.64 40.96 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.01 170.44 9.28 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -150.86 123.11 8.32 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.601 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -116.02 113.33 23.07 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.813 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.0 tt -56.06 154.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 122.09 0.947 . . . . 0.0 111.37 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.19 -32.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.382 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -137.08 167.49 21.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.865 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.813 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.8 p -177.12 152.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -0.773 . . . . 0.0 109.792 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -151.45 168.42 24.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.833 -0.542 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.5 m-80 59.85 26.48 15.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.749 . . . . 0.0 110.059 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -63.75 -62.87 1.37 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.31 -0.869 . . . . 0.0 108.686 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.1 mt-10 -57.03 -28.42 62.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.278 -0.889 . . . . 0.0 109.281 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.08 -38.69 92.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.729 -0.607 . . . . 0.0 109.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.1 tp -79.43 -17.96 53.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.8 mt -89.59 -17.32 28.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.194 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.3 mmmm -87.44 -29.63 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -77.71 -41.15 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -66.62 -52.63 43.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.038 0.923 . . . . 0.0 108.667 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.17 -148.36 20.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 23' ' ' GLY . 18.2 m -155.87 -34.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.958 -0.731 . . . . 0.0 110.387 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.902 ' HB2' HD22 ' A' ' 28' ' ' LEU . 4.3 t30 -60.96 -153.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.574 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.6 m -129.61 -48.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.024 -1.047 . . . . 0.0 109.652 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.406 ' H ' HG23 ' A' ' 26' ' ' VAL . 17.0 ttp -68.11 -30.24 69.35 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -51.61 -35.35 41.36 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.913 -0.492 . . . . 0.0 110.698 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.7 mtp180 -77.21 -38.54 51.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.561 -0.712 . . . . 0.0 109.59 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -64.88 -24.35 67.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.69 -0.631 . . . . 0.0 110.297 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.63 -29.56 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 108.956 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.23 34.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.0 t -76.22 -37.77 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.36 -35.51 61.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.69 88.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.59 -69.63 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t 47.82 50.04 15.98 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.465 0.65 . . . . 0.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 mttt 65.47 72.81 0.44 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -72.11 153.98 57.28 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.083 1.856 . . . . 0.0 110.769 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.59 175.66 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 109.741 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ALA . 23.7 t -155.07 166.25 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -157.41 113.68 2.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.725 . . . . 0.0 109.384 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.724 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.8 mp -101.33 144.3 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.894 0.854 . . . . 0.0 110.303 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 7.3 mttt -123.7 104.35 8.94 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.4 tt0 -98.06 121.93 40.58 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.178 -0.951 . . . . 0.0 111.219 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -124.07 52.35 1.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -129.14 9.79 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -75.4 -2.45 28.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -1.063 . . . . 0.0 110.111 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.9 m -96.7 124.49 40.7 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.821 -1.174 . . . . 0.0 108.516 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 87.9 m-85 -120.5 122.98 41.84 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.857 0.836 . . . . 0.0 108.9 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.4 t80 -107.09 138.2 43.72 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.576 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -122.54 137.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -137.75 105.92 5.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.77 147.12 25.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.255 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.12 116.86 10.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.19 169.04 8.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -168.09 112.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 110.516 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 52' ' ' ILE . 29.5 pt -98.94 172.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.545 -0.722 . . . . 0.0 109.1 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.0 134.81 5.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.0 110.05 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 41.4 p90 -163.04 -171.26 2.59 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.437 1.113 . . . . 0.0 112.508 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -130.7 153.15 49.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.71 94.82 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.099 -1.001 . . . . 0.0 109.557 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.46 -27.65 1.35 Allowed Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.699 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -122.99 157.49 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -1.105 . . . . 0.0 110.131 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' CA ' HD13 ' A' ' 84' ' ' LEU . 8.8 pm0 -86.72 169.61 12.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.635 -0.666 . . . . 0.0 109.359 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 16.2 p90 -161.94 -172.89 3.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.6 -0.687 . . . . 0.0 109.386 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 20.3 mt-10 -115.83 147.76 40.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.7 pt-20 -161.64 179.74 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.682 -0.636 . . . . 0.0 109.596 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -105.73 159.18 16.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.327 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -92.38 -143.73 0.21 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.577 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 t -117.78 -17.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.161 . . . . 0.0 110.67 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.61 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -87.95 -34.64 18.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.75 45.99 0.18 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.653 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.6 146.85 62.2 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.749 -0.854 . . . . 0.0 109.268 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -80.02 136.09 11.5 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.687 1.591 . . . . 0.0 110.284 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.0 p -161.0 141.48 11.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB3' HD21 ' A' ' 100' ' ' LEU . 9.2 ptmt -80.41 161.71 24.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.5 t -141.88 160.69 39.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.0 tp -142.07 154.27 44.81 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 20.3 t -144.25 129.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.358 -1.337 . . . . 0.0 112.222 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -124.24 159.58 29.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.648 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.8 m95 -82.82 172.06 13.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 0.0 110.498 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.5 tp10 -135.99 -45.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.7 p -132.65 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.74 -26.35 54.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.858 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -143.09 27.82 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 19.4 tttt -131.8 111.12 11.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.7 ptp -116.23 148.86 40.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.45 -0.781 . . . . 0.0 110.239 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.652 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -100.26 171.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.478 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.46 141.75 26.25 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.41 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -107.4 164.12 12.46 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -162.15 131.31 4.38 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.616 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -138.74 155.12 48.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.76 169.29 4.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 82' ' ' LYS . 62.5 mt -102.59 -2.66 28.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.73 133.93 10.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 108.968 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.57 -155.71 43.89 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -175.7 140.5 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.439 -1.036 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.8 -87.0 0.06 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.6 -176.9 2.92 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.816 1.677 . . . . 0.0 109.697 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -132.84 138.44 47.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 144.8 49.82 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.215 1.007 . . . . 0.0 110.867 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.9 m -163.13 139.32 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.409 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.3 p-90 -142.62 175.73 9.58 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.956 -1.09 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.652 HG22 HG13 ' A' ' 94' ' ' VAL . 14.9 p -140.05 171.39 14.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.529 0.68 . . . . 0.0 109.838 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.455 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.1 ptp -154.14 140.52 18.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.15 149.44 47.28 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.324 -0.86 . . . . 0.0 109.501 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.3 46.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.67 160.9 14.78 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.725 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -60.45 -21.75 62.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.643 -0.66 . . . . 0.0 110.218 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.98 -28.67 25.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.9 -9.13 7.6 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.76 171.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.097 -1.237 . . . . 0.0 108.966 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.9 tt -146.62 110.11 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.19 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.77 153.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 133.3 36.84 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.496 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.508 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -112.88 167.2 10.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 24.7 mtp -146.49 164.74 31.55 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.399 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.2 m -147.86 152.27 37.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.67 95.93 1.35 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.595 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.21 -79.25 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -147.6 24.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.248 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.9 m -118.97 -179.25 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.61 117.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.696 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.841 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.4 t -98.46 113.81 25.96 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.508 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.3 m -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 0.0 109.715 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.46 118.74 5.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.19 136.98 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -125.77 121.74 34.22 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.16 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.39 141.13 20.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.76 126.25 13.45 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.23 -0.919 . . . . 0.0 111.189 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.635 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.5 m120 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.45 0.643 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.5 m-85 -99.22 -8.11 25.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -67.01 115.64 6.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.301 -0.874 . . . . 0.0 111.893 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.32 -173.38 41.08 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.16 169.99 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.3 m95 -152.38 131.4 12.61 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.079 -1.049 . . . . 0.0 113.038 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -122.82 116.72 24.16 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.0 tt -58.57 145.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.603 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.15 -24.43 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.961 -0.462 . . . . 0.0 110.324 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -149.66 168.02 24.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.221 -0.924 . . . . 0.0 110.602 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p 178.0 170.11 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.19 30.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.903 -1.123 . . . . 0.0 111.635 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.9 33.49 0.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.284 -0.885 . . . . 0.0 109.134 -178.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.66 -64.99 0.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 21.7 tt0 -57.09 -27.12 61.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.58 -39.66 94.97 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.756 -0.59 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.9 tp -80.03 -15.8 56.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.675 -0.641 . . . . 0.0 110.016 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.971 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.6 mt -90.22 -18.97 24.75 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.054 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.22 -28.66 25.25 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.7 p -79.46 -41.22 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.97 -51.71 56.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.05 0.929 . . . . 0.0 109.041 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.15 -147.76 20.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 25' ' ' ASN . 23.1 m -155.74 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.978 -0.719 . . . . 0.0 109.721 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.0 t30 -60.46 -159.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.682 . . . . 0.0 109.885 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG13 ' NH2' ' A' ' 29' ' ' ARG . 2.5 t -122.18 -49.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.875 . . . . 0.0 109.429 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -66.39 -29.79 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -57.05 -25.68 59.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.827 -0.545 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.5 mtp180 -87.24 -42.7 12.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.785 . . . . 0.0 109.272 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -22.37 66.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.753 -0.592 . . . . 0.0 110.54 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.68 -29.99 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 108.774 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.971 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.17 -24.97 34.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.9 t -77.11 -35.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.52 -35.89 52.97 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.34 -35.51 80.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -71.19 -67.14 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.6 m 49.23 51.37 16.41 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.8 mttt 65.64 73.73 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.5 Cg_endo -72.37 154.28 55.96 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 111.063 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.54 176.37 5.88 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 42.9 t -155.57 164.59 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.6 tt0 -152.21 112.49 4.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.664 HG13 HG23 ' A' ' 52' ' ' ILE . 2.4 mp -98.04 136.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.767 0.794 . . . . 0.0 110.002 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.445 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.35 106.38 13.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.9 tt0 -97.7 124.3 41.97 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.112 -0.993 . . . . 0.0 111.193 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -124.44 53.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.3 -127.26 8.87 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.03 -1.13 24.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -1.029 . . . . 0.0 110.074 178.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.7 m -97.14 138.58 34.43 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.706 -1.246 . . . . 0.0 108.31 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 93.6 m-85 -134.11 118.11 17.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.764 0.793 . . . . 0.0 109.464 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.5 t80 -102.65 146.97 27.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.98 HD12 HD11 ' A' ' 63' ' ' ILE . 2.9 mt -141.73 100.81 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.947 -1.096 . . . . 0.0 110.45 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -99.39 114.07 26.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.393 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 18.0 m -99.87 144.76 28.55 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.9 p -135.51 144.19 46.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.2 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.878 0.847 . . . . 0.0 108.738 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.8 m . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.224 0.535 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.01 177.58 4.8 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.2 pm0 -171.37 143.75 1.88 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.69 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 52' ' ' ILE . 33.3 pt -128.18 170.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.0 132.69 4.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.987 -1.071 . . . . 0.0 109.457 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.7 p90 -162.25 -172.39 3.18 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.409 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.81 152.6 48.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.64 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.97 96.89 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.36 -34.88 1.48 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.559 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.76 157.34 21.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -1.046 . . . . 0.0 109.968 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.2 mt-10 -85.8 168.88 13.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 22.3 p90 -161.21 -172.9 3.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 21.8 mt-10 -116.39 148.86 40.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.651 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.9 pt-20 -161.29 179.8 8.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.444 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.8 144.14 42.85 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 79' ' ' ARG . 7.9 t -81.54 177.62 8.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.407 -0.808 . . . . 0.0 108.985 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 76' ' ' VAL . 13.5 p -84.7 -0.35 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.6 -0.688 . . . . 0.0 111.396 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 75' ' ' THR . 5.2 t0 -95.68 -44.61 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.89 -1.132 . . . . 0.0 109.955 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 75' ' ' THR . . . 134.19 45.3 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mmm180 -139.9 149.88 60.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.796 -0.826 . . . . 0.0 109.088 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HB2' HD12 ' A' ' 100' ' ' LEU . 37.2 Cg_endo -80.46 135.03 10.33 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.49 1.46 . . . . 0.0 110.048 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.1 p -160.45 141.45 12.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.701 -0.624 . . . . 0.0 109.55 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 2.1 ptmm? -80.69 163.34 23.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.9 t -144.56 160.52 40.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD22 ' HG2' ' A' ' 70' ' ' GLU . 58.2 tp -142.13 153.57 44.2 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.6 t -144.7 125.77 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.772 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -120.58 162.28 19.89 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.64 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.1 m95 -85.51 168.7 14.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' OE1' HG21 ' A' ' 94' ' ' VAL . 5.4 tp10 -131.81 -45.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.6 p -133.04 -153.81 0.57 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -77.14 -25.14 51.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -143.83 26.6 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.877 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 15.5 tttt -131.5 109.65 10.43 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' CZ2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.25 150.67 35.82 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -102.8 171.36 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.3 t -148.93 140.41 23.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.185 -0.947 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -107.17 164.75 11.9 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -161.96 133.41 5.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.988 -1.07 . . . . 0.0 110.752 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -140.89 153.67 45.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.35 169.59 3.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 0.0 110.684 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 80' ' ' PRO . 40.7 mt -98.01 -7.48 29.83 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -159.98 157.03 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 108.774 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.69 -158.5 18.94 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -176.73 139.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.514 -0.992 . . . . 0.0 109.691 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.35 -85.35 0.06 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.48 -176.75 2.65 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.95 1.767 . . . . 0.0 110.17 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -138.67 141.19 39.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.81 145.28 50.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.163 0.982 . . . . 0.0 110.839 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 m -162.99 137.23 6.22 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.7 p-90 -143.21 174.55 10.61 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.674 HG22 HG13 ' A' ' 94' ' ' VAL . 12.2 p -139.29 175.31 9.67 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.512 0.672 . . . . 0.0 109.674 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.7 ptp -158.34 141.1 14.62 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -136.09 150.28 49.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.451 -0.78 . . . . 0.0 109.158 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.42 143.3 44.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -93.03 160.49 14.84 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.809 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -60.01 -21.04 60.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 110.229 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.0 -29.7 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.838 . . . . 0.0 109.177 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.07 -9.84 7.03 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.9 172.88 0.23 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.215 -1.168 . . . . 0.0 109.432 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.596 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -146.12 108.57 4.46 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.225 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.8 tt -103.62 147.87 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tt -129.93 147.75 51.72 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.263 -0.898 . . . . 0.0 109.637 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.469 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.22 164.57 18.48 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.5 mtp -146.88 164.49 32.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.534 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 8.4 m -146.52 153.08 39.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -161.5 98.72 1.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.51 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.43 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.27 24.19 1.03 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.519 -0.738 . . . . 0.0 109.426 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.1 m -119.15 -179.22 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.07 116.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.423 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.864 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.0 t -99.68 114.49 27.62 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.79 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.469 ' OG1' HG22 ' A' ' 122' ' ' THR . 76.9 m -104.57 126.61 51.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.36 -0.838 . . . . 0.0 109.296 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -126.39 101.96 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.15 136.17 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.413 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.3 m-85 -125.43 127.59 46.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.0 137.56 41.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.494 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.57 127.57 15.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 111.405 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.604 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.246 0.546 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.5 m-85 -99.33 -8.79 24.38 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.732 -0.605 . . . . 0.0 109.61 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p -68.87 116.91 9.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.207 -0.933 . . . . 0.0 111.895 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.61 -171.95 39.39 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.89 169.04 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.56 121.55 7.67 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.717 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -115.25 113.7 24.24 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.6 tt -56.55 144.88 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.686 0.755 . . . . 0.0 110.804 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -125.21 -23.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.934 -0.479 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 10' ' ' ILE . 10.9 mtt180 -144.98 173.5 11.83 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.225 -0.922 . . . . 0.0 110.527 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t 170.29 168.79 0.06 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.78 31.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.961 -1.087 . . . . 0.0 111.893 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.38 32.11 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.167 -0.958 . . . . 0.0 109.237 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.832 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -66.92 -61.86 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.462 -0.774 . . . . 0.0 110.174 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.3 mm-40 -58.07 -30.08 65.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.357 -0.839 . . . . 0.0 110.988 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -71.69 -27.45 63.05 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.621 -178.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.7 tp -81.52 -20.65 39.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 13.7 mt -88.43 -16.68 32.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 109.187 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.9 mtmt -85.56 -32.86 21.91 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.47 -40.58 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -67.52 -48.74 66.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.886 0.85 . . . . 0.0 109.099 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.86 -160.52 26.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.61 -44.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.896 -0.767 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.8 t30 -58.69 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 109.141 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.5 m -111.86 -43.52 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.6 ttp -66.92 -28.53 68.38 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm? -59.6 -23.57 63.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.729 -0.607 . . . . 0.0 110.57 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 33' ' ' VAL . 56.4 mtt180 -86.82 -47.59 8.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.641 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.74 -23.61 65.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 110.696 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.1 mt -77.25 -29.18 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.306 -0.871 . . . . 0.0 109.086 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.62 -26.44 34.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.7 t -76.86 -37.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 -33.47 55.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.55 92.77 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.92 -67.83 0.4 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m 51.13 53.4 13.05 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mttt 66.04 73.32 0.41 Allowed Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.2 Cg_endo -71.22 143.41 43.85 Favored 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 121.939 1.759 . . . . 0.0 110.632 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.1 176.13 6.21 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 54' ' ' THR . 54.2 t -155.36 163.97 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 31.0 tt0 -148.15 111.53 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.8 mt -99.68 140.9 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.81 0.814 . . . . 0.0 110.75 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -118.86 116.12 25.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -98.92 116.91 32.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.085 -1.009 . . . . 0.0 110.948 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -118.5 52.11 1.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.75 -125.97 8.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -76.91 -0.65 24.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.395 -1.062 . . . . 0.0 110.029 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.63 139.97 31.92 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.772 -1.205 . . . . 0.0 108.371 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CD2' ' HE1' ' A' ' 93' ' ' MET . 94.7 m-85 -135.02 116.94 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.879 0.847 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -102.18 148.72 25.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -147.24 105.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 O-C-N 120.909 -1.119 . . . . 0.0 111.665 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -102.17 115.36 30.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.331 -0.856 . . . . 0.0 108.836 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 41' ' ' VAL . 60.1 m -103.08 137.15 41.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.34 143.16 50.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.303 -0.873 . . . . 0.0 110.032 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.593 0.711 . . . . 0.0 109.27 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.83 HG22 ' OE2' ' A' ' 62' ' ' GLU . 13.1 m . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.5 p -79.37 162.87 25.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.707 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.83 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.9 mp0 -156.12 122.92 5.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.69 -0.631 . . . . 0.0 109.499 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 52' ' ' ILE . 37.2 pt -121.56 165.66 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.48 129.34 3.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.144 -0.972 . . . . 0.0 108.833 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.2 p90 -161.33 -172.43 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -128.55 153.38 47.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.54 95.3 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.554 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.91 -35.55 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -112.05 155.86 23.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.411 -1.052 . . . . 0.0 109.909 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -86.61 170.51 11.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.56 173.7 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.0 109.811 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -103.18 143.98 31.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.22 -175.4 4.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 109.445 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -102.55 154.87 18.7 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.2 t -90.19 -142.34 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.4 -0.813 . . . . 0.0 108.958 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 14.9 t -110.95 -20.8 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.733 -1.229 . . . . 0.0 110.445 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -88.57 -42.62 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.0 109.438 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.4 44.66 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.691 ' H ' HG22 ' A' ' 75' ' ' THR . 12.2 mtp180 -131.07 150.03 75.43 Favored Pre-proline 0 C--N 1.308 -1.237 0 O-C-N 121.696 -0.885 . . . . 0.0 109.003 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -77.94 140.72 18.4 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.615 1.543 . . . . 0.0 110.674 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -160.84 141.48 11.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.683 -0.636 . . . . 0.0 109.668 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.632 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.1 ttmt -87.23 116.35 25.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -99.48 164.58 12.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.295 0.569 . . . . 0.0 110.117 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.9 tp -143.98 153.18 41.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.3 t -145.58 124.94 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.656 -1.218 . . . . 0.0 111.761 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -119.17 155.34 31.81 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.526 ' NE1' HG21 ' A' ' 67' ' ' VAL . 80.6 m95 -77.19 175.15 9.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.881 0.848 . . . . 0.0 110.163 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -138.08 -46.41 0.52 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.9 p -131.22 -152.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -78.14 -25.56 47.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -142.99 27.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 110.571 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.7 tttm -133.34 113.34 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.891 -1.131 . . . . 0.0 108.288 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.38 150.82 39.53 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.493 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.71 172.21 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.506 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.7 t -147.79 139.66 24.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.781 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.93 162.84 13.65 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.23 133.59 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.552 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -141.93 151.13 42.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.23 167.93 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.98 . . . . 0.0 110.718 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 80' ' ' PRO . 50.9 mt -98.41 -6.27 30.95 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -155.09 141.1 18.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.99 -158.07 38.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -175.97 140.98 0.44 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.458 -1.024 . . . . 0.0 109.871 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.13 -85.51 0.05 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.19 -176.52 2.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.905 1.737 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -137.17 136.21 38.02 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.55 145.51 48.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.123 0.964 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.1 m -162.84 135.75 5.69 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.408 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.4 p-90 -141.73 175.41 9.72 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.669 HG22 HG13 ' A' ' 94' ' ' VAL . 11.8 p -138.15 174.38 10.62 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.696 . . . . 0.0 109.888 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 1.5 ptt? -156.77 133.35 10.06 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -131.07 146.45 52.37 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.393 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.3 143.07 39.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -92.65 161.41 14.58 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.833 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -60.27 -21.27 61.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.18 -29.62 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 0.0 109.179 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.15 -7.91 8.05 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 113' ' ' LEU . 36.2 mt-10 -59.37 172.37 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -1.167 . . . . 0.0 109.05 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -143.41 108.96 5.09 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.122 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.3 tt -103.13 148.48 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.68 145.35 51.9 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.489 -0.885 . . . . 0.0 109.489 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.14 167.19 12.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 14.2 mtp -148.32 164.65 33.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.474 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 128' ' ' VAL . 7.3 m -146.71 152.38 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.1 97.73 1.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.547 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.87 -79.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -149.65 24.47 0.87 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.398 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.3 m -120.92 -179.3 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -156.85 117.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.689 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.838 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.9 t -99.92 116.71 32.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.581 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -108.11 130.28 55.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.561 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 104.01 7.18 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.76 135.58 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.6 m-85 -124.52 122.08 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.394 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.34 140.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.45 126.0 12.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.254 -0.904 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.64 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.532 0.682 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.679 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 m-85 -99.56 -11.44 21.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 116.81 6.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.25 -0.906 . . . . 0.0 111.689 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.72 -172.95 39.74 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.02 170.11 9.51 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.11 122.83 8.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.547 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -115.75 112.07 21.48 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.778 HG21 ' HD2' ' A' ' 39' ' ' PRO . 9.1 tt -52.47 156.5 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.994 0.902 . . . . 0.0 111.547 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -128.8 -33.31 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 10' ' ' ILE . 40.1 mtt180 -146.69 170.14 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.407 ' HB2' HD11 ' A' ' 9' ' ' ILE . 6.4 t -179.35 155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.3 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -152.08 171.95 17.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.688 -0.633 . . . . 0.0 110.048 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.3 m-80 60.31 27.77 17.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 109.798 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -66.32 -64.27 0.89 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 108.976 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 tt0 -59.1 -28.53 66.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.613 -0.679 . . . . 0.0 109.719 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.77 -37.63 84.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 130' ' ' CYS . 48.2 tp -83.58 -13.61 53.98 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.684 -0.635 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.46 -21.7 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.003 -1.061 . . . . 0.0 108.946 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mmmt -82.64 -29.28 30.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.25 -41.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 122.098 0.951 . . . . 0.0 108.472 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.505 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -65.66 -53.56 39.63 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.149 0.976 . . . . 0.0 108.99 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.95 -146.37 17.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.5 m -155.58 -37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.014 -0.698 . . . . 0.0 110.175 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -57.52 -170.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 109.744 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH2' ' A' ' 29' ' ' ARG . 3.0 m -119.78 -43.8 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 110.084 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 31' ' ' ILE . 16.6 ttp -68.68 -23.02 64.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 0.0 109.281 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.4 mm? -65.35 -30.59 71.44 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.522 -0.736 . . . . 0.0 110.921 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -85.11 -45.31 12.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 0.0 110.65 -178.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -25.43 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.0 110.834 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.558 HD11 ' HG2' ' A' ' 27' ' ' MET . 96.0 mt -80.04 -27.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.365 -0.835 . . . . 0.0 108.879 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.99 -24.45 35.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.686 -0.634 . . . . 0.0 109.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.5 t -82.23 -49.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.95 97.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.25 86.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.58 40.72 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.684 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -64.25 -54.46 32.97 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.777 -1.202 . . . . 0.0 108.12 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -139.21 71.06 40.42 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.96 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.9 Cg_endo -72.89 147.95 44.88 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.947 1.765 . . . . 0.0 110.954 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -94.31 172.52 8.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.618 ' CG2' HG23 ' A' ' 54' ' ' THR . 17.0 t -155.3 166.34 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.0 tt0 -156.77 112.44 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.331 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.5 mp -100.07 141.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.753 0.787 . . . . 0.0 110.105 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 29.7 mttt -117.03 91.28 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.21 126.28 42.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -177.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -135.54 64.88 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.43 -131.62 10.85 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -74.75 -2.34 26.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -1.044 . . . . 0.0 110.418 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -96.44 132.09 42.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.543 -1.348 . . . . 0.0 108.31 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.04 121.11 25.8 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.811 0.815 . . . . 0.0 109.047 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.74 ' O ' HD13 ' A' ' 52' ' ' ILE . 13.3 t80 -105.78 151.41 24.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -138.55 135.48 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -138.89 105.35 5.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.315 -0.866 . . . . 0.0 108.797 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.618 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.2 m -98.74 148.43 23.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 108.975 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.01 113.02 5.79 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.037 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.96 HG22 ' HB3' ' A' ' 39' ' ' PRO . 35.6 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.61 168.53 9.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -165.73 113.37 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.545 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -99.84 172.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.463 -0.773 . . . . 0.0 109.059 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.4 135.66 5.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -163.02 -171.69 2.76 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.354 1.073 . . . . 0.0 112.661 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 153.68 47.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.68 96.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.095 -1.003 . . . . 0.0 109.615 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.1 -22.69 1.92 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.941 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -126.03 156.95 39.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.256 -1.144 . . . . 0.0 110.261 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' HD13 ' A' ' 84' ' ' LEU . 4.5 mt-10 -86.65 168.3 13.73 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.5 p90 -161.93 175.17 12.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' HD11 ' A' ' 100' ' ' LEU . 7.3 mt-10 -110.32 142.75 41.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 4.9 pm0 -162.08 -169.69 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -99.71 159.79 14.78 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.17 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.748 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.8 t -96.85 -143.04 0.29 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.379 -0.825 . . . . 0.0 109.242 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 21.9 t -106.44 -23.86 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.762 -1.211 . . . . 0.0 110.914 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 p30 -88.87 -41.61 12.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.43 45.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.748 ' H ' HG22 ' A' ' 75' ' ' THR . 5.3 mmm180 -131.45 153.08 81.49 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.683 -0.892 . . . . 0.0 109.188 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.52 140.09 14.82 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.76 1.64 . . . . 0.0 110.439 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.2 p -160.57 144.65 13.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.517 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.793 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.1 tppt? -90.48 122.09 33.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 11.9 t -104.52 168.92 8.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.543 . . . . 0.0 110.206 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.605 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.2 tp -148.24 153.43 38.72 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.636 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.6 t -144.92 126.48 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.908 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.57 ' CD1' HG11 ' A' ' 67' ' ' VAL . 76.6 m95 -76.94 174.01 11.1 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.913 0.863 . . . . 0.0 110.769 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -136.65 -45.68 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.4 p -134.89 -150.66 0.4 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.87 -26.59 49.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -142.36 24.03 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 11.0 tttt -131.13 113.86 14.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.93 -1.106 . . . . 0.0 108.289 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.464 ' HE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.24 149.96 40.89 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.512 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.15 173.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.53 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.5 t -147.57 141.09 25.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.2 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.55 163.25 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -160.33 138.83 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.654 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -145.59 150.73 36.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.55 166.56 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.032 -1.043 . . . . 0.0 110.775 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.1 mt -98.68 -5.48 31.53 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -147.76 129.79 15.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 108.945 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.18 -155.83 45.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -176.27 141.82 0.45 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.524 -0.986 . . . . 0.0 109.686 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.76 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -82.18 -176.89 3.19 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.749 1.632 . . . . 0.0 109.925 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -130.42 133.83 46.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.4 144.16 46.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.115 0.96 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -163.34 135.55 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -142.78 177.66 8.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.061 -1.024 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.67 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -139.23 166.86 23.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.516 0.674 . . . . 0.0 109.956 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.56 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 19.2 ptm -148.92 124.72 10.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -122.64 151.14 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.38 144.48 43.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 18.7 p -93.87 161.77 14.18 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.859 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -60.65 -23.05 64.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.635 -0.666 . . . . 0.0 110.114 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.4 -27.95 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.67 -10.08 7.6 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 114' ' ' THR . 25.4 mt-10 -55.47 173.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.156 -1.202 . . . . 0.0 109.412 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.5 tt -147.71 114.63 6.12 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.45 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.25 150.92 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 132.98 42.16 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.49 -0.756 . . . . 0.0 109.546 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.67 165.23 13.27 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 129' ' ' VAL . 32.4 mtp -144.73 163.45 33.98 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.649 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 129' ' ' VAL . 2.6 m -146.86 149.09 32.59 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.99 93.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.52 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -147.47 23.16 1.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.665 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -118.47 -179.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.57 118.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.893 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.651 ' HB2' HD22 ' A' ' 18' ' ' LEU . 28.1 t -98.96 112.8 24.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.7 m -110.77 147.64 34.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -151.37 120.29 6.64 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.1 t -81.31 138.71 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.098 -1.001 . . . . 0.0 108.428 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.3 m-85 -127.07 125.98 42.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.153 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.99 139.92 28.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.2 125.72 11.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.224 -0.922 . . . . 0.0 111.102 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.48 179.662 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.389 0.614 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 2.6 m-85 -98.65 0.59 45.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -73.25 118.5 16.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 111.97 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.66 -171.77 38.56 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.82 170.03 9.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.891 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.52 121.77 7.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.508 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -115.25 113.22 23.6 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 12' ' ' SER . 8.6 tt -52.22 157.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.012 0.911 . . . . 0.0 111.684 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.57 -32.72 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.441 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.722 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.1 ttp180 -146.52 171.3 15.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.877 . . . . 0.0 109.034 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 9' ' ' ILE . 81.7 p -177.52 158.15 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.781 . . . . 0.0 109.641 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.64 169.86 22.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.678 -0.638 . . . . 0.0 110.034 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 43.9 m-20 58.68 23.88 11.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.538 -0.726 . . . . 0.0 110.194 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -66.42 -63.39 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -56.88 -27.8 61.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.57 -39.02 93.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.634 -0.666 . . . . 0.0 109.681 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 8.4 tp -78.49 -18.04 55.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.717 -0.614 . . . . 0.0 110.157 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.5 mt -90.23 -17.76 26.9 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -86.29 -28.32 23.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.5 p -80.21 -40.96 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 76' ' ' VAL . 4.6 mp -67.28 -52.31 42.23 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.097 0.951 . . . . 0.0 109.314 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.1 -149.34 22.06 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.462 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 23' ' ' GLY . 21.1 m -155.71 -34.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 122.104 -0.645 . . . . 0.0 110.375 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.93 ' HB2' HD22 ' A' ' 28' ' ' LEU . 4.1 t30 -61.71 -152.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 110.033 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.12 -50.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.977 -1.077 . . . . 0.0 109.051 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 8.9 ttm -65.95 -30.98 71.64 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -52.82 -33.93 51.46 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.465 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.4 mtp180 -83.31 -46.55 12.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -62.88 -15.19 53.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.691 -0.631 . . . . 0.0 111.206 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.6 -30.46 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.094 -1.004 . . . . 0.0 108.474 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.75 -24.14 33.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.5 t -80.45 -44.33 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.06 -41.33 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.07 83.49 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.21 45.21 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.844 -0.535 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -60.66 -34.72 74.72 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.572 -1.33 . . . . 0.0 108.37 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -165.68 72.88 1.32 Allowed Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.731 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.2 Cg_endo -73.15 149.78 46.67 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.811 1.674 . . . . 0.0 110.759 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.73 175.07 5.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 54' ' ' THR . 55.8 t -155.61 164.43 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 41' ' ' VAL . 44.2 tt0 -150.58 110.82 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.891 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -98.25 133.38 40.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.786 0.803 . . . . 0.0 110.161 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -113.03 106.9 15.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.7 tt0 -97.48 122.99 41.17 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.14 -0.975 . . . . 0.0 111.017 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -122.58 56.42 1.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.86 -126.06 8.13 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.77 -0.42 23.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.378 -1.072 . . . . 0.0 110.163 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 65' ' ' PHE . 14.4 m -96.89 138.06 35.02 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 120.712 -1.243 . . . . 0.0 108.556 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.6 m-85 -132.49 116.01 16.22 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.891 0.853 . . . . 0.0 109.342 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.4 t80 -101.77 146.98 27.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -143.15 99.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.026 -1.046 . . . . 0.0 110.161 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 14.6 tttt -99.45 111.82 24.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.449 -0.782 . . . . 0.0 109.718 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 41' ' ' VAL . 24.4 m -99.51 146.4 26.42 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.2 p -139.9 119.5 13.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.997 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.731 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.3 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.766 0.793 . . . . 0.0 108.917 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.6 m . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.239 0.543 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 p -108.25 176.96 4.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.0 109.34 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 2.5 pt-20 -170.26 124.05 0.71 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 109.849 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 52' ' ' ILE . 35.6 pt -114.87 170.91 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 133.88 5.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.949 . . . . 0.0 109.51 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.5 p90 -161.91 -171.52 2.92 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.44 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.09 152.81 49.13 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -83.0 94.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.129 -0.982 . . . . 0.0 109.64 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.08 -27.56 1.26 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.662 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.38 156.81 34.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.322 -1.105 . . . . 0.0 110.177 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -86.39 169.78 12.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.592 -0.692 . . . . 0.0 109.395 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.9 p90 -163.0 174.42 12.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.616 -0.678 . . . . 0.0 109.612 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -103.65 144.33 31.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -162.35 -174.93 4.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.564 -0.71 . . . . 0.0 109.443 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -99.83 159.25 15.21 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.3 t -95.13 -150.05 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 22' ' ' LEU . 13.7 p -98.54 -21.18 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.976 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -91.99 -51.21 5.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.64 44.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.742 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mtm180 -128.88 152.63 79.38 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.584 -0.951 . . . . 0.0 109.05 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.07 139.88 17.46 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.599 1.532 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.82 140.96 11.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.745 -0.597 . . . . 0.0 109.445 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.683 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.3 ttmt -86.4 117.28 25.1 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.0 t -99.41 168.25 10.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.18 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 70' ' ' GLU . 61.5 tp -147.01 154.08 40.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.6 t -146.65 130.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 118.441 -1.303 . . . . 0.0 112.153 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -125.51 160.04 30.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.9 m95 -83.63 169.83 14.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.129 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.446 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -132.45 -46.22 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.0 p -130.6 -153.47 0.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.11 -26.35 47.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -142.2 27.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.806 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 1.2 tttt -132.03 108.58 9.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.822 -1.173 . . . . 0.0 107.933 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.7 ptp -114.77 149.74 36.47 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.43 -0.794 . . . . 0.0 110.509 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -102.21 171.5 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.2 t -146.71 141.5 26.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.756 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.66 162.91 13.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -160.69 136.96 8.53 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.655 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -142.25 149.8 40.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.62 166.06 4.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 110.805 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 82' ' ' LYS . 48.2 mt -101.07 -3.15 29.82 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 132.41 13.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 108.796 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.77 -159.86 42.24 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.25 141.33 0.43 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.396 -1.061 . . . . 0.0 109.857 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.98 -85.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.18 -177.05 3.1 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.816 1.677 . . . . 0.0 109.793 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -132.55 138.14 47.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.37 144.47 48.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.106 0.955 . . . . 0.0 110.698 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.96 135.82 5.61 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -139.21 173.71 11.27 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.056 -1.028 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.709 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -137.57 174.05 11.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.482 0.658 . . . . 0.0 110.073 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' A' ' 111' ' ' MET . 11.0 ptp -160.35 132.83 6.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 15.3 pt-20 -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.62 145.23 40.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -92.95 161.0 14.64 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -60.14 -21.92 62.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.655 -0.653 . . . . 0.0 110.323 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -85.31 -28.37 25.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.87 -8.84 7.64 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 113' ' ' LEU . 46.3 mt-10 -57.18 172.53 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.095 -1.238 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -147.29 112.13 5.39 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.111 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.1 tt -108.04 146.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 139.8 52.3 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.536 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -118.47 169.9 9.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.8 mtp -148.81 166.25 29.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.355 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' VAL . 4.9 m -149.0 151.75 35.08 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.434 0.635 . . . . 0.0 109.459 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.36 95.07 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -147.42 24.0 1.13 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.54 -0.725 . . . . 0.0 109.282 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -118.78 -178.75 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.61 117.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.841 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.4 t -98.38 120.08 38.18 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.536 ' OG1' HG22 ' A' ' 122' ' ' THR . 90.0 m -117.85 145.51 44.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.25 118.0 7.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.56 138.48 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.0 108.398 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.7 m-85 -127.13 123.84 37.74 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.226 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 140.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.25 125.69 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.239 -0.913 . . . . 0.0 111.137 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.593 179.645 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.305 0.574 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.96 -2.42 37.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.704 -0.623 . . . . 0.0 109.366 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 t -72.15 117.71 14.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 111.936 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.6 -172.25 38.62 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 170.08 9.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.5 m95 -149.97 118.93 6.67 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.653 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -110.65 115.28 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.832 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.4 tt -56.67 158.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.01 0.91 . . . . 0.0 111.117 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -130.7 -33.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.421 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB2' HD12 ' A' ' 10' ' ' ILE . 43.3 mtt85 -146.23 168.4 21.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 108.844 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.684 ' HB3' HD11 ' A' ' 9' ' ' ILE . 97.0 p -177.56 139.76 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.512 -0.743 . . . . 0.0 109.406 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.9 169.71 16.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.672 -0.642 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 42.2 m-20 61.24 29.4 18.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.735 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.8 t80 -64.68 -63.64 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.0 109.074 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.1 pt-20 -60.53 -26.58 66.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.675 -0.641 . . . . 0.0 109.629 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -64.57 -41.48 96.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.6 tp -80.67 -13.24 59.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.0 -20.33 22.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.038 -1.038 . . . . 0.0 109.207 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.6 mmmm -84.23 -29.54 26.45 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 18' ' ' LEU . 14.3 p -78.61 -40.78 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.88 -53.1 29.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.139 0.971 . . . . 0.0 109.159 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.73 -148.72 20.8 Favored Glycine 0 N--CA 1.491 2.364 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.265 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.96 -36.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.982 -0.716 . . . . 0.0 110.418 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.37 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.865 . . . . 0.0 109.993 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 HG13 HH12 ' A' ' 29' ' ' ARG . 2.2 t -126.43 -48.24 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.362 -0.836 . . . . 0.0 109.705 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.55 ' HG2' HD11 ' A' ' 31' ' ' ILE . 1.5 ttt -67.2 -25.95 66.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.8 mm? -62.96 -28.83 70.35 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.697 -0.627 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.5 mtp180 -87.71 -46.88 9.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 0.0 110.449 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -60.44 -30.77 69.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.505 -0.747 . . . . 0.0 110.656 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 27' ' ' MET . 80.5 mt -76.18 -27.34 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.474 -0.766 . . . . 0.0 109.188 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.2 -22.3 36.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.1 t -81.21 -43.41 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.86 85.38 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.0 -46.17 88.92 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.2 41.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -65.69 -32.73 74.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.908 -1.12 . . . . 0.0 108.293 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -159.11 70.54 3.47 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.937 ' HB3' HG23 ' A' ' 56' ' ' THR . 29.8 Cg_endo -73.92 135.2 20.9 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.897 1.731 . . . . 0.0 109.741 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -86.55 170.29 12.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.581 -0.7 . . . . 0.0 109.803 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 54' ' ' THR . 20.2 t -156.76 130.91 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.18 112.03 18.14 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.919 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.0 mt -99.21 136.13 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.657 0.741 . . . . 0.0 110.106 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -113.59 114.99 27.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.87 117.15 32.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.1 -1.0 . . . . 0.0 110.9 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -118.21 52.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 -125.1 7.67 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -77.75 0.04 25.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.366 -1.079 . . . . 0.0 109.991 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.7 m -96.42 140.2 31.43 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.763 -1.21 . . . . 0.0 108.424 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.9 m-85 -136.02 116.57 13.82 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.85 0.834 . . . . 0.0 109.488 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.7 t80 -102.36 148.44 25.47 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.126 HD12 HD11 ' A' ' 63' ' ' ILE . 1.7 mt -144.46 105.59 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 120.937 -1.102 . . . . 0.0 111.275 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.35 106.29 18.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 108.928 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 41' ' ' VAL . 14.4 m -98.17 144.61 27.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 108.559 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 118.79 12.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.852 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.413 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 p -91.11 166.87 12.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.367 -0.833 . . . . 0.0 109.99 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.04 123.06 4.36 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.126 HD11 HD12 ' A' ' 52' ' ' ILE . 35.4 pt -123.06 167.59 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.49 128.98 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.184 -0.947 . . . . 0.0 109.26 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.68 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.4 p90 -162.09 -172.24 3.16 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.281 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -129.75 153.57 48.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.95 93.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 109.668 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.87 -26.44 1.3 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.741 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -122.82 157.68 31.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.321 -1.105 . . . . 0.0 110.079 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' HG2' HD22 ' A' ' 84' ' ' LEU . 30.6 mt-10 -86.63 168.08 13.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.12 173.33 14.47 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.708 -0.62 . . . . 0.0 109.398 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -102.68 143.11 32.76 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.8 pt-20 -162.34 -175.74 4.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.628 . . . . 0.0 109.433 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.92 157.63 16.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -91.88 -142.97 0.19 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.406 -0.809 . . . . 0.0 109.005 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.27 -19.56 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.785 -1.197 . . . . 0.0 110.649 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.676 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t0 -91.89 -44.52 8.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.557 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.99 45.1 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 0.6 OUTLIER -131.79 151.17 78.1 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 121.617 -0.931 . . . . 0.0 109.019 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.775 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.51 140.26 16.84 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.618 1.546 . . . . 0.0 110.677 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.94 141.72 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.657 -0.652 . . . . 0.0 109.606 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.7 ttmt -87.03 116.26 24.96 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -99.54 166.39 11.17 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.499 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.09 153.07 40.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.68 HG21 ' CE2' ' A' ' 65' ' ' PHE . 12.0 t -145.03 126.65 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.861 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.39 155.46 33.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.517 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.5 m95 -78.0 173.62 11.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.78 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.29 -46.26 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.8 p -131.47 -153.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.91 -23.09 44.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.85 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -144.3 26.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 20.8 tttm -133.82 112.25 11.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.905 -1.122 . . . . 0.0 108.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.495 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 ptm -118.18 149.84 40.39 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.26 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.84 172.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.497 ' H ' HG12 ' A' ' 94' ' ' VAL . 46.4 t -147.78 137.78 22.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.818 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.98 163.48 12.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -160.23 135.41 7.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.563 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -141.22 148.41 39.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.69 167.3 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.3 mt -94.98 -8.81 35.85 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.66 155.29 31.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.53 -161.04 16.97 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -176.89 138.64 0.27 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.503 -0.999 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.25 -85.05 0.05 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.02 -176.83 2.79 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.91 1.74 . . . . 0.0 109.9 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -135.97 136.42 40.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.16 47.56 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.154 0.978 . . . . 0.0 110.966 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -162.92 136.27 5.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.3 p-90 -140.54 174.68 10.28 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.31 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 94' ' ' VAL . 12.3 p -138.83 171.21 14.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.598 0.713 . . . . 0.0 109.855 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.441 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 9.8 ptp -153.04 136.48 15.86 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -132.99 149.93 52.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.703 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.99 143.73 43.79 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.9 p -92.75 161.02 14.7 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.58 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -60.42 -21.67 62.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.624 -0.672 . . . . 0.0 110.214 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.42 -28.45 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 109.32 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.35 -9.84 7.34 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 56.3 mt-10 -56.16 172.28 0.22 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.148 -1.207 . . . . 0.0 109.212 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -146.84 111.46 5.25 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.405 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.06 156.45 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.72 133.67 32.56 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.354 -0.841 . . . . 0.0 109.515 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 166.76 11.23 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.448 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.4 mtp -144.93 163.13 35.09 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.243 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -147.01 151.17 36.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.407 0.622 . . . . 0.0 109.331 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 95.13 1.42 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.564 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.27 -79.12 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.63 23.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.519 -0.738 . . . . 0.0 109.319 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.1 m -118.22 -179.88 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.52 118.4 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.744 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.741 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.32 113.0 24.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.6 m -107.14 148.34 28.95 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.911 0.862 . . . . 0.0 109.985 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -152.81 119.02 5.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.0 138.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.571 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -126.53 131.07 51.67 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.3 139.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.47 125.58 11.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.262 -0.899 . . . . 0.0 111.21 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.59 179.473 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 122.116 0.96 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.1 m-85 -104.49 -3.79 23.52 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.7 p -68.15 118.81 11.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 112.132 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.06 -173.33 38.37 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.2 m120 -95.75 170.22 9.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.22 122.86 7.98 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.814 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -114.36 114.03 25.34 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.79 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.3 tt -54.4 157.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.97 0.89 . . . . 0.0 111.46 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.778 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -130.72 -32.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -147.34 169.57 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 9' ' ' ILE . 93.3 p -176.94 160.84 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -0.794 . . . . 0.0 109.824 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.45 166.58 32.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 110.016 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.28 29.67 18.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.965 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.4 t80 -64.19 -64.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 109.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 36.2 tt0 -60.4 -26.39 66.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.721 -0.612 . . . . 0.0 109.623 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.36 -41.56 96.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 0.0 109.922 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.5 tp -81.13 -12.84 59.14 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.1 -20.59 21.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.95 -1.094 . . . . 0.0 109.102 179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.2 mmmt -84.5 -30.05 25.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' ' 125' ' ' ALA . 14.5 p -77.4 -40.9 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.582 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -67.41 -53.02 32.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.19 0.995 . . . . 0.0 109.075 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.63 21.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -150.91 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.861 -0.788 . . . . 0.0 110.343 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -58.21 -169.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.261 -0.899 . . . . 0.0 109.786 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG12 ' NH2' ' A' ' 29' ' ' ARG . 14.1 m -121.7 -43.59 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.594 -0.692 . . . . 0.0 110.121 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.402 ' N ' HG23 ' A' ' 26' ' ' VAL . 7.5 ttm -68.46 -28.02 66.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.753 . . . . 0.0 109.03 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.98 -50.29 73.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.734 -0.604 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -64.0 -44.46 92.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 110.22 -178.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -59.87 -25.63 65.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.624 -0.672 . . . . 0.0 111.219 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -80.27 -28.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.165 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.43 -23.36 34.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.61 -0.681 . . . . 0.0 109.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.965 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.0 t -82.25 -47.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.24 96.82 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.49 37.39 0.57 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 p -63.69 -33.19 75.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.694 -1.254 . . . . 0.0 108.224 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -163.12 71.58 1.96 Allowed Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' HG21 ' A' ' 9' ' ' ILE . 33.3 Cg_endo -75.23 -176.31 2.85 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 122.033 1.822 . . . . 0.0 110.793 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -126.21 172.11 10.34 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 54' ' ' THR . 41.4 t -155.57 164.95 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.6 tt0 -153.72 112.4 3.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.599 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.6 mp -98.73 133.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 109.99 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.3 mttt -113.92 103.59 11.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 59.1 tt0 -97.49 127.18 43.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.143 -0.973 . . . . 0.0 111.156 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.54 55.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.05 -126.05 8.34 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.34 -0.07 24.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.434 -1.039 . . . . 0.0 110.148 178.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 m -97.48 140.64 31.63 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.745 -1.222 . . . . 0.0 108.545 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 94.1 m-85 -136.4 118.09 15.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.693 0.759 . . . . 0.0 109.547 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.8 t80 -102.47 145.78 29.06 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 63' ' ' ILE . 3.9 mt -140.34 99.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 120.987 -1.071 . . . . 0.0 110.663 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -98.79 113.46 25.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.756 . . . . 0.0 109.764 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 41' ' ' VAL . 58.6 m -106.18 143.3 34.5 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 60' ' ' THR . 2.2 p -148.8 123.44 9.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.837 . . . . 0.0 109.195 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.96 -179.295 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.727 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.7 m . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -109.28 177.22 4.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.576 -0.703 . . . . 0.0 109.939 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 pt-20 -170.66 136.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.714 -0.616 . . . . 0.0 109.342 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 52' ' ' ILE . 28.8 pt -125.97 172.54 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.0 109.292 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.535 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -162.45 130.34 3.91 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 108.882 179.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.2 p90 -161.97 -172.72 3.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.313 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 152.79 48.54 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.726 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.23 95.69 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.89 1.57 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.911 -1.137 . . . . 0.0 110.666 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -111.2 154.91 23.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.302 -1.117 . . . . 0.0 110.065 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.459 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -86.46 167.38 14.72 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.0 p90 -162.43 173.28 14.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 110.005 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.84 145.54 29.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.683 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.1 -177.8 5.98 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -99.82 155.51 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.713 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -91.14 -142.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HB ' HD21 ' A' ' 22' ' ' LEU . 24.5 t -110.3 -20.22 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.205 . . . . 0.0 110.618 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.64 ' H ' HG23 ' A' ' 75' ' ' THR . 2.1 t70 -89.19 -41.91 11.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.78 45.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.713 ' H ' HG22 ' A' ' 75' ' ' THR . 4.8 mmm180 -131.91 151.51 78.64 Favored Pre-proline 0 N--CA 1.485 1.322 0 O-C-N 121.618 -0.931 . . . . 0.0 109.31 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.69 141.55 17.41 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.715 1.61 . . . . 0.0 110.482 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.21 141.07 10.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.676 -0.64 . . . . 0.0 109.772 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.7 ttmm -90.5 115.22 27.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -103.04 176.43 5.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.754 -0.591 . . . . 0.0 110.136 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.5 tp -151.18 152.97 34.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.709 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.7 t -140.17 130.27 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -124.43 159.31 30.74 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.726 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.2 m95 -84.54 170.19 13.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.266 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.53 -46.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.7 p -131.63 -154.75 0.64 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -76.74 -24.44 53.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.677 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -144.49 27.07 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.2 tttm -130.81 108.1 9.61 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.918 -1.114 . . . . 0.0 107.995 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.541 ' HE1' HG13 ' A' ' 67' ' ' VAL . 1.1 ptp -115.84 148.85 39.47 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.63 0.729 . . . . 0.0 110.497 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 110' ' ' THR . 1.0 OUTLIER -103.03 171.01 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 85' ' ' VAL . 42.6 t -148.63 129.95 14.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.197 -0.939 . . . . 0.0 110.675 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -100.49 164.46 11.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.48 143.49 13.35 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.773 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -146.28 149.24 33.48 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.74 166.17 3.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.054 -1.029 . . . . 0.0 110.84 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.0 mt -98.54 -5.49 32.01 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -151.52 139.6 20.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 108.958 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.71 -159.19 42.97 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -176.86 140.59 0.33 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.492 -1.005 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.8 -84.66 0.05 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.53 -177.11 3.04 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.86 1.707 . . . . 0.0 110.12 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -136.11 135.8 39.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.97 145.67 46.56 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.119 0.961 . . . . 0.0 110.793 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 m -162.64 130.4 3.82 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -133.41 168.68 18.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.765 HG22 HG13 ' A' ' 94' ' ' VAL . 17.8 p -134.25 174.6 10.33 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.449 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.6 ptp -159.13 130.23 6.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -123.66 151.5 43.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.511 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.81 142.78 46.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.6 159.15 15.35 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.761 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -59.65 -21.59 60.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.692 . . . . 0.0 110.234 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.38 -30.23 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.77 -9.48 6.79 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -56.67 171.8 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.146 -1.208 . . . . 0.0 109.08 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.8 tt -147.18 111.2 5.08 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.189 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.6 tt -105.24 156.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -135.76 153.89 51.41 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.461 -0.775 . . . . 0.0 109.302 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.64 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -136.12 169.05 18.24 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.492 ' O ' HG22 ' A' ' 129' ' ' VAL . 13.6 mtp -150.15 165.82 31.68 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.669 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -148.34 151.24 34.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.16 95.93 1.41 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.4 -79.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.13 23.87 1.17 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.539 -0.726 . . . . 0.0 109.311 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -117.77 -179.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.88 118.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.813 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -98.15 121.13 39.71 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.64 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.8 m -119.55 145.95 45.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -150.56 121.24 7.5 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.23 139.8 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.1 m-85 -128.3 126.77 41.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.89 139.03 31.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.486 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.07 125.62 10.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.212 -0.93 . . . . 0.0 111.289 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.699 179.684 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.327 0.584 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.531 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.9 m-85 -99.39 -5.43 29.55 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.627 -0.67 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 p -71.92 117.8 13.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.147 -0.97 . . . . 0.0 111.805 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.26 -173.58 39.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.0 m120 -95.61 172.27 8.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.6 124.51 9.25 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.643 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -116.46 113.7 23.2 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 6.3 tt -53.05 152.76 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.73 0.776 . . . . 0.0 111.183 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.16 -25.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.99 -0.444 . . . . 0.0 110.543 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.493 ' HB2' HD12 ' A' ' 10' ' ' ILE . 21.5 mtm-85 -152.42 -179.85 7.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 110.72 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 170.22 168.91 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.81 29.33 0.06 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.941 -1.1 . . . . 0.0 112.252 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.21 37.79 0.12 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.16 -0.962 . . . . 0.0 108.999 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.779 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.76 -63.33 1.41 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.562 -0.712 . . . . 0.0 109.558 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.3 mt-10 -57.52 -30.67 65.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.382 -0.824 . . . . 0.0 110.581 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -73.49 -30.58 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.243 -179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 130' ' ' CYS . 34.1 tp -78.71 -17.1 56.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.779 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.25 -19.97 23.51 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.067 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.1 mtmt -81.14 -30.6 34.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.72 -41.4 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.977 0.894 . . . . 0.0 108.848 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.59 -50.94 61.43 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.081 0.943 . . . . 0.0 109.279 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.23 -153.01 24.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -150.42 -37.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.956 -0.732 . . . . 0.0 110.335 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -60.9 -159.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.6 t -127.93 -47.34 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 0.0 109.471 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.3 ttt -65.82 -30.42 71.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.1 mm? -60.18 -28.19 67.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.724 -0.61 . . . . 0.0 110.49 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -89.49 -44.95 9.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.379 -0.825 . . . . 0.0 110.145 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -61.56 -25.08 67.08 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.632 -0.667 . . . . 0.0 110.895 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.5 -26.73 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 108.914 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -81.09 -25.89 36.66 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.631 -0.668 . . . . 0.0 109.232 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.67 -45.64 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.13 85.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.99 49.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.73 50.62 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.854 -0.529 . . . . 0.0 110.467 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.4 p -61.99 -34.03 75.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.707 -1.246 . . . . 0.0 108.236 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -162.93 74.31 2.0 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.936 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.9 Cg_endo -73.5 134.25 20.27 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.941 1.761 . . . . 0.0 111.267 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.08 177.3 7.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.651 ' CG2' HG23 ' A' ' 54' ' ' THR . 19.1 t -155.98 164.58 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -153.51 113.17 3.85 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.905 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -105.71 141.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.705 0.764 . . . . 0.0 110.676 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HE3' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.84 117.09 27.24 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.3 tt0 -99.04 118.17 35.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.115 -0.99 . . . . 0.0 110.996 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -119.69 45.8 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.31 -128.56 9.57 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.35 -3.48 30.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -1.066 . . . . 0.0 110.006 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -96.45 133.86 40.35 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.81 -1.181 . . . . 0.0 108.142 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.8 m-85 -129.54 114.87 16.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.758 0.79 . . . . 0.0 109.7 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.4 t80 -99.67 148.02 24.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.066 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -140.81 143.45 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.096 -1.002 . . . . 0.0 108.745 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -139.58 107.24 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.402 -0.811 . . . . 0.0 109.247 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.651 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.9 m -98.74 147.89 24.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -145.64 118.58 8.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.327 -0.858 . . . . 0.0 110.37 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 39' ' ' PRO . 76.1 p . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 156.49 18.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.449 -0.782 . . . . 0.0 109.877 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -151.05 103.08 3.01 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.066 HD11 HD12 ' A' ' 52' ' ' ILE . 38.8 pt -102.85 165.46 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.328 -0.857 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.18 129.15 3.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.075 -1.015 . . . . 0.0 109.201 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.69 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.3 p90 -161.48 -172.4 3.35 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.344 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -128.86 153.37 47.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.4 95.52 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.145 -0.972 . . . . 0.0 109.755 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.05 -33.89 1.58 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.672 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.99 154.99 23.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -1.088 . . . . 0.0 109.978 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.603 ' HG3' HD13 ' A' ' 84' ' ' LEU . 7.5 mp0 -86.12 168.02 14.41 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.65 175.27 11.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.0 109.567 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.33 144.67 31.31 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -177.71 5.93 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -99.6 155.47 17.58 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.26 -142.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.4 -0.812 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.572 ' N ' HG23 ' A' ' 75' ' ' THR . 24.9 t -111.39 -20.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 110.657 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' H ' HG23 ' A' ' 75' ' ' THR . 2.7 t0 -87.21 -39.23 15.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.186 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.31 44.82 0.14 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 35.2 mtp180 -132.36 151.82 78.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.739 -0.859 . . . . 0.0 109.311 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.81 142.13 17.54 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.603 1.535 . . . . 0.0 110.348 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 p -161.04 142.32 11.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.673 -0.642 . . . . 0.0 109.81 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -90.55 113.69 25.75 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.3 t -102.08 175.2 5.61 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.139 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.6 tp -151.32 152.92 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.1 t -140.81 126.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.762 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -119.51 155.62 31.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.523 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.2 m95 -77.46 173.3 12.12 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.018 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.07 -46.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.9 p -131.52 -152.61 0.51 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -78.06 -25.92 47.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -142.96 26.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 110.782 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 79.0 tttt -132.16 111.2 11.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.937 -1.102 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.488 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.4 ptm -117.94 149.58 40.67 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.388 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.66 172.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.505 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.7 t -149.13 128.71 13.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 0.0 110.731 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -99.9 163.5 12.42 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -160.35 142.15 12.65 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.963 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -146.82 148.92 32.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.521 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.3 mt -58.94 166.49 1.96 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.985 . . . . 0.0 110.972 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.3 mt -97.44 -6.5 33.77 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -152.27 141.13 21.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 108.962 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.91 -159.78 39.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -176.8 141.19 0.35 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.998 . . . . 0.0 109.665 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.68 -84.77 0.05 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.04 -176.54 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.89 1.727 . . . . 0.0 110.022 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -136.08 137.59 41.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.41 145.3 48.41 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.101 0.953 . . . . 0.0 110.676 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.77 130.08 3.66 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -134.13 172.1 13.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.041 -1.037 . . . . 0.0 110.121 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.749 HG22 HG13 ' A' ' 94' ' ' VAL . 14.0 p -135.15 175.21 9.79 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.4 ptp -158.08 133.8 9.06 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -131.81 147.68 52.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.386 -0.821 . . . . 0.0 109.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.96 143.17 38.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 160.29 15.72 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.648 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -60.19 -21.54 61.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.666 -0.646 . . . . 0.0 110.064 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.59 -29.81 25.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.97 -8.97 7.14 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.8 mp0 -58.11 174.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.698 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -146.04 110.27 5.0 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.914 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.665 ' CD1' HG22 ' A' ' 133' ' ' VAL . 9.0 tt -106.11 146.32 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.76 141.96 51.44 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.639 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.49 171.99 7.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.3 mtp -152.75 165.11 36.35 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.583 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.23 152.99 39.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.48 97.46 1.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.627 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.95 -79.83 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.33 24.26 1.02 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 109.387 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -119.75 -179.72 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.83 117.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.374 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.59 ' HB2' HD22 ' A' ' 18' ' ' LEU . 6.4 t -98.93 133.95 42.47 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -125.61 125.73 43.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -122.38 101.54 7.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' A' ' 120' ' ' ILE . 48.8 t -68.18 136.95 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.403 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 28.3 m-85 -127.9 130.79 49.08 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.416 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.5 137.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -49.12 128.63 16.71 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.211 -0.931 . . . . 0.0 111.634 -178.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 tm-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.751 0.786 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.556 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.6 m-85 -99.59 -2.74 34.9 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.634 -0.666 . . . . 0.0 109.441 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -70.53 118.5 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.944 . . . . 0.0 112.186 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.46 -172.08 38.46 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.77 170.48 9.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.888 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.23 122.17 7.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.609 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -114.13 114.49 26.13 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.4 tt -57.68 153.64 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.928 0.87 . . . . 0.0 111.326 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.731 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.1 pp -127.25 -31.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.731 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -144.26 173.08 12.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.338 -0.851 . . . . 0.0 108.842 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.63 ' HB2' HD11 ' A' ' 9' ' ' ILE . 11.8 t 179.94 165.29 1.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.303 -0.873 . . . . 0.0 109.715 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -159.99 163.12 34.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.748 -0.595 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 26.6 m-80 62.64 33.3 15.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.72 . . . . 0.0 109.719 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.949 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.7 -64.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 110.165 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 18.7 mt-10 -56.91 -33.82 67.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.869 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -70.71 -29.7 66.04 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.467 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' HB2' ' A' ' 130' ' ' CYS . 15.4 tp -77.61 -21.4 52.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.037 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.982 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -88.99 -16.13 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.036 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -86.14 -32.6 21.2 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -75.14 -38.91 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.7 mp -69.28 -45.63 69.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.797 0.808 . . . . 0.0 109.476 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.8 -159.56 27.66 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.4 m -146.63 -38.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.963 -0.728 . . . . 0.0 110.051 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.0 t30 -61.28 -156.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.422 -0.799 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.45 -47.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.429 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 31' ' ' ILE . 2.5 ttt -68.01 -27.98 67.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.8 mm? -59.94 -16.96 34.17 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.684 -0.635 . . . . 0.0 111.243 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.4 mpt_? -97.11 -50.14 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.009 . . . . 0.0 110.048 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -23.38 67.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.73 . . . . 0.0 110.717 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.57 HD11 ' HG2' ' A' ' 27' ' ' MET . 74.3 mt -77.17 -28.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 108.768 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.91 -25.15 35.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.5 t -76.06 -37.98 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.88 46.33 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.57 92.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -70.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t 48.51 52.62 13.41 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.497 0.665 . . . . 0.0 109.763 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 66.23 70.39 0.52 Allowed Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.0 Cg_endo -72.87 164.55 35.25 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.988 1.792 . . . . 0.0 111.027 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.36 173.77 6.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 HG23 ' A' ' 54' ' ' THR . 47.9 t -154.8 166.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.9 tt0 -154.38 110.24 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.888 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.8 mt -97.33 133.52 38.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.845 0.831 . . . . 0.0 110.298 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 6.8 mttm -107.94 93.79 4.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.72 125.53 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.4 -0.813 . . . . 0.0 110.373 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.45 59.36 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.64 -130.05 10.15 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.65 -2.42 26.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.394 -1.062 . . . . 0.0 110.209 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -96.93 137.05 36.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.571 -1.331 . . . . 0.0 108.269 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.648 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 97.5 m-85 -135.35 125.97 27.05 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.69 0.757 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.3 t80 -108.74 143.06 38.37 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -130.05 106.54 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 106.21 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 41' ' ' VAL . 15.1 m -99.22 146.82 25.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 108.896 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.7 p -142.69 134.31 26.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.433 -0.792 . . . . 0.0 110.323 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.87 0.843 . . . . 0.0 108.829 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 3.2 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.292 0.567 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -119.65 171.44 8.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -160.93 157.09 25.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.717 HD11 HG13 ' A' ' 52' ' ' ILE . 29.7 pt -144.22 170.72 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.56 -0.712 . . . . 0.0 109.157 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -161.6 134.65 6.23 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.8 p90 -162.96 -173.23 3.37 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.289 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -127.88 153.0 47.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.72 95.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.257 -0.902 . . . . 0.0 109.666 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.85 -24.57 1.63 Allowed Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.815 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -124.57 155.57 38.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.296 -1.12 . . . . 0.0 110.229 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -86.18 168.02 14.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.47 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.58 174.35 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.617 -0.677 . . . . 0.0 109.717 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -103.04 144.93 30.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -176.04 4.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.655 -0.653 . . . . 0.0 109.513 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.88 156.98 16.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.721 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.58 -143.82 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.375 -0.828 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.4 t -111.59 -21.07 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.825 -1.172 . . . . 0.0 110.876 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.594 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -89.03 -39.84 13.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.649 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 46.89 0.09 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 75' ' ' THR . 7.4 mmm180 -136.3 151.99 74.28 Favored Pre-proline 0 C--N 1.306 -1.308 0 O-C-N 121.759 -0.847 . . . . 0.0 109.353 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.643 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -79.07 141.76 16.73 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.764 1.643 . . . . 0.0 110.512 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 p -161.01 142.26 11.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.666 -0.646 . . . . 0.0 109.707 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.579 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.8 ttpt -86.68 117.65 25.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.24 164.48 12.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.845 -0.534 . . . . 0.0 109.731 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' CA ' ' A' ' 70' ' ' GLU . 62.5 tp -144.24 153.81 42.44 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG21 ' CE2' ' A' ' 65' ' ' PHE . 29.0 t -147.09 130.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 118.5 -1.28 . . . . 0.0 112.108 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -125.04 157.85 35.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.544 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.8 m95 -79.82 172.26 14.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -135.68 -45.85 0.67 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.8 p -131.47 -154.18 0.61 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -76.59 -25.13 53.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.666 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -144.36 26.88 1.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.823 . . . . 0.0 110.817 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 51.9 tttt -130.75 110.86 11.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.901 -1.124 . . . . 0.0 108.154 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.657 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -115.5 146.96 41.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.446 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -100.18 170.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.467 ' H ' HG12 ' A' ' 94' ' ' VAL . 52.2 t -146.38 140.94 26.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.739 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.7 162.8 14.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -160.21 135.74 8.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 149.97 41.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.87 167.63 2.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 80' ' ' PRO . 46.7 mt -98.64 -6.55 29.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.02 143.66 19.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.77 -162.66 34.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.99 139.38 0.38 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.44 -1.035 . . . . 0.0 109.975 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.18 -85.84 0.05 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.86 -176.94 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.811 1.674 . . . . 0.0 109.721 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -135.29 139.67 44.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.14 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.139 0.971 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.3 m -163.01 139.1 7.1 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -142.64 173.25 11.71 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.037 -1.039 . . . . 0.0 110.568 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.746 HG22 HG13 ' A' ' 94' ' ' VAL . 16.0 p -137.58 172.65 12.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.909 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.408 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 11.6 ptp -160.11 136.34 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.406 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.6 pt-20 -135.41 154.76 51.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.237 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.551 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.71 144.36 42.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.7 p -91.18 159.95 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.406 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.73 -19.45 50.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.591 -0.693 . . . . 0.0 110.45 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.98 -28.54 21.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.3 -9.16 7.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 113' ' ' LEU . 60.8 mt-10 -57.63 172.67 0.34 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.082 -1.246 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.803 HD13 HD13 ' A' ' 43' ' ' ILE . 8.0 tt -147.13 112.15 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.251 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -108.52 148.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -131.35 137.99 48.99 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.363 -0.836 . . . . 0.0 109.684 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.54 170.75 8.02 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.8 mtp -147.65 168.19 22.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.573 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.1 m -151.85 150.94 30.67 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.712 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.9 94.21 1.42 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.534 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.9 -78.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -146.88 24.62 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.7 m -118.13 -179.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.33 119.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.827 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.875 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.46 123.25 43.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.4 m -116.61 148.04 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -151.94 120.37 6.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 50.3 t -82.38 137.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.005 . . . . 0.0 108.351 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.8 m-85 -127.28 124.99 40.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.351 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.64 139.85 28.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.483 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.12 125.72 11.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.176 -0.952 . . . . 0.0 111.193 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.942 -1.028 . . . . 0.0 111.607 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.322 0.582 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.5 m-85 -98.86 -1.78 39.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.712 -0.617 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 t -70.9 116.61 11.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.144 -0.972 . . . . 0.0 112.011 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.45 -172.83 39.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.8 168.23 10.78 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.67 124.65 8.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.566 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -118.83 112.59 19.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.436 HD12 ' HD2' ' A' ' 132' ' ' ARG . 5.7 tt -54.25 143.92 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.626 0.727 . . . . 0.0 110.882 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.61 -24.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.999 -0.438 . . . . 0.0 109.936 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.05 174.24 10.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.282 -0.886 . . . . 0.0 110.069 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t 170.2 168.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.62 28.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.91 -1.119 . . . . 0.0 111.654 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.53 29.65 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -178.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.869 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.05 -66.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -0.851 . . . . 0.0 108.752 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' HG21 ' A' ' 33' ' ' VAL . 15.4 mt-10 -55.97 -31.1 62.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -61.29 -38.46 86.88 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.129 0.49 . . . . 0.0 110.469 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.675 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.3 tp -80.17 -17.45 52.41 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.717 -0.614 . . . . 0.0 110.137 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.3 mt -89.67 -17.65 27.96 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.088 -1.007 . . . . 0.0 109.013 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -84.05 -32.19 24.98 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -76.28 -40.21 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.84 -46.28 72.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.838 0.827 . . . . 0.0 109.6 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.16 -157.01 27.16 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.341 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.8 m -148.78 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 122.037 -0.684 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.7 t30 -61.65 -156.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.474 -0.767 . . . . 0.0 109.132 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.97 -47.09 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 109.695 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 ttp -68.16 -28.36 67.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -59.49 -23.79 63.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.811 -0.556 . . . . 0.0 110.64 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -91.33 -46.91 7.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.905 . . . . 0.0 109.727 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -62.15 -20.88 64.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.664 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.54 -28.92 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.261 -0.9 . . . . 0.0 108.925 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.95 -26.05 34.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -76.48 -41.21 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.62 64.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.92 97.47 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.554 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.43 -66.19 0.59 Allowed 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.566 -0.708 . . . . 0.0 109.289 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m 52.83 57.64 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 66.71 73.61 0.38 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.0 Cg_endo -70.91 153.39 63.69 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 122.167 1.912 . . . . 0.0 111.003 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -105.28 174.02 6.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.698 -0.626 . . . . 0.0 109.464 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.691 HG22 HG23 ' A' ' 54' ' ' THR . 47.2 t -154.86 165.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.1 tt0 -149.7 112.47 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.612 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -97.81 133.88 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.806 0.812 . . . . 0.0 110.264 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.05 106.29 14.23 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 61.2 tt0 -97.55 126.43 42.83 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.078 -1.014 . . . . 0.0 111.36 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -125.76 55.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -126.94 8.62 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.53 -0.33 22.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 110.12 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -97.22 139.98 32.38 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.72 -1.237 . . . . 0.0 108.498 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.7 m-85 -134.57 118.27 17.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.536 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.2 t80 -102.78 144.98 30.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 63' ' ' ILE . 3.3 mt -140.67 101.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -98.92 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.572 -0.705 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.691 HG23 HG22 ' A' ' 41' ' ' VAL . 12.8 m -99.38 141.01 32.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.55 118.92 17.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 110.434 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -95.66 175.43 6.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.3 pm0 -171.35 142.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.045 HD11 HD12 ' A' ' 52' ' ' ILE . 31.7 pt -129.04 171.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.89 130.58 4.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.178 -0.951 . . . . 0.0 109.217 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -162.07 -172.17 3.14 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 153.35 48.28 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.35 89.26 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.143 -0.973 . . . . 0.0 109.661 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.1 -23.26 0.99 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.938 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -122.02 154.94 36.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.55 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.4 mt-10 -86.26 165.56 16.37 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.18 173.93 13.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.866 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -102.28 146.74 27.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.5 pt-20 -162.53 -175.49 4.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 109.408 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -101.01 155.65 17.86 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.9 t -93.89 -143.75 0.24 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.354 -0.841 . . . . 0.0 109.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 23.3 t -112.67 -19.87 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.807 -1.183 . . . . 0.0 110.638 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.631 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t70 -88.04 -40.89 13.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.44 44.77 0.1 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.698 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mmm180 -135.98 154.13 77.42 Favored Pre-proline 0 C--N 1.308 -1.229 0 O-C-N 121.654 -0.91 . . . . 0.0 109.095 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.23 144.61 20.92 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.7 1.6 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.5 p -161.24 141.75 11.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.688 -0.633 . . . . 0.0 109.616 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.677 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.4 tttp -88.02 117.21 26.73 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.0 t -99.94 168.11 10.07 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.207 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' HG2' ' A' ' 70' ' ' GLU . 62.0 tp -150.61 152.99 34.89 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.9 t -144.08 135.88 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.236 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -128.3 159.23 35.93 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.598 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.6 m95 -84.97 167.3 16.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 110.062 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.4 tp10 -129.79 -45.61 1.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.6 p -131.83 -154.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.31 -25.38 51.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -142.67 26.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.898 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 46.4 tttm -131.41 104.96 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 108.302 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.2 ptp -112.22 147.55 35.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.581 -0.699 . . . . 0.0 110.221 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 110' ' ' THR . 1.6 t -103.57 169.05 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.9 t -144.55 140.76 29.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.169 -0.957 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -109.55 160.73 15.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 176.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -158.95 139.6 12.57 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.433 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -143.53 150.56 39.07 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.42 166.39 3.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.7 mt -99.74 -4.24 31.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.95 130.68 15.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 108.672 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.49 -159.46 45.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -176.82 141.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.469 -1.018 . . . . 0.0 109.713 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.29 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.46 -176.78 2.91 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.804 1.669 . . . . 0.0 109.752 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -131.95 142.8 49.74 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.2 146.32 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.85 126.75 2.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -130.86 163.94 26.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.136 -0.977 . . . . 0.0 110.39 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 94' ' ' VAL . 21.6 p -130.02 166.44 20.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.548 ' HE3' HD11 ' A' ' 52' ' ' ILE . 11.2 ptp -150.01 117.75 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 151.98 28.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.433 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.499 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -117.06 143.12 46.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.4 p -94.35 178.46 5.61 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.932 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -75.76 -24.15 56.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.641 -0.662 . . . . 0.0 110.448 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.73 -19.64 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.741 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 119.41 -5.13 13.27 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.1 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.48 177.99 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 118.924 1.362 . . . . 0.0 108.439 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.605 HD11 ' HD2' ' A' ' 3' ' ' PHE . 7.8 tt -153.4 115.89 4.43 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.965 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.27 154.59 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.767 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -136.61 109.2 7.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -99.09 167.21 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 129' ' ' VAL . 38.4 mtp -145.93 164.35 32.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.552 -0.717 . . . . 0.0 109.603 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.89 152.67 39.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.73 94.94 1.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.537 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.52 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -148.11 23.72 1.06 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.57 -0.706 . . . . 0.0 109.382 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.3 m -120.23 -179.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.46 117.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.456 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.675 ' CB ' HD22 ' A' ' 18' ' ' LEU . 10.7 t -99.37 111.7 24.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 122' ' ' THR . 75.1 m -99.26 152.74 19.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.866 0.841 . . . . 0.0 109.469 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.436 ' HD2' HD12 ' A' ' 9' ' ' ILE . 27.7 mtm180 -151.88 94.83 2.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.61 128.74 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.5 m-85 -115.82 133.88 55.58 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.491 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.85 137.75 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.479 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.9 mtm180 -47.38 124.22 6.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.387 -0.821 . . . . 0.0 111.468 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.755 179.816 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.708 0.766 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.5 m-85 -111.58 0.54 16.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -72.95 117.5 14.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 112.13 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.86 -171.74 37.86 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.446 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 169.39 10.05 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.38 118.6 6.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.591 -177.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -110.51 113.74 26.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.736 HG21 ' HD2' ' A' ' 39' ' ' PRO . 11.1 tt -55.61 157.78 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.921 0.867 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.798 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.81 -32.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.497 179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.798 ' HB2' HD12 ' A' ' 10' ' ' ILE . 4.1 ttp180 -146.13 170.33 16.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 108.812 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.6 t 177.64 141.24 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -136.58 178.44 7.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.701 -0.625 . . . . 0.0 109.875 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 72.2 m-20 58.86 26.59 15.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.728 . . . . 0.0 109.99 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -65.55 -62.95 1.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.822 . . . . 0.0 109.072 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 8.4 pt-20 -58.73 -29.13 66.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.643 -0.661 . . . . 0.0 109.565 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.01 -39.61 93.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.738 -0.601 . . . . 0.0 110.235 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.748 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.6 tp -82.02 -13.97 56.6 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.708 -0.62 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.34 -20.27 22.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.931 -1.106 . . . . 0.0 109.11 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.5 mtmt -83.32 -29.58 28.18 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 14.6 p -78.79 -41.82 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.66 -56.39 10.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 122.381 1.086 . . . . 0.0 108.523 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -103.59 -145.84 15.6 Favored Glycine 0 N--CA 1.489 2.221 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.79 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.0 m -156.29 -37.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.706 . . . . 0.0 110.364 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.51 -175.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.204 -0.935 . . . . 0.0 110.126 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.5 t -116.3 -44.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.554 -0.716 . . . . 0.0 109.574 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.449 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.1 ttp -65.41 -24.75 67.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.8 mm? -64.11 -40.14 95.56 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.675 -0.64 . . . . 0.0 110.57 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 33' ' ' VAL . 10.3 mtp180 -70.54 -48.33 55.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.379 -0.825 . . . . 0.0 110.139 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -55.72 -46.65 77.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.449 HD11 ' HG2' ' A' ' 27' ' ' MET . 48.7 mt -67.1 -26.07 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.801 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.25 -21.95 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.353 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.6 t -82.12 -44.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.29 91.63 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.63 -53.28 56.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.93 37.71 0.61 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.868 -0.52 . . . . 0.0 110.511 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 t -66.02 -34.09 77.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.796 -1.19 . . . . 0.0 108.501 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -157.27 69.68 4.37 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.736 ' HD2' HG21 ' A' ' 9' ' ' ILE . 29.7 Cg_endo -74.24 137.37 23.47 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 121.948 1.765 . . . . 0.0 110.2 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -85.57 166.86 15.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.583 -0.698 . . . . 0.0 109.37 -179.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.704 ' CG2' HG23 ' A' ' 54' ' ' THR . 16.0 t -154.34 127.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -117.9 111.02 18.45 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.5 mt -98.33 132.16 43.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.728 0.775 . . . . 0.0 110.334 -178.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttm -106.48 94.15 4.98 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.68 123.85 40.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.344 -0.848 . . . . 0.0 110.366 -177.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -132.61 68.17 1.51 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.11 -130.59 10.26 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.1 p30 -75.43 -1.6 24.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.357 -1.084 . . . . 0.0 110.388 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -95.98 139.28 32.4 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.701 -1.249 . . . . 0.0 109.003 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.9 m-85 -136.31 118.81 15.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.753 0.787 . . . . 0.0 108.951 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 16.2 t80 -104.41 150.85 24.17 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -149.35 104.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.895 -1.128 . . . . 0.0 111.288 -176.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -103.23 102.44 12.41 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.704 HG23 ' CG2' ' A' ' 41' ' ' VAL . 32.5 m -98.09 127.1 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.849 . . . . 0.0 109.359 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.8 OUTLIER -121.11 130.48 53.76 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.799 -179.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' THR . 12.1 m . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.267 0.556 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 60' ' ' THR . 3.1 p -156.86 156.41 33.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.45 109.19 2.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 110.247 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 52' ' ' ILE . 40.0 pt -113.5 164.32 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p-10 -162.44 132.25 4.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.131 -0.981 . . . . 0.0 109.497 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.764 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.7 p90 -161.87 -171.42 2.89 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.224 1.011 . . . . 0.0 111.83 -178.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.85 154.72 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.28 93.9 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.09 -1.006 . . . . 0.0 109.657 -178.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.26 -19.46 0.63 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.683 -1.246 . . . . 0.0 111.298 179.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -134.9 160.7 37.42 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.121 -1.223 . . . . 0.0 111.205 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.769 ' HG3' HD13 ' A' ' 84' ' ' LEU . 3.7 mt-10 -86.63 164.83 16.6 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.1 p90 -162.2 173.62 14.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -102.1 144.53 30.56 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.617 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.36 -176.67 5.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.62 . . . . 0.0 109.363 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.27 157.3 16.7 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.4 t -93.05 -144.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -0.867 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.2 t -107.75 -22.2 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.856 -1.152 . . . . 0.0 110.571 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.637 ' H ' HG23 ' A' ' 75' ' ' THR . 19.9 t0 -86.62 -47.71 8.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 108.955 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -132.1 151.69 78.86 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.671 -0.899 . . . . 0.0 109.226 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.3 Cg_endo -78.35 140.5 17.36 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.618 1.545 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.3 p -161.05 142.38 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HB2' HD21 ' A' ' 100' ' ' LEU . 4.5 tttt -88.25 118.56 27.93 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -99.57 168.08 10.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.496 0.665 . . . . 0.0 110.459 -178.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.769 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.2 tp -148.0 149.95 33.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.764 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.3 t -141.78 134.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.111 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.9 pttt -130.47 161.83 30.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.582 ' CE2' HG21 ' A' ' 67' ' ' VAL . 85.0 m95 -85.44 170.27 12.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.63 -45.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -132.9 -153.18 0.53 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.97 -23.78 44.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -143.0 22.26 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.834 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 73.1 tttt -130.78 111.81 12.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.832 -1.167 . . . . 0.0 108.639 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.489 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 3.7 ptp -116.0 154.97 28.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.601 -0.687 . . . . 0.0 109.981 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 110' ' ' THR . 1.8 t -108.92 168.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.41 132.81 20.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -104.02 158.11 16.64 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -154.76 142.04 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.91 -177.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -144.0 150.87 38.94 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.59 168.17 2.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 110.783 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 80' ' ' PRO . 33.2 mt -99.79 -5.29 28.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -153.99 138.7 17.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 108.84 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.63 -158.79 39.56 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -176.33 140.55 0.39 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.475 -1.015 . . . . 0.0 109.888 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.83 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.96 -176.7 2.75 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.822 1.681 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -134.31 137.24 44.07 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.69 145.81 47.64 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.123 0.963 . . . . 0.0 110.854 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.41 131.56 4.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -134.98 169.78 16.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.364 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 94' ' ' VAL . 22.7 p -134.34 170.17 16.13 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.5 0.667 . . . . 0.0 109.817 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.552 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.6 ptm -153.05 124.38 7.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -119.05 152.39 36.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.431 -0.793 . . . . 0.0 110.185 -178.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.77 144.43 44.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.8 p -89.87 167.12 13.08 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.802 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -63.81 -20.36 65.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.647 -0.658 . . . . 0.0 110.687 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.35 -32.66 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.06 -13.24 2.84 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.704 -1.236 . . . . 0.0 111.336 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -53.11 170.89 0.08 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 118.828 1.314 . . . . 0.0 109.345 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.9 tt -147.36 114.23 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.725 -178.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.19 158.62 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.81 134.37 30.08 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.393 -0.817 . . . . 0.0 109.57 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.0 170.04 8.57 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.496 ' O ' HG22 ' A' ' 129' ' ' VAL . 17.6 mtp -147.8 164.53 33.34 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.178 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.4 m -148.46 151.97 36.11 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.448 0.642 . . . . 0.0 109.434 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.35 96.88 1.45 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.518 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.86 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.44 24.41 1.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.559 -0.713 . . . . 0.0 109.268 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -118.87 -179.29 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.78 118.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.651 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.748 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.33 115.57 28.72 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.6 m -110.8 147.63 34.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 -179.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 120.74 6.34 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.78 142.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -129.39 133.28 47.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.59 139.31 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.1 125.29 10.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.244 -0.91 . . . . 0.0 111.33 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.602 179.466 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.261 0.553 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.702 ' HB3' HG21 ' A' ' 43' ' ' ILE . 6.3 m-85 -99.37 -10.92 21.66 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.712 -0.617 . . . . 0.0 109.576 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 t -65.71 115.39 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.219 -0.925 . . . . 0.0 111.819 -177.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.78 -172.71 39.73 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.71 168.49 10.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 178.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.926 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.72 124.63 8.57 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.375 -177.288 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -118.91 112.95 20.29 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.571 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.6 tt -57.11 140.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.41 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -120.95 -23.18 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.9 -0.5 . . . . 0.0 110.055 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -139.42 172.81 12.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t 171.29 168.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.15 29.97 0.12 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.948 -1.095 . . . . 0.0 111.713 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.09 33.55 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.285 -0.884 . . . . 0.0 109.082 -178.51 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -65.7 -66.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -0.784 . . . . 0.0 108.979 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 pt-20 -57.5 -26.73 61.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -64.3 -39.66 94.36 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.65 -0.656 . . . . 0.0 109.706 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.4 tp -80.17 -15.3 57.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.697 -0.627 . . . . 0.0 110.016 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.6 mt -90.05 -19.8 23.96 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.976 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmt -84.98 -28.15 25.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -79.82 -41.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.716 HD21 HG13 ' A' ' 76' ' ' VAL . 4.4 mp -65.93 -53.71 35.79 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.04 0.924 . . . . 0.0 109.114 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 -151.62 23.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.56 -42.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.981 -0.717 . . . . 0.0 109.407 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -56.37 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.793 . . . . 0.0 109.681 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.618 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.2 m -113.2 -43.77 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.03 -26.69 66.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.532 -0.73 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -57.61 -45.26 85.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.681 -0.637 . . . . 0.0 110.491 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.904 ' O ' HG23 ' A' ' 33' ' ' VAL . 4.2 mtp180 -67.34 -40.95 85.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -62.75 -24.38 67.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.678 -0.639 . . . . 0.0 110.838 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 28' ' ' LEU . 34.2 mt -78.67 -28.81 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.062 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.952 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.92 34.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 109.237 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.9 t -79.22 -38.72 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.67 -35.65 62.81 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.03 -37.58 81.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.1 -67.7 0.43 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t 49.87 50.46 18.38 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm 66.3 74.19 0.37 Allowed Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.6 Cg_endo -71.72 146.21 48.09 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 122.01 1.807 . . . . 0.0 110.797 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -92.56 175.48 6.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.765 -0.584 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.547 ' CG2' HG23 ' A' ' 54' ' ' THR . 24.7 t -155.31 165.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.9 tt0 -149.88 112.87 4.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.926 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.7 mt -99.85 140.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.806 0.812 . . . . 0.0 110.443 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.9 mttt -119.14 114.37 22.36 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 57.1 tt0 -98.9 111.61 23.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.0 110.786 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -115.57 47.95 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.18 -127.57 9.07 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.4 p30 -74.85 -3.28 31.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.444 -1.033 . . . . 0.0 110.048 178.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 m -96.39 134.9 38.97 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.689 -1.257 . . . . 0.0 108.309 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.9 m-85 -131.37 119.2 21.34 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.875 0.845 . . . . 0.0 109.22 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.0 t80 -104.61 133.16 49.92 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.791 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 mm -115.45 137.18 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.1 tttt -132.4 98.65 4.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.0 108.704 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.547 HG23 ' CG2' ' A' ' 41' ' ' VAL . 17.8 m -98.45 145.37 26.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.446 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.59 136.42 24.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.853 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.848 0.832 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 152.83 19.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.409 -0.807 . . . . 0.0 109.123 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG3' ' CG ' ' A' ' 53' ' ' LYS . 1.2 mp0 -150.98 101.7 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.563 -0.711 . . . . 0.0 109.735 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -104.71 167.35 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.632 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.78 132.49 5.07 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.483 -0.761 . . . . 0.0 109.064 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.3 p90 -161.88 -172.46 3.29 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.061 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.45 154.27 46.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.27 95.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -33.77 1.68 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.712 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.42 153.77 23.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.367 -1.078 . . . . 0.0 109.977 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' CA ' HD13 ' A' ' 84' ' ' LEU . 20.1 mt-10 -85.96 166.95 15.51 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.24 173.3 14.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.875 -178.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.13 145.04 30.52 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -178.21 6.24 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.573 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.62 155.2 17.72 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.8 t -91.66 -152.2 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 109.331 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.716 HG13 HD21 ' A' ' 22' ' ' LEU . 14.7 p -99.29 -20.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.992 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.716 ' H ' HG23 ' A' ' 75' ' ' THR . 1.8 t70 -88.61 -50.86 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.211 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.06 44.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 3.0 mmm-85 -130.67 152.01 79.72 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 121.613 -0.933 . . . . 0.0 109.127 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.54 141.05 17.36 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.581 1.521 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 p -161.07 142.02 11.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.7 ttmm -90.65 115.08 27.48 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -102.95 176.66 5.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.411 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.4 tp -152.36 152.15 31.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.5 t -140.87 125.54 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.543 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -120.47 156.0 32.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.525 ' NE1' HG21 ' A' ' 67' ' ' VAL . 83.8 m95 -77.91 172.28 13.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.805 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 6.9 tp10 -134.52 -46.61 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.9 p -129.27 -152.79 0.53 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.17 -24.98 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -143.3 25.68 1.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 29.0 tttm -131.06 108.29 9.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.82 -1.175 . . . . 0.0 108.211 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.506 ' HE3' HG13 ' A' ' 67' ' ' VAL . 1.6 ptm -114.47 148.21 38.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.366 -0.834 . . . . 0.0 110.239 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.861 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.66 172.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.502 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -148.37 129.81 14.82 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.21 141.35 12.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.9 -178.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -145.75 148.4 32.94 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 110.872 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 80' ' ' PRO . 35.6 mt -96.98 -7.09 33.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -154.18 146.31 23.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.839 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.73 -162.51 34.23 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -176.94 140.14 0.3 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -1.033 . . . . 0.0 109.798 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.92 -84.79 0.05 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.93 -176.79 2.8 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.883 1.722 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -137.74 139.22 39.99 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.24 146.04 47.65 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.072 0.939 . . . . 0.0 110.669 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -162.61 131.27 4.07 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -135.85 170.05 16.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.968 -1.082 . . . . 0.0 110.362 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 94' ' ' VAL . 18.5 p -133.55 165.33 25.14 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.462 0.649 . . . . 0.0 109.395 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.437 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.3 ptm -152.72 124.86 8.04 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.5 pt-20 -129.98 158.8 38.58 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.965 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -113.65 145.2 41.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 p -92.38 161.26 14.73 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.425 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.72 -18.62 55.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.528 -0.732 . . . . 0.0 110.515 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -88.39 -27.02 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.17 -7.87 8.58 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 113' ' ' LEU . 27.1 mt-10 -59.97 172.33 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.243 . . . . 0.0 108.579 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -145.64 113.11 6.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.065 -178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 12.5 tt -99.76 151.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.764 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -133.87 112.14 11.05 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.438 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -99.22 166.51 11.19 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.1 mtp -145.4 163.97 32.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.543 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.12 152.35 39.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.56 95.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.548 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 78.08 -79.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -147.64 23.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.7 m -120.25 -179.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.16 117.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.594 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.825 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.7 t -99.6 112.64 24.84 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -99.2 153.81 18.64 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.847 0.832 . . . . 0.0 109.139 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.571 ' HB3' HD12 ' A' ' 9' ' ' ILE . 36.5 mtm180 -151.42 93.6 1.91 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.54 127.39 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.7 m-85 -114.79 130.34 56.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.239 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.24 138.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.57 124.12 6.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.307 -0.871 . . . . 0.0 111.391 -178.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.702 179.907 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.34 0.591 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.3 m-85 -99.59 -18.08 17.52 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -60.65 116.21 4.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 111.827 -177.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.33 -173.06 39.43 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -96.03 169.53 9.91 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -151.95 126.21 9.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.718 -176.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -117.36 113.08 21.59 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.54 HD13 ' C ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -61.59 140.99 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.711 0.767 . . . . 0.0 110.236 -178.929 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 11' ' ' ARG . 2.5 pp -126.36 -22.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 10' ' ' ILE . 1.9 mmm180 -133.22 167.29 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.159 -0.963 . . . . 0.0 110.442 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 170.05 167.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -161.04 29.3 0.14 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.019 -1.05 . . . . 0.0 111.289 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.85 34.3 0.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.06 -65.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.534 -0.729 . . . . 0.0 109.235 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.2 mt-10 -58.65 -26.44 63.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.429 -0.795 . . . . 0.0 109.138 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.11 -38.12 89.92 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.717 -0.614 . . . . 0.0 109.841 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.5 tp -81.58 -16.28 52.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.686 -0.634 . . . . 0.0 110.033 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' HB3' ' A' ' 32' ' ' ALA . 9.4 mt -89.67 -19.25 25.07 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -85.84 -29.09 24.01 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.651 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.9 p -78.5 -41.25 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.0 -52.51 48.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.001 0.905 . . . . 0.0 108.905 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.32 -147.58 19.63 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.4 m -154.91 -41.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.927 -0.749 . . . . 0.0 109.531 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.6 t30 -57.68 -171.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.536 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH1' ' A' ' 29' ' ' ARG . 7.0 m -116.14 -43.91 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 110.077 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.81 -29.52 68.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -55.39 -46.31 76.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 mtp180 -64.49 -39.75 94.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.429 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -63.41 -15.68 58.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.575 . . . . 0.0 111.22 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mm -84.2 -30.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 108.709 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.36 32.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.0 t -80.4 -44.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.49 85.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -48.95 77.65 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 56' ' ' THR . . . -49.87 -72.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.954 -0.466 . . . . 0.0 110.439 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t 47.39 48.56 16.41 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.574 0.702 . . . . 0.0 109.171 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.2 mttp 71.19 73.23 0.26 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -177.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.6 Cg_endo -71.4 -179.54 3.72 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.053 1.836 . . . . 0.0 110.623 -178.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -123.36 172.56 8.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.464 -0.773 . . . . 0.0 110.401 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 54' ' ' THR . 41.2 t -155.31 166.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 tm-20 -155.47 111.33 3.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 108.768 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.2 mp -96.48 143.16 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.964 0.888 . . . . 0.0 110.151 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 2.7 mttm -119.73 108.66 14.69 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.42 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.3 tt0 -98.52 117.41 32.89 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.05 . . . . 0.0 110.993 -178.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -119.43 45.92 2.02 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.44 -127.41 9.13 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 p30 -73.93 -3.05 26.66 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -1.079 . . . . 0.0 110.045 178.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -96.73 133.98 40.58 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.623 -1.298 . . . . 0.0 108.196 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.5 m-85 -130.41 122.86 28.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.763 0.792 . . . . 0.0 109.164 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.2 t80 -106.03 140.46 38.99 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.835 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.95 110.88 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -107.79 100.56 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 41' ' ' VAL . 17.8 m -99.65 143.57 29.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 0.0 109.01 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.8 p -156.56 125.88 6.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 36' ' ' ALA . 19.6 m . . . . . 0 C--N 1.306 -1.312 0 O-C-N 121.705 -0.622 . . . . 0.0 110.021 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 55' ' ' SER . 88.0 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.6 p -106.76 160.87 15.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.04 136.62 14.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.314 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.835 HD11 HG13 ' A' ' 52' ' ' ILE . 27.2 pt -138.81 168.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.554 -0.716 . . . . 0.0 109.394 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.513 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.51 132.78 5.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.5 p90 -162.05 -173.61 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.948 -1.101 . . . . 0.0 112.095 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -127.94 154.25 45.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.43 93.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.069 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.15 -23.64 1.58 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.727 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.87 156.99 35.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.279 -1.13 . . . . 0.0 110.119 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.593 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.1 mt-10 -86.61 169.58 12.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.693 -0.629 . . . . 0.0 109.357 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 11.8 p90 -162.41 174.24 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.371 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -111.43 143.11 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.4 pm0 -162.43 -168.66 1.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.449 0.642 . . . . 0.0 109.341 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -99.9 159.52 15.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.77 -144.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 109.02 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -107.33 -19.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.841 -1.162 . . . . 0.0 110.74 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.708 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -93.24 -44.93 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.17 45.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.739 ' H ' HG22 ' A' ' 75' ' ' THR . 4.6 mmm180 -132.67 152.57 80.17 Favored Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.634 -0.921 . . . . 0.0 109.232 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.73 140.41 16.48 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.707 1.605 . . . . 0.0 110.471 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.5 p -160.76 143.41 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.632 -0.667 . . . . 0.0 109.822 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.786 ' HB2' HD21 ' A' ' 100' ' ' LEU . 18.0 ttmt -90.9 120.3 31.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -103.52 168.43 9.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.671 -0.643 . . . . 0.0 110.299 -178.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.8 tp -147.54 153.2 39.17 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 13.3 t -145.46 126.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.962 -178.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -120.2 155.54 32.95 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.58 ' CD1' HG11 ' A' ' 67' ' ' VAL . 79.4 m95 -77.89 173.88 11.66 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.857 0.837 . . . . 0.0 110.27 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.73 -45.98 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -131.83 -153.41 0.55 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -25.6 52.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 110.042 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -143.93 27.38 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.817 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 9.3 tttt -132.39 110.73 10.76 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.448 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -117.41 149.86 39.85 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.285 -179.229 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.43 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.71 141.12 25.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.976 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.06 162.3 14.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.27 135.52 8.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.82 -178.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -142.47 154.21 44.34 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.21 169.38 5.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.041 -1.037 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.1 mt -101.47 -5.64 25.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.38 135.11 12.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.904 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.78 -160.46 37.62 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -175.86 139.2 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.426 -1.044 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.42 -88.38 0.09 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.13 -176.78 2.75 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.677 1.585 . . . . 0.0 109.368 178.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -131.53 141.31 49.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.94 145.02 48.85 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.141 0.972 . . . . 0.0 110.686 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -162.96 136.75 6.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.8 p-90 -144.54 175.57 10.04 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.522 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 7.8 p -139.61 171.83 13.68 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.499 0.666 . . . . 0.0 109.636 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.8 ptp -153.56 139.29 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -136.94 150.18 48.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 109.522 -178.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.1 140.91 48.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.464 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.2 p -89.72 160.15 16.72 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.471 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -60.18 -20.59 59.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 110.29 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.18 -29.74 24.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.232 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.52 -9.31 6.9 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -57.34 171.9 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.108 -1.231 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.2 tt -144.73 107.95 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.973 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.44 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.0 tt -103.4 147.65 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.72 145.33 51.91 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.467 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -120.55 162.34 19.77 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.185 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 22.0 mtp -143.99 162.1 37.05 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.324 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 129' ' ' VAL . 7.2 m -145.89 152.41 39.42 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.73 97.24 1.3 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.489 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.78 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.12 23.85 0.94 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.5 -0.75 . . . . 0.0 109.506 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -120.2 179.34 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.98 116.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.63 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.875 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.2 t -100.73 113.7 26.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.625 . . . . 0.0 109.576 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.0 m -103.11 128.92 49.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.413 -0.805 . . . . 0.0 109.312 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -126.56 102.89 7.3 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 120' ' ' ILE . 57.5 t -67.19 132.59 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -122.08 121.69 37.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.513 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.08 140.24 22.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.18 125.31 10.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.269 -0.894 . . . . 0.0 111.303 -178.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.667 179.582 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.36 0.6 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.8 m-85 -99.16 -15.17 19.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -63.17 115.54 4.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -0.819 . . . . 0.0 111.597 -177.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.04 -172.04 39.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -96.14 169.2 10.12 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.842 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.1 120.89 7.04 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.619 -177.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -112.75 112.22 23.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.3 tt -56.0 141.67 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.667 0.746 . . . . 0.0 110.842 -178.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -121.71 -23.55 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.959 -0.463 . . . . 0.0 110.171 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.598 ' HG3' HD12 ' A' ' 10' ' ' ILE . 18.6 mtt-85 -143.73 170.64 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.877 . . . . 0.0 110.393 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t 170.65 167.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.02 31.83 0.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 111.988 -179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.13 29.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.075 -1.016 . . . . 0.0 109.803 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.97 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.59 -60.03 3.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.775 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' HG21 ' A' ' 33' ' ' VAL . 24.3 mt-10 -58.09 -29.07 65.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 111.283 -178.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 1.7 pt-20 -72.63 -27.39 62.11 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.734 -178.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.8 HD22 ' CB ' ' A' ' 130' ' ' CYS . 2.2 tp -83.34 -18.81 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 32' ' ' ALA . 14.1 mt -90.25 -16.18 29.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.11 -0.994 . . . . 0.0 109.094 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.8 -33.01 21.49 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.634 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.09 -40.53 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.8 mp -66.95 -48.06 69.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.883 0.849 . . . . 0.0 108.921 179.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.11 21.09 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' ASN . 24.3 m -154.8 -42.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.825 -0.809 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 4.3 t30 -57.14 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 0.0 109.66 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.698 HG12 ' NH1' ' A' ' 29' ' ' ARG . 2.5 m -112.47 -43.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.813 . . . . 0.0 110.096 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -27.12 65.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -56.29 -48.13 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.669 . . . . 0.0 110.871 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.793 . . . . 0.0 110.213 -178.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.23 -23.49 64.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 111.615 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 48.1 mm -82.78 -27.5 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.052 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -26.41 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.265 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -79.1 -46.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.1 75.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' ILE . . . -63.62 -44.95 92.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.46 -66.96 0.47 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.4 -0.812 . . . . 0.0 109.161 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 p 51.83 61.61 3.13 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.87 70.85 0.46 Allowed Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.972 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.2 Cg_endo -71.53 139.73 34.9 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 122.102 1.868 . . . . 0.0 110.857 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.39 176.5 7.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 HG23 ' A' ' 54' ' ' THR . 25.5 t -154.86 165.67 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.5 tt0 -154.05 113.2 3.72 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.842 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.3 mp -100.17 149.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.759 0.79 . . . . 0.0 110.19 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 4.3 mttt -129.01 106.4 8.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 66.7 tt0 -98.22 120.44 38.64 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 111.191 -177.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -123.76 49.14 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -130.17 10.14 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.62 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -75.15 -2.96 30.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.201 178.747 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -97.43 118.59 34.25 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.857 -1.152 . . . . 0.0 108.782 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 85.3 m-85 -114.11 127.57 55.98 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.867 0.842 . . . . 0.0 109.126 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' ILE . 19.8 t80 -109.58 147.13 33.54 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.792 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -133.46 138.07 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.234 -0.916 . . . . 0.0 108.636 -178.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.28 103.66 5.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.568 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.41 143.13 29.19 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.7 p -140.46 118.14 11.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.206 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 39' ' ' PRO . 70.5 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 55' ' ' SER . 9.4 m . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -85.27 158.99 20.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -155.8 100.75 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 0.0 109.86 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.792 HD11 HG13 ' A' ' 52' ' ' ILE . 24.5 pt -101.78 168.27 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.516 -0.74 . . . . 0.0 109.33 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.509 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.02 135.3 5.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.438 -0.789 . . . . 0.0 109.603 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -162.61 -171.82 2.89 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.35 1.071 . . . . 0.0 112.358 -178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -129.79 153.24 48.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.637 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.44 95.5 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.157 -0.964 . . . . 0.0 109.542 -179.135 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.98 -31.65 1.45 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.684 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -117.09 157.34 26.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -1.077 . . . . 0.0 110.127 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG2' HD22 ' A' ' 84' ' ' LEU . 17.7 mt-10 -86.05 169.42 13.19 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.06 172.85 15.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 -179.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -104.11 144.35 31.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.25 -176.86 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.99 158.73 15.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.6 t -92.6 -144.07 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.418 -0.801 . . . . 0.0 109.109 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -106.42 -21.61 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.857 -1.152 . . . . 0.0 110.611 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.675 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 t70 -89.51 -46.93 8.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.414 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.47 44.71 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 75' ' ' THR . 3.9 mmm180 -129.95 152.41 79.9 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.572 -0.958 . . . . 0.0 108.994 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.83 140.69 16.48 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 121.696 1.597 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.05 141.81 11.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.514 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.2 ttpm? -88.2 117.07 26.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.1 t -99.63 166.53 11.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.847 -0.533 . . . . 0.0 109.809 -178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' HG2' ' A' ' 70' ' ' GLU . 52.1 tp -145.83 155.41 42.89 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.3 t -146.46 129.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.088 -178.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' HG12 ' A' ' 67' ' ' VAL . 2.7 ptpp? -123.85 161.74 24.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 67' ' ' VAL . 83.9 m95 -84.29 171.38 12.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.499 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -136.12 -45.31 0.64 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -132.78 -154.51 0.62 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.19 -26.49 56.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.786 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -143.68 29.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.794 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 28.5 tttt -132.3 109.26 9.76 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.637 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.2 ptp -115.09 147.69 39.88 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.665 0.745 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 110' ' ' THR . 2.9 t -99.88 172.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.504 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.4 t -146.79 141.88 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.922 . . . . 0.0 110.951 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.72 162.04 14.83 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -160.45 133.87 6.82 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.597 -178.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 150.05 39.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.07 167.3 1.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.869 -178.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD12 ' HB2' ' A' ' 80' ' ' PRO . 37.2 mt -94.35 -9.28 36.34 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -156.93 156.28 32.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 108.927 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.31 -160.15 17.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -176.24 139.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.484 -1.01 . . . . 0.0 109.837 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.64 -84.13 0.05 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.54 -177.05 3.0 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 121.938 1.758 . . . . 0.0 110.177 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -139.74 137.9 35.48 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.37 145.89 49.18 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.109 0.957 . . . . 0.0 110.831 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.7 m -162.76 135.48 5.64 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.405 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.4 p-90 -141.92 175.62 9.58 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.942 -1.099 . . . . 0.0 110.686 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.684 HG22 HG13 ' A' ' 94' ' ' VAL . 11.4 p -138.01 173.23 11.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.479 0.657 . . . . 0.0 109.987 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.509 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.5 ptm -157.17 126.63 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -124.65 153.75 41.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.82 142.73 46.16 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.032 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.9 p -91.2 160.78 15.36 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.525 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -60.21 -21.0 61.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.457 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.07 -28.31 24.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -8.46 7.52 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 113' ' ' LEU . 47.1 mt-10 -58.19 171.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -1.223 . . . . 0.0 109.032 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.814 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.28 109.77 5.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.0 109.963 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -104.35 150.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -132.27 145.25 51.17 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.479 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.408 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -121.65 169.26 10.88 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.523 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.1 mtp -150.3 165.87 31.7 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.51 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.81 152.53 37.82 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.431 0.634 . . . . 0.0 109.367 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.17 97.92 1.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.607 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.57 -79.34 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.23 24.77 0.91 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.527 -0.733 . . . . 0.0 109.252 178.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.0 m -120.89 -179.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -156.36 118.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.754 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.8 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.5 t -99.67 118.81 37.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.5 m -111.37 130.38 55.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.908 . . . . 0.0 109.55 -179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -129.77 103.95 7.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 136.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -125.88 127.47 46.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.499 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.12 139.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 177.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.03 125.35 10.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.0 111.219 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.599 179.574 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.354 0.597 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -98.86 -3.91 34.28 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.9 p -72.13 119.98 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.112 -0.992 . . . . 0.0 112.194 -177.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.74 -173.56 37.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 8.8 m120 -95.22 171.77 8.52 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 177.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.9 126.11 9.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.336 -176.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -116.28 111.52 20.25 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -62.86 140.64 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.607 0.718 . . . . 0.0 109.711 -179.378 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.13 -23.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.19 162.77 32.02 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.195 -0.941 . . . . 0.0 110.745 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p 178.26 168.88 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 14' ' ' ASN . 2.6 pt-20 -161.35 26.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.91 -1.119 . . . . 0.0 111.443 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -161.65 29.06 0.13 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.488 -0.757 . . . . 0.0 108.986 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.897 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.56 -64.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.3 tt0 -57.0 -28.74 62.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.19 -35.96 82.69 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.773 -0.579 . . . . 0.0 110.375 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.671 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.5 tp -82.46 -17.34 45.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.637 -0.665 . . . . 0.0 110.363 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD11 ' CE1' ' A' ' 15' ' ' PHE . 8.1 mt -90.61 -18.29 25.41 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.763 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.4 mmmm -85.32 -29.54 24.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -77.69 -39.46 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -69.03 -46.56 67.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.781 0.801 . . . . 0.0 110.008 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -156.58 27.14 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.708 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -149.67 -36.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.985 -0.715 . . . . 0.0 110.477 -179.434 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -62.86 -148.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.473 -0.767 . . . . 0.0 109.466 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.28 -46.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.661 -1.274 . . . . 0.0 109.151 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.7 ttt -67.59 -33.52 75.17 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.7 mm? -57.31 -24.36 54.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.811 -0.555 . . . . 0.0 110.544 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.892 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.7 mtt180 -92.69 -48.4 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 110.181 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -63.93 -16.87 62.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.549 -0.719 . . . . 0.0 111.447 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.6 mm -85.7 -28.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.944 . . . . 0.0 108.634 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.73 34.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.8 t -80.17 -48.22 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.16 60.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.785 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.68 57.06 4.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.722 -0.611 . . . . 0.0 110.68 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -66.27 -36.22 82.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.7 -1.25 . . . . 0.0 107.793 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -155.14 72.51 5.68 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.75 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 33.5 Cg_endo -72.37 163.16 39.47 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.138 1.892 . . . . 0.0 111.168 -178.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -117.37 173.41 6.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.696 -0.627 . . . . 0.0 109.668 -179.424 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -155.4 165.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 41' ' ' VAL . 29.5 tt0 -152.52 109.12 3.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.5 mt -97.98 135.78 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.667 0.746 . . . . 0.0 110.22 -178.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -114.33 111.44 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.878 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -98.2 121.93 40.74 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.031 -1.043 . . . . 0.0 110.974 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -123.02 51.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.04 -127.96 9.16 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.9 p30 -74.97 -2.0 25.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 110.124 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -96.51 134.69 39.4 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.724 -1.235 . . . . 0.0 108.12 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.09 116.69 18.86 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.931 0.872 . . . . 0.0 109.416 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.6 t80 -102.29 148.2 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.655 HD12 HD11 ' A' ' 63' ' ' ILE . 1.2 mt -145.45 101.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.991 -1.068 . . . . 0.0 110.459 -177.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 3.3 ttmt -99.47 113.74 26.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.673 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 41' ' ' VAL . 29.4 m -101.42 143.29 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 115.45 11.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 109.955 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.8 p -103.7 176.0 5.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -171.34 120.7 0.5 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.743 -0.598 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 73' ' ' GLU . 41.2 pt -109.01 171.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.6 p-10 -162.58 134.61 5.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.165 -0.96 . . . . 0.0 109.361 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.95 -171.43 2.87 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.395 1.093 . . . . 0.0 112.5 -178.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -129.76 152.66 49.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.3 95.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -178.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -35.14 1.58 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.681 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -110.56 155.33 22.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -1.065 . . . . 0.0 109.999 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HD22 ' A' ' 84' ' ' LEU . 32.8 mt-10 -86.16 169.2 13.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.567 -0.708 . . . . 0.0 109.245 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.08 173.92 13.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.63 144.04 32.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -162.24 -177.34 5.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.298 -179.526 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.96 155.95 17.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -92.86 -143.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 28.6 t -110.92 -20.44 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.789 -1.195 . . . . 0.0 110.608 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.62 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 t70 -88.02 -40.99 13.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.92 . . . . 0.0 109.26 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.16 44.69 0.1 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mmm180 -133.02 151.89 78.75 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.619 -0.93 . . . . 0.0 109.323 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.732 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.97 141.76 16.91 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.737 1.625 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -161.03 143.26 12.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.734 -0.604 . . . . 0.0 109.46 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -88.67 117.16 27.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.9 t -99.78 166.36 11.13 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.283 0.564 . . . . 0.0 109.749 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG2' ' A' ' 70' ' ' GLU . 63.2 tp -148.77 150.76 33.65 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.7 t -141.92 127.18 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.024 -177.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.73 156.03 28.97 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.617 ' CD1' HG11 ' A' ' 67' ' ' VAL . 75.8 m95 -76.87 -175.04 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.576 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -142.68 -53.76 0.4 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.0 p -131.36 -152.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.54 -24.15 45.81 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 110.003 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -138.82 22.26 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 0.0 111.167 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -130.49 129.65 43.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.746 -1.221 . . . . 0.0 108.325 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -134.96 151.09 50.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.918 -179.622 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.752 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -103.31 171.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.2 t -147.91 133.2 18.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.3 -0.875 . . . . 0.0 110.82 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 4.7 pt-20 -105.95 153.28 22.2 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -151.36 140.53 21.24 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.939 -177.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -144.92 148.45 33.89 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.11 168.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.049 -1.032 . . . . 0.0 110.886 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.2 mt -93.78 -10.1 35.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.95 160.19 35.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.74 -161.58 22.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -176.72 138.62 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.427 -1.043 . . . . 0.0 109.941 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.94 -85.42 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.91 -176.73 2.54 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.932 1.755 . . . . 0.0 110.142 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -139.97 138.8 35.82 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.81 146.01 47.92 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.071 0.939 . . . . 0.0 110.778 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 m -162.38 129.89 3.84 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -136.39 171.05 15.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.092 -1.005 . . . . 0.0 110.608 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.752 HG22 HG13 ' A' ' 94' ' ' VAL . 13.3 p -134.06 176.0 8.98 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.472 0.653 . . . . 0.0 109.884 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.4 ' CE ' ' HG3' ' A' ' 93' ' ' MET . 3.0 ptt? -160.23 124.07 3.62 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -120.06 146.6 45.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.679 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.92 143.52 38.05 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.101 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.73 160.94 14.74 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.676 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.39 -22.67 63.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.646 . . . . 0.0 110.21 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.49 -29.22 28.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.164 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.29 7.22 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' O ' HD13 ' A' ' 113' ' ' LEU . 22.6 mt-10 -56.2 171.7 0.25 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.145 -1.209 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.697 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -146.4 110.16 4.9 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.995 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.5 tt -106.24 145.01 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -126.59 142.08 51.65 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.322 -0.861 . . . . 0.0 109.604 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -119.01 170.67 8.85 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.252 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 68.1 mtp -152.18 166.09 32.79 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.659 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.1 m -147.07 152.54 38.69 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.35 96.74 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.14 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.1 23.96 1.05 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 178.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.8 m -120.14 -179.2 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.27 117.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.589 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.671 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.6 t -99.25 132.64 44.43 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.424 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.7 m -124.96 126.16 45.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.36 -0.838 . . . . 0.0 109.436 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -123.15 100.4 6.85 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 120' ' ' ILE . 59.2 t -66.58 130.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.7 m-85 -120.1 132.25 55.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.404 -179.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.81 137.18 47.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.14 127.63 14.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.215 -0.928 . . . . 0.0 111.867 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.992 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.342 0.591 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.9 m-85 -99.11 -5.34 30.35 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.714 -0.616 . . . . 0.0 109.509 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 p -72.15 118.66 15.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 111.945 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.87 -173.36 38.21 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.4 m120 -95.45 171.87 8.43 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.918 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.2 m95 -150.73 125.35 9.64 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.482 -176.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -118.9 114.76 23.1 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 132' ' ' ARG . 11.0 tt -58.15 143.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.414 -179.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.15 -24.44 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.893 -0.504 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -150.16 176.32 10.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -0.912 . . . . 0.0 110.383 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t 176.56 167.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.56 26.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.2 m-20 -160.53 27.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.752 -0.592 . . . . 0.0 109.851 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.871 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.19 -66.36 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.854 . . . . 0.0 109.053 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.9 mt-10 -55.53 -31.56 62.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.446 -0.784 . . . . 0.0 109.476 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.61 -39.54 91.61 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.157 0.504 . . . . 0.0 110.506 -179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.769 HD22 ' HB2' ' A' ' 130' ' ' CYS . 17.0 tp -79.0 -16.88 56.3 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' A' ' 32' ' ' ALA . 4.8 mt -90.14 -18.92 24.91 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.055 -1.028 . . . . 0.0 109.077 179.23 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mtmm -82.3 -31.48 29.97 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 128' ' ' VAL . 13.6 p -77.84 -40.37 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.011 0.91 . . . . 0.0 108.714 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.32 -47.17 71.33 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.884 0.849 . . . . 0.0 109.428 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -151.31 24.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.1 m -153.74 -41.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.968 -0.725 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.3 t30 -60.89 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.525 -0.734 . . . . 0.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 m -123.62 -46.84 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.809 179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.58 -29.39 68.73 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.0 mm? -58.34 -32.17 68.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.788 -0.57 . . . . 0.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.9 mpp_? -82.69 -44.29 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 109.903 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -61.96 -22.3 65.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 110.682 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mt -79.48 -28.54 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.0 109.04 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.925 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.06 -26.21 33.9 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.8 t -77.94 -39.83 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.65 -33.59 60.45 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.69 94.45 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.87 -67.48 0.43 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.618 -0.676 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 m 51.64 55.3 9.56 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mttm 66.69 73.51 0.38 Allowed Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.462 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.4 Cg_endo -70.99 153.92 63.08 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.024 1.816 . . . . 0.0 110.605 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.95 173.2 6.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.015 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 53.9 t -154.99 164.49 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.3 tm-20 -149.43 109.49 4.11 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.918 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -98.61 139.7 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 121.802 0.81 . . . . 0.0 110.605 -178.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.0 116.47 27.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.666 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.0 tt0 -98.77 116.52 31.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.123 -0.985 . . . . 0.0 110.837 -178.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -116.9 49.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.3 -125.84 8.19 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.6 p30 -75.78 -1.83 26.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -1.04 . . . . 0.0 110.023 178.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.56 138.91 33.43 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.787 -1.196 . . . . 0.0 108.434 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 92.5 m-85 -134.06 116.31 15.32 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.865 0.84 . . . . 0.0 109.431 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.9 147.75 26.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -143.45 105.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.289 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.23 112.09 24.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 109.466 179.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 34.4 m -102.54 141.09 35.93 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.48 140.99 39.42 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.129 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.841 0.829 . . . . 0.0 109.466 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.55 165.27 16.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.731 . . . . 0.0 109.679 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -159.57 123.51 3.79 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.641 -0.662 . . . . 0.0 109.307 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 52' ' ' ILE . 39.7 pt -123.98 166.34 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.02 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.531 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.19 129.45 3.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 109.052 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.0 p90 -161.65 -173.0 3.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.689 -1.204 . . . . 0.0 112.273 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 153.6 47.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 94.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.649 -178.997 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.72 -34.1 1.37 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.495 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -112.42 156.61 22.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.403 -1.057 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.498 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.1 mt-10 -86.39 169.16 13.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 -179.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 15.9 p90 -162.26 173.47 14.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.563 -0.711 . . . . 0.0 109.816 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.28 145.2 29.79 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -162.32 -176.17 4.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 109.528 -179.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -100.71 157.51 16.64 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -95.2 -143.13 0.26 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.862 . . . . 0.0 109.24 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' THR . 24.3 t -110.1 -22.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.754 -1.216 . . . . 0.0 110.814 -179.051 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.581 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -88.12 -40.27 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.589 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.38 45.1 0.1 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.709 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.32 152.1 78.76 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.714 -0.874 . . . . 0.0 109.046 -179.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.766 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.42 142.38 18.63 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.655 1.57 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.14 141.12 10.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 109.552 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 100' ' ' LEU . 8.7 ttmm -86.67 116.13 24.58 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.91 165.42 11.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.735 -0.603 . . . . 0.0 110.268 -178.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 70' ' ' GLU . 57.7 tp -145.69 153.84 41.43 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.7 t -146.17 125.13 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.728 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.1 156.05 29.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.4 m95 -78.03 174.84 10.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.876 0.846 . . . . 0.0 110.126 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -137.84 -46.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.2 p -130.51 -152.68 0.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.67 -28.35 51.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -141.04 28.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 27.3 tttt -132.69 111.52 11.23 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.439 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -118.36 150.17 39.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.25 -0.906 . . . . 0.0 110.398 -179.295 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.47 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.494 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.8 t -147.45 140.3 24.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 110.895 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.68 163.01 13.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -160.3 135.38 7.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.781 -1.167 . . . . 0.0 111.642 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -143.63 150.55 38.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.94 168.94 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.005 . . . . 0.0 110.842 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 80' ' ' PRO . 39.1 mt -99.04 -5.98 29.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.68 133.72 14.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.669 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.86 -157.37 38.94 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -176.15 139.97 0.39 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.438 -1.036 . . . . 0.0 109.915 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.0 -87.9 0.09 OUTLIER Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.36 -176.69 2.89 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.682 1.588 . . . . 0.0 109.474 178.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -130.46 136.31 48.87 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.95 144.41 48.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.151 0.977 . . . . 0.0 110.749 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.7 m -163.04 136.88 6.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.8 p-90 -142.49 174.83 10.28 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.436 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 94' ' ' VAL . 13.0 p -138.36 170.53 15.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.556 0.693 . . . . 0.0 109.801 -179.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.42 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.9 ptp -153.37 137.0 15.99 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -133.19 149.42 52.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.388 -0.82 . . . . 0.0 109.413 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -111.84 141.44 45.47 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 p -90.4 161.12 15.72 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.763 -179.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.33 -22.01 62.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -84.35 -29.19 26.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.284 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.63 -9.85 7.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.55 172.62 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.158 -1.201 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 43' ' ' ILE . 7.2 tt -145.08 108.38 4.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 109.974 -179.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -135.6 137.52 42.02 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.248 -0.907 . . . . 0.0 109.771 -178.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -114.65 168.59 9.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.974 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.505 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.7 mtp -147.55 167.86 23.43 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.636 -179.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.0 m -150.65 150.2 30.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.692 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.25 93.84 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.83 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -146.69 23.52 1.25 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.576 -0.702 . . . . 0.0 109.286 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 125' ' ' ALA . 23.2 m -117.14 -178.52 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.012 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.79 118.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.436 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.769 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.6 t -97.66 116.98 30.92 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.5 m -114.45 126.26 54.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -0.999 . . . . 0.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 9' ' ' ILE . 1.1 mtt-85 -133.22 107.76 8.36 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.04 135.4 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -123.36 126.12 46.26 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.274 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.48 138.48 33.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.496 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -49.96 128.22 18.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.242 -0.911 . . . . 0.0 111.559 -178.617 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.6 tm-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.762 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.348 0.594 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.688 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.3 m-85 -98.84 -9.8 23.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -65.37 118.09 8.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 112.293 -177.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.24 -172.84 37.57 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.63 171.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.818 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.22 120.01 7.08 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.891 -1.123 . . . . 0.0 112.613 -177.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -111.43 114.11 27.02 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' HD2' ' A' ' 39' ' ' PRO . 7.2 tt -56.26 155.45 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.907 0.861 . . . . 0.0 111.195 -178.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.41 -32.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.436 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -145.0 171.04 15.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.029 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t 179.52 157.44 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 109.335 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 170.74 19.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.616 . . . . 0.0 110.049 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 37.5 m-80 61.04 29.99 19.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.476 -0.765 . . . . 0.0 109.887 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.812 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.7 t80 -65.55 -63.17 1.16 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.282 -0.886 . . . . 0.0 108.85 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 2.5 pt-20 -59.76 -28.35 67.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.736 -0.603 . . . . 0.0 109.641 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.73 -38.97 90.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.626 -0.671 . . . . 0.0 110.411 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.8 tp -83.12 -13.39 55.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.686 -0.634 . . . . 0.0 109.711 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -91.82 -20.96 20.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.959 -1.088 . . . . 0.0 108.952 179.572 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmm -83.37 -30.04 27.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.508 HG11 HD12 ' A' ' 18' ' ' LEU . 14.4 p -77.43 -41.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -66.41 -53.55 34.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.25 1.024 . . . . 0.0 108.865 179.251 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.06 -144.9 14.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.6 m -154.99 -38.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.901 -0.764 . . . . 0.0 110.244 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.7 t30 -57.29 -171.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.248 -0.907 . . . . 0.0 109.779 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.677 HG12 ' NH1' ' A' ' 29' ' ' ARG . 4.8 m -121.12 -43.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.77 . . . . 0.0 110.112 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.0 ttm -67.83 -26.35 66.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.57 -0.706 . . . . 0.0 109.131 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.74 -49.2 78.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.704 -0.622 . . . . 0.0 110.525 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.886 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -66.03 -42.3 89.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.463 -0.773 . . . . 0.0 110.029 -178.87 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -57.52 -38.98 75.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.567 -0.708 . . . . 0.0 110.705 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.03 -26.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.429 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.51 -22.1 38.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.66 -0.65 . . . . 0.0 110.169 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -81.99 -45.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.25 91.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.27 71.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.35 42.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.547 179.15 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.8 t -64.97 -35.39 81.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.841 -1.162 . . . . 0.0 108.313 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -157.4 71.22 4.43 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.5 Cg_endo -73.57 146.33 38.89 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 122.012 1.808 . . . . 0.0 110.545 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -93.04 173.22 7.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.664 -0.648 . . . . 0.0 109.618 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 40' ' ' ALA . 4.7 t -153.53 165.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.2 tt0 -156.87 116.98 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.653 -0.654 . . . . 0.0 109.427 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.818 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.1 mp -107.21 138.04 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.582 0.706 . . . . 0.0 109.769 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 3.8 mttt -117.53 109.16 16.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.2 tt0 -98.1 117.07 31.63 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.07 -1.019 . . . . 0.0 111.113 -177.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.84 56.01 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.08 -126.37 8.39 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -77.79 -0.4 26.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.418 -1.048 . . . . 0.0 109.954 178.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 m -96.19 139.99 31.54 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.781 -1.2 . . . . 0.0 108.862 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.4 m-85 -136.66 117.44 14.06 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.774 0.797 . . . . 0.0 108.92 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 4.5 t80 -104.53 119.12 38.24 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 HG13 HD11 ' A' ' 63' ' ' ILE . 1.7 mm -99.84 146.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 120.785 -1.197 . . . . 0.0 107.991 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.8 tttt -145.11 102.58 3.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.93 . . . . 0.0 108.785 179.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 25.0 m -99.56 154.9 17.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.723 . . . . 0.0 109.486 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.69 116.0 6.59 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.01 169.53 8.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.395 -0.816 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.1 pt-20 -173.44 113.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 73' ' ' GLU . 37.5 pt -103.65 173.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.467 -0.77 . . . . 0.0 110.052 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -160.68 130.34 5.02 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.2 p90 -162.38 -171.62 2.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.089 0.947 . . . . 0.0 111.448 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 15.4 ptmt -132.31 154.67 49.47 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.59 94.3 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -178.541 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.74 -23.02 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.865 -1.159 . . . . 0.0 110.607 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -136.41 163.59 30.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.296 -1.12 . . . . 0.0 110.727 -179.6 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.16 171.2 11.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.765 -0.584 . . . . 0.0 109.578 -179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.0 p90 -162.63 175.32 11.51 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.03 143.62 39.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 5.7 pm0 -162.16 -169.18 2.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 109.343 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -99.6 160.07 14.57 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.348 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -97.84 -143.72 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.386 -0.821 . . . . 0.0 109.227 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 27.4 t -110.78 -20.99 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.731 -1.23 . . . . 0.0 110.897 -179.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.603 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -90.39 -40.39 12.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.821 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.89 46.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 8.4 mmm180 -137.28 154.01 75.24 Favored Pre-proline 0 C--N 1.306 -1.292 0 O-C-N 121.743 -0.857 . . . . 0.0 109.269 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.734 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -79.34 142.94 17.05 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 110.439 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.6 p -160.66 142.41 12.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.0 ttpt -90.71 120.76 32.03 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 2.6 t -100.31 172.8 6.93 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.516 0.674 . . . . 0.0 110.347 -178.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.7 tp -148.7 152.72 37.14 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 65' ' ' PHE . 15.5 t -147.74 131.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 118.441 -1.304 . . . . 0.0 112.266 -178.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.64 161.23 29.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.0 m95 -84.36 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.923 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -134.84 -46.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -132.25 -153.66 0.57 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -24.77 47.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -142.16 24.76 1.95 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.8 tttm -130.77 111.85 12.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 0.0 108.522 179.622 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.576 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.06 149.42 38.96 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.628 0.728 . . . . 0.0 110.39 -178.876 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.608 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -101.88 171.74 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.495 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.4 t -149.12 138.29 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.915 . . . . 0.0 110.966 -179.498 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -108.59 163.39 13.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.65 139.69 10.46 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.873 -178.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -141.42 157.13 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.75 168.81 12.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 110.612 -179.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 80' ' ' PRO . 52.9 mt -101.65 -6.07 24.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 138.73 18.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.46 -156.86 41.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -176.87 140.08 0.31 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.567 -0.961 . . . . 0.0 109.603 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.46 -85.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.43 -177.11 3.06 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.88 1.72 . . . . 0.0 109.936 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -135.92 139.02 42.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.84 145.09 48.42 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.16 0.981 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.1 p -163.07 137.71 6.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CZ3' ' CE ' ' A' ' 111' ' ' MET . 61.7 p-90 -142.32 176.0 9.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.023 -1.048 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.608 HG22 HG13 ' A' ' 94' ' ' VAL . 7.3 p -140.41 174.46 10.49 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.817 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.602 ' CE ' HD12 ' A' ' 121' ' ' LEU . 2.4 mtm -157.16 128.5 6.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -124.35 146.83 48.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.529 -0.732 . . . . 0.0 109.63 -179.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.46 144.25 39.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.349 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.18 160.52 14.81 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.6 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.66 -21.61 62.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.171 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.99 -29.23 27.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 109.106 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.45 -9.39 7.34 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' O ' HD13 ' A' ' 113' ' ' LEU . 54.3 mt-10 -56.65 171.68 0.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -1.227 . . . . 0.0 109.293 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.738 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -146.25 112.03 5.63 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.149 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -106.72 147.7 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.602 HD12 ' CE ' ' A' ' 111' ' ' MET . 7.5 tt -129.43 147.96 51.3 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.193 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -127.96 163.37 24.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.474 ' O ' HG22 ' A' ' 129' ' ' VAL . 20.0 mtp -143.13 163.34 33.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.368 -179.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 129' ' ' VAL . 6.6 m -146.7 152.05 38.21 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.33 96.75 1.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.98 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.73 23.91 1.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.546 -0.721 . . . . 0.0 109.407 178.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -119.3 -179.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.03 117.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.716 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.3 t -98.89 112.08 24.29 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.455 ' OG1' HG22 ' A' ' 122' ' ' THR . 77.7 m -107.92 148.9 29.0 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.767 0.794 . . . . 0.0 110.074 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -151.0 118.18 5.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.32 138.97 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.123 -0.986 . . . . 0.0 108.385 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 22.5 m-85 -127.49 125.3 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.367 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.03 139.59 28.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.482 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.36 125.63 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.215 -0.928 . . . . 0.0 111.207 -178.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.515 179.578 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.383 0.611 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 5.1 m-85 -98.85 -8.1 26.29 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.7 p -69.6 118.09 12.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.209 -0.932 . . . . 0.0 111.938 -177.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.3 -171.54 37.34 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.1 m120 -95.59 169.94 9.69 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 177.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.945 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.67 120.43 7.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.643 -177.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -112.66 120.76 42.64 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.7 tt -64.56 151.97 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.845 0.831 . . . . 0.0 111.116 -178.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.03 -31.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -139.73 168.84 18.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 108.985 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.821 ' HB3' HD11 ' A' ' 9' ' ' ILE . 83.8 p -176.82 149.61 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.489 -0.757 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -148.2 163.64 36.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.86 27.48 16.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.917 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.85 -65.47 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.588 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.8 pt-20 -58.01 -27.89 63.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.39 -34.83 79.22 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.553 -0.717 . . . . 0.0 110.018 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' A' ' 130' ' ' CYS . 18.4 tp -82.9 -18.58 39.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.729 -0.607 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.917 HD11 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -91.37 -16.81 26.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.909 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 mmmt -87.94 -28.49 21.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.156 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 12.6 p -76.77 -41.14 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.1 -54.6 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.99 -148.2 19.86 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 23' ' ' GLY . 15.8 m -157.28 -43.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.815 -0.815 . . . . 0.0 109.407 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.607 ' HB3' HD23 ' A' ' 28' ' ' LEU . 7.0 t30 -54.28 176.07 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.472 -0.767 . . . . 0.0 109.516 179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.68 -43.68 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.6 ttm -62.74 -26.38 68.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 25' ' ' ASN . 3.8 mm? -64.8 -69.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.634 -0.666 . . . . 0.0 109.993 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.914 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -52.21 -38.32 57.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 110.62 -179.299 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -61.01 -39.33 89.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.61 -0.681 . . . . 0.0 110.373 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.82 -26.8 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.6 -26.02 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.6 t -75.9 -35.98 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.01 41.74 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.52 93.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.41 -69.49 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m 49.19 51.19 16.71 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.495 0.664 . . . . 0.0 109.46 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.3 mttt 65.38 72.31 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.3 Cg_endo -72.1 156.96 55.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.05 1.833 . . . . 0.0 110.613 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 41' ' ' VAL . . . -105.95 174.38 5.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.355 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 71.8 t -154.23 164.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.8 tt0 -149.68 108.61 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.2 mt -98.45 139.13 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.19 113.1 21.74 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.711 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.2 tt0 -98.48 118.38 35.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.07 -1.019 . . . . 0.0 110.976 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.38 52.45 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -124.44 7.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -178.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.4 p30 -76.31 -1.25 25.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.33 141.77 29.26 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 120.808 -1.183 . . . . 0.0 108.807 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 97.8 m-85 -137.3 115.52 11.73 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.839 0.828 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -101.43 147.5 26.28 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.09 107.52 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.197 -177.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.7 109.84 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.091 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 41' ' ' VAL . 22.6 m -99.36 135.86 40.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.37 121.01 26.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.25 -0.906 . . . . 0.0 110.314 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.75 160.97 22.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -152.51 125.21 8.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 0.0 109.791 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 52' ' ' ILE . 37.9 pt -124.73 165.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.124 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.72 129.03 3.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.001 -1.062 . . . . 0.0 109.887 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 85' ' ' VAL . 49.0 p90 -162.25 -171.87 2.98 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.734 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -132.06 155.91 47.24 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.689 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -83.47 91.63 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.109 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.78 -27.08 0.65 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.124 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HG2' ' CG ' ' A' ' 66' ' ' LYS . 4.9 pt-20 -124.77 159.09 31.73 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.182 -1.187 . . . . 0.0 110.3 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD22 ' A' ' 84' ' ' LEU . 33.8 mt-10 -86.82 166.23 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.2 173.6 14.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.686 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.97 146.12 28.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.37 -177.52 5.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.667 -0.645 . . . . 0.0 109.342 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.44 155.83 17.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.0 t -94.49 -142.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 39.5 t -113.71 -18.64 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.218 . . . . 0.0 110.64 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -89.39 -36.59 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.42 44.84 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.679 ' H ' HG22 ' A' ' 75' ' ' THR . 48.2 mtp180 -134.23 151.85 77.15 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.779 -0.836 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.809 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.8 143.4 18.49 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.658 1.572 . . . . 0.0 110.553 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -161.14 141.65 11.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.717 -0.615 . . . . 0.0 109.625 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.1 ttmm -88.32 116.74 26.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.4 t -99.47 168.08 10.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.428 0.632 . . . . 0.0 110.458 -178.241 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.56 HD22 ' HG2' ' A' ' 70' ' ' GLU . 60.2 tp -151.12 153.77 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.7 t -146.04 134.63 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.214 -177.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -126.17 157.4 38.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.558 ' CE2' HG21 ' A' ' 67' ' ' VAL . 84.6 m95 -81.58 171.05 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.098 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 19.2 tp10 -134.17 -45.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -132.31 -154.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -76.56 -25.52 54.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.18 27.69 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.825 . . . . 0.0 110.717 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 38.8 tttt -130.84 106.87 8.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 108.16 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.608 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.2 ptp -115.18 145.88 41.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 110' ' ' THR . 1.5 t -102.12 171.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.6 t -145.47 138.74 26.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.268 -0.895 . . . . 0.0 110.475 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 7.3 pt-20 -109.62 154.35 22.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -152.46 142.02 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.905 -177.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -143.6 153.32 42.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.66 169.3 3.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.092 -1.005 . . . . 0.0 110.527 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 80' ' ' PRO . 47.2 mt -98.07 -7.93 28.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -155.14 145.31 21.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 108.946 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.04 -158.71 37.51 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.54 140.41 0.36 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.505 -0.997 . . . . 0.0 109.743 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.43 -85.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.99 -176.9 2.83 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.872 1.714 . . . . 0.0 109.905 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -137.92 138.95 39.52 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.99 145.97 48.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.024 0.916 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -162.49 131.1 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -136.16 167.26 21.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.123 -0.986 . . . . 0.0 110.839 -179.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 HG13 ' A' ' 94' ' ' VAL . 21.5 p -131.63 169.77 15.7 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.386 0.612 . . . . 0.0 109.9 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.629 ' HB3' HD12 ' A' ' 121' ' ' LEU . 11.4 ptp -154.98 123.44 6.01 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.31 155.68 29.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 110.412 -178.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.45 141.65 48.95 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.823 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.5 p -93.86 161.03 14.48 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.804 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -60.79 -22.01 63.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.678 . . . . 0.0 110.142 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.65 -28.9 28.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.67 -10.36 7.15 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -54.97 170.89 0.16 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.159 -1.201 . . . . 0.0 109.275 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.605 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.8 tt -147.42 110.12 4.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.49 161.07 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -145.08 132.22 20.43 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.215 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.41 171.55 7.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.0 mtp -149.76 163.91 36.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.093 -179.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.6 m -147.51 152.7 38.44 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.436 0.636 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.669 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.72 96.53 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.645 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.76 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 24.12 1.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.563 -0.711 . . . . 0.0 109.312 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -119.09 -179.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.56 117.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.765 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.21 117.33 32.35 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -111.35 149.77 30.68 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.882 0.848 . . . . 0.0 109.925 -179.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -152.49 118.2 5.38 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.17 137.8 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.8 m-85 -126.93 124.87 40.51 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.446 -179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.55 140.78 24.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -50.02 125.99 13.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.176 -0.952 . . . . 0.0 111.131 -178.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.544 179.569 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.706 0.765 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.581 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.3 m-85 -99.59 -1.09 39.06 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.66 -0.65 . . . . 0.0 109.44 179.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -72.37 120.56 18.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.123 -0.986 . . . . 0.0 112.122 -177.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.54 -171.97 36.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -95.86 169.78 9.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.47 120.97 7.41 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.639 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -113.69 115.7 28.27 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.784 HG21 ' HD2' ' A' ' 39' ' ' PRO . 8.0 tt -55.6 156.61 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.994 0.902 . . . . 0.0 111.418 -178.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -132.21 -32.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.527 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 10' ' ' ILE . 1.3 mtt180 -143.82 169.61 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.254 -0.904 . . . . 0.0 108.938 179.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.57 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.0 p -177.19 145.37 0.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 109.754 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -141.18 165.7 26.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.759 -0.588 . . . . 0.0 109.657 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.1 m-80 58.77 22.54 10.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.474 -0.766 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -65.19 -64.2 0.92 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 108.943 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 42.9 tt0 -57.5 -29.12 64.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -65.36 -34.19 77.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.664 -0.648 . . . . 0.0 110.167 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.808 HD22 ' CB ' ' A' ' 130' ' ' CYS . 12.5 tp -82.72 -19.0 38.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.758 -0.589 . . . . 0.0 110.375 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -90.86 -17.03 27.2 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -87.33 -29.28 21.69 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.216 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.1 p -77.06 -41.01 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.7 mp -65.73 -50.8 63.49 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -143.93 14.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.0 m -154.5 -43.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.697 -0.884 . . . . 0.0 109.985 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.6 t30 -61.97 -172.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.483 -0.761 . . . . 0.0 109.033 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.46 -42.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -61.45 -23.34 65.79 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.9 mm? -79.82 -39.63 30.31 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.736 -0.602 . . . . 0.0 110.086 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.895 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.1 -37.39 85.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.701 -0.624 . . . . 0.0 109.502 -179.223 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -11.97 57.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 111.043 -179.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' ILE . 42.4 mm -85.84 -30.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.897 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.28 -27.25 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.7 t -79.52 -46.13 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.65 89.86 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.98 88.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.693 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.47 40.69 0.74 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.824 -0.547 . . . . 0.0 111.56 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.4 p -58.31 -26.66 63.3 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.487 -1.383 . . . . 0.0 108.679 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.19 73.01 0.23 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.784 ' HD2' HG21 ' A' ' 9' ' ' ILE . 32.4 Cg_endo -73.18 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.996 1.798 . . . . 0.0 111.089 -178.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -138.96 173.43 11.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 55.1 t -156.43 163.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.9 tt0 -150.47 111.0 4.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -99.37 133.37 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.636 0.731 . . . . 0.0 110.366 -178.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -112.72 111.92 23.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.666 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 61.8 tt0 -98.57 119.39 37.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.11 -0.994 . . . . 0.0 111.002 -178.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -120.69 54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.9 -126.74 8.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.23 -0.44 25.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.387 -1.066 . . . . 0.0 109.987 178.663 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.65 140.75 30.8 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.653 -1.279 . . . . 0.0 108.512 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.7 m-85 -136.67 116.39 13.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.8 0.81 . . . . 0.0 109.465 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.67 147.45 26.42 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.141 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -142.27 104.8 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.25 -177.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.44 109.35 21.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.067 178.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 60.6 m -103.21 141.8 35.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.6 p -148.88 124.88 10.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 109.592 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.532 -0.73 . . . . 0.0 109.634 -179.703 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.2 m . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.42 169.06 10.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.554 -0.716 . . . . 0.0 110.079 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -160.42 123.32 3.37 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.141 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -124.49 168.85 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.376 -0.827 . . . . 0.0 109.407 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.54 129.32 3.61 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.234 -0.916 . . . . 0.0 109.08 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.2 p90 -162.14 -172.16 3.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.388 -179.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -130.54 153.12 49.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.42 95.15 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 109.79 -178.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.3 -33.58 1.57 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.772 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -110.88 153.59 25.23 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.356 -1.085 . . . . 0.0 109.869 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.15 167.21 15.13 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.684 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.463 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.39 173.61 13.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.818 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -103.94 143.66 32.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.7 pt-20 -162.09 -176.86 5.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.82 155.67 17.53 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.6 t -91.19 -142.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.46 -0.775 . . . . 0.0 109.194 -179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 25.4 t -110.02 -20.63 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.74 -1.225 . . . . 0.0 110.624 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.638 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.43 -39.96 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.57 44.88 0.11 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -130.61 150.82 77.43 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.629 -0.924 . . . . 0.0 109.342 -179.628 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.92 140.29 15.98 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.7 1.6 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.4 p -161.36 141.86 10.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.637 -0.664 . . . . 0.0 109.811 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.3 ttmm -90.57 114.32 26.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.81 177.5 4.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.715 -0.615 . . . . 0.0 110.235 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' ' 70' ' ' GLU . 64.4 tp -151.75 152.01 32.15 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.4 t -140.74 130.25 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.516 -177.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.5 ptmt -125.89 162.48 25.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.562 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.3 m95 -85.69 167.35 15.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.969 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -129.93 -45.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 p -132.01 -154.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.29 -24.65 50.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.733 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -143.91 27.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.5 tttt -132.27 106.4 7.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 107.977 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.496 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.4 ptp -113.18 149.89 33.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.316 -178.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.946 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -104.7 172.11 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.49 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.8 t -149.58 129.79 13.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 110.747 -179.412 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -100.68 163.99 12.08 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 176.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.41 142.91 13.09 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.945 -178.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -147.08 149.25 32.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.43 167.9 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.065 -1.022 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 80' ' ' PRO . 30.3 mt -98.0 -7.44 29.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -152.44 141.14 20.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 108.922 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.07 -159.72 36.04 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -176.37 139.91 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.493 -1.004 . . . . 0.0 109.829 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.45 -86.67 0.06 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.1 -176.97 2.83 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.834 1.689 . . . . 0.0 109.774 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -135.5 138.53 43.2 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 146.05 47.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.068 0.937 . . . . 0.0 110.872 -179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -162.7 128.79 3.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -133.34 166.01 23.49 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.098 -1.001 . . . . 0.0 110.85 -179.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.946 HG22 HG13 ' A' ' 94' ' ' VAL . 18.8 p -130.4 174.69 9.61 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.415 0.626 . . . . 0.0 109.692 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -160.09 122.33 3.31 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.112 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -116.95 154.1 31.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -115.22 142.73 46.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.282 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -95.03 160.34 14.61 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.987 -179.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.9 -23.19 63.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.688 -0.632 . . . . 0.0 110.139 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -81.69 -31.06 32.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.16 -8.6 7.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -58.12 170.73 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.124 -1.221 . . . . 0.0 108.97 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.737 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -143.87 113.74 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.123 -178.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.81 152.45 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -135.01 132.78 38.71 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.46 -0.775 . . . . 0.0 109.557 -179.156 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.487 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -113.29 170.65 8.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.242 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.4 mtp -150.01 165.04 33.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.418 -179.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.7 m -146.9 152.22 38.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.674 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.94 96.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.561 179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.45 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -146.38 24.23 1.27 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.456 -0.778 . . . . 0.0 109.393 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 125' ' ' ALA . 24.4 m -119.59 -178.29 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.39 117.49 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.665 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.808 ' CB ' HD22 ' A' ' 18' ' ' LEU . 13.9 t -98.41 119.4 37.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.066 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' HG22 ' A' ' 122' ' ' THR . 92.0 m -115.5 149.79 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 110.075 -179.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -152.07 118.27 5.57 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.52 138.38 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.96 . . . . 0.0 108.446 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.4 m-85 -126.88 124.48 39.67 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.019 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.35 139.94 26.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -49.2 125.67 11.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.228 -0.92 . . . . 0.0 111.214 -178.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.628 179.573 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.576 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.58 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.18 -8.87 24.48 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.744 -0.598 . . . . 0.0 109.478 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.6 p -68.73 118.05 11.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.225 -0.922 . . . . 0.0 111.869 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.4 -174.41 38.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.2 m120 -95.45 172.24 8.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.72 124.66 8.59 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.964 -1.094 . . . . 0.0 112.54 -176.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -116.8 117.77 30.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 12' ' ' SER . 13.9 tt -61.73 151.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.914 0.864 . . . . 0.0 111.082 -178.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.28 -31.37 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -141.72 172.1 13.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.768 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.1 t -179.7 145.68 0.24 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.456 -0.777 . . . . 0.0 109.443 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -142.19 163.11 33.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.0 109.992 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.2 m-20 62.87 32.8 15.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.607 -0.683 . . . . 0.0 109.754 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.955 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.88 -64.11 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.139 -179.728 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 tt0 -57.22 -35.87 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.815 . . . . 0.0 110.919 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -67.97 -29.7 68.79 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.179 -178.848 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.2 tp -77.49 -22.28 51.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.3 mt -89.95 -15.97 30.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.301 -0.875 . . . . 0.0 109.14 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -87.58 -31.4 19.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.0 p -74.59 -39.03 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -69.2 -45.8 69.02 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.736 0.779 . . . . 0.0 109.492 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.88 -161.63 27.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -146.29 -35.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.891 -0.77 . . . . 0.0 110.463 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.6 t30 -62.21 -149.72 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 109.372 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.98 -47.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.7 -1.25 . . . . 0.0 109.323 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.484 ' HG2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttt -71.27 -26.89 63.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.2 mm? -58.73 -18.8 34.57 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.74 -0.6 . . . . 0.0 111.054 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.9 mpt_? -96.19 -47.9 5.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.754 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -21.32 65.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.662 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.484 HD11 ' HG2' ' A' ' 27' ' ' MET . 58.9 mt -78.21 -29.09 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -0.904 . . . . 0.0 108.728 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.973 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 14.4 t -76.56 -37.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -31.73 45.98 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.49 -39.18 91.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.46 -69.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 p 48.33 50.79 16.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.467 0.651 . . . . 0.0 109.662 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 64.63 72.3 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -73.06 159.32 47.98 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 122.059 1.84 . . . . 0.0 110.714 -179.293 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.88 174.34 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.561 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 54' ' ' THR . 53.7 t -155.58 164.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 41' ' ' VAL . 55.0 tt0 -151.23 110.53 3.95 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -98.62 140.14 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.753 0.787 . . . . 0.0 110.376 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -118.18 111.09 18.38 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.478 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.25 120.62 38.98 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.068 -1.02 . . . . 0.0 111.091 -177.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.03 54.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.89 -127.55 8.89 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.211 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.36 -0.85 24.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.403 -1.057 . . . . 0.0 110.079 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 m -97.02 138.74 34.09 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.753 -1.217 . . . . 0.0 108.489 -179.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.1 m-85 -133.98 118.02 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 0.0 109.446 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.98 147.97 26.27 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.337 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.069 HD12 HD11 ' A' ' 63' ' ' ILE . 1.8 mt -144.57 103.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.884 -1.135 . . . . 0.0 111.585 -177.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 113.02 25.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 41' ' ' VAL . 57.1 m -104.44 141.83 35.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.96 144.33 41.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.323 -0.86 . . . . 0.0 110.059 -179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.934 0.873 . . . . 0.0 109.291 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.59 164.97 23.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.787 . . . . 0.0 109.585 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -165.41 119.41 1.23 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.069 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -123.44 168.61 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 109.341 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.26 129.23 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.186 -0.946 . . . . 0.0 108.937 179.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.3 p90 -162.03 -172.44 3.25 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.394 -179.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -129.56 153.33 48.15 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 90.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.121 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.41 -24.68 1.09 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.795 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.88 156.89 33.72 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.266 -1.137 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG2' HD22 ' A' ' 84' ' ' LEU . 49.2 mt-10 -86.3 167.47 14.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.705 -0.622 . . . . 0.0 109.489 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.484 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.41 175.81 11.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.698 -0.626 . . . . 0.0 109.49 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.39 145.81 29.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.8 pt-20 -162.26 -175.81 4.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.69 -0.631 . . . . 0.0 109.375 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -100.19 158.3 15.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.3 t -97.96 -144.34 0.31 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.396 -0.815 . . . . 0.0 109.326 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.581 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -109.93 -24.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.86 -1.15 . . . . 0.0 110.841 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -84.5 -40.74 17.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.75 45.41 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 mmm180 -135.4 154.66 78.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.731 -0.864 . . . . 0.0 108.971 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -78.89 144.29 18.98 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.703 1.602 . . . . 0.0 110.703 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 p -160.86 141.81 11.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.718 -0.614 . . . . 0.0 109.549 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -87.05 116.75 25.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.825 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.48 166.45 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 -178.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.25 154.51 41.81 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.4 t -146.24 131.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.319 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.5 pttt -125.57 160.55 29.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.8 m95 -83.65 171.76 12.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.193 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 10.9 tp10 -134.87 -46.16 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -131.9 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.66 -24.58 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 109.745 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -143.65 26.45 1.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 110.788 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 14.0 tttt -131.44 110.48 11.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.902 -1.124 . . . . 0.0 108.085 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.1 ptp -116.13 148.29 40.46 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.297 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -100.88 170.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.479 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.9 t -146.36 142.46 28.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -109.77 163.47 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -160.36 135.34 7.79 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.528 -178.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -143.1 148.94 37.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.59 166.37 2.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.052 -1.03 . . . . 0.0 110.94 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.716 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.5 mt -98.45 -5.99 31.33 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -150.91 133.87 15.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.72 -161.21 36.26 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.95 140.79 0.44 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.43 -1.041 . . . . 0.0 109.874 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.04 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.25 -176.71 2.93 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.712 1.608 . . . . 0.0 109.536 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -129.94 137.65 50.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.95 145.04 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.118 0.961 . . . . 0.0 110.608 -179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -163.13 143.44 9.14 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.3 p-90 -144.05 173.47 11.7 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 15.2 p -139.51 170.33 16.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 121' ' ' LEU . 9.6 ptp -154.56 137.1 15.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -131.11 151.37 51.51 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.371 -0.831 . . . . 0.0 109.468 -179.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.7 142.09 46.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -90.63 161.47 15.39 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.36 -22.1 62.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.653 . . . . 0.0 110.182 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.9 -28.69 25.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.07 -9.24 7.51 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.699 ' OE1' HG22 ' A' ' 135' ' ' VAL . 67.8 mm-40 -57.02 172.99 0.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.079 -1.248 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -146.1 112.47 5.85 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.923 -178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -105.06 158.43 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD21 ' SD ' ' A' ' 123' ' ' MET . 0.7 OUTLIER -142.41 134.02 26.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -178.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.38 166.91 10.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 121' ' ' LEU . 75.2 mmm -141.27 165.86 26.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 108.992 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -151.72 149.78 29.47 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.446 0.641 . . . . 0.0 109.338 178.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.77 94.58 1.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.9 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -147.67 24.14 1.1 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.533 -0.73 . . . . 0.0 109.137 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -117.38 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.084 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.68 119.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.9 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.44 114.15 26.93 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.067 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.0 m -104.08 149.51 25.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.16 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.498 ' HD2' HD12 ' A' ' 9' ' ' ILE . 18.9 mtm180 -153.21 120.13 5.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.6 137.07 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.0 m-85 -126.0 125.36 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.082 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.699 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -107.54 137.08 40.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.426 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.48 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.2 127.98 15.72 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.011 0.91 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 6.8 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.725 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.348 0.594 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.795 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.01 -13.47 19.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -63.21 117.67 6.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.359 -0.838 . . . . 0.0 112.033 -177.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.57 -175.06 38.17 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.0 m120 -95.5 172.2 8.22 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.592 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.854 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.7 120.4 7.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.753 -176.404 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -109.08 117.15 33.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.682 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 12' ' ' SER . 7.2 tt -60.4 154.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.921 0.867 . . . . 0.0 111.072 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -126.79 -32.3 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.207 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.754 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.8 ttp85 -149.49 169.25 21.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.108 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 9' ' ' ILE . 94.7 p -177.46 139.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.528 -0.733 . . . . 0.0 109.301 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.66 174.83 10.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.622 -0.674 . . . . 0.0 109.868 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 69.4 m-20 59.17 25.43 13.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.066 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.657 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -64.8 -64.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 108.718 179.582 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 pt-20 -56.78 -28.06 60.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 0.0 109.509 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -65.14 -39.88 93.64 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.052 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 130' ' ' CYS . 37.2 tp -80.91 -14.33 58.09 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.748 -0.595 . . . . 0.0 109.821 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 1.3 mt -91.41 -20.16 22.09 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.063 -1.023 . . . . 0.0 109.173 178.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mmmt -83.65 -28.62 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.172 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 HD12 ' A' ' 18' ' ' LEU . 14.7 p -78.81 -41.48 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.456 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.471 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.18 -53.54 36.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.198 0.999 . . . . 0.0 108.908 179.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.64 -145.5 15.87 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 23' ' ' GLY . 20.9 m -155.35 -39.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.914 -0.757 . . . . 0.0 110.234 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.6 t30 -57.93 -171.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 0.0 109.724 -179.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.481 HG12 ' NH1' ' A' ' 29' ' ' ARG . 15.6 m -121.43 -43.44 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.593 -0.692 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.416 ' N ' HG23 ' A' ' 26' ' ' VAL . 6.7 ttt -68.23 -28.15 66.98 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.682 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.4 mm? -58.77 -52.04 67.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.758 -0.589 . . . . 0.0 110.553 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.893 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 mpp_? -60.35 -39.51 87.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.506 -0.746 . . . . 0.0 110.262 -178.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -60.33 -29.24 68.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 110.667 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.8 mt -77.54 -27.76 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.115 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.21 -22.54 35.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.2 t -81.01 -42.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.657 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.22 81.79 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.34 -49.79 75.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.49 48.63 1.54 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.783 -0.573 . . . . 0.0 110.6 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -63.33 -33.1 74.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.777 -1.202 . . . . 0.0 108.55 179.441 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 72.12 2.01 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.863 ' HB3' HG22 ' A' ' 56' ' ' THR . 33.5 Cg_endo -74.01 141.05 29.25 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.909 1.739 . . . . 0.0 111.085 -178.32 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.96 177.07 5.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 54' ' ' THR . 50.4 t -155.74 165.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 42.9 tt0 -151.62 110.18 3.8 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -97.93 138.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.849 0.833 . . . . 0.0 110.124 -178.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 12.7 mttt -116.56 108.93 16.58 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.1 tt0 -98.56 114.72 27.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -178.483 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -120.45 60.64 0.88 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.71 -127.93 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.02 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -78.56 0.74 25.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -1.085 . . . . 0.0 110.014 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -97.05 142.11 29.39 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.713 -1.242 . . . . 0.0 108.778 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.9 m-85 -138.45 120.1 15.13 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.808 0.813 . . . . 0.0 109.288 179.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.417 ' CG ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 t80 -102.9 139.91 37.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.447 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.34 116.97 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.022 -1.048 . . . . 0.0 109.292 -179.518 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.7 tttt -115.08 101.08 8.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.523 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.69 HG23 HG22 ' A' ' 41' ' ' VAL . 16.5 m -100.0 144.89 28.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 109.056 179.5 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -145.16 125.94 14.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.429 -0.794 . . . . 0.0 110.028 -179.721 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 39' ' ' PRO . 21.8 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.551 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.773 HG22 ' OE2' ' A' ' 62' ' ' GLU . 12.3 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -95.88 156.14 16.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.397 -0.815 . . . . 0.0 109.322 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.773 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.1 mp0 -151.03 137.58 18.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.594 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.865 HD11 HG13 ' A' ' 52' ' ' ILE . 24.4 pt -142.85 169.5 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.557 -0.715 . . . . 0.0 109.519 179.39 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -162.6 135.95 6.01 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.46 -0.775 . . . . 0.0 108.945 179.325 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 52.5 p90 -161.85 -173.45 3.71 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.93 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 152.87 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 92.2 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -178.881 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.91 -29.8 1.25 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.841 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -116.33 155.84 27.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.308 -1.113 . . . . 0.0 110.26 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' HD22 ' A' ' 84' ' ' LEU . 37.1 mt-10 -85.72 167.35 15.35 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 17.1 p90 -162.84 174.74 12.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.894 -178.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -104.38 144.89 31.03 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.1 -177.27 5.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.42 156.21 17.14 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.011 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.1 t -93.53 -142.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.366 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' N ' HG23 ' A' ' 75' ' ' THR . 24.0 t -108.64 -23.23 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.751 -1.218 . . . . 0.0 110.875 -179.039 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.583 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -87.38 -40.86 14.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.397 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.35 44.53 0.1 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 13.5 mtp180 -130.72 152.11 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.676 -0.896 . . . . 0.0 109.146 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.09 142.24 19.3 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.643 1.562 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.0 p -160.91 141.47 11.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.672 -0.643 . . . . 0.0 109.782 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.603 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -90.56 114.05 26.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.5 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -101.78 177.22 4.97 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.88 -178.756 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' HG2' ' A' ' 70' ' ' GLU . 59.3 tp -151.83 152.92 33.26 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.29 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.1 t -140.36 131.99 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.843 -177.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -126.83 159.89 32.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.671 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -83.8 170.13 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.025 -179.602 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.4 tp10 -132.99 -45.7 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.092 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -133.19 -153.94 0.58 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -77.6 -24.87 49.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 109.792 179.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -143.03 26.74 1.66 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 60.7 tttt -131.21 107.96 9.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.943 -1.098 . . . . 0.0 108.113 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.509 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -115.61 147.29 40.95 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.501 -0.749 . . . . 0.0 110.175 -179.141 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -102.55 172.16 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.0 t -149.38 130.5 14.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.789 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.0 pt-20 -101.35 163.62 12.18 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 8.4 tt0 -160.18 143.25 13.65 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.962 -178.222 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -147.37 150.74 35.28 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.83 167.1 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.861 -179.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.1 mt -97.5 -7.61 31.08 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 134.26 18.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.8 -158.39 44.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.414 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -176.35 141.37 0.41 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.501 -1.0 . . . . 0.0 109.808 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.65 -86.23 0.05 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.26 -176.87 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.841 1.694 . . . . 0.0 109.911 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -132.46 135.04 45.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.56 145.49 47.92 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.068 0.937 . . . . 0.0 110.774 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 p -163.14 134.27 4.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -135.6 169.29 17.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.086 -1.009 . . . . 0.0 110.202 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.842 HG22 HG13 ' A' ' 94' ' ' VAL . 17.6 p -134.95 171.4 14.46 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.429 0.633 . . . . 0.0 109.791 -179.566 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.436 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 2.1 ptp -154.46 130.82 10.47 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 154.04 39.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.246 -178.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.47 141.71 48.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.032 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.5 p -93.77 160.55 14.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.682 -179.477 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -60.74 -21.48 63.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.104 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.22 -29.33 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.16 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.36 -9.18 7.39 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 170.32 0.4 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.256 . . . . 0.0 108.944 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.836 HD13 HD13 ' A' ' 43' ' ' ILE . 7.6 tt -146.75 112.54 5.69 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.228 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.9 tt -104.45 160.3 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.69 132.63 27.67 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.359 -0.838 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.75 170.8 7.99 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.362 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 27.9 mtp -148.4 166.0 29.42 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.353 -179.333 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 5.7 m -150.11 151.96 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.44 0.638 . . . . 0.0 109.369 179.212 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.85 96.08 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.501 179.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.13 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -147.37 24.03 1.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.495 -0.753 . . . . 0.0 109.22 178.516 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.7 m -117.87 -179.07 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.81 118.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.628 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.704 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -97.36 121.32 39.13 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -116.72 148.17 41.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.007 0.908 . . . . 0.0 110.283 -178.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -153.1 121.82 6.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.95 139.19 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.087 -1.008 . . . . 0.0 108.697 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 21.7 m-85 -127.65 133.38 49.65 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.232 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.15 138.32 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.24 128.25 16.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.204 -0.935 . . . . 0.0 111.644 -178.482 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.656 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.498 1.741 0 N-CA-C 109.868 -0.858 . . . . 1.72 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -162.78 123.0 2.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.366 -0.834 . . . . 1.29 109.564 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.653 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.0 m-85 -99.73 -8.15 24.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.915 -0.772 . . . . 0.17999999999999999 108.915 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 45' ' ' GLN . 23.0 t -66.62 116.39 7.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.405 -0.81 . . . . 1.22 111.352 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -169.89 37.65 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.609 -1.796 . . . . 0.14000000000000001 108.609 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 6.4 m120 -96.62 169.88 9.58 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.537 -1.653 . . . . 0.57999999999999996 106.537 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.927 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.84 119.78 6.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.474 -1.29 . . . . 0.20999999999999999 112.385 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -114.12 113.72 25.09 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.829 -1.175 . . . . 1.75 107.829 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.3 tt -56.52 154.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.847 0.832 . . . . 0.68999999999999995 110.907 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.99 -31.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.979 -0.748 . . . . 0.46000000000000002 108.979 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HB2' HD12 ' A' ' 10' ' ' ILE . 5.5 mtt180 -139.88 168.1 20.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.343 -0.848 . . . . 2.8599999999999999 108.753 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 9' ' ' ILE . 4.2 t 177.74 152.37 0.25 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.04 109.689 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.54 171.01 16.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.579 -0.701 . . . . 1.25 109.456 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 62.7 m-20 61.34 32.11 19.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 1.78 109.865 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.976 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.18 -62.65 1.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.41999999999999998 110.084 -179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -59.2 -36.51 75.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.268 -0.895 . . . . 2.2799999999999998 110.354 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 8.1 pt-20 -68.02 -28.62 67.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.274 -0.97 . . . . 2.0800000000000001 109.795 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD22 ' HB2' ' A' ' 130' ' ' CYS . 43.4 tp -79.41 -21.34 45.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.191 -0.943 . . . . 0.59999999999999998 108.998 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 32' ' ' ALA . 3.9 mt -89.5 -18.45 26.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.161 -0.962 . . . . 0.71999999999999997 108.596 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -84.13 -30.3 26.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.738 -1.208 . . . . 1.1100000000000001 107.738 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.7 p -77.48 -41.02 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.875 -1.157 . . . . 0.45000000000000001 107.875 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.4 mp -65.51 -50.62 64.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.608 -0.886 . . . . 0.56999999999999995 108.608 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.704 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.72 -142.25 12.46 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.136 -1.186 . . . . 0.71999999999999997 110.136 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -164.67 -34.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.655 -0.909 . . . . 1.53 109.415 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.0 t30 -61.71 -159.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.411 -0.806 . . . . 1.54 109.497 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.6 HG12 HH12 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -120.97 -48.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.24 109.397 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.9 ttt -68.96 -24.46 64.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.54 -0.911 . . . . 2.21 108.54 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -60.8 -27.75 68.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.763 -0.586 . . . . 1.3999999999999999 110.219 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.856 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -87.38 -45.19 10.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 2.4399999999999999 109.901 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -61.43 -25.09 66.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 2.77 110.526 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.9 mt -76.5 -29.66 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.117 -0.989 . . . . 1.45 108.85 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.22 -26.04 33.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.561 -0.712 . . . . 0.41999999999999998 109.166 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.1 t -77.15 -36.15 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.768 -1.197 . . . . 0.44 107.768 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.37 -33.57 48.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.13 -1.063 . . . . 0.68000000000000005 108.13 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.31 94.91 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.912 -0.773 . . . . 0.80000000000000004 108.912 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.84 -69.07 0.25 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.741 -0.837 . . . . 1.6899999999999999 108.741 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 44.18 46.78 7.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.608 -0.683 . . . . 1.6000000000000001 109.348 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 67.34 73.46 0.36 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.436 -0.95 . . . . 3.0800000000000001 108.436 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.3 Cg_endo -74.58 157.13 44.75 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.596 2.198 . . . . 0.57999999999999996 110.437 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -99.67 173.15 6.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.447 -0.783 . . . . 0.23999999999999999 109.488 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.582 ' CG2' HG23 ' A' ' 54' ' ' THR . 13.3 t -156.15 160.74 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.89 -0.781 . . . . 0.28000000000000003 108.89 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 35.3 tt0 -146.68 113.11 5.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 1.47 108.746 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.9 mt -99.94 136.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.395 -0.816 . . . . 0.31 110.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.23 111.06 20.93 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.297 -1.371 . . . . 1.23 107.297 178.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.5 tt0 -98.52 122.33 41.58 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.985 -1.072 . . . . 1.6100000000000001 110.781 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -125.47 46.72 2.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.565 -0.902 . . . . 1.97 108.565 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.47 -131.33 10.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.749 -1.74 . . . . 0.38 108.749 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.26 -0.31 19.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -1.179 . . . . 1.1299999999999999 109.555 179.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.3 m -98.81 131.53 44.86 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.897 -1.127 . . . . 0.25 108.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.591 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.3 m-85 -128.25 118.62 23.62 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.22 110.049 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.694 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.0 t80 -102.24 144.71 30.42 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.082 -1.451 . . . . 0.31 107.082 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.851 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -141.79 107.35 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.684 -1.26 . . . . 0.56000000000000005 110.562 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 1.6 tttt -104.72 115.46 30.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 1.8 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' CG2' ' A' ' 41' ' ' VAL . 44.4 m -104.2 144.79 31.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.38 109.1 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -140.65 134.57 30.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 0.54000000000000004 109.615 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -102.8 -71.73 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.93 0.871 . . . . 1.05 109.329 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.819 HG23 HG23 ' A' ' 58' ' ' VAL . 5.1 t -172.95 -41.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.809 -1.552 . . . . 1.26 106.809 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.819 HG23 HG23 ' A' ' 57' ' ' THR . 38.1 t -113.96 -9.85 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.701 -0.851 . . . . 1.3600000000000001 108.701 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' CG ' ' N ' ' A' ' 60' ' ' THR . 35.8 ttm180 -123.3 163.81 20.0 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.278 -0.889 . . . . 3.29 109.411 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 55' ' ' SER . 20.4 m -164.31 102.96 0.85 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.545 -0.722 . . . . 0.63 109.301 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -101.71 172.69 6.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.77000000000000002 109.504 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 3.7 pt-20 -171.87 125.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 1.8500000000000001 109.332 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.851 HD11 HD12 ' A' ' 52' ' ' ILE . 38.0 pt -117.57 170.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.34999999999999998 109.289 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -161.25 130.53 4.68 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.942 . . . . 1.1699999999999999 108.939 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -161.54 -172.93 3.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.16 111.484 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 11.6 ptpt -128.91 152.74 48.21 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.027 -1.101 . . . . 1.8400000000000001 108.027 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.2 92.55 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 0.17999999999999999 109.734 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.67 -26.97 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.519 -1.324 . . . . 0.27000000000000002 110.579 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -124.65 159.51 30.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.246 . . . . 2.3799999999999999 109.995 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HG2' HD22 ' A' ' 84' ' ' LEU . 27.2 mt-10 -87.51 167.96 13.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 1.6499999999999999 109.207 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 18.3 p90 -161.38 178.36 9.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.419 -0.801 . . . . 0.20000000000000001 109.713 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -107.56 143.31 36.17 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.374 -0.973 . . . . 1.1399999999999999 108.374 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.698 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.1 pt-20 -161.99 -176.21 5.07 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.462 -0.774 . . . . 1.5900000000000001 109.46 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -99.55 153.06 19.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.817 -0.808 . . . . 1.9199999999999999 108.817 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.71 HG23 ' H ' ' A' ' 77' ' ' ASP . 9.2 t -90.18 -144.99 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 1.04 109.529 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 21.5 t -107.96 -19.21 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.78 -1.2 . . . . 2.02 110.56 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.71 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.6 -44.21 10.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.063 -1.023 . . . . 2.0299999999999998 109.305 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.88 39.65 0.09 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.425 . . . . 0.45000000000000001 109.536 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 1.5 mmm180 -129.41 152.91 80.36 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.469 -1.019 . . . . 2.6600000000000001 109.052 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD2' ' HD2' ' A' ' 79' ' ' ARG . 35.9 Cg_endo -78.41 139.71 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.164 1.909 . . . . 0.28999999999999998 110.537 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.416 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 13.1 p -160.58 144.06 13.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.23999999999999999 109.559 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -86.4 117.28 25.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.293 -1.003 . . . . 1.5 108.293 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 97' ' ' GLN . 1.9 t -99.88 165.63 11.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -0.787 . . . . 0.75 109.971 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.0 tp -144.94 155.63 43.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.473 -1.306 . . . . 0.53000000000000003 107.473 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.8 t -148.41 128.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.37 -1.332 . . . . 0.20000000000000001 111.855 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.66 158.48 28.57 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.274 -1.38 . . . . 1.9099999999999999 107.274 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.54 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.6 m95 -81.36 166.53 20.36 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.959 -1.088 . . . . 0.14999999999999999 110.178 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.7 tp10 -130.99 -42.2 1.11 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.845 -1.169 . . . . 1.1100000000000001 107.845 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -136.71 -153.31 0.49 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.75 -1.204 . . . . 0.16 107.75 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.94 -18.94 49.17 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.118 -0.989 . . . . 2.1499999999999999 109.594 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -147.93 26.84 0.99 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.091 -1.005 . . . . 0.25 110.355 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 57.5 tttt -134.38 109.33 8.71 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.73 -1.231 . . . . 1.3400000000000001 108.617 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.591 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -115.17 148.02 39.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.404 -0.81 . . . . 0.67000000000000004 110.073 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.6 t -100.32 172.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.774 -0.824 . . . . 0.20000000000000001 108.774 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.441 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 53.6 t -147.99 140.12 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.018 . . . . 0.20999999999999999 111.078 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -107.57 164.49 12.17 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.867 -1.531 . . . . 2.1099999999999999 106.867 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 4.5 tt0 -160.2 135.84 8.29 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.412 -1.315 . . . . 0.78000000000000003 111.554 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 56.0 pttt -145.16 144.28 30.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.134 -1.061 . . . . 2.4500000000000002 108.134 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 168.14 1.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.898 -1.126 . . . . 0.87 110.808 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 82' ' ' LYS . 67.3 mt -102.78 -3.83 25.83 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.931 -1.137 . . . . 0.97999999999999998 107.931 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -153.88 148.2 25.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.942 -0.762 . . . . 2.8500000000000001 108.942 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.16 -162.71 22.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.079 -1.609 . . . . 1.9399999999999999 109.079 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.94 141.73 0.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.266 -1.138 . . . . 5.2599999999999998 109.645 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.45 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.856 -1.697 . . . . 1.3200000000000001 108.856 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.17 -176.15 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.448 2.099 . . . . 0.83999999999999997 110.056 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.5 tttm -137.18 136.8 38.51 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.232 -1.025 . . . . 1.28 108.232 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.91 145.2 46.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 0.35999999999999999 110.753 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.8 m -162.73 136.59 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.819 -1.178 . . . . 0.84999999999999998 107.819 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.441 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 53.4 p-90 -142.96 176.7 8.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.23999999999999999 110.323 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.43 171.83 13.52 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.462 0.649 . . . . 0.23000000000000001 109.599 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.539 ' HB2' ' HE2' ' A' ' 111' ' ' MET . 13.3 ptm -153.97 125.83 7.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.584 -0.895 . . . . 1.9299999999999999 108.584 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -120.53 154.12 35.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 1.97 110.232 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.93 144.78 41.91 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.839 -1.171 . . . . 0.17000000000000001 107.839 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.403 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 41.4 p -93.26 161.55 14.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.854 -1.154 . . . . 0.23999999999999999 109.715 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -62.14 -19.49 63.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.399 -0.813 . . . . 2.1499999999999999 109.794 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.21 -26.46 23.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.8600000000000001 109.184 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.1 -9.68 8.4 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.847 -1.301 . . . . 0.17999999999999999 109.847 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.426 ' O ' HD13 ' A' ' 113' ' ' LEU . 62.0 mt-10 -55.88 172.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 1.48 109.03 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.764 HD13 HD13 ' A' ' 43' ' ' ILE . 7.9 tt -144.84 113.21 6.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.14999999999999999 110.18 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 tt -105.74 154.44 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.914 -1.143 . . . . 0.68000000000000005 107.914 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -137.91 131.3 30.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.023 -1.048 . . . . 1.3799999999999999 109.893 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -109.02 162.32 14.34 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.835 -1.172 . . . . 0.27000000000000002 107.835 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 13.9 mtp -142.4 159.09 42.92 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.164 -0.96 . . . . 0.81000000000000005 109.774 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 129' ' ' VAL . 3.4 m -143.87 152.56 41.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.15 -0.685 . . . . 0.31 109.15 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 128' ' ' VAL . . . -155.94 91.14 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.567 -0.708 . . . . 0.31 109.586 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 0.6 OUTLIER 78.72 -76.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.924 -0.769 . . . . 1.21 108.924 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.25 22.67 1.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.751 -0.833 . . . . 2.1400000000000001 108.751 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 125' ' ' ALA . 16.6 m -117.36 179.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.197 -1.038 . . . . 0.37 108.197 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.85 117.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.132 -1.027 . . . . 0.28999999999999998 110.077 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.915 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.14 107.74 20.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 0.40000000000000002 109.321 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 122' ' ' THR . 93.7 m -99.71 145.98 27.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.37 109.507 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -151.02 122.69 8.01 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.503 -0.925 . . . . 1.8100000000000001 108.503 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.54 135.52 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.911 -1.118 . . . . 0.23999999999999999 108.767 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.477 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.1 m-85 -124.37 124.35 42.18 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.508 -0.877 . . . . 0.40000000000000002 109.916 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.48 49.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.575 -1.269 . . . . 0.17999999999999999 107.575 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -44.52 125.88 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.1399999999999999 110.565 -178.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' ARG . 9.1 tt0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.101 -0.952 . . . . 2.2999999999999998 111.057 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.972 0 N-CA-C 110.359 -0.67 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -153.65 121.64 6.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.506 -0.747 . . . . 0.0 109.707 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.4 m-85 -99.4 -11.46 21.13 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -66.12 117.08 7.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 0.0 111.958 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.11 -174.09 38.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 3.9 m120 -95.02 171.73 8.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.868 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.3 m95 -151.22 128.79 11.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.513 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -120.41 115.82 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.801 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.1 tt -58.51 153.56 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.918 0.866 . . . . 0.0 111.2 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.48 -32.89 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -140.77 168.69 19.19 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.801 ' HB2' HD11 ' A' ' 9' ' ' ILE . 13.4 t 177.95 147.09 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -144.39 168.79 19.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.433 0.635 . . . . 0.0 109.951 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 22.4 m-80 61.66 31.38 18.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.624 -0.672 . . . . 0.0 109.66 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.969 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.11 -64.72 0.99 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.528 -0.732 . . . . 0.0 110.111 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.709 ' HG2' HG21 ' A' ' 33' ' ' VAL . 46.8 mt-10 -56.51 -34.83 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 110.959 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -69.81 -29.97 67.39 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.469 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.911 HD22 ' HB2' ' A' ' 130' ' ' CYS . 22.3 tp -77.46 -19.8 55.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 109.908 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -89.99 -16.85 28.99 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.149 -0.97 . . . . 0.0 109.291 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mtmm -86.19 -33.69 20.72 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -72.07 -39.76 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -68.56 -46.26 69.92 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.832 0.825 . . . . 0.0 109.266 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.12 -163.44 27.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 25' ' ' ASN . 27.1 m -140.21 -40.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.894 -0.768 . . . . 0.0 109.75 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.5 t30 -59.74 -165.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.483 -0.761 . . . . 0.0 109.482 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.484 HG13 ' NH1' ' A' ' 29' ' ' ARG . 1.7 t -115.45 -48.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.29 -28.17 67.79 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.9 mm? -56.98 -20.31 23.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -91.78 -50.48 5.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 109.787 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -62.35 -19.84 63.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.579 -0.7 . . . . 0.0 111.076 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -78.58 -29.86 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.195 -0.941 . . . . 0.0 108.752 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.66 -25.1 33.38 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.9 t -76.89 -37.08 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.34 -33.61 49.04 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.03 93.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.36 -69.93 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m 47.79 49.84 16.17 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.498 0.666 . . . . 0.0 109.626 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mttp 66.37 72.49 0.43 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -72.9 166.4 30.11 Favored 'Trans proline' 0 C--N 1.326 -0.632 0 C-N-CA 121.974 1.782 . . . . 0.0 110.811 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.53 173.02 6.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.65 -0.657 . . . . 0.0 109.536 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 54' ' ' THR . 53.5 t -154.55 165.31 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.4 tt0 -151.82 110.92 3.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.868 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.6 mt -97.83 138.43 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.806 0.812 . . . . 0.0 110.084 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttt -116.95 104.96 11.81 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.2 tt0 -97.34 125.37 41.9 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -125.33 54.15 1.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.55 -126.18 8.35 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.619 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -75.5 -1.36 23.86 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.413 -1.051 . . . . 0.0 110.252 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -97.14 136.49 37.6 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.741 -1.224 . . . . 0.0 108.338 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -131.16 116.48 17.76 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.857 0.837 . . . . 0.0 109.297 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.8 t80 -102.29 148.95 24.83 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.882 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -146.31 99.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.996 -1.065 . . . . 0.0 110.426 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 62' ' ' GLU . 1.7 tttp -99.98 114.23 27.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.391 -0.818 . . . . 0.0 109.883 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 41' ' ' VAL . 31.6 m -101.96 144.69 30.26 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.4 OUTLIER -142.57 131.65 23.18 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.408 -0.807 . . . . 0.0 109.777 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -100.37 -80.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.665 . . . . 0.0 109.446 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.4 HG23 ' C ' ' A' ' 56' ' ' THR . 77.5 p -158.06 -46.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.7 t -112.7 -10.45 12.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -117.24 162.02 18.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 55' ' ' SER . 15.1 m -163.83 103.47 0.9 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -102.07 172.85 6.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.767 . . . . 0.0 109.329 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . 2.6 pt-20 -171.94 119.58 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.69 . . . . 0.0 109.736 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.882 HD11 HD12 ' A' ' 52' ' ' ILE . 37.7 pt -110.43 170.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.528 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.35 133.87 5.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.292 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.1 p90 -161.98 -172.37 3.23 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.637 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -129.19 153.01 48.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.39 95.4 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.139 -0.976 . . . . 0.0 109.825 -178.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.12 -27.36 1.72 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.734 -1.222 . . . . 0.0 111.013 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -119.39 156.19 30.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -1.151 . . . . 0.0 110.204 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.676 ' HG2' HD13 ' A' ' 84' ' ' LEU . 14.1 mt-10 -86.28 167.27 14.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.7 p90 -162.72 174.46 12.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.698 . . . . 0.0 109.634 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -102.94 147.5 26.85 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.671 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.4 pt-20 -161.74 179.49 8.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.679 -0.638 . . . . 0.0 109.324 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.72 128.1 55.05 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.265 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -63.86 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' N ' HG23 ' A' ' 75' ' ' THR . 12.3 p -103.1 -16.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.018 -1.051 . . . . 0.0 111.322 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.7 ' H ' HG23 ' A' ' 75' ' ' THR . 3.9 t70 -86.66 -40.85 14.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 109.28 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.51 43.49 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 75' ' ' THR . 6.9 mmm180 -130.52 148.89 71.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.661 -0.905 . . . . 0.0 108.937 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 140.51 17.15 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.454 1.436 . . . . 0.0 110.356 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.6 p -160.86 141.69 11.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.682 -0.636 . . . . 0.0 109.633 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.828 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -90.45 114.27 26.39 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.21 176.21 5.33 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.947 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -152.93 153.32 32.76 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.6 t -140.75 127.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.989 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.07 155.3 34.7 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.687 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.6 m95 -78.01 173.16 12.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.058 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.3 tp10 -135.11 -46.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.1 p -129.99 -152.67 0.52 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.25 -25.71 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -143.78 25.27 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 110.981 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 34.7 tttm -130.08 110.93 12.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.893 -1.13 . . . . 0.0 108.065 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.446 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.41 150.17 38.22 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.661 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -99.52 172.15 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.492 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.2 t -149.15 129.76 14.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.88 . . . . 0.0 110.752 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -101.04 162.37 12.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.406 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 9.0 tt0 -160.44 139.76 10.78 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.878 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.05 149.74 37.11 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.69 165.59 3.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.974 . . . . 0.0 111.085 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.828 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.3 mt -100.49 -2.97 31.77 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -153.36 134.31 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.963 . . . . 0.0 108.807 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.87 -160.7 41.46 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -176.26 141.41 0.43 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.467 -1.019 . . . . 0.0 109.841 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.0 -85.39 0.05 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.53 -177.14 3.05 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.82 1.68 . . . . 0.0 109.857 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -134.44 138.51 44.83 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.03 145.25 48.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.008 0.909 . . . . 0.0 110.69 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.5 m -163.39 132.53 4.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -135.96 170.45 15.98 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.037 -1.039 . . . . 0.0 110.422 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 HG13 ' A' ' 94' ' ' VAL . 14.1 p -134.54 173.12 12.0 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.532 0.682 . . . . 0.0 109.722 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.7 ptp -158.6 139.57 12.97 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.0 pt-20 -140.64 144.87 35.97 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.366 -0.834 . . . . 0.0 109.1 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -105.02 144.79 31.34 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.8 p -91.75 160.38 15.36 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.15 -19.87 55.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.62 -0.675 . . . . 0.0 110.337 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.11 -28.56 22.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.29 -8.79 7.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 113' ' ' LEU . 8.1 mt-10 -57.94 171.3 0.53 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.046 -1.267 . . . . 0.0 108.95 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD13 HD13 ' A' ' 43' ' ' ILE . 7.5 tt -146.01 110.87 5.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.452 -0.78 . . . . 0.0 109.883 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.407 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -107.34 148.47 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -132.87 138.56 47.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.378 -0.826 . . . . 0.0 109.59 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.44 169.04 9.46 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 36.2 mtp -146.96 165.25 30.38 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.197 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.1 m -147.63 151.11 35.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.715 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.67 92.44 1.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.559 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.78 -78.36 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -146.57 24.11 1.25 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.6 m -117.74 -179.53 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.69 118.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.722 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.911 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -99.53 113.67 26.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 122' ' ' THR . 85.8 m -109.34 147.94 31.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.737 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -152.59 117.59 5.15 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.9 t -80.18 139.17 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 108.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.7 m-85 -127.68 123.51 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.315 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.03 138.45 31.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.495 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.15 128.56 16.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.181 -0.95 . . . . 0.0 111.543 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 4.1 tt0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.322 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.502 1.987 0 N-CA-C 110.381 -0.661 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -132.49 135.41 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.503 -0.748 . . . . 0.0 110.143 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.4 m-85 -98.69 1.38 46.11 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 120.12 18.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 111.925 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.17 -174.19 38.58 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.5 m120 -95.58 172.03 8.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.543 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 99.1 m95 -151.49 125.23 9.05 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.573 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -117.54 114.04 22.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' A' ' 39' ' ' PRO . 4.6 tt -52.63 147.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.661 0.744 . . . . 0.0 111.13 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.67 -25.11 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 122.003 -0.436 . . . . 0.0 110.24 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -152.57 177.43 10.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.164 -0.96 . . . . 0.0 110.469 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.1 p -179.47 166.05 1.41 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.79 24.57 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 111.708 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 61.1 m-20 -161.14 27.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.607 -0.683 . . . . 0.0 110.197 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.815 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -65.44 -66.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 108.738 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 14.9 pt-20 -56.52 -28.64 60.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 109.641 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.35 -38.9 91.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.677 -0.639 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 130' ' ' CYS . 36.7 tp -79.4 -16.13 56.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.773 -0.58 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.83 -20.29 22.47 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.954 -1.091 . . . . 0.0 109.18 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.7 mmmt -83.03 -28.17 29.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -80.42 -40.64 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 122.127 0.965 . . . . 0.0 108.477 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.3 mp -67.76 -50.02 59.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.919 0.866 . . . . 0.0 109.87 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.77 -154.21 25.86 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.79 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.0 t -150.7 -39.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 122.029 -0.689 . . . . 0.0 110.029 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -60.8 -160.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.38 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.09 -45.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.892 . . . . 0.0 109.775 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.423 ' O ' HD12 ' A' ' 31' ' ' ILE . 4.1 ttt -66.12 -30.9 71.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.4 mm? -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.857 -0.527 . . . . 0.0 110.213 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 33' ' ' VAL . 43.4 mtt180 -84.87 -47.48 10.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.499 -0.751 . . . . 0.0 109.968 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -61.61 -21.86 64.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.691 -0.63 . . . . 0.0 111.06 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 27' ' ' MET . 29.5 mt -81.26 -28.8 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.22 -25.87 36.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.665 -0.647 . . . . 0.0 109.354 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.33 -44.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.21 85.54 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.41 -56.23 23.9 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.775 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.9 57.96 4.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.757 -0.589 . . . . 0.0 110.287 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.7 t -64.21 -43.11 96.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.697 -1.252 . . . . 0.0 107.726 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -151.36 74.19 8.2 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.948 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.1 Cg_endo -71.5 142.11 39.83 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.846 1.697 . . . . 0.0 111.262 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -98.94 174.73 6.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 54' ' ' THR . 50.8 t -155.74 163.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -151.31 111.6 4.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.881 HG13 HG23 ' A' ' 52' ' ' ILE . 2.6 mp -98.08 135.81 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 122.019 0.914 . . . . 0.0 110.442 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 4.4 mttm -109.91 93.45 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.65 125.44 41.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.31 -0.869 . . . . 0.0 110.42 -176.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -132.65 56.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.55 -132.29 10.97 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.5 p30 -71.71 -4.36 27.05 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.384 -1.068 . . . . 0.0 110.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 m -96.79 134.08 40.54 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.656 -1.278 . . . . 0.0 108.476 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.685 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 98.7 m-85 -131.15 119.06 21.36 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.687 0.756 . . . . 0.0 109.336 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 15.0 t80 -103.15 150.46 23.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.094 HD12 HD11 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -148.58 104.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.94 -1.1 . . . . 0.0 110.97 -177.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -104.81 113.11 26.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 108.864 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG22 ' A' ' 41' ' ' VAL . 41.6 m -102.49 145.5 29.49 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.459 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.9 p -142.77 119.15 10.91 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.674 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.948 HG22 ' HB3' ' A' ' 39' ' ' PRO . 82.8 p -99.26 -158.87 0.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.498 HG23 ' N ' ' A' ' 58' ' ' VAL . 5.6 t -57.39 -45.11 84.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.194 -0.942 . . . . 0.0 110.923 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.498 ' N ' HG23 ' A' ' 57' ' ' THR . 33.0 t -131.42 -7.67 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.314 -0.866 . . . . 0.0 111.975 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -98.94 165.75 11.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.072 -1.017 . . . . 0.0 110.008 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 55' ' ' SER . 7.1 m -163.71 95.44 0.81 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.534 -0.729 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 169.17 12.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.772 . . . . 0.0 109.724 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.34 111.35 1.22 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.489 -0.757 . . . . 0.0 109.699 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.094 HD11 HD12 ' A' ' 52' ' ' ILE . 42.7 pt -116.53 165.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.3 p-10 -162.58 132.51 4.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.3 p90 -161.67 -172.7 3.43 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.404 1.097 . . . . 0.0 112.445 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.76 153.54 48.11 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.32 93.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.133 -0.98 . . . . 0.0 109.681 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.31 -22.91 1.55 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.906 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.69 155.63 37.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.22 -1.165 . . . . 0.0 110.219 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.566 ' HG2' HD13 ' A' ' 84' ' ' LEU . 32.3 mt-10 -86.64 166.41 15.38 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.17 174.57 12.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -105.55 144.22 32.62 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.709 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.31 -174.79 4.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -99.75 159.91 14.7 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.9 t -97.31 -142.14 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.5 t -111.13 -19.2 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.783 -1.198 . . . . 0.0 110.824 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t70 -90.67 -37.11 13.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.486 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.71 45.14 0.15 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 7.1 mtm-85 -133.3 153.54 80.65 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 121.691 -0.888 . . . . 0.0 109.447 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -79.0 142.04 17.05 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.767 1.645 . . . . 0.0 110.505 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -161.26 143.06 11.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.657 -0.652 . . . . 0.0 109.517 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.598 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -89.46 117.33 28.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.48 166.54 11.11 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.266 0.555 . . . . 0.0 109.988 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' A' ' 70' ' ' GLU . 49.1 tp -148.77 153.02 37.56 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.695 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.8 t -143.4 136.13 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.417 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.21 157.22 41.45 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.556 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.6 m95 -81.15 172.83 13.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.019 0.914 . . . . 0.0 110.627 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -136.69 -45.98 0.6 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.9 p -131.81 -153.63 0.57 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -76.47 -26.97 55.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.801 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -143.46 28.53 1.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 48.7 tttt -130.54 110.37 11.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.989 -1.069 . . . . 0.0 108.188 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.685 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.3 ptp -117.43 147.5 42.64 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.728 0.775 . . . . 0.0 110.572 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 110' ' ' THR . 2.2 t -100.73 171.5 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.423 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.0 t -146.83 137.43 23.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' OE2' HD23 ' A' ' 84' ' ' LEU . 7.4 pt-20 -108.77 156.13 19.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -154.65 142.2 19.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.974 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -143.73 152.05 40.78 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.17 168.03 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 110.755 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.6 mt -99.6 -5.75 28.51 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 137.2 14.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 108.621 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.85 -163.12 37.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -175.96 140.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.43 -1.041 . . . . 0.0 109.995 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.35 -86.83 0.06 OUTLIER Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.83 -176.91 2.87 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.783 1.655 . . . . 0.0 109.643 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -131.41 139.87 49.52 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.12 144.63 48.46 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.172 0.987 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 m -162.92 131.8 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 48.9 p-90 -137.12 172.79 12.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.143 -0.973 . . . . 0.0 110.231 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.813 HG22 HG13 ' A' ' 94' ' ' VAL . 19.8 p -135.92 174.16 10.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.542 0.687 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.497 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.9 ptm -157.95 124.31 4.79 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -119.54 147.64 44.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.488 -0.758 . . . . 0.0 109.889 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.01 143.52 39.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 p -93.55 159.48 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.779 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -59.28 -21.9 60.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.605 -0.684 . . . . 0.0 110.257 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.96 -30.19 24.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.3 -9.82 6.56 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.9 173.91 0.13 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.084 -1.245 . . . . 0.0 109.349 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.597 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.5 tt -148.17 111.14 4.83 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.124 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.409 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.1 tt -106.82 151.47 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.94 147.08 52.44 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.423 -0.798 . . . . 0.0 109.439 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.559 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -127.73 170.36 12.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.5 mtp -150.6 167.77 26.29 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.675 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.5 m -149.31 151.31 33.94 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.82 94.07 1.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.53 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.15 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.19 23.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.808 HG21 HG11 ' A' ' 21' ' ' VAL . 24.7 m -117.23 -178.86 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.5 t -157.86 118.24 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.589 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.755 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -97.9 121.52 39.92 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.559 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.6 m -119.93 134.62 55.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.111 -0.993 . . . . 0.0 110.224 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.6 mtm-85 -139.86 108.43 5.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 120' ' ' ILE . 43.5 t -72.39 140.38 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.2 m-85 -129.07 128.79 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.235 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.2 137.63 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -49.48 128.33 17.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.233 -0.917 . . . . 0.0 111.687 -178.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.4 tm-20 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.807 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.624 ' HD2' HD12 ' A' ' 113' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.501 1.931 0 N-CA-C 110.58 -0.585 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.34 128.96 38.8 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 110.044 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.543 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -99.06 -2.13 37.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.7 p -71.82 118.74 15.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.955 . . . . 0.0 111.943 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.64 -173.62 38.04 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.6 m120 -95.36 170.67 9.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -150.91 128.12 11.23 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.488 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt -121.66 116.36 24.42 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 132' ' ' ARG . 9.4 tt -59.48 141.84 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.525 0.678 . . . . 0.0 110.294 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 pp -119.52 -23.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.875 -0.516 . . . . 0.0 110.101 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -145.66 176.73 9.41 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.236 -0.915 . . . . 0.0 110.27 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 176.29 165.43 0.43 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -159.32 25.77 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.091 -1.006 . . . . 0.0 111.292 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.4 m-20 -160.85 29.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.637 -0.665 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.49 -65.66 0.65 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -0.902 . . . . 0.0 109.008 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.6 mt-10 -56.68 -27.07 58.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.359 -0.838 . . . . 0.0 109.288 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.81 -40.9 97.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.667 -0.645 . . . . 0.0 109.791 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.781 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.8 tp -77.75 -16.73 58.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.662 -0.649 . . . . 0.0 110.091 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.7 mt -89.43 -19.24 25.39 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.055 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.1 mmmt -85.57 -28.6 24.76 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 128' ' ' VAL . 14.9 p -79.57 -41.06 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.69 -53.13 45.29 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.018 0.913 . . . . 0.0 108.935 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.75 -146.26 17.13 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 25' ' ' ASN . 19.3 m -155.93 -43.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' N ' HG23 ' A' ' 24' ' ' VAL . 5.1 t30 -56.95 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.518 -0.739 . . . . 0.0 109.56 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' NH2' ' A' ' 29' ' ' ARG . 2.1 m -109.83 -44.49 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.416 -0.802 . . . . 0.0 109.899 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.1 ttm -66.3 -27.27 67.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.8 mm? -57.71 -41.9 82.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.675 -0.641 . . . . 0.0 110.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.844 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.2 mtp180 -71.36 -42.66 68.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -62.44 -20.24 64.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.755 -0.59 . . . . 0.0 111.115 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 28' ' ' LEU . 45.4 mt -79.47 -30.04 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 108.879 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.6 32.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.7 t -79.13 -35.93 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.69 -36.17 51.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.91 79.44 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' A' ' 39' ' ' PRO . . . -69.42 -67.56 0.47 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 49.23 52.08 15.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 67.36 73.7 0.36 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.46 158.35 54.23 Favored 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.017 1.811 . . . . 0.0 110.795 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.51 173.13 6.45 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.743 -0.598 . . . . 0.0 109.528 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 54' ' ' THR . 48.8 t -155.0 164.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 tt0 -148.68 111.53 4.82 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -97.9 132.59 42.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.786 0.803 . . . . 0.0 110.054 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -111.78 106.49 15.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -97.47 123.97 41.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.064 -1.022 . . . . 0.0 111.176 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -123.62 55.22 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -126.03 8.15 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -75.97 -1.09 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -1.034 . . . . 0.0 110.143 178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.4 m -96.44 136.05 37.47 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 120.782 -1.199 . . . . 0.0 108.551 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.9 m-85 -130.96 115.66 16.8 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.863 0.839 . . . . 0.0 109.227 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.6 t80 -102.29 148.17 25.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.964 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -145.17 99.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.019 -1.05 . . . . 0.0 110.389 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -99.25 113.71 26.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 109.766 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.587 HG23 HG22 ' A' ' 41' ' ' VAL . 34.0 m -100.53 144.7 29.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.799 . . . . 0.0 108.964 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 136.9 32.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.46 -0.775 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -106.27 -65.93 1.04 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.916 0.865 . . . . 0.0 109.708 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.637 HG23 HG23 ' A' ' 58' ' ' VAL . 2.6 t 178.64 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG23 HG23 ' A' ' 57' ' ' THR . 45.4 t -112.93 -11.64 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -124.37 163.81 20.96 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.083 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.9 m -163.28 103.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 p -101.84 173.87 6.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.8 . . . . 0.0 109.55 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -172.27 118.96 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.773 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 52' ' ' ILE . 40.2 pt -108.56 169.55 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.517 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 132.82 4.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 109.764 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.728 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.92 -172.21 3.18 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.069 0.938 . . . . 0.0 111.739 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -131.53 154.53 48.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.58 95.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.187 -0.945 . . . . 0.0 109.636 -178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.66 -21.8 0.62 Allowed Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.606 -1.283 . . . . 0.0 111.038 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -135.82 163.57 29.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.256 -1.144 . . . . 0.0 110.714 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.1 mt-10 -86.28 169.31 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.4 p90 -162.6 174.39 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -103.14 144.78 30.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -161.89 178.65 8.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.84 151.61 21.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.4 t -88.26 -142.96 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.485 -0.759 . . . . 0.0 109.125 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 22.5 t -112.2 -19.77 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.741 -1.224 . . . . 0.0 110.657 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t70 -88.75 -41.31 12.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 44.25 0.1 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mtp180 -131.63 147.19 65.04 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.666 -0.902 . . . . 0.0 108.89 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD11 ' A' ' 100' ' ' LEU . 37.8 Cg_endo -79.8 142.72 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.441 1.427 . . . . 0.0 110.237 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.3 p -161.05 143.24 12.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.645 -0.66 . . . . 0.0 109.569 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -89.64 114.36 25.96 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.6 t -98.91 176.29 5.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.706 -0.621 . . . . 0.0 109.71 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' A' ' 70' ' ' GLU . 50.1 tp -150.32 154.41 37.79 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.1 t -143.33 129.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.663 -1.215 . . . . 0.0 112.089 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.94 155.46 39.55 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.663 ' CD1' HG11 ' A' ' 67' ' ' VAL . 81.9 m95 -79.67 173.16 12.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -135.39 -46.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -130.7 -153.61 0.57 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.08 -25.77 52.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.21 -0.931 . . . . 0.0 109.936 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.08 26.85 1.65 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 110.892 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 78.8 tttt -132.15 109.58 10.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.0 108.078 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.46 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.6 OUTLIER -115.66 150.36 36.87 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.243 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -100.09 173.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.522 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.4 t -149.81 135.84 18.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -105.04 163.3 12.65 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -160.92 138.69 9.42 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.798 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -152.46 144.55 23.82 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.576 HD22 HH21 ' A' ' 79' ' ' ARG . 7.5 mt -58.74 164.27 2.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.099 -1.001 . . . . 0.0 110.651 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -107.87 5.6 26.58 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.412 ' N ' HD12 ' A' ' 100' ' ' LEU . 22.9 tptt -153.75 113.14 3.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.99 -163.83 45.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -176.34 140.97 0.4 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.393 -1.063 . . . . 0.0 110.066 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.67 -86.95 0.06 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.31 -176.49 2.59 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.846 1.697 . . . . 0.0 109.695 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -131.55 139.87 49.33 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 145.15 49.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.121 0.963 . . . . 0.0 110.84 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.88 137.04 6.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -142.79 175.44 9.82 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.986 -1.085 . . . . 0.0 110.56 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.643 HG22 HG13 ' A' ' 94' ' ' VAL . 13.2 p -137.91 172.67 12.59 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.551 0.691 . . . . 0.0 110.028 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.492 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 21.8 ptm -157.84 128.59 6.43 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.9 pt-20 -131.67 154.89 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.586 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.624 HD12 ' HD2' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -112.13 144.71 41.05 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -91.99 162.19 14.48 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.585 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -61.36 -21.1 63.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.614 -0.679 . . . . 0.0 110.377 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.22 -26.58 24.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.15 -8.13 8.57 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 48.6 mt-10 -58.7 172.94 0.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.113 -1.227 . . . . 0.0 109.234 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.727 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.92 110.36 5.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.501 -0.749 . . . . 0.0 109.618 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' A' ' 133' ' ' VAL . 14.0 tt -106.08 145.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -130.22 133.07 46.28 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.713 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.78 165.97 11.28 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.468 ' O ' HG22 ' A' ' 129' ' ' VAL . 12.1 mtp -144.14 164.52 30.46 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.383 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 m -147.4 151.4 36.42 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.722 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.68 95.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.17 -80.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.33 24.89 1.25 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.525 -0.734 . . . . 0.0 109.168 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -118.34 -178.93 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.94 118.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.781 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.49 112.18 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 77.7 m -106.32 143.61 34.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.496 ' HB3' HD12 ' A' ' 9' ' ' ILE . 20.7 mtt180 -150.5 105.23 3.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.512 HG22 ' CD1' ' A' ' 120' ' ' ILE . 53.7 t -69.47 133.48 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 30.1 m-85 -121.2 123.5 42.41 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.075 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.32 139.71 26.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.59 128.08 16.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.221 -0.925 . . . . 0.0 111.351 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.245 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.023 0 N-CA-C 110.362 -0.668 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -150.66 126.38 10.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.724 . . . . 0.0 109.361 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.606 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.9 m-85 -99.42 -11.36 21.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -67.78 117.42 9.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 111.841 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.45 -173.46 38.73 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.9 m120 -95.45 170.84 9.08 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.45 128.12 10.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.666 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.603 ' HE2' ' HB2' ' A' ' 40' ' ' ALA . 12.4 mmtt -122.48 116.32 23.74 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 132' ' ' ARG . 10.0 tt -58.94 142.07 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.587 0.708 . . . . 0.0 110.474 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.3 -24.26 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.959 -0.463 . . . . 0.0 110.068 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -143.25 174.83 10.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.277 -0.889 . . . . 0.0 110.08 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 178.42 163.1 0.7 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.34 24.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.196 -0.94 . . . . 0.0 111.457 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 76.0 m-20 -160.59 27.37 0.15 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.91 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.981 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.1 t80 -65.16 -64.76 0.79 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 110.192 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 27.2 tt0 -55.86 -31.0 62.37 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.581 -0.699 . . . . 0.0 111.296 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 7.0 pt-20 -73.1 -31.51 64.38 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.51 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.856 HD22 ' CB ' ' A' ' 130' ' ' CYS . 27.4 tp -75.58 -19.42 59.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.828 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.02 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.6 mt -90.17 -18.18 26.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 109.388 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.8 mtmt -84.6 -32.63 23.64 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 128' ' ' VAL . 14.2 p -74.61 -39.96 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -68.04 -45.59 73.53 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.756 0.788 . . . . 0.0 109.458 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.94 -159.97 27.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.2 t -144.61 -41.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.982 -0.717 . . . . 0.0 109.722 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.4 t30 -60.64 -162.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.455 -0.778 . . . . 0.0 109.459 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG13 ' NH1' ' A' ' 29' ' ' ARG . 2.2 t -117.63 -49.02 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.409 ' O ' HD12 ' A' ' 31' ' ' ILE . 1.4 ttt -67.41 -27.73 67.32 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.8 mm? -58.15 -19.62 34.25 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.79 -0.569 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -92.72 -49.26 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.16 -0.962 . . . . 0.0 109.59 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -62.25 -20.25 64.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.645 -0.659 . . . . 0.0 110.793 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 27' ' ' MET . 19.6 mt -78.42 -29.64 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 108.831 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.02 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.16 -25.62 34.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.2 t -77.52 -36.98 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.41 -34.16 48.2 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.64 93.97 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.463 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.33 -67.87 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.67 52.41 14.96 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 67.25 73.41 0.37 Allowed Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.9 Cg_endo -71.61 155.9 58.44 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 C-N-CA 122.055 1.837 . . . . 0.0 110.829 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.603 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . . . -102.47 172.99 6.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 HG23 ' A' ' 54' ' ' THR . 53.4 t -155.49 164.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.465 ' N ' HG12 ' A' ' 41' ' ' VAL . 48.5 tt0 -151.11 110.6 3.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.79 HG13 HG23 ' A' ' 52' ' ' ILE . 1.8 mp -98.65 141.99 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.817 0.818 . . . . 0.0 110.543 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.36 111.93 18.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.36 117.73 33.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.97 -1.081 . . . . 0.0 111.026 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.63 50.05 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -125.43 8.11 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.8 p30 -75.66 -1.82 26.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.431 -1.04 . . . . 0.0 110.052 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 m -96.35 138.4 34.01 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.816 -1.177 . . . . 0.0 108.636 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 97.8 m-85 -134.18 117.68 16.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.795 0.807 . . . . 0.0 109.217 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.558 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -103.43 147.98 26.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -144.01 104.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 C-N-CA 118.974 -1.091 . . . . 0.0 111.445 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.13 113.61 26.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.514 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.665 HG23 HG22 ' A' ' 41' ' ' VAL . 31.9 m -103.28 142.35 34.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.87 143.16 38.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -115.55 -65.91 1.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.917 0.865 . . . . 0.0 109.43 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.671 HG23 HG23 ' A' ' 58' ' ' VAL . 2.8 t 178.82 -41.76 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.671 HG23 HG23 ' A' ' 57' ' ' THR . 40.3 t -113.58 -10.83 12.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -125.08 164.71 19.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 109.103 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.9 m -162.44 96.25 0.95 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.697 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.62 165.31 23.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 109.974 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -164.12 118.69 1.49 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 52' ' ' ILE . 31.9 pt -121.87 165.99 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 108.93 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.15 127.59 3.45 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.146 -0.971 . . . . 0.0 109.438 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.742 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.9 p90 -162.18 -172.64 3.29 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.009 -1.076 . . . . 0.0 111.763 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -131.12 154.65 48.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.57 95.05 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.92 . . . . 0.0 109.828 -178.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.87 -20.04 0.67 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.13 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -135.02 162.18 33.19 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.185 -1.185 . . . . 0.0 110.841 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.43 165.63 16.17 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.7 p90 -161.75 173.84 14.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -101.73 144.77 30.01 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.1 pt-20 -162.18 -178.28 6.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -99.66 155.69 17.48 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.7 t -92.91 -142.33 0.21 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 109.325 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -111.2 -21.01 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.717 -1.239 . . . . 0.0 110.837 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -88.75 -40.0 13.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.67 45.19 0.11 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 75' ' ' THR . 34.8 mtp180 -131.96 150.62 76.64 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 121.708 -0.878 . . . . 0.0 109.161 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.79 141.68 17.26 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.676 1.584 . . . . 0.0 110.408 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.7 p -161.19 141.46 10.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.645 -0.659 . . . . 0.0 109.862 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.796 ' HB2' HD21 ' A' ' 100' ' ' LEU . 10.3 ttmt -89.7 114.17 25.79 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -99.68 174.05 6.42 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.301 0.572 . . . . 0.0 110.416 -178.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 85' ' ' VAL . 44.4 tp -148.05 152.39 37.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.742 HG21 ' CE2' ' A' ' 65' ' ' PHE . 7.0 t -142.36 126.89 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.976 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -122.33 155.2 36.48 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.555 ' CE2' HG21 ' A' ' 67' ' ' VAL . 79.0 m95 -77.42 176.22 9.06 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.892 0.854 . . . . 0.0 110.242 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.2 tp10 -138.44 -46.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.1 p -131.01 -152.51 0.51 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.6 -25.42 45.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -142.8 27.63 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.4 tttp -132.98 113.31 12.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.935 -1.103 . . . . 0.0 108.283 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.494 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -120.37 150.44 40.75 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.521 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.82 172.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.5 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.0 t -149.89 134.81 17.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -103.95 165.21 11.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -160.87 138.93 9.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.84 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -144.84 148.9 34.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.5 mt -60.86 166.86 3.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.041 -1.037 . . . . 0.0 110.994 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.5 mt -101.54 -3.56 28.28 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -150.8 130.34 13.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 108.892 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.93 -157.4 42.66 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -176.43 140.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.47 -1.018 . . . . 0.0 109.863 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.39 -87.3 0.06 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.64 -176.82 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 C-N-CA 121.8 1.666 . . . . 0.0 109.645 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -130.66 138.52 50.1 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.67 144.83 48.88 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.189 0.995 . . . . 0.0 110.734 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.9 m -163.44 136.67 5.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -139.21 172.38 12.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.707 HG22 HG13 ' A' ' 94' ' ' VAL . 16.8 p -136.43 170.16 16.5 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.476 0.655 . . . . 0.0 109.848 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.424 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 7.1 ptp -154.01 137.16 15.6 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -134.01 146.26 50.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.392 -0.817 . . . . 0.0 109.225 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.7 141.53 42.18 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.3 p -90.27 160.65 16.05 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.791 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -21.45 61.67 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.657 -0.652 . . . . 0.0 110.078 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -85.08 -29.49 24.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.99 -9.21 7.12 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.12 172.2 0.31 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.158 -1.201 . . . . 0.0 109.21 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -145.14 107.98 4.49 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.097 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.797 HD13 ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -101.87 150.73 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -135.03 133.68 39.64 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.59 8.01 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 129' ' ' VAL . 11.8 mtp -148.41 166.78 27.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.742 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.1 m -150.07 148.07 28.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.668 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.56 93.05 1.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.521 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.79 -78.26 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -147.07 23.72 1.18 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.6 m -118.31 -179.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.7 t -156.41 119.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.46 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.856 ' CB ' HD22 ' A' ' 18' ' ' LEU . 2.2 t -98.39 118.46 35.1 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.7 m -112.92 143.37 44.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.762 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.483 ' HB3' HD12 ' A' ' 9' ' ' ILE . 24.0 mtm180 -150.82 105.01 3.22 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.2 133.05 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.4 m-85 -120.83 120.81 36.65 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.154 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.14 139.98 22.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.98 128.48 18.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.196 -0.94 . . . . 0.0 111.322 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.3 tp10 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.009 0 N-CA-C 110.222 -0.722 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -152.39 124.07 7.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.555 -0.716 . . . . 0.0 109.766 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.583 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.7 m-85 -99.26 -7.85 25.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.3 p -69.11 117.54 10.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.955 . . . . 0.0 111.9 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.12 38.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.0 m120 -95.72 169.39 10.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.924 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.08 122.23 7.73 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.064 -1.054 . . . . 0.0 112.687 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -114.28 112.82 23.72 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 8.9 tt -56.53 146.93 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 110.67 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -127.64 -23.33 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.62 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -143.46 173.46 11.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t 169.57 168.51 0.05 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.66 28.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.013 -1.054 . . . . 0.0 112.02 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.428 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.01 31.69 0.12 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.205 -0.934 . . . . 0.0 109.106 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.916 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.0 -62.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 110.019 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.0 pt-20 -58.49 -31.15 67.59 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 111.097 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -71.18 -26.55 63.01 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.696 -178.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.9 tp -81.76 -21.38 37.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.424 -0.797 . . . . 0.0 109.975 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.936 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -86.94 -17.62 32.72 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.099 -1.001 . . . . 0.0 109.305 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.6 mtmt -85.05 -34.64 22.24 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -73.69 -40.54 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 77' ' ' ASP . 5.0 mp -67.32 -46.11 74.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.828 0.823 . . . . 0.0 108.988 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -162.59 27.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.98 -37.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.831 -0.805 . . . . 0.0 110.183 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.2 t30 -62.0 -158.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.443 -0.786 . . . . 0.0 109.163 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.646 HG13 HH21 ' A' ' 29' ' ' ARG . 1.8 t -125.07 -47.56 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 109.316 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 ttt -68.08 -28.42 67.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -59.39 -19.26 45.64 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.737 -0.602 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -95.58 -47.4 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 109.876 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -62.73 -22.58 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.612 -0.68 . . . . 0.0 110.569 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.42 -28.28 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.842 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.936 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.88 -25.59 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.3 t -76.67 -38.9 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.62 57.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.71 -40.4 95.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.544 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -66.63 -65.57 0.66 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 121.627 -0.671 . . . . 0.0 109.237 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p 47.89 55.3 8.76 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.671 0.748 . . . . 0.0 109.082 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 69.29 72.73 0.32 Allowed Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.451 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.9 Cg_endo -71.67 162.66 41.42 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.146 1.898 . . . . 0.0 110.808 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -109.97 172.8 6.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.711 -0.618 . . . . 0.0 109.432 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.762 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -154.07 165.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 47.3 tt0 -150.69 110.75 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.924 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.6 mt -98.34 137.1 26.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.677 0.751 . . . . 0.0 110.335 -178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.63 112.08 21.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.4 tt0 -98.24 121.7 40.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.008 -1.057 . . . . 0.0 111.106 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -121.52 51.77 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -125.4 7.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -76.27 -0.95 24.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.415 -1.05 . . . . 0.0 110.102 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 m -96.68 140.93 30.56 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.789 -1.194 . . . . 0.0 108.353 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.8 m-85 -136.07 115.33 12.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.923 0.868 . . . . 0.0 109.718 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.1 t80 -101.04 147.03 26.67 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.026 HD12 HD11 ' A' ' 63' ' ' ILE . 3.0 mt -142.31 100.92 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.989 -1.07 . . . . 0.0 110.327 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 2.2 tttt -98.8 114.64 27.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.535 -0.728 . . . . 0.0 109.961 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.762 HG23 HG22 ' A' ' 41' ' ' VAL . 7.1 m -99.22 142.2 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 p -136.54 118.32 15.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.357 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -99.28 -169.7 1.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.572 HG23 HG23 ' A' ' 58' ' ' VAL . 5.8 t -51.66 -42.35 62.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.493 -0.755 . . . . 0.0 111.204 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 57' ' ' THR . 22.9 t -132.36 -7.36 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.274 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -106.13 173.33 6.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.917 -1.114 . . . . 0.0 110.228 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -164.39 93.91 0.69 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.3 p -92.43 176.04 6.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.102 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.7 pt-20 -172.4 139.81 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.026 HD11 HD12 ' A' ' 52' ' ' ILE . 31.2 pt -128.66 170.07 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.55 130.76 3.96 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.9 p90 -161.58 -172.2 3.25 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.896 -1.121 . . . . 0.0 112.062 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -128.89 153.31 47.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 96.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.529 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.6 -32.28 1.61 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.56 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -113.64 155.8 24.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -1.069 . . . . 0.0 109.893 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.0 mt-10 -86.33 167.72 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 17.2 p90 -162.14 173.08 14.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.551 -0.718 . . . . 0.0 109.809 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -104.24 144.52 31.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.724 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.13 -175.75 4.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -99.53 156.88 16.81 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.682 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.4 t -94.39 -142.1 0.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.415 -0.803 . . . . 0.0 109.22 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.45 -20.57 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.712 -1.242 . . . . 0.0 110.828 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.63 ' H ' HG23 ' A' ' 75' ' ' THR . 0.9 OUTLIER -89.82 -38.18 13.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 109.428 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 44.13 0.15 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.682 ' H ' HG22 ' A' ' 75' ' ' THR . 2.1 mtm-85 -130.28 151.9 79.26 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 121.656 -0.908 . . . . 0.0 109.256 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.66 141.06 17.1 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.644 1.563 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.6 p -160.75 140.79 11.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.683 -0.636 . . . . 0.0 109.692 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.758 ' HB2' HD21 ' A' ' 100' ' ' LEU . 26.7 ttpt -90.85 113.96 26.26 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -102.74 177.76 4.76 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.224 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 85' ' ' VAL . 50.3 tp -152.94 153.15 32.4 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.7 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.0 t -141.37 127.72 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.874 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.97 155.78 33.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.536 ' NE1' HG21 ' A' ' 67' ' ' VAL . 84.2 m95 -78.69 172.38 13.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.37 -0.831 . . . . 0.0 109.851 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -133.44 -47.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 p -132.17 -151.69 0.47 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -77.98 -26.87 48.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.308 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -140.2 23.93 2.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 111.466 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 53.0 tttp -131.83 111.69 11.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.749 -1.22 . . . . 0.0 108.451 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.477 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.71 149.26 40.13 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.119 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.63 173.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.517 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -149.45 130.35 14.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.32 -0.862 . . . . 0.0 110.887 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -101.97 163.45 12.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -160.34 143.8 13.75 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.759 -1.176 . . . . 0.0 112.006 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -146.18 151.38 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.405 HD21 ' HE ' ' A' ' 79' ' ' ARG . 7.1 mt -63.23 166.66 5.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.935 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD21 ' HB2' ' A' ' 82' ' ' LYS . 50.6 mt -101.03 -4.11 28.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 108.963 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.6 -157.03 42.09 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -177.34 140.43 0.28 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.514 -0.992 . . . . 0.0 109.529 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.19 -85.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.59 -176.84 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.82 1.68 . . . . 0.0 109.956 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -136.12 141.26 44.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.05 145.09 48.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.125 0.964 . . . . 0.0 110.596 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 p -162.79 129.65 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -136.57 173.69 11.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.226 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 94' ' ' VAL . 9.2 p -135.84 172.43 13.03 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.54 0.686 . . . . 0.0 109.901 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.464 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 9.8 ptm -155.91 124.84 6.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.94 152.7 39.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.899 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.55 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.75 142.13 46.93 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.8 p -91.77 160.09 15.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -60.45 -21.8 62.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -83.76 -29.7 27.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.137 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.47 -9.01 7.36 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -57.32 172.44 0.32 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.12 -1.223 . . . . 0.0 109.061 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.697 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.62 110.13 5.04 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.86 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.6 tt -105.99 148.97 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.58 145.95 51.99 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.668 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.59 169.65 11.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.419 -1.696 . . . . 0.0 106.419 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 35.4 mtp -151.66 164.26 37.32 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.574 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 129' ' ' VAL . 7.6 m -146.34 152.51 39.22 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.653 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.94 97.61 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.635 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.97 -79.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.43 24.27 1.01 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.566 -0.709 . . . . 0.0 109.342 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.1 m -119.54 -179.73 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -158.05 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.593 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 5.8 t -99.27 131.65 45.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.2 m -123.39 127.58 48.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -125.18 102.56 7.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.4 t -67.68 134.13 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.5 m-85 -124.15 129.99 51.77 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.604 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.91 138.45 40.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -48.73 125.28 9.81 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.246 -0.909 . . . . 0.0 111.285 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.6 179.647 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.011 0 N-CA-C 110.35 -0.673 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -163.53 123.11 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.62 -0.85 42.21 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -71.12 117.14 12.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.128 -0.983 . . . . 0.0 112.023 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.5 -172.18 38.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.78 168.26 10.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -151.88 125.0 8.66 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.112 -1.035 . . . . 0.0 112.493 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -120.86 115.36 23.09 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 12' ' ' SER . 7.5 tt -56.29 139.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.556 0.693 . . . . 0.0 110.582 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.15 -24.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.852 -0.53 . . . . 0.0 109.823 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -142.93 174.41 10.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.356 -0.84 . . . . 0.0 110.075 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.535 ' HB2' HD11 ' A' ' 9' ' ' ILE . 20.7 t 178.86 164.51 0.84 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.45 25.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 74.8 m-20 -160.5 27.76 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.709 -0.619 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.905 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.49 -66.94 0.47 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.1 tt0 -55.54 -27.78 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.488 -0.757 . . . . 0.0 109.672 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -63.6 -40.56 97.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.674 -0.641 . . . . 0.0 110.205 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.7 tp -79.59 -16.44 55.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.7 -0.625 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.2 mt -90.67 -17.49 26.72 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.97 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.3 mmmt -85.6 -30.45 23.3 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 128' ' ' VAL . 14.3 p -77.55 -40.2 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.37 -47.5 70.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.86 0.838 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -156.12 26.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.2 -36.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.925 -0.75 . . . . 0.0 110.311 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.937 ' HB2' HD22 ' A' ' 28' ' ' LEU . 4.7 t30 -62.41 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 27' ' ' MET . 5.1 m -132.0 -47.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.661 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.408 ' N ' HG23 ' A' ' 26' ' ' VAL . 9.7 ttt -69.58 -33.13 72.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.1 mp -48.05 -34.62 9.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.937 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -79.73 -42.88 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.489 -0.757 . . . . 0.0 109.393 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -61.96 -19.8 63.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.687 -0.633 . . . . 0.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.31 -29.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 108.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.47 -25.77 33.24 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.7 t -77.33 -39.86 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.5 62.88 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.57 94.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.01 -67.62 0.44 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.36 55.22 9.78 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.4 mttm 65.08 73.35 0.43 Allowed Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.5 Cg_endo -71.46 151.95 59.8 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.031 1.821 . . . . 0.0 110.822 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -101.87 173.64 6.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 54' ' ' THR . 46.4 t -155.8 164.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.448 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.8 tt0 -147.77 111.98 5.2 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -98.01 131.47 44.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.805 0.812 . . . . 0.0 110.348 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HD2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -110.82 107.83 17.45 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.6 tt0 -97.63 123.81 41.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.114 -0.991 . . . . 0.0 111.177 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -124.17 54.43 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.41 -126.93 8.65 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.18 -1.09 24.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -1.049 . . . . 0.0 110.088 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.7 m -96.81 136.8 36.84 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.763 -1.211 . . . . 0.0 108.394 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.5 m-85 -131.81 116.04 16.73 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.877 0.846 . . . . 0.0 109.346 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.1 t80 -101.42 147.98 25.71 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.88 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -144.77 100.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.982 -1.074 . . . . 0.0 110.328 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 112.1 24.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.599 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 41' ' ' VAL . 29.9 m -99.1 146.31 26.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.8 p -139.3 132.16 29.26 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -111.75 -63.14 1.46 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.702 HG23 HG23 ' A' ' 58' ' ' VAL . 3.7 t 177.37 -40.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.702 HG23 HG23 ' A' ' 57' ' ' THR . 41.2 t -122.81 -9.64 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.753 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -97.47 -83.25 0.4 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.044 . . . . 0.0 109.473 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.4 m 69.36 85.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.0 110.105 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.19 176.97 4.9 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.0 pt-20 -168.4 124.25 0.99 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.908 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.88 HD11 HD12 ' A' ' 52' ' ' ILE . 37.6 pt -111.68 170.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.522 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.7 p-10 -162.74 133.99 5.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.133 -0.98 . . . . 0.0 109.467 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.3 p90 -161.92 -171.66 2.97 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 122.372 1.082 . . . . 0.0 112.615 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -129.62 152.65 48.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 95.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.19 -29.86 1.49 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.733 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -119.24 157.32 28.27 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.302 -1.117 . . . . 0.0 110.035 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HG2' HD22 ' A' ' 84' ' ' LEU . 21.1 mt-10 -86.14 169.15 13.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.594 -0.691 . . . . 0.0 109.22 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.5 p90 -162.13 174.09 13.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 0.0 109.765 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.55 145.87 29.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.2 pt-20 -162.14 -177.71 5.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.472 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -104.66 157.75 16.97 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.211 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.859 HG23 ' SG ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -95.36 -170.4 2.17 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.333 -0.854 . . . . 0.0 110.19 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.92 -20.71 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.89 -0.506 . . . . 0.0 110.169 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.54 -41.66 13.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.73 43.63 0.2 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -127.9 152.19 76.89 Favored Pre-proline 0 N--CA 1.484 1.248 0 O-C-N 121.628 -0.925 . . . . 0.0 109.142 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.61 137.36 14.43 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.336 1.357 . . . . 0.0 110.21 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.859 ' SG ' HG23 ' A' ' 75' ' ' THR . 12.8 p -160.69 142.47 12.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.656 -0.653 . . . . 0.0 109.466 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.763 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -86.79 117.35 25.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.5 t -99.14 166.52 11.2 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.494 HD22 ' HG2' ' A' ' 70' ' ' GLU . 56.3 tp -147.28 153.97 40.4 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 65' ' ' PHE . 21.3 t -145.79 131.16 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.722 -1.191 . . . . 0.0 112.019 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.1 pttt -125.63 159.9 31.01 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.572 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.3 m95 -82.86 170.04 15.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.89 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.1 tp10 -133.4 -46.0 0.83 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 p -131.18 -154.28 0.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -77.66 -25.53 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.594 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -141.85 26.06 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.991 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 31.8 tttm -131.42 108.77 9.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.885 -1.134 . . . . 0.0 108.316 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.522 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -113.88 145.96 40.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.513 -0.742 . . . . 0.0 110.286 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 110' ' ' THR . 2.5 t -99.91 172.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.526 ' H ' HG12 ' A' ' 94' ' ' VAL . 54.0 t -148.4 139.59 23.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.653 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.29 163.15 13.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' SER . 7.3 tt0 -160.5 137.99 9.45 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.729 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -144.5 147.52 33.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.46 166.83 2.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 82' ' ' LYS . 58.0 mt -101.17 -3.43 29.13 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -156.01 139.94 16.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 108.79 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.17 -162.68 35.68 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -176.49 139.33 0.33 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.41 -1.053 . . . . 0.0 109.947 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.75 -87.25 0.06 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.67 -176.88 2.65 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.824 1.683 . . . . 0.0 109.663 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -132.61 141.38 48.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.44 144.42 49.52 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.163 0.982 . . . . 0.0 110.861 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -163.67 138.66 6.19 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -140.66 172.52 12.6 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.953 -1.092 . . . . 0.0 110.729 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.723 HG22 HG13 ' A' ' 94' ' ' VAL . 17.9 p -134.16 169.16 17.59 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.366 0.603 . . . . 0.0 109.422 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.635 ' HG3' HD23 ' A' ' 121' ' ' LEU . 2.1 ttt -154.53 122.01 5.74 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -118.82 154.62 32.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.478 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -118.7 144.96 45.88 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.3 p -96.83 161.36 13.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.791 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -22.38 63.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -84.36 -27.94 27.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.295 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.52 -11.1 7.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.87 172.12 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.067 -1.255 . . . . 0.0 109.073 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.585 HD11 ' HD2' ' A' ' 3' ' ' PHE . 8.0 tt -149.72 113.64 5.1 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.648 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -98.62 155.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.801 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.81 111.72 8.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -101.35 168.63 9.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.451 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.9 mtp -145.73 169.19 18.97 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.64 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 3.0 m -151.31 150.48 30.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.34 91.41 1.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.448 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -78.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.24 23.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.572 -0.705 . . . . 0.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.5 m -117.68 -179.8 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.8 t -156.7 119.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.474 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.722 ' CB ' HD22 ' A' ' 18' ' ' LEU . 3.2 t -98.08 109.92 22.59 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 HG23 ' A' ' 122' ' ' THR . 39.1 m -101.48 147.0 26.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.048 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 9' ' ' ILE . 60.8 mtm180 -152.19 97.26 2.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.48 129.97 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -116.47 124.3 49.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.49 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.83 139.0 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.474 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -48.1 125.15 8.69 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.274 -0.891 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.051 -0.976 . . . . 0.0 111.66 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.31 123.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.653 0.74 . . . . 0.0 110.236 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.5 m-85 -99.56 1.22 43.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.665 -0.647 . . . . 0.0 109.573 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 t -73.04 118.19 15.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.117 -0.989 . . . . 0.0 111.939 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.47 -172.52 38.57 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.3 m120 -95.16 168.29 10.84 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.8 m95 -150.11 123.23 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.552 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -118.58 113.5 21.35 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 132' ' ' ARG . 8.8 tt -56.93 145.75 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.711 0.767 . . . . 0.0 110.806 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.4 pp -126.55 -23.72 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.331 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HG3' HD12 ' A' ' 10' ' ' ILE . 2.3 mtt180 -141.54 175.62 9.54 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 0.0 110.468 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 169.15 168.04 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.06 30.41 0.09 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.877 -1.139 . . . . 0.0 112.036 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 32.95 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.195 -0.941 . . . . 0.0 108.975 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.994 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -66.35 -63.73 1.01 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.55 -0.719 . . . . 0.0 110.331 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 3.7 mt-10 -58.23 -27.17 63.71 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.497 -0.752 . . . . 0.0 111.25 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -73.08 -28.07 62.09 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.629 -1.228 . . . . 0.0 110.423 -178.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 130' ' ' CYS . 7.6 tp -84.82 -17.69 37.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 110.277 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 15' ' ' PHE . 7.8 mt -90.33 -16.8 28.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.014 -1.054 . . . . 0.0 109.049 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HD2' ' NE ' ' A' ' 29' ' ' ARG . 1.3 mmmm -86.52 -33.09 20.41 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -74.17 -40.36 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.48 -48.45 67.11 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.867 0.841 . . . . 0.0 109.05 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -101.65 -150.61 23.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.0 m -155.19 -43.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.922 -0.752 . . . . 0.0 109.275 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 5.4 t30 -56.72 -175.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.529 -0.732 . . . . 0.0 109.576 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.1 m -108.35 -44.5 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 0.0 110.034 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.0 ttt -68.23 -25.83 65.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 108.933 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.6 mm? -58.46 -34.97 71.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.63 -0.669 . . . . 0.0 110.66 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.884 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -76.37 -47.47 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.436 -0.79 . . . . 0.0 110.08 -179.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -24.8 67.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 111.149 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.97 -28.47 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 109.304 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.978 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.76 -26.03 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 0.0 109.266 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.5 t -77.57 -39.43 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.1 60.95 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.68 97.06 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.449 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.38 -68.84 0.29 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m 50.13 52.3 15.0 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 64.22 73.33 0.47 Allowed Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.4 Cg_endo -71.32 153.22 61.55 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.051 1.834 . . . . 0.0 110.728 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.36 174.15 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.686 -0.634 . . . . 0.0 109.532 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 54' ' ' THR . 48.3 t -154.98 164.21 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 6.8 tp10 -145.71 110.86 5.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.4 mt -99.05 132.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.442 -0.786 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -112.38 114.45 27.18 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.77 119.55 37.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -119.06 52.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.07 -125.24 7.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.626 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.2 p30 -76.88 -0.43 24.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.388 -1.066 . . . . 0.0 109.953 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.5 m -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 120.841 -1.162 . . . . 0.0 108.648 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.1 m-85 -135.71 115.5 13.0 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.842 0.829 . . . . 0.0 109.323 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.0 147.52 26.46 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.95 105.09 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.983 -1.073 . . . . 0.0 111.196 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.67 112.07 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.654 HG23 HG22 ' A' ' 41' ' ' VAL . 23.9 m -99.52 141.73 31.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.77 120.22 18.07 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.246 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -99.22 -169.45 1.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.55 HG23 HG23 ' A' ' 58' ' ' VAL . 5.4 t -51.49 -42.36 61.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.55 HG23 HG23 ' A' ' 57' ' ' THR . 22.0 t -133.82 -6.9 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.382 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -106.29 175.98 5.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.955 -1.09 . . . . 0.0 110.223 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -164.57 96.56 0.76 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.765 -0.584 . . . . 0.0 109.646 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 167.55 16.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 109.315 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -160.22 124.17 3.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 109.785 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 52' ' ' ILE . 36.4 pt -123.71 165.56 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.545 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.3 128.13 3.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.043 -1.035 . . . . 0.0 109.669 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.5 p90 -162.04 -172.02 3.08 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.622 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.04 154.6 49.23 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.63 93.35 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -178.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.49 -24.16 0.51 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.603 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -132.43 161.93 32.42 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -1.075 . . . . 0.0 110.47 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.68 168.8 13.25 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.671 -0.643 . . . . 0.0 109.359 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 16.6 p90 -162.06 173.59 14.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.699 -0.626 . . . . 0.0 109.456 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.25 144.18 31.1 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.722 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.9 pt-20 -162.24 -175.98 4.87 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -100.07 157.6 16.44 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 79' ' ' ARG . 9.7 t -93.59 -141.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.345 -0.847 . . . . 0.0 108.856 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' N ' HG23 ' A' ' 75' ' ' THR . 25.9 t -112.81 -18.89 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.695 -1.253 . . . . 0.0 110.77 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.628 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -91.37 -37.41 13.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.97 45.64 0.12 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.7 151.03 76.34 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.699 -0.883 . . . . 0.0 109.193 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.76 141.06 16.89 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.675 1.583 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -161.05 142.18 11.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.655 -0.653 . . . . 0.0 109.592 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.8 ttpt -87.97 117.31 26.74 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -99.32 162.27 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.733 -0.605 . . . . 0.0 109.837 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.6 tp -139.87 153.5 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.1 t -146.98 128.03 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.379 -1.329 . . . . 0.0 112.171 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 155.46 37.48 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE2' HG21 ' A' ' 67' ' ' VAL . 80.7 m95 -78.18 174.64 10.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 109.89 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -137.45 -46.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.1 p -130.9 -153.23 0.55 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.55 -24.87 45.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.725 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -143.09 28.13 1.56 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.839 . . . . 0.0 110.502 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 22.1 tttm -133.79 110.43 9.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.888 -1.133 . . . . 0.0 108.277 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.512 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 ptm -117.47 149.68 40.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.861 . . . . 0.0 110.141 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.647 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.7 172.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.511 ' H ' HG12 ' A' ' 94' ' ' VAL . 45.7 t -148.55 138.32 22.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.867 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -105.22 164.02 12.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -160.06 132.99 6.65 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.515 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -141.18 149.25 41.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.16 167.51 3.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.641 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 80' ' ' PRO . 41.0 mt -96.19 -8.42 33.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -158.08 156.19 30.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.67 -162.74 20.34 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -176.85 139.06 0.28 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.512 -0.993 . . . . 0.0 109.829 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.77 -84.81 0.05 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.42 -176.95 2.74 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.938 1.758 . . . . 0.0 109.994 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -137.12 139.94 41.57 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 146.32 48.07 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.092 0.948 . . . . 0.0 110.759 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.18 137.86 6.34 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.9 p-90 -144.18 175.96 9.68 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.74 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 94' ' ' VAL . 13.1 p -138.33 169.85 17.06 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.532 0.682 . . . . 0.0 109.955 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.519 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 20.5 ptm -152.8 124.16 7.65 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -124.38 153.04 42.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.423 -0.798 . . . . 0.0 109.957 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.9 45.33 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.4 p -91.06 161.11 15.25 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.5 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.91 -20.72 62.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -28.3 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.838 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.48 -8.36 7.85 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 113' ' ' LEU . 44.0 mt-10 -58.25 172.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.157 -1.202 . . . . 0.0 109.146 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.0 tt -144.84 110.46 5.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.151 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 133' ' ' VAL . 11.1 tt -105.35 143.9 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -128.23 131.49 48.8 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.48 163.71 12.83 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 21.6 mtp -142.49 160.13 40.87 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.039 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 129' ' ' VAL . 7.7 m -143.4 152.88 42.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.62 98.15 1.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.54 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.21 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.62 23.86 0.99 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.517 -0.74 . . . . 0.0 109.534 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.2 m -120.15 -179.37 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.54 116.01 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.659 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.713 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.0 t -99.65 112.06 24.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.8 m -100.85 151.47 21.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 108.845 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.525 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.9 mtm180 -150.63 102.43 3.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 120' ' ' ILE . 52.5 t -67.02 133.23 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.3 m-85 -121.55 120.29 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.907 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.89 142.86 16.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -50.08 126.14 13.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.303 -0.873 . . . . 0.0 111.146 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.961 -1.018 . . . . 0.0 111.752 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.832 ' HD2' HD12 ' A' ' 113' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.499 1.847 0 N-CA-C 110.559 -0.593 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -156.29 141.1 17.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.509 -0.744 . . . . 0.0 110.169 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.3 m-85 -98.01 -2.49 40.23 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 t -71.96 118.01 14.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 112.028 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.52 -173.84 38.83 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.864 -2.095 . . . . 0.0 107.864 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 137' ' ' GLU . 4.3 m120 -95.16 171.45 8.73 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.874 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.4 m95 -151.13 126.95 10.29 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.014 -1.075 . . . . 0.0 112.777 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.49 118.04 31.1 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.833 HD11 ' HB3' ' A' ' 12' ' ' SER . 13.6 tt -61.85 150.86 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.871 0.843 . . . . 0.0 111.016 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.65 -30.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.627 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -141.96 165.8 26.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 108.917 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.833 ' HB3' HD11 ' A' ' 9' ' ' ILE . 56.9 p -177.01 147.19 0.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 0.0 109.469 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -145.61 165.65 28.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.714 -0.616 . . . . 0.0 109.953 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.2 m-80 62.64 32.69 16.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.578 -0.701 . . . . 0.0 109.581 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.937 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.35 -64.22 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.472 -0.767 . . . . 0.0 110.188 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.727 ' CD ' HG21 ' A' ' 33' ' ' VAL . 4.5 mm-40 -57.41 -36.08 70.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.0 110.903 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -68.41 -28.81 67.41 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.28 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.889 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.7 tp -78.89 -22.04 46.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.941 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.0 mt -89.33 -16.26 31.48 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.204 -0.935 . . . . 0.0 109.143 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.2 mmmm -87.02 -32.61 19.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.2 p -73.42 -38.3 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.6 mp -70.43 -45.12 66.5 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 109.562 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.84 -161.45 27.74 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.301 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.36 -36.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.925 -0.75 . . . . 0.0 110.419 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.3 t30 -62.28 -148.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.462 -0.774 . . . . 0.0 109.617 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.48 -45.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.744 -1.223 . . . . 0.0 109.237 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -72.35 -26.91 62.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.3 mm? -60.22 -17.14 39.43 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.706 -0.621 . . . . 0.0 111.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -98.15 -47.77 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.15 -0.969 . . . . 0.0 109.578 -179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -62.8 -22.33 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.636 -0.665 . . . . 0.0 110.516 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 27' ' ' MET . 35.1 mt -78.05 -28.59 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 108.934 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.941 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.47 34.95 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -77.38 -37.67 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.77 -31.62 46.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.33 83.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.44 -69.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.514 -0.741 . . . . 0.0 109.139 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m 48.79 49.09 19.49 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.658 -0.652 . . . . 0.0 109.677 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.3 mttt 65.27 72.17 0.48 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.6 Cg_endo -73.15 151.26 49.18 Favored 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 122.026 1.817 . . . . 0.0 110.726 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -88.8 174.75 7.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.655 -0.653 . . . . 0.0 109.466 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 40' ' ' ALA . 10.1 t -153.58 164.91 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 49.0 tt0 -154.94 115.14 3.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.592 -0.693 . . . . 0.0 109.236 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.874 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -106.15 138.83 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.764 0.792 . . . . 0.0 110.279 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.44 113.51 21.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.7 tt0 -98.53 115.34 28.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.162 -0.961 . . . . 0.0 110.796 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -118.52 56.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.54 8.78 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -77.69 -0.13 25.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.366 -1.079 . . . . 0.0 110.047 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.91 137.01 36.65 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.706 -1.246 . . . . 0.0 108.555 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.8 m-85 -132.56 117.0 17.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.783 0.802 . . . . 0.0 108.871 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.9 t80 -104.46 125.51 50.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.795 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -108.0 141.06 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.948 -1.095 . . . . 0.0 108.658 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 62' ' ' GLU . 2.2 tttt -138.55 101.44 4.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.171 -0.956 . . . . 0.0 108.946 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 31.5 m -99.76 147.25 25.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.36 140.8 30.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.63 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -112.01 -63.93 1.36 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.949 0.881 . . . . 0.0 109.451 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.609 HG23 HG23 ' A' ' 58' ' ' VAL . 2.5 t 179.2 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.609 HG23 HG23 ' A' ' 57' ' ' THR . 40.9 t -114.99 -11.66 11.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -122.31 165.03 16.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.896 . . . . 0.0 109.026 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -162.63 100.48 1.03 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.499 -0.75 . . . . 0.0 109.423 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.9 153.29 29.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.106 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG2' ' HG3' ' A' ' 53' ' ' LYS . 10.7 mt-10 -156.23 97.78 1.8 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.51 -0.744 . . . . 0.0 109.689 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.795 HD11 HG13 ' A' ' 52' ' ' ILE . 24.2 pt -105.34 167.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.506 -0.746 . . . . 0.0 109.052 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.19 135.13 5.97 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.374 -0.829 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.6 p90 -162.74 -172.29 3.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.388 1.089 . . . . 0.0 112.545 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.11 152.75 48.36 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.81 95.07 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.102 -0.999 . . . . 0.0 109.833 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.8 -25.06 1.63 Allowed Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.929 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.5 156.95 34.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.295 -1.12 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.748 ' HG3' HD13 ' A' ' 84' ' ' LEU . 6.2 mp0 -85.8 167.98 14.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.31 174.0 13.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.565 -0.709 . . . . 0.0 109.42 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.31 144.59 31.42 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.14 -177.19 5.58 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -99.65 156.99 16.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.2 -142.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.418 -0.801 . . . . 0.0 108.98 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 t -109.72 -21.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.723 -1.236 . . . . 0.0 110.672 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 2.3 t70 -88.35 -39.97 13.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 109.354 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 133.97 44.73 0.12 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.97 151.87 79.7 Favored Pre-proline 0 N--CA 1.484 1.265 0 O-C-N 121.669 -0.901 . . . . 0.0 109.283 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.71 141.38 17.24 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.665 1.577 . . . . 0.0 110.604 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.2 p -161.12 141.26 10.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.627 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.5 ttmm -90.2 113.63 25.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -100.58 174.48 6.06 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.768 -0.582 . . . . 0.0 109.933 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.748 HD13 ' HG3' ' A' ' 70' ' ' GLU . 44.5 tp -147.92 153.47 39.11 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.9 t -141.86 128.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.465 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.2 ptpt -125.97 164.5 20.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -86.09 169.58 13.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.097 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.8 tp10 -133.19 -45.2 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -133.46 -154.25 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.81 -25.66 53.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.219 -0.925 . . . . 0.0 110.062 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -143.26 27.47 1.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 110.774 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 24.4 tttm -132.92 110.0 9.98 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.885 -1.134 . . . . 0.0 108.114 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.484 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 1.5 ptp -114.87 151.98 33.02 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.481 -0.762 . . . . 0.0 110.13 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.839 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -105.04 171.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.491 ' H ' HG12 ' A' ' 94' ' ' VAL . 48.0 t -148.29 131.97 16.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 110.621 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.7 165.07 11.41 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -160.96 138.67 9.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.745 -1.182 . . . . 0.0 111.818 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -144.85 150.3 36.86 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -60.29 167.48 2.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.039 -1.038 . . . . 0.0 110.857 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 80' ' ' PRO . 34.6 mt -98.4 -6.88 29.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.97 137.95 18.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.13 -158.85 41.3 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -175.8 142.64 0.55 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.414 -1.05 . . . . 0.0 109.759 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 -85.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.5 -176.96 2.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.922 1.748 . . . . 0.0 109.93 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -136.54 135.14 38.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 145.98 47.39 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.163 0.982 . . . . 0.0 110.712 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.3 p -163.01 133.02 4.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -136.7 169.41 17.77 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.049 -1.061 . . . . 0.0 110.727 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 94' ' ' VAL . 13.5 p -134.43 170.72 15.33 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.561 0.696 . . . . 0.0 109.935 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.451 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 1.7 ptp -153.38 134.35 13.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -129.71 152.9 48.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.832 HD12 ' HD2' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -114.93 143.55 44.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.3 162.14 14.12 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -61.29 -22.63 65.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.617 -0.677 . . . . 0.0 110.077 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.13 -27.68 27.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.432 -0.793 . . . . 0.0 109.236 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.93 -9.75 7.96 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 52.5 mt-10 -56.49 172.35 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.166 -1.197 . . . . 0.0 109.18 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -145.6 109.69 4.89 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.919 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.414 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.4 tt -103.61 160.7 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.8 tt -140.52 153.64 46.25 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.374 -0.829 . . . . 0.0 109.218 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.578 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.24 165.86 24.44 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 26.7 mtp -147.27 165.24 30.69 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.491 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.2 m -147.09 150.42 35.0 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.731 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -155.33 93.86 1.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.516 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.0 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -145.84 24.84 1.33 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.1 m -118.68 -179.65 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.54 117.81 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.017 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.889 ' HB2' HD22 ' A' ' 18' ' ' LEU . 8.4 t -99.93 112.5 24.78 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.578 ' OG1' HG22 ' A' ' 122' ' ' THR . 91.7 m -107.39 146.73 31.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 119.74 6.29 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 120' ' ' ILE . 42.0 t -84.12 143.61 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.141 -0.974 . . . . 0.0 108.666 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -130.99 127.94 39.39 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.477 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.54 138.39 37.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.62 128.21 17.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.204 -0.935 . . . . 0.0 111.518 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 6' ' ' ASN . 1.4 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.156 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.019 0 N-CA-C 110.318 -0.686 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -156.12 124.52 5.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 0.0 109.756 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -99.1 -5.74 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.1 p -68.3 117.23 9.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.143 -0.973 . . . . 0.0 111.939 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.85 -172.13 37.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.7 m120 -95.69 168.08 10.89 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -151.88 124.97 8.64 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.485 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -120.01 113.7 20.91 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.5 tt -56.42 143.21 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.563 0.697 . . . . 0.0 110.381 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.3 pp -123.8 -23.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.942 -0.474 . . . . 0.0 110.181 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.544 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -141.4 178.3 7.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.214 -0.929 . . . . 0.0 110.257 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 t 169.13 168.81 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.76 28.93 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.898 -1.126 . . . . 0.0 112.093 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.52 34.99 0.11 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.816 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.18 -60.38 2.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.442 -0.786 . . . . 0.0 110.097 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.8 pt-20 -58.42 -26.86 63.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 111.082 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 2.1 pt-20 -72.79 -29.37 63.23 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.493 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.903 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.2 tp -82.28 -18.3 42.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.917 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.04 HD13 ' HB3' ' A' ' 32' ' ' ALA . 22.9 mt -90.28 -16.35 29.47 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.149 -0.969 . . . . 0.0 109.397 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.9 mmmm -87.21 -31.76 20.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -75.54 -40.74 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 76' ' ' VAL . 4.7 mp -66.75 -49.58 65.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.953 0.882 . . . . 0.0 108.776 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.8 -147.5 19.99 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 25' ' ' ASN . 22.1 m -155.34 -42.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.852 -0.793 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 24' ' ' VAL . 4.2 t30 -57.42 -172.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 109.615 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.35 -43.71 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.362 -0.836 . . . . 0.0 110.116 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.4 ttt -69.88 -25.6 63.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.2 mm? -57.07 -43.9 82.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.603 -0.685 . . . . 0.0 110.694 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.2 mpp_? -63.29 -41.73 99.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.577 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -61.31 -21.5 64.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.658 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.68 -29.31 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 109.059 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.4 -26.41 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 29' ' ' ARG . 7.3 t -76.52 -40.39 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -36.01 65.0 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.19 90.16 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -65.68 -68.69 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.1 t 49.19 51.05 16.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.432 0.634 . . . . 0.0 109.376 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm 63.75 72.36 0.55 Allowed Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -72.11 157.38 54.29 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.973 1.782 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -104.99 174.07 6.04 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 47.8 t -156.18 163.94 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' N ' HG12 ' A' ' 41' ' ' VAL . 41.7 tt0 -147.24 112.26 5.45 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.934 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.3 mt -98.54 134.2 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.798 0.808 . . . . 0.0 110.497 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -113.78 109.16 18.1 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -97.89 120.82 38.97 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.035 -1.041 . . . . 0.0 111.146 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -120.93 53.57 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.44 -126.43 8.35 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.594 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -75.59 -1.25 23.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.4 -1.059 . . . . 0.0 110.095 178.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 m -96.08 137.37 35.24 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.795 -1.19 . . . . 0.0 108.619 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 98.4 m-85 -132.83 114.45 14.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.826 0.822 . . . . 0.0 109.198 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.2 t80 -100.93 148.73 24.66 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.115 HD12 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -144.95 103.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.009 -1.057 . . . . 0.0 110.844 -177.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HG3' ' CG ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -99.81 111.49 23.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.508 -0.745 . . . . 0.0 109.023 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 22.8 m -99.53 148.27 24.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -143.41 128.82 18.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.357 -0.839 . . . . 0.0 110.45 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.583 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -109.4 -63.12 1.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.677 HG23 HG23 ' A' ' 58' ' ' VAL . 3.3 t 176.4 -39.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.677 HG23 HG23 ' A' ' 57' ' ' THR . 39.6 t -123.61 -8.94 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.884 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -99.0 -80.73 0.46 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.965 -1.084 . . . . 0.0 109.684 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.457 HG22 ' OE2' ' A' ' 62' ' ' GLU . 2.6 m 69.89 90.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 109.643 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.07 168.82 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.527 -0.733 . . . . 0.0 109.544 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 60' ' ' THR . 2.6 mp0 -158.7 112.37 2.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.637 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.115 HD11 HD12 ' A' ' 52' ' ' ILE . 41.6 pt -115.32 165.06 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.4 p-10 -162.68 131.83 4.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.4 p90 -161.6 -171.68 3.04 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 122.175 0.988 . . . . 0.0 111.769 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 4.0 ptpt -132.96 155.34 49.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.8 96.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.31 -20.97 0.74 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.923 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 1.2 pt-20 -138.06 163.53 31.37 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.188 -1.184 . . . . 0.0 110.941 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.7 ' HG2' HD13 ' A' ' 84' ' ' LEU . 20.8 mt-10 -86.99 168.8 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.473 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.17 174.48 12.86 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -101.5 145.02 29.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.693 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.4 pt-20 -162.17 -177.11 5.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -104.62 154.17 20.28 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.374 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 77' ' ' ASP . 13.9 t -91.75 -170.28 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 HD21 ' A' ' 22' ' ' LEU . 9.8 p -87.63 -6.27 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 0.0 111.21 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.796 ' H ' HG23 ' A' ' 75' ' ' THR . 1.3 t0 -98.18 -55.07 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.997 -1.065 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.7 46.22 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 75' ' ' THR . 8.0 mmm180 -137.08 152.6 74.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.73 -0.865 . . . . 0.0 109.214 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.85 141.14 16.75 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.533 1.489 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.6 p -160.82 141.17 11.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.64 -0.663 . . . . 0.0 109.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.8 tttp -87.63 118.94 27.46 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -99.7 167.16 10.74 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.7 HD13 ' HG2' ' A' ' 70' ' ' GLU . 45.0 tp -146.03 152.25 39.05 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 65' ' ' PHE . 11.3 t -144.74 127.68 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.112 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -123.13 155.97 35.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.549 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.4 m95 -78.76 173.69 12.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.779 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.73 -46.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.7 p -131.43 -153.55 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.76 -25.43 49.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.777 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -142.72 27.43 1.67 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.588 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 66.0 tttt -132.85 109.68 9.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.962 -1.086 . . . . 0.0 108.376 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.517 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.9 ptm -116.38 148.89 40.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.828 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.64 172.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.498 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.9 t -148.54 134.58 19.19 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.693 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -103.05 165.15 11.19 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -160.45 135.31 7.68 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.293 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.67 40.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -60.95 166.7 3.3 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.065 -1.022 . . . . 0.0 110.722 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 82' ' ' LYS . 46.5 mt -98.76 -5.51 31.18 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -152.45 137.2 17.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 108.962 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.47 -158.72 42.71 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.14 141.05 0.43 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.461 -1.023 . . . . 0.0 109.795 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.97 -85.47 0.05 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.35 -176.83 2.95 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.883 1.722 . . . . 0.0 109.752 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -136.18 137.03 40.47 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.9 146.08 47.89 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.051 0.929 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.3 m -163.03 136.48 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 55.0 p-90 -138.91 175.11 9.84 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.891 -1.13 . . . . 0.0 110.343 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.671 HG22 HG13 ' A' ' 94' ' ' VAL . 12.6 p -137.7 166.45 23.92 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.547 0.689 . . . . 0.0 109.831 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.452 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 10.8 ptm -149.2 119.74 7.44 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -118.46 152.77 35.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.458 -0.777 . . . . 0.0 110.589 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -116.26 143.3 45.71 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -97.13 161.07 13.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.907 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.89 -21.39 63.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.675 -0.64 . . . . 0.0 110.217 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.37 -29.13 28.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.75 -7.59 8.86 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -59.96 171.27 0.98 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -1.233 . . . . 0.0 108.643 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.623 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.01 114.7 7.69 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.343 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.8 tt -99.17 148.32 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.746 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -129.29 110.32 11.85 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.423 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -98.97 171.3 8.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.497 ' O ' HG22 ' A' ' 129' ' ' VAL . 45.3 mtp -150.35 165.87 31.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.596 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.516 HG23 HG23 ' A' ' 129' ' ' VAL . 5.3 m -148.85 151.92 35.57 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 96.39 1.52 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.51 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.83 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -148.38 23.57 1.03 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.539 -0.726 . . . . 0.0 109.617 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.0 m -122.17 179.64 2.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -155.48 118.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.031 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.903 ' CB ' HD22 ' A' ' 18' ' ' LEU . 35.7 t -99.11 133.38 43.46 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 132' ' ' ARG . 38.6 m -120.44 156.02 32.31 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.865 0.841 . . . . 0.0 109.818 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HB3' HD12 ' A' ' 9' ' ' ILE . 15.3 mtm180 -151.97 92.35 1.72 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.16 117.03 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 42.6 m-85 -102.13 133.92 46.2 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.562 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.77 138.08 47.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.83 124.49 7.42 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.3 -0.875 . . . . 0.0 111.331 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.757 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 2.029 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -147.8 127.46 13.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.543 -0.723 . . . . 0.0 109.605 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.724 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.2 m-85 -99.29 -17.38 18.1 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 t -60.97 113.94 2.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 111.85 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.33 -172.64 40.96 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.01 170.44 9.28 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -150.86 123.11 8.32 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.927 -1.109 . . . . 0.0 112.601 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -116.02 113.33 23.07 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.813 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.0 tt -56.06 154.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 122.09 0.947 . . . . 0.0 111.37 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.19 -32.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.382 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.7 mtt-85 -137.08 167.49 21.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.865 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.813 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.8 p -177.12 152.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -0.773 . . . . 0.0 109.792 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -151.45 168.42 24.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.833 -0.542 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.5 m-80 59.85 26.48 15.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.749 . . . . 0.0 110.059 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -63.75 -62.87 1.37 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.31 -0.869 . . . . 0.0 108.686 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.1 mt-10 -57.03 -28.42 62.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.278 -0.889 . . . . 0.0 109.281 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -63.08 -38.69 92.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.729 -0.607 . . . . 0.0 109.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.841 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.1 tp -79.43 -17.96 53.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.8 mt -89.59 -17.32 28.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.194 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.3 mmmm -87.44 -29.63 21.29 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.6 p -77.71 -41.15 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -66.62 -52.63 43.06 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.038 0.923 . . . . 0.0 108.667 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.17 -148.36 20.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 23' ' ' GLY . 18.2 m -155.87 -34.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.958 -0.731 . . . . 0.0 110.387 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.902 ' HB2' HD22 ' A' ' 28' ' ' LEU . 4.3 t30 -60.96 -153.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 109.736 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.574 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.6 m -129.61 -48.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.024 -1.047 . . . . 0.0 109.652 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.406 ' H ' HG23 ' A' ' 26' ' ' VAL . 17.0 ttp -68.11 -30.24 69.35 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -51.61 -35.35 41.36 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.913 -0.492 . . . . 0.0 110.698 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.871 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.7 mtp180 -77.21 -38.54 51.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.561 -0.712 . . . . 0.0 109.59 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -64.88 -24.35 67.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.69 -0.631 . . . . 0.0 110.297 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.63 -29.56 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 108.956 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.23 34.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 29' ' ' ARG . 11.0 t -76.22 -37.77 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.36 -35.51 61.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.56 -37.69 88.28 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -62.59 -69.63 0.25 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t 47.82 50.04 15.98 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.465 0.65 . . . . 0.0 109.557 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 mttt 65.47 72.81 0.44 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 29.7 Cg_endo -72.11 153.98 57.28 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.083 1.856 . . . . 0.0 110.769 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.59 175.66 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 109.741 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 40' ' ' ALA . 23.7 t -155.07 166.25 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -157.41 113.68 2.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.725 . . . . 0.0 109.384 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.724 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.8 mp -101.33 144.3 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.894 0.854 . . . . 0.0 110.303 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 7.3 mttt -123.7 104.35 8.94 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.4 tt0 -98.06 121.93 40.58 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.178 -0.951 . . . . 0.0 111.219 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -124.07 52.35 1.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -129.14 9.79 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -75.4 -2.45 28.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.393 -1.063 . . . . 0.0 110.111 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.9 m -96.7 124.49 40.7 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.821 -1.174 . . . . 0.0 108.516 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 87.9 m-85 -120.5 122.98 41.84 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.857 0.836 . . . . 0.0 108.9 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.4 t80 -107.09 138.2 43.72 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.576 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -122.54 137.87 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -137.75 105.92 5.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.77 147.12 25.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.255 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.12 116.86 10.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.598 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.08 -169.78 1.87 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 58' ' ' VAL . 5.5 t -52.93 -43.15 66.06 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 111.293 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' N ' HG23 ' A' ' 57' ' ' THR . 39.5 t -130.44 -6.51 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.363 -0.836 . . . . 0.0 112.093 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -109.07 172.86 6.6 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.963 -1.086 . . . . 0.0 110.473 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 m -165.1 100.79 0.75 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.19 169.04 8.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -168.09 112.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 110.516 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 52' ' ' ILE . 29.5 pt -98.94 172.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.545 -0.722 . . . . 0.0 109.1 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.0 134.81 5.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.319 -0.863 . . . . 0.0 110.05 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 41.4 p90 -163.04 -171.26 2.59 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.437 1.113 . . . . 0.0 112.508 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -130.7 153.15 49.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.648 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.71 94.82 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.099 -1.001 . . . . 0.0 109.557 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.46 -27.65 1.35 Allowed Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.699 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -122.99 157.49 32.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -1.105 . . . . 0.0 110.131 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' CA ' HD13 ' A' ' 84' ' ' LEU . 8.8 pm0 -86.72 169.61 12.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.635 -0.666 . . . . 0.0 109.359 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 16.2 p90 -161.94 -172.89 3.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.6 -0.687 . . . . 0.0 109.386 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 20.3 mt-10 -115.83 147.76 40.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.7 pt-20 -161.64 179.74 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.682 -0.636 . . . . 0.0 109.596 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -105.73 159.18 16.19 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.327 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.653 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -92.38 -143.73 0.21 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.371 -0.831 . . . . 0.0 109.07 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.577 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 t -117.78 -17.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.161 . . . . 0.0 110.67 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.61 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -87.95 -34.64 18.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.75 45.99 0.18 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.653 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.6 146.85 62.2 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.749 -0.854 . . . . 0.0 109.268 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -80.02 136.09 11.5 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.687 1.591 . . . . 0.0 110.284 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.0 p -161.0 141.48 11.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB3' HD21 ' A' ' 100' ' ' LEU . 9.2 ptmt -80.41 161.71 24.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.5 t -141.88 160.69 39.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD13 ' CA ' ' A' ' 70' ' ' GLU . 60.0 tp -142.07 154.27 44.81 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 20.3 t -144.25 129.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.358 -1.337 . . . . 0.0 112.222 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -124.24 159.58 29.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.648 ' CD1' HG11 ' A' ' 67' ' ' VAL . 82.8 m95 -82.82 172.06 13.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 0.0 110.498 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.5 tp10 -135.99 -45.67 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.7 p -132.65 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.74 -26.35 54.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.936 . . . . 0.0 109.858 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -143.09 27.82 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 0.0 110.773 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 19.4 tttt -131.8 111.12 11.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.532 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.7 ptp -116.23 148.86 40.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.45 -0.781 . . . . 0.0 110.239 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.652 HG13 HG22 ' A' ' 110' ' ' THR . 3.0 t -100.26 171.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.478 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.46 141.75 26.25 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.41 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -107.4 164.12 12.46 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -162.15 131.31 4.38 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.616 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -138.74 155.12 48.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.76 169.29 4.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.48 HD21 ' HB3' ' A' ' 82' ' ' LYS . 62.5 mt -102.59 -2.66 28.0 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -156.73 133.93 10.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -0.981 . . . . 0.0 108.968 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.57 -155.71 43.89 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -175.7 140.5 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.439 -1.036 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.8 -87.0 0.06 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.6 -176.9 2.92 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.816 1.677 . . . . 0.0 109.697 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -132.84 138.44 47.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 144.8 49.82 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.215 1.007 . . . . 0.0 110.867 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.9 m -163.13 139.32 7.08 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.409 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.3 p-90 -142.62 175.73 9.58 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.956 -1.09 . . . . 0.0 110.467 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.652 HG22 HG13 ' A' ' 94' ' ' VAL . 14.9 p -140.05 171.39 14.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.529 0.68 . . . . 0.0 109.838 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.455 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.1 ptp -154.14 140.52 18.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.15 149.44 47.28 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.324 -0.86 . . . . 0.0 109.501 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.39 142.3 46.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.67 160.9 14.78 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.725 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -60.45 -21.75 62.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.643 -0.66 . . . . 0.0 110.218 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.98 -28.67 25.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.9 -9.13 7.6 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.76 171.53 0.32 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.097 -1.237 . . . . 0.0 108.966 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.9 tt -146.62 110.11 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.19 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -102.77 153.15 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 133.3 36.84 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.386 -0.821 . . . . 0.0 109.496 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.508 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -112.88 167.2 10.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.469 ' O ' HG22 ' A' ' 129' ' ' VAL . 24.7 mtp -146.49 164.74 31.55 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.399 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.2 m -147.86 152.27 37.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.67 95.93 1.35 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.595 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.21 -79.25 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -147.6 24.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.248 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.9 m -118.97 -179.25 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.61 117.64 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.696 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.841 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.4 t -98.46 113.81 25.96 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.508 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.3 m -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 0.0 109.715 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.46 118.74 5.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.19 136.98 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -125.77 121.74 34.22 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.16 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.39 141.13 20.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.76 126.25 13.45 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.23 -0.919 . . . . 0.0 111.189 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.635 179.567 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.021 0 N-CA-C 110.307 -0.689 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -154.7 125.43 7.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.549 -0.72 . . . . 0.0 109.727 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.5 m-85 -99.22 -8.11 25.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -67.01 115.64 6.95 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.301 -0.874 . . . . 0.0 111.893 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.32 -173.38 41.08 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.16 169.99 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.3 m95 -152.38 131.4 12.61 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.079 -1.049 . . . . 0.0 113.038 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -122.82 116.72 24.16 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 10.0 tt -58.57 145.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.603 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.15 -24.43 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.961 -0.462 . . . . 0.0 110.324 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -149.66 168.02 24.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.221 -0.924 . . . . 0.0 110.602 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p 178.0 170.11 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.19 30.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.903 -1.123 . . . . 0.0 111.635 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.9 33.49 0.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.284 -0.885 . . . . 0.0 109.134 -178.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.66 -64.99 0.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 21.7 tt0 -57.09 -27.12 61.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.58 -39.66 94.97 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.756 -0.59 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 130' ' ' CYS . 1.9 tp -80.03 -15.8 56.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.675 -0.641 . . . . 0.0 110.016 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.971 HD13 ' HB3' ' A' ' 32' ' ' ALA . 11.6 mt -90.22 -18.97 24.75 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.054 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.22 -28.66 25.25 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.7 p -79.46 -41.22 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.5 mp -65.97 -51.71 56.04 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.05 0.929 . . . . 0.0 109.041 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.15 -147.76 20.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 25' ' ' ASN . 23.1 m -155.74 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.978 -0.719 . . . . 0.0 109.721 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 3.0 t30 -60.46 -159.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.682 . . . . 0.0 109.885 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG13 ' NH2' ' A' ' 29' ' ' ARG . 2.5 t -122.18 -49.75 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.875 . . . . 0.0 109.429 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -66.39 -29.79 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 25' ' ' ASN . 1.7 mm? -57.05 -25.68 59.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.827 -0.545 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.5 mtp180 -87.24 -42.7 12.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.785 . . . . 0.0 109.272 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.56 -22.37 66.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.753 -0.592 . . . . 0.0 110.54 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.68 -29.99 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 108.774 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.971 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.17 -24.97 34.71 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.9 t -77.11 -35.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.52 -35.89 52.97 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.34 -35.51 80.56 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB2' ' HZ ' ' A' ' 15' ' ' PHE . . . -71.19 -67.14 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.6 m 49.23 51.37 16.41 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.8 mttt 65.64 73.73 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.5 Cg_endo -72.37 154.28 55.96 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 111.063 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -97.54 176.37 5.88 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 42.9 t -155.57 164.59 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.6 tt0 -152.21 112.49 4.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.664 HG13 HG23 ' A' ' 52' ' ' ILE . 2.4 mp -98.04 136.32 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.767 0.794 . . . . 0.0 110.002 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.445 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -115.35 106.38 13.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 63.9 tt0 -97.7 124.3 41.97 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.112 -0.993 . . . . 0.0 111.193 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -124.44 53.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.3 -127.26 8.87 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.03 -1.13 24.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -1.029 . . . . 0.0 110.074 178.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.7 m -97.14 138.58 34.43 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.706 -1.246 . . . . 0.0 108.31 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 93.6 m-85 -134.11 118.11 17.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.764 0.793 . . . . 0.0 109.464 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.5 t80 -102.65 146.97 27.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.98 HD12 HD11 ' A' ' 63' ' ' ILE . 2.9 mt -141.73 100.81 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.947 -1.096 . . . . 0.0 110.45 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -99.39 114.07 26.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.55 -0.719 . . . . 0.0 110.393 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 18.0 m -99.87 144.76 28.55 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.9 p -135.51 144.19 46.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.2 p -123.78 -62.18 1.32 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.878 0.847 . . . . 0.0 108.738 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.688 HG23 HG23 ' A' ' 58' ' ' VAL . 3.0 t 176.49 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.688 HG23 HG23 ' A' ' 57' ' ' THR . 24.4 t -125.15 -8.23 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.989 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -82.81 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.0 109.604 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 1.8 m 69.85 84.51 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.452 -0.78 . . . . 0.0 109.913 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.01 177.58 4.8 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.2 pm0 -171.37 143.75 1.88 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.69 . . . . 0.0 110.296 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 52' ' ' ILE . 33.3 pt -128.18 170.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.0 132.69 4.99 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.987 -1.071 . . . . 0.0 109.457 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.7 p90 -162.25 -172.39 3.18 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.409 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.81 152.6 48.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.64 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.97 96.89 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.227 -0.92 . . . . 0.0 109.856 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.36 -34.88 1.48 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.559 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.76 157.34 21.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.421 -1.046 . . . . 0.0 109.968 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' HG2' HD22 ' A' ' 84' ' ' LEU . 28.2 mt-10 -85.8 168.88 13.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.547 -0.721 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 22.3 p90 -161.21 -172.9 3.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.689 -0.632 . . . . 0.0 109.368 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 21.8 mt-10 -116.39 148.86 40.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.651 ' HB2' HG22 ' A' ' 63' ' ' ILE . 3.9 pt-20 -161.29 179.8 8.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.444 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.8 144.14 42.85 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 79' ' ' ARG . 7.9 t -81.54 177.62 8.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.407 -0.808 . . . . 0.0 108.985 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 76' ' ' VAL . 13.5 p -84.7 -0.35 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.6 -0.688 . . . . 0.0 111.396 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 75' ' ' THR . 5.2 t0 -95.68 -44.61 7.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.89 -1.132 . . . . 0.0 109.955 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 75' ' ' THR . . . 134.19 45.3 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mmm180 -139.9 149.88 60.52 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.796 -0.826 . . . . 0.0 109.088 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HB2' HD12 ' A' ' 100' ' ' LEU . 37.2 Cg_endo -80.46 135.03 10.33 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.49 1.46 . . . . 0.0 110.048 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.1 p -160.45 141.45 12.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.701 -0.624 . . . . 0.0 109.55 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 2.1 ptmm? -80.69 163.34 23.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 6.9 t -144.56 160.52 40.99 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD22 ' HG2' ' A' ' 70' ' ' GLU . 58.2 tp -142.13 153.57 44.2 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.6 t -144.7 125.77 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.772 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -120.58 162.28 19.89 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.64 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.1 m95 -85.51 168.7 14.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 110.306 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' OE1' HG21 ' A' ' 94' ' ' VAL . 5.4 tp10 -131.81 -45.72 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.6 p -133.04 -153.81 0.57 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -77.14 -25.14 51.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -143.83 26.6 1.54 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.877 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 15.5 tttt -131.5 109.65 10.43 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' CZ2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -115.25 150.67 35.82 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -102.8 171.36 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 94' ' ' VAL . 43.3 t -148.93 140.41 23.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.185 -0.947 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -107.17 164.75 11.9 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -161.96 133.41 5.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.988 -1.07 . . . . 0.0 110.752 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -140.89 153.67 45.8 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.35 169.59 3.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.117 -0.99 . . . . 0.0 110.684 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' A' ' 80' ' ' PRO . 40.7 mt -98.01 -7.48 29.83 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -159.98 157.03 28.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 108.774 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.69 -158.5 18.94 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -176.73 139.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.514 -0.992 . . . . 0.0 109.691 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.35 -85.35 0.06 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.48 -176.75 2.65 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.95 1.767 . . . . 0.0 110.17 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -138.67 141.19 39.02 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.81 145.28 50.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.163 0.982 . . . . 0.0 110.839 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 m -162.99 137.23 6.22 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.411 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.7 p-90 -143.21 174.55 10.61 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 118.899 -1.121 . . . . 0.0 110.571 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.674 HG22 HG13 ' A' ' 94' ' ' VAL . 12.2 p -139.29 175.31 9.67 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.512 0.672 . . . . 0.0 109.674 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.454 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 9.7 ptp -158.34 141.1 14.62 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -136.09 150.28 49.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.451 -0.78 . . . . 0.0 109.158 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -113.42 143.3 44.71 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 p -93.03 160.49 14.84 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.809 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -60.01 -21.04 60.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 110.229 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.0 -29.7 24.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.838 . . . . 0.0 109.177 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.07 -9.84 7.03 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.9 172.88 0.23 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.215 -1.168 . . . . 0.0 109.432 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.596 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -146.12 108.57 4.46 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.225 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.8 tt -103.62 147.87 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.8 tt -129.93 147.75 51.72 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.263 -0.898 . . . . 0.0 109.637 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.469 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -123.22 164.57 18.48 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 31.5 mtp -146.88 164.49 32.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.534 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 8.4 m -146.52 153.08 39.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -161.5 98.72 1.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.51 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.43 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.27 24.19 1.03 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.519 -0.738 . . . . 0.0 109.426 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.659 ' O ' HG23 ' A' ' 129' ' ' VAL . 24.1 m -119.15 -179.22 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.07 116.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.423 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.864 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.0 t -99.68 114.49 27.62 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.79 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.469 ' OG1' HG22 ' A' ' 122' ' ' THR . 76.9 m -104.57 126.61 51.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.36 -0.838 . . . . 0.0 109.296 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -126.39 101.96 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.15 136.17 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.413 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 29.3 m-85 -125.43 127.59 46.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -110.0 137.56 41.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.494 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.57 127.57 15.83 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.197 -0.939 . . . . 0.0 111.405 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.604 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.98 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -161.13 122.39 2.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.475 -0.766 . . . . 0.0 109.819 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.5 m-85 -99.33 -8.79 24.38 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.732 -0.605 . . . . 0.0 109.61 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p -68.87 116.91 9.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.207 -0.933 . . . . 0.0 111.895 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.61 -171.95 39.39 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.89 169.04 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.56 121.55 7.67 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.717 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -115.25 113.7 24.24 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.6 tt -56.55 144.88 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.686 0.755 . . . . 0.0 110.804 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -125.21 -23.46 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.934 -0.479 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 10' ' ' ILE . 10.9 mtt180 -144.98 173.5 11.83 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.225 -0.922 . . . . 0.0 110.527 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t 170.29 168.79 0.06 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.78 31.7 0.08 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.961 -1.087 . . . . 0.0 111.893 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' CA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.38 32.11 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.167 -0.958 . . . . 0.0 109.237 -178.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.832 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -66.92 -61.86 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.462 -0.774 . . . . 0.0 110.174 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.3 mm-40 -58.07 -30.08 65.92 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.357 -0.839 . . . . 0.0 110.988 -177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -71.69 -27.45 63.05 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.621 -178.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.838 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.7 tp -81.52 -20.65 39.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' HB3' ' A' ' 32' ' ' ALA . 13.7 mt -88.43 -16.68 32.2 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 109.187 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.9 mtmt -85.56 -32.86 21.91 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.47 -40.58 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.8 mp -67.52 -48.74 66.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.886 0.85 . . . . 0.0 109.099 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.86 -160.52 26.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.3 t -141.61 -44.52 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.896 -0.767 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.8 t30 -58.69 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.45 -0.781 . . . . 0.0 109.141 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' NH1' ' A' ' 29' ' ' ARG . 1.5 m -111.86 -43.52 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 13.6 ttp -66.92 -28.53 68.38 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm? -59.6 -23.57 63.07 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.729 -0.607 . . . . 0.0 110.57 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.726 ' O ' HG23 ' A' ' 33' ' ' VAL . 56.4 mtt180 -86.82 -47.59 8.93 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.641 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.74 -23.61 65.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.691 . . . . 0.0 110.696 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.1 mt -77.25 -29.18 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.306 -0.871 . . . . 0.0 109.086 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.027 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.62 -26.44 34.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.7 t -76.86 -37.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 -33.47 55.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.55 92.77 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.92 -67.83 0.4 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m 51.13 53.4 13.05 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mttt 66.04 73.32 0.41 Allowed Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.2 Cg_endo -71.22 143.41 43.85 Favored 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 121.939 1.759 . . . . 0.0 110.632 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.1 176.13 6.21 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 54' ' ' THR . 54.2 t -155.36 163.97 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 31.0 tt0 -148.15 111.53 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.8 mt -99.68 140.9 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.81 0.814 . . . . 0.0 110.75 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -118.86 116.12 25.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.6 tt0 -98.92 116.91 32.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.085 -1.009 . . . . 0.0 110.948 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -118.5 52.11 1.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.75 -125.97 8.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -76.91 -0.65 24.98 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.395 -1.062 . . . . 0.0 110.029 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.63 139.97 31.92 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.772 -1.205 . . . . 0.0 108.371 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CD2' ' HE1' ' A' ' 93' ' ' MET . 94.7 m-85 -135.02 116.94 15.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.879 0.847 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.1 t80 -102.18 148.72 25.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 63' ' ' ILE . 1.3 mt -147.24 105.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 O-C-N 120.909 -1.119 . . . . 0.0 111.665 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -102.17 115.36 30.4 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.331 -0.856 . . . . 0.0 108.836 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 HG23 HG22 ' A' ' 41' ' ' VAL . 60.1 m -103.08 137.15 41.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.34 143.16 50.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.303 -0.873 . . . . 0.0 110.032 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -110.9 -77.37 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.593 0.711 . . . . 0.0 109.27 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 56' ' ' THR . 66.9 p -157.73 -47.58 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.62 -9.56 12.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.522 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -115.87 163.65 15.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.83 HG22 ' OE2' ' A' ' 62' ' ' GLU . 13.1 m -162.81 94.17 0.84 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.5 p -79.37 162.87 25.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.568 -0.707 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.83 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.9 mp0 -156.12 122.92 5.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.69 -0.631 . . . . 0.0 109.499 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 52' ' ' ILE . 37.2 pt -121.56 165.66 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.48 129.34 3.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.144 -0.972 . . . . 0.0 108.833 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.2 p90 -161.33 -172.43 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.731 -1.188 . . . . 0.0 112.272 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -128.55 153.38 47.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.54 95.3 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.554 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.91 -35.55 1.27 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -112.05 155.86 23.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.411 -1.052 . . . . 0.0 109.909 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -86.61 170.51 11.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.536 -0.728 . . . . 0.0 109.414 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.1 p90 -162.56 173.7 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.0 109.811 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -103.18 143.98 31.92 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.22 -175.4 4.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.693 -0.629 . . . . 0.0 109.445 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -102.55 154.87 18.7 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.2 t -90.19 -142.34 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.4 -0.813 . . . . 0.0 108.958 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 14.9 t -110.95 -20.8 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.733 -1.229 . . . . 0.0 110.445 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -88.57 -42.62 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.0 109.438 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.4 44.66 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.691 ' H ' HG22 ' A' ' 75' ' ' THR . 12.2 mtp180 -131.07 150.03 75.43 Favored Pre-proline 0 C--N 1.308 -1.237 0 O-C-N 121.696 -0.885 . . . . 0.0 109.003 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -77.94 140.72 18.4 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.615 1.543 . . . . 0.0 110.674 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.5 p -160.84 141.48 11.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.683 -0.636 . . . . 0.0 109.668 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.632 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.1 ttmt -87.23 116.35 25.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -99.48 164.58 12.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.295 0.569 . . . . 0.0 110.117 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.9 tp -143.98 153.18 41.99 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.3 t -145.58 124.94 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.656 -1.218 . . . . 0.0 111.761 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -119.17 155.34 31.81 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.526 ' NE1' HG21 ' A' ' 67' ' ' VAL . 80.6 m95 -77.19 175.15 9.94 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.881 0.848 . . . . 0.0 110.163 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.4 tp10 -138.08 -46.41 0.52 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.9 p -131.22 -152.89 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -78.14 -25.56 47.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -142.99 27.47 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 110.571 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.7 tttm -133.34 113.34 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.891 -1.131 . . . . 0.0 108.288 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.542 ' HE1' ' CD2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.38 150.82 39.53 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.493 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.71 172.21 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.506 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.7 t -147.79 139.66 24.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.781 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.93 162.84 13.65 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.23 133.59 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.552 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -141.93 151.13 42.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.23 167.93 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.131 -0.98 . . . . 0.0 110.718 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 80' ' ' PRO . 50.9 mt -98.41 -6.27 30.95 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -155.09 141.1 18.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.99 -158.07 38.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -175.97 140.98 0.44 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.458 -1.024 . . . . 0.0 109.871 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.13 -85.51 0.05 OUTLIER Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.19 -176.52 2.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.905 1.737 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -137.17 136.21 38.02 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.55 145.51 48.27 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.123 0.964 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.1 m -162.84 135.75 5.69 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.408 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.4 p-90 -141.73 175.41 9.72 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.669 HG22 HG13 ' A' ' 94' ' ' VAL . 11.8 p -138.15 174.38 10.62 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.696 . . . . 0.0 109.888 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 1.5 ptt? -156.77 133.35 10.06 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -131.07 146.45 52.37 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.393 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -109.3 143.07 39.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -92.65 161.41 14.58 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.833 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -60.27 -21.27 61.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.603 -0.686 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.18 -29.62 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 0.0 109.179 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.15 -7.91 8.05 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 113' ' ' LEU . 36.2 mt-10 -59.37 172.37 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.216 -1.167 . . . . 0.0 109.05 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -143.41 108.96 5.09 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.122 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.3 tt -103.13 148.48 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.68 145.35 51.9 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.489 -0.885 . . . . 0.0 109.489 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.14 167.19 12.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 14.2 mtp -148.32 164.65 33.41 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.474 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 128' ' ' VAL . 7.3 m -146.71 152.38 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.1 97.73 1.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.547 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.87 -79.18 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -149.65 24.47 0.87 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.555 -0.716 . . . . 0.0 109.398 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.3 m -120.92 -179.3 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -156.85 117.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.689 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.838 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.9 t -99.92 116.71 32.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.581 . . . . 0.0 109.499 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -108.11 130.28 55.11 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.34 -0.85 . . . . 0.0 109.561 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 104.01 7.18 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.76 135.58 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.6 m-85 -124.52 122.08 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.394 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.34 140.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.45 126.0 12.38 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.254 -0.904 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.64 179.633 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 110.336 -0.678 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -170.63 128.73 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 109.576 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 m-85 -99.56 -11.44 21.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 116.81 6.5 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.25 -0.906 . . . . 0.0 111.689 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.72 -172.95 39.74 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.7 m120 -96.02 170.11 9.51 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.535 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.6 m95 -151.11 122.83 8.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.547 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -115.75 112.07 21.48 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.778 HG21 ' HD2' ' A' ' 39' ' ' PRO . 9.1 tt -52.47 156.5 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.994 0.902 . . . . 0.0 111.547 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -128.8 -33.31 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 10' ' ' ILE . 40.1 mtt180 -146.69 170.14 17.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 108.954 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.407 ' HB2' HD11 ' A' ' 9' ' ' ILE . 6.4 t -179.35 155.43 0.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 109.3 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -152.08 171.95 17.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.688 -0.633 . . . . 0.0 110.048 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 36.3 m-80 60.31 27.77 17.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 109.798 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -66.32 -64.27 0.89 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 108.976 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 tt0 -59.1 -28.53 66.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.613 -0.679 . . . . 0.0 109.719 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.77 -37.63 84.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.631 -0.668 . . . . 0.0 110.257 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 130' ' ' CYS . 48.2 tp -83.58 -13.61 53.98 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.684 -0.635 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -91.46 -21.7 20.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.003 -1.061 . . . . 0.0 108.946 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mmmt -82.64 -29.28 30.15 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.25 -41.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 122.098 0.951 . . . . 0.0 108.472 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.505 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -65.66 -53.56 39.63 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.149 0.976 . . . . 0.0 108.99 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.95 -146.37 17.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.5 m -155.58 -37.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 122.014 -0.698 . . . . 0.0 110.175 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -57.52 -170.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.273 -0.892 . . . . 0.0 109.744 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH2' ' A' ' 29' ' ' ARG . 3.0 m -119.78 -43.8 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 110.084 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 31' ' ' ILE . 16.6 ttp -68.68 -23.02 64.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 0.0 109.281 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.4 mm? -65.35 -30.59 71.44 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.522 -0.736 . . . . 0.0 110.921 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.864 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -85.11 -45.31 12.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.362 -0.836 . . . . 0.0 110.65 -178.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -25.43 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.448 -0.783 . . . . 0.0 110.834 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.558 HD11 ' HG2' ' A' ' 27' ' ' MET . 96.0 mt -80.04 -27.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.365 -0.835 . . . . 0.0 108.879 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.99 -24.45 35.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.686 -0.634 . . . . 0.0 109.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.5 t -82.23 -49.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.45 -43.95 97.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.25 86.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.58 40.72 0.81 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.684 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -64.25 -54.46 32.97 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.777 -1.202 . . . . 0.0 108.12 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -139.21 71.06 40.42 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.96 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.9 Cg_endo -72.89 147.95 44.88 Favored 'Trans proline' 0 C--N 1.322 -0.835 0 C-N-CA 121.947 1.765 . . . . 0.0 110.954 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -94.31 172.52 8.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.618 ' CG2' HG23 ' A' ' 54' ' ' THR . 17.0 t -155.3 166.34 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.0 tt0 -156.77 112.44 2.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.331 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.679 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.5 mp -100.07 141.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.753 0.787 . . . . 0.0 110.105 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 29.7 mttt -117.03 91.28 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.21 126.28 42.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -177.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -135.54 64.88 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.43 -131.62 10.85 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.5 p30 -74.75 -2.34 26.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -1.044 . . . . 0.0 110.418 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 m -96.44 132.09 42.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.543 -1.348 . . . . 0.0 108.31 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.04 121.11 25.8 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.811 0.815 . . . . 0.0 109.047 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.74 ' O ' HD13 ' A' ' 52' ' ' ILE . 13.3 t80 -105.78 151.41 24.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -138.55 135.48 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -138.89 105.35 5.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.315 -0.866 . . . . 0.0 108.797 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.618 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.2 m -98.74 148.43 23.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.443 -0.786 . . . . 0.0 108.975 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.01 113.02 5.79 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.037 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.96 HG22 ' HB3' ' A' ' 39' ' ' PRO . 35.6 p -98.22 -169.01 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.822 HG23 HG23 ' A' ' 58' ' ' VAL . 8.1 t -58.23 -39.76 79.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.6 -0.687 . . . . 0.0 111.517 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.822 HG23 HG23 ' A' ' 57' ' ' THR . 25.6 t -125.67 -7.25 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.225 -0.922 . . . . 0.0 112.204 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -113.3 166.18 11.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 0.0 110.618 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -164.83 101.25 0.78 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.61 168.53 9.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -165.73 113.37 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.545 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -99.84 172.61 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.463 -0.773 . . . . 0.0 109.059 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.4 135.66 5.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -163.02 -171.69 2.76 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 122.354 1.073 . . . . 0.0 112.661 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 153.68 47.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.68 96.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.095 -1.003 . . . . 0.0 109.615 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.1 -22.69 1.92 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.941 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -126.03 156.95 39.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.256 -1.144 . . . . 0.0 110.261 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.605 ' HG3' HD13 ' A' ' 84' ' ' LEU . 4.5 mt-10 -86.65 168.3 13.73 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.5 p90 -161.93 175.17 12.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' HD11 ' A' ' 100' ' ' LEU . 7.3 mt-10 -110.32 142.75 41.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 4.9 pm0 -162.08 -169.69 2.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -99.71 159.79 14.78 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.17 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.748 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.8 t -96.85 -143.04 0.29 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.379 -0.825 . . . . 0.0 109.242 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' N ' HG23 ' A' ' 75' ' ' THR . 21.9 t -106.44 -23.86 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.762 -1.211 . . . . 0.0 110.914 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 p30 -88.87 -41.61 12.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.43 45.72 0.08 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.748 ' H ' HG22 ' A' ' 75' ' ' THR . 5.3 mmm180 -131.45 153.08 81.49 Favored Pre-proline 0 N--CA 1.484 1.268 0 O-C-N 121.683 -0.892 . . . . 0.0 109.188 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.52 140.09 14.82 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.76 1.64 . . . . 0.0 110.439 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.2 p -160.57 144.65 13.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.517 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.793 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.1 tppt? -90.48 122.09 33.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 11.9 t -104.52 168.92 8.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.543 . . . . 0.0 110.206 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.605 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.2 tp -148.24 153.43 38.72 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.636 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.6 t -144.92 126.48 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.908 -178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -119.96 155.08 33.51 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.57 ' CD1' HG11 ' A' ' 67' ' ' VAL . 76.6 m95 -76.94 174.01 11.1 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.913 0.863 . . . . 0.0 110.769 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -136.65 -45.68 0.6 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.4 p -134.89 -150.66 0.4 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.87 -26.59 49.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 0.0 110.516 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -142.36 24.03 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 11.0 tttt -131.13 113.86 14.41 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.93 -1.106 . . . . 0.0 108.289 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.464 ' HE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -119.24 149.96 40.89 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.512 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 110' ' ' THR . 2.3 t -99.15 173.18 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.53 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.5 t -147.57 141.09 25.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.2 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.55 163.25 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -160.33 138.83 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.654 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -145.59 150.73 36.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -61.55 166.56 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.032 -1.043 . . . . 0.0 110.775 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.1 mt -98.68 -5.48 31.53 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -147.76 129.79 15.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 108.945 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.18 -155.83 45.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -176.27 141.82 0.45 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.524 -0.986 . . . . 0.0 109.686 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.76 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -82.18 -176.89 3.19 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.749 1.632 . . . . 0.0 109.925 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -130.42 133.83 46.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.4 144.16 46.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.115 0.96 . . . . 0.0 110.546 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -163.34 135.55 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 57.0 p-90 -142.78 177.66 8.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.061 -1.024 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.67 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -139.23 166.86 23.41 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.516 0.674 . . . . 0.0 109.956 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.56 ' HE2' ' CE2' ' A' ' 3' ' ' PHE . 19.2 ptm -148.92 124.72 10.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -122.64 151.14 41.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.343 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.38 144.48 43.22 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 118' ' ' GLU . 18.7 p -93.87 161.77 14.18 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.859 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -60.65 -23.05 64.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.635 -0.666 . . . . 0.0 110.114 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.4 -27.95 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.67 -10.08 7.6 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 114' ' ' THR . 25.4 mt-10 -55.47 173.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.156 -1.202 . . . . 0.0 109.412 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.5 tt -147.71 114.63 6.12 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.45 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.25 150.92 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.2 132.98 42.16 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.49 -0.756 . . . . 0.0 109.546 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.612 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -115.67 165.23 13.27 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.484 ' O ' HG22 ' A' ' 129' ' ' VAL . 32.4 mtp -144.73 163.45 33.98 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.649 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 129' ' ' VAL . 2.6 m -146.86 149.09 32.59 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -154.99 93.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.52 -78.43 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -147.47 23.16 1.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.665 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -118.47 -179.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.57 118.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.893 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.651 ' HB2' HD22 ' A' ' 18' ' ' LEU . 28.1 t -98.96 112.8 24.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 122' ' ' THR . 97.7 m -110.77 147.64 34.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -151.37 120.29 6.64 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.1 t -81.31 138.71 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.098 -1.001 . . . . 0.0 108.428 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.3 m-85 -127.07 125.98 42.25 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.153 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.99 139.92 28.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.2 125.72 11.36 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.224 -0.922 . . . . 0.0 111.102 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.48 179.662 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 113' ' ' LEU . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.029 0 N-CA-C 110.389 -0.658 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -133.64 132.01 40.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.767 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' A' ' 119' ' ' LEU . 2.6 m-85 -98.65 0.59 45.04 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -73.25 118.5 16.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 111.97 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.66 -171.77 38.56 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.4 m120 -95.82 170.03 9.59 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.891 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.52 121.77 7.81 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.508 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -115.25 113.22 23.6 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 12' ' ' SER . 8.6 tt -52.22 157.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.012 0.911 . . . . 0.0 111.684 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.57 -32.72 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.441 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.722 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.1 ttp180 -146.52 171.3 15.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.877 . . . . 0.0 109.034 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' HD11 ' A' ' 9' ' ' ILE . 81.7 p -177.52 158.15 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.781 . . . . 0.0 109.641 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.64 169.86 22.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.678 -0.638 . . . . 0.0 110.034 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 43.9 m-20 58.68 23.88 11.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.538 -0.726 . . . . 0.0 110.194 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -66.42 -63.39 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.3 tt0 -56.88 -27.8 61.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.57 -39.02 93.31 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.634 -0.666 . . . . 0.0 109.681 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 8.4 tp -78.49 -18.04 55.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.717 -0.614 . . . . 0.0 110.157 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.915 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.5 mt -90.23 -17.76 26.9 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -86.29 -28.32 23.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.5 p -80.21 -40.96 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 76' ' ' VAL . 4.6 mp -67.28 -52.31 42.23 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.097 0.951 . . . . 0.0 109.314 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.1 -149.34 22.06 Favored Glycine 0 N--CA 1.489 2.224 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.462 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 23' ' ' GLY . 21.1 m -155.71 -34.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 122.104 -0.645 . . . . 0.0 110.375 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.93 ' HB2' HD22 ' A' ' 28' ' ' LEU . 4.1 t30 -61.71 -152.06 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 110.033 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.12 -50.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.977 -1.077 . . . . 0.0 109.051 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 8.9 ttm -65.95 -30.98 71.64 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 25' ' ' ASN . 6.3 mp -52.82 -33.93 51.46 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.465 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.831 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.4 mtp180 -83.31 -46.55 12.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.867 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -62.88 -15.19 53.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.691 -0.631 . . . . 0.0 111.206 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.6 -30.46 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.094 -1.004 . . . . 0.0 108.474 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.75 -24.14 33.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.5 t -80.45 -44.33 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.06 -41.33 86.63 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.07 83.49 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.21 45.21 1.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.844 -0.535 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -60.66 -34.72 74.72 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.572 -1.33 . . . . 0.0 108.37 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -165.68 72.88 1.32 Allowed Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.731 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.2 Cg_endo -73.15 149.78 46.67 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 121.811 1.674 . . . . 0.0 110.759 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.73 175.07 5.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 54' ' ' THR . 55.8 t -155.61 164.43 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' N ' HG12 ' A' ' 41' ' ' VAL . 44.2 tt0 -150.58 110.82 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.891 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.0 mt -98.25 133.38 40.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.786 0.803 . . . . 0.0 110.161 -178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -113.03 106.9 15.24 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 60.7 tt0 -97.48 122.99 41.17 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.14 -0.975 . . . . 0.0 111.017 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -122.58 56.42 1.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.86 -126.06 8.13 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -76.77 -0.42 23.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.378 -1.072 . . . . 0.0 110.163 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 65' ' ' PHE . 14.4 m -96.89 138.06 35.02 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 120.712 -1.243 . . . . 0.0 108.556 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 96.6 m-85 -132.49 116.01 16.22 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.891 0.853 . . . . 0.0 109.342 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.4 t80 -101.77 146.98 27.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.856 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -143.15 99.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.026 -1.046 . . . . 0.0 110.161 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 62' ' ' GLU . 14.6 tttt -99.45 111.82 24.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.449 -0.782 . . . . 0.0 109.718 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 41' ' ' VAL . 24.4 m -99.51 146.4 26.42 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 1.2 p -139.9 119.5 13.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.997 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.731 HG22 ' HB3' ' A' ' 39' ' ' PRO . 1.3 p -99.84 -63.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.766 0.793 . . . . 0.0 108.917 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.777 HG23 HG23 ' A' ' 58' ' ' VAL . 2.8 t 174.94 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.777 HG23 HG23 ' A' ' 57' ' ' THR . 25.7 t -120.6 -9.33 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -100.19 -81.89 0.46 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 109.599 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 2.6 m 69.63 85.12 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 109.752 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.9 p -108.25 176.96 4.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.0 109.34 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 53' ' ' LYS . 2.5 pt-20 -170.26 124.05 0.71 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 109.849 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.856 HD11 HD12 ' A' ' 52' ' ' ILE . 35.6 pt -114.87 170.91 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.5 p-10 -162.56 133.88 5.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.949 . . . . 0.0 109.51 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 85' ' ' VAL . 47.5 p90 -161.91 -171.52 2.92 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.44 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.09 152.81 49.13 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -83.0 94.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.129 -0.982 . . . . 0.0 109.64 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.08 -27.56 1.26 Allowed Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.662 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.38 156.81 34.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.322 -1.105 . . . . 0.0 110.177 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -86.39 169.78 12.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.592 -0.692 . . . . 0.0 109.395 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.9 p90 -163.0 174.42 12.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.616 -0.678 . . . . 0.0 109.612 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -103.65 144.33 31.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -162.35 -174.93 4.27 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.564 -0.71 . . . . 0.0 109.443 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -99.83 159.25 15.21 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.3 t -95.13 -150.05 0.31 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 22' ' ' LEU . 13.7 p -98.54 -21.18 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.976 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -91.99 -51.21 5.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.64 44.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.742 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mtm180 -128.88 152.63 79.38 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.584 -0.951 . . . . 0.0 109.05 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.07 139.88 17.46 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.599 1.532 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.82 140.96 11.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.745 -0.597 . . . . 0.0 109.445 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.683 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.3 ttmt -86.4 117.28 25.1 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.0 t -99.41 168.25 10.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.18 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 70' ' ' GLU . 61.5 tp -147.01 154.08 40.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 65' ' ' PHE . 24.6 t -146.65 130.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 118.441 -1.303 . . . . 0.0 112.153 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -125.51 160.04 30.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.9 m95 -83.63 169.83 14.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.129 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.446 ' OE1' HG21 ' A' ' 94' ' ' VAL . 6.1 tp10 -132.45 -46.22 0.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.0 p -130.6 -153.47 0.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.11 -26.35 47.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -142.2 27.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.806 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 1.2 tttt -132.03 108.58 9.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.822 -1.173 . . . . 0.0 107.933 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.7 ptp -114.77 149.74 36.47 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.43 -0.794 . . . . 0.0 110.509 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -102.21 171.5 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.2 t -146.71 141.5 26.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.756 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.66 162.91 13.98 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -160.69 136.96 8.53 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.655 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -142.25 149.8 40.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.5 mt -61.62 166.06 4.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 110.805 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' A' ' 82' ' ' LYS . 48.2 mt -101.07 -3.15 29.82 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 132.41 13.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 108.796 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.77 -159.86 42.24 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.25 141.33 0.43 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.396 -1.061 . . . . 0.0 109.857 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.98 -85.77 0.05 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.18 -177.05 3.1 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.816 1.677 . . . . 0.0 109.793 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -132.55 138.14 47.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.37 144.47 48.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.106 0.955 . . . . 0.0 110.698 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.96 135.82 5.61 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 49.5 p-90 -139.21 173.71 11.27 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.056 -1.028 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.709 HG22 HG13 ' A' ' 94' ' ' VAL . 15.8 p -137.57 174.05 11.01 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.482 0.658 . . . . 0.0 110.073 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' A' ' 111' ' ' MET . 11.0 ptp -160.35 132.83 6.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 15.3 pt-20 -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -112.62 145.23 40.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -92.95 161.0 14.64 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -60.14 -21.92 62.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.655 -0.653 . . . . 0.0 110.323 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -85.31 -28.37 25.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.87 -8.84 7.64 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 113' ' ' LEU . 46.3 mt-10 -57.18 172.53 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.095 -1.238 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.665 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -147.29 112.13 5.39 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.111 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.1 tt -108.04 146.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.11 139.8 52.3 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.536 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -118.47 169.9 9.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.8 mtp -148.81 166.25 29.03 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.355 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' VAL . 4.9 m -149.0 151.75 35.08 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.434 0.635 . . . . 0.0 109.459 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.36 95.07 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -147.42 24.0 1.13 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.54 -0.725 . . . . 0.0 109.282 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -118.78 -178.75 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -157.61 117.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.841 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.4 t -98.38 120.08 38.18 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.536 ' OG1' HG22 ' A' ' 122' ' ' THR . 90.0 m -117.85 145.51 44.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.25 118.0 7.58 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.56 138.48 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.0 108.398 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.7 m-85 -127.13 123.84 37.74 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.226 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.73 140.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.25 125.69 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.239 -0.913 . . . . 0.0 111.137 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.593 179.645 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.501 1.969 0 N-CA-C 110.347 -0.674 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -159.86 122.33 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.749 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.3 m-85 -98.96 -2.42 37.46 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.704 -0.623 . . . . 0.0 109.366 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 t -72.15 117.71 14.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 111.936 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.6 -172.25 38.62 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 170.08 9.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.5 m95 -149.97 118.93 6.67 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.653 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -110.65 115.28 29.3 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.832 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.4 tt -56.67 158.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.01 0.91 . . . . 0.0 111.117 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -130.7 -33.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.421 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HB2' HD12 ' A' ' 10' ' ' ILE . 43.3 mtt85 -146.23 168.4 21.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 108.844 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.684 ' HB3' HD11 ' A' ' 9' ' ' ILE . 97.0 p -177.56 139.76 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.512 -0.743 . . . . 0.0 109.406 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.9 169.71 16.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.672 -0.642 . . . . 0.0 110.058 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 42.2 m-20 61.24 29.4 18.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.525 -0.735 . . . . 0.0 109.7 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.8 t80 -64.68 -63.64 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.0 109.074 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 5.1 pt-20 -60.53 -26.58 66.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.675 -0.641 . . . . 0.0 109.629 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -64.57 -41.48 96.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.6 tp -80.67 -13.24 59.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.0 -20.33 22.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.038 -1.038 . . . . 0.0 109.207 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.6 mmmm -84.23 -29.54 26.45 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 18' ' ' LEU . 14.3 p -78.61 -40.78 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.88 -53.1 29.25 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.139 0.971 . . . . 0.0 109.159 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.73 -148.72 20.8 Favored Glycine 0 N--CA 1.491 2.364 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.265 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -154.96 -36.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.982 -0.716 . . . . 0.0 110.418 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.37 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.865 . . . . 0.0 109.993 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 HG13 HH12 ' A' ' 29' ' ' ARG . 2.2 t -126.43 -48.24 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.362 -0.836 . . . . 0.0 109.705 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.55 ' HG2' HD11 ' A' ' 31' ' ' ILE . 1.5 ttt -67.2 -25.95 66.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.8 mm? -62.96 -28.83 70.35 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.697 -0.627 . . . . 0.0 110.647 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.5 mtp180 -87.71 -46.88 9.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 0.0 110.449 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -60.44 -30.77 69.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.505 -0.747 . . . . 0.0 110.656 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 27' ' ' MET . 80.5 mt -76.18 -27.34 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.474 -0.766 . . . . 0.0 109.188 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.2 -22.3 36.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.587 -0.696 . . . . 0.0 109.869 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.1 t -81.21 -43.41 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.86 85.38 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HB1' HG22 ' A' ' 57' ' ' THR . . . -63.0 -46.17 88.92 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.534 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.2 41.06 0.8 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.919 -0.488 . . . . 0.0 110.784 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -65.69 -32.73 74.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.908 -1.12 . . . . 0.0 108.293 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -159.11 70.54 3.47 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.937 ' HB3' HG23 ' A' ' 56' ' ' THR . 29.8 Cg_endo -73.92 135.2 20.9 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.897 1.731 . . . . 0.0 109.741 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -86.55 170.29 12.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.581 -0.7 . . . . 0.0 109.803 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 54' ' ' THR . 20.2 t -156.76 130.91 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.18 112.03 18.14 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.919 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.0 mt -99.21 136.13 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.657 0.741 . . . . 0.0 110.106 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.4 mttt -113.59 114.99 27.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 60.6 tt0 -98.87 117.15 32.71 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.1 -1.0 . . . . 0.0 110.9 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -118.21 52.72 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.47 -125.1 7.67 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -77.75 0.04 25.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.366 -1.079 . . . . 0.0 109.991 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.7 m -96.42 140.2 31.43 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.763 -1.21 . . . . 0.0 108.424 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.9 m-85 -136.02 116.57 13.82 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.85 0.834 . . . . 0.0 109.488 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.7 t80 -102.36 148.44 25.47 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.126 HD12 HD11 ' A' ' 63' ' ' ILE . 1.7 mt -144.46 105.59 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 120.937 -1.102 . . . . 0.0 111.275 -177.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.35 106.29 18.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 108.928 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 41' ' ' VAL . 14.4 m -98.17 144.61 27.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 108.559 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 118.79 12.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.852 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -97.44 -159.04 0.71 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.724 HG23 HG23 ' A' ' 58' ' ' VAL . 8.5 t -62.23 -43.09 99.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.063 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.724 HG23 HG23 ' A' ' 57' ' ' THR . 21.8 t -130.24 -6.57 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.529 -0.732 . . . . 0.0 111.892 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 -102.54 168.2 9.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.066 -1.021 . . . . 0.0 110.07 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 m -163.85 93.89 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.522 -0.736 . . . . 0.0 109.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 p -91.11 166.87 12.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.367 -0.833 . . . . 0.0 109.99 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.04 123.06 4.36 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.126 HD11 HD12 ' A' ' 52' ' ' ILE . 35.4 pt -123.06 167.59 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.49 128.98 3.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.184 -0.947 . . . . 0.0 109.26 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.68 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.4 p90 -162.09 -172.24 3.16 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.774 -1.17 . . . . 0.0 112.281 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -129.75 153.57 48.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.95 93.96 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.191 -0.943 . . . . 0.0 109.668 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.87 -26.44 1.3 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.741 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -122.82 157.68 31.92 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.321 -1.105 . . . . 0.0 110.079 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' HG2' HD22 ' A' ' 84' ' ' LEU . 30.6 mt-10 -86.63 168.08 13.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.12 173.33 14.47 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.708 -0.62 . . . . 0.0 109.398 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -102.68 143.11 32.76 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.8 pt-20 -162.34 -175.74 4.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.628 . . . . 0.0 109.433 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.92 157.63 16.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -91.88 -142.97 0.19 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.406 -0.809 . . . . 0.0 109.005 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 75' ' ' THR . 22.9 t -109.27 -19.56 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.785 -1.197 . . . . 0.0 110.649 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.676 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t0 -91.89 -44.52 8.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.557 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.99 45.1 0.06 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 0.6 OUTLIER -131.79 151.17 78.1 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 121.617 -0.931 . . . . 0.0 109.019 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.775 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.51 140.26 16.84 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.618 1.546 . . . . 0.0 110.677 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -160.94 141.72 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.657 -0.652 . . . . 0.0 109.606 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HB2' HD21 ' A' ' 100' ' ' LEU . 19.7 ttmt -87.03 116.26 24.96 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -99.54 166.39 11.17 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.499 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.09 153.07 40.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.68 HG21 ' CE2' ' A' ' 65' ' ' PHE . 12.0 t -145.03 126.65 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.861 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.39 155.46 33.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.517 ' CE2' HG21 ' A' ' 67' ' ' VAL . 82.5 m95 -78.0 173.62 11.98 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.78 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.29 -46.26 0.63 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.8 p -131.47 -153.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -78.91 -23.09 44.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.85 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -144.3 26.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 20.8 tttm -133.82 112.25 11.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.905 -1.122 . . . . 0.0 108.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.495 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 ptm -118.18 149.84 40.39 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.26 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -99.84 172.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.497 ' H ' HG12 ' A' ' 94' ' ' VAL . 46.4 t -147.78 137.78 22.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.818 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.98 163.48 12.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -160.23 135.41 7.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.563 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -141.22 148.41 39.86 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.69 167.3 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 0.0 110.773 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.775 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.3 mt -94.98 -8.81 35.85 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.66 155.29 31.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.53 -161.04 16.97 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -176.89 138.64 0.27 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.503 -0.999 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.25 -85.05 0.05 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.02 -176.83 2.79 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.91 1.74 . . . . 0.0 109.9 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -135.97 136.42 40.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.16 47.56 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.154 0.978 . . . . 0.0 110.966 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -162.92 136.27 5.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.3 p-90 -140.54 174.68 10.28 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.31 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 94' ' ' VAL . 12.3 p -138.83 171.21 14.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.598 0.713 . . . . 0.0 109.855 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.441 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 9.8 ptp -153.04 136.48 15.86 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -132.99 149.93 52.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.703 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.99 143.73 43.79 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.9 p -92.75 161.02 14.7 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.58 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -60.42 -21.67 62.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.624 -0.672 . . . . 0.0 110.214 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.42 -28.45 25.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.38 -0.825 . . . . 0.0 109.32 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.35 -9.84 7.34 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 113' ' ' LEU . 56.3 mt-10 -56.16 172.28 0.22 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.148 -1.207 . . . . 0.0 109.212 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.613 HD13 HD13 ' A' ' 43' ' ' ILE . 7.7 tt -146.84 111.46 5.25 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.405 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.06 156.45 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.72 133.67 32.56 Favored 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.354 -0.841 . . . . 0.0 109.515 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 166.76 11.23 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.448 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.4 mtp -144.93 163.13 35.09 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.243 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -147.01 151.17 36.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.407 0.622 . . . . 0.0 109.331 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.54 95.13 1.42 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.564 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.27 -79.12 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.63 23.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.519 -0.738 . . . . 0.0 109.319 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.1 m -118.22 -179.88 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.52 118.4 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.744 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.741 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.32 113.0 24.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.6 m -107.14 148.34 28.95 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.911 0.862 . . . . 0.0 109.985 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -152.81 119.02 5.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.0 138.82 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.571 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -126.53 131.07 51.67 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.3 139.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.4 mtm180 -49.47 125.58 11.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.262 -0.899 . . . . 0.0 111.21 -178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 111.59 179.473 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.973 0 N-CA-C 110.317 -0.686 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.65 141.03 0.15 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.116 0.96 . . . . 0.0 110.197 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.1 m-85 -104.49 -3.79 23.52 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.7 p -68.15 118.81 11.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 112.132 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.06 -173.33 38.37 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.2 m120 -95.75 170.22 9.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.22 122.86 7.98 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.814 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -114.36 114.03 25.34 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.79 HG21 ' HD2' ' A' ' 39' ' ' PRO . 10.3 tt -54.4 157.35 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.97 0.89 . . . . 0.0 111.46 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.778 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -130.72 -32.09 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.778 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -147.34 169.57 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 9' ' ' ILE . 93.3 p -176.94 160.84 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.429 -0.794 . . . . 0.0 109.824 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -157.45 166.58 32.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 110.016 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.28 29.67 18.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.965 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.4 t80 -64.19 -64.29 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.0 109.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 36.2 tt0 -60.4 -26.39 66.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.721 -0.612 . . . . 0.0 109.623 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -64.36 -41.56 96.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 0.0 109.922 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.736 HD22 ' HB2' ' A' ' 130' ' ' CYS . 46.5 tp -81.13 -12.84 59.14 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.1 -20.59 21.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.95 -1.094 . . . . 0.0 109.102 179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 2.2 mmmt -84.5 -30.05 25.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' A' ' 125' ' ' ALA . 14.5 p -77.4 -40.9 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.582 HD21 ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -67.41 -53.02 32.78 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.19 0.995 . . . . 0.0 109.075 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.63 21.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 t -150.91 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.861 -0.788 . . . . 0.0 110.343 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -58.21 -169.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.261 -0.899 . . . . 0.0 109.786 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG12 ' NH2' ' A' ' 29' ' ' ARG . 14.1 m -121.7 -43.59 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.594 -0.692 . . . . 0.0 110.121 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.402 ' N ' HG23 ' A' ' 26' ' ' VAL . 7.5 ttm -68.46 -28.02 66.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.753 . . . . 0.0 109.03 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -57.98 -50.29 73.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.734 -0.604 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -64.0 -44.46 92.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.712 . . . . 0.0 110.22 -178.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -59.87 -25.63 65.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.624 -0.672 . . . . 0.0 111.219 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -80.27 -28.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.165 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.43 -23.36 34.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.61 -0.681 . . . . 0.0 109.94 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.965 HG22 ' CD1' ' A' ' 15' ' ' PHE . 3.0 t -82.25 -47.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.24 96.82 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.49 37.39 0.57 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 p -63.69 -33.19 75.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.694 -1.254 . . . . 0.0 108.224 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -163.12 71.58 1.96 Allowed Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.79 ' HD2' HG21 ' A' ' 9' ' ' ILE . 33.3 Cg_endo -75.23 -176.31 2.85 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 122.033 1.822 . . . . 0.0 110.793 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -126.21 172.11 10.34 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 54' ' ' THR . 41.4 t -155.57 164.95 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.6 tt0 -153.72 112.4 3.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.599 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.6 mp -98.73 133.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 109.99 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.3 mttt -113.92 103.59 11.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 59.1 tt0 -97.49 127.18 43.24 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.143 -0.973 . . . . 0.0 111.156 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -126.54 55.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.05 -126.05 8.34 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.34 -0.07 24.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.434 -1.039 . . . . 0.0 110.148 178.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 m -97.48 140.64 31.63 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 120.745 -1.222 . . . . 0.0 108.545 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 94.1 m-85 -136.4 118.09 15.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.693 0.759 . . . . 0.0 109.547 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 7.8 t80 -102.47 145.78 29.06 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 HD11 ' A' ' 63' ' ' ILE . 3.9 mt -140.34 99.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 120.987 -1.071 . . . . 0.0 110.663 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -98.79 113.46 25.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.756 . . . . 0.0 109.764 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 41' ' ' VAL . 58.6 m -106.18 143.3 34.5 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.727 ' HB3' HG23 ' A' ' 60' ' ' THR . 2.2 p -148.8 123.44 9.82 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.837 . . . . 0.0 109.195 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.603 HG22 HG22 ' A' ' 57' ' ' THR . 62.0 m -97.96 -66.83 0.88 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.96 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.838 HG23 HG23 ' A' ' 58' ' ' VAL . 5.0 t -175.94 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.838 HG23 HG23 ' A' ' 57' ' ' THR . 25.3 t -107.16 -14.85 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -130.36 162.46 29.03 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.727 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.7 m -162.0 108.1 1.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -109.28 177.22 4.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.576 -0.703 . . . . 0.0 109.939 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 pt-20 -170.66 136.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.714 -0.616 . . . . 0.0 109.342 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 52' ' ' ILE . 28.8 pt -125.97 172.54 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.0 109.292 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.535 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -162.45 130.34 3.91 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.212 -0.93 . . . . 0.0 108.882 179.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.2 p90 -161.97 -172.72 3.37 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.313 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.37 152.79 48.54 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.726 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.23 95.69 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.205 -0.934 . . . . 0.0 109.768 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.89 1.57 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.911 -1.137 . . . . 0.0 110.666 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -111.2 154.91 23.71 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.302 -1.117 . . . . 0.0 110.065 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.459 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -86.46 167.38 14.72 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.0 p90 -162.43 173.28 14.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -0.772 . . . . 0.0 110.005 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.84 145.54 29.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.683 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.1 -177.8 5.98 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -99.82 155.51 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.713 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -91.14 -142.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.412 -0.805 . . . . 0.0 109.026 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HB ' HD21 ' A' ' 22' ' ' LEU . 24.5 t -110.3 -20.22 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.773 -1.205 . . . . 0.0 110.618 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.64 ' H ' HG23 ' A' ' 75' ' ' THR . 2.1 t70 -89.19 -41.91 11.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.78 45.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.713 ' H ' HG22 ' A' ' 75' ' ' THR . 4.8 mmm180 -131.91 151.51 78.64 Favored Pre-proline 0 N--CA 1.485 1.322 0 O-C-N 121.618 -0.931 . . . . 0.0 109.31 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.644 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.69 141.55 17.41 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.715 1.61 . . . . 0.0 110.482 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.2 p -161.21 141.07 10.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.676 -0.64 . . . . 0.0 109.772 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HB2' HD21 ' A' ' 100' ' ' LEU . 16.7 ttmm -90.5 115.22 27.48 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -103.04 176.43 5.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.754 -0.591 . . . . 0.0 110.136 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.5 tp -151.18 152.97 34.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.709 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.7 t -140.17 130.27 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.805 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -124.43 159.31 30.74 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.726 ' CD1' HG11 ' A' ' 67' ' ' VAL . 87.2 m95 -84.54 170.19 13.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 110.266 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.53 -46.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.7 p -131.63 -154.75 0.64 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -76.74 -24.44 53.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 109.677 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -144.49 27.07 1.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 21.2 tttm -130.81 108.1 9.61 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.918 -1.114 . . . . 0.0 107.995 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.541 ' HE1' HG13 ' A' ' 67' ' ' VAL . 1.1 ptp -115.84 148.85 39.47 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.63 0.729 . . . . 0.0 110.497 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 110' ' ' THR . 1.0 OUTLIER -103.03 171.01 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 85' ' ' VAL . 42.6 t -148.63 129.95 14.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.197 -0.939 . . . . 0.0 110.675 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -100.49 164.46 11.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.48 143.49 13.35 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.773 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -146.28 149.24 33.48 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.74 166.17 3.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.054 -1.029 . . . . 0.0 110.84 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.0 mt -98.54 -5.49 32.01 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -151.52 139.6 20.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 108.958 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.71 -159.19 42.97 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -176.86 140.59 0.33 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.492 -1.005 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.8 -84.66 0.05 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.53 -177.11 3.04 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.86 1.707 . . . . 0.0 110.12 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -136.11 135.8 39.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.97 145.67 46.56 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.119 0.961 . . . . 0.0 110.793 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.8 m -162.64 130.4 3.82 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -133.41 168.68 18.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.082 -1.011 . . . . 0.0 110.292 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.765 HG22 HG13 ' A' ' 94' ' ' VAL . 17.8 p -134.25 174.6 10.33 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.449 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 8.6 ptp -159.13 130.23 6.13 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -123.66 151.5 43.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.511 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.81 142.78 46.09 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.6 159.15 15.35 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.761 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -59.65 -21.59 60.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.592 -0.692 . . . . 0.0 110.234 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.38 -30.23 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.77 -9.48 6.79 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -56.67 171.8 0.29 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.146 -1.208 . . . . 0.0 109.08 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.8 tt -147.18 111.2 5.08 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.189 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.6 tt -105.24 156.41 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -135.76 153.89 51.41 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.461 -0.775 . . . . 0.0 109.302 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.64 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -136.12 169.05 18.24 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.492 ' O ' HG22 ' A' ' 129' ' ' VAL . 13.6 mtp -150.15 165.82 31.68 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.669 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 m -148.34 151.24 34.99 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.16 95.93 1.41 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.4 -79.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.13 23.87 1.17 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.539 -0.726 . . . . 0.0 109.311 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -117.77 -179.29 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.88 118.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.813 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.736 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -98.15 121.13 39.71 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.64 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.8 m -119.55 145.95 45.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.354 -0.841 . . . . 0.0 109.91 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -150.56 121.24 7.5 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.23 139.8 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.1 m-85 -128.3 126.77 41.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.89 139.03 31.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.3 mtm180 -49.07 125.62 10.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.212 -0.93 . . . . 0.0 111.289 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.699 179.684 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 110.34 -0.677 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -153.69 125.56 7.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.531 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.9 m-85 -99.39 -5.43 29.55 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.627 -0.67 . . . . 0.0 109.515 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 p -71.92 117.8 13.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.147 -0.97 . . . . 0.0 111.805 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.26 -173.58 39.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.0 m120 -95.61 172.27 8.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 177.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.1 m95 -150.6 124.51 9.25 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.643 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -116.46 113.7 23.2 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 6.3 tt -53.05 152.76 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.73 0.776 . . . . 0.0 111.183 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -131.16 -25.07 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.99 -0.444 . . . . 0.0 110.543 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.493 ' HB2' HD12 ' A' ' 10' ' ' ILE . 21.5 mtm-85 -152.42 -179.85 7.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 110.72 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 t 170.22 168.91 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.81 29.33 0.06 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.941 -1.1 . . . . 0.0 112.252 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -162.21 37.79 0.12 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.16 -0.962 . . . . 0.0 108.999 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.779 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -77.76 -63.33 1.41 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.562 -0.712 . . . . 0.0 109.558 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.3 mt-10 -57.52 -30.67 65.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.382 -0.824 . . . . 0.0 110.581 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -73.49 -30.58 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.243 -179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 130' ' ' CYS . 34.1 tp -78.71 -17.1 56.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.779 HD11 ' CE1' ' A' ' 15' ' ' PHE . 2.7 mt -90.25 -19.97 23.51 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 109.067 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 5.1 mtmt -81.14 -30.6 34.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG11 HD12 ' A' ' 18' ' ' LEU . 13.9 p -79.72 -41.4 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.977 0.894 . . . . 0.0 108.848 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.59 -50.94 61.43 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 122.081 0.943 . . . . 0.0 109.279 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.23 -153.01 24.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -150.42 -37.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.956 -0.732 . . . . 0.0 110.335 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -60.9 -159.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 1.6 t -127.93 -47.34 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 0.0 109.471 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.3 ttt -65.82 -30.42 71.05 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.1 mm? -60.18 -28.19 67.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.724 -0.61 . . . . 0.0 110.49 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -89.49 -44.95 9.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.379 -0.825 . . . . 0.0 110.145 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -61.56 -25.08 67.08 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.632 -0.667 . . . . 0.0 110.895 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.5 -26.73 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 108.914 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -81.09 -25.89 36.66 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.631 -0.668 . . . . 0.0 109.232 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.0 t -80.67 -45.64 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.13 85.69 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.99 49.03 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.73 50.62 1.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.854 -0.529 . . . . 0.0 110.467 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.4 p -61.99 -34.03 75.41 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.707 -1.246 . . . . 0.0 108.236 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -162.93 74.31 2.0 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.936 ' HB3' HG22 ' A' ' 56' ' ' THR . 32.9 Cg_endo -73.5 134.25 20.27 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.941 1.761 . . . . 0.0 111.267 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.08 177.3 7.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.651 ' CG2' HG23 ' A' ' 54' ' ' THR . 19.1 t -155.98 164.58 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -153.51 113.17 3.85 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.905 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -105.71 141.27 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.705 0.764 . . . . 0.0 110.676 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HE3' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -119.84 117.09 27.24 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 63.3 tt0 -99.04 118.17 35.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.115 -0.99 . . . . 0.0 110.996 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -119.69 45.8 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.31 -128.56 9.57 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.35 -3.48 30.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -1.066 . . . . 0.0 110.006 178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -96.45 133.86 40.35 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.81 -1.181 . . . . 0.0 108.142 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 94.8 m-85 -129.54 114.87 16.62 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.758 0.79 . . . . 0.0 109.7 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 14.4 t80 -99.67 148.02 24.79 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.066 HD12 HD11 ' A' ' 63' ' ' ILE . 1.5 mt -140.81 143.45 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.096 -1.002 . . . . 0.0 108.745 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -139.58 107.24 5.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.402 -0.811 . . . . 0.0 109.247 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.651 HG23 ' CG2' ' A' ' 41' ' ' VAL . 6.9 m -98.74 147.89 24.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -145.64 118.58 8.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.327 -0.858 . . . . 0.0 110.37 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 39' ' ' PRO . 76.1 p -98.87 -149.65 0.35 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 p -72.19 -41.94 66.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.928 -1.107 . . . . 0.0 110.286 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 58' ' ' VAL . 24.5 t -128.68 -6.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.437 -0.789 . . . . 0.0 111.649 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -104.94 165.6 10.96 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.122 -0.986 . . . . 0.0 110.271 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.1 m -163.82 99.87 0.88 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.655 -0.653 . . . . 0.0 109.281 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 156.49 18.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.449 -0.782 . . . . 0.0 109.877 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -151.05 103.08 3.01 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.066 HD11 HD12 ' A' ' 52' ' ' ILE . 38.8 pt -102.85 165.46 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.328 -0.857 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.18 129.15 3.76 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.075 -1.015 . . . . 0.0 109.201 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.69 ' CE2' HG21 ' A' ' 85' ' ' VAL . 48.3 p90 -161.48 -172.4 3.35 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.344 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -128.86 153.37 47.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.4 95.52 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.145 -0.972 . . . . 0.0 109.755 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.05 -33.89 1.58 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.672 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.99 154.99 23.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -1.088 . . . . 0.0 109.978 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.603 ' HG3' HD13 ' A' ' 84' ' ' LEU . 7.5 mp0 -86.12 168.02 14.41 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.65 175.27 11.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.0 109.567 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -104.33 144.67 31.31 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -177.71 5.93 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -99.6 155.47 17.58 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.9 t -93.26 -142.48 0.22 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.4 -0.812 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.572 ' N ' HG23 ' A' ' 75' ' ' THR . 24.9 t -111.39 -20.83 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 110.657 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' H ' HG23 ' A' ' 75' ' ' THR . 2.7 t0 -87.21 -39.23 15.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.186 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.31 44.82 0.14 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 35.2 mtp180 -132.36 151.82 78.97 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.739 -0.859 . . . . 0.0 109.311 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.81 142.13 17.54 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.603 1.535 . . . . 0.0 110.348 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.2 p -161.04 142.32 11.73 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.673 -0.642 . . . . 0.0 109.81 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -90.55 113.69 25.75 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.3 t -102.08 175.2 5.61 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.139 -178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 70' ' ' GLU . 50.6 tp -151.32 152.92 33.85 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.69 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.1 t -140.81 126.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.762 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -119.51 155.62 31.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.523 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.2 m95 -77.46 173.3 12.12 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.018 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.5 tp10 -136.07 -46.19 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.9 p -131.52 -152.61 0.51 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -78.06 -25.92 47.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -142.96 26.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 110.782 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 79.0 tttt -132.16 111.2 11.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.937 -1.102 . . . . 0.0 108.084 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.488 ' HE1' ' CZ2' ' A' ' 87' ' ' TRP . 1.4 ptm -117.94 149.58 40.67 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.388 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.749 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.66 172.61 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.505 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.7 t -149.13 128.71 13.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 0.0 110.731 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -99.9 163.5 12.42 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -160.35 142.15 12.65 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.963 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -146.82 148.92 32.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.521 HD22 ' CZ ' ' A' ' 79' ' ' ARG . 7.3 mt -58.94 166.49 1.96 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.985 . . . . 0.0 110.972 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.3 mt -97.44 -6.5 33.77 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -152.27 141.13 21.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 108.962 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.91 -159.78 39.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -176.8 141.19 0.35 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.503 -0.998 . . . . 0.0 109.665 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.68 -84.77 0.05 OUTLIER Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.04 -176.54 2.9 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.89 1.727 . . . . 0.0 110.022 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -136.08 137.59 41.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.41 145.3 48.41 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.101 0.953 . . . . 0.0 110.676 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 p -162.77 130.08 3.66 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -134.13 172.1 13.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.041 -1.037 . . . . 0.0 110.121 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.749 HG22 HG13 ' A' ' 94' ' ' VAL . 14.0 p -135.15 175.21 9.79 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.504 0.669 . . . . 0.0 109.804 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.4 ptp -158.08 133.8 9.06 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -131.81 147.68 52.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.386 -0.821 . . . . 0.0 109.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.96 143.17 38.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 160.29 15.72 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.648 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -60.19 -21.54 61.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.666 -0.646 . . . . 0.0 110.064 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.59 -29.81 25.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.97 -8.97 7.14 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.8 mp0 -58.11 174.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.061 -1.258 . . . . 0.0 109.223 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.698 HD13 HD13 ' A' ' 43' ' ' ILE . 7.0 tt -146.04 110.27 5.0 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.914 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.665 ' CD1' HG22 ' A' ' 133' ' ' VAL . 9.0 tt -106.11 146.32 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.76 141.96 51.44 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.639 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.49 171.99 7.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.477 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.3 mtp -152.75 165.11 36.35 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.583 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.23 152.99 39.26 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.48 97.46 1.21 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.627 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.95 -79.83 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.33 24.26 1.02 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.565 -0.709 . . . . 0.0 109.387 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.7 m -119.75 -179.72 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.83 117.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.374 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.59 ' HB2' HD22 ' A' ' 18' ' ' LEU . 6.4 t -98.93 133.95 42.47 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 98.0 m -125.61 125.73 43.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -122.38 101.54 7.56 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' A' ' 120' ' ' ILE . 48.8 t -68.18 136.95 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.403 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 28.3 m-85 -127.9 130.79 49.08 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.416 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.5 137.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -49.12 128.63 16.71 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.211 -0.931 . . . . 0.0 111.634 -178.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 tm-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.503 2.03 0 N-CA-C 110.685 -0.544 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.88 124.2 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.751 0.786 . . . . 0.0 110.213 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.556 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.6 m-85 -99.59 -2.74 34.9 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.634 -0.666 . . . . 0.0 109.441 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.3 p -70.53 118.5 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.944 . . . . 0.0 112.186 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.46 -172.08 38.46 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.77 170.48 9.29 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.888 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.23 122.17 7.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.609 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -114.13 114.49 26.13 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 12' ' ' SER . 11.4 tt -57.68 153.64 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.928 0.87 . . . . 0.0 111.326 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.731 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.1 pp -127.25 -31.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.731 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -144.26 173.08 12.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.338 -0.851 . . . . 0.0 108.842 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.63 ' HB2' HD11 ' A' ' 9' ' ' ILE . 11.8 t 179.94 165.29 1.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.303 -0.873 . . . . 0.0 109.715 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -159.99 163.12 34.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.748 -0.595 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 26.6 m-80 62.64 33.3 15.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.72 . . . . 0.0 109.719 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.949 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -75.7 -64.17 1.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 110.165 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 18.7 mt-10 -56.91 -33.82 67.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.486 -0.759 . . . . 0.0 110.869 -178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -70.71 -29.7 66.04 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.467 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' HB2' ' A' ' 130' ' ' CYS . 15.4 tp -77.61 -21.4 52.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.037 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.982 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.8 mt -88.99 -16.13 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.036 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -86.14 -32.6 21.2 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -75.14 -38.91 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.7 mp -69.28 -45.63 69.18 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.797 0.808 . . . . 0.0 109.476 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.8 -159.56 27.66 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.4 m -146.63 -38.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.963 -0.728 . . . . 0.0 110.051 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.0 t30 -61.28 -156.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.422 -0.799 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.45 -47.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.429 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.57 ' HG2' HD11 ' A' ' 31' ' ' ILE . 2.5 ttt -68.01 -27.98 67.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.8 mm? -59.94 -16.96 34.17 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.684 -0.635 . . . . 0.0 111.243 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.4 mpt_? -97.11 -50.14 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.009 . . . . 0.0 110.048 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -23.38 67.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.531 -0.73 . . . . 0.0 110.717 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.57 HD11 ' HG2' ' A' ' 27' ' ' MET . 74.3 mt -77.17 -28.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 108.768 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.982 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.91 -25.15 35.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 29' ' ' ARG . 13.5 t -76.06 -37.98 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.88 46.33 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.57 92.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -70.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t 48.51 52.62 13.41 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.497 0.665 . . . . 0.0 109.763 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 66.23 70.39 0.52 Allowed Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 56' ' ' THR . 31.0 Cg_endo -72.87 164.55 35.25 Favored 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 121.988 1.792 . . . . 0.0 111.027 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -106.36 173.77 6.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG22 HG23 ' A' ' 54' ' ' THR . 47.9 t -154.8 166.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.9 tt0 -154.38 110.24 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.888 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.8 mt -97.33 133.52 38.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.845 0.831 . . . . 0.0 110.298 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 6.8 mttm -107.94 93.79 4.72 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -97.72 125.53 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.4 -0.813 . . . . 0.0 110.373 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.45 59.36 1.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.64 -130.05 10.15 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.1 p30 -74.65 -2.42 26.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.394 -1.062 . . . . 0.0 110.209 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -96.93 137.05 36.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.571 -1.331 . . . . 0.0 108.269 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.648 ' CE1' ' HE3' ' A' ' 93' ' ' MET . 97.5 m-85 -135.35 125.97 27.05 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.69 0.757 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.563 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.3 t80 -108.74 143.06 38.37 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -130.05 106.54 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 106.21 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.723 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 41' ' ' VAL . 15.1 m -99.22 146.82 25.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 108.896 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 2.7 p -142.69 134.31 26.62 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.433 -0.792 . . . . 0.0 110.323 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -115.53 -65.1 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.87 0.843 . . . . 0.0 108.829 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.75 HG23 HG23 ' A' ' 58' ' ' VAL . 3.1 t 175.78 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.75 HG23 HG23 ' A' ' 57' ' ' THR . 35.0 t -118.66 -10.2 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.663 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -101.12 -85.89 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.994 -1.066 . . . . 0.0 109.322 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 3.2 m 67.81 90.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.887 . . . . 0.0 110.104 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.8 p -119.65 171.44 8.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -160.93 157.09 25.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.337 -0.852 . . . . 0.0 110.412 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.717 HD11 HG13 ' A' ' 52' ' ' ILE . 29.7 pt -144.22 170.72 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.56 -0.712 . . . . 0.0 109.157 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.563 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -161.6 134.65 6.23 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.8 p90 -162.96 -173.23 3.37 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.289 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -127.88 153.0 47.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.72 95.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.257 -0.902 . . . . 0.0 109.666 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.85 -24.57 1.63 Allowed Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.815 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -124.57 155.57 38.84 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.296 -1.12 . . . . 0.0 110.229 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -86.18 168.02 14.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.47 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 14.7 p90 -162.58 174.35 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.617 -0.677 . . . . 0.0 109.717 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -103.04 144.93 30.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.24 -176.04 4.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.655 -0.653 . . . . 0.0 109.513 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.88 156.98 16.84 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.721 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.58 -143.82 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.375 -0.828 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.58 ' N ' HG23 ' A' ' 75' ' ' THR . 23.4 t -111.59 -21.07 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.825 -1.172 . . . . 0.0 110.876 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.594 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -89.03 -39.84 13.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.649 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.52 46.89 0.09 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 75' ' ' THR . 7.4 mmm180 -136.3 151.99 74.28 Favored Pre-proline 0 C--N 1.306 -1.308 0 O-C-N 121.759 -0.847 . . . . 0.0 109.353 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.643 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -79.07 141.76 16.73 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.764 1.643 . . . . 0.0 110.512 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 p -161.01 142.26 11.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.666 -0.646 . . . . 0.0 109.707 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.579 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.8 ttpt -86.68 117.65 25.58 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.5 t -99.24 164.48 12.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.845 -0.534 . . . . 0.0 109.731 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' CA ' ' A' ' 70' ' ' GLU . 62.5 tp -144.24 153.81 42.44 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG21 ' CE2' ' A' ' 65' ' ' PHE . 29.0 t -147.09 130.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 118.5 -1.28 . . . . 0.0 112.108 -178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -125.04 157.85 35.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.544 ' NE1' HG21 ' A' ' 67' ' ' VAL . 79.8 m95 -79.82 172.26 14.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -135.68 -45.85 0.67 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.8 p -131.47 -154.18 0.61 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -76.59 -25.13 53.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.666 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -144.36 26.88 1.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.384 -0.823 . . . . 0.0 110.817 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 51.9 tttt -130.75 110.86 11.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.901 -1.124 . . . . 0.0 108.154 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.657 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.5 ptp -115.5 146.96 41.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.446 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.746 HG13 HG22 ' A' ' 110' ' ' THR . 3.2 t -100.18 170.72 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.467 ' H ' HG12 ' A' ' 94' ' ' VAL . 52.2 t -146.38 140.94 26.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.739 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.7 162.8 14.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -160.21 135.74 8.22 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 149.97 41.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.87 167.63 2.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.113 -0.992 . . . . 0.0 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.643 HD12 ' HB2' ' A' ' 80' ' ' PRO . 46.7 mt -98.64 -6.55 29.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.02 143.66 19.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 108.883 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.77 -162.66 34.14 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.99 139.38 0.38 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.44 -1.035 . . . . 0.0 109.975 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.18 -85.84 0.05 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.86 -176.94 2.88 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.811 1.674 . . . . 0.0 109.721 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -135.29 139.67 44.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.14 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.139 0.971 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.3 m -163.01 139.1 7.1 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -142.64 173.25 11.71 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.037 -1.039 . . . . 0.0 110.568 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.746 HG22 HG13 ' A' ' 94' ' ' VAL . 16.0 p -137.58 172.65 12.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.909 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.408 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 11.6 ptp -160.11 136.34 8.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 11.6 pt-20 -135.41 154.76 51.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.237 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.551 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -112.71 144.36 42.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.7 p -91.18 159.95 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.406 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.73 -19.45 50.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.591 -0.693 . . . . 0.0 110.45 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.98 -28.54 21.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.584 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.3 -9.16 7.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 113' ' ' LEU . 60.8 mt-10 -57.63 172.67 0.34 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.082 -1.246 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.803 HD13 HD13 ' A' ' 43' ' ' ILE . 8.0 tt -147.13 112.15 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.251 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 14.3 tt -108.52 148.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -131.35 137.99 48.99 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.363 -0.836 . . . . 0.0 109.684 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.54 170.75 8.02 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.8 mtp -147.65 168.19 22.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.573 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.1 m -151.85 150.94 30.67 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.712 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.9 94.21 1.42 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.534 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.9 -78.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -146.88 24.62 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 125' ' ' ALA . 19.7 m -118.13 -179.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.4 t -157.33 119.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.827 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.875 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.46 123.25 43.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.4 m -116.61 148.04 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -151.94 120.37 6.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 50.3 t -82.38 137.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.005 . . . . 0.0 108.351 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 25.8 m-85 -127.28 124.99 40.09 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.351 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.64 139.85 28.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.12 125.72 11.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.176 -0.952 . . . . 0.0 111.193 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.942 -1.028 . . . . 0.0 111.607 179.622 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.0 0 N-CA-C 110.455 -0.633 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -154.2 123.67 6.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.556 -0.715 . . . . 0.0 109.661 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.5 m-85 -98.86 -1.78 39.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.712 -0.617 . . . . 0.0 109.361 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.9 t -70.9 116.61 11.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.144 -0.972 . . . . 0.0 112.011 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.45 -172.83 39.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.8 168.23 10.78 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.524 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.7 m95 -151.67 124.65 8.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.566 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -118.83 112.59 19.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.436 HD12 ' HD2' ' A' ' 132' ' ' ARG . 5.7 tt -54.25 143.92 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.626 0.727 . . . . 0.0 110.882 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.61 -24.39 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.999 -0.438 . . . . 0.0 109.936 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -143.05 174.24 10.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.282 -0.886 . . . . 0.0 110.069 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 t 170.2 168.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.62 28.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.91 -1.119 . . . . 0.0 111.654 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.53 29.65 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -178.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.869 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.05 -66.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.338 -0.851 . . . . 0.0 108.752 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' HG21 ' A' ' 33' ' ' VAL . 15.4 mt-10 -55.97 -31.1 62.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -61.29 -38.46 86.88 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.129 0.49 . . . . 0.0 110.469 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.675 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.3 tp -80.17 -17.45 52.41 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.717 -0.614 . . . . 0.0 110.137 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.953 HD13 ' HB3' ' A' ' 32' ' ' ALA . 8.3 mt -89.67 -17.65 27.96 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.088 -1.007 . . . . 0.0 109.013 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -84.05 -32.19 24.98 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.3 p -76.28 -40.21 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -67.84 -46.28 72.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.838 0.827 . . . . 0.0 109.6 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.16 -157.01 27.16 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.341 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.8 m -148.78 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 122.037 -0.684 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.7 t30 -61.65 -156.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.474 -0.767 . . . . 0.0 109.132 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.97 -47.09 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.932 . . . . 0.0 109.695 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 ttp -68.16 -28.36 67.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mm? -59.49 -23.79 63.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.811 -0.556 . . . . 0.0 110.64 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -91.33 -46.91 7.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.905 . . . . 0.0 109.727 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -62.15 -20.88 64.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.664 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.54 -28.92 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.261 -0.9 . . . . 0.0 108.925 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.953 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.95 -26.05 34.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 29' ' ' ARG . 9.8 t -76.48 -41.21 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -33.62 64.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 57' ' ' THR . . . -63.99 -40.92 97.47 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.554 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.43 -66.19 0.59 Allowed 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.566 -0.708 . . . . 0.0 109.289 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m 52.83 57.64 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 66.71 73.61 0.38 Allowed Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' HG22 ' A' ' 56' ' ' THR . 28.0 Cg_endo -70.91 153.39 63.69 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 122.167 1.912 . . . . 0.0 111.003 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -105.28 174.02 6.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.698 -0.626 . . . . 0.0 109.464 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.691 HG22 HG23 ' A' ' 54' ' ' THR . 47.2 t -154.86 165.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.1 tt0 -149.7 112.47 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -97.81 133.88 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.806 0.812 . . . . 0.0 110.264 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -114.05 106.29 14.23 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 61.2 tt0 -97.55 126.43 42.83 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.078 -1.014 . . . . 0.0 111.36 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -125.76 55.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.96 -126.94 8.62 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.53 -0.33 22.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 110.12 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 m -97.22 139.98 32.38 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 120.72 -1.237 . . . . 0.0 108.498 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.7 m-85 -134.57 118.27 17.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.536 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 9.2 t80 -102.78 144.98 30.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 63' ' ' ILE . 3.3 mt -140.67 101.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -98.92 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.572 -0.705 . . . . 0.0 110.049 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.691 HG23 HG22 ' A' ' 41' ' ' VAL . 12.8 m -99.38 141.01 32.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.55 118.92 17.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 110.434 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -99.2 -170.75 1.96 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 58' ' ' VAL . 5.7 t -52.68 -42.66 64.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.571 -0.706 . . . . 0.0 111.33 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.519 HG23 HG23 ' A' ' 57' ' ' THR . 39.9 t -130.09 -6.83 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.395 -0.815 . . . . 0.0 112.168 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -109.32 173.13 6.46 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.011 -1.056 . . . . 0.0 110.447 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.4 m -164.69 95.17 0.71 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -95.66 175.43 6.54 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.3 pm0 -171.35 142.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.586 -0.696 . . . . 0.0 110.289 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.045 HD11 HD12 ' A' ' 52' ' ' ILE . 31.7 pt -129.04 171.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.553 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.89 130.58 4.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.178 -0.951 . . . . 0.0 109.217 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 85' ' ' VAL . 44.5 p90 -162.07 -172.17 3.14 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.158 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.74 153.35 48.28 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.35 89.26 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.143 -0.973 . . . . 0.0 109.661 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.1 -23.26 0.99 Allowed Glycine 0 N--CA 1.495 2.632 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.938 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -122.02 154.94 36.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.55 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.4 mt-10 -86.26 165.56 16.37 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.18 173.93 13.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.491 -0.756 . . . . 0.0 109.866 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -102.28 146.74 27.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.5 pt-20 -162.53 -175.49 4.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.646 -0.659 . . . . 0.0 109.408 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -101.01 155.65 17.86 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.9 t -93.89 -143.75 0.24 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.354 -0.841 . . . . 0.0 109.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 23.3 t -112.67 -19.87 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.807 -1.183 . . . . 0.0 110.638 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.631 ' H ' HG23 ' A' ' 75' ' ' THR . 2.5 t70 -88.04 -40.89 13.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.44 44.77 0.1 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.698 ' H ' HG22 ' A' ' 75' ' ' THR . 1.6 mmm180 -135.98 154.13 77.42 Favored Pre-proline 0 C--N 1.308 -1.229 0 O-C-N 121.654 -0.91 . . . . 0.0 109.095 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.23 144.61 20.92 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.7 1.6 . . . . 0.0 110.616 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.5 p -161.24 141.75 11.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.688 -0.633 . . . . 0.0 109.616 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.677 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.4 tttp -88.02 117.21 26.73 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.0 t -99.94 168.11 10.07 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.207 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' HG2' ' A' ' 70' ' ' GLU . 62.0 tp -150.61 152.99 34.89 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.9 t -144.08 135.88 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.236 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -128.3 159.23 35.93 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.598 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.6 m95 -84.97 167.3 16.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 110.062 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 4.4 tp10 -129.79 -45.61 1.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.6 p -131.83 -154.17 0.6 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -77.31 -25.38 51.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -142.67 26.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.898 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 46.4 tttm -131.41 104.96 7.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 108.302 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.2 ptp -112.22 147.55 35.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.581 -0.699 . . . . 0.0 110.221 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 110' ' ' THR . 1.6 t -103.57 169.05 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.9 t -144.55 140.76 29.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.169 -0.957 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 1.0 OUTLIER -109.55 160.73 15.99 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 176.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -158.95 139.6 12.57 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.433 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -143.53 150.56 39.07 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -60.42 166.39 3.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 110.905 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 82' ' ' LYS . 41.7 mt -99.74 -4.24 31.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.95 130.68 15.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 108.672 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.49 -159.46 45.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -176.82 141.57 0.37 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.469 -1.018 . . . . 0.0 109.713 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.29 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.46 -176.78 2.91 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.804 1.669 . . . . 0.0 109.752 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -131.95 142.8 49.74 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.2 146.32 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.519 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.85 126.75 2.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -130.86 163.94 26.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.136 -0.977 . . . . 0.0 110.39 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 94' ' ' VAL . 21.6 p -130.02 166.44 20.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.548 ' HE3' HD11 ' A' ' 52' ' ' ILE . 11.2 ptp -150.01 117.75 6.22 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 151.98 28.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.433 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.499 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -117.06 143.12 46.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.4 p -94.35 178.46 5.61 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.932 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -75.76 -24.15 56.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.641 -0.662 . . . . 0.0 110.448 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.73 -19.64 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.741 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 119.41 -5.13 13.27 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.1 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.48 177.99 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 118.924 1.362 . . . . 0.0 108.439 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.605 HD11 ' HD2' ' A' ' 3' ' ' PHE . 7.8 tt -153.4 115.89 4.43 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.965 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.27 154.59 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.767 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -136.61 109.2 7.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 131' ' ' THR . 0.1 OUTLIER -99.09 167.21 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 129' ' ' VAL . 38.4 mtp -145.93 164.35 32.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.552 -0.717 . . . . 0.0 109.603 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.89 152.67 39.08 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.73 94.94 1.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.537 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 78.52 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -148.11 23.72 1.06 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.57 -0.706 . . . . 0.0 109.382 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.3 m -120.23 -179.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.46 117.72 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.456 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.675 ' CB ' HD22 ' A' ' 18' ' ' LEU . 10.7 t -99.37 111.7 24.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.443 HG23 HG23 ' A' ' 122' ' ' THR . 75.1 m -99.26 152.74 19.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.866 0.841 . . . . 0.0 109.469 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.436 ' HD2' HD12 ' A' ' 9' ' ' ILE . 27.7 mtm180 -151.88 94.83 2.02 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.61 128.74 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.5 m-85 -115.82 133.88 55.58 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.491 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.85 137.75 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.479 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.9 mtm180 -47.38 124.22 6.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.387 -0.821 . . . . 0.0 111.468 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.755 179.816 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.502 1.983 0 N-CA-C 110.207 -0.728 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -143.15 115.17 8.31 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.708 0.766 . . . . 0.0 110.436 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CD2' HD23 ' A' ' 113' ' ' LEU . 3.5 m-85 -111.58 0.54 16.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.8 p -72.95 117.5 14.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 112.13 -177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.86 -171.74 37.86 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.8 m120 -95.68 169.39 10.05 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.93 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.6 m95 -150.38 118.6 6.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.591 -177.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -110.51 113.74 26.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.736 HG21 ' HD2' ' A' ' 39' ' ' PRO . 11.1 tt -55.61 157.78 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.921 0.867 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.798 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -129.81 -32.85 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.497 179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.798 ' HB2' HD12 ' A' ' 10' ' ' ILE . 4.1 ttp180 -146.13 170.33 16.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 108.812 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.6 t 177.64 141.24 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.0 109.317 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -136.58 178.44 7.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.701 -0.625 . . . . 0.0 109.875 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 72.2 m-20 58.86 26.59 15.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.536 -0.728 . . . . 0.0 109.99 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.5 t80 -65.55 -62.95 1.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.822 . . . . 0.0 109.072 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 8.4 pt-20 -58.73 -29.13 66.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.643 -0.661 . . . . 0.0 109.565 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.01 -39.61 93.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.738 -0.601 . . . . 0.0 110.235 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.748 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.6 tp -82.02 -13.97 56.6 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.708 -0.62 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -91.34 -20.27 22.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.931 -1.106 . . . . 0.0 109.11 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 6.5 mtmt -83.32 -29.58 28.18 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.501 HG11 HD12 ' A' ' 18' ' ' LEU . 14.6 p -78.79 -41.82 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.66 -56.39 10.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 122.381 1.086 . . . . 0.0 108.523 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -103.59 -145.84 15.6 Favored Glycine 0 N--CA 1.489 2.221 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.79 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 23' ' ' GLY . 19.0 m -156.29 -37.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.706 . . . . 0.0 110.364 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.51 -175.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.204 -0.935 . . . . 0.0 110.126 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 1.5 t -116.3 -44.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.554 -0.716 . . . . 0.0 109.574 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.449 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.1 ttp -65.41 -24.75 67.29 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.8 mm? -64.11 -40.14 95.56 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.675 -0.64 . . . . 0.0 110.57 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 33' ' ' VAL . 10.3 mtp180 -70.54 -48.33 55.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.379 -0.825 . . . . 0.0 110.139 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -55.72 -46.65 77.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 -178.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.449 HD11 ' HG2' ' A' ' 27' ' ' MET . 48.7 mt -67.1 -26.07 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.418 -0.801 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.25 -21.95 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.61 -0.681 . . . . 0.0 110.353 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.6 t -82.12 -44.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.52 -39.29 91.63 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.63 -53.28 56.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.93 37.71 0.61 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.868 -0.52 . . . . 0.0 110.511 178.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 t -66.02 -34.09 77.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.796 -1.19 . . . . 0.0 108.501 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -157.27 69.68 4.37 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.736 ' HD2' HG21 ' A' ' 9' ' ' ILE . 29.7 Cg_endo -74.24 137.37 23.47 Favored 'Trans proline' 0 C--N 1.322 -0.822 0 C-N-CA 121.948 1.765 . . . . 0.0 110.2 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -85.57 166.86 15.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.583 -0.698 . . . . 0.0 109.37 -179.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.704 ' CG2' HG23 ' A' ' 54' ' ' THR . 16.0 t -154.34 127.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -117.9 111.02 18.45 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.5 mt -98.33 132.16 43.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.728 0.775 . . . . 0.0 110.334 -178.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 2.2 mttm -106.48 94.15 4.98 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -96.68 123.85 40.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.344 -0.848 . . . . 0.0 110.366 -177.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -132.61 68.17 1.51 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.11 -130.59 10.26 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.1 p30 -75.43 -1.6 24.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.357 -1.084 . . . . 0.0 110.388 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -95.98 139.28 32.4 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.701 -1.249 . . . . 0.0 109.003 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CE1' ' NE2' ' A' ' 45' ' ' GLN . 98.9 m-85 -136.31 118.81 15.85 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.753 0.787 . . . . 0.0 108.951 179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 16.2 t80 -104.41 150.85 24.17 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -149.35 104.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.895 -1.128 . . . . 0.0 111.288 -176.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -103.23 102.44 12.41 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.704 HG23 ' CG2' ' A' ' 41' ' ' VAL . 32.5 m -98.09 127.1 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.849 . . . . 0.0 109.359 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 0.8 OUTLIER -121.11 130.48 53.76 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.799 -179.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -98.64 -165.45 1.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.745 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 58' ' ' VAL . 6.8 t -57.57 -42.58 83.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.564 -0.71 . . . . 0.0 110.338 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.6 HG23 HG23 ' A' ' 57' ' ' THR . 22.3 t -134.35 -2.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.534 -0.729 . . . . 0.0 111.87 -178.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -109.44 -178.42 3.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.92 -1.113 . . . . 0.0 109.804 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' THR . 12.1 m -162.13 162.17 28.41 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.692 -0.63 . . . . 0.0 109.677 -179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 60' ' ' THR . 3.1 p -156.86 156.41 33.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.45 109.19 2.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 110.247 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 52' ' ' ILE . 40.0 pt -113.5 164.32 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p-10 -162.44 132.25 4.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.131 -0.981 . . . . 0.0 109.497 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.764 ' CE2' HG21 ' A' ' 85' ' ' VAL . 50.7 p90 -161.87 -171.42 2.89 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.224 1.011 . . . . 0.0 111.83 -178.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HG3' ' HG3' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -132.85 154.72 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.28 93.9 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.09 -1.006 . . . . 0.0 109.657 -178.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.26 -19.46 0.63 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.683 -1.246 . . . . 0.0 111.298 179.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -134.9 160.7 37.42 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.121 -1.223 . . . . 0.0 111.205 -179.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.769 ' HG3' HD13 ' A' ' 84' ' ' LEU . 3.7 mt-10 -86.63 164.83 16.6 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.1 p90 -162.2 173.62 14.02 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -102.1 144.53 30.56 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.617 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -162.36 -176.67 5.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.62 . . . . 0.0 109.363 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.27 157.3 16.7 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.4 t -93.05 -144.7 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -0.867 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 ' N ' HG23 ' A' ' 75' ' ' THR . 23.2 t -107.75 -22.2 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.856 -1.152 . . . . 0.0 110.571 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.637 ' H ' HG23 ' A' ' 75' ' ' THR . 19.9 t0 -86.62 -47.71 8.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 108.955 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -132.1 151.69 78.86 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.671 -0.899 . . . . 0.0 109.226 -179.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.608 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.3 Cg_endo -78.35 140.5 17.36 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.618 1.545 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.3 p -161.05 142.38 11.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.664 -0.648 . . . . 0.0 109.626 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HB2' HD21 ' A' ' 100' ' ' LEU . 4.5 tttt -88.25 118.56 27.93 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -99.57 168.08 10.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.496 0.665 . . . . 0.0 110.459 -178.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.769 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.2 tp -148.0 149.95 33.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.764 HG21 ' CE2' ' A' ' 65' ' ' PHE . 5.3 t -141.78 134.68 28.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 118.814 -1.155 . . . . 0.0 112.111 -177.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' A' ' 67' ' ' VAL . 8.9 pttt -130.47 161.83 30.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.582 ' CE2' HG21 ' A' ' 67' ' ' VAL . 85.0 m95 -85.44 170.27 12.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -133.63 -45.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -132.9 -153.18 0.53 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.97 -23.78 44.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.917 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -143.0 22.26 1.92 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.834 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 73.1 tttt -130.78 111.81 12.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.832 -1.167 . . . . 0.0 108.639 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.489 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 3.7 ptp -116.0 154.97 28.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.601 -0.687 . . . . 0.0 109.981 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 110' ' ' THR . 1.8 t -108.92 168.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -145.41 132.81 20.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -104.02 158.11 16.64 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -154.76 142.04 19.51 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.91 -177.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -144.0 150.87 38.94 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.59 168.17 2.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 110.783 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 80' ' ' PRO . 33.2 mt -99.79 -5.29 28.85 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -153.99 138.7 17.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 108.84 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.63 -158.79 39.56 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -176.33 140.55 0.39 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.475 -1.015 . . . . 0.0 109.888 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.83 -86.7 0.06 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.96 -176.7 2.75 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.822 1.681 . . . . 0.0 109.877 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -134.31 137.24 44.07 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.69 145.81 47.64 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.123 0.963 . . . . 0.0 110.854 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.41 131.56 4.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -134.98 169.78 16.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.364 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 94' ' ' VAL . 22.7 p -134.34 170.17 16.13 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.5 0.667 . . . . 0.0 109.817 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.552 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 6.6 ptm -153.05 124.38 7.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -119.05 152.39 36.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.431 -0.793 . . . . 0.0 110.185 -178.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -116.77 144.43 44.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.8 p -89.87 167.12 13.08 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.802 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -63.81 -20.36 65.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.647 -0.658 . . . . 0.0 110.687 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.35 -32.66 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.06 -13.24 2.84 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.704 -1.236 . . . . 0.0 111.336 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -53.11 170.89 0.08 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 118.828 1.314 . . . . 0.0 109.345 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.9 tt -147.36 114.23 6.11 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.725 -178.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.19 158.62 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.81 134.37 30.08 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.393 -0.817 . . . . 0.0 109.57 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.0 170.04 8.57 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.496 ' O ' HG22 ' A' ' 129' ' ' VAL . 17.6 mtp -147.8 164.53 33.34 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.178 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.4 m -148.46 151.97 36.11 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.448 0.642 . . . . 0.0 109.434 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.35 96.88 1.45 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.518 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.86 -79.79 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -147.44 24.41 1.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.559 -0.713 . . . . 0.0 109.268 178.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.2 m -118.87 -179.29 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.78 118.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.651 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.748 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -98.33 115.57 28.72 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.6 m -110.8 147.63 34.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 110.158 -179.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 120.74 6.34 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.78 142.78 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 108.958 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.433 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -129.39 133.28 47.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.59 139.31 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 177.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.1 125.29 10.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.244 -0.91 . . . . 0.0 111.33 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.602 179.466 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.009 0 N-CA-C 110.306 -0.69 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -152.84 124.28 7.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.747 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.702 ' HB3' HG21 ' A' ' 43' ' ' ILE . 6.3 m-85 -99.37 -10.92 21.66 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.712 -0.617 . . . . 0.0 109.576 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 t -65.71 115.39 5.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.219 -0.925 . . . . 0.0 111.819 -177.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.78 -172.71 39.73 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.455 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 5.9 m120 -95.71 168.49 10.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 178.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.926 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.7 m95 -151.72 124.63 8.57 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.375 -177.288 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -118.91 112.95 20.29 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.571 HD12 ' HB3' ' A' ' 132' ' ' ARG . 6.6 tt -57.11 140.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.41 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.2 pp -120.95 -23.18 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.9 -0.5 . . . . 0.0 110.055 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.506 ' HB2' HD12 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -139.42 172.81 12.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t 171.29 168.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.15 29.97 0.12 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.948 -1.095 . . . . 0.0 111.713 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.09 33.55 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.285 -0.884 . . . . 0.0 109.082 -178.51 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -65.7 -66.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -0.784 . . . . 0.0 108.979 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 6.9 pt-20 -57.5 -26.73 61.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -64.3 -39.66 94.36 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.65 -0.656 . . . . 0.0 109.706 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' A' ' 130' ' ' CYS . 4.4 tp -80.17 -15.3 57.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.697 -0.627 . . . . 0.0 110.016 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 32' ' ' ALA . 7.6 mt -90.05 -19.8 23.96 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.976 179.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmt -84.98 -28.15 25.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.9 p -79.82 -41.09 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.716 HD21 HG13 ' A' ' 76' ' ' VAL . 4.4 mp -65.93 -53.71 35.79 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.04 0.924 . . . . 0.0 109.114 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 -151.62 23.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.56 -42.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.981 -0.717 . . . . 0.0 109.407 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -56.37 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.793 . . . . 0.0 109.681 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.618 HG12 ' NH1' ' A' ' 29' ' ' ARG . 3.2 m -113.2 -43.77 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.412 -0.805 . . . . 0.0 110.116 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.03 -26.69 66.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.532 -0.73 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -57.61 -45.26 85.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.681 -0.637 . . . . 0.0 110.491 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.904 ' O ' HG23 ' A' ' 33' ' ' VAL . 4.2 mtp180 -67.34 -40.95 85.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -62.75 -24.38 67.67 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.678 -0.639 . . . . 0.0 110.838 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 28' ' ' LEU . 34.2 mt -78.67 -28.81 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.062 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.952 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -24.92 34.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 109.237 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.9 t -79.22 -38.72 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.67 -35.65 62.81 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.03 -37.58 81.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -67.1 -67.7 0.43 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t 49.87 50.46 18.38 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm 66.3 74.19 0.37 Allowed Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.6 Cg_endo -71.72 146.21 48.09 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 122.01 1.807 . . . . 0.0 110.797 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -92.56 175.48 6.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.765 -0.584 . . . . 0.0 109.778 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.547 ' CG2' HG23 ' A' ' 54' ' ' THR . 24.7 t -155.31 165.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.9 tt0 -149.88 112.87 4.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.926 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.7 mt -99.85 140.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.806 0.812 . . . . 0.0 110.443 -178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 1.9 mttt -119.14 114.37 22.36 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 57.1 tt0 -98.9 111.61 23.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.0 110.786 -178.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -115.57 47.95 1.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.18 -127.57 9.07 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.4 p30 -74.85 -3.28 31.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.444 -1.033 . . . . 0.0 110.048 178.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 m -96.39 134.9 38.97 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.689 -1.257 . . . . 0.0 108.309 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.9 m-85 -131.37 119.2 21.34 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.875 0.845 . . . . 0.0 109.22 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 8.0 t80 -104.61 133.16 49.92 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.791 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 mm -115.45 137.18 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.1 tttt -132.4 98.65 4.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.0 108.704 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.547 HG23 ' CG2' ' A' ' 41' ' ' VAL . 17.8 m -98.45 145.37 26.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.349 -0.845 . . . . 0.0 109.446 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.59 136.42 24.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.853 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -106.28 -66.54 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.848 0.832 . . . . 0.0 109.511 -179.629 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.614 HG23 HG23 ' A' ' 58' ' ' VAL . 2.9 t -179.61 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.614 HG23 HG23 ' A' ' 57' ' ' THR . 46.4 t -113.77 -10.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -124.01 164.01 20.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.299 -0.876 . . . . 0.0 109.06 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.6 m -163.49 106.7 1.0 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.678 -0.639 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 152.83 19.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.409 -0.807 . . . . 0.0 109.123 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HG3' ' CG ' ' A' ' 53' ' ' LYS . 1.2 mp0 -150.98 101.7 2.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.563 -0.711 . . . . 0.0 109.735 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD11 HG13 ' A' ' 52' ' ' ILE . 26.2 pt -104.71 167.35 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.632 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.78 132.49 5.07 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.483 -0.761 . . . . 0.0 109.064 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.3 p90 -161.88 -172.46 3.29 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.061 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.45 154.27 46.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.27 95.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -33.77 1.68 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.712 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -109.42 153.77 23.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.367 -1.078 . . . . 0.0 109.977 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' CA ' HD13 ' A' ' 84' ' ' LEU . 20.1 mt-10 -85.96 166.95 15.51 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.24 173.3 14.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.875 -178.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -103.13 145.04 30.52 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -162.11 -178.21 6.24 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.573 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.62 155.2 17.72 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 5.8 t -91.66 -152.2 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 0.0 109.331 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.716 HG13 HD21 ' A' ' 22' ' ' LEU . 14.7 p -99.29 -20.99 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.992 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.716 ' H ' HG23 ' A' ' 75' ' ' THR . 1.8 t70 -88.61 -50.86 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.211 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.06 44.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 3.0 mmm-85 -130.67 152.01 79.72 Favored Pre-proline 0 N--CA 1.484 1.271 0 O-C-N 121.613 -0.933 . . . . 0.0 109.127 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.631 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.54 141.05 17.36 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.581 1.521 . . . . 0.0 110.431 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 p -161.07 142.02 11.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 109.697 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.7 ttmm -90.65 115.08 27.48 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -102.95 176.66 5.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.275 -178.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD13 ' CA ' ' A' ' 70' ' ' GLU . 63.4 tp -152.36 152.15 31.72 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 65' ' ' PHE . 6.5 t -140.87 125.54 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.543 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -120.47 156.0 32.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.525 ' NE1' HG21 ' A' ' 67' ' ' VAL . 83.8 m95 -77.91 172.28 13.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.805 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 6.9 tp10 -134.52 -46.61 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.9 p -129.27 -152.79 0.53 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.17 -24.98 47.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -143.3 25.68 1.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 29.0 tttm -131.06 108.29 9.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.82 -1.175 . . . . 0.0 108.211 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.506 ' HE3' HG13 ' A' ' 67' ' ' VAL . 1.6 ptm -114.47 148.21 38.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.366 -0.834 . . . . 0.0 110.239 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.861 HG13 HG22 ' A' ' 110' ' ' THR . 2.4 t -99.66 172.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.502 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.6 t -148.37 129.81 14.82 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.21 141.35 12.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.9 -178.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -145.75 148.4 32.94 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 110.872 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 80' ' ' PRO . 35.6 mt -96.98 -7.09 33.94 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -154.18 146.31 23.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.839 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.73 -162.51 34.23 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -176.94 140.14 0.3 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -1.033 . . . . 0.0 109.798 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.92 -84.79 0.05 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.93 -176.79 2.8 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.883 1.722 . . . . 0.0 109.957 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -137.74 139.22 39.99 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.24 146.04 47.65 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.072 0.939 . . . . 0.0 110.669 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m -162.61 131.27 4.07 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -135.85 170.05 16.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.968 -1.082 . . . . 0.0 110.362 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 94' ' ' VAL . 18.5 p -133.55 165.33 25.14 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.462 0.649 . . . . 0.0 109.395 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.437 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.3 ptm -152.72 124.86 8.04 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 120' ' ' ILE . 14.5 pt-20 -129.98 158.8 38.58 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.965 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -113.65 145.2 41.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 p -92.38 161.26 14.73 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.425 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -60.72 -18.62 55.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.528 -0.732 . . . . 0.0 110.515 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -88.39 -27.02 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.17 -7.87 8.58 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 113' ' ' LEU . 27.1 mt-10 -59.97 172.33 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.087 -1.243 . . . . 0.0 108.579 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.684 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.1 tt -145.64 113.11 6.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.065 -178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' CG2' ' CG ' ' A' ' 112' ' ' GLU . 12.5 tt -99.76 151.9 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.764 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -133.87 112.14 11.05 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.438 ' N ' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -99.22 166.51 11.19 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.1 mtp -145.4 163.97 32.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.543 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 129' ' ' VAL . 4.9 m -146.12 152.35 39.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.593 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.56 95.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.548 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 78.08 -79.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -147.64 23.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.7 m -120.25 -179.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.16 117.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.594 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.825 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.7 t -99.6 112.64 24.84 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.1 m -99.2 153.81 18.64 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.847 0.832 . . . . 0.0 109.139 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.571 ' HB3' HD12 ' A' ' 9' ' ' ILE . 36.5 mtm180 -151.42 93.6 1.91 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.54 127.39 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 132' ' ' ARG . 37.7 m-85 -114.79 130.34 56.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.239 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.24 138.31 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 2.3 mtm180 -47.57 124.12 6.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.307 -0.871 . . . . 0.0 111.391 -178.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.702 179.907 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.979 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -154.67 122.22 5.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.531 -0.73 . . . . 0.0 109.794 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.837 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.3 m-85 -99.59 -18.08 17.52 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -60.65 116.21 4.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 111.827 -177.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.33 -173.06 39.43 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -96.03 169.53 9.91 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.537 ' CH2' ' HB2' ' A' ' 119' ' ' LEU . 98.5 m95 -151.95 126.21 9.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.718 -176.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -117.36 113.08 21.59 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.54 HD13 ' C ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -61.59 140.99 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.711 0.767 . . . . 0.0 110.236 -178.929 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 11' ' ' ARG . 2.5 pp -126.36 -22.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.597 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' CG ' HD12 ' A' ' 10' ' ' ILE . 1.9 mmm180 -133.22 167.29 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.159 -0.963 . . . . 0.0 110.442 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 t 170.05 167.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -161.04 29.3 0.14 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.019 -1.05 . . . . 0.0 111.289 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.85 34.3 0.13 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -64.06 -65.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.534 -0.729 . . . . 0.0 109.235 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.2 mt-10 -58.65 -26.44 63.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.429 -0.795 . . . . 0.0 109.138 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.11 -38.12 89.92 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.717 -0.614 . . . . 0.0 109.841 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD22 ' CB ' ' A' ' 130' ' ' CYS . 3.5 tp -81.58 -16.28 52.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.686 -0.634 . . . . 0.0 110.033 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' HB3' ' A' ' 32' ' ' ALA . 9.4 mt -89.67 -19.25 25.07 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.23 -0.988 . . . . 0.0 108.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -85.84 -29.09 24.01 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.651 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 125' ' ' ALA . 14.9 p -78.5 -41.25 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.0 -52.51 48.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.001 0.905 . . . . 0.0 108.905 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.32 -147.58 19.63 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 25' ' ' ASN . 30.4 m -154.91 -41.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.927 -0.749 . . . . 0.0 109.531 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.464 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.6 t30 -57.68 -171.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.393 -0.817 . . . . 0.0 109.536 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' NH1' ' A' ' 29' ' ' ARG . 7.0 m -116.14 -43.91 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 110.077 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.81 -29.52 68.71 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.4 mm? -55.39 -46.31 76.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.0 mtp180 -64.49 -39.75 94.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.498 -0.751 . . . . 0.0 109.429 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -63.41 -15.68 58.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.779 -0.575 . . . . 0.0 111.22 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mm -84.2 -30.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 108.709 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.99 -25.36 32.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.0 t -80.4 -44.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.49 85.71 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -48.95 77.65 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HA ' ' CG2' ' A' ' 56' ' ' THR . . . -49.87 -72.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.954 -0.466 . . . . 0.0 110.439 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t 47.39 48.56 16.41 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.574 0.702 . . . . 0.0 109.171 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.2 mttp 71.19 73.23 0.26 Allowed Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -177.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.6 Cg_endo -71.4 -179.54 3.72 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.053 1.836 . . . . 0.0 110.623 -178.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -123.36 172.56 8.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.464 -0.773 . . . . 0.0 110.401 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 54' ' ' THR . 41.2 t -155.31 166.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 tm-20 -155.47 111.33 3.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 108.768 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.837 HG21 ' HB3' ' A' ' 3' ' ' PHE . 2.2 mp -96.48 143.16 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.964 0.888 . . . . 0.0 110.151 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 2.7 mttm -119.73 108.66 14.69 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.42 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.3 tt0 -98.52 117.41 32.89 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.05 . . . . 0.0 110.993 -178.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -119.43 45.92 2.02 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.44 -127.41 9.13 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.3 p30 -73.93 -3.05 26.66 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -1.079 . . . . 0.0 110.045 178.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.6 m -96.73 133.98 40.58 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.623 -1.298 . . . . 0.0 108.196 -179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.5 m-85 -130.41 122.86 28.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.763 0.792 . . . . 0.0 109.164 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.2 t80 -106.03 140.46 38.99 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.835 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.95 110.88 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -107.79 100.56 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 41' ' ' VAL . 17.8 m -99.65 143.57 29.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 0.0 109.01 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.8 p -156.56 125.88 6.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 109.478 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 57' ' ' THR . 19.6 m -99.51 -64.77 1.01 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.705 -0.622 . . . . 0.0 110.021 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.771 HG23 HG23 ' A' ' 58' ' ' VAL . 3.8 t 179.94 -41.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.771 HG23 HG23 ' A' ' 57' ' ' THR . 28.2 t -109.12 -16.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -127.74 162.42 26.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.444 -0.785 . . . . 0.0 108.984 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 55' ' ' SER . 88.0 m -162.71 115.75 1.66 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.66 -0.65 . . . . 0.0 109.301 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.6 p -106.76 160.87 15.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -155.04 136.62 14.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 109.314 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.835 HD11 HG13 ' A' ' 52' ' ' ILE . 27.2 pt -138.81 168.23 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.554 -0.716 . . . . 0.0 109.394 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.513 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -161.51 132.78 5.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.5 p90 -162.05 -173.61 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 118.948 -1.101 . . . . 0.0 112.095 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -127.94 154.25 45.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.43 93.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.069 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.15 -23.64 1.58 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.727 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.87 156.99 35.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.279 -1.13 . . . . 0.0 110.119 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.593 ' HG3' HD13 ' A' ' 84' ' ' LEU . 5.1 mt-10 -86.61 169.58 12.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.693 -0.629 . . . . 0.0 109.357 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 11.8 p90 -162.41 174.24 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.371 -178.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -111.43 143.11 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' OE1' ' CD2' ' A' ' 71' ' ' PHE . 5.4 pm0 -162.43 -168.66 1.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.449 0.642 . . . . 0.0 109.341 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -99.9 159.52 15.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -94.77 -144.05 0.25 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 109.02 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 24.1 t -107.33 -19.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.841 -1.162 . . . . 0.0 110.74 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.708 ' H ' HG23 ' A' ' 75' ' ' THR . 2.2 t0 -93.24 -44.93 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.605 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.17 45.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.739 ' H ' HG22 ' A' ' 75' ' ' THR . 4.6 mmm180 -132.67 152.57 80.17 Favored Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.634 -0.921 . . . . 0.0 109.232 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -78.73 140.41 16.48 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.707 1.605 . . . . 0.0 110.471 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.5 p -160.76 143.41 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.632 -0.667 . . . . 0.0 109.822 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.786 ' HB2' HD21 ' A' ' 100' ' ' LEU . 18.0 ttmt -90.9 120.3 31.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.2 t -103.52 168.43 9.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.671 -0.643 . . . . 0.0 110.299 -178.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HG3' ' A' ' 70' ' ' GLU . 46.8 tp -147.54 153.2 39.17 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 65' ' ' PHE . 13.3 t -145.46 126.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.962 -178.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -120.2 155.54 32.95 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.58 ' CD1' HG11 ' A' ' 67' ' ' VAL . 79.4 m95 -77.89 173.88 11.66 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.857 0.837 . . . . 0.0 110.27 -179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 3.2 tp10 -136.73 -45.98 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -131.83 -153.41 0.55 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -25.6 52.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 110.042 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -143.93 27.38 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 110.817 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 9.3 tttt -132.39 110.73 10.76 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.448 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -117.41 149.86 39.85 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.285 -179.229 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 2.7 t -99.43 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.0 t -147.71 141.12 25.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.976 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.06 162.3 14.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -160.27 135.52 8.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.82 -178.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -142.47 154.21 44.34 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.21 169.38 5.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.041 -1.037 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.786 HD21 ' HB2' ' A' ' 82' ' ' LYS . 54.1 mt -101.47 -5.64 25.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.38 135.11 12.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.904 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.78 -160.46 37.62 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -175.86 139.2 0.39 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.426 -1.044 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.42 -88.38 0.09 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.13 -176.78 2.75 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.677 1.585 . . . . 0.0 109.368 178.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -131.53 141.31 49.7 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.94 145.02 48.85 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.141 0.972 . . . . 0.0 110.686 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -162.96 136.75 6.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 56.8 p-90 -144.54 175.57 10.04 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.522 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 7.8 p -139.61 171.83 13.68 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.499 0.666 . . . . 0.0 109.636 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 93' ' ' MET . 8.8 ptp -153.56 139.29 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -136.94 150.18 48.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 109.522 -178.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.1 140.91 48.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.464 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.2 p -89.72 160.15 16.72 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.471 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -60.18 -20.59 59.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.579 -0.701 . . . . 0.0 110.29 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.18 -29.74 24.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.232 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.52 -9.31 6.9 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -57.34 171.9 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.108 -1.231 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.577 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.2 tt -144.73 107.95 4.56 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.973 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.44 ' CD1' HG22 ' A' ' 133' ' ' VAL . 12.0 tt -103.4 147.65 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.72 145.33 51.91 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.467 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -120.55 162.34 19.77 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.185 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 129' ' ' VAL . 22.0 mtp -143.99 162.1 37.05 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.324 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 129' ' ' VAL . 7.2 m -145.89 152.41 39.42 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.73 97.24 1.3 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.489 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.78 -79.2 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.12 23.85 0.94 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.5 -0.75 . . . . 0.0 109.506 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -120.2 179.34 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.98 116.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.63 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.875 ' CB ' HD22 ' A' ' 18' ' ' LEU . 8.2 t -100.73 113.7 26.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.699 -0.625 . . . . 0.0 109.576 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.0 m -103.11 128.92 49.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.413 -0.805 . . . . 0.0 109.312 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -126.56 102.89 7.3 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 120' ' ' ILE . 57.5 t -67.19 132.59 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 9' ' ' ILE . 23.8 m-85 -122.08 121.69 37.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.513 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.08 140.24 22.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.8 mtm180 -49.18 125.31 10.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.269 -0.894 . . . . 0.0 111.303 -178.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.667 179.582 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.501 1.966 0 N-CA-C 110.324 -0.683 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -175.36 126.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.691 . . . . 0.0 109.784 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.8 m-85 -99.16 -15.17 19.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 t -63.17 115.54 4.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -0.819 . . . . 0.0 111.597 -177.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.04 -172.04 39.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.514 -1.835 . . . . 0.0 108.514 178.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -96.14 169.2 10.12 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.842 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.1 120.89 7.04 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.619 -177.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -112.75 112.22 23.56 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HB ' ' CE1' ' A' ' 134' ' ' TYR . 9.3 tt -56.0 141.67 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 121.667 0.746 . . . . 0.0 110.842 -178.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 11' ' ' ARG . 2.2 pp -121.71 -23.55 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.959 -0.463 . . . . 0.0 110.171 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.598 ' HG3' HD12 ' A' ' 10' ' ' ILE . 18.6 mtt-85 -143.73 170.64 15.48 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.296 -0.877 . . . . 0.0 110.393 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t 170.65 167.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.02 31.83 0.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 111.988 -179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -162.13 29.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.075 -1.016 . . . . 0.0 109.803 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.97 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.59 -60.03 3.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.799 . . . . 0.0 109.775 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' HG21 ' A' ' 33' ' ' VAL . 24.3 mt-10 -58.09 -29.07 65.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 111.283 -178.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HG2' ' CA ' ' A' ' 14' ' ' ASN . 1.7 pt-20 -72.63 -27.39 62.11 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.739 -1.184 . . . . 0.0 110.734 -178.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.8 HD22 ' CB ' ' A' ' 130' ' ' CYS . 2.2 tp -83.34 -18.81 37.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB3' ' A' ' 32' ' ' ALA . 14.1 mt -90.25 -16.18 29.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.11 -0.994 . . . . 0.0 109.094 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -85.8 -33.01 21.49 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.634 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.8 p -75.09 -40.53 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.8 mp -66.95 -48.06 69.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.883 0.849 . . . . 0.0 108.921 179.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.48 -148.11 21.09 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 25' ' ' ASN . 24.3 m -154.8 -42.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.825 -0.809 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 24' ' ' VAL . 4.3 t30 -57.14 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 0.0 109.66 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.698 HG12 ' NH1' ' A' ' 29' ' ' ARG . 2.5 m -112.47 -43.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.813 . . . . 0.0 110.096 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -27.12 65.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.5 mm? -56.29 -48.13 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.629 -0.669 . . . . 0.0 110.871 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.881 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.793 . . . . 0.0 110.213 -178.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.23 -23.49 64.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 111.615 -178.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 48.1 mm -82.78 -27.5 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.052 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.42 -26.41 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.554 -0.716 . . . . 0.0 109.265 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -79.1 -46.66 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.92 -34.1 75.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 57' ' ' THR . . . -63.62 -44.95 92.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' HB3' ' HE2' ' A' ' 15' ' ' PHE . . . -64.46 -66.96 0.47 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.4 -0.812 . . . . 0.0 109.161 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 p 51.83 61.61 3.13 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.87 70.85 0.46 Allowed Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.972 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.2 Cg_endo -71.53 139.73 34.9 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 122.102 1.868 . . . . 0.0 110.857 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -87.39 176.5 7.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 HG23 ' A' ' 54' ' ' THR . 25.5 t -154.86 165.67 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.5 tt0 -154.05 113.2 3.72 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.842 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.3 mp -100.17 149.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.759 0.79 . . . . 0.0 110.19 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HE3' ' CE1' ' A' ' 51' ' ' TYR . 4.3 mttt -129.01 106.4 8.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 66.7 tt0 -98.22 120.44 38.64 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 111.191 -177.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -123.76 49.14 1.77 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -130.17 10.14 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.62 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -75.15 -2.96 30.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.419 -1.048 . . . . 0.0 110.201 178.747 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -97.43 118.59 34.25 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.857 -1.152 . . . . 0.0 108.782 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 85.3 m-85 -114.11 127.57 55.98 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.867 0.842 . . . . 0.0 109.126 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' O ' HD13 ' A' ' 52' ' ' ILE . 19.8 t80 -109.58 147.13 33.54 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.792 HG13 HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -133.46 138.07 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.234 -0.916 . . . . 0.0 108.636 -178.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.28 103.66 5.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.568 HG23 HG22 ' A' ' 41' ' ' VAL . 6.8 m -98.41 143.13 29.19 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.7 p -140.46 118.14 11.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.206 -179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.972 HG22 ' HB3' ' A' ' 39' ' ' PRO . 70.5 p -99.17 -158.52 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 58' ' ' VAL . 6.7 t -56.2 -45.62 79.78 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 0.0 110.863 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 57' ' ' THR . 22.0 t -133.07 -7.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.33 -0.857 . . . . 0.0 111.974 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 ttp-105 -98.03 166.27 11.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.014 -1.053 . . . . 0.0 109.777 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 55' ' ' SER . 9.4 m -163.21 94.69 0.82 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.562 -0.711 . . . . 0.0 109.603 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -85.27 158.99 20.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -155.8 100.75 2.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 0.0 109.86 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.792 HD11 HG13 ' A' ' 52' ' ' ILE . 24.5 pt -101.78 168.27 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.516 -0.74 . . . . 0.0 109.33 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.509 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.8 p-10 -163.02 135.3 5.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.438 -0.789 . . . . 0.0 109.603 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.584 ' CE2' HG21 ' A' ' 85' ' ' VAL . 42.2 p90 -162.61 -171.82 2.89 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.35 1.071 . . . . 0.0 112.358 -178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -129.79 153.24 48.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.637 HG22 ' HE1' ' A' ' 93' ' ' MET . 0.2 OUTLIER -82.44 95.5 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.157 -0.964 . . . . 0.0 109.542 -179.135 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.98 -31.65 1.45 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.684 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -117.09 157.34 26.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -1.077 . . . . 0.0 110.127 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG2' HD22 ' A' ' 84' ' ' LEU . 17.7 mt-10 -86.05 169.42 13.19 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.9 p90 -162.06 172.85 15.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.823 -179.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -104.11 144.35 31.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.25 -176.86 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.99 158.73 15.62 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.6 t -92.6 -144.07 0.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.418 -0.801 . . . . 0.0 109.109 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -106.42 -21.61 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.857 -1.152 . . . . 0.0 110.611 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.675 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 t70 -89.51 -46.93 8.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.414 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.47 44.71 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 75' ' ' THR . 3.9 mmm180 -129.95 152.41 79.9 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.572 -0.958 . . . . 0.0 108.994 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.7 Cg_endo -78.83 140.69 16.48 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 121.696 1.597 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.05 141.81 11.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.514 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.2 ttpm? -88.2 117.07 26.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.417 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 4.1 t -99.63 166.53 11.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.847 -0.533 . . . . 0.0 109.809 -178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' HG2' ' A' ' 70' ' ' GLU . 52.1 tp -145.83 155.41 42.89 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.3 t -146.46 129.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 118.588 -1.245 . . . . 0.0 112.088 -178.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HA ' HG12 ' A' ' 67' ' ' VAL . 2.7 ptpp? -123.85 161.74 24.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CD1' HG11 ' A' ' 67' ' ' VAL . 83.9 m95 -84.29 171.38 12.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.499 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.7 tp10 -136.12 -45.31 0.64 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -132.78 -154.51 0.62 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.19 -26.49 56.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.786 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -143.68 29.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.794 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 28.5 tttt -132.3 109.26 9.76 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.637 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.2 ptp -115.09 147.69 39.88 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.665 0.745 . . . . 0.0 110.04 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 110' ' ' THR . 2.9 t -99.88 172.04 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.504 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.4 t -146.79 141.88 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.922 . . . . 0.0 110.951 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -109.72 162.04 14.83 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -160.45 133.87 6.82 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.597 -178.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 150.05 39.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.07 167.3 1.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.869 -178.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD12 ' HB2' ' A' ' 80' ' ' PRO . 37.2 mt -94.35 -9.28 36.34 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -156.93 156.28 32.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 108.927 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.31 -160.15 17.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -176.24 139.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.484 -1.01 . . . . 0.0 109.837 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.64 -84.13 0.05 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.54 -177.05 3.0 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 121.938 1.758 . . . . 0.0 110.177 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -139.74 137.9 35.48 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.37 145.89 49.18 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.109 0.957 . . . . 0.0 110.831 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.7 m -162.76 135.48 5.64 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.405 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.4 p-90 -141.92 175.62 9.58 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.942 -1.099 . . . . 0.0 110.686 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.684 HG22 HG13 ' A' ' 94' ' ' VAL . 11.4 p -138.01 173.23 11.85 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.479 0.657 . . . . 0.0 109.987 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.509 ' HE3' ' CD2' ' A' ' 3' ' ' PHE . 8.5 ptm -157.17 126.63 6.06 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -124.65 153.75 41.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -178.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.569 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.82 142.73 46.16 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.032 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.9 p -91.2 160.78 15.36 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.525 -179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -60.21 -21.0 61.23 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.599 -0.688 . . . . 0.0 110.457 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.07 -28.31 24.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -8.46 7.52 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 113' ' ' LEU . 47.1 mt-10 -58.19 171.66 0.53 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.121 -1.223 . . . . 0.0 109.032 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.814 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -144.28 109.77 5.2 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.433 -0.792 . . . . 0.0 109.963 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.2 tt -104.35 150.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -132.27 145.25 51.17 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.479 -179.097 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.408 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -121.65 169.26 10.88 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.523 ' O ' HG22 ' A' ' 129' ' ' VAL . 36.1 mtp -150.3 165.87 31.7 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.51 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.5 m -147.81 152.53 37.82 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.431 0.634 . . . . 0.0 109.367 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -160.17 97.92 1.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.607 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.57 -79.34 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.23 24.77 0.91 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.527 -0.733 . . . . 0.0 109.252 178.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.0 m -120.89 -179.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.2 t -156.36 118.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.754 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.8 ' CB ' HD22 ' A' ' 18' ' ' LEU . 4.5 t -99.67 118.81 37.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 122' ' ' THR . 98.5 m -111.37 130.38 55.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.908 . . . . 0.0 109.55 -179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -129.77 103.95 7.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 136.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 23.1 m-85 -125.88 127.47 46.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.499 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.12 139.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 177.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.7 mtm180 -49.03 125.35 10.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.272 -0.893 . . . . 0.0 111.219 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.599 179.574 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.978 0 N-CA-C 110.28 -0.7 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -163.77 124.41 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 109.754 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.2 m-85 -98.86 -3.91 34.28 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.9 p -72.13 119.98 17.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.112 -0.992 . . . . 0.0 112.194 -177.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.74 -173.56 37.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 8.8 m120 -95.22 171.77 8.52 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 177.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.917 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.9 126.11 9.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.336 -176.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -116.28 111.52 20.25 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -62.86 140.64 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.607 0.718 . . . . 0.0 109.711 -179.378 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.13 -23.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.19 162.77 32.02 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.195 -0.941 . . . . 0.0 110.745 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p 178.26 168.88 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 14' ' ' ASN . 2.6 pt-20 -161.35 26.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.91 -1.119 . . . . 0.0 111.443 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 0.0 OUTLIER -161.65 29.06 0.13 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.488 -0.757 . . . . 0.0 108.986 -179.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.897 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -64.56 -64.76 0.79 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 7.3 tt0 -57.0 -28.74 62.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.19 -35.96 82.69 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.773 -0.579 . . . . 0.0 110.375 -179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.671 HD22 ' CB ' ' A' ' 130' ' ' CYS . 6.5 tp -82.46 -17.34 45.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.637 -0.665 . . . . 0.0 110.363 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD11 ' CE1' ' A' ' 15' ' ' PHE . 8.1 mt -90.61 -18.29 25.41 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.763 179.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.4 mmmm -85.32 -29.54 24.44 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.7 p -77.69 -39.46 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -69.03 -46.56 67.61 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.781 0.801 . . . . 0.0 110.008 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 -156.58 27.14 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.708 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 m -149.67 -36.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.985 -0.715 . . . . 0.0 110.477 -179.434 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -62.86 -148.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.473 -0.767 . . . . 0.0 109.466 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.28 -46.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.661 -1.274 . . . . 0.0 109.151 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.7 ttt -67.59 -33.52 75.17 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.7 mm? -57.31 -24.36 54.5 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.811 -0.555 . . . . 0.0 110.544 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.892 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.7 mtt180 -92.69 -48.4 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -0.817 . . . . 0.0 110.181 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -63.93 -16.87 62.5 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.549 -0.719 . . . . 0.0 111.447 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.6 mm -85.7 -28.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.944 . . . . 0.0 108.634 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.829 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.9 -25.73 34.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.8 t -80.17 -48.22 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.16 60.19 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.785 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.68 57.06 4.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.722 -0.611 . . . . 0.0 110.68 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -66.27 -36.22 82.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.7 -1.25 . . . . 0.0 107.793 178.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -155.14 72.51 5.68 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.75 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 33.5 Cg_endo -72.37 163.16 39.47 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.138 1.892 . . . . 0.0 111.168 -178.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -117.37 173.41 6.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.696 -0.627 . . . . 0.0 109.668 -179.424 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 54' ' ' THR . 55.2 t -155.4 165.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 41' ' ' VAL . 29.5 tt0 -152.52 109.12 3.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.917 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.5 mt -97.98 135.78 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.667 0.746 . . . . 0.0 110.22 -178.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -114.33 111.44 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.878 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 66.1 tt0 -98.2 121.93 40.74 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.031 -1.043 . . . . 0.0 110.974 -178.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -123.02 51.72 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.04 -127.96 9.16 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.9 p30 -74.97 -2.0 25.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -1.046 . . . . 0.0 110.124 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -96.51 134.69 39.4 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.724 -1.235 . . . . 0.0 108.12 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CE2' ' HE1' ' A' ' 93' ' ' MET . 97.6 m-85 -130.09 116.69 18.86 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.931 0.872 . . . . 0.0 109.416 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.6 t80 -102.29 148.2 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.655 HD12 HD11 ' A' ' 63' ' ' ILE . 1.2 mt -145.45 101.32 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.991 -1.068 . . . . 0.0 110.459 -177.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 3.3 ttmt -99.47 113.74 26.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.673 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 41' ' ' VAL . 29.4 m -101.42 143.29 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 115.45 11.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 109.955 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -98.47 -171.7 2.18 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.518 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.872 HG23 HG23 ' A' ' 58' ' ' VAL . 8.3 t -58.95 -37.55 77.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.671 -0.643 . . . . 0.0 111.186 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.872 HG23 HG23 ' A' ' 57' ' ' THR . 22.1 t -126.23 -7.34 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.339 -0.85 . . . . 0.0 112.161 -177.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -116.4 172.23 7.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.876 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.5 m -165.33 94.9 0.64 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.8 p -103.7 176.0 5.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 1.6 pt-20 -171.34 120.7 0.5 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.743 -0.598 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 73' ' ' GLU . 41.2 pt -109.01 171.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.6 p-10 -162.58 134.61 5.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.165 -0.96 . . . . 0.0 109.361 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.666 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.1 p90 -161.95 -171.43 2.87 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.395 1.093 . . . . 0.0 112.5 -178.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -129.76 152.66 49.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.3 95.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -178.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.28 -35.14 1.58 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.681 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -110.56 155.33 22.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -1.065 . . . . 0.0 109.999 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HG2' HD22 ' A' ' 84' ' ' LEU . 32.8 mt-10 -86.16 169.2 13.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.567 -0.708 . . . . 0.0 109.245 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.8 p90 -162.08 173.92 13.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.874 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -105.63 144.04 32.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.0 OUTLIER -162.24 -177.34 5.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.641 -0.662 . . . . 0.0 109.298 -179.526 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -99.96 155.95 17.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.5 t -92.86 -143.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' N ' HG23 ' A' ' 75' ' ' THR . 28.6 t -110.92 -20.44 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.789 -1.195 . . . . 0.0 110.608 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.62 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 t70 -88.02 -40.99 13.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.92 . . . . 0.0 109.26 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.16 44.69 0.1 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.696 ' H ' HG22 ' A' ' 75' ' ' THR . 4.9 mmm180 -133.02 151.89 78.75 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.619 -0.93 . . . . 0.0 109.323 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.732 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.97 141.76 16.91 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.737 1.625 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -161.03 143.26 12.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.734 -0.604 . . . . 0.0 109.46 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -88.67 117.16 27.44 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.9 t -99.78 166.36 11.13 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.283 0.564 . . . . 0.0 109.749 -178.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG2' ' A' ' 70' ' ' GLU . 63.2 tp -148.77 150.76 33.65 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.666 HG21 ' CE2' ' A' ' 65' ' ' PHE . 10.7 t -141.92 127.18 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.024 -177.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.73 156.03 28.97 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.617 ' CD1' HG11 ' A' ' 67' ' ' VAL . 75.8 m95 -76.87 -175.04 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 0.0 110.576 -178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -142.68 -53.76 0.4 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.0 p -131.36 -152.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.54 -24.15 45.81 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 110.003 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -138.82 22.26 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 0.0 111.167 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -130.49 129.65 43.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.746 -1.221 . . . . 0.0 108.325 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.465 ' CE ' ' CH2' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -134.96 151.09 50.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.918 -179.622 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.752 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -103.31 171.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.503 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.2 t -147.91 133.2 18.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.3 -0.875 . . . . 0.0 110.82 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 4.7 pt-20 -105.95 153.28 22.2 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -151.36 140.53 21.24 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.939 -177.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -144.92 148.45 33.89 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.11 168.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.049 -1.032 . . . . 0.0 110.886 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.2 mt -93.78 -10.1 35.29 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.95 160.19 35.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 108.772 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.74 -161.58 22.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -176.72 138.62 0.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.427 -1.043 . . . . 0.0 109.941 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -162.94 -85.42 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -84.91 -176.73 2.54 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.932 1.755 . . . . 0.0 110.142 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -139.97 138.8 35.82 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.81 146.01 47.92 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.071 0.939 . . . . 0.0 110.778 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.8 m -162.38 129.89 3.84 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -136.39 171.05 15.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.092 -1.005 . . . . 0.0 110.608 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.752 HG22 HG13 ' A' ' 94' ' ' VAL . 13.3 p -134.06 176.0 8.98 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.472 0.653 . . . . 0.0 109.884 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.4 ' CE ' ' HG3' ' A' ' 93' ' ' MET . 3.0 ptt? -160.23 124.07 3.62 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -120.06 146.6 45.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.679 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -108.92 143.52 38.05 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.101 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.9 p -92.73 160.94 14.74 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.676 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.39 -22.67 63.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.667 -0.646 . . . . 0.0 110.21 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.49 -29.22 28.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.164 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.74 -9.29 7.22 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' O ' HD13 ' A' ' 113' ' ' LEU . 22.6 mt-10 -56.2 171.7 0.25 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.145 -1.209 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.697 HD13 HD13 ' A' ' 43' ' ' ILE . 7.1 tt -146.4 110.16 4.9 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.995 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CD1' HG22 ' A' ' 133' ' ' VAL . 11.5 tt -106.24 145.01 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -126.59 142.08 51.65 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.322 -0.861 . . . . 0.0 109.604 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -119.01 170.67 8.85 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.252 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.486 ' O ' HG22 ' A' ' 129' ' ' VAL . 68.1 mtp -152.18 166.09 32.79 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.659 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 7.1 m -147.07 152.54 38.69 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -159.35 96.74 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 77.14 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.1 23.96 1.05 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 178.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 129' ' ' VAL . 19.8 m -120.14 -179.2 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.27 117.93 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.589 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.671 ' CB ' HD22 ' A' ' 18' ' ' LEU . 5.6 t -99.25 132.64 44.43 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.424 ' OG1' HG22 ' A' ' 122' ' ' THR . 95.7 m -124.96 126.16 45.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.36 -0.838 . . . . 0.0 109.436 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -123.15 100.4 6.85 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 120' ' ' ILE . 59.2 t -66.58 130.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.7 m-85 -120.1 132.25 55.35 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.404 -179.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.81 137.18 47.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.14 127.63 14.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.215 -0.928 . . . . 0.0 111.867 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.992 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.501 1.968 0 N-CA-C 110.3 -0.692 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -153.08 126.13 8.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.479 -0.763 . . . . 0.0 109.638 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HD2' HD11 ' A' ' 119' ' ' LEU . 4.9 m-85 -99.11 -5.34 30.35 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.714 -0.616 . . . . 0.0 109.509 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 p -72.15 118.66 15.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.148 -0.97 . . . . 0.0 111.945 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.87 -173.36 38.21 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.4 m120 -95.45 171.87 8.43 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.918 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.2 m95 -150.73 125.35 9.64 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.482 -176.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -118.9 114.76 23.1 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 132' ' ' ARG . 11.0 tt -58.15 143.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.648 -0.657 . . . . 0.0 110.414 -179.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.15 -24.44 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.893 -0.504 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -150.16 176.32 10.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -0.912 . . . . 0.0 110.383 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t 176.56 167.28 0.49 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.56 26.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.146 -0.971 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 67.2 m-20 -160.53 27.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.752 -0.592 . . . . 0.0 109.851 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.871 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -63.19 -66.36 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.334 -0.854 . . . . 0.0 109.053 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 9.9 mt-10 -55.53 -31.56 62.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.446 -0.784 . . . . 0.0 109.476 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.61 -39.54 91.61 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.157 0.504 . . . . 0.0 110.506 -179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.769 HD22 ' HB2' ' A' ' 130' ' ' CYS . 17.0 tp -79.0 -16.88 56.3 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.726 -0.609 . . . . 0.0 110.113 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' A' ' 32' ' ' ALA . 4.8 mt -90.14 -18.92 24.91 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.055 -1.028 . . . . 0.0 109.077 179.23 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 mtmm -82.3 -31.48 29.97 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 128' ' ' VAL . 13.6 p -77.84 -40.37 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.011 0.91 . . . . 0.0 108.714 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -67.32 -47.17 71.33 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.884 0.849 . . . . 0.0 109.428 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -151.31 24.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.1 m -153.74 -41.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.968 -0.725 . . . . 0.0 109.506 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.3 t30 -60.89 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.525 -0.734 . . . . 0.0 109.444 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 2.6 m -123.62 -46.84 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.809 179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.3 ttt -67.58 -29.39 68.73 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 28' ' ' LEU . 2.0 mm? -58.34 -32.17 68.27 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.788 -0.57 . . . . 0.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.839 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.9 mpp_? -82.69 -44.29 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -0.859 . . . . 0.0 109.903 -179.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -61.96 -22.3 65.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 110.682 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mt -79.48 -28.54 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.0 109.04 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.925 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.06 -26.21 33.9 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 29' ' ' ARG . 8.8 t -77.94 -39.83 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.65 -33.59 60.45 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.69 94.45 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -63.87 -67.48 0.43 Allowed 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.618 -0.676 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 m 51.64 55.3 9.56 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mttm 66.69 73.51 0.38 Allowed Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.462 ' HD3' ' HB1' ' A' ' 36' ' ' ALA . 28.4 Cg_endo -70.99 153.92 63.08 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.024 1.816 . . . . 0.0 110.605 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.95 173.2 6.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.015 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HG23 ' A' ' 54' ' ' THR . 53.9 t -154.99 164.49 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.3 tm-20 -149.43 109.49 4.11 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.918 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.4 mt -98.61 139.7 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 121.802 0.81 . . . . 0.0 110.605 -178.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.0 116.47 27.43 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.666 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 62.0 tt0 -98.77 116.52 31.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.123 -0.985 . . . . 0.0 110.837 -178.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -116.9 49.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.3 -125.84 8.19 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.6 p30 -75.78 -1.83 26.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -1.04 . . . . 0.0 110.023 178.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -96.56 138.91 33.43 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.787 -1.196 . . . . 0.0 108.434 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 45' ' ' GLN . 92.5 m-85 -134.06 116.31 15.32 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.865 0.84 . . . . 0.0 109.431 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.9 147.75 26.15 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.053 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -143.45 105.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 120.968 -1.083 . . . . 0.0 111.289 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.23 112.09 24.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 109.466 179.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.624 HG23 HG22 ' A' ' 41' ' ' VAL . 34.4 m -102.54 141.09 35.93 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.48 140.99 39.42 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.129 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 36' ' ' ALA . 0.7 OUTLIER -110.41 -65.36 1.17 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.841 0.829 . . . . 0.0 109.466 -179.825 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.622 HG23 HG23 ' A' ' 58' ' ' VAL . 2.4 t 179.21 -42.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.622 HG23 HG23 ' A' ' 57' ' ' THR . 40.2 t -113.87 -11.37 12.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -123.65 163.99 19.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.253 -0.904 . . . . 0.0 109.028 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m -163.0 100.02 0.97 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.59 -0.694 . . . . 0.0 109.258 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.55 165.27 16.35 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.53 -0.731 . . . . 0.0 109.679 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -159.57 123.51 3.79 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.641 -0.662 . . . . 0.0 109.307 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 52' ' ' ILE . 39.7 pt -123.98 166.34 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.02 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.531 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.19 129.45 3.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.189 -0.945 . . . . 0.0 109.052 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 85' ' ' VAL . 46.0 p90 -161.65 -173.0 3.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.689 -1.204 . . . . 0.0 112.273 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.71 153.6 47.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.44 94.88 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.649 -178.997 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.72 -34.1 1.37 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.495 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -112.42 156.61 22.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.403 -1.057 . . . . 0.0 109.974 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.498 ' HG2' HD22 ' A' ' 84' ' ' LEU . 29.1 mt-10 -86.39 169.16 13.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.594 -0.691 . . . . 0.0 109.204 -179.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 65' ' ' PHE . 15.9 p90 -162.26 173.47 14.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.563 -0.711 . . . . 0.0 109.816 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.28 145.2 29.79 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.675 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.3 pt-20 -162.32 -176.17 4.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.578 -0.702 . . . . 0.0 109.528 -179.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -100.71 157.51 16.64 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.0 t -95.2 -143.13 0.26 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.32 -0.862 . . . . 0.0 109.24 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' THR . 24.3 t -110.1 -22.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.754 -1.216 . . . . 0.0 110.814 -179.051 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.581 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -88.12 -40.27 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.589 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.38 45.1 0.1 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.709 ' H ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.32 152.1 78.76 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.714 -0.874 . . . . 0.0 109.046 -179.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.766 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.6 Cg_endo -78.42 142.38 18.63 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.655 1.57 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 11.4 p -161.14 141.12 10.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 109.552 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 100' ' ' LEU . 8.7 ttmm -86.67 116.13 24.58 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.91 165.42 11.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.735 -0.603 . . . . 0.0 110.268 -178.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 70' ' ' GLU . 57.7 tp -145.69 153.84 41.43 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 65' ' ' PHE . 14.7 t -146.17 125.13 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.728 -178.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.1 156.05 29.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' A' ' 67' ' ' VAL . 81.4 m95 -78.03 174.84 10.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.876 0.846 . . . . 0.0 110.126 -179.191 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -137.84 -46.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.2 p -130.51 -152.68 0.52 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.67 -28.35 51.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -141.04 28.59 1.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 27.3 tttt -132.69 111.52 11.23 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.439 ' HB3' ' CE3' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -118.36 150.17 39.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.25 -0.906 . . . . 0.0 110.398 -179.295 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -99.47 172.27 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.494 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.8 t -147.45 140.3 24.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 110.895 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.68 163.01 13.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -160.3 135.38 7.88 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.781 -1.167 . . . . 0.0 111.642 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -143.63 150.55 38.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.94 168.94 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.005 . . . . 0.0 110.842 -179.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 80' ' ' PRO . 39.1 mt -99.04 -5.98 29.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.68 133.72 14.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.669 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.86 -157.37 38.94 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -176.15 139.97 0.39 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.438 -1.036 . . . . 0.0 109.915 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.0 -87.9 0.09 OUTLIER Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -83.36 -176.69 2.89 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.682 1.588 . . . . 0.0 109.474 178.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -130.46 136.31 48.87 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.95 144.41 48.48 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.151 0.977 . . . . 0.0 110.749 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.7 m -163.04 136.88 6.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.8 p-90 -142.49 174.83 10.28 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.436 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 94' ' ' VAL . 13.0 p -138.36 170.53 15.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.556 0.693 . . . . 0.0 109.801 -179.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.42 ' HB3' HD12 ' A' ' 121' ' ' LEU . 7.9 ptp -153.37 137.0 15.99 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -133.19 149.42 52.04 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.388 -0.82 . . . . 0.0 109.413 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -111.84 141.44 45.47 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 p -90.4 161.12 15.72 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.763 -179.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -60.33 -22.01 62.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.699 . . . . 0.0 110.149 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -84.35 -29.19 26.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.284 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.63 -9.85 7.22 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.55 172.62 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.158 -1.201 . . . . 0.0 109.369 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 43' ' ' ILE . 7.2 tt -145.08 108.38 4.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 109.974 -179.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.7 tt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.7 OUTLIER -135.6 137.52 42.02 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.248 -0.907 . . . . 0.0 109.771 -178.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -114.65 168.59 9.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 177.974 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.505 ' O ' HG22 ' A' ' 129' ' ' VAL . 31.7 mtp -147.55 167.86 23.43 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.636 -179.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 4.0 m -150.65 150.2 30.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.692 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.25 93.84 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 77.83 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -146.69 23.52 1.25 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.576 -0.702 . . . . 0.0 109.286 178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 125' ' ' ALA . 23.2 m -117.14 -178.52 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.012 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.79 118.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.436 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.769 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.6 t -97.66 116.98 30.92 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.421 ' OG1' HG22 ' A' ' 122' ' ' THR . 89.5 m -114.45 126.26 54.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -0.999 . . . . 0.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 9' ' ' ILE . 1.1 mtt-85 -133.22 107.76 8.36 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.04 135.4 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.3 m-85 -123.36 126.12 46.26 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.274 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.48 138.48 33.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.496 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -49.96 128.22 18.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.242 -0.911 . . . . 0.0 111.559 -178.617 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 1.6 tm-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.762 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.001 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -157.08 126.82 6.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.532 -0.73 . . . . 0.0 109.666 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' HB3' HG21 ' A' ' 43' ' ' ILE . 4.3 m-85 -98.84 -9.8 23.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -65.37 118.09 8.86 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 112.293 -177.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.24 -172.84 37.57 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 178.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.6 m120 -95.63 171.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.818 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.22 120.01 7.08 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.891 -1.123 . . . . 0.0 112.613 -177.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -111.43 114.11 27.02 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.679 HG21 ' HD2' ' A' ' 39' ' ' PRO . 7.2 tt -56.26 155.45 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.907 0.861 . . . . 0.0 111.195 -178.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.41 -32.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.436 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -145.0 171.04 15.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.029 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 t 179.52 157.44 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 109.335 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.42 170.74 19.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.715 -0.616 . . . . 0.0 110.049 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 37.5 m-80 61.04 29.99 19.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.476 -0.765 . . . . 0.0 109.887 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.812 ' CD1' HG22 ' A' ' 33' ' ' VAL . 3.7 t80 -65.55 -63.17 1.16 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.282 -0.886 . . . . 0.0 108.85 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 2.5 pt-20 -59.76 -28.35 67.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.736 -0.603 . . . . 0.0 109.641 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.73 -38.97 90.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.626 -0.671 . . . . 0.0 110.411 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' A' ' 130' ' ' CYS . 47.8 tp -83.12 -13.39 55.72 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.686 -0.634 . . . . 0.0 109.711 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -91.82 -20.96 20.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.959 -1.088 . . . . 0.0 108.952 179.572 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 1.2 mmmm -83.37 -30.04 27.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 HG11 HD12 ' A' ' 18' ' ' LEU . 14.4 p -77.43 -41.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 77' ' ' ASP . 4.6 mp -66.41 -53.55 34.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.25 1.024 . . . . 0.0 108.865 179.251 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.06 -144.9 14.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 25' ' ' ASN . 29.6 m -154.99 -38.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.901 -0.764 . . . . 0.0 110.244 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.7 t30 -57.29 -171.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.248 -0.907 . . . . 0.0 109.779 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.677 HG12 ' NH1' ' A' ' 29' ' ' ARG . 4.8 m -121.12 -43.0 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.77 . . . . 0.0 110.112 -179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.0 ttm -67.83 -26.35 66.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.57 -0.706 . . . . 0.0 109.131 179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.74 -49.2 78.47 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.704 -0.622 . . . . 0.0 110.525 -179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.886 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -66.03 -42.3 89.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.463 -0.773 . . . . 0.0 110.029 -178.87 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -57.52 -38.98 75.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.567 -0.708 . . . . 0.0 110.705 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.03 -26.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.429 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HD12 ' A' ' 19' ' ' LEU . . . -81.51 -22.1 38.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.66 -0.65 . . . . 0.0 110.169 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 29' ' ' ARG . 3.5 t -81.99 -45.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.25 91.88 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.27 71.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.35 42.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.547 179.15 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.8 t -64.97 -35.39 81.03 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.841 -1.162 . . . . 0.0 108.313 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -157.4 71.22 4.43 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.5 Cg_endo -73.57 146.33 38.89 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 122.012 1.808 . . . . 0.0 110.545 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -93.04 173.22 7.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.664 -0.648 . . . . 0.0 109.618 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 40' ' ' ALA . 4.7 t -153.53 165.28 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 41' ' ' VAL . 38.2 tt0 -156.87 116.98 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.653 -0.654 . . . . 0.0 109.427 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.818 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.1 mp -107.21 138.04 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 121.582 0.706 . . . . 0.0 109.769 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 3.8 mttt -117.53 109.16 16.38 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.2 tt0 -98.1 117.07 31.63 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.07 -1.019 . . . . 0.0 111.113 -177.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.84 56.01 0.96 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.08 -126.37 8.39 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.63 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.2 p30 -77.79 -0.4 26.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.418 -1.048 . . . . 0.0 109.954 178.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 m -96.19 139.99 31.54 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.781 -1.2 . . . . 0.0 108.862 -178.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 95.4 m-85 -136.66 117.44 14.06 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.774 0.797 . . . . 0.0 108.92 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 4.5 t80 -104.53 119.12 38.24 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG13 HD11 ' A' ' 63' ' ' ILE . 1.7 mm -99.84 146.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 O-C-N 120.785 -1.197 . . . . 0.0 107.991 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 16.8 tttt -145.11 102.58 3.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.93 . . . . 0.0 108.785 179.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . 25.0 m -99.56 154.9 17.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.723 . . . . 0.0 109.486 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.69 116.0 6.59 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.649 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -98.53 -172.14 2.26 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.861 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.887 HG23 HG23 ' A' ' 58' ' ' VAL . 7.5 t -58.13 -38.1 75.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 111.214 -179.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.887 HG23 HG23 ' A' ' 57' ' ' THR . 21.4 t -127.75 -6.03 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.382 -0.824 . . . . 0.0 112.216 -177.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -117.18 175.26 5.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.034 -1.041 . . . . 0.0 110.763 -178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.6 m -164.72 105.12 0.82 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.01 169.53 8.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.395 -0.816 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 2.1 pt-20 -173.44 113.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 73' ' ' GLU . 37.5 pt -103.65 173.53 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.467 -0.77 . . . . 0.0 110.052 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -160.68 130.34 5.02 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' CE2' HG21 ' A' ' 85' ' ' VAL . 43.2 p90 -162.38 -171.62 2.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.089 0.947 . . . . 0.0 111.448 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 15.4 ptmt -132.31 154.67 49.47 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.59 94.3 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -178.541 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 155.74 -23.02 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.865 -1.159 . . . . 0.0 110.607 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' CG ' ' HG3' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -136.41 163.59 30.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.296 -1.12 . . . . 0.0 110.727 -179.6 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.16 171.2 11.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.765 -0.584 . . . . 0.0 109.578 -179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 12.0 p90 -162.63 175.32 11.51 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.03 143.62 39.79 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' HG22 ' A' ' 63' ' ' ILE . 5.7 pm0 -162.16 -169.18 2.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.659 -0.651 . . . . 0.0 109.343 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -99.6 160.07 14.57 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.348 179.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.5 t -97.84 -143.72 0.3 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.386 -0.821 . . . . 0.0 109.227 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 27.4 t -110.78 -20.99 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.731 -1.23 . . . . 0.0 110.897 -179.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.603 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -90.39 -40.39 12.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.821 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.89 46.93 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.731 ' H ' HG22 ' A' ' 75' ' ' THR . 8.4 mmm180 -137.28 154.01 75.24 Favored Pre-proline 0 C--N 1.306 -1.292 0 O-C-N 121.743 -0.857 . . . . 0.0 109.269 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.734 ' HB2' HD12 ' A' ' 100' ' ' LEU . 36.0 Cg_endo -79.34 142.94 17.05 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 110.439 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.6 p -160.66 142.41 12.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' HB2' HD21 ' A' ' 100' ' ' LEU . 22.0 ttpt -90.71 120.76 32.03 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 2.6 t -100.31 172.8 6.93 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.516 0.674 . . . . 0.0 110.347 -178.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.7 tp -148.7 152.72 37.14 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.549 HG21 ' CE2' ' A' ' 65' ' ' PHE . 15.5 t -147.74 131.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 118.441 -1.304 . . . . 0.0 112.266 -178.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.64 161.23 29.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.592 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.0 m95 -84.36 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.923 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.3 tp10 -134.84 -46.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -132.25 -153.66 0.57 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -24.77 47.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -142.16 24.76 1.95 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.8 tttm -130.77 111.85 12.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 0.0 108.522 179.622 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.576 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.06 149.42 38.96 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.628 0.728 . . . . 0.0 110.39 -178.876 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.608 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -101.88 171.74 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.495 ' H ' HG12 ' A' ' 94' ' ' VAL . 47.4 t -149.12 138.29 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.915 . . . . 0.0 110.966 -179.498 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -108.59 163.39 13.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.65 139.69 10.46 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.873 -178.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -141.42 157.13 45.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -68.75 168.81 12.53 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 110.612 -179.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 80' ' ' PRO . 52.9 mt -101.65 -6.07 24.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.04 138.73 18.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.46 -156.86 41.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -176.87 140.08 0.31 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.567 -0.961 . . . . 0.0 109.603 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.46 -85.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.43 -177.11 3.06 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.88 1.72 . . . . 0.0 109.936 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -135.92 139.02 42.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.84 145.09 48.42 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.16 0.981 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.1 p -163.07 137.71 6.37 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CZ3' ' CE ' ' A' ' 111' ' ' MET . 61.7 p-90 -142.32 176.0 9.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.023 -1.048 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.608 HG22 HG13 ' A' ' 94' ' ' VAL . 7.3 p -140.41 174.46 10.49 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.817 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.602 ' CE ' HD12 ' A' ' 121' ' ' LEU . 2.4 mtm -157.16 128.5 6.88 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -124.35 146.83 48.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.529 -0.732 . . . . 0.0 109.63 -179.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -110.46 144.25 39.55 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.349 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -93.18 160.52 14.81 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.6 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -60.66 -21.61 62.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.689 -0.632 . . . . 0.0 110.171 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.99 -29.23 27.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 109.106 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.45 -9.39 7.34 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' O ' HD13 ' A' ' 113' ' ' LEU . 54.3 mt-10 -56.65 171.68 0.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -1.227 . . . . 0.0 109.293 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.738 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -146.25 112.03 5.63 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.149 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -106.72 147.7 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.602 HD12 ' CE ' ' A' ' 111' ' ' MET . 7.5 tt -129.43 147.96 51.3 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.193 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.1 OUTLIER -127.96 163.37 24.66 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.474 ' O ' HG22 ' A' ' 129' ' ' VAL . 20.0 mtp -143.13 163.34 33.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.368 -179.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 129' ' ' VAL . 6.6 m -146.7 152.05 38.21 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.33 96.75 1.44 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.98 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.73 23.91 1.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.546 -0.721 . . . . 0.0 109.407 178.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.0 m -119.3 -179.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -158.03 117.17 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.716 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.3 t -98.89 112.08 24.29 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.455 ' OG1' HG22 ' A' ' 122' ' ' THR . 77.7 m -107.92 148.9 29.0 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.767 0.794 . . . . 0.0 110.074 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -151.0 118.18 5.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.32 138.97 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.123 -0.986 . . . . 0.0 108.385 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 22.5 m-85 -127.49 125.3 40.2 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.367 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.03 139.59 28.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 mtm180 -49.36 125.63 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.215 -0.928 . . . . 0.0 111.207 -178.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.515 179.578 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.502 1.971 0 N-CA-C 110.287 -0.697 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -152.59 128.12 10.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.565 ' HD2' HD11 ' A' ' 119' ' ' LEU . 5.1 m-85 -98.85 -8.1 26.29 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.7 p -69.6 118.09 12.03 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.209 -0.932 . . . . 0.0 111.938 -177.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.3 -171.54 37.34 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.1 m120 -95.59 169.94 9.69 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 177.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.945 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.67 120.43 7.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.643 -177.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -112.66 120.76 42.64 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 12' ' ' SER . 11.7 tt -64.56 151.97 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.845 0.831 . . . . 0.0 111.116 -178.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.03 -31.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -139.73 168.84 18.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 108.985 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.821 ' HB3' HD11 ' A' ' 9' ' ' ILE . 83.8 p -176.82 149.61 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.489 -0.757 . . . . 0.0 109.606 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -148.2 163.64 36.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.9 m-80 61.86 27.48 16.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.766 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.917 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.85 -65.47 0.67 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.588 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.8 pt-20 -58.01 -27.89 63.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 109.614 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.39 -34.83 79.22 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.553 -0.717 . . . . 0.0 110.018 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' A' ' 130' ' ' CYS . 18.4 tp -82.9 -18.58 39.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.729 -0.607 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.917 HD11 ' CE1' ' A' ' 15' ' ' PHE . 5.9 mt -91.37 -16.81 26.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.909 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 mmmt -87.94 -28.49 21.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.156 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 12.6 p -76.77 -41.14 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -66.1 -54.6 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.99 -148.2 19.86 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 23' ' ' GLY . 15.8 m -157.28 -43.76 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.815 -0.815 . . . . 0.0 109.407 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.607 ' HB3' HD23 ' A' ' 28' ' ' LEU . 7.0 t30 -54.28 176.07 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.472 -0.767 . . . . 0.0 109.516 179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.68 -43.68 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.6 ttm -62.74 -26.38 68.67 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 25' ' ' ASN . 3.8 mm? -64.8 -69.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.634 -0.666 . . . . 0.0 109.993 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.914 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -52.21 -38.32 57.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 110.62 -179.299 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -61.01 -39.33 89.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.61 -0.681 . . . . 0.0 110.373 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.82 -26.8 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -81.6 -26.02 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.53 -0.731 . . . . 0.0 109.45 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 29' ' ' ARG . 10.6 t -75.9 -35.98 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.01 41.74 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.52 93.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.41 -69.49 0.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.5 m 49.19 51.19 16.71 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.495 0.664 . . . . 0.0 109.46 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.3 mttt 65.38 72.31 0.47 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' A' ' 56' ' ' THR . 29.3 Cg_endo -72.1 156.96 55.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.05 1.833 . . . . 0.0 110.613 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 41' ' ' VAL . . . -105.95 174.38 5.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.355 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 54' ' ' THR . 71.8 t -154.23 164.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' N ' HG12 ' A' ' 41' ' ' VAL . 43.8 tt0 -149.68 108.61 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.945 HD12 ' CD1' ' A' ' 7' ' ' TRP . 4.2 mt -98.45 139.13 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.709 0.766 . . . . 0.0 110.883 -178.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -117.19 113.1 21.74 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.711 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.2 tt0 -98.48 118.38 35.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.07 -1.019 . . . . 0.0 110.976 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.38 52.45 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -124.44 7.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -178.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 67' ' ' VAL . 3.4 p30 -76.31 -1.25 25.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.7 m -96.33 141.77 29.26 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 120.808 -1.183 . . . . 0.0 108.807 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.608 ' CE2' ' HE3' ' A' ' 93' ' ' MET . 97.8 m-85 -137.3 115.52 11.73 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.839 0.828 . . . . 0.0 109.258 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -101.43 147.5 26.28 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.046 HD12 HD11 ' A' ' 63' ' ' ILE . 1.4 mt -142.09 107.52 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.197 -177.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -102.7 109.84 21.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.091 179.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.763 HG23 HG22 ' A' ' 41' ' ' VAL . 22.6 m -99.36 135.86 40.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.37 121.01 26.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.25 -0.906 . . . . 0.0 110.314 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -99.29 -168.99 1.69 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.33 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.521 HG23 HG23 ' A' ' 58' ' ' VAL . 5.4 t -51.06 -42.54 60.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.504 -0.747 . . . . 0.0 111.008 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 57' ' ' THR . 22.1 t -134.14 -7.02 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.345 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.98 174.96 5.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.905 -1.122 . . . . 0.0 110.377 -179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 m -164.3 93.03 0.67 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.689 -0.632 . . . . 0.0 109.509 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.75 160.97 22.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -152.51 125.21 8.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 0.0 109.791 -179.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.046 HD11 HD12 ' A' ' 52' ' ' ILE . 37.9 pt -124.73 165.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.124 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.2 p30 -162.72 129.03 3.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.001 -1.062 . . . . 0.0 109.887 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.571 ' CE2' HG21 ' A' ' 85' ' ' VAL . 49.0 p90 -162.25 -171.87 2.98 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.734 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -132.06 155.91 47.24 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.689 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -83.47 91.63 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 -179.109 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.78 -27.08 0.65 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.124 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HG2' ' CG ' ' A' ' 66' ' ' LYS . 4.9 pt-20 -124.77 159.09 31.73 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.182 -1.187 . . . . 0.0 110.3 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD22 ' A' ' 84' ' ' LEU . 33.8 mt-10 -86.82 166.23 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 17.3 p90 -162.2 173.6 14.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.53 -0.731 . . . . 0.0 109.686 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -101.97 146.12 28.32 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.37 -177.52 5.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.667 -0.645 . . . . 0.0 109.342 -179.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -100.44 155.83 17.6 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.0 t -94.49 -142.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.358 -0.839 . . . . 0.0 109.134 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' THR . 39.5 t -113.71 -18.64 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.218 . . . . 0.0 110.64 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.625 ' H ' HG23 ' A' ' 75' ' ' THR . 2.0 t0 -89.39 -36.59 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 -179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.42 44.84 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.679 ' H ' HG22 ' A' ' 75' ' ' THR . 48.2 mtp180 -134.23 151.85 77.15 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.779 -0.836 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.809 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.5 Cg_endo -78.8 143.4 18.49 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 121.658 1.572 . . . . 0.0 110.553 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.9 p -161.14 141.65 11.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.717 -0.615 . . . . 0.0 109.625 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 100' ' ' LEU . 6.1 ttmm -88.32 116.74 26.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.4 t -99.47 168.08 10.21 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.428 0.632 . . . . 0.0 110.458 -178.241 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.56 HD22 ' HG2' ' A' ' 70' ' ' GLU . 60.2 tp -151.12 153.77 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG21 ' CE2' ' A' ' 65' ' ' PHE . 38.7 t -146.04 134.63 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.214 -177.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -126.17 157.4 38.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.558 ' CE2' HG21 ' A' ' 67' ' ' VAL . 84.6 m95 -81.58 171.05 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.098 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 19.2 tp10 -134.17 -45.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -132.31 -154.66 0.63 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -76.56 -25.52 54.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.833 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -143.18 27.69 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.825 . . . . 0.0 110.717 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 38.8 tttt -130.84 106.87 8.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 108.16 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.608 ' HE3' ' CE2' ' A' ' 50' ' ' PHE . 1.2 ptp -115.18 145.88 41.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 110' ' ' THR . 1.5 t -102.12 171.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.6 t -145.47 138.74 26.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.268 -0.895 . . . . 0.0 110.475 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 7.3 pt-20 -109.62 154.35 22.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -152.46 142.02 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.803 -1.159 . . . . 0.0 111.905 -177.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -143.6 153.32 42.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.66 169.3 3.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.092 -1.005 . . . . 0.0 110.527 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 80' ' ' PRO . 47.2 mt -98.07 -7.93 28.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -155.14 145.31 21.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 108.946 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.04 -158.71 37.51 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.54 140.41 0.36 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.505 -0.997 . . . . 0.0 109.743 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.43 -85.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -83.99 -176.9 2.83 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 121.872 1.714 . . . . 0.0 109.905 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -137.92 138.95 39.52 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.99 145.97 48.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.024 0.916 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.7 m -162.49 131.1 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -136.16 167.26 21.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.123 -0.986 . . . . 0.0 110.839 -179.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.921 HG22 HG13 ' A' ' 94' ' ' VAL . 21.5 p -131.63 169.77 15.7 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.386 0.612 . . . . 0.0 109.9 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.629 ' HB3' HD12 ' A' ' 121' ' ' LEU . 11.4 ptp -154.98 123.44 6.01 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.31 155.68 29.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.418 -0.801 . . . . 0.0 110.412 -178.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.45 141.65 48.95 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.823 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.5 p -93.86 161.03 14.48 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.804 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -60.79 -22.01 63.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.616 -0.678 . . . . 0.0 110.142 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -83.65 -28.9 28.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.35 -0.844 . . . . 0.0 109.158 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.67 -10.36 7.15 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -54.97 170.89 0.16 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.159 -1.201 . . . . 0.0 109.275 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.605 ' CD1' HD13 ' A' ' 43' ' ' ILE . 7.8 tt -147.42 110.12 4.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.49 161.07 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -145.08 132.22 20.43 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.349 -0.845 . . . . 0.0 109.661 -179.215 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.41 171.55 7.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.462 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.0 mtp -149.76 163.91 36.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.093 -179.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.6 m -147.51 152.7 38.44 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.436 0.636 . . . . 0.0 109.415 179.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.669 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.72 96.53 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.645 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.76 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -147.38 24.12 1.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.563 -0.711 . . . . 0.0 109.312 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 125' ' ' ALA . 21.9 m -119.09 -179.07 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.56 117.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.659 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.765 ' HB2' HD22 ' A' ' 18' ' ' LEU . 4.0 t -98.21 117.33 32.35 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -111.35 149.77 30.68 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.882 0.848 . . . . 0.0 109.925 -179.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -152.49 118.2 5.38 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.17 137.8 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.44 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 27.8 m-85 -126.93 124.87 40.51 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.446 -179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.55 140.78 24.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -50.02 125.99 13.37 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.176 -0.952 . . . . 0.0 111.131 -178.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.544 179.569 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.535 ' CA ' HD12 ' A' ' 113' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.502 2.006 0 N-CA-C 110.746 -0.521 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.91 123.21 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.706 0.765 . . . . 0.0 110.216 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.581 ' HD2' HD11 ' A' ' 119' ' ' LEU . 3.3 m-85 -99.59 -1.09 39.06 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.66 -0.65 . . . . 0.0 109.44 179.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -72.37 120.56 18.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.123 -0.986 . . . . 0.0 112.122 -177.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.54 -171.97 36.82 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 178.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 6.5 m120 -95.86 169.78 9.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -150.47 120.97 7.41 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.994 -1.083 . . . . 0.0 112.639 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -113.69 115.7 28.27 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.784 HG21 ' HD2' ' A' ' 39' ' ' PRO . 8.0 tt -55.6 156.61 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.994 0.902 . . . . 0.0 111.418 -178.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.455 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.5 pp -132.21 -32.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.527 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 10' ' ' ILE . 1.3 mtt180 -143.82 169.61 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.254 -0.904 . . . . 0.0 108.938 179.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.57 ' HB3' HD11 ' A' ' 9' ' ' ILE . 89.0 p -177.19 145.37 0.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 109.754 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -141.18 165.7 26.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.759 -0.588 . . . . 0.0 109.657 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 29.1 m-80 58.77 22.54 10.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.474 -0.766 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.925 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -65.19 -64.2 0.92 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 108.943 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 42.9 tt0 -57.5 -29.12 64.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -65.36 -34.19 77.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.664 -0.648 . . . . 0.0 110.167 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.808 HD22 ' CB ' ' A' ' 130' ' ' CYS . 12.5 tp -82.72 -19.0 38.82 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.758 -0.589 . . . . 0.0 110.375 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 15' ' ' PHE . 6.8 mt -90.86 -17.03 27.2 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -87.33 -29.28 21.69 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.216 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 22' ' ' LEU . 14.1 p -77.06 -41.01 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 77' ' ' ASP . 4.7 mp -65.73 -50.8 63.49 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 -143.93 14.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 25' ' ' ASN . 26.0 m -154.5 -43.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.697 -0.884 . . . . 0.0 109.985 179.664 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.484 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.6 t30 -61.97 -172.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.483 -0.761 . . . . 0.0 109.033 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.46 -42.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.1 ttt -61.45 -23.34 65.79 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.9 mm? -79.82 -39.63 30.31 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.736 -0.602 . . . . 0.0 110.086 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.895 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -66.1 -37.39 85.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.701 -0.624 . . . . 0.0 109.502 -179.223 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -11.97 57.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.654 -0.654 . . . . 0.0 111.043 -179.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' ILE . 42.4 mm -85.84 -30.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.897 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.28 -27.25 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.7 t -79.52 -46.13 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.65 89.86 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.98 88.0 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.693 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -83.47 40.69 0.74 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.824 -0.547 . . . . 0.0 111.56 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.4 p -58.31 -26.66 63.3 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.487 -1.383 . . . . 0.0 108.679 178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.19 73.01 0.23 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.784 ' HD2' HG21 ' A' ' 9' ' ' ILE . 32.4 Cg_endo -73.18 -166.41 0.3 Allowed 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.996 1.798 . . . . 0.0 111.089 -178.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -138.96 173.43 11.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 HG23 ' A' ' 54' ' ' THR . 55.1 t -156.43 163.82 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' N ' HG12 ' A' ' 41' ' ' VAL . 39.9 tt0 -150.47 111.0 4.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.908 HD12 ' CD1' ' A' ' 7' ' ' TRP . 3.3 mt -99.37 133.37 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.636 0.731 . . . . 0.0 110.366 -178.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -112.72 111.92 23.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.666 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 61.8 tt0 -98.57 119.39 37.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.11 -0.994 . . . . 0.0 111.002 -178.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -120.69 54.74 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.9 -126.74 8.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -77.23 -0.44 25.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.387 -1.066 . . . . 0.0 109.987 178.663 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -96.65 140.75 30.8 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.653 -1.279 . . . . 0.0 108.512 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 97.7 m-85 -136.67 116.39 13.02 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.8 0.81 . . . . 0.0 109.465 179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 t80 -101.67 147.45 26.42 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.141 HD12 HD11 ' A' ' 63' ' ' ILE . 1.6 mt -142.27 104.8 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 118.938 -1.105 . . . . 0.0 111.25 -177.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.44 109.35 21.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.401 -0.812 . . . . 0.0 109.067 178.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG22 ' A' ' 41' ' ' VAL . 60.6 m -103.21 141.8 35.26 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.6 p -148.88 124.88 10.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.325 -0.86 . . . . 0.0 109.592 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 57' ' ' THR . 67.1 m -98.24 -65.15 0.98 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.532 -0.73 . . . . 0.0 109.634 -179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.822 HG23 HG23 ' A' ' 58' ' ' VAL . 4.7 t -174.36 -41.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.822 HG23 HG23 ' A' ' 57' ' ' THR . 23.8 t -109.24 -17.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 ttm105 -124.21 162.24 24.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.502 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 55' ' ' SER . 61.2 m -161.24 104.66 1.29 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.42 169.06 10.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.554 -0.716 . . . . 0.0 110.079 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -160.42 123.32 3.37 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.141 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -124.49 168.85 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.376 -0.827 . . . . 0.0 109.407 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.54 129.32 3.61 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.234 -0.916 . . . . 0.0 109.08 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 85' ' ' VAL . 51.2 p90 -162.14 -172.16 3.12 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.609 -1.236 . . . . 0.0 112.388 -179.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -130.54 153.12 49.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.42 95.15 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 109.79 -178.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.3 -33.58 1.57 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.772 179.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -110.88 153.59 25.23 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.356 -1.085 . . . . 0.0 109.869 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' CA ' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.15 167.21 15.13 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.684 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.463 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 16.6 p90 -162.39 173.61 13.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.507 -0.746 . . . . 0.0 109.818 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -103.94 143.66 32.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' HB2' HG22 ' A' ' 63' ' ' ILE . 1.7 pt-20 -162.09 -176.86 5.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.82 155.67 17.53 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 79' ' ' ARG . 8.6 t -91.19 -142.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.46 -0.775 . . . . 0.0 109.194 -179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 75' ' ' THR . 25.4 t -110.02 -20.63 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.74 -1.225 . . . . 0.0 110.624 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.638 ' H ' HG23 ' A' ' 75' ' ' THR . 1.7 t0 -89.43 -39.96 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.57 44.88 0.11 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -130.61 150.82 77.43 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.629 -0.924 . . . . 0.0 109.342 -179.628 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.9 Cg_endo -78.92 140.29 15.98 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.7 1.6 . . . . 0.0 110.26 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.4 p -161.36 141.86 10.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.637 -0.664 . . . . 0.0 109.811 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HB2' HD21 ' A' ' 100' ' ' LEU . 15.3 ttmm -90.57 114.32 26.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 t -101.81 177.5 4.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.715 -0.615 . . . . 0.0 110.235 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' ' 70' ' ' GLU . 64.4 tp -151.75 152.01 32.15 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 65' ' ' PHE . 3.4 t -140.74 130.25 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.516 -177.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.5 ptmt -125.89 162.48 25.08 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.562 ' CD1' HG11 ' A' ' 67' ' ' VAL . 88.3 m95 -85.69 167.35 15.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.969 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 1.8 tp10 -129.93 -45.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 p -132.01 -154.43 0.62 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.29 -24.65 50.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.733 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -143.91 27.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 36.5 tttt -132.27 106.4 7.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.872 -1.142 . . . . 0.0 107.977 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.496 ' HE1' HG22 ' A' ' 67' ' ' VAL . 1.4 ptp -113.18 149.89 33.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.316 -178.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.946 HG13 HG22 ' A' ' 110' ' ' THR . 2.8 t -104.7 172.11 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.49 ' H ' HG12 ' A' ' 94' ' ' VAL . 42.8 t -149.58 129.79 13.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 110.747 -179.412 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.8 pt-20 -100.68 163.99 12.08 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 176.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -160.41 142.91 13.09 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.945 -178.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -147.08 149.25 32.69 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.43 167.9 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.065 -1.022 . . . . 0.0 110.86 -179.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 80' ' ' PRO . 30.3 mt -98.0 -7.44 29.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -152.44 141.14 20.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 108.922 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.07 -159.72 36.04 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -176.37 139.91 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.493 -1.004 . . . . 0.0 109.829 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.45 -86.67 0.06 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -84.1 -176.97 2.83 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.834 1.689 . . . . 0.0 109.774 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -135.5 138.53 43.2 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 146.05 47.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.068 0.937 . . . . 0.0 110.872 -179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 p -162.7 128.79 3.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -133.34 166.01 23.49 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.098 -1.001 . . . . 0.0 110.85 -179.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.946 HG22 HG13 ' A' ' 94' ' ' VAL . 18.8 p -130.4 174.69 9.61 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.415 0.626 . . . . 0.0 109.692 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -160.09 122.33 3.31 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.112 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -116.95 154.1 31.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.535 HD12 ' CA ' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -115.22 142.73 46.27 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.282 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.7 p -95.03 160.34 14.61 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.987 -179.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.9 -23.19 63.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.688 -0.632 . . . . 0.0 110.139 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -81.69 -31.06 32.37 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.16 -8.6 7.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -58.12 170.73 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.124 -1.221 . . . . 0.0 108.97 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.737 HD13 HD13 ' A' ' 43' ' ' ILE . 7.3 tt -143.87 113.74 7.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.123 -178.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.81 152.45 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 111' ' ' MET . 0.6 OUTLIER -135.01 132.78 38.71 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.46 -0.775 . . . . 0.0 109.557 -179.156 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.487 HG22 ' OG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -113.29 170.65 8.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.242 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 129' ' ' VAL . 34.4 mtp -150.01 165.04 33.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.418 -179.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 128' ' ' VAL . 6.7 m -146.9 152.22 38.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.674 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -157.94 96.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.561 179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 76.45 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -146.38 24.23 1.27 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.456 -0.778 . . . . 0.0 109.393 178.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 125' ' ' ALA . 24.4 m -119.59 -178.29 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.39 117.49 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.665 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.808 ' CB ' HD22 ' A' ' 18' ' ' LEU . 13.9 t -98.41 119.4 37.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.066 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.487 ' OG1' HG22 ' A' ' 122' ' ' THR . 92.0 m -115.5 149.79 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 110.075 -179.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -152.07 118.27 5.57 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.52 138.38 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.96 . . . . 0.0 108.446 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 24.4 m-85 -126.88 124.48 39.67 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.019 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.35 139.94 26.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.6 mtm180 -49.2 125.67 11.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.228 -0.92 . . . . 0.0 111.214 -178.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.628 179.573 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.503 2.03 0 N-CA-C 110.368 -0.666 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -165.87 124.76 1.61 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.736 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.58 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.18 -8.87 24.48 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.744 -0.598 . . . . 0.0 109.478 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.6 p -68.73 118.05 11.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.225 -0.922 . . . . 0.0 111.869 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.4 -174.41 38.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 179.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 9.2 m120 -95.45 172.24 8.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 43' ' ' ILE . 99.0 m95 -151.72 124.66 8.59 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.964 -1.094 . . . . 0.0 112.54 -176.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -116.8 117.77 30.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 12' ' ' SER . 13.9 tt -61.73 151.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.914 0.864 . . . . 0.0 111.082 -178.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.28 -31.37 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -141.72 172.1 13.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.768 ' HB2' HD11 ' A' ' 9' ' ' ILE . 14.1 t -179.7 145.68 0.24 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.456 -0.777 . . . . 0.0 109.443 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -142.19 163.11 33.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.0 109.992 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 32.2 m-20 62.87 32.8 15.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.607 -0.683 . . . . 0.0 109.754 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.955 ' CE1' HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -74.88 -64.11 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 110.139 -179.728 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 tt0 -57.22 -35.87 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.815 . . . . 0.0 110.919 -177.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -67.97 -29.7 68.79 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.179 -178.848 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 130' ' ' CYS . 23.2 tp -77.49 -22.28 51.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 32' ' ' ALA . 6.3 mt -89.95 -15.97 30.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.301 -0.875 . . . . 0.0 109.14 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -87.58 -31.4 19.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 22' ' ' LEU . 13.0 p -74.59 -39.03 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mp -69.2 -45.8 69.02 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.736 0.779 . . . . 0.0 109.492 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.88 -161.63 27.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 m -146.29 -35.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.891 -0.77 . . . . 0.0 110.463 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 4.6 t30 -62.21 -149.72 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 0.0 109.372 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.98 -47.32 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.7 -1.25 . . . . 0.0 109.323 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.484 ' HG2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttt -71.27 -26.89 63.08 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.2 mm? -58.73 -18.8 34.57 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.74 -0.6 . . . . 0.0 111.054 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.763 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.9 mpt_? -96.19 -47.9 5.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.116 -0.99 . . . . 0.0 109.754 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -21.32 65.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.662 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.484 HD11 ' HG2' ' A' ' 27' ' ' MET . 58.9 mt -78.21 -29.09 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -0.904 . . . . 0.0 108.728 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.973 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 29' ' ' ARG . 14.4 t -76.56 -37.63 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -31.73 45.98 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.49 -39.18 91.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.46 -69.93 0.18 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 p 48.33 50.79 16.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 121.467 0.651 . . . . 0.0 109.662 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt 64.63 72.3 0.51 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.54 ' HB3' HG22 ' A' ' 56' ' ' THR . 30.1 Cg_endo -73.06 159.32 47.98 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 122.059 1.84 . . . . 0.0 110.714 -179.293 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -103.88 174.34 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.561 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 54' ' ' THR . 53.7 t -155.58 164.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' N ' HG12 ' A' ' 41' ' ' VAL . 55.0 tt0 -151.23 110.53 3.95 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 52' ' ' ILE . 2.2 mp -98.62 140.14 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.753 0.787 . . . . 0.0 110.376 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -118.18 111.09 18.38 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.478 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 50' ' ' PHE . 65.6 tt0 -98.25 120.62 38.98 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.068 -1.02 . . . . 0.0 111.091 -177.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.03 54.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.89 -127.55 8.89 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.211 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -76.36 -0.85 24.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.403 -1.057 . . . . 0.0 110.079 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.2 m -97.02 138.74 34.09 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.753 -1.217 . . . . 0.0 108.489 -179.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 98.1 m-85 -133.98 118.02 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 0.0 109.446 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 64' ' ' ASN . 11.7 t80 -102.98 147.97 26.27 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.337 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.069 HD12 HD11 ' A' ' 63' ' ' ILE . 1.8 mt -144.57 103.97 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.884 -1.135 . . . . 0.0 111.585 -177.488 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 113.02 25.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 178.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 41' ' ' VAL . 57.1 m -104.44 141.83 35.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.96 144.33 41.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.323 -0.86 . . . . 0.0 110.059 -179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 39' ' ' PRO . 0.6 OUTLIER -115.8 -65.95 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.934 0.873 . . . . 0.0 109.291 -179.878 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 58' ' ' VAL . 2.8 t 178.92 -41.76 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG23 HG23 ' A' ' 57' ' ' THR . 45.3 t -113.89 -11.28 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -124.62 164.64 19.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.277 -0.889 . . . . 0.0 108.939 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m -162.44 95.97 0.94 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.599 -0.688 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.59 164.97 23.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.787 . . . . 0.0 109.585 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -165.41 119.41 1.23 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.069 HD11 HD12 ' A' ' 52' ' ' ILE . 32.6 pt -123.44 168.61 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 109.341 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 1.1 p30 -162.26 129.23 3.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.186 -0.946 . . . . 0.0 108.937 179.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 85' ' ' VAL . 45.3 p90 -162.03 -172.44 3.25 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.394 -179.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -129.56 153.33 48.15 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -82.64 90.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.121 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.41 -24.68 1.09 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.795 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.88 156.89 33.72 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.266 -1.137 . . . . 0.0 110.287 -179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG2' HD22 ' A' ' 84' ' ' LEU . 49.2 mt-10 -86.3 167.47 14.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.705 -0.622 . . . . 0.0 109.489 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.484 ' CE1' ' CB ' ' A' ' 65' ' ' PHE . 15.2 p90 -162.41 175.81 11.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.698 -0.626 . . . . 0.0 109.49 -178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.39 145.81 29.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.721 ' HB2' HG22 ' A' ' 63' ' ' ILE . 2.8 pt-20 -162.26 -175.81 4.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.69 -0.631 . . . . 0.0 109.375 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -100.19 158.3 15.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 79' ' ' ARG . 6.3 t -97.96 -144.34 0.31 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.396 -0.815 . . . . 0.0 109.326 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.581 ' N ' HG23 ' A' ' 75' ' ' THR . 24.5 t -109.93 -24.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.86 -1.15 . . . . 0.0 110.841 -179.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' H ' HG23 ' A' ' 75' ' ' THR . 1.4 p30 -84.5 -40.74 17.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.75 45.41 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 mmm180 -135.4 154.66 78.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.731 -0.864 . . . . 0.0 108.971 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.716 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.2 Cg_endo -78.89 144.29 18.98 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.703 1.602 . . . . 0.0 110.703 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 p -160.86 141.81 11.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.718 -0.614 . . . . 0.0 109.549 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -87.05 116.75 25.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.825 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 3.7 t -99.48 166.45 11.16 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.261 0.553 . . . . 0.0 109.984 -178.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 70' ' ' GLU . 46.8 tp -146.25 154.51 41.81 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' CE2' ' A' ' 65' ' ' PHE . 25.4 t -146.24 131.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.319 -178.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 67' ' ' VAL . 3.5 pttt -125.57 160.55 29.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CD1' HG11 ' A' ' 67' ' ' VAL . 85.8 m95 -83.65 171.76 12.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.193 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 10.9 tp10 -134.87 -46.16 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -131.9 -153.89 0.58 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.66 -24.58 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 109.745 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -143.65 26.45 1.58 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 110.788 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 14.0 tttt -131.44 110.48 11.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.902 -1.124 . . . . 0.0 108.085 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' HG11 ' A' ' 85' ' ' VAL . 1.1 ptp -116.13 148.29 40.46 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.297 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.649 HG13 HG22 ' A' ' 110' ' ' THR . 3.1 t -100.88 170.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.479 ' H ' HG12 ' A' ' 94' ' ' VAL . 49.9 t -146.36 142.46 28.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -109.77 163.47 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -160.36 135.34 7.79 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.528 -178.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -143.1 148.94 37.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.59 166.37 2.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.052 -1.03 . . . . 0.0 110.94 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.716 HD12 ' HB2' ' A' ' 80' ' ' PRO . 36.5 mt -98.45 -5.99 31.33 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -150.91 133.87 15.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.72 -161.21 36.26 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.348 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.95 140.79 0.44 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.43 -1.041 . . . . 0.0 109.874 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.04 -86.98 0.06 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.25 -176.71 2.93 Favored 'Trans proline' 0 C--N 1.322 -0.826 0 C-N-CA 121.712 1.608 . . . . 0.0 109.536 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -129.94 137.65 50.46 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.95 145.04 48.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.118 0.961 . . . . 0.0 110.608 -179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -163.13 143.44 9.14 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.419 ' CE2' ' SG ' ' A' ' 95' ' ' CYS . 54.3 p-90 -144.05 173.47 11.7 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.649 HG22 HG13 ' A' ' 94' ' ' VAL . 15.2 p -139.51 170.33 16.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.438 ' HB3' HD12 ' A' ' 121' ' ' LEU . 9.6 ptp -154.56 137.1 15.09 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -131.11 151.37 51.51 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.371 -0.831 . . . . 0.0 109.468 -179.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -114.7 142.09 46.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.2 p -90.63 161.47 15.39 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.36 -22.1 62.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.656 -0.653 . . . . 0.0 110.182 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.9 -28.69 25.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.07 -9.24 7.51 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.699 ' OE1' HG22 ' A' ' 135' ' ' VAL . 67.8 mm-40 -57.02 172.99 0.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.079 -1.248 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -146.1 112.47 5.85 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.923 -178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -105.06 158.43 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD21 ' SD ' ' A' ' 123' ' ' MET . 0.7 OUTLIER -142.41 134.02 26.69 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.236 -0.915 . . . . 0.0 109.712 -178.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.38 166.91 10.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 121' ' ' LEU . 75.2 mmm -141.27 165.86 26.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 108.992 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.1 m -151.72 149.78 29.47 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.446 0.641 . . . . 0.0 109.338 178.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -156.77 94.58 1.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.9 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -147.67 24.14 1.1 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.533 -0.73 . . . . 0.0 109.137 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' VAL . 18.9 m -117.38 -179.9 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.084 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.68 119.31 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.9 ' HB2' HD22 ' A' ' 18' ' ' LEU . 1.8 t -99.44 114.15 26.93 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.067 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.0 m -104.08 149.51 25.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.16 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.498 ' HD2' HD12 ' A' ' 9' ' ' ILE . 18.9 mtm180 -153.21 120.13 5.73 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.6 137.07 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 26.0 m-85 -126.0 125.36 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.082 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.699 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -107.54 137.08 40.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.426 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.48 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.2 127.98 15.72 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.011 0.91 . . . . 0.0 111.716 -178.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 6.8 tm-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.725 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.502 1.983 0 N-CA-C 110.396 -0.655 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -168.11 124.89 1.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.525 -0.734 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.795 ' HB3' HG21 ' A' ' 43' ' ' ILE . 5.0 m-85 -99.01 -13.47 19.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.25 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.6 p -63.21 117.67 6.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.359 -0.838 . . . . 0.0 112.033 -177.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.57 -175.06 38.17 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 7' ' ' TRP . 9.0 m120 -95.5 172.2 8.22 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 177.592 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.854 ' CD1' HD12 ' A' ' 43' ' ' ILE . 98.9 m95 -150.7 120.4 7.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.753 -176.404 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -109.08 117.15 33.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.682 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 12' ' ' SER . 7.2 tt -60.4 154.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.921 0.867 . . . . 0.0 111.072 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 11' ' ' ARG . 2.4 pp -126.79 -32.3 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.207 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.754 ' HB2' HD12 ' A' ' 10' ' ' ILE . 10.8 ttp85 -149.49 169.25 21.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.108 179.686 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.627 ' HB3' HD11 ' A' ' 9' ' ' ILE . 94.7 p -177.46 139.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.528 -0.733 . . . . 0.0 109.301 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.66 174.83 10.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.622 -0.674 . . . . 0.0 109.868 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 130' ' ' CYS . 69.4 m-20 59.17 25.43 13.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -0.788 . . . . 0.0 110.066 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.657 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -64.8 -64.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 108.718 179.582 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 4.5 pt-20 -56.78 -28.06 60.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 0.0 109.509 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -65.14 -39.88 93.64 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.052 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 130' ' ' CYS . 37.2 tp -80.91 -14.33 58.09 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.748 -0.595 . . . . 0.0 109.821 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' ' HB3' ' A' ' 32' ' ' ALA . 1.3 mt -91.41 -20.16 22.09 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.063 -1.023 . . . . 0.0 109.173 178.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 4.0 mmmt -83.65 -28.62 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.172 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 HD12 ' A' ' 18' ' ' LEU . 14.7 p -78.81 -41.48 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.456 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.471 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.6 mp -66.18 -53.54 36.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.198 0.999 . . . . 0.0 108.908 179.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 24' ' ' VAL . . . -102.64 -145.5 15.87 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 23' ' ' GLY . 20.9 m -155.35 -39.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.914 -0.757 . . . . 0.0 110.234 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.6 t30 -57.93 -171.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.262 -0.899 . . . . 0.0 109.724 -179.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.481 HG12 ' NH1' ' A' ' 29' ' ' ARG . 15.6 m -121.43 -43.44 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.593 -0.692 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.416 ' N ' HG23 ' A' ' 26' ' ' VAL . 6.7 ttt -68.23 -28.15 66.98 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.682 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 31' ' ' ILE . 2.4 mm? -58.77 -52.04 67.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.758 -0.589 . . . . 0.0 110.553 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.893 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 mpp_? -60.35 -39.51 87.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.506 -0.746 . . . . 0.0 110.262 -178.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -60.33 -29.24 68.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.663 . . . . 0.0 110.667 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 28' ' ' LEU . 12.8 mt -77.54 -27.76 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.115 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.752 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -82.21 -22.54 35.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.2 t -81.01 -42.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.657 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.22 81.79 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.34 -49.79 75.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.61 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . . . -84.49 48.63 1.54 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.783 -0.573 . . . . 0.0 110.6 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 t -63.33 -33.1 74.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.777 -1.202 . . . . 0.0 108.55 179.441 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.97 72.12 2.01 Favored Pre-proline 0 N--CA 1.487 1.386 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.863 ' HB3' HG22 ' A' ' 56' ' ' THR . 33.5 Cg_endo -74.01 141.05 29.25 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.909 1.739 . . . . 0.0 111.085 -178.32 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 41' ' ' VAL . . . -96.96 177.07 5.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 54' ' ' THR . 50.4 t -155.74 165.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 41' ' ' VAL . 42.9 tt0 -151.62 110.18 3.8 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.854 HD12 ' CD1' ' A' ' 7' ' ' TRP . 2.4 mp -97.93 138.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.849 0.833 . . . . 0.0 110.124 -178.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CG ' ' A' ' 51' ' ' TYR . 12.7 mttt -116.56 108.93 16.58 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 50' ' ' PHE . 64.1 tt0 -98.56 114.72 27.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -178.483 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -120.45 60.64 0.88 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.71 -127.93 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.02 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 67' ' ' VAL . 6.9 p30 -78.56 0.74 25.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -1.085 . . . . 0.0 110.014 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.4 m -97.05 142.11 29.39 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 120.713 -1.242 . . . . 0.0 108.778 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . 96.9 m-85 -138.45 120.1 15.13 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.808 0.813 . . . . 0.0 109.288 179.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.417 ' CG ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 t80 -102.9 139.91 37.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.447 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.865 HG13 HD11 ' A' ' 63' ' ' ILE . 1.3 mm -123.34 116.97 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.022 -1.048 . . . . 0.0 109.292 -179.518 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 62' ' ' GLU . 9.7 tttt -115.08 101.08 8.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.523 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.69 HG23 HG22 ' A' ' 41' ' ' VAL . 16.5 m -100.0 144.89 28.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.207 -0.933 . . . . 0.0 109.056 179.5 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER -145.16 125.94 14.32 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.429 -0.794 . . . . 0.0 110.028 -179.721 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 39' ' ' PRO . 21.8 p -98.55 -121.97 0.14 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.9 p -108.77 -36.85 6.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.526 -1.359 . . . . 0.0 108.326 179.397 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 58' ' ' VAL . 23.4 t -125.11 -5.23 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.916 -0.49 . . . . 0.0 110.692 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -115.84 165.38 13.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 0.0 110.118 -179.177 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.773 HG22 ' OE2' ' A' ' 62' ' ' GLU . 12.3 m -163.51 105.3 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.654 -0.654 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -95.88 156.14 16.46 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.397 -0.815 . . . . 0.0 109.322 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.773 ' OE2' HG22 ' A' ' 60' ' ' THR . 1.1 mp0 -151.03 137.58 18.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.594 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.865 HD11 HG13 ' A' ' 52' ' ' ILE . 24.4 pt -142.85 169.5 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.557 -0.715 . . . . 0.0 109.519 179.39 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -162.6 135.95 6.01 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.46 -0.775 . . . . 0.0 108.945 179.325 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.706 ' CE2' HG21 ' A' ' 85' ' ' VAL . 52.5 p90 -161.85 -173.45 3.71 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.93 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.43 152.87 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -82.68 92.2 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -178.881 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.91 -29.8 1.25 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.841 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -116.33 155.84 27.73 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.308 -1.113 . . . . 0.0 110.26 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG2' HD22 ' A' ' 84' ' ' LEU . 37.1 mt-10 -85.72 167.35 15.35 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 65' ' ' PHE . 17.1 p90 -162.84 174.74 12.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.894 -178.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -104.38 144.89 31.03 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -162.1 -177.27 5.64 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.42 156.21 17.14 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.011 179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 79' ' ' ARG . 7.1 t -93.53 -142.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.366 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' N ' HG23 ' A' ' 75' ' ' THR . 24.0 t -108.64 -23.23 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.751 -1.218 . . . . 0.0 110.875 -179.039 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.583 ' H ' HG23 ' A' ' 75' ' ' THR . 1.5 p30 -87.38 -40.86 14.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.397 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.35 44.53 0.1 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.715 ' H ' HG22 ' A' ' 75' ' ' THR . 13.5 mtp180 -130.72 152.11 79.93 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.676 -0.896 . . . . 0.0 109.146 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HB2' HD12 ' A' ' 100' ' ' LEU . 35.1 Cg_endo -78.09 142.24 19.3 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.643 1.562 . . . . 0.0 110.413 -179.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.0 p -160.91 141.47 11.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.672 -0.643 . . . . 0.0 109.782 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.603 ' HB2' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -90.56 114.05 26.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.5 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 1.2 t -101.78 177.22 4.97 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.88 -178.756 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' HG2' ' A' ' 70' ' ' GLU . 59.3 tp -151.83 152.92 33.26 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.29 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 65' ' ' PHE . 9.1 t -140.36 131.99 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.843 -177.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 pttt -126.83 159.89 32.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 177.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.671 ' CD1' HG11 ' A' ' 67' ' ' VAL . 86.5 m95 -83.8 170.13 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.025 -179.602 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 92' ' ' LYS . 2.4 tp10 -132.99 -45.7 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.092 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.7 p -133.19 -153.94 0.58 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -77.6 -24.87 49.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 109.792 179.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -143.03 26.74 1.66 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 110.693 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 88' ' ' GLU . 60.7 tttt -131.21 107.96 9.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.943 -1.098 . . . . 0.0 108.113 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.509 ' HE3' ' CH2' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -115.61 147.29 40.95 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.501 -0.749 . . . . 0.0 110.175 -179.141 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 110' ' ' THR . 2.6 t -102.55 172.16 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.487 ' H ' HG12 ' A' ' 94' ' ' VAL . 44.0 t -149.38 130.5 14.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.789 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 84' ' ' LEU . 6.0 pt-20 -101.35 163.62 12.18 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 83' ' ' SER . 8.4 tt0 -160.18 143.25 13.65 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.962 -178.222 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -147.37 150.74 35.28 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.83 167.1 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.861 -179.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 80' ' ' PRO . 32.1 mt -97.5 -7.61 31.08 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 134.26 18.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.8 -158.39 44.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.414 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -176.35 141.37 0.41 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.501 -1.0 . . . . 0.0 109.808 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.65 -86.23 0.05 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.26 -176.87 2.99 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.841 1.694 . . . . 0.0 109.911 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -132.46 135.04 45.78 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.56 145.49 47.92 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.068 0.937 . . . . 0.0 110.774 -179.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.3 p -163.14 134.27 4.82 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -135.6 169.29 17.75 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.086 -1.009 . . . . 0.0 110.202 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.842 HG22 HG13 ' A' ' 94' ' ' VAL . 17.6 p -134.95 171.4 14.46 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.429 0.633 . . . . 0.0 109.791 -179.566 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.436 ' HG3' ' HG3' ' A' ' 93' ' ' MET . 2.1 ptp -154.46 130.82 10.47 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -123.57 154.04 39.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.246 -178.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -119.47 141.71 48.91 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.032 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.5 p -93.77 160.55 14.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.682 -179.477 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -60.74 -21.48 63.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.661 -0.649 . . . . 0.0 110.104 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.22 -29.33 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.16 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.36 -9.18 7.39 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 170.32 0.4 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.065 -1.256 . . . . 0.0 108.944 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.836 HD13 HD13 ' A' ' 43' ' ' ILE . 7.6 tt -146.75 112.54 5.69 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.228 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.9 tt -104.45 160.3 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.69 132.63 27.67 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.359 -0.838 . . . . 0.0 109.5 -179.331 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.75 170.8 7.99 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.362 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 27.9 mtp -148.4 166.0 29.42 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.353 -179.333 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 5.7 m -150.11 151.96 34.0 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.44 0.638 . . . . 0.0 109.369 179.212 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 128' ' ' VAL . . . -158.85 96.08 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.501 179.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 77.13 -79.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -147.37 24.03 1.14 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.495 -0.753 . . . . 0.0 109.22 178.516 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 125' ' ' ALA . 20.7 m -117.87 -179.07 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 128' ' ' VAL . 2.3 t -157.81 118.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.628 179.491 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.704 ' HB2' HD22 ' A' ' 18' ' ' LEU . 2.0 t -97.36 121.32 39.13 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -116.72 148.17 41.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.007 0.908 . . . . 0.0 110.283 -178.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -153.1 121.82 6.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.95 139.19 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.087 -1.008 . . . . 0.0 108.697 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.435 ' CE1' ' HB ' ' A' ' 9' ' ' ILE . 21.7 m-85 -127.65 133.38 49.65 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.232 -179.756 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.15 138.32 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' N ' ' CZ3' ' A' ' 7' ' ' TRP . 1.1 mtm180 -49.24 128.25 16.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.204 -0.935 . . . . 0.0 111.644 -178.482 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.656 179.704 . . . . . . . . 2 2 . 1 stop_ save_